BioInfer.d0.s0.p0	P	PROTEIN2 inhibits PROTEIN signaling by preventing formation of a PROTEIN * PROTEIN1 *DNA complex.
BioInfer.d0.s0.p1	P	PROTEIN inhibits PROTEIN2 signaling by preventing formation of a PROTEIN * PROTEIN1 *DNA complex.
BioInfer.d0.s0.p2	P	PROTEIN inhibits PROTEIN signaling by preventing formation of a PROTEIN2 * PROTEIN1 *DNA complex.
BioInfer.d0.s0.p3	P	PROTEIN1 inhibits PROTEIN2 signaling by preventing formation of a PROTEIN * PROTEIN *DNA complex.
BioInfer.d0.s0.p4	P	PROTEIN1 inhibits PROTEIN signaling by preventing formation of a PROTEIN2 * PROTEIN *DNA complex.
BioInfer.d0.s0.p5	P	PROTEIN inhibits PROTEIN1 signaling by preventing formation of a PROTEIN2 * PROTEIN *DNA complex.
BioInfer.d1.s0.p0	P	A binary complex of birch PROTEIN1 and PROTEIN2 could be isolated by gel chromatography.
BioInfer.d1.s1.p0	P	Birch PROTEIN2 increased the critical concentration required for PROTEIN and PROTEIN1 polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal PROTEIN .
BioInfer.d1.s1.p1	N	Birch PROTEIN increased the critical concentration required for PROTEIN2 and PROTEIN1 polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal PROTEIN .
BioInfer.d1.s1.p2	N	Birch PROTEIN increased the critical concentration required for PROTEIN and PROTEIN1 polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal PROTEIN2 .
BioInfer.d1.s1.p3	P	Birch PROTEIN1 increased the critical concentration required for PROTEIN2 and PROTEIN polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal PROTEIN .
BioInfer.d1.s1.p4	P	Birch PROTEIN1 increased the critical concentration required for PROTEIN and PROTEIN polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal PROTEIN2 .
BioInfer.d1.s1.p5	N	Birch PROTEIN increased the critical concentration required for PROTEIN1 and PROTEIN polymerization in a concentration-dependent manner, supporting the notion of the formation of a heterologous complex between the plant protein and animal PROTEIN2 .
BioInfer.d1.s2.p0	P	Interaction of plant PROTEIN1 with mammalian PROTEIN2 .
BioInfer.d1.s3.p0	P	In viscometric assays, the birch protein was seen to modulate PROTEIN1 filament formation analogous to animal PROTEIN2 .
BioInfer.d1.s4.p0	P	These data indicate that the PROTEIN2 -binding domains in plant and animal PROTEIN1 are functionally highly conserved, although the overall sequence similarity is less than 25%.
BioInfer.d2.s0.p0	N	Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for PROTEIN , in 35 (66.0%) for PROTEIN1 , in 20 (37.7%) for PROTEIN , and in 37 (69.8%) for PROTEIN2 .
BioInfer.d2.s0.p1	N	Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for PROTEIN2 , in 35 (66.0%) for PROTEIN1 , in 20 (37.7%) for PROTEIN , and in 37 (69.8%) for PROTEIN .
BioInfer.d2.s0.p2	N	Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for PROTEIN , in 35 (66.0%) for PROTEIN1 , in 20 (37.7%) for PROTEIN2 , and in 37 (69.8%) for PROTEIN .
BioInfer.d2.s0.p3	N	Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for PROTEIN2 , in 35 (66.0%) for PROTEIN , in 20 (37.7%) for PROTEIN , and in 37 (69.8%) for PROTEIN1 .
BioInfer.d2.s0.p4	N	Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for PROTEIN , in 35 (66.0%) for PROTEIN , in 20 (37.7%) for PROTEIN2 , and in 37 (69.8%) for PROTEIN1 .
BioInfer.d2.s0.p5	N	Abnormal immunoreactivity in the tumor tissue was observed in 18 patients (34.0%) for PROTEIN1 , in 35 (66.0%) for PROTEIN , in 20 (37.7%) for PROTEIN2 , and in 37 (69.8%) for PROTEIN .
BioInfer.d3.s0.p0	P	Absence of PROTEIN2 leads to structurally aberrant neuromuscular synapses deficient in PROTEIN1 .
BioInfer.d3.s1.p0	N	Thus, PROTEIN has an important role in synapse formation and in the organization of PROTEIN , PROTEIN1 , and PROTEIN2 at the neuromuscular synapse.
BioInfer.d3.s1.p1	N	Thus, PROTEIN has an important role in synapse formation and in the organization of PROTEIN2 , PROTEIN1 , and PROTEIN at the neuromuscular synapse.
BioInfer.d3.s1.p2	P	Thus, PROTEIN2 has an important role in synapse formation and in the organization of PROTEIN , PROTEIN1 , and PROTEIN at the neuromuscular synapse.
BioInfer.d3.s1.p3	N	Thus, PROTEIN has an important role in synapse formation and in the organization of PROTEIN2 , PROTEIN , and PROTEIN1 at the neuromuscular synapse.
BioInfer.d3.s1.p4	P	Thus, PROTEIN2 has an important role in synapse formation and in the organization of PROTEIN , PROTEIN , and PROTEIN1 at the neuromuscular synapse.
BioInfer.d3.s1.p5	P	Thus, PROTEIN2 has an important role in synapse formation and in the organization of PROTEIN1 , PROTEIN , and PROTEIN at the neuromuscular synapse.
BioInfer.d4.s0.p0	P	Abundance of PROTEIN , PROTEIN , PROTEIN and PROTEIN , PROTEIN  PROTEIN , and PROTEIN1 is not affected by the differential PROTEIN2 expression.
BioInfer.d4.s0.p1	N	Abundance of PROTEIN2 , PROTEIN , PROTEIN and PROTEIN , PROTEIN  PROTEIN , and PROTEIN1 is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p2	N	Abundance of PROTEIN , PROTEIN , PROTEIN2 and PROTEIN , PROTEIN  PROTEIN , and PROTEIN1 is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p3	N	Abundance of PROTEIN , PROTEIN , PROTEIN and PROTEIN , PROTEIN2  PROTEIN , and PROTEIN1 is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p4	N	Abundance of PROTEIN , PROTEIN , PROTEIN and PROTEIN2 , PROTEIN  PROTEIN , and PROTEIN1 is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p5	N	Abundance of PROTEIN , PROTEIN2 , PROTEIN and PROTEIN , PROTEIN  PROTEIN , and PROTEIN1 is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p6	N	Abundance of PROTEIN , PROTEIN , PROTEIN and PROTEIN , PROTEIN  PROTEIN2 , and PROTEIN1 is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p7	P	Abundance of PROTEIN2 , PROTEIN , PROTEIN and PROTEIN , PROTEIN  PROTEIN , and PROTEIN is not affected by the differential PROTEIN1 expression.
BioInfer.d4.s0.p8	P	Abundance of PROTEIN , PROTEIN , PROTEIN2 and PROTEIN , PROTEIN  PROTEIN , and PROTEIN is not affected by the differential PROTEIN1 expression.
BioInfer.d4.s0.p9	P	Abundance of PROTEIN , PROTEIN , PROTEIN and PROTEIN , PROTEIN2  PROTEIN , and PROTEIN is not affected by the differential PROTEIN1 expression.
BioInfer.d4.s0.p10	P	Abundance of PROTEIN , PROTEIN , PROTEIN and PROTEIN2 , PROTEIN  PROTEIN , and PROTEIN is not affected by the differential PROTEIN1 expression.
BioInfer.d4.s0.p11	P	Abundance of PROTEIN , PROTEIN2 , PROTEIN and PROTEIN , PROTEIN  PROTEIN , and PROTEIN is not affected by the differential PROTEIN1 expression.
BioInfer.d4.s0.p12	N	Abundance of PROTEIN , PROTEIN , PROTEIN and PROTEIN , PROTEIN  PROTEIN2 , and PROTEIN is not affected by the differential PROTEIN1 expression.
BioInfer.d4.s0.p13	N	Abundance of PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN , PROTEIN  PROTEIN , and PROTEIN is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p14	N	Abundance of PROTEIN1 , PROTEIN , PROTEIN and PROTEIN , PROTEIN2  PROTEIN , and PROTEIN is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p15	N	Abundance of PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 , PROTEIN  PROTEIN , and PROTEIN is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p16	N	Abundance of PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN , PROTEIN  PROTEIN , and PROTEIN is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p17	N	Abundance of PROTEIN1 , PROTEIN , PROTEIN and PROTEIN , PROTEIN  PROTEIN2 , and PROTEIN is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p18	N	Abundance of PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , PROTEIN2  PROTEIN , and PROTEIN is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p19	N	Abundance of PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 , PROTEIN  PROTEIN , and PROTEIN is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p20	N	Abundance of PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN , PROTEIN  PROTEIN , and PROTEIN is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p21	N	Abundance of PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , PROTEIN  PROTEIN2 , and PROTEIN is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p22	N	Abundance of PROTEIN , PROTEIN , PROTEIN and PROTEIN2 , PROTEIN1  PROTEIN , and PROTEIN is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p23	N	Abundance of PROTEIN , PROTEIN2 , PROTEIN and PROTEIN , PROTEIN1  PROTEIN , and PROTEIN is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p24	P	Abundance of PROTEIN , PROTEIN , PROTEIN and PROTEIN , PROTEIN1  PROTEIN2 , and PROTEIN is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p25	N	Abundance of PROTEIN , PROTEIN2 , PROTEIN and PROTEIN1 , PROTEIN  PROTEIN , and PROTEIN is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p26	N	Abundance of PROTEIN , PROTEIN , PROTEIN and PROTEIN1 , PROTEIN  PROTEIN2 , and PROTEIN is not affected by the differential PROTEIN expression.
BioInfer.d4.s0.p27	N	Abundance of PROTEIN , PROTEIN1 , PROTEIN and PROTEIN , PROTEIN  PROTEIN2 , and PROTEIN is not affected by the differential PROTEIN expression.
BioInfer.d5.s0.p0	P	Acanthamoeba PROTEIN1 and PROTEIN2 can be cross-linked between glutamic acid 364 of PROTEIN and lysine 115 of PROTEIN .
BioInfer.d5.s0.p1	N	Acanthamoeba PROTEIN1 and PROTEIN can be cross-linked between glutamic acid 364 of PROTEIN2 and lysine 115 of PROTEIN .
BioInfer.d5.s0.p2	N	Acanthamoeba PROTEIN1 and PROTEIN can be cross-linked between glutamic acid 364 of PROTEIN and lysine 115 of PROTEIN2 .
BioInfer.d5.s0.p3	N	Acanthamoeba PROTEIN and PROTEIN1 can be cross-linked between glutamic acid 364 of PROTEIN2 and lysine 115 of PROTEIN .
BioInfer.d5.s0.p4	N	Acanthamoeba PROTEIN and PROTEIN1 can be cross-linked between glutamic acid 364 of PROTEIN and lysine 115 of PROTEIN2 .
BioInfer.d5.s0.p5	P	Acanthamoeba PROTEIN and PROTEIN can be cross-linked between glutamic acid 364 of PROTEIN1 and lysine 115 of PROTEIN2 .
BioInfer.d5.s1.p0	P	Acanthamoeba PROTEIN1 was cross-linked to PROTEIN2 via a zero-length isopeptide bond using carbodiimide.
BioInfer.d5.s2.p0	N	Since the NH2 terminus of PROTEIN1 is blocked, Edman degradation gave only the sequence of the conjugated PROTEIN2 CNBr fragment beginning with Trp-356.
BioInfer.d6.s0.p0	P	Acanthamoeba PROTEIN2 affects the mechanical properties of nonfilamentous PROTEIN1 .
BioInfer.d6.s1.p0	P	In contrast, PROTEIN1 had little effect on the rigidity and viscosity of PROTEIN2 filaments.
BioInfer.d6.s2.p0	N	We speculate that nonfilamentous PROTEIN2 and PROTEIN1 , both of which form shear-sensitive structures, can be modeled as flocculant materials.
BioInfer.d7.s0.p0	N	Acanthamoeba PROTEIN has similar but weaker effects on PROTEIN2 , requiring 5 to 10 times more PROTEIN1 than with amoeba PROTEIN .
BioInfer.d7.s0.p1	N	Acanthamoeba PROTEIN has similar but weaker effects on PROTEIN , requiring 5 to 10 times more PROTEIN1 than with amoeba PROTEIN2 .
BioInfer.d7.s0.p2	N	Acanthamoeba PROTEIN2 has similar but weaker effects on PROTEIN , requiring 5 to 10 times more PROTEIN1 than with amoeba PROTEIN .
BioInfer.d7.s0.p3	N	Acanthamoeba PROTEIN has similar but weaker effects on PROTEIN1 , requiring 5 to 10 times more PROTEIN than with amoeba PROTEIN2 .
BioInfer.d7.s0.p4	P	Acanthamoeba PROTEIN2 has similar but weaker effects on PROTEIN1 , requiring 5 to 10 times more PROTEIN than with amoeba PROTEIN .
BioInfer.d7.s0.p5	N	Acanthamoeba PROTEIN2 has similar but weaker effects on PROTEIN , requiring 5 to 10 times more PROTEIN than with amoeba PROTEIN1 .
BioInfer.d7.s1.p0	P	Acanthamoeba PROTEIN2 strongly inhibits in a concentration-dependent fashion the rate and extent of Acanthamoeba PROTEIN1 polymerization in 50 mM KCl.
BioInfer.d7.s2.p0	P	Addition of PROTEIN1 to polymerized PROTEIN2 causes it to depolymerize until a new steady-state, dependent on PROTEIN concentration, is achieved.
BioInfer.d7.s2.p1	N	Addition of PROTEIN1 to polymerized PROTEIN causes it to depolymerize until a new steady-state, dependent on PROTEIN2 concentration, is achieved.
BioInfer.d7.s2.p2	N	Addition of PROTEIN to polymerized PROTEIN1 causes it to depolymerize until a new steady-state, dependent on PROTEIN2 concentration, is achieved.
BioInfer.d7.s3.p0	N	Mechanism of action of Acanthamoeba PROTEIN1 : demonstration of PROTEIN2 species specificity and regulation by micromolar concentrations of MgCl2.
BioInfer.d7.s4.p0	P	MgCl2 strongly inhibits these effects of PROTEIN2 , most likely by binding to the high-affinity divalent cation site on the PROTEIN1 .
BioInfer.d8.s0.p0	N	Accordingly, PROTEIN2 is also found in these structures, again in the absence of PROTEIN1 .
BioInfer.d8.s1.p0	P	In addition to its presence in cell-cell adhesion sites, we have found PROTEIN1 , but not PROTEIN2 , in the Z-discs of heart and skeletal striated muscles.
BioInfer.d9.s0.p0	N	A chimera consisting of the PROTEIN -binding region of PROTEIN1 linked to the amino terminus of PROTEIN behaves as a monomer in solution, as expected, since PROTEIN2 binding disrupts the PROTEIN dimer.
BioInfer.d9.s0.p1	P	A chimera consisting of the PROTEIN -binding region of PROTEIN1 linked to the amino terminus of PROTEIN2 behaves as a monomer in solution, as expected, since PROTEIN binding disrupts the PROTEIN dimer.
BioInfer.d9.s0.p2	N	A chimera consisting of the PROTEIN -binding region of PROTEIN1 linked to the amino terminus of PROTEIN behaves as a monomer in solution, as expected, since PROTEIN binding disrupts the PROTEIN2 dimer.
BioInfer.d9.s0.p3	P	A chimera consisting of the PROTEIN2 -binding region of PROTEIN1 linked to the amino terminus of PROTEIN behaves as a monomer in solution, as expected, since PROTEIN binding disrupts the PROTEIN dimer.
BioInfer.d9.s0.p4	N	A chimera consisting of the PROTEIN -binding region of PROTEIN linked to the amino terminus of PROTEIN2 behaves as a monomer in solution, as expected, since PROTEIN1 binding disrupts the PROTEIN dimer.
BioInfer.d9.s0.p5	P	A chimera consisting of the PROTEIN -binding region of PROTEIN linked to the amino terminus of PROTEIN behaves as a monomer in solution, as expected, since PROTEIN1 binding disrupts the PROTEIN2 dimer.
BioInfer.d9.s0.p6	N	A chimera consisting of the PROTEIN2 -binding region of PROTEIN linked to the amino terminus of PROTEIN behaves as a monomer in solution, as expected, since PROTEIN1 binding disrupts the PROTEIN dimer.
BioInfer.d9.s0.p7	N	A chimera consisting of the PROTEIN -binding region of PROTEIN linked to the amino terminus of PROTEIN1 behaves as a monomer in solution, as expected, since PROTEIN binding disrupts the PROTEIN2 dimer.
BioInfer.d9.s0.p8	N	A chimera consisting of the PROTEIN2 -binding region of PROTEIN linked to the amino terminus of PROTEIN1 behaves as a monomer in solution, as expected, since PROTEIN binding disrupts the PROTEIN dimer.
BioInfer.d9.s0.p9	N	A chimera consisting of the PROTEIN2 -binding region of PROTEIN linked to the amino terminus of PROTEIN behaves as a monomer in solution, as expected, since PROTEIN binding disrupts the PROTEIN1 dimer.
BioInfer.d10.s0.p0	P	Acidic domain of the PROTEIN2 ( PROTEIN ) of vesicular stomatitis virus differentially interacts with homologous and heterologous PROTEIN1 ( PROTEIN ).
BioInfer.d10.s0.p1	P	Acidic domain of the PROTEIN ( PROTEIN2 ) of vesicular stomatitis virus differentially interacts with homologous and heterologous PROTEIN1 ( PROTEIN ).
BioInfer.d10.s0.p2	N	Acidic domain of the PROTEIN ( PROTEIN ) of vesicular stomatitis virus differentially interacts with homologous and heterologous PROTEIN1 ( PROTEIN2 ).
BioInfer.d10.s0.p3	N	Acidic domain of the PROTEIN1 ( PROTEIN2 ) of vesicular stomatitis virus differentially interacts with homologous and heterologous PROTEIN ( PROTEIN ).
BioInfer.d10.s0.p4	P	Acidic domain of the PROTEIN1 ( PROTEIN ) of vesicular stomatitis virus differentially interacts with homologous and heterologous PROTEIN ( PROTEIN2 ).
BioInfer.d10.s0.p5	P	Acidic domain of the PROTEIN ( PROTEIN1 ) of vesicular stomatitis virus differentially interacts with homologous and heterologous PROTEIN ( PROTEIN2 ).
BioInfer.d11.s0.p0	N	A common feature of these PROTEIN2 -positive domains is the deep membrane infoldings, where bundles of PROTEIN1 filaments are inserted into the membrane.
BioInfer.d12.s0.p0	P	A core activity associated with the N terminus of the yeast PROTEIN protein is revealed by PROTEIN2 overexpression suppression of C-terminal PROTEIN1 truncation alleles.
BioInfer.d12.s0.p1	N	A core activity associated with the N terminus of the yeast PROTEIN2 protein is revealed by PROTEIN overexpression suppression of C-terminal PROTEIN1 truncation alleles.
BioInfer.d12.s0.p2	N	A core activity associated with the N terminus of the yeast PROTEIN2 protein is revealed by PROTEIN1 overexpression suppression of C-terminal PROTEIN truncation alleles.
BioInfer.d13.s0.p0	P	PROTEIN1 appears to control at least four functions that collectively lead to PROTEIN -based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN2 .
BioInfer.d13.s0.p1	P	PROTEIN1 appears to control at least four functions that collectively lead to PROTEIN -based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN2 function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN .
BioInfer.d13.s0.p2	P	PROTEIN1 appears to control at least four functions that collectively lead to PROTEIN -based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN2 polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN .
BioInfer.d13.s0.p3	N	PROTEIN1 appears to control at least four functions that collectively lead to PROTEIN2 -based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN .
BioInfer.d13.s0.p4	P	PROTEIN1 appears to control at least four functions that collectively lead to PROTEIN -based motility: (1) initiation of PROTEIN2 polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN .
BioInfer.d13.s0.p5	N	PROTEIN appears to control at least four functions that collectively lead to PROTEIN -based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN2 function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN1 .
BioInfer.d13.s0.p6	N	PROTEIN appears to control at least four functions that collectively lead to PROTEIN -based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN2 polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN1 .
BioInfer.d13.s0.p7	P	PROTEIN appears to control at least four functions that collectively lead to PROTEIN2 -based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN1 .
BioInfer.d13.s0.p8	N	PROTEIN appears to control at least four functions that collectively lead to PROTEIN -based motility: (1) initiation of PROTEIN2 polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN1 .
BioInfer.d13.s0.p9	N	PROTEIN appears to control at least four functions that collectively lead to PROTEIN -based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN1 function, (3) transformation of PROTEIN2 polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN .
BioInfer.d13.s0.p10	P	PROTEIN appears to control at least four functions that collectively lead to PROTEIN2 -based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN1 function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN .
BioInfer.d13.s0.p11	N	PROTEIN appears to control at least four functions that collectively lead to PROTEIN -based motility: (1) initiation of PROTEIN2 polymerization, (2) polarization of PROTEIN1 function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN .
BioInfer.d13.s0.p12	P	PROTEIN appears to control at least four functions that collectively lead to PROTEIN2 -based motility: (1) initiation of PROTEIN polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN1 polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN .
BioInfer.d13.s0.p13	N	PROTEIN appears to control at least four functions that collectively lead to PROTEIN -based motility: (1) initiation of PROTEIN2 polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN1 polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN .
BioInfer.d13.s0.p14	P	PROTEIN appears to control at least four functions that collectively lead to PROTEIN1 -based motility: (1) initiation of PROTEIN2 polymerization, (2) polarization of PROTEIN function, (3) transformation of PROTEIN polymerization into a motile force and (4) acceleration of movement mediated by the host protein PROTEIN .
BioInfer.d14.s0.p0	N	PROTEIN such as PROTEIN and PROTEIN1 bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric PROTEIN2 .
BioInfer.d14.s0.p1	P	PROTEIN2 such as PROTEIN and PROTEIN1 bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric PROTEIN .
BioInfer.d14.s0.p2	N	PROTEIN such as PROTEIN2 and PROTEIN1 bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric PROTEIN .
BioInfer.d14.s0.p3	P	PROTEIN2 such as PROTEIN and PROTEIN bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric PROTEIN1 .
BioInfer.d14.s0.p4	N	PROTEIN such as PROTEIN2 and PROTEIN bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric PROTEIN1 .
BioInfer.d14.s0.p5	P	PROTEIN1 such as PROTEIN2 and PROTEIN bind to phosphatidylinositol (PI) 4,5-bisphosphate (PI 4,5-P2) and regulate the concentration of monomeric PROTEIN .
BioInfer.d14.s1.p0	N	These studies suggest that PROTEIN1 and PROTEIN may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the PROTEIN2 polymerization.
BioInfer.d14.s1.p1	N	These studies suggest that PROTEIN1 and PROTEIN2 may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the PROTEIN polymerization.
BioInfer.d14.s1.p2	N	These studies suggest that PROTEIN and PROTEIN2 may control the generation of 3-OH phosphorylated phosphoinositides, which in turn may regulate the PROTEIN1 polymerization.
BioInfer.d14.s2.p0	N	This effect is specific to PROTEIN1 and PROTEIN because other cytoskeletal proteins such as PROTEIN or PROTEIN do not affect PROTEIN2 activity.
BioInfer.d14.s2.p1	N	This effect is specific to PROTEIN1 and PROTEIN because other cytoskeletal proteins such as PROTEIN2 or PROTEIN do not affect PROTEIN activity.
BioInfer.d14.s2.p2	N	This effect is specific to PROTEIN1 and PROTEIN because other cytoskeletal proteins such as PROTEIN or PROTEIN2 do not affect PROTEIN activity.
BioInfer.d14.s2.p3	N	This effect is specific to PROTEIN1 and PROTEIN2 because other cytoskeletal proteins such as PROTEIN or PROTEIN do not affect PROTEIN activity.
BioInfer.d14.s2.p4	P	This effect is specific to PROTEIN and PROTEIN because other cytoskeletal proteins such as PROTEIN2 or PROTEIN do not affect PROTEIN1 activity.
BioInfer.d14.s2.p5	P	This effect is specific to PROTEIN and PROTEIN because other cytoskeletal proteins such as PROTEIN or PROTEIN2 do not affect PROTEIN1 activity.
BioInfer.d14.s2.p6	N	This effect is specific to PROTEIN and PROTEIN2 because other cytoskeletal proteins such as PROTEIN or PROTEIN do not affect PROTEIN1 activity.
BioInfer.d14.s2.p7	N	This effect is specific to PROTEIN and PROTEIN because other cytoskeletal proteins such as PROTEIN1 or PROTEIN2 do not affect PROTEIN activity.
BioInfer.d14.s2.p8	N	This effect is specific to PROTEIN and PROTEIN2 because other cytoskeletal proteins such as PROTEIN1 or PROTEIN do not affect PROTEIN activity.
BioInfer.d14.s2.p9	N	This effect is specific to PROTEIN and PROTEIN2 because other cytoskeletal proteins such as PROTEIN or PROTEIN1 do not affect PROTEIN activity.
BioInfer.d15.s0.p0	P	PROTEIN1 such as PROTEIN participate in the restructuration of the PROTEIN2 cytoskeleton in plant cells.
BioInfer.d15.s0.p1	P	PROTEIN1 such as PROTEIN2 participate in the restructuration of the PROTEIN cytoskeleton in plant cells.
BioInfer.d15.s0.p2	N	PROTEIN such as PROTEIN2 participate in the restructuration of the PROTEIN1 cytoskeleton in plant cells.
BioInfer.d16.s0.p0	N	PROTEIN2 ( PROTEIN1 ) and PROTEIN define a family of PROTEIN essential for the rapid turnover of filamentous PROTEIN in vivo.
BioInfer.d16.s0.p1	N	PROTEIN ( PROTEIN1 ) and PROTEIN2 define a family of PROTEIN essential for the rapid turnover of filamentous PROTEIN in vivo.
BioInfer.d16.s0.p2	N	PROTEIN ( PROTEIN1 ) and PROTEIN define a family of PROTEIN essential for the rapid turnover of filamentous PROTEIN2 in vivo.
BioInfer.d16.s0.p3	P	PROTEIN ( PROTEIN1 ) and PROTEIN define a family of PROTEIN2 essential for the rapid turnover of filamentous PROTEIN in vivo.
BioInfer.d16.s0.p4	N	PROTEIN1 ( PROTEIN ) and PROTEIN2 define a family of PROTEIN essential for the rapid turnover of filamentous PROTEIN in vivo.
BioInfer.d16.s0.p5	N	PROTEIN1 ( PROTEIN ) and PROTEIN define a family of PROTEIN essential for the rapid turnover of filamentous PROTEIN2 in vivo.
BioInfer.d16.s0.p6	P	PROTEIN1 ( PROTEIN ) and PROTEIN define a family of PROTEIN2 essential for the rapid turnover of filamentous PROTEIN in vivo.
BioInfer.d16.s0.p7	N	PROTEIN ( PROTEIN ) and PROTEIN1 define a family of PROTEIN essential for the rapid turnover of filamentous PROTEIN2 in vivo.
BioInfer.d16.s0.p8	P	PROTEIN ( PROTEIN ) and PROTEIN1 define a family of PROTEIN2 essential for the rapid turnover of filamentous PROTEIN in vivo.
BioInfer.d16.s0.p9	P	PROTEIN ( PROTEIN ) and PROTEIN define a family of PROTEIN2 essential for the rapid turnover of filamentous PROTEIN1 in vivo.
BioInfer.d17.s0.p0	N	PROTEIN1 expression was reduced by 25-50%, relative to that of PROTEIN , in smooth muscle of KO mice, without any change in the relative distribution of the PROTEIN2 isoforms.
BioInfer.d17.s0.p1	N	PROTEIN1 expression was reduced by 25-50%, relative to that of PROTEIN2 , in smooth muscle of KO mice, without any change in the relative distribution of the PROTEIN isoforms.
BioInfer.d17.s0.p2	N	PROTEIN expression was reduced by 25-50%, relative to that of PROTEIN2 , in smooth muscle of KO mice, without any change in the relative distribution of the PROTEIN1 isoforms.
BioInfer.d18.s0.p0	N	PROTEIN1 isoforms from different species were also compared, and the effect of PROTEIN on the thermal stability of PROTEIN2 was studied.
BioInfer.d18.s0.p1	N	PROTEIN1 isoforms from different species were also compared, and the effect of PROTEIN2 on the thermal stability of PROTEIN was studied.
BioInfer.d18.s0.p2	P	PROTEIN isoforms from different species were also compared, and the effect of PROTEIN2 on the thermal stability of PROTEIN1 was studied.
BioInfer.d19.s0.p0	P	[Activation induces dephosphorylation of PROTEIN1 (an PROTEIN2 /PIP2-binding protein) and its translocation to plasma membranes in leukocytes].
BioInfer.d20.s0.p0	P	Active, Ser133-phosphorylated PROTEIN effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein PROTEIN1 , PROTEIN , which bridges the CRE/ PROTEIN2 complex to components of the basal transcriptional apparatus.
BioInfer.d20.s0.p1	P	Active, Ser133-phosphorylated PROTEIN2 effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein PROTEIN1 , PROTEIN , which bridges the CRE/ PROTEIN complex to components of the basal transcriptional apparatus.
BioInfer.d20.s0.p2	N	Active, Ser133-phosphorylated PROTEIN effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein PROTEIN1 , PROTEIN2 , which bridges the CRE/ PROTEIN complex to components of the basal transcriptional apparatus.
BioInfer.d20.s0.p3	N	Active, Ser133-phosphorylated PROTEIN2 effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein PROTEIN , PROTEIN , which bridges the CRE/ PROTEIN1 complex to components of the basal transcriptional apparatus.
BioInfer.d20.s0.p4	P	Active, Ser133-phosphorylated PROTEIN effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein PROTEIN , PROTEIN2 , which bridges the CRE/ PROTEIN1 complex to components of the basal transcriptional apparatus.
BioInfer.d20.s0.p5	P	Active, Ser133-phosphorylated PROTEIN1 effects transcription of CRE-dependent genes via interaction with the 265-kDa co-activator protein PROTEIN , PROTEIN2 , which bridges the CRE/ PROTEIN complex to components of the basal transcriptional apparatus.
BioInfer.d21.s0.p0	N	PROTEIN and PROTEIN2 have opposite effects on the rate of exchange of nucleotide bound to PROTEIN1 monomers.
BioInfer.d21.s0.p1	N	PROTEIN2 and PROTEIN have opposite effects on the rate of exchange of nucleotide bound to PROTEIN1 monomers.
BioInfer.d21.s0.p2	N	PROTEIN2 and PROTEIN1 have opposite effects on the rate of exchange of nucleotide bound to PROTEIN monomers.
BioInfer.d22.s0.p0	N	Additional studies demonstrated the PROTEIN distribution to be remarkably similar to that of PROTEIN1 , whereas PROTEIN2 staining was more diffuse in the cytoplasm of airway epithelial and gland bud cells.
BioInfer.d22.s0.p1	P	Additional studies demonstrated the PROTEIN2 distribution to be remarkably similar to that of PROTEIN1 , whereas PROTEIN staining was more diffuse in the cytoplasm of airway epithelial and gland bud cells.
BioInfer.d22.s0.p2	N	Additional studies demonstrated the PROTEIN2 distribution to be remarkably similar to that of PROTEIN , whereas PROTEIN1 staining was more diffuse in the cytoplasm of airway epithelial and gland bud cells.
BioInfer.d23.s0.p0	P	Addition of Acanthamoeba PROTEIN1 in molar ratios to PROTEIN of about 1.1:1 and 2.3:1 retarded the initial kinetics of assembly (induced by addition of 2mM Mg+2) and reduced the fraction of PROTEIN2 incorporated into filaments.
BioInfer.d23.s0.p1	N	Addition of Acanthamoeba PROTEIN1 in molar ratios to PROTEIN2 of about 1.1:1 and 2.3:1 retarded the initial kinetics of assembly (induced by addition of 2mM Mg+2) and reduced the fraction of PROTEIN incorporated into filaments.
BioInfer.d23.s0.p2	N	Addition of Acanthamoeba PROTEIN in molar ratios to PROTEIN2 of about 1.1:1 and 2.3:1 retarded the initial kinetics of assembly (induced by addition of 2mM Mg+2) and reduced the fraction of PROTEIN1 incorporated into filaments.
BioInfer.d24.s0.p0	N	Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of PROTEIN2 , PROTEIN , and PROTEIN1 in response to A23187 (1 microM).
BioInfer.d24.s0.p1	N	Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of PROTEIN , PROTEIN2 , and PROTEIN1 in response to A23187 (1 microM).
BioInfer.d24.s0.p2	N	Addition of EGTA (3 mM) to the extracellular media completely inhibited the cleavage of PROTEIN1 , PROTEIN2 , and PROTEIN in response to A23187 (1 microM).
BioInfer.d25.s0.p0	N	Adherens junction proteins ( PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN ) and the proliferation marker PROTEIN were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p1	N	Adherens junction proteins ( PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN ) and the proliferation marker PROTEIN were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p2	N	Adherens junction proteins ( PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN ) and the proliferation marker PROTEIN were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p3	N	Adherens junction proteins ( PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN ) and the proliferation marker PROTEIN2 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p4	N	Adherens junction proteins ( PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 ) and the proliferation marker PROTEIN were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p5	N	Adherens junction proteins ( PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN ) and the proliferation marker PROTEIN were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p6	N	Adherens junction proteins ( PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN ) and the proliferation marker PROTEIN were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p7	N	Adherens junction proteins ( PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) and the proliferation marker PROTEIN were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p8	N	Adherens junction proteins ( PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) and the proliferation marker PROTEIN2 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p9	N	Adherens junction proteins ( PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 ) and the proliferation marker PROTEIN were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p10	N	Adherens junction proteins ( PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN ) and the proliferation marker PROTEIN were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p11	N	Adherens junction proteins ( PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN ) and the proliferation marker PROTEIN were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p12	N	Adherens junction proteins ( PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN ) and the proliferation marker PROTEIN2 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p13	N	Adherens junction proteins ( PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 ) and the proliferation marker PROTEIN were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p14	N	Adherens junction proteins ( PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN ) and the proliferation marker PROTEIN were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p15	N	Adherens junction proteins ( PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) and the proliferation marker PROTEIN2 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p16	N	Adherens junction proteins ( PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 ) and the proliferation marker PROTEIN were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p17	N	Adherens junction proteins ( PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN ) and the proliferation marker PROTEIN were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p18	N	Adherens junction proteins ( PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 ) and the proliferation marker PROTEIN1 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p19	N	Adherens junction proteins ( PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN ) and the proliferation marker PROTEIN1 were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d25.s0.p20	N	Adherens junction proteins ( PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 ) and the proliferation marker PROTEIN were localized in the cultures by fluorescence microscopy, and in vitro wound healing was compared.
BioInfer.d26.s0.p0	P	A distinct modulating domain in PROTEIN2 monomers in the repression of activity of the transcription factor PROTEIN1 .
BioInfer.d27.s0.p0	P	ADP-ribosylation of PROTEIN1 at Arg 177 by Clostridium perfringens PROTEIN2 increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the PROTEIN -induced stimulation of nucleotide exchange.
BioInfer.d27.s0.p1	N	ADP-ribosylation of PROTEIN1 at Arg 177 by Clostridium perfringens PROTEIN increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the PROTEIN2 -induced stimulation of nucleotide exchange.
BioInfer.d27.s0.p2	P	ADP-ribosylation of PROTEIN at Arg 177 by Clostridium perfringens PROTEIN1 increased the nucleotide dissociation rate from 2.2 x 10(-3) s-1 to 4.5 x 10(-3) s-1 without affecting the PROTEIN2 -induced stimulation of nucleotide exchange.
BioInfer.d27.s1.p0	N	In contrast, ADP-ribosylation of PROTEIN at Arg95/Arg372 induced by turkey PROTEIN2 decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the PROTEIN1 -induced stimulation of nucleotide exchange.
BioInfer.d27.s1.p1	N	In contrast, ADP-ribosylation of PROTEIN2 at Arg95/Arg372 induced by turkey PROTEIN decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the PROTEIN1 -induced stimulation of nucleotide exchange.
BioInfer.d27.s1.p2	P	In contrast, ADP-ribosylation of PROTEIN2 at Arg95/Arg372 induced by turkey PROTEIN1 decreased the nucleotide dissociation rate to 1.5 x 10(3) s-1 and inhibited the PROTEIN -induced stimulation of nucleotide exchange.
BioInfer.d28.s0.p0	N	After 24 or 48 hours of shear, staining for PROTEIN2 , PROTEIN , and PROTEIN1 was intense and peripheral, forming a band of "dashes" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.
BioInfer.d28.s0.p1	N	After 24 or 48 hours of shear, staining for PROTEIN , PROTEIN2 , and PROTEIN1 was intense and peripheral, forming a band of "dashes" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.
BioInfer.d28.s0.p2	N	After 24 or 48 hours of shear, staining for PROTEIN1 , PROTEIN2 , and PROTEIN was intense and peripheral, forming a band of "dashes" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.
BioInfer.d28.s1.p0	N	Cells were fixed and stained with antibodies to PROTEIN1 (VE) cadherin, PROTEIN , PROTEIN2 , or PROTEIN .
BioInfer.d28.s1.p1	N	Cells were fixed and stained with antibodies to PROTEIN1 (VE) cadherin, PROTEIN2 , PROTEIN , or PROTEIN .
BioInfer.d28.s1.p2	N	Cells were fixed and stained with antibodies to PROTEIN1 (VE) cadherin, PROTEIN , PROTEIN , or PROTEIN2 .
BioInfer.d28.s1.p3	N	Cells were fixed and stained with antibodies to PROTEIN (VE) cadherin, PROTEIN2 , PROTEIN1 , or PROTEIN .
BioInfer.d28.s1.p4	N	Cells were fixed and stained with antibodies to PROTEIN (VE) cadherin, PROTEIN , PROTEIN1 , or PROTEIN2 .
BioInfer.d28.s1.p5	N	Cells were fixed and stained with antibodies to PROTEIN (VE) cadherin, PROTEIN1 , PROTEIN , or PROTEIN2 .
BioInfer.d29.s0.p0	P	After digestion of the 60 kDa fragment with cyanogen bromide, the N-terminal 21-amino acid sequence of one of the resulting peptides was found to show sequence similarity to a region near the PROTEIN2 -binding site (amino acid residues 260-281) of yeast PROTEIN1 .
BioInfer.d30.s0.p0	N	After elution of the three PROTEIN , PROTEIN1 and PROTEIN were recovered from the PROTEIN2 column with 2 M urea solution.
BioInfer.d30.s0.p1	N	After elution of the three PROTEIN2 , PROTEIN1 and PROTEIN were recovered from the PROTEIN column with 2 M urea solution.
BioInfer.d30.s0.p2	N	After elution of the three PROTEIN , PROTEIN1 and PROTEIN2 were recovered from the PROTEIN column with 2 M urea solution.
BioInfer.d30.s0.p3	N	After elution of the three PROTEIN2 , PROTEIN and PROTEIN were recovered from the PROTEIN1 column with 2 M urea solution.
BioInfer.d30.s0.p4	N	After elution of the three PROTEIN , PROTEIN and PROTEIN2 were recovered from the PROTEIN1 column with 2 M urea solution.
BioInfer.d30.s0.p5	N	After elution of the three PROTEIN1 , PROTEIN and PROTEIN2 were recovered from the PROTEIN column with 2 M urea solution.
BioInfer.d31.s0.p0	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN2  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p1	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN2  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p2	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN2  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p3	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN2  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p4	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN2  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p5	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p6	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN2  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p7	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN2  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p8	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN2 variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p9	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p10	P	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN2 .
BioInfer.d31.s0.p11	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p12	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p13	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN2 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p14	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN2 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p15	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p16	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p17	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p18	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p19	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN1  PROTEIN .
BioInfer.d31.s0.p20	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN2  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p21	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN2  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p22	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN2  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p23	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN2  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p24	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p25	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN2  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p26	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN2  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p27	P	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN2 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p28	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p29	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN2 .
BioInfer.d31.s0.p30	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p31	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p32	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN2 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p33	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN2 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p34	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p35	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p36	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p37	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p38	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN1  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p39	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN2  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p40	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN2  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p41	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN2  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p42	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p43	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN2  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p44	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN2  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p45	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN2 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p46	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p47	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN2 .
BioInfer.d31.s0.p48	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p49	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p50	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN2 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p51	P	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN2 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p52	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p53	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p54	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p55	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p56	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN1  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p57	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN2  PROTEIN , PROTEIN1  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p58	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN2  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN1  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p59	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN1  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p60	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN1  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN2  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p61	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN1  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN2  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p62	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN1  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN2 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p63	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN1  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p64	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN1  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN2 .
BioInfer.d31.s0.p65	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN1  PROTEIN , oxidized PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p66	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN2 , PROTEIN1  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p67	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN2 subfractions, PROTEIN  PROTEIN , PROTEIN1  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p68	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN2 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN1  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p69	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN1  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p70	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN1  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p71	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN1  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p72	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN1  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p73	P	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN1  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p74	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN2  PROTEIN subfractions, PROTEIN1  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p75	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN1  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p76	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN1  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN2  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p77	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN1  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN2  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p78	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN1  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN2 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p79	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN1  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p80	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN1  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN2 .
BioInfer.d31.s0.p81	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN1  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p82	P	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN1  PROTEIN2 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p83	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN2 subfractions, PROTEIN1  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p84	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN2 , four PROTEIN  PROTEIN subfractions, PROTEIN1  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p85	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN1  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p86	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN1  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p87	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN1  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p88	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN1  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p89	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN1  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p90	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN1  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p91	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN1  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN2  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p92	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN1  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN2  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p93	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN1  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN2 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p94	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN1  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p95	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN1  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN2 .
BioInfer.d31.s0.p96	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN1  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p97	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN1  PROTEIN subfractions, PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p98	P	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN1  PROTEIN2 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p99	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN2 , four PROTEIN1  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p100	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN1  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p101	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN1  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p102	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN1  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p103	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN1  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p104	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN1  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p105	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN2  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p106	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN2  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p107	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN2 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p108	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p109	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN2 .
BioInfer.d31.s0.p110	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN2  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p111	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p112	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN2 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p113	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN2 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p114	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p115	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p116	P	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN1  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p117	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p118	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p119	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN2  PROTEIN , PROTEIN1  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p120	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , three PROTEIN  PROTEIN2 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p121	P	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN2 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p122	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN2 .
BioInfer.d31.s0.p123	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p124	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p125	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN2 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p126	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN2 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p127	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p128	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN1  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p129	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p130	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p131	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p132	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN2 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p133	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN2 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p134	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN2 .
BioInfer.d31.s0.p135	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p136	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p137	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN2 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p138	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN2 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p139	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p140	P	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN2 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p141	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p142	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p143	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN1  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p144	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , three PROTEIN  PROTEIN1 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p145	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN1 variants and PROTEIN  PROTEIN2 .
BioInfer.d31.s0.p146	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN1 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p147	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN1 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p148	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN2 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN1 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p149	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN2 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN1 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p150	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN1 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p151	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN1 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p152	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN1 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p153	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN1 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p154	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN1 variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p155	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN1 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN2 .
BioInfer.d31.s0.p156	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN1 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p157	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN1 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p158	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN2 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN1 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p159	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN2 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN1 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p160	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN1 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p161	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN1 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p162	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN1 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p163	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN1 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p164	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN1 , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p165	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN2  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN1 .
BioInfer.d31.s0.p166	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN1 .
BioInfer.d31.s0.p167	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN2 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN1 .
BioInfer.d31.s0.p168	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN2 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN1 .
BioInfer.d31.s0.p169	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN1 .
BioInfer.d31.s0.p170	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN1 .
BioInfer.d31.s0.p171	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN1 .
BioInfer.d31.s0.p172	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN1 .
BioInfer.d31.s0.p173	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN1 .
BioInfer.d31.s0.p174	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , oxidized PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p175	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN2 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p176	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN2 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p177	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p178	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p179	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN1  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p180	P	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN1  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p181	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN1  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p182	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN2 subfractions, PROTEIN  PROTEIN1 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p183	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN2 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN1 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p184	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN1 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p185	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN1 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p186	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN1 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p187	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN1 , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p188	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN1 , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p189	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN2 , four PROTEIN  PROTEIN1 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p190	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN1 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p191	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN1 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p192	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN1 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p193	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN1 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p194	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN1 subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p195	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN2 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN1 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p196	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN1 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p197	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN1 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p198	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN1 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p199	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN1 , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p200	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN1 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p201	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN1 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p202	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN1 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p203	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN1 were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p204	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , PROTEIN  PROTEIN1 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p205	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN , PROTEIN  PROTEIN1 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p206	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN1 , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p207	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN , oxidized PROTEIN  PROTEIN2 , PROTEIN  PROTEIN1 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p208	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN , PROTEIN  PROTEIN1 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d31.s0.p209	N	After in vitro labelling of isolated rat liver nuclei, the following ADP-ribosylated and unmodified PROTEIN were identified by HPLC and gel electrophoresis: PROTEIN  PROTEIN , four PROTEIN  PROTEIN subfractions, PROTEIN  PROTEIN , PROTEIN  PROTEIN2 , oxidized PROTEIN  PROTEIN1 , PROTEIN  PROTEIN , PROTEIN  PROTEIN , PROTEIN  PROTEIN , three PROTEIN  PROTEIN variants and PROTEIN  PROTEIN .
BioInfer.d32.s0.p0	N	A further outcome of this study is that the PROTEIN filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either PROTEIN , PROTEIN2 or PROTEIN1 of the intestinal brush border.
BioInfer.d32.s0.p1	N	A further outcome of this study is that the PROTEIN2 filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either PROTEIN , PROTEIN or PROTEIN1 of the intestinal brush border.
BioInfer.d32.s0.p2	N	A further outcome of this study is that the PROTEIN filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either PROTEIN2 , PROTEIN or PROTEIN1 of the intestinal brush border.
BioInfer.d32.s0.p3	N	A further outcome of this study is that the PROTEIN2 filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either PROTEIN , PROTEIN1 or PROTEIN of the intestinal brush border.
BioInfer.d32.s0.p4	N	A further outcome of this study is that the PROTEIN filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either PROTEIN2 , PROTEIN1 or PROTEIN of the intestinal brush border.
BioInfer.d32.s0.p5	N	A further outcome of this study is that the PROTEIN1 filament core bundles in microvilli of chicken pigment epithelial cells are presumed to contain a crosslinking protein, which is not immunologically related to either PROTEIN2 , PROTEIN or PROTEIN of the intestinal brush border.
BioInfer.d33.s0.p0	P	A highly significant correlation was observed between the loss of expression of PROTEIN2 , PROTEIN1 and PROTEIN , but not PROTEIN , with increased TNM stage (p <0.05).
BioInfer.d33.s0.p1	P	A highly significant correlation was observed between the loss of expression of PROTEIN , PROTEIN1 and PROTEIN , but not PROTEIN2 , with increased TNM stage (p <0.05).
BioInfer.d33.s0.p2	P	A highly significant correlation was observed between the loss of expression of PROTEIN , PROTEIN1 and PROTEIN2 , but not PROTEIN , with increased TNM stage (p <0.05).
BioInfer.d33.s0.p3	P	A highly significant correlation was observed between the loss of expression of PROTEIN1 , PROTEIN and PROTEIN , but not PROTEIN2 , with increased TNM stage (p <0.05).
BioInfer.d33.s0.p4	P	A highly significant correlation was observed between the loss of expression of PROTEIN1 , PROTEIN and PROTEIN2 , but not PROTEIN , with increased TNM stage (p <0.05).
BioInfer.d33.s0.p5	P	A highly significant correlation was observed between the loss of expression of PROTEIN , PROTEIN and PROTEIN2 , but not PROTEIN1 , with increased TNM stage (p <0.05).
BioInfer.d33.s1.p0	N	Loss of normal surface PROTEIN2 , PROTEIN , PROTEIN1 and PROTEIN expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).
BioInfer.d33.s1.p1	N	Loss of normal surface PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).
BioInfer.d33.s1.p2	N	Loss of normal surface PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).
BioInfer.d33.s1.p3	N	Loss of normal surface PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).
BioInfer.d33.s1.p4	N	Loss of normal surface PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).
BioInfer.d33.s1.p5	N	Loss of normal surface PROTEIN , PROTEIN2 , PROTEIN and PROTEIN1 expression was found in 52/68 (76.4%) tumors, 57/68 (83.8%) tumors, 54/68 (79.4%) tumors and 54/68 (79.4%) tumors (p <0.001).
BioInfer.d33.s2.p0	N	MATERIALS AND METHODS: We used an PROTEIN1 -biotin immunoperoxidase technique to examine the cellular localization of PROTEIN , PROTEIN2 , PROTEIN and PROTEIN in 68 TCC and 14 normal bladder biopsies.
BioInfer.d33.s2.p1	N	MATERIALS AND METHODS: We used an PROTEIN1 -biotin immunoperoxidase technique to examine the cellular localization of PROTEIN2 , PROTEIN , PROTEIN and PROTEIN in 68 TCC and 14 normal bladder biopsies.
BioInfer.d33.s2.p2	N	MATERIALS AND METHODS: We used an PROTEIN1 -biotin immunoperoxidase technique to examine the cellular localization of PROTEIN , PROTEIN , PROTEIN and PROTEIN2 in 68 TCC and 14 normal bladder biopsies.
BioInfer.d33.s2.p3	N	MATERIALS AND METHODS: We used an PROTEIN1 -biotin immunoperoxidase technique to examine the cellular localization of PROTEIN , PROTEIN , PROTEIN2 and PROTEIN in 68 TCC and 14 normal bladder biopsies.
BioInfer.d33.s2.p4	N	MATERIALS AND METHODS: We used an PROTEIN -biotin immunoperoxidase technique to examine the cellular localization of PROTEIN2 , PROTEIN1 , PROTEIN and PROTEIN in 68 TCC and 14 normal bladder biopsies.
BioInfer.d33.s2.p5	N	MATERIALS AND METHODS: We used an PROTEIN -biotin immunoperoxidase technique to examine the cellular localization of PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 in 68 TCC and 14 normal bladder biopsies.
BioInfer.d33.s2.p6	N	MATERIALS AND METHODS: We used an PROTEIN -biotin immunoperoxidase technique to examine the cellular localization of PROTEIN , PROTEIN1 , PROTEIN2 and PROTEIN in 68 TCC and 14 normal bladder biopsies.
BioInfer.d33.s2.p7	N	MATERIALS AND METHODS: We used an PROTEIN -biotin immunoperoxidase technique to examine the cellular localization of PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 in 68 TCC and 14 normal bladder biopsies.
BioInfer.d33.s2.p8	N	MATERIALS AND METHODS: We used an PROTEIN -biotin immunoperoxidase technique to examine the cellular localization of PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN in 68 TCC and 14 normal bladder biopsies.
BioInfer.d33.s2.p9	N	MATERIALS AND METHODS: We used an PROTEIN -biotin immunoperoxidase technique to examine the cellular localization of PROTEIN , PROTEIN , PROTEIN2 and PROTEIN1 in 68 TCC and 14 normal bladder biopsies.
BioInfer.d33.s3.p0	N	RESULTS: PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 were expressed in a normal membranous pattern in all normal bladder epithelium specimens.
BioInfer.d33.s3.p1	N	RESULTS: PROTEIN2 , PROTEIN1 , PROTEIN and PROTEIN were expressed in a normal membranous pattern in all normal bladder epithelium specimens.
BioInfer.d33.s3.p2	N	RESULTS: PROTEIN , PROTEIN1 , PROTEIN2 and PROTEIN were expressed in a normal membranous pattern in all normal bladder epithelium specimens.
BioInfer.d33.s3.p3	N	RESULTS: PROTEIN2 , PROTEIN , PROTEIN and PROTEIN1 were expressed in a normal membranous pattern in all normal bladder epithelium specimens.
BioInfer.d33.s3.p4	N	RESULTS: PROTEIN , PROTEIN , PROTEIN2 and PROTEIN1 were expressed in a normal membranous pattern in all normal bladder epithelium specimens.
BioInfer.d33.s3.p5	N	RESULTS: PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN were expressed in a normal membranous pattern in all normal bladder epithelium specimens.
BioInfer.d34.s0.p0	N	AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN ) in ACC, and compared it with that in the normal labial gland.
BioInfer.d34.s0.p1	N	AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of PROTEIN1 ( PROTEIN ), PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN ) in ACC, and compared it with that in the normal labial gland.
BioInfer.d34.s0.p2	N	AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) in ACC, and compared it with that in the normal labial gland.
BioInfer.d34.s0.p3	N	AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN ) in ACC, and compared it with that in the normal labial gland.
BioInfer.d34.s0.p4	N	AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of PROTEIN1 ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) in ACC, and compared it with that in the normal labial gland.
BioInfer.d34.s0.p5	N	AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) and PROTEIN1 ( PROTEIN ) in ACC, and compared it with that in the normal labial gland.
BioInfer.d34.s0.p6	N	AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN2 ) in ACC, and compared it with that in the normal labial gland.
BioInfer.d34.s0.p7	N	AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN1 ( PROTEIN ) in ACC, and compared it with that in the normal labial gland.
BioInfer.d34.s0.p8	N	AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) in ACC, and compared it with that in the normal labial gland.
BioInfer.d34.s0.p9	N	AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN2 ) in ACC, and compared it with that in the normal labial gland.
BioInfer.d34.s0.p10	N	AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN2 ) and PROTEIN ( PROTEIN ) in ACC, and compared it with that in the normal labial gland.
BioInfer.d34.s0.p11	N	AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of PROTEIN ( PROTEIN2 ), PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) in ACC, and compared it with that in the normal labial gland.
BioInfer.d34.s0.p12	N	AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN1 ) in ACC, and compared it with that in the normal labial gland.
BioInfer.d34.s0.p13	N	AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN1 ) in ACC, and compared it with that in the normal labial gland.
BioInfer.d34.s0.p14	N	AIMS: To investigate the disturbance of intercellular adhesion in adenoid cystic carcinoma (ACC), we examined the ultrastructural localization of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) in ACC, and compared it with that in the normal labial gland.
BioInfer.d35.s0.p0	P	PROTEIN1 interacts with PROTEIN to disassemble PROTEIN2 filaments.
BioInfer.d35.s0.p1	P	PROTEIN1 interacts with PROTEIN2 to disassemble PROTEIN filaments.
BioInfer.d35.s0.p2	P	PROTEIN interacts with PROTEIN2 to disassemble PROTEIN1 filaments.
BioInfer.d35.s1.p0	P	PROTEIN localizes to cortical PROTEIN1 patches in yeast cells, and this localization is disrupted by specific PROTEIN2 and PROTEIN mutations.
BioInfer.d35.s1.p1	P	PROTEIN2 localizes to cortical PROTEIN1 patches in yeast cells, and this localization is disrupted by specific PROTEIN and PROTEIN mutations.
BioInfer.d35.s1.p2	P	PROTEIN localizes to cortical PROTEIN1 patches in yeast cells, and this localization is disrupted by specific PROTEIN and PROTEIN2 mutations.
BioInfer.d35.s1.p3	N	PROTEIN2 localizes to cortical PROTEIN patches in yeast cells, and this localization is disrupted by specific PROTEIN1 and PROTEIN mutations.
BioInfer.d35.s1.p4	N	PROTEIN localizes to cortical PROTEIN patches in yeast cells, and this localization is disrupted by specific PROTEIN1 and PROTEIN2 mutations.
BioInfer.d35.s1.p5	N	PROTEIN1 localizes to cortical PROTEIN patches in yeast cells, and this localization is disrupted by specific PROTEIN and PROTEIN2 mutations.
BioInfer.d35.s2.p0	N	A two-hybrid-based approach using PROTEIN2 and PROTEIN1 mutants identified residues necessary for the interaction of PROTEIN , PROTEIN , and PROTEIN in an apparent ternary complex.
BioInfer.d35.s2.p1	N	A two-hybrid-based approach using PROTEIN and PROTEIN1 mutants identified residues necessary for the interaction of PROTEIN2 , PROTEIN , and PROTEIN in an apparent ternary complex.
BioInfer.d35.s2.p2	N	A two-hybrid-based approach using PROTEIN and PROTEIN1 mutants identified residues necessary for the interaction of PROTEIN , PROTEIN2 , and PROTEIN in an apparent ternary complex.
BioInfer.d35.s2.p3	N	A two-hybrid-based approach using PROTEIN and PROTEIN1 mutants identified residues necessary for the interaction of PROTEIN , PROTEIN , and PROTEIN2 in an apparent ternary complex.
BioInfer.d35.s2.p4	N	A two-hybrid-based approach using PROTEIN1 and PROTEIN mutants identified residues necessary for the interaction of PROTEIN2 , PROTEIN , and PROTEIN in an apparent ternary complex.
BioInfer.d35.s2.p5	N	A two-hybrid-based approach using PROTEIN1 and PROTEIN mutants identified residues necessary for the interaction of PROTEIN , PROTEIN2 , and PROTEIN in an apparent ternary complex.
BioInfer.d35.s2.p6	N	A two-hybrid-based approach using PROTEIN1 and PROTEIN mutants identified residues necessary for the interaction of PROTEIN , PROTEIN , and PROTEIN2 in an apparent ternary complex.
BioInfer.d35.s2.p7	P	A two-hybrid-based approach using PROTEIN and PROTEIN mutants identified residues necessary for the interaction of PROTEIN1 , PROTEIN2 , and PROTEIN in an apparent ternary complex.
BioInfer.d35.s2.p8	P	A two-hybrid-based approach using PROTEIN and PROTEIN mutants identified residues necessary for the interaction of PROTEIN1 , PROTEIN , and PROTEIN2 in an apparent ternary complex.
BioInfer.d35.s2.p9	P	A two-hybrid-based approach using PROTEIN and PROTEIN mutants identified residues necessary for the interaction of PROTEIN , PROTEIN1 , and PROTEIN2 in an apparent ternary complex.
BioInfer.d35.s3.p0	P	Here, we report that PROTEIN also interacts with the ubiquitous PROTEIN1  PROTEIN2 .
BioInfer.d35.s3.p1	N	Here, we report that PROTEIN2 also interacts with the ubiquitous PROTEIN1  PROTEIN .
BioInfer.d35.s3.p2	P	Here, we report that PROTEIN2 also interacts with the ubiquitous PROTEIN  PROTEIN1 .
BioInfer.d35.s4.p0	N	We conclude that PROTEIN is a PROTEIN -associated protein that enhances the filament disassembly activity of PROTEIN1 and restricts PROTEIN localization to cortical PROTEIN2 patches.
BioInfer.d35.s4.p1	P	We conclude that PROTEIN2 is a PROTEIN -associated protein that enhances the filament disassembly activity of PROTEIN1 and restricts PROTEIN localization to cortical PROTEIN patches.
BioInfer.d35.s4.p2	N	We conclude that PROTEIN is a PROTEIN -associated protein that enhances the filament disassembly activity of PROTEIN1 and restricts PROTEIN2 localization to cortical PROTEIN patches.
BioInfer.d35.s4.p3	N	We conclude that PROTEIN is a PROTEIN2 -associated protein that enhances the filament disassembly activity of PROTEIN1 and restricts PROTEIN localization to cortical PROTEIN patches.
BioInfer.d35.s4.p4	P	We conclude that PROTEIN2 is a PROTEIN -associated protein that enhances the filament disassembly activity of PROTEIN and restricts PROTEIN localization to cortical PROTEIN1 patches.
BioInfer.d35.s4.p5	P	We conclude that PROTEIN is a PROTEIN -associated protein that enhances the filament disassembly activity of PROTEIN and restricts PROTEIN2 localization to cortical PROTEIN1 patches.
BioInfer.d35.s4.p6	N	We conclude that PROTEIN is a PROTEIN2 -associated protein that enhances the filament disassembly activity of PROTEIN and restricts PROTEIN localization to cortical PROTEIN1 patches.
BioInfer.d35.s4.p7	N	We conclude that PROTEIN1 is a PROTEIN -associated protein that enhances the filament disassembly activity of PROTEIN and restricts PROTEIN2 localization to cortical PROTEIN patches.
BioInfer.d35.s4.p8	P	We conclude that PROTEIN1 is a PROTEIN2 -associated protein that enhances the filament disassembly activity of PROTEIN and restricts PROTEIN localization to cortical PROTEIN patches.
BioInfer.d35.s4.p9	N	We conclude that PROTEIN is a PROTEIN2 -associated protein that enhances the filament disassembly activity of PROTEIN and restricts PROTEIN1 localization to cortical PROTEIN patches.
BioInfer.d36.s0.p0	P	A PROTEIN mutant with replacement of threonine 505 by valine abolished PROTEIN activities for PROTEIN phosphorylation and PROTEIN cytoskeletal changes, whereas replacement by glutamate enhanced the PROTEIN1 activity and stress fiber formation by PROTEIN2 .
BioInfer.d36.s0.p1	N	A PROTEIN mutant with replacement of threonine 505 by valine abolished PROTEIN activities for PROTEIN2 phosphorylation and PROTEIN cytoskeletal changes, whereas replacement by glutamate enhanced the PROTEIN1 activity and stress fiber formation by PROTEIN .
BioInfer.d36.s0.p2	N	A PROTEIN2 mutant with replacement of threonine 505 by valine abolished PROTEIN activities for PROTEIN phosphorylation and PROTEIN cytoskeletal changes, whereas replacement by glutamate enhanced the PROTEIN1 activity and stress fiber formation by PROTEIN .
BioInfer.d36.s0.p3	N	A PROTEIN mutant with replacement of threonine 505 by valine abolished PROTEIN activities for PROTEIN phosphorylation and PROTEIN2 cytoskeletal changes, whereas replacement by glutamate enhanced the PROTEIN1 activity and stress fiber formation by PROTEIN .
BioInfer.d36.s0.p4	N	A PROTEIN mutant with replacement of threonine 505 by valine abolished PROTEIN2 activities for PROTEIN phosphorylation and PROTEIN cytoskeletal changes, whereas replacement by glutamate enhanced the PROTEIN1 activity and stress fiber formation by PROTEIN .
BioInfer.d36.s0.p5	N	A PROTEIN mutant with replacement of threonine 505 by valine abolished PROTEIN activities for PROTEIN2 phosphorylation and PROTEIN cytoskeletal changes, whereas replacement by glutamate enhanced the PROTEIN activity and stress fiber formation by PROTEIN1 .
BioInfer.d36.s0.p6	N	A PROTEIN2 mutant with replacement of threonine 505 by valine abolished PROTEIN activities for PROTEIN phosphorylation and PROTEIN cytoskeletal changes, whereas replacement by glutamate enhanced the PROTEIN activity and stress fiber formation by PROTEIN1 .
BioInfer.d36.s0.p7	N	A PROTEIN mutant with replacement of threonine 505 by valine abolished PROTEIN activities for PROTEIN phosphorylation and PROTEIN2 cytoskeletal changes, whereas replacement by glutamate enhanced the PROTEIN activity and stress fiber formation by PROTEIN1 .
BioInfer.d36.s0.p8	N	A PROTEIN mutant with replacement of threonine 505 by valine abolished PROTEIN2 activities for PROTEIN phosphorylation and PROTEIN cytoskeletal changes, whereas replacement by glutamate enhanced the PROTEIN activity and stress fiber formation by PROTEIN1 .
BioInfer.d36.s0.p9	P	A PROTEIN2 mutant with replacement of threonine 505 by valine abolished PROTEIN activities for PROTEIN1 phosphorylation and PROTEIN cytoskeletal changes, whereas replacement by glutamate enhanced the PROTEIN activity and stress fiber formation by PROTEIN .
BioInfer.d36.s0.p10	N	A PROTEIN mutant with replacement of threonine 505 by valine abolished PROTEIN activities for PROTEIN1 phosphorylation and PROTEIN2 cytoskeletal changes, whereas replacement by glutamate enhanced the PROTEIN activity and stress fiber formation by PROTEIN .
BioInfer.d36.s0.p11	P	A PROTEIN mutant with replacement of threonine 505 by valine abolished PROTEIN2 activities for PROTEIN1 phosphorylation and PROTEIN cytoskeletal changes, whereas replacement by glutamate enhanced the PROTEIN activity and stress fiber formation by PROTEIN .
BioInfer.d36.s0.p12	P	A PROTEIN1 mutant with replacement of threonine 505 by valine abolished PROTEIN activities for PROTEIN phosphorylation and PROTEIN2 cytoskeletal changes, whereas replacement by glutamate enhanced the PROTEIN activity and stress fiber formation by PROTEIN .
BioInfer.d36.s0.p13	N	A PROTEIN1 mutant with replacement of threonine 505 by valine abolished PROTEIN2 activities for PROTEIN phosphorylation and PROTEIN cytoskeletal changes, whereas replacement by glutamate enhanced the PROTEIN activity and stress fiber formation by PROTEIN .
BioInfer.d36.s0.p14	P	A PROTEIN mutant with replacement of threonine 505 by valine abolished PROTEIN2 activities for PROTEIN phosphorylation and PROTEIN1 cytoskeletal changes, whereas replacement by glutamate enhanced the PROTEIN activity and stress fiber formation by PROTEIN .
BioInfer.d37.s0.p0	P	All of the experimental data were quantitatively accounted for on the basis of a 1:1 complex between PROTEIN1 and monomeric PROTEIN2 with a Kr between 4 and 9 microM, the same value obtained previously in the absence of MgCl2.
BioInfer.d37.s1.p0	P	The interaction of Acanthamoeba PROTEIN1 and Acanthamoeba PROTEIN2 was evaluated as a function of ionic conditions.
BioInfer.d38.s0.p0	P	All these results suggest that PROTEIN2 is a new type of PROTEIN1 -associated protein.
BioInfer.d38.s1.p0	N	The centrifugation assay and the PROTEIN1 inhibition assay demonstrate that PROTEIN2 binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p1	N	The centrifugation assay and the PROTEIN1 inhibition assay demonstrate that PROTEIN binds to PROTEIN2 filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p2	N	The centrifugation assay and the PROTEIN1 inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN2 increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p3	N	The centrifugation assay and the PROTEIN1 inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN2 to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p4	N	The centrifugation assay and the PROTEIN1 inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN2 monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p5	N	The centrifugation assay and the PROTEIN1 inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN2 to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p6	P	The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN1 binds to PROTEIN2 filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p7	N	The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN1 binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN2 increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p8	N	The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN1 binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN2 to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p9	N	The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN1 binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN2 monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p10	N	The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN1 binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN2 to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p11	N	The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN1 filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN2 increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p12	N	The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN1 filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN2 to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p13	N	The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN1 filaments in a 1:1 molar ratio of PROTEIN to PROTEIN2 monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p14	N	The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN1 filaments in a 1:1 molar ratio of PROTEIN2 to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p15	P	The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN monomer in the filament and that PROTEIN1 increases the monomeric PROTEIN2 to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p16	N	The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN2 monomer in the filament and that PROTEIN1 increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p17	N	The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN2 to PROTEIN monomer in the filament and that PROTEIN1 increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p18	N	The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN to PROTEIN2 monomer in the filament and that PROTEIN increases the monomeric PROTEIN1 to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p19	N	The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN2 to PROTEIN monomer in the filament and that PROTEIN increases the monomeric PROTEIN1 to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s1.p20	N	The centrifugation assay and the PROTEIN inhibition assay demonstrate that PROTEIN binds to PROTEIN filaments in a 1:1 molar ratio of PROTEIN2 to PROTEIN1 monomer in the filament and that PROTEIN increases the monomeric PROTEIN to a limited extent (up to 1.1-1.5 microM monomer) in the presence of physiological concentrations of Mg2+ and KCl.
BioInfer.d38.s2.p0	P	The gel point assay using an PROTEIN cross-linking protein and the nucleation assay also suggested that PROTEIN2 shortens the PROTEIN1 filaments and hence increases the filament number.
BioInfer.d38.s2.p1	N	The gel point assay using an PROTEIN2 cross-linking protein and the nucleation assay also suggested that PROTEIN shortens the PROTEIN1 filaments and hence increases the filament number.
BioInfer.d38.s2.p2	N	The gel point assay using an PROTEIN2 cross-linking protein and the nucleation assay also suggested that PROTEIN1 shortens the PROTEIN filaments and hence increases the filament number.
BioInfer.d39.s0.p0	P	Although binding patterns of different sera were not identical, almost all sera caused PROTEIN1 binding to platelet components of 87-90 kD, 140 kD (identified as PROTEIN ) and 220-240 kD (tentatively identified as PROTEIN and PROTEIN2 ).
BioInfer.d39.s0.p1	P	Although binding patterns of different sera were not identical, almost all sera caused PROTEIN1 binding to platelet components of 87-90 kD, 140 kD (identified as PROTEIN ) and 220-240 kD (tentatively identified as PROTEIN2 and PROTEIN ).
BioInfer.d39.s0.p2	P	Although binding patterns of different sera were not identical, almost all sera caused PROTEIN1 binding to platelet components of 87-90 kD, 140 kD (identified as PROTEIN2 ) and 220-240 kD (tentatively identified as PROTEIN and PROTEIN ).
BioInfer.d39.s0.p3	N	Although binding patterns of different sera were not identical, almost all sera caused PROTEIN binding to platelet components of 87-90 kD, 140 kD (identified as PROTEIN ) and 220-240 kD (tentatively identified as PROTEIN2 and PROTEIN1 ).
BioInfer.d39.s0.p4	N	Although binding patterns of different sera were not identical, almost all sera caused PROTEIN binding to platelet components of 87-90 kD, 140 kD (identified as PROTEIN2 ) and 220-240 kD (tentatively identified as PROTEIN and PROTEIN1 ).
BioInfer.d39.s0.p5	N	Although binding patterns of different sera were not identical, almost all sera caused PROTEIN binding to platelet components of 87-90 kD, 140 kD (identified as PROTEIN2 ) and 220-240 kD (tentatively identified as PROTEIN1 and PROTEIN ).
BioInfer.d40.s0.p0	N	Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN , only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN2 , PROTEIN1 , and the ends of PROTEIN filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.
BioInfer.d40.s0.p1	N	Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN , only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN , PROTEIN1 , and the ends of PROTEIN2 filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.
BioInfer.d40.s0.p2	P	Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN , only a PROTEIN2 can be detected in focal contacts, colocalizing with PROTEIN , PROTEIN1 , and the ends of PROTEIN filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.
BioInfer.d40.s0.p3	N	Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN , only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN , PROTEIN1 , and the ends of PROTEIN filaments, while PROTEIN2 shows a distinct, nonfocal contact, distribution on the cell surface.
BioInfer.d40.s0.p4	N	Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN2 , only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN , PROTEIN1 , and the ends of PROTEIN filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.
BioInfer.d40.s0.p5	N	Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN , only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN1 , PROTEIN , and the ends of PROTEIN2 filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.
BioInfer.d40.s0.p6	P	Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN , only a PROTEIN2 can be detected in focal contacts, colocalizing with PROTEIN1 , PROTEIN , and the ends of PROTEIN filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.
BioInfer.d40.s0.p7	N	Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN , only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN1 , PROTEIN , and the ends of PROTEIN filaments, while PROTEIN2 shows a distinct, nonfocal contact, distribution on the cell surface.
BioInfer.d40.s0.p8	N	Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN2 , only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN1 , PROTEIN , and the ends of PROTEIN filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.
BioInfer.d40.s0.p9	P	Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN , only a PROTEIN2 can be detected in focal contacts, colocalizing with PROTEIN , PROTEIN , and the ends of PROTEIN1 filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.
BioInfer.d40.s0.p10	N	Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN , only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN , PROTEIN , and the ends of PROTEIN1 filaments, while PROTEIN2 shows a distinct, nonfocal contact, distribution on the cell surface.
BioInfer.d40.s0.p11	N	Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN2 , only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN , PROTEIN , and the ends of PROTEIN1 filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.
BioInfer.d40.s0.p12	N	Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN , only a PROTEIN1 can be detected in focal contacts, colocalizing with PROTEIN , PROTEIN , and the ends of PROTEIN filaments, while PROTEIN2 shows a distinct, nonfocal contact, distribution on the cell surface.
BioInfer.d40.s0.p13	P	Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN2 , only a PROTEIN1 can be detected in focal contacts, colocalizing with PROTEIN , PROTEIN , and the ends of PROTEIN filaments, while PROTEIN shows a distinct, nonfocal contact, distribution on the cell surface.
BioInfer.d40.s0.p14	P	Although both receptors are involved in M21 and H2981 cell adhesion to PROTEIN2 , only a PROTEIN can be detected in focal contacts, colocalizing with PROTEIN , PROTEIN , and the ends of PROTEIN filaments, while PROTEIN1 shows a distinct, nonfocal contact, distribution on the cell surface.
BioInfer.d41.s0.p0	N	Although PROTEIN1 released PROTEIN at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN2 released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p1	P	Although PROTEIN1 released PROTEIN at the appropriate time to stimulate PROTEIN2 assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p2	P	Although PROTEIN1 released PROTEIN2 at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p3	N	Although PROTEIN1 released PROTEIN at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN2 content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p4	N	Although PROTEIN1 released PROTEIN at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN2 in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p5	N	Although PROTEIN1 released PROTEIN at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN2 associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p6	N	Although PROTEIN1 released PROTEIN at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN2 too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p7	N	Although PROTEIN released PROTEIN at the appropriate time to stimulate PROTEIN2 assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN1 released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p8	N	Although PROTEIN released PROTEIN2 at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN1 released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p9	N	Although PROTEIN released PROTEIN at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN2 content in unstimulated PMN and the quantity of PROTEIN1 released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p10	N	Although PROTEIN released PROTEIN at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN2 in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN1 released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p11	P	Although PROTEIN released PROTEIN at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN1 released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN2 associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p12	P	Although PROTEIN released PROTEIN at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN1 released from PROTEIN2 too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p13	P	Although PROTEIN released PROTEIN2 at the appropriate time to stimulate PROTEIN1 assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p14	N	Although PROTEIN released PROTEIN at the appropriate time to stimulate PROTEIN1 assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN2 content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p15	N	Although PROTEIN released PROTEIN at the appropriate time to stimulate PROTEIN1 assembly during exposure to chemoattractants, the concentration of PROTEIN2 in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p16	N	Although PROTEIN released PROTEIN at the appropriate time to stimulate PROTEIN1 assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN2 associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p17	N	Although PROTEIN released PROTEIN at the appropriate time to stimulate PROTEIN1 assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN2 too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p18	N	Although PROTEIN released PROTEIN1 at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN2 content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p19	N	Although PROTEIN released PROTEIN1 at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN2 in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p20	N	Although PROTEIN released PROTEIN1 at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN2 associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p21	N	Although PROTEIN released PROTEIN1 at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN2 too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p22	P	Although PROTEIN released PROTEIN at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN2 in PMN was insufficient to explain the high unpolymerized PROTEIN1 content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p23	N	Although PROTEIN released PROTEIN at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN1 content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN2 associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p24	N	Although PROTEIN released PROTEIN at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN1 content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN2 too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p25	N	Although PROTEIN released PROTEIN at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN1 in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN too small to account for the large shifts from unpolymerized to polymerized PROTEIN2 associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p26	N	Although PROTEIN released PROTEIN at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN1 in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN2 too small to account for the large shifts from unpolymerized to polymerized PROTEIN associated with maximal chemoattractant stimulation.
BioInfer.d41.s0.p27	N	Although PROTEIN released PROTEIN at the appropriate time to stimulate PROTEIN assembly during exposure to chemoattractants, the concentration of PROTEIN in PMN was insufficient to explain the high unpolymerized PROTEIN content in unstimulated PMN and the quantity of PROTEIN released from PROTEIN2 too small to account for the large shifts from unpolymerized to polymerized PROTEIN1 associated with maximal chemoattractant stimulation.
BioInfer.d41.s1.p0	N	Determination of the total PROTEIN and PROTEIN1 concentrations in PMN revealed that the molar ratio of PROTEIN to PROTEIN2 was 1 to 5.2.
BioInfer.d41.s1.p1	N	Determination of the total PROTEIN2 and PROTEIN1 concentrations in PMN revealed that the molar ratio of PROTEIN to PROTEIN was 1 to 5.2.
BioInfer.d41.s1.p2	N	Determination of the total PROTEIN and PROTEIN1 concentrations in PMN revealed that the molar ratio of PROTEIN2 to PROTEIN was 1 to 5.2.
BioInfer.d41.s1.p3	N	Determination of the total PROTEIN2 and PROTEIN concentrations in PMN revealed that the molar ratio of PROTEIN to PROTEIN1 was 1 to 5.2.
BioInfer.d41.s1.p4	N	Determination of the total PROTEIN and PROTEIN concentrations in PMN revealed that the molar ratio of PROTEIN2 to PROTEIN1 was 1 to 5.2.
BioInfer.d41.s1.p5	N	Determination of the total PROTEIN1 and PROTEIN concentrations in PMN revealed that the molar ratio of PROTEIN2 to PROTEIN was 1 to 5.2.
BioInfer.d41.s2.p0	P	We examined the role of the PROTEIN2 monomer sequestering protein, PROTEIN1 , in the regulation of PROTEIN filament assembly during chemoattractant stimulation using a Triton extraction method.
BioInfer.d41.s2.p1	P	We examined the role of the PROTEIN monomer sequestering protein, PROTEIN1 , in the regulation of PROTEIN2 filament assembly during chemoattractant stimulation using a Triton extraction method.
BioInfer.d41.s2.p2	N	We examined the role of the PROTEIN1 monomer sequestering protein, PROTEIN , in the regulation of PROTEIN2 filament assembly during chemoattractant stimulation using a Triton extraction method.
BioInfer.d42.s0.p2	N	Although PROTEIN has been suggested to act as a linkage protein mediating the attachment of PROTEIN2 -IIIa to PROTEIN filaments, direct binding of PROTEIN1 -IIIa to this cytoskeletal protein has not been demonstrated.
BioInfer.d42.s0.p3	P	Although PROTEIN2 has been suggested to act as a linkage protein mediating the attachment of PROTEIN -IIIa to PROTEIN filaments, direct binding of PROTEIN1 -IIIa to this cytoskeletal protein has not been demonstrated.
BioInfer.d42.s0.p4	N	Although PROTEIN has been suggested to act as a linkage protein mediating the attachment of PROTEIN -IIIa to PROTEIN2 filaments, direct binding of PROTEIN1 -IIIa to this cytoskeletal protein has not been demonstrated.
BioInfer.d42.s0.p12	P	Although PROTEIN2 has been suggested to act as a linkage protein mediating the attachment of PROTEIN1 -IIIa to PROTEIN filaments, direct binding of PROTEIN -IIIa to this cytoskeletal protein has not been demonstrated.
BioInfer.d42.s0.p13	P	Although PROTEIN has been suggested to act as a linkage protein mediating the attachment of PROTEIN1 -IIIa to PROTEIN2 filaments, direct binding of PROTEIN -IIIa to this cytoskeletal protein has not been demonstrated.
BioInfer.d42.s0.p14	P	Although PROTEIN1 has been suggested to act as a linkage protein mediating the attachment of PROTEIN -IIIa to PROTEIN2 filaments, direct binding of PROTEIN -IIIa to this cytoskeletal protein has not been demonstrated.
BioInfer.d43.s0.p0	P	Although co-localization of PROTEIN2 with PROTEIN1 filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, PROTEIN was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.
BioInfer.d43.s0.p1	N	Although co-localization of PROTEIN with PROTEIN1 filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, PROTEIN2 was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.
BioInfer.d43.s0.p2	N	Although co-localization of PROTEIN1 with PROTEIN filaments was not clearly demonstrated in the pancreatic beta-cell line MIN6, PROTEIN2 was found to be present in both the nucleus and the cytoplasm, though predominantly in the nucleus.
BioInfer.d43.s1.p0	P	A portion of PROTEIN1 appeared to be co-localized with PROTEIN2 filaments in the cytoplasm of cultured rat hepatocytes incubated with 25 mM glucose.
BioInfer.d43.s2.p0	P	Co-localization of PROTEIN2 with PROTEIN1 filaments.
BioInfer.d43.s3.p0	N	When PROTEIN or PROTEIN1 was transiently expressed in COS-7 cells, the expressed PROTEIN2 was also co-localized with PROTEIN filaments in the cytoplasm of these transfected cells.
BioInfer.d43.s3.p1	N	When PROTEIN2 or PROTEIN1 was transiently expressed in COS-7 cells, the expressed PROTEIN was also co-localized with PROTEIN filaments in the cytoplasm of these transfected cells.
BioInfer.d43.s3.p2	N	When PROTEIN or PROTEIN1 was transiently expressed in COS-7 cells, the expressed PROTEIN was also co-localized with PROTEIN2 filaments in the cytoplasm of these transfected cells.
BioInfer.d43.s3.p3	N	When PROTEIN2 or PROTEIN was transiently expressed in COS-7 cells, the expressed PROTEIN1 was also co-localized with PROTEIN filaments in the cytoplasm of these transfected cells.
BioInfer.d43.s3.p4	P	When PROTEIN or PROTEIN was transiently expressed in COS-7 cells, the expressed PROTEIN1 was also co-localized with PROTEIN2 filaments in the cytoplasm of these transfected cells.
BioInfer.d43.s3.p5	N	When PROTEIN1 or PROTEIN was transiently expressed in COS-7 cells, the expressed PROTEIN was also co-localized with PROTEIN2 filaments in the cytoplasm of these transfected cells.
BioInfer.d44.s0.p0	N	Although neither activation of PROTEIN1 ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN2 ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p1	P	Although neither activation of PROTEIN1 ( PROTEIN ) by the dominant PROTEIN2 mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p2	N	Although neither activation of PROTEIN1 ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN2 / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p3	N	Although neither activation of PROTEIN1 ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN2 pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p4	N	Although neither activation of PROTEIN1 ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN2 / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p5	N	Although neither activation of PROTEIN1 ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN2 also suppressed PROTEIN effectively.
BioInfer.d44.s0.p6	N	Although neither activation of PROTEIN1 ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN2 , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p7	N	Although neither activation of PROTEIN1 ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN2 ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p8	N	Although neither activation of PROTEIN1 ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN2 , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p9	N	Although neither activation of PROTEIN1 ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN2 effectively.
BioInfer.d44.s0.p10	P	Although neither activation of PROTEIN1 ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN2 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p11	N	Although neither activation of PROTEIN1 ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN2 as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p12	N	Although neither activation of PROTEIN1 ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN2 and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p13	P	Although neither activation of PROTEIN1 ( PROTEIN2 ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p14	N	Although neither activation of PROTEIN1 ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p15	N	Although neither activation of PROTEIN1 ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN2 ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p16	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN2 mutation nor increased dosage of PROTEIN1 ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p17	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN1 ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN2 / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p18	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN1 ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN2 pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p19	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN1 ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN2 / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p20	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN1 ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN2 also suppressed PROTEIN effectively.
BioInfer.d44.s0.p21	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN1 ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN2 , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p22	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN1 ( PROTEIN ) or PROTEIN2 ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p23	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN1 ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN2 , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p24	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN1 ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN2 effectively.
BioInfer.d44.s0.p25	P	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN1 ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN2 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p26	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN1 ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN2 as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p27	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN1 ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN2 and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p28	N	Although neither activation of PROTEIN ( PROTEIN2 ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN1 ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p29	P	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN1 ( PROTEIN2 ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p30	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN1 ( PROTEIN ) or PROTEIN ( PROTEIN2 ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p31	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN1 mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN2 / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p32	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN1 mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN2 pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p33	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN1 mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN2 / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p34	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN1 mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN2 also suppressed PROTEIN effectively.
BioInfer.d44.s0.p35	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN1 mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN2 , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p36	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN1 mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN2 ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p37	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN1 mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN2 , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p38	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN1 mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN2 effectively.
BioInfer.d44.s0.p39	P	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN1 mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN2 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p40	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN1 mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN2 as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p41	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN1 mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN2 and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p42	N	Although neither activation of PROTEIN ( PROTEIN2 ) by the dominant PROTEIN1 mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p43	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN1 mutation nor increased dosage of PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p44	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN1 mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN2 ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p45	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN2 pathway such as PROTEIN , PROTEIN , PROTEIN1 / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p46	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN1 / PROTEIN2 / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p47	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN1 / PROTEIN / PROTEIN and PROTEIN2 also suppressed PROTEIN effectively.
BioInfer.d44.s0.p48	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN2 , PROTEIN1 / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p49	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN2 ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN1 / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p50	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN2 , PROTEIN , PROTEIN1 / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p51	P	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN1 / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN2 effectively.
BioInfer.d44.s0.p52	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN2 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN1 / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p53	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN2 as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN1 / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p54	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN1 / PROTEIN / PROTEIN2 and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p55	N	Although neither activation of PROTEIN ( PROTEIN2 ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN1 / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p56	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN1 / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p57	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN2 ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN1 / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p58	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN1 pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN2 / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p59	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN1 pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN2 also suppressed PROTEIN effectively.
BioInfer.d44.s0.p60	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN1 pathway such as PROTEIN , PROTEIN2 , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p61	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN2 ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN1 pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p62	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN1 pathway such as PROTEIN2 , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p63	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN1 pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN2 effectively.
BioInfer.d44.s0.p64	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN2 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN1 pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p65	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN2 as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN1 pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p66	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN1 pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN2 and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p67	N	Although neither activation of PROTEIN ( PROTEIN2 ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN1 pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p68	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN1 pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p69	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN2 ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN1 pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p70	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN1 / PROTEIN and PROTEIN2 also suppressed PROTEIN effectively.
BioInfer.d44.s0.p71	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN2 , PROTEIN / PROTEIN1 / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p72	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN2 ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN1 / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p73	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN2 , PROTEIN , PROTEIN / PROTEIN1 / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p74	P	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN1 / PROTEIN and PROTEIN also suppressed PROTEIN2 effectively.
BioInfer.d44.s0.p75	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN2 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN1 / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p76	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN2 as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN1 / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p77	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN1 / PROTEIN2 and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p78	N	Although neither activation of PROTEIN ( PROTEIN2 ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN1 / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p79	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN1 / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p80	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN2 ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN1 / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p81	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN2 , PROTEIN / PROTEIN / PROTEIN and PROTEIN1 also suppressed PROTEIN effectively.
BioInfer.d44.s0.p82	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN2 ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN1 also suppressed PROTEIN effectively.
BioInfer.d44.s0.p83	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN2 , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN1 also suppressed PROTEIN effectively.
BioInfer.d44.s0.p84	P	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN1 also suppressed PROTEIN2 effectively.
BioInfer.d44.s0.p85	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN2 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN1 also suppressed PROTEIN effectively.
BioInfer.d44.s0.p86	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN2 as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN1 also suppressed PROTEIN effectively.
BioInfer.d44.s0.p87	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN2 and PROTEIN1 also suppressed PROTEIN effectively.
BioInfer.d44.s0.p88	N	Although neither activation of PROTEIN ( PROTEIN2 ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN1 also suppressed PROTEIN effectively.
BioInfer.d44.s0.p89	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN1 also suppressed PROTEIN effectively.
BioInfer.d44.s0.p90	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN2 ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN1 also suppressed PROTEIN effectively.
BioInfer.d44.s0.p91	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN2 ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN1 , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p92	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN2 , PROTEIN1 , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p93	P	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN1 , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN2 effectively.
BioInfer.d44.s0.p94	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN2 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN1 , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p95	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN2 as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN1 , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p96	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN1 , PROTEIN / PROTEIN / PROTEIN2 and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p97	N	Although neither activation of PROTEIN ( PROTEIN2 ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN1 , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p98	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN1 , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p99	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN2 ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN1 , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p100	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN1 ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN2 , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p101	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN1 ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN2 effectively.
BioInfer.d44.s0.p102	P	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN1 ( PROTEIN ) mimicked PROTEIN as a PROTEIN2 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p103	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN1 ( PROTEIN ) mimicked PROTEIN2 as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p104	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN1 ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN2 and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p105	N	Although neither activation of PROTEIN ( PROTEIN2 ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN1 ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p106	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN2 ) or PROTEIN1 ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p107	P	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN1 ( PROTEIN2 ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p108	P	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN1 , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN2 effectively.
BioInfer.d44.s0.p109	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN2 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN1 , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p110	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN2 as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN1 , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p111	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN1 , PROTEIN , PROTEIN / PROTEIN / PROTEIN2 and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p112	N	Although neither activation of PROTEIN ( PROTEIN2 ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN1 , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p113	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN1 , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p114	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN2 ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN1 , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p115	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN2 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN1 effectively.
BioInfer.d44.s0.p116	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN2 as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN1 effectively.
BioInfer.d44.s0.p117	P	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN2 and PROTEIN also suppressed PROTEIN1 effectively.
BioInfer.d44.s0.p118	N	Although neither activation of PROTEIN ( PROTEIN2 ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN1 effectively.
BioInfer.d44.s0.p119	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN1 effectively.
BioInfer.d44.s0.p120	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN2 ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN1 effectively.
BioInfer.d44.s0.p121	P	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN2 as a PROTEIN1 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p122	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN1 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN2 and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p123	N	Although neither activation of PROTEIN ( PROTEIN2 ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN1 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p124	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN1 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p125	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN2 ) mimicked PROTEIN as a PROTEIN1 dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p126	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN1 as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN2 and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p127	N	Although neither activation of PROTEIN ( PROTEIN2 ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN1 as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p128	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) mimicked PROTEIN1 as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p129	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN2 ) mimicked PROTEIN1 as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p130	N	Although neither activation of PROTEIN ( PROTEIN2 ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN1 and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p131	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN1 and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p132	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN2 ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN1 and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p133	N	Although neither activation of PROTEIN ( PROTEIN1 ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p134	N	Although neither activation of PROTEIN ( PROTEIN1 ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN2 ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d44.s0.p135	N	Although neither activation of PROTEIN ( PROTEIN ) by the dominant PROTEIN mutation nor increased dosage of PROTEIN ( PROTEIN1 ) or PROTEIN ( PROTEIN2 ) mimicked PROTEIN as a PROTEIN dosage suppressor, extra copies of genes encoding upstream components of the PROTEIN pathway such as PROTEIN , PROTEIN , PROTEIN / PROTEIN / PROTEIN and PROTEIN also suppressed PROTEIN effectively.
BioInfer.d45.s0.p0	N	Although platelets contain only 1 PROTEIN for every 5-10 PROTEIN2 molecules, these complex reactions may allow substoichiometric PROTEIN to have an important influence on PROTEIN1 assembly.
BioInfer.d45.s0.p1	N	Although platelets contain only 1 PROTEIN2 for every 5-10 PROTEIN molecules, these complex reactions may allow substoichiometric PROTEIN to have an important influence on PROTEIN1 assembly.
BioInfer.d45.s0.p2	P	Although platelets contain only 1 PROTEIN for every 5-10 PROTEIN molecules, these complex reactions may allow substoichiometric PROTEIN2 to have an important influence on PROTEIN1 assembly.
BioInfer.d45.s0.p3	N	Although platelets contain only 1 PROTEIN2 for every 5-10 PROTEIN1 molecules, these complex reactions may allow substoichiometric PROTEIN to have an important influence on PROTEIN assembly.
BioInfer.d45.s0.p4	N	Although platelets contain only 1 PROTEIN for every 5-10 PROTEIN1 molecules, these complex reactions may allow substoichiometric PROTEIN2 to have an important influence on PROTEIN assembly.
BioInfer.d45.s0.p5	N	Although platelets contain only 1 PROTEIN1 for every 5-10 PROTEIN molecules, these complex reactions may allow substoichiometric PROTEIN2 to have an important influence on PROTEIN assembly.
BioInfer.d45.s1.p0	P	Kinetic simulation showed that the PROTEIN1 exchanges between PROTEIN2 monomers on a subsecond time scale that allows it to catalyze nucleotide exchange.
BioInfer.d45.s2.p0	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN2 has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN1 inhibits the elongation of PROTEIN much more strongly than PROTEIN ; and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p1	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN2 filaments; PROTEIN1 inhibits the elongation of PROTEIN much more strongly than PROTEIN ; and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p2	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN1 inhibits the elongation of PROTEIN much more strongly than PROTEIN ; and simple formation of 1:1 complexes of PROTEIN with PROTEIN2 cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p3	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN1 inhibits the elongation of PROTEIN much more strongly than PROTEIN ; and simple formation of 1:1 complexes of PROTEIN2 with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p4	P	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN1 inhibits the elongation of PROTEIN much more strongly than PROTEIN2 ; and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p5	P	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN1 inhibits the elongation of PROTEIN2 much more strongly than PROTEIN ; and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p6	P	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN1 has different effects on elongation at the two ends of PROTEIN2 filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN ; and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p7	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN1 has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN ; and simple formation of 1:1 complexes of PROTEIN with PROTEIN2 cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p8	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN1 has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN ; and simple formation of 1:1 complexes of PROTEIN2 with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p9	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN1 has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN2 ; and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p10	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN1 has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN2 much more strongly than PROTEIN ; and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p11	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN1 filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN ; and simple formation of 1:1 complexes of PROTEIN with PROTEIN2 cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p12	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN1 filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN ; and simple formation of 1:1 complexes of PROTEIN2 with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p13	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN1 filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN2 ; and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p14	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN1 filaments; PROTEIN inhibits the elongation of PROTEIN2 much more strongly than PROTEIN ; and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p15	P	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN ; and simple formation of 1:1 complexes of PROTEIN2 with PROTEIN1 cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p16	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN2 ; and simple formation of 1:1 complexes of PROTEIN with PROTEIN1 cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p17	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN2 much more strongly than PROTEIN ; and simple formation of 1:1 complexes of PROTEIN with PROTEIN1 cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p18	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN much more strongly than PROTEIN2 ; and simple formation of 1:1 complexes of PROTEIN1 with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p19	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN2 much more strongly than PROTEIN ; and simple formation of 1:1 complexes of PROTEIN1 with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d45.s2.p20	N	On the other hand, polymerization assays give disparate results that are inconsistent with the binding assays and each other: PROTEIN has different effects on elongation at the two ends of PROTEIN filaments; PROTEIN inhibits the elongation of PROTEIN2 much more strongly than PROTEIN1 ; and simple formation of 1:1 complexes of PROTEIN with PROTEIN cannot account for the strong inhibition of spontaneous polymerization.
BioInfer.d47.s0.p0	N	Although the chemical basis of these results is not known, they indicate that PROTEIN2 can tightly sequester PROTEIN monomers and support the earlier suggestion that the affinity of PROTEIN for PROTEIN1 may be under metabolic control.
BioInfer.d47.s0.p1	N	Although the chemical basis of these results is not known, they indicate that PROTEIN can tightly sequester PROTEIN2 monomers and support the earlier suggestion that the affinity of PROTEIN for PROTEIN1 may be under metabolic control.
BioInfer.d47.s0.p2	P	Although the chemical basis of these results is not known, they indicate that PROTEIN can tightly sequester PROTEIN monomers and support the earlier suggestion that the affinity of PROTEIN2 for PROTEIN1 may be under metabolic control.
BioInfer.d47.s0.p3	P	Although the chemical basis of these results is not known, they indicate that PROTEIN1 can tightly sequester PROTEIN2 monomers and support the earlier suggestion that the affinity of PROTEIN for PROTEIN may be under metabolic control.
BioInfer.d47.s0.p4	N	Although the chemical basis of these results is not known, they indicate that PROTEIN1 can tightly sequester PROTEIN monomers and support the earlier suggestion that the affinity of PROTEIN2 for PROTEIN may be under metabolic control.
BioInfer.d47.s0.p5	N	Although the chemical basis of these results is not known, they indicate that PROTEIN can tightly sequester PROTEIN1 monomers and support the earlier suggestion that the affinity of PROTEIN2 for PROTEIN may be under metabolic control.
BioInfer.d47.s1.p0	N	Recent evidence that PROTEIN inhibits PROTEIN and enhances nucleotide exchange of PROTEIN1 has led some to question whether PROTEIN is ever truly an PROTEIN2 monomer sequestering agent.
BioInfer.d47.s1.p1	N	Recent evidence that PROTEIN inhibits PROTEIN and enhances nucleotide exchange of PROTEIN1 has led some to question whether PROTEIN2 is ever truly an PROTEIN monomer sequestering agent.
BioInfer.d47.s1.p2	P	Recent evidence that PROTEIN2 inhibits PROTEIN and enhances nucleotide exchange of PROTEIN1 has led some to question whether PROTEIN is ever truly an PROTEIN monomer sequestering agent.
BioInfer.d47.s1.p3	N	Recent evidence that PROTEIN inhibits PROTEIN2 and enhances nucleotide exchange of PROTEIN1 has led some to question whether PROTEIN is ever truly an PROTEIN monomer sequestering agent.
BioInfer.d47.s1.p4	P	Recent evidence that PROTEIN inhibits PROTEIN and enhances nucleotide exchange of PROTEIN has led some to question whether PROTEIN2 is ever truly an PROTEIN1 monomer sequestering agent.
BioInfer.d47.s1.p5	N	Recent evidence that PROTEIN2 inhibits PROTEIN and enhances nucleotide exchange of PROTEIN has led some to question whether PROTEIN is ever truly an PROTEIN1 monomer sequestering agent.
BioInfer.d47.s1.p6	N	Recent evidence that PROTEIN inhibits PROTEIN2 and enhances nucleotide exchange of PROTEIN has led some to question whether PROTEIN is ever truly an PROTEIN1 monomer sequestering agent.
BioInfer.d47.s1.p7	N	Recent evidence that PROTEIN2 inhibits PROTEIN and enhances nucleotide exchange of PROTEIN has led some to question whether PROTEIN1 is ever truly an PROTEIN monomer sequestering agent.
BioInfer.d47.s1.p8	N	Recent evidence that PROTEIN inhibits PROTEIN2 and enhances nucleotide exchange of PROTEIN has led some to question whether PROTEIN1 is ever truly an PROTEIN monomer sequestering agent.
BioInfer.d47.s1.p9	P	Recent evidence that PROTEIN1 inhibits PROTEIN2 and enhances nucleotide exchange of PROTEIN has led some to question whether PROTEIN is ever truly an PROTEIN monomer sequestering agent.
BioInfer.d48.s0.p0	P	A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of PROTEIN and PROTEIN1 on the structure, chain dynamics, elasticity and viscoelasticity of PROTEIN2 filaments with time.
BioInfer.d48.s0.p1	N	A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of PROTEIN2 and PROTEIN1 on the structure, chain dynamics, elasticity and viscoelasticity of PROTEIN filaments with time.
BioInfer.d48.s0.p2	P	A major point of interest was to clarify whether rheological, high precision measurements can yield quantitative information about the influence of PROTEIN2 and PROTEIN on the structure, chain dynamics, elasticity and viscoelasticity of PROTEIN1 filaments with time.
BioInfer.d48.s1.p0	P	The viscoelasticity of entangled PROTEIN1 networks: the influence of defects and modulation by PROTEIN2 and PROTEIN .
BioInfer.d48.s1.p1	P	The viscoelasticity of entangled PROTEIN1 networks: the influence of defects and modulation by PROTEIN and PROTEIN2 .
BioInfer.d48.s1.p2	N	The viscoelasticity of entangled PROTEIN networks: the influence of defects and modulation by PROTEIN1 and PROTEIN2 .
BioInfer.d49.s0.p0	P	A model is proposed for the function of PROTEIN2 in PROTEIN1 -based motility.
BioInfer.d49.s1.p0	P	As a consequence, in the presence of PROTEIN ( PROTEIN ), low amounts of PROTEIN1 promote extensive PROTEIN2 assembly off of the pool of PROTEIN - PROTEIN complex.
BioInfer.d49.s1.p1	N	As a consequence, in the presence of PROTEIN ( PROTEIN ), low amounts of PROTEIN1 promote extensive PROTEIN assembly off of the pool of PROTEIN2 - PROTEIN complex.
BioInfer.d49.s1.p2	N	As a consequence, in the presence of PROTEIN2 ( PROTEIN ), low amounts of PROTEIN1 promote extensive PROTEIN assembly off of the pool of PROTEIN - PROTEIN complex.
BioInfer.d49.s1.p3	N	As a consequence, in the presence of PROTEIN ( PROTEIN ), low amounts of PROTEIN1 promote extensive PROTEIN assembly off of the pool of PROTEIN - PROTEIN2 complex.
BioInfer.d49.s1.p4	N	As a consequence, in the presence of PROTEIN ( PROTEIN2 ), low amounts of PROTEIN1 promote extensive PROTEIN assembly off of the pool of PROTEIN - PROTEIN complex.
BioInfer.d49.s1.p5	P	As a consequence, in the presence of PROTEIN ( PROTEIN ), low amounts of PROTEIN promote extensive PROTEIN1 assembly off of the pool of PROTEIN2 - PROTEIN complex.
BioInfer.d49.s1.p6	N	As a consequence, in the presence of PROTEIN2 ( PROTEIN ), low amounts of PROTEIN promote extensive PROTEIN1 assembly off of the pool of PROTEIN - PROTEIN complex.
BioInfer.d49.s1.p7	P	As a consequence, in the presence of PROTEIN ( PROTEIN ), low amounts of PROTEIN promote extensive PROTEIN1 assembly off of the pool of PROTEIN - PROTEIN2 complex.
BioInfer.d49.s1.p8	N	As a consequence, in the presence of PROTEIN ( PROTEIN2 ), low amounts of PROTEIN promote extensive PROTEIN1 assembly off of the pool of PROTEIN - PROTEIN complex.
BioInfer.d49.s1.p9	N	As a consequence, in the presence of PROTEIN2 ( PROTEIN ), low amounts of PROTEIN promote extensive PROTEIN assembly off of the pool of PROTEIN1 - PROTEIN complex.
BioInfer.d49.s1.p10	P	As a consequence, in the presence of PROTEIN ( PROTEIN ), low amounts of PROTEIN promote extensive PROTEIN assembly off of the pool of PROTEIN1 - PROTEIN2 complex.
BioInfer.d49.s1.p11	N	As a consequence, in the presence of PROTEIN ( PROTEIN2 ), low amounts of PROTEIN promote extensive PROTEIN assembly off of the pool of PROTEIN1 - PROTEIN complex.
BioInfer.d49.s1.p12	N	As a consequence, in the presence of PROTEIN1 ( PROTEIN ), low amounts of PROTEIN promote extensive PROTEIN assembly off of the pool of PROTEIN - PROTEIN2 complex.
BioInfer.d49.s1.p13	N	As a consequence, in the presence of PROTEIN1 ( PROTEIN2 ), low amounts of PROTEIN promote extensive PROTEIN assembly off of the pool of PROTEIN - PROTEIN complex.
BioInfer.d49.s1.p14	N	As a consequence, in the presence of PROTEIN ( PROTEIN2 ), low amounts of PROTEIN promote extensive PROTEIN assembly off of the pool of PROTEIN - PROTEIN1 complex.
BioInfer.d49.s2.p0	N	How PROTEIN promotes PROTEIN1 filament assembly in the presence of PROTEIN2 .
BioInfer.d49.s2.p1	P	How PROTEIN2 promotes PROTEIN1 filament assembly in the presence of PROTEIN .
BioInfer.d49.s2.p2	N	How PROTEIN2 promotes PROTEIN filament assembly in the presence of PROTEIN1 .
BioInfer.d49.s3.p0	P	The role of PROTEIN2 in the regulation of PROTEIN1 assembly has been reexamined.
BioInfer.d49.s4.p0	P	When barbed ends are capped, PROTEIN1 simply sequesters globular PROTEIN2 .
BioInfer.d50.s0.p0	P	PROTEIN1 binds PROTEIN2 likely to promote PROTEIN polymerization.
BioInfer.d50.s0.p1	P	PROTEIN1 binds PROTEIN likely to promote PROTEIN2 polymerization.
BioInfer.d50.s0.p2	P	PROTEIN binds PROTEIN1 likely to promote PROTEIN2 polymerization.
BioInfer.d51.s0.p0	N	PROTEIN1 plays a fundamental role in mispair recognition whereas PROTEIN and PROTEIN2 appear to modify the specificity of this recognition.
BioInfer.d51.s0.p1	N	PROTEIN1 plays a fundamental role in mispair recognition whereas PROTEIN2 and PROTEIN appear to modify the specificity of this recognition.
BioInfer.d51.s0.p2	N	PROTEIN plays a fundamental role in mispair recognition whereas PROTEIN2 and PROTEIN1 appear to modify the specificity of this recognition.
BioInfer.d52.s0.p0	N	PROTEIN2 is a PROTEIN homologue enriched in epithelial cells and forms a complex with PROTEIN , a PROTEIN1 localized to the apical plasma membrane.
BioInfer.d52.s0.p1	N	PROTEIN is a PROTEIN2 homologue enriched in epithelial cells and forms a complex with PROTEIN , a PROTEIN1 localized to the apical plasma membrane.
BioInfer.d52.s0.p2	P	PROTEIN is a PROTEIN homologue enriched in epithelial cells and forms a complex with PROTEIN2 , a PROTEIN1 localized to the apical plasma membrane.
BioInfer.d52.s0.p3	P	PROTEIN1 is a PROTEIN2 homologue enriched in epithelial cells and forms a complex with PROTEIN , a PROTEIN localized to the apical plasma membrane.
BioInfer.d52.s0.p4	P	PROTEIN1 is a PROTEIN homologue enriched in epithelial cells and forms a complex with PROTEIN2 , a PROTEIN localized to the apical plasma membrane.
BioInfer.d52.s0.p5	N	PROTEIN is a PROTEIN1 homologue enriched in epithelial cells and forms a complex with PROTEIN2 , a PROTEIN localized to the apical plasma membrane.
BioInfer.d52.s1.p0	P	Even the PROTEIN mutants that do not detectably bind PROTEIN were membrane associated in Caco-2 cells, suggesting that the PROTEIN1 interaction is not the sole determinant of PROTEIN2 protein membrane attachment.
BioInfer.d52.s1.p1	N	Even the PROTEIN mutants that do not detectably bind PROTEIN2 were membrane associated in Caco-2 cells, suggesting that the PROTEIN1 interaction is not the sole determinant of PROTEIN protein membrane attachment.
BioInfer.d52.s1.p2	N	Even the PROTEIN2 mutants that do not detectably bind PROTEIN were membrane associated in Caco-2 cells, suggesting that the PROTEIN1 interaction is not the sole determinant of PROTEIN protein membrane attachment.
BioInfer.d52.s1.p3	N	Even the PROTEIN mutants that do not detectably bind PROTEIN2 were membrane associated in Caco-2 cells, suggesting that the PROTEIN interaction is not the sole determinant of PROTEIN1 protein membrane attachment.
BioInfer.d52.s1.p4	N	Even the PROTEIN2 mutants that do not detectably bind PROTEIN were membrane associated in Caco-2 cells, suggesting that the PROTEIN interaction is not the sole determinant of PROTEIN1 protein membrane attachment.
BioInfer.d52.s1.p5	P	Even the PROTEIN2 mutants that do not detectably bind PROTEIN1 were membrane associated in Caco-2 cells, suggesting that the PROTEIN interaction is not the sole determinant of PROTEIN protein membrane attachment.
BioInfer.d52.s2.p0	P	The in vitro and in vivo binding patterns were highly similar, and the association of the PROTEIN1 variants with PROTEIN correlated well with their ability to displace PROTEIN from PROTEIN2 complexes when overexpressed in Caco-2 cells.
BioInfer.d52.s2.p1	P	The in vitro and in vivo binding patterns were highly similar, and the association of the PROTEIN1 variants with PROTEIN correlated well with their ability to displace PROTEIN2 from PROTEIN complexes when overexpressed in Caco-2 cells.
BioInfer.d52.s2.p2	P	The in vitro and in vivo binding patterns were highly similar, and the association of the PROTEIN1 variants with PROTEIN2 correlated well with their ability to displace PROTEIN from PROTEIN complexes when overexpressed in Caco-2 cells.
BioInfer.d52.s2.p3	P	The in vitro and in vivo binding patterns were highly similar, and the association of the PROTEIN variants with PROTEIN correlated well with their ability to displace PROTEIN2 from PROTEIN1 complexes when overexpressed in Caco-2 cells.
BioInfer.d52.s2.p4	P	The in vitro and in vivo binding patterns were highly similar, and the association of the PROTEIN variants with PROTEIN2 correlated well with their ability to displace PROTEIN from PROTEIN1 complexes when overexpressed in Caco-2 cells.
BioInfer.d52.s2.p5	P	The in vitro and in vivo binding patterns were highly similar, and the association of the PROTEIN variants with PROTEIN2 correlated well with their ability to displace PROTEIN1 from PROTEIN complexes when overexpressed in Caco-2 cells.
BioInfer.d52.s3.p0	N	This implies that PROTEIN2 function in apical membrane trafficking involves aspects independent of the PROTEIN1 interaction.
BioInfer.d53.s0.p0	N	Analyses of PROTEIN or PROTEIN1 immunoprecipitates from BMMC lysate revealed that PROTEIN , PROTEIN2 , and PROTEIN were co-precipitated, suggesting that PROTEIN and PROTEIN form a complex in mast cells.
BioInfer.d53.s0.p1	N	Analyses of PROTEIN or PROTEIN1 immunoprecipitates from BMMC lysate revealed that PROTEIN , PROTEIN , and PROTEIN were co-precipitated, suggesting that PROTEIN and PROTEIN2 form a complex in mast cells.
BioInfer.d53.s0.p2	N	Analyses of PROTEIN or PROTEIN1 immunoprecipitates from BMMC lysate revealed that PROTEIN , PROTEIN , and PROTEIN were co-precipitated, suggesting that PROTEIN2 and PROTEIN form a complex in mast cells.
BioInfer.d53.s0.p3	N	Analyses of PROTEIN2 or PROTEIN1 immunoprecipitates from BMMC lysate revealed that PROTEIN , PROTEIN , and PROTEIN were co-precipitated, suggesting that PROTEIN and PROTEIN form a complex in mast cells.
BioInfer.d53.s0.p4	N	Analyses of PROTEIN or PROTEIN1 immunoprecipitates from BMMC lysate revealed that PROTEIN2 , PROTEIN , and PROTEIN were co-precipitated, suggesting that PROTEIN and PROTEIN form a complex in mast cells.
BioInfer.d53.s0.p5	N	Analyses of PROTEIN or PROTEIN1 immunoprecipitates from BMMC lysate revealed that PROTEIN , PROTEIN , and PROTEIN2 were co-precipitated, suggesting that PROTEIN and PROTEIN form a complex in mast cells.
BioInfer.d53.s0.p6	N	Analyses of PROTEIN or PROTEIN immunoprecipitates from BMMC lysate revealed that PROTEIN , PROTEIN1 , and PROTEIN were co-precipitated, suggesting that PROTEIN and PROTEIN2 form a complex in mast cells.
BioInfer.d53.s0.p7	N	Analyses of PROTEIN or PROTEIN immunoprecipitates from BMMC lysate revealed that PROTEIN , PROTEIN1 , and PROTEIN were co-precipitated, suggesting that PROTEIN2 and PROTEIN form a complex in mast cells.
BioInfer.d53.s0.p8	N	Analyses of PROTEIN2 or PROTEIN immunoprecipitates from BMMC lysate revealed that PROTEIN , PROTEIN1 , and PROTEIN were co-precipitated, suggesting that PROTEIN and PROTEIN form a complex in mast cells.
BioInfer.d53.s0.p9	P	Analyses of PROTEIN or PROTEIN immunoprecipitates from BMMC lysate revealed that PROTEIN2 , PROTEIN1 , and PROTEIN were co-precipitated, suggesting that PROTEIN and PROTEIN form a complex in mast cells.
BioInfer.d53.s0.p10	P	Analyses of PROTEIN or PROTEIN immunoprecipitates from BMMC lysate revealed that PROTEIN , PROTEIN1 , and PROTEIN2 were co-precipitated, suggesting that PROTEIN and PROTEIN form a complex in mast cells.
BioInfer.d53.s0.p11	P	Analyses of PROTEIN or PROTEIN immunoprecipitates from BMMC lysate revealed that PROTEIN , PROTEIN , and PROTEIN were co-precipitated, suggesting that PROTEIN2 and PROTEIN1 form a complex in mast cells.
BioInfer.d53.s0.p12	N	Analyses of PROTEIN2 or PROTEIN immunoprecipitates from BMMC lysate revealed that PROTEIN , PROTEIN , and PROTEIN were co-precipitated, suggesting that PROTEIN and PROTEIN1 form a complex in mast cells.
BioInfer.d53.s0.p13	N	Analyses of PROTEIN or PROTEIN immunoprecipitates from BMMC lysate revealed that PROTEIN2 , PROTEIN , and PROTEIN were co-precipitated, suggesting that PROTEIN and PROTEIN1 form a complex in mast cells.
BioInfer.d53.s0.p14	N	Analyses of PROTEIN or PROTEIN immunoprecipitates from BMMC lysate revealed that PROTEIN , PROTEIN , and PROTEIN2 were co-precipitated, suggesting that PROTEIN and PROTEIN1 form a complex in mast cells.
BioInfer.d53.s0.p15	N	Analyses of PROTEIN2 or PROTEIN immunoprecipitates from BMMC lysate revealed that PROTEIN , PROTEIN , and PROTEIN were co-precipitated, suggesting that PROTEIN1 and PROTEIN form a complex in mast cells.
BioInfer.d53.s0.p16	N	Analyses of PROTEIN or PROTEIN immunoprecipitates from BMMC lysate revealed that PROTEIN2 , PROTEIN , and PROTEIN were co-precipitated, suggesting that PROTEIN1 and PROTEIN form a complex in mast cells.
BioInfer.d53.s0.p17	N	Analyses of PROTEIN or PROTEIN immunoprecipitates from BMMC lysate revealed that PROTEIN , PROTEIN , and PROTEIN2 were co-precipitated, suggesting that PROTEIN1 and PROTEIN form a complex in mast cells.
BioInfer.d53.s0.p18	N	Analyses of PROTEIN1 or PROTEIN immunoprecipitates from BMMC lysate revealed that PROTEIN2 , PROTEIN , and PROTEIN were co-precipitated, suggesting that PROTEIN and PROTEIN form a complex in mast cells.
BioInfer.d53.s0.p19	N	Analyses of PROTEIN1 or PROTEIN immunoprecipitates from BMMC lysate revealed that PROTEIN , PROTEIN , and PROTEIN2 were co-precipitated, suggesting that PROTEIN and PROTEIN form a complex in mast cells.
BioInfer.d53.s0.p20	P	Analyses of PROTEIN or PROTEIN immunoprecipitates from BMMC lysate revealed that PROTEIN1 , PROTEIN , and PROTEIN2 were co-precipitated, suggesting that PROTEIN and PROTEIN form a complex in mast cells.
BioInfer.d54.s0.p0	N	Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN2 has a negligible influence on internal PROTEIN filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN , another PROTEIN1 and PROTEIN -binding protein from focal adhesions.
BioInfer.d54.s0.p1	P	Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN2 , another PROTEIN1 and PROTEIN -binding protein from focal adhesions.
BioInfer.d54.s0.p2	N	Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN filament dynamics and PROTEIN2 bending stiffness which contrasts with our previous observations with PROTEIN , another PROTEIN1 and PROTEIN -binding protein from focal adhesions.
BioInfer.d54.s0.p3	N	Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN , another PROTEIN1 and PROTEIN2 -binding protein from focal adhesions.
BioInfer.d54.s0.p4	N	Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN2 filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN , another PROTEIN1 and PROTEIN -binding protein from focal adhesions.
BioInfer.d54.s0.p5	N	Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN1 has a negligible influence on internal PROTEIN filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN2 , another PROTEIN and PROTEIN -binding protein from focal adhesions.
BioInfer.d54.s0.p6	P	Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN1 has a negligible influence on internal PROTEIN filament dynamics and PROTEIN2 bending stiffness which contrasts with our previous observations with PROTEIN , another PROTEIN and PROTEIN -binding protein from focal adhesions.
BioInfer.d54.s0.p7	N	Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN1 has a negligible influence on internal PROTEIN filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN , another PROTEIN and PROTEIN2 -binding protein from focal adhesions.
BioInfer.d54.s0.p8	P	Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN1 has a negligible influence on internal PROTEIN2 filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN , another PROTEIN and PROTEIN -binding protein from focal adhesions.
BioInfer.d54.s0.p9	N	Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN filament dynamics and PROTEIN2 bending stiffness which contrasts with our previous observations with PROTEIN1 , another PROTEIN and PROTEIN -binding protein from focal adhesions.
BioInfer.d54.s0.p10	P	Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN1 , another PROTEIN and PROTEIN2 -binding protein from focal adhesions.
BioInfer.d54.s0.p11	N	Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN2 filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN1 , another PROTEIN and PROTEIN -binding protein from focal adhesions.
BioInfer.d54.s0.p12	N	Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN filament dynamics and PROTEIN1 bending stiffness which contrasts with our previous observations with PROTEIN , another PROTEIN and PROTEIN2 -binding protein from focal adhesions.
BioInfer.d54.s0.p13	N	Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN2 filament dynamics and PROTEIN1 bending stiffness which contrasts with our previous observations with PROTEIN , another PROTEIN and PROTEIN -binding protein from focal adhesions.
BioInfer.d54.s0.p14	N	Analyses of dynamic light scattering data by stretched exponential fit show that PROTEIN has a negligible influence on internal PROTEIN2 filament dynamics and PROTEIN bending stiffness which contrasts with our previous observations with PROTEIN , another PROTEIN and PROTEIN1 -binding protein from focal adhesions.
BioInfer.d55.s0.p0	N	Analysis of PROTEIN1 : PROTEIN crystals reveals an extensive intermolecular network, rather than a discrete "monomeric complex", comprising stacked PROTEIN ribbons held in place by columns of PROTEIN2 molecules, wedged in between neighboring PROTEIN subunits and running perpendicular to the ribbons.
BioInfer.d55.s0.p1	N	Analysis of PROTEIN1 : PROTEIN crystals reveals an extensive intermolecular network, rather than a discrete "monomeric complex", comprising stacked PROTEIN2 ribbons held in place by columns of PROTEIN molecules, wedged in between neighboring PROTEIN subunits and running perpendicular to the ribbons.
BioInfer.d55.s0.p2	N	Analysis of PROTEIN1 : PROTEIN2 crystals reveals an extensive intermolecular network, rather than a discrete "monomeric complex", comprising stacked PROTEIN ribbons held in place by columns of PROTEIN molecules, wedged in between neighboring PROTEIN subunits and running perpendicular to the ribbons.
BioInfer.d55.s0.p3	N	Analysis of PROTEIN1 : PROTEIN crystals reveals an extensive intermolecular network, rather than a discrete "monomeric complex", comprising stacked PROTEIN ribbons held in place by columns of PROTEIN molecules, wedged in between neighboring PROTEIN2 subunits and running perpendicular to the ribbons.
BioInfer.d55.s0.p4	N	Analysis of PROTEIN : PROTEIN crystals reveals an extensive intermolecular network, rather than a discrete "monomeric complex", comprising stacked PROTEIN2 ribbons held in place by columns of PROTEIN1 molecules, wedged in between neighboring PROTEIN subunits and running perpendicular to the ribbons.
BioInfer.d55.s0.p5	N	Analysis of PROTEIN : PROTEIN2 crystals reveals an extensive intermolecular network, rather than a discrete "monomeric complex", comprising stacked PROTEIN ribbons held in place by columns of PROTEIN1 molecules, wedged in between neighboring PROTEIN subunits and running perpendicular to the ribbons.
BioInfer.d55.s0.p6	N	Analysis of PROTEIN : PROTEIN crystals reveals an extensive intermolecular network, rather than a discrete "monomeric complex", comprising stacked PROTEIN ribbons held in place by columns of PROTEIN1 molecules, wedged in between neighboring PROTEIN2 subunits and running perpendicular to the ribbons.
BioInfer.d55.s0.p7	N	Analysis of PROTEIN : PROTEIN2 crystals reveals an extensive intermolecular network, rather than a discrete "monomeric complex", comprising stacked PROTEIN1 ribbons held in place by columns of PROTEIN molecules, wedged in between neighboring PROTEIN subunits and running perpendicular to the ribbons.
BioInfer.d55.s0.p8	N	Analysis of PROTEIN : PROTEIN crystals reveals an extensive intermolecular network, rather than a discrete "monomeric complex", comprising stacked PROTEIN1 ribbons held in place by columns of PROTEIN molecules, wedged in between neighboring PROTEIN2 subunits and running perpendicular to the ribbons.
BioInfer.d55.s0.p9	N	Analysis of PROTEIN : PROTEIN1 crystals reveals an extensive intermolecular network, rather than a discrete "monomeric complex", comprising stacked PROTEIN ribbons held in place by columns of PROTEIN molecules, wedged in between neighboring PROTEIN2 subunits and running perpendicular to the ribbons.
BioInfer.d55.s1.p0	N	Molecular packing in PROTEIN1 : PROTEIN2 crystals and its implications.
BioInfer.d56.s0.p0	N	Analysis of changes in state suggests that PROTEIN protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas PROTEIN1 , PROTEIN , and PROTEIN2 are required for maintenance.
BioInfer.d56.s0.p1	N	Analysis of changes in state suggests that PROTEIN2 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas PROTEIN1 , PROTEIN , and PROTEIN are required for maintenance.
BioInfer.d56.s0.p2	N	Analysis of changes in state suggests that PROTEIN protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas PROTEIN1 , PROTEIN2 , and PROTEIN are required for maintenance.
BioInfer.d56.s0.p3	N	Analysis of changes in state suggests that PROTEIN2 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas PROTEIN , PROTEIN , and PROTEIN1 are required for maintenance.
BioInfer.d56.s0.p4	N	Analysis of changes in state suggests that PROTEIN protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas PROTEIN , PROTEIN2 , and PROTEIN1 are required for maintenance.
BioInfer.d56.s0.p5	N	Analysis of changes in state suggests that PROTEIN1 protein has a role in the establishment but not the maintenance of repression of silent mating type genes, whereas PROTEIN , PROTEIN2 , and PROTEIN are required for maintenance.
BioInfer.d57.s0.p0	P	Analysis of the formation of the calf spleen complex in the presence of varying concentrations of divalent cations gave evidence for the presence of a high-affinity divalent-cation-binding site on the PROTEIN2 (beta, gamma) which appears to regulate the interaction with PROTEIN1 .
BioInfer.d57.s1.p0	N	The interaction between calf PROTEIN and actin depends critically on the status of the C-terminus of the PROTEIN2 , and in the case of PROTEIN1 , the C-terminus is of great importance for the physiochemical behaviour of the protein.
BioInfer.d57.s1.p2	N	The interaction between calf PROTEIN2 and actin depends critically on the status of the C-terminus of the PROTEIN , and in the case of PROTEIN1 , the C-terminus is of great importance for the physiochemical behaviour of the protein.
BioInfer.d57.s1.p4	P	The interaction between calf PROTEIN2 and actin depends critically on the status of the C-terminus of the PROTEIN1 , and in the case of PROTEIN , the C-terminus is of great importance for the physiochemical behaviour of the protein.
BioInfer.d58.s0.p0	N	Analysis of the u.v. absorbance and far-u.v. circular dichroism spectra of PROTEIN1 and PROTEIN2 did not reveal any major changes in the conformation of the proteins accompanying the modifications at the C-terminal ends.
BioInfer.d59.s0.p0	P	Analysis of this product by peptide mapping (Sutoh (1982) Biochemistry 21, 3654-3661) showed that PROTEIN2 was cross-linked with the N-terminal segment of PROTEIN1 containing residues 1-12.
BioInfer.d59.s1.p0	P	Purification of PROTEIN , a 21,000 molecular weight PROTEIN , from porcine kidney and identification of the PROTEIN2 -binding site in the PROTEIN1 sequence.
BioInfer.d59.s1.p1	N	Purification of PROTEIN , a 21,000 molecular weight PROTEIN2 , from porcine kidney and identification of the PROTEIN -binding site in the PROTEIN1 sequence.
BioInfer.d59.s1.p2	N	Purification of PROTEIN2 , a 21,000 molecular weight PROTEIN , from porcine kidney and identification of the PROTEIN -binding site in the PROTEIN1 sequence.
BioInfer.d59.s1.p3	N	Purification of PROTEIN , a 21,000 molecular weight PROTEIN2 , from porcine kidney and identification of the PROTEIN1 -binding site in the PROTEIN sequence.
BioInfer.d59.s1.p4	N	Purification of PROTEIN2 , a 21,000 molecular weight PROTEIN , from porcine kidney and identification of the PROTEIN1 -binding site in the PROTEIN sequence.
BioInfer.d59.s1.p5	P	Purification of PROTEIN2 , a 21,000 molecular weight PROTEIN1 , from porcine kidney and identification of the PROTEIN -binding site in the PROTEIN sequence.
BioInfer.d60.s0.p0	P	Analysis of V3, a hamster equivalent of SCID, indicates that the protein level increases of PROTEIN2 and PROTEIN from G0 to G1/S/G2 do not require PROTEIN1 .
BioInfer.d60.s0.p1	P	Analysis of V3, a hamster equivalent of SCID, indicates that the protein level increases of PROTEIN and PROTEIN2 from G0 to G1/S/G2 do not require PROTEIN1 .
BioInfer.d60.s0.p2	N	Analysis of V3, a hamster equivalent of SCID, indicates that the protein level increases of PROTEIN1 and PROTEIN2 from G0 to G1/S/G2 do not require PROTEIN .
BioInfer.d60.s1.p0	N	In this study, cell cycle-dependent expression of human and rodent PROTEIN2 and PROTEIN1 proteins was monitored using two approaches.
BioInfer.d61.s0.p0	N	Analysis of various truncated PROTEIN molecules revealed that amino-terminal residues 48-163 are able to bind to PROTEIN2 and PROTEIN1 .
BioInfer.d61.s0.p1	P	Analysis of various truncated PROTEIN2 molecules revealed that amino-terminal residues 48-163 are able to bind to PROTEIN and PROTEIN1 .
BioInfer.d61.s0.p2	P	Analysis of various truncated PROTEIN2 molecules revealed that amino-terminal residues 48-163 are able to bind to PROTEIN1 and PROTEIN .
BioInfer.d61.s1.p0	N	Consistent with the observation that PROTEIN and PROTEIN bind to the same region of PROTEIN1 , PROTEIN competed with the binding of PROTEIN to PROTEIN2 and vice versa.
BioInfer.d61.s1.p1	N	Consistent with the observation that PROTEIN and PROTEIN bind to the same region of PROTEIN1 , PROTEIN2 competed with the binding of PROTEIN to PROTEIN and vice versa.
BioInfer.d61.s1.p2	N	Consistent with the observation that PROTEIN and PROTEIN bind to the same region of PROTEIN1 , PROTEIN competed with the binding of PROTEIN2 to PROTEIN and vice versa.
BioInfer.d61.s1.p3	P	Consistent with the observation that PROTEIN and PROTEIN2 bind to the same region of PROTEIN1 , PROTEIN competed with the binding of PROTEIN to PROTEIN and vice versa.
BioInfer.d61.s1.p4	P	Consistent with the observation that PROTEIN2 and PROTEIN bind to the same region of PROTEIN1 , PROTEIN competed with the binding of PROTEIN to PROTEIN and vice versa.
BioInfer.d61.s1.p5	P	Consistent with the observation that PROTEIN and PROTEIN bind to the same region of PROTEIN , PROTEIN2 competed with the binding of PROTEIN to PROTEIN1 and vice versa.
BioInfer.d61.s1.p6	P	Consistent with the observation that PROTEIN and PROTEIN bind to the same region of PROTEIN , PROTEIN competed with the binding of PROTEIN2 to PROTEIN1 and vice versa.
BioInfer.d61.s1.p7	N	Consistent with the observation that PROTEIN and PROTEIN2 bind to the same region of PROTEIN , PROTEIN competed with the binding of PROTEIN to PROTEIN1 and vice versa.
BioInfer.d61.s1.p8	N	Consistent with the observation that PROTEIN2 and PROTEIN bind to the same region of PROTEIN , PROTEIN competed with the binding of PROTEIN to PROTEIN1 and vice versa.
BioInfer.d61.s1.p9	N	Consistent with the observation that PROTEIN and PROTEIN bind to the same region of PROTEIN , PROTEIN1 competed with the binding of PROTEIN2 to PROTEIN and vice versa.
BioInfer.d61.s1.p10	N	Consistent with the observation that PROTEIN and PROTEIN2 bind to the same region of PROTEIN , PROTEIN1 competed with the binding of PROTEIN to PROTEIN and vice versa.
BioInfer.d61.s1.p11	N	Consistent with the observation that PROTEIN2 and PROTEIN bind to the same region of PROTEIN , PROTEIN1 competed with the binding of PROTEIN to PROTEIN and vice versa.
BioInfer.d61.s1.p12	N	Consistent with the observation that PROTEIN and PROTEIN2 bind to the same region of PROTEIN , PROTEIN competed with the binding of PROTEIN1 to PROTEIN and vice versa.
BioInfer.d61.s1.p13	N	Consistent with the observation that PROTEIN2 and PROTEIN bind to the same region of PROTEIN , PROTEIN competed with the binding of PROTEIN1 to PROTEIN and vice versa.
BioInfer.d61.s1.p14	N	Consistent with the observation that PROTEIN2 and PROTEIN1 bind to the same region of PROTEIN , PROTEIN competed with the binding of PROTEIN to PROTEIN and vice versa.
BioInfer.d61.s2.p0	N	Using an in vitro assay system involving bacterially expressed proteins, we localized a region in PROTEIN required for molecular interaction with PROTEIN1 and PROTEIN2 .
BioInfer.d61.s2.p1	P	Using an in vitro assay system involving bacterially expressed proteins, we localized a region in PROTEIN2 required for molecular interaction with PROTEIN1 and PROTEIN .
BioInfer.d61.s2.p2	P	Using an in vitro assay system involving bacterially expressed proteins, we localized a region in PROTEIN2 required for molecular interaction with PROTEIN and PROTEIN1 .
BioInfer.d61.s3.p0	N	When transfected into L cells expressing PROTEIN2 , the amino-terminal region of PROTEIN1 (from residue 1 to 226) formed complexes with PROTEIN supporting the in vitro binding experiment results.
BioInfer.d61.s3.p1	P	When transfected into L cells expressing PROTEIN , the amino-terminal region of PROTEIN1 (from residue 1 to 226) formed complexes with PROTEIN2 supporting the in vitro binding experiment results.
BioInfer.d61.s3.p2	N	When transfected into L cells expressing PROTEIN1 , the amino-terminal region of PROTEIN (from residue 1 to 226) formed complexes with PROTEIN2 supporting the in vitro binding experiment results.
BioInfer.d62.s0.p0	P	An assembly of the PROTEIN2 and PROTEIN1 subunits retains both enzymic activities, and the PROTEIN protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.
BioInfer.d62.s0.p1	P	An assembly of the PROTEIN and PROTEIN1 subunits retains both enzymic activities, and the PROTEIN2 protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.
BioInfer.d62.s0.p2	P	An assembly of the PROTEIN1 and PROTEIN subunits retains both enzymic activities, and the PROTEIN2 protein has been implicated in modulating these functions, facilitating efficient nuclear uptake of the complex and interacting with other viral DNA replication proteins.
BioInfer.d62.s1.p0	N	Deletion mutants of the herpes simplex virus type 1 PROTEIN protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the PROTEIN2 and PROTEIN1 proteins.
BioInfer.d62.s1.p1	P	Deletion mutants of the herpes simplex virus type 1 PROTEIN2 protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the PROTEIN and PROTEIN1 proteins.
BioInfer.d62.s1.p2	P	Deletion mutants of the herpes simplex virus type 1 PROTEIN2 protein: effect on DNA synthesis and ability to interact with and influence the intracellular localization of the PROTEIN1 and PROTEIN proteins.
BioInfer.d62.s2.p0	P	The herpes simplex virus type 1 (HSV-1) PROTEIN1 , an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded PROTEIN2 , PROTEIN , and PROTEIN proteins.
BioInfer.d62.s2.p1	P	The herpes simplex virus type 1 (HSV-1) PROTEIN1 , an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded PROTEIN , PROTEIN2 , and PROTEIN proteins.
BioInfer.d62.s2.p2	P	The herpes simplex virus type 1 (HSV-1) PROTEIN1 , an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded PROTEIN , PROTEIN , and PROTEIN2 proteins.
BioInfer.d62.s2.p3	P	The herpes simplex virus type 1 (HSV-1) PROTEIN , an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded PROTEIN1 , PROTEIN2 , and PROTEIN proteins.
BioInfer.d62.s2.p4	P	The herpes simplex virus type 1 (HSV-1) PROTEIN , an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded PROTEIN1 , PROTEIN , and PROTEIN2 proteins.
BioInfer.d62.s2.p5	P	The herpes simplex virus type 1 (HSV-1) PROTEIN , an essential component of the viral DNA replication machinery, is a trimeric complex of the virus-coded PROTEIN , PROTEIN1 , and PROTEIN2 proteins.
BioInfer.d63.s0.p0	N	An association was seen between PROTEIN and PROTEIN2 expression, in both effusions and solid tumours, and for PROTEIN1 in solid tumours (range p<0. 001 to p=0.014).
BioInfer.d63.s0.p1	N	An association was seen between PROTEIN2 and PROTEIN expression, in both effusions and solid tumours, and for PROTEIN1 in solid tumours (range p<0. 001 to p=0.014).
BioInfer.d63.s0.p2	P	An association was seen between PROTEIN2 and PROTEIN1 expression, in both effusions and solid tumours, and for PROTEIN in solid tumours (range p<0. 001 to p=0.014).
BioInfer.d64.s0.p0	P	An atomic model of PROTEIN2 filaments cross-linked by PROTEIN1 and its implications for bundle assembly and function.
BioInfer.d65.s0.p0	P	An oligomeric form of simian virus 40 PROTEIN1 is immunologically related to the cellular tumor antigen PROTEIN2 .
BioInfer.d65.s1.p0	P	The cellular tumor antigen PROTEIN1 is bound to the simian virus 40 (SV40) PROTEIN2 in SV40-infected and -transformed cells.
BioInfer.d66.s0.p0	N	Another PROTEIN2 , PROTEIN , and PROTEIN increased slightly, whereas PROTEIN1 and PROTEIN remained unchanged.
BioInfer.d66.s0.p1	N	Another PROTEIN , PROTEIN , and PROTEIN increased slightly, whereas PROTEIN1 and PROTEIN2 remained unchanged.
BioInfer.d66.s0.p2	N	Another PROTEIN , PROTEIN2 , and PROTEIN increased slightly, whereas PROTEIN1 and PROTEIN remained unchanged.
BioInfer.d66.s0.p3	N	Another PROTEIN , PROTEIN , and PROTEIN2 increased slightly, whereas PROTEIN1 and PROTEIN remained unchanged.
BioInfer.d66.s0.p4	N	Another PROTEIN1 , PROTEIN , and PROTEIN increased slightly, whereas PROTEIN and PROTEIN2 remained unchanged.
BioInfer.d66.s0.p5	P	Another PROTEIN1 , PROTEIN2 , and PROTEIN increased slightly, whereas PROTEIN and PROTEIN remained unchanged.
BioInfer.d66.s0.p6	N	Another PROTEIN1 , PROTEIN , and PROTEIN2 increased slightly, whereas PROTEIN and PROTEIN remained unchanged.
BioInfer.d66.s0.p7	N	Another PROTEIN , PROTEIN2 , and PROTEIN increased slightly, whereas PROTEIN and PROTEIN1 remained unchanged.
BioInfer.d66.s0.p8	N	Another PROTEIN , PROTEIN , and PROTEIN2 increased slightly, whereas PROTEIN and PROTEIN1 remained unchanged.
BioInfer.d66.s0.p9	N	Another PROTEIN , PROTEIN1 , and PROTEIN2 increased slightly, whereas PROTEIN and PROTEIN remained unchanged.
BioInfer.d67.s0.p0	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN1 ) genes have relatively mild or no effects.
BioInfer.d67.s0.p1	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN1 ) genes have relatively mild or no effects.
BioInfer.d67.s0.p2	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN1 ) genes have relatively mild or no effects.
BioInfer.d67.s0.p3	N	A null mutation of the PROTEIN2 gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN1 ) genes have relatively mild or no effects.
BioInfer.d67.s0.p4	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN2 and PROTEIN1 ) genes have relatively mild or no effects.
BioInfer.d67.s0.p5	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN1 ) genes have relatively mild or no effects.
BioInfer.d67.s0.p6	P	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN and PROTEIN1 ) genes have relatively mild or no effects.
BioInfer.d67.s0.p7	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN and PROTEIN1 ) genes have relatively mild or no effects.
BioInfer.d67.s0.p8	N	A null mutation of the PROTEIN gene ( PROTEIN2 ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN1 ) genes have relatively mild or no effects.
BioInfer.d67.s0.p9	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN1 ) genes have relatively mild or no effects.
BioInfer.d67.s0.p10	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN1 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p11	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p12	N	A null mutation of the PROTEIN2 gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p13	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN2 and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p14	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN2 ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p15	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p16	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p17	N	A null mutation of the PROTEIN gene ( PROTEIN2 ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p18	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p19	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN2 ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p20	N	A null mutation of the PROTEIN2 gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p21	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN2 and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p22	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN2 ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p23	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p24	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p25	N	A null mutation of the PROTEIN gene ( PROTEIN2 ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p26	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN2 ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p27	N	A null mutation of the PROTEIN2 gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p28	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN2 and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p29	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p30	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p31	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p32	N	A null mutation of the PROTEIN gene ( PROTEIN2 ) is lethal, but null mutations in the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p33	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN1 ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p34	N	A null mutation of the PROTEIN1 gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN2 and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p35	N	A null mutation of the PROTEIN1 gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p36	N	A null mutation of the PROTEIN1 gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p37	N	A null mutation of the PROTEIN1 gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p38	N	A null mutation of the PROTEIN1 gene ( PROTEIN2 ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p39	N	A null mutation of the PROTEIN1 gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p40	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), and PROTEIN ( PROTEIN1 and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p41	P	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN1 and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p42	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN1 and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p43	N	A null mutation of the PROTEIN gene ( PROTEIN2 ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN1 and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p44	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN1 and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p45	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), and PROTEIN2 ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p46	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN2 ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p47	N	A null mutation of the PROTEIN gene ( PROTEIN2 ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p48	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p49	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN1 ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p50	N	A null mutation of the PROTEIN gene ( PROTEIN2 ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN1 ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p51	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN1 ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p52	N	A null mutation of the PROTEIN gene ( PROTEIN2 ) is lethal, but null mutations in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p53	N	A null mutation of the PROTEIN gene ( PROTEIN ) is lethal, but null mutations in the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d67.s0.p54	N	A null mutation of the PROTEIN gene ( PROTEIN1 ) is lethal, but null mutations in the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN and PROTEIN ) genes have relatively mild or no effects.
BioInfer.d68.s0.p0	P	PROTEIN2 , PROTEIN1 and PROTEIN were stable (T1/2 >2 h) and associated with a chromatin-containing fraction throughout the cell cycle.
BioInfer.d68.s0.p1	P	PROTEIN , PROTEIN1 and PROTEIN2 were stable (T1/2 >2 h) and associated with a chromatin-containing fraction throughout the cell cycle.
BioInfer.d68.s0.p2	P	PROTEIN1 , PROTEIN and PROTEIN2 were stable (T1/2 >2 h) and associated with a chromatin-containing fraction throughout the cell cycle.
BioInfer.d68.s1.p0	N	PROTEIN1 -tagged PROTEIN associated with chromatin throughout mitosis in living cells and co-localized with PROTEIN2 in metaphase spreads.
BioInfer.d68.s1.p1	P	PROTEIN1 -tagged PROTEIN2 associated with chromatin throughout mitosis in living cells and co-localized with PROTEIN in metaphase spreads.
BioInfer.d68.s1.p2	P	PROTEIN -tagged PROTEIN2 associated with chromatin throughout mitosis in living cells and co-localized with PROTEIN1 in metaphase spreads.
BioInfer.d69.s0.p0	N	A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral PROTEIN ( PROTEIN ) protein and PROTEIN1 ( PROTEIN2 ) in a dose-dependent manner.
BioInfer.d69.s0.p1	N	A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral PROTEIN2 ( PROTEIN ) protein and PROTEIN1 ( PROTEIN ) in a dose-dependent manner.
BioInfer.d69.s0.p2	N	A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral PROTEIN ( PROTEIN2 ) protein and PROTEIN1 ( PROTEIN ) in a dose-dependent manner.
BioInfer.d69.s0.p3	N	A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral PROTEIN2 ( PROTEIN ) protein and PROTEIN ( PROTEIN1 ) in a dose-dependent manner.
BioInfer.d69.s0.p4	N	A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral PROTEIN ( PROTEIN2 ) protein and PROTEIN ( PROTEIN1 ) in a dose-dependent manner.
BioInfer.d69.s0.p5	N	A pre-treatment of cells with SGE from partially fed ticks in amounts corresponding to 1 or 3 salivary glands increased the level of both viral PROTEIN1 ( PROTEIN2 ) protein and PROTEIN ( PROTEIN ) in a dose-dependent manner.
BioInfer.d70.s0.p0	N	PROTEIN inhibited platelet aggregation induced by PROTEIN (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by PROTEIN2 (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of PROTEIN and PROTEIN1 associated with cytoskeletons.
BioInfer.d70.s0.p1	P	PROTEIN2 inhibited platelet aggregation induced by PROTEIN (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by PROTEIN (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of PROTEIN and PROTEIN1 associated with cytoskeletons.
BioInfer.d70.s0.p2	N	PROTEIN inhibited platelet aggregation induced by PROTEIN2 (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by PROTEIN (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of PROTEIN and PROTEIN1 associated with cytoskeletons.
BioInfer.d70.s0.p3	N	PROTEIN inhibited platelet aggregation induced by PROTEIN (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by PROTEIN (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of PROTEIN2 and PROTEIN1 associated with cytoskeletons.
BioInfer.d70.s0.p4	P	PROTEIN2 inhibited platelet aggregation induced by PROTEIN (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by PROTEIN1 (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of PROTEIN and PROTEIN associated with cytoskeletons.
BioInfer.d70.s0.p5	N	PROTEIN inhibited platelet aggregation induced by PROTEIN2 (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by PROTEIN1 (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of PROTEIN and PROTEIN associated with cytoskeletons.
BioInfer.d70.s0.p6	N	PROTEIN inhibited platelet aggregation induced by PROTEIN (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by PROTEIN1 (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of PROTEIN2 and PROTEIN associated with cytoskeletons.
BioInfer.d70.s0.p7	N	PROTEIN1 inhibited platelet aggregation induced by PROTEIN2 (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by PROTEIN (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of PROTEIN and PROTEIN associated with cytoskeletons.
BioInfer.d70.s0.p8	P	PROTEIN1 inhibited platelet aggregation induced by PROTEIN (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by PROTEIN (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of PROTEIN2 and PROTEIN associated with cytoskeletons.
BioInfer.d70.s0.p9	N	PROTEIN inhibited platelet aggregation induced by PROTEIN1 (0.25 U.ml-1) with IC50 200 kIU.ml-1, and inhibited the rise of cytosolic free calcium concentration in platelets stimulated by PROTEIN (0.1 U.ml-1) in the absence and in the presence of Ca2+ 0.5 mmol.L-1 (IC50 117 and 50 kIU.ml-1, respectively), but had no effect on the amounts of PROTEIN2 and PROTEIN associated with cytoskeletons.
BioInfer.d71.s0.p0	N	PROTEIN2 , PROTEIN1 , and PROTEIN encode proteins that are critical to the repair of double-strand DNA breaks by homologous recombination.
BioInfer.d71.s0.p1	N	PROTEIN , PROTEIN1 , and PROTEIN2 encode proteins that are critical to the repair of double-strand DNA breaks by homologous recombination.
BioInfer.d71.s0.p2	N	PROTEIN1 , PROTEIN , and PROTEIN2 encode proteins that are critical to the repair of double-strand DNA breaks by homologous recombination.
BioInfer.d72.s0.p0	N	PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 were required for efficient gap repair using either chromosomal or plasmid donors.
BioInfer.d72.s0.p1	N	PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 were required for efficient gap repair using either chromosomal or plasmid donors.
BioInfer.d72.s0.p2	N	PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 were required for efficient gap repair using either chromosomal or plasmid donors.
BioInfer.d72.s0.p3	N	PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN were required for efficient gap repair using either chromosomal or plasmid donors.
BioInfer.d72.s0.p4	N	PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN were required for efficient gap repair using either chromosomal or plasmid donors.
BioInfer.d72.s0.p5	N	PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN were required for efficient gap repair using either chromosomal or plasmid donors.
BioInfer.d73.s0.p0	N	PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN are all required to facilitate strand invasion into otherwise inaccessible donor sequences.
BioInfer.d73.s0.p1	N	PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN are all required to facilitate strand invasion into otherwise inaccessible donor sequences.
BioInfer.d73.s0.p2	N	PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.
BioInfer.d73.s0.p3	N	PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN are all required to facilitate strand invasion into otherwise inaccessible donor sequences.
BioInfer.d73.s0.p4	N	PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.
BioInfer.d73.s0.p5	N	PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 are all required to facilitate strand invasion into otherwise inaccessible donor sequences.
BioInfer.d73.s1.p0	N	PROTEIN2 , PROTEIN , PROTEIN1 and PROTEIN are still required when the same transcribed donor is on the chromosome.
BioInfer.d73.s1.p1	N	PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 are still required when the same transcribed donor is on the chromosome.
BioInfer.d73.s1.p2	N	PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN are still required when the same transcribed donor is on the chromosome.
BioInfer.d73.s1.p3	N	PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 are still required when the same transcribed donor is on the chromosome.
BioInfer.d73.s1.p4	N	PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN are still required when the same transcribed donor is on the chromosome.
BioInfer.d73.s1.p5	N	PROTEIN , PROTEIN2 , PROTEIN and PROTEIN1 are still required when the same transcribed donor is on the chromosome.
BioInfer.d73.s2.p0	N	Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 or PROTEIN .
BioInfer.d73.s2.p1	N	Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes PROTEIN , PROTEIN , PROTEIN , PROTEIN1 or PROTEIN2 .
BioInfer.d73.s2.p2	N	Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 or PROTEIN .
BioInfer.d73.s2.p3	N	Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 or PROTEIN .
BioInfer.d73.s2.p4	N	Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes PROTEIN , PROTEIN1 , PROTEIN , PROTEIN or PROTEIN2 .
BioInfer.d73.s2.p5	N	Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN or PROTEIN .
BioInfer.d73.s2.p6	N	Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN or PROTEIN .
BioInfer.d73.s2.p7	N	Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes PROTEIN2 , PROTEIN , PROTEIN , PROTEIN or PROTEIN1 .
BioInfer.d73.s2.p8	N	Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes PROTEIN , PROTEIN , PROTEIN2 , PROTEIN or PROTEIN1 .
BioInfer.d73.s2.p9	N	Here we use physical monitoring of DNA to show that MAT switching is completely blocked at an early step in recombination in strains deleted for the DNA repair genes PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN or PROTEIN .
BioInfer.d74.s0.p0	N	Archaeal PROTEIN2 are most similar to the globular PROTEIN fold region of eukaryal PROTEIN1  PROTEIN , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN + PROTEIN )2tetramers.
BioInfer.d74.s0.p1	N	Archaeal PROTEIN are most similar to the globular PROTEIN2 fold region of eukaryal PROTEIN1  PROTEIN , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN + PROTEIN )2tetramers.
BioInfer.d74.s0.p2	N	Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN1  PROTEIN , and the results reported are consistent with archaeal PROTEIN2 resembling the structure formed by eukaryal PROTEIN ( PROTEIN + PROTEIN )2tetramers.
BioInfer.d74.s0.p3	N	Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN1  PROTEIN , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN + PROTEIN2 )2tetramers.
BioInfer.d74.s0.p4	P	Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN1  PROTEIN2 , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN + PROTEIN )2tetramers.
BioInfer.d74.s0.p5	N	Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN1  PROTEIN , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN2 + PROTEIN )2tetramers.
BioInfer.d74.s0.p6	N	Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN1  PROTEIN , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN2 ( PROTEIN + PROTEIN )2tetramers.
BioInfer.d74.s0.p7	P	Archaeal PROTEIN1 are most similar to the globular PROTEIN2 fold region of eukaryal PROTEIN  PROTEIN , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN + PROTEIN )2tetramers.
BioInfer.d74.s0.p8	N	Archaeal PROTEIN1 are most similar to the globular PROTEIN fold region of eukaryal PROTEIN  PROTEIN , and the results reported are consistent with archaeal PROTEIN2 resembling the structure formed by eukaryal PROTEIN ( PROTEIN + PROTEIN )2tetramers.
BioInfer.d74.s0.p9	N	Archaeal PROTEIN1 are most similar to the globular PROTEIN fold region of eukaryal PROTEIN  PROTEIN , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN + PROTEIN2 )2tetramers.
BioInfer.d74.s0.p10	N	Archaeal PROTEIN1 are most similar to the globular PROTEIN fold region of eukaryal PROTEIN  PROTEIN2 , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN + PROTEIN )2tetramers.
BioInfer.d74.s0.p11	N	Archaeal PROTEIN1 are most similar to the globular PROTEIN fold region of eukaryal PROTEIN  PROTEIN , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN2 + PROTEIN )2tetramers.
BioInfer.d74.s0.p12	N	Archaeal PROTEIN1 are most similar to the globular PROTEIN fold region of eukaryal PROTEIN  PROTEIN , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN2 ( PROTEIN + PROTEIN )2tetramers.
BioInfer.d74.s0.p13	N	Archaeal PROTEIN are most similar to the globular PROTEIN1 fold region of eukaryal PROTEIN  PROTEIN , and the results reported are consistent with archaeal PROTEIN2 resembling the structure formed by eukaryal PROTEIN ( PROTEIN + PROTEIN )2tetramers.
BioInfer.d74.s0.p14	N	Archaeal PROTEIN are most similar to the globular PROTEIN1 fold region of eukaryal PROTEIN  PROTEIN , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN + PROTEIN2 )2tetramers.
BioInfer.d74.s0.p15	P	Archaeal PROTEIN are most similar to the globular PROTEIN1 fold region of eukaryal PROTEIN  PROTEIN2 , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN + PROTEIN )2tetramers.
BioInfer.d74.s0.p16	N	Archaeal PROTEIN are most similar to the globular PROTEIN1 fold region of eukaryal PROTEIN  PROTEIN , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN2 + PROTEIN )2tetramers.
BioInfer.d74.s0.p17	N	Archaeal PROTEIN are most similar to the globular PROTEIN1 fold region of eukaryal PROTEIN  PROTEIN , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN2 ( PROTEIN + PROTEIN )2tetramers.
BioInfer.d74.s0.p18	P	Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN  PROTEIN , and the results reported are consistent with archaeal PROTEIN1 resembling the structure formed by eukaryal PROTEIN ( PROTEIN + PROTEIN2 )2tetramers.
BioInfer.d74.s0.p19	N	Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN  PROTEIN2 , and the results reported are consistent with archaeal PROTEIN1 resembling the structure formed by eukaryal PROTEIN ( PROTEIN + PROTEIN )2tetramers.
BioInfer.d74.s0.p20	P	Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN  PROTEIN , and the results reported are consistent with archaeal PROTEIN1 resembling the structure formed by eukaryal PROTEIN ( PROTEIN2 + PROTEIN )2tetramers.
BioInfer.d74.s0.p21	N	Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN  PROTEIN , and the results reported are consistent with archaeal PROTEIN1 resembling the structure formed by eukaryal PROTEIN2 ( PROTEIN + PROTEIN )2tetramers.
BioInfer.d74.s0.p22	N	Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN  PROTEIN2 , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN + PROTEIN1 )2tetramers.
BioInfer.d74.s0.p23	P	Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN  PROTEIN , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN2 + PROTEIN1 )2tetramers.
BioInfer.d74.s0.p24	P	Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN  PROTEIN , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN2 ( PROTEIN + PROTEIN1 )2tetramers.
BioInfer.d74.s0.p25	N	Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN  PROTEIN1 , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN ( PROTEIN2 + PROTEIN )2tetramers.
BioInfer.d74.s0.p26	N	Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN  PROTEIN1 , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN2 ( PROTEIN + PROTEIN )2tetramers.
BioInfer.d74.s0.p27	P	Archaeal PROTEIN are most similar to the globular PROTEIN fold region of eukaryal PROTEIN  PROTEIN , and the results reported are consistent with archaeal PROTEIN resembling the structure formed by eukaryal PROTEIN2 ( PROTEIN1 + PROTEIN )2tetramers.
BioInfer.d75.s0.p0	N	A reconstitution is described that requires not only the growth factor, its receptor with PROTEIN activity, and the soluble PROTEIN1 , but also the small soluble PROTEIN2  PROTEIN .
BioInfer.d75.s0.p1	N	A reconstitution is described that requires not only the growth factor, its receptor with PROTEIN activity, and the soluble PROTEIN1 , but also the small soluble PROTEIN  PROTEIN2 .
BioInfer.d75.s0.p2	N	A reconstitution is described that requires not only the growth factor, its receptor with PROTEIN2 activity, and the soluble PROTEIN1 , but also the small soluble PROTEIN  PROTEIN .
BioInfer.d75.s0.p3	P	A reconstitution is described that requires not only the growth factor, its receptor with PROTEIN activity, and the soluble PROTEIN , but also the small soluble PROTEIN1  PROTEIN2 .
BioInfer.d75.s0.p4	N	A reconstitution is described that requires not only the growth factor, its receptor with PROTEIN2 activity, and the soluble PROTEIN , but also the small soluble PROTEIN1  PROTEIN .
BioInfer.d75.s0.p5	N	A reconstitution is described that requires not only the growth factor, its receptor with PROTEIN2 activity, and the soluble PROTEIN , but also the small soluble PROTEIN  PROTEIN1 .
BioInfer.d76.s0.p0	P	PROTEIN ( PROTEIN2 ) repeat 10 to the COOH terminus of PROTEIN is involved in binding to PROTEIN1 , whereas PROTEIN interacts directly with the PROTEIN -binding domain of PROTEIN .
BioInfer.d76.s0.p1	N	PROTEIN ( PROTEIN ) repeat 10 to the COOH terminus of PROTEIN is involved in binding to PROTEIN1 , whereas PROTEIN2 interacts directly with the PROTEIN -binding domain of PROTEIN .
BioInfer.d76.s0.p2	N	PROTEIN ( PROTEIN ) repeat 10 to the COOH terminus of PROTEIN is involved in binding to PROTEIN1 , whereas PROTEIN interacts directly with the PROTEIN2 -binding domain of PROTEIN .
BioInfer.d76.s0.p3	P	PROTEIN2 ( PROTEIN ) repeat 10 to the COOH terminus of PROTEIN is involved in binding to PROTEIN1 , whereas PROTEIN interacts directly with the PROTEIN -binding domain of PROTEIN .
BioInfer.d76.s0.p4	N	PROTEIN ( PROTEIN ) repeat 10 to the COOH terminus of PROTEIN is involved in binding to PROTEIN1 , whereas PROTEIN interacts directly with the PROTEIN -binding domain of PROTEIN2 .
BioInfer.d76.s0.p5	P	PROTEIN ( PROTEIN ) repeat 10 to the COOH terminus of PROTEIN2 is involved in binding to PROTEIN1 , whereas PROTEIN interacts directly with the PROTEIN -binding domain of PROTEIN .
BioInfer.d76.s0.p6	N	PROTEIN ( PROTEIN1 ) repeat 10 to the COOH terminus of PROTEIN is involved in binding to PROTEIN , whereas PROTEIN2 interacts directly with the PROTEIN -binding domain of PROTEIN .
BioInfer.d76.s0.p7	N	PROTEIN ( PROTEIN1 ) repeat 10 to the COOH terminus of PROTEIN is involved in binding to PROTEIN , whereas PROTEIN interacts directly with the PROTEIN2 -binding domain of PROTEIN .
BioInfer.d76.s0.p8	N	PROTEIN2 ( PROTEIN1 ) repeat 10 to the COOH terminus of PROTEIN is involved in binding to PROTEIN , whereas PROTEIN interacts directly with the PROTEIN -binding domain of PROTEIN .
BioInfer.d76.s0.p9	N	PROTEIN ( PROTEIN1 ) repeat 10 to the COOH terminus of PROTEIN is involved in binding to PROTEIN , whereas PROTEIN interacts directly with the PROTEIN -binding domain of PROTEIN2 .
BioInfer.d76.s0.p10	P	PROTEIN ( PROTEIN1 ) repeat 10 to the COOH terminus of PROTEIN2 is involved in binding to PROTEIN , whereas PROTEIN interacts directly with the PROTEIN -binding domain of PROTEIN .
BioInfer.d76.s0.p11	N	PROTEIN ( PROTEIN ) repeat 10 to the COOH terminus of PROTEIN is involved in binding to PROTEIN , whereas PROTEIN1 interacts directly with the PROTEIN2 -binding domain of PROTEIN .
BioInfer.d76.s0.p12	N	PROTEIN2 ( PROTEIN ) repeat 10 to the COOH terminus of PROTEIN is involved in binding to PROTEIN , whereas PROTEIN1 interacts directly with the PROTEIN -binding domain of PROTEIN .
BioInfer.d76.s0.p13	P	PROTEIN ( PROTEIN ) repeat 10 to the COOH terminus of PROTEIN is involved in binding to PROTEIN , whereas PROTEIN1 interacts directly with the PROTEIN -binding domain of PROTEIN2 .
BioInfer.d76.s0.p14	N	PROTEIN ( PROTEIN ) repeat 10 to the COOH terminus of PROTEIN2 is involved in binding to PROTEIN , whereas PROTEIN1 interacts directly with the PROTEIN -binding domain of PROTEIN .
BioInfer.d76.s0.p15	N	PROTEIN2 ( PROTEIN ) repeat 10 to the COOH terminus of PROTEIN is involved in binding to PROTEIN , whereas PROTEIN interacts directly with the PROTEIN1 -binding domain of PROTEIN .
BioInfer.d76.s0.p16	P	PROTEIN ( PROTEIN ) repeat 10 to the COOH terminus of PROTEIN is involved in binding to PROTEIN , whereas PROTEIN interacts directly with the PROTEIN1 -binding domain of PROTEIN2 .
BioInfer.d76.s0.p17	N	PROTEIN ( PROTEIN ) repeat 10 to the COOH terminus of PROTEIN2 is involved in binding to PROTEIN , whereas PROTEIN interacts directly with the PROTEIN1 -binding domain of PROTEIN .
BioInfer.d76.s0.p18	N	PROTEIN1 ( PROTEIN ) repeat 10 to the COOH terminus of PROTEIN is involved in binding to PROTEIN , whereas PROTEIN interacts directly with the PROTEIN -binding domain of PROTEIN2 .
BioInfer.d76.s0.p19	P	PROTEIN1 ( PROTEIN ) repeat 10 to the COOH terminus of PROTEIN2 is involved in binding to PROTEIN , whereas PROTEIN interacts directly with the PROTEIN -binding domain of PROTEIN .
BioInfer.d76.s0.p20	N	PROTEIN ( PROTEIN ) repeat 10 to the COOH terminus of PROTEIN2 is involved in binding to PROTEIN , whereas PROTEIN interacts directly with the PROTEIN -binding domain of PROTEIN1 .
BioInfer.d77.s0.p0	P	PROTEIN2 /3 complex from Acanthamoeba binds PROTEIN1 and cross-links PROTEIN filaments.
BioInfer.d77.s0.p2	N	PROTEIN /3 complex from Acanthamoeba binds PROTEIN1 and cross-links PROTEIN2 filaments.
BioInfer.d77.s0.p4	P	PROTEIN1 /3 complex from Acanthamoeba binds PROTEIN and cross-links PROTEIN2 filaments.
BioInfer.d77.s1.p0	P	By analytical ultracentrifugation, rhodamine-labeled PROTEIN binds PROTEIN /3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of PROTEIN2 for barbed ends of PROTEIN filaments and its high affinity for PROTEIN1 monomers.
BioInfer.d77.s1.p1	N	By analytical ultracentrifugation, rhodamine-labeled PROTEIN binds PROTEIN2 /3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of PROTEIN for barbed ends of PROTEIN filaments and its high affinity for PROTEIN1 monomers.
BioInfer.d77.s1.p2	N	By analytical ultracentrifugation, rhodamine-labeled PROTEIN2 binds PROTEIN /3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of PROTEIN for barbed ends of PROTEIN filaments and its high affinity for PROTEIN1 monomers.
BioInfer.d77.s1.p3	N	By analytical ultracentrifugation, rhodamine-labeled PROTEIN binds PROTEIN /3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of PROTEIN for barbed ends of PROTEIN2 filaments and its high affinity for PROTEIN1 monomers.
BioInfer.d77.s1.p5	N	By analytical ultracentrifugation, rhodamine-labeled PROTEIN binds PROTEIN2 /3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of PROTEIN1 for barbed ends of PROTEIN filaments and its high affinity for PROTEIN monomers.
BioInfer.d77.s1.p6	N	By analytical ultracentrifugation, rhodamine-labeled PROTEIN2 binds PROTEIN /3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of PROTEIN1 for barbed ends of PROTEIN filaments and its high affinity for PROTEIN monomers.
BioInfer.d77.s1.p7	P	By analytical ultracentrifugation, rhodamine-labeled PROTEIN binds PROTEIN /3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of PROTEIN1 for barbed ends of PROTEIN2 filaments and its high affinity for PROTEIN monomers.
BioInfer.d77.s1.p9	P	By analytical ultracentrifugation, rhodamine-labeled PROTEIN2 binds PROTEIN1 /3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of PROTEIN for barbed ends of PROTEIN filaments and its high affinity for PROTEIN monomers.
BioInfer.d77.s1.p10	N	By analytical ultracentrifugation, rhodamine-labeled PROTEIN binds PROTEIN1 /3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of PROTEIN for barbed ends of PROTEIN2 filaments and its high affinity for PROTEIN monomers.
BioInfer.d77.s1.p12	N	By analytical ultracentrifugation, rhodamine-labeled PROTEIN1 binds PROTEIN /3 complex with a Kd of 7 microM, an affinity intermediate between the low affinity of PROTEIN for barbed ends of PROTEIN2 filaments and its high affinity for PROTEIN monomers.
BioInfer.d77.s2.p0	N	Here we show that the PROTEIN2 subunit of the complex can be chemically cross-linked to the PROTEIN1 -binding site of PROTEIN .
BioInfer.d77.s2.p1	P	Here we show that the PROTEIN subunit of the complex can be chemically cross-linked to the PROTEIN1 -binding site of PROTEIN2 .
BioInfer.d77.s2.p2	P	Here we show that the PROTEIN1 subunit of the complex can be chemically cross-linked to the PROTEIN -binding site of PROTEIN2 .
BioInfer.d78.s0.p0	N	As a nuclear transport signal sequence exists in PROTEIN and PROTEIN but not in PROTEIN2 , PROTEIN and/or PROTEIN1 may be responsible for the nuclear import of PROTEIN in myogenic cells under certain conditions.
BioInfer.d78.s0.p1	N	As a nuclear transport signal sequence exists in PROTEIN2 and PROTEIN but not in PROTEIN , PROTEIN and/or PROTEIN1 may be responsible for the nuclear import of PROTEIN in myogenic cells under certain conditions.
BioInfer.d78.s0.p2	P	As a nuclear transport signal sequence exists in PROTEIN and PROTEIN but not in PROTEIN , PROTEIN and/or PROTEIN1 may be responsible for the nuclear import of PROTEIN2 in myogenic cells under certain conditions.
BioInfer.d78.s0.p3	N	As a nuclear transport signal sequence exists in PROTEIN and PROTEIN but not in PROTEIN , PROTEIN2 and/or PROTEIN1 may be responsible for the nuclear import of PROTEIN in myogenic cells under certain conditions.
BioInfer.d78.s0.p4	N	As a nuclear transport signal sequence exists in PROTEIN and PROTEIN2 but not in PROTEIN , PROTEIN and/or PROTEIN1 may be responsible for the nuclear import of PROTEIN in myogenic cells under certain conditions.
BioInfer.d78.s0.p5	N	As a nuclear transport signal sequence exists in PROTEIN2 and PROTEIN but not in PROTEIN1 , PROTEIN and/or PROTEIN may be responsible for the nuclear import of PROTEIN in myogenic cells under certain conditions.
BioInfer.d78.s0.p6	N	As a nuclear transport signal sequence exists in PROTEIN and PROTEIN but not in PROTEIN1 , PROTEIN and/or PROTEIN may be responsible for the nuclear import of PROTEIN2 in myogenic cells under certain conditions.
BioInfer.d78.s0.p7	N	As a nuclear transport signal sequence exists in PROTEIN and PROTEIN but not in PROTEIN1 , PROTEIN2 and/or PROTEIN may be responsible for the nuclear import of PROTEIN in myogenic cells under certain conditions.
BioInfer.d78.s0.p8	N	As a nuclear transport signal sequence exists in PROTEIN and PROTEIN2 but not in PROTEIN1 , PROTEIN and/or PROTEIN may be responsible for the nuclear import of PROTEIN in myogenic cells under certain conditions.
BioInfer.d78.s0.p9	N	As a nuclear transport signal sequence exists in PROTEIN1 and PROTEIN but not in PROTEIN , PROTEIN and/or PROTEIN may be responsible for the nuclear import of PROTEIN2 in myogenic cells under certain conditions.
BioInfer.d78.s0.p10	N	As a nuclear transport signal sequence exists in PROTEIN1 and PROTEIN but not in PROTEIN , PROTEIN2 and/or PROTEIN may be responsible for the nuclear import of PROTEIN in myogenic cells under certain conditions.
BioInfer.d78.s0.p11	N	As a nuclear transport signal sequence exists in PROTEIN1 and PROTEIN2 but not in PROTEIN , PROTEIN and/or PROTEIN may be responsible for the nuclear import of PROTEIN in myogenic cells under certain conditions.
BioInfer.d78.s0.p12	P	As a nuclear transport signal sequence exists in PROTEIN and PROTEIN but not in PROTEIN , PROTEIN2 and/or PROTEIN may be responsible for the nuclear import of PROTEIN1 in myogenic cells under certain conditions.
BioInfer.d78.s0.p13	N	As a nuclear transport signal sequence exists in PROTEIN and PROTEIN2 but not in PROTEIN , PROTEIN and/or PROTEIN may be responsible for the nuclear import of PROTEIN1 in myogenic cells under certain conditions.
BioInfer.d78.s0.p14	N	As a nuclear transport signal sequence exists in PROTEIN and PROTEIN2 but not in PROTEIN , PROTEIN1 and/or PROTEIN may be responsible for the nuclear import of PROTEIN in myogenic cells under certain conditions.
BioInfer.d78.s1.p0	N	Immunofluorescence microscopy revealed that two PROTEIN of low molecular weight with different functional activity, PROTEIN2 and PROTEIN1 , are transported into nuclei of cultured myogenic cells to form rod structures there together with PROTEIN , when the cells were incubated in medium containing dimethylsulfoxide.
BioInfer.d78.s1.p1	P	Immunofluorescence microscopy revealed that two PROTEIN of low molecular weight with different functional activity, PROTEIN and PROTEIN1 , are transported into nuclei of cultured myogenic cells to form rod structures there together with PROTEIN2 , when the cells were incubated in medium containing dimethylsulfoxide.
BioInfer.d78.s1.p2	P	Immunofluorescence microscopy revealed that two PROTEIN2 of low molecular weight with different functional activity, PROTEIN and PROTEIN1 , are transported into nuclei of cultured myogenic cells to form rod structures there together with PROTEIN , when the cells were incubated in medium containing dimethylsulfoxide.
BioInfer.d78.s1.p3	P	Immunofluorescence microscopy revealed that two PROTEIN of low molecular weight with different functional activity, PROTEIN1 and PROTEIN , are transported into nuclei of cultured myogenic cells to form rod structures there together with PROTEIN2 , when the cells were incubated in medium containing dimethylsulfoxide.
BioInfer.d78.s1.p4	P	Immunofluorescence microscopy revealed that two PROTEIN2 of low molecular weight with different functional activity, PROTEIN1 and PROTEIN , are transported into nuclei of cultured myogenic cells to form rod structures there together with PROTEIN , when the cells were incubated in medium containing dimethylsulfoxide.
BioInfer.d78.s1.p5	N	Immunofluorescence microscopy revealed that two PROTEIN2 of low molecular weight with different functional activity, PROTEIN and PROTEIN , are transported into nuclei of cultured myogenic cells to form rod structures there together with PROTEIN1 , when the cells were incubated in medium containing dimethylsulfoxide.
BioInfer.d78.s2.p0	N	In most cases, PROTEIN2 and PROTEIN colocalized in the same nuclear PROTEIN rods, but PROTEIN appeared to predominate in mononucleated cells, while PROTEIN1 was present in multinucleated myotubes.
BioInfer.d78.s2.p1	N	In most cases, PROTEIN and PROTEIN colocalized in the same nuclear PROTEIN rods, but PROTEIN2 appeared to predominate in mononucleated cells, while PROTEIN1 was present in multinucleated myotubes.
BioInfer.d78.s2.p2	N	In most cases, PROTEIN and PROTEIN colocalized in the same nuclear PROTEIN2 rods, but PROTEIN appeared to predominate in mononucleated cells, while PROTEIN1 was present in multinucleated myotubes.
BioInfer.d78.s2.p3	N	In most cases, PROTEIN and PROTEIN2 colocalized in the same nuclear PROTEIN rods, but PROTEIN appeared to predominate in mononucleated cells, while PROTEIN1 was present in multinucleated myotubes.
BioInfer.d78.s2.p4	N	In most cases, PROTEIN1 and PROTEIN colocalized in the same nuclear PROTEIN rods, but PROTEIN2 appeared to predominate in mononucleated cells, while PROTEIN was present in multinucleated myotubes.
BioInfer.d78.s2.p5	P	In most cases, PROTEIN1 and PROTEIN colocalized in the same nuclear PROTEIN2 rods, but PROTEIN appeared to predominate in mononucleated cells, while PROTEIN was present in multinucleated myotubes.
BioInfer.d78.s2.p6	P	In most cases, PROTEIN1 and PROTEIN2 colocalized in the same nuclear PROTEIN rods, but PROTEIN appeared to predominate in mononucleated cells, while PROTEIN was present in multinucleated myotubes.
BioInfer.d78.s2.p7	N	In most cases, PROTEIN and PROTEIN colocalized in the same nuclear PROTEIN2 rods, but PROTEIN1 appeared to predominate in mononucleated cells, while PROTEIN was present in multinucleated myotubes.
BioInfer.d78.s2.p8	N	In most cases, PROTEIN and PROTEIN2 colocalized in the same nuclear PROTEIN rods, but PROTEIN1 appeared to predominate in mononucleated cells, while PROTEIN was present in multinucleated myotubes.
BioInfer.d78.s2.p9	P	In most cases, PROTEIN and PROTEIN2 colocalized in the same nuclear PROTEIN1 rods, but PROTEIN appeared to predominate in mononucleated cells, while PROTEIN was present in multinucleated myotubes.
BioInfer.d79.s0.p0	P	A series of truncations was carried out at the C terminus of PROTEIN2 , a region that has been implicated in PROTEIN1 binding.
BioInfer.d79.s1.p0	P	Since our earlier studies of Acanthamoeba PROTEIN suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and PROTEIN2 binding may be important for PROTEIN1 function.
BioInfer.d79.s1.p1	N	Since our earlier studies of Acanthamoeba PROTEIN2 suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and PROTEIN binding may be important for PROTEIN1 function.
BioInfer.d79.s1.p2	N	Since our earlier studies of Acanthamoeba PROTEIN2 suggested the importance of PIP2 binding for suppression, we conclude that both activities are implicated and that an interplay between PIP2 binding and PROTEIN1 binding may be important for PROTEIN function.
BioInfer.d80.s0.p0	P	As expected, PROTEIN was found to interact with three domains of PROTEIN including PROTEIN binding domain or PROTEIN -inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN2  PROTEIN1 -interacting domain.
BioInfer.d80.s0.p1	N	As expected, PROTEIN was found to interact with three domains of PROTEIN including PROTEIN binding domain or PROTEIN2 -inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN  PROTEIN1 -interacting domain.
BioInfer.d80.s0.p2	N	As expected, PROTEIN was found to interact with three domains of PROTEIN including PROTEIN2 binding domain or PROTEIN -inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN  PROTEIN1 -interacting domain.
BioInfer.d80.s0.p3	P	As expected, PROTEIN was found to interact with three domains of PROTEIN2 including PROTEIN binding domain or PROTEIN -inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN  PROTEIN1 -interacting domain.
BioInfer.d80.s0.p4	N	As expected, PROTEIN2 was found to interact with three domains of PROTEIN including PROTEIN binding domain or PROTEIN -inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN  PROTEIN1 -interacting domain.
BioInfer.d80.s0.p5	N	As expected, PROTEIN was found to interact with three domains of PROTEIN including PROTEIN binding domain or PROTEIN2 -inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN1  PROTEIN -interacting domain.
BioInfer.d80.s0.p6	N	As expected, PROTEIN was found to interact with three domains of PROTEIN including PROTEIN2 binding domain or PROTEIN -inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN1  PROTEIN -interacting domain.
BioInfer.d80.s0.p7	N	As expected, PROTEIN was found to interact with three domains of PROTEIN2 including PROTEIN binding domain or PROTEIN -inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN1  PROTEIN -interacting domain.
BioInfer.d80.s0.p8	N	As expected, PROTEIN2 was found to interact with three domains of PROTEIN including PROTEIN binding domain or PROTEIN -inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN1  PROTEIN -interacting domain.
BioInfer.d80.s0.p9	N	As expected, PROTEIN was found to interact with three domains of PROTEIN including PROTEIN2 binding domain or PROTEIN1 -inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN  PROTEIN -interacting domain.
BioInfer.d80.s0.p10	N	As expected, PROTEIN was found to interact with three domains of PROTEIN2 including PROTEIN binding domain or PROTEIN1 -inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN  PROTEIN -interacting domain.
BioInfer.d80.s0.p11	N	As expected, PROTEIN2 was found to interact with three domains of PROTEIN including PROTEIN binding domain or PROTEIN1 -inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN  PROTEIN -interacting domain.
BioInfer.d80.s0.p12	P	As expected, PROTEIN was found to interact with three domains of PROTEIN2 including PROTEIN1 binding domain or PROTEIN -inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN  PROTEIN -interacting domain.
BioInfer.d80.s0.p13	N	As expected, PROTEIN2 was found to interact with three domains of PROTEIN including PROTEIN1 binding domain or PROTEIN -inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN  PROTEIN -interacting domain.
BioInfer.d80.s0.p14	P	As expected, PROTEIN2 was found to interact with three domains of PROTEIN1 including PROTEIN binding domain or PROTEIN -inducible interaction (KIX) domain, the third cysteine-histidine-rich region (CH3 domain) and the PROTEIN  PROTEIN -interacting domain.
BioInfer.d81.s0.p0	P	As expected from immunofluorescence experiments, PROTEIN , PROTEIN1 , and PROTEIN2 colocalized in immuno-EM to the dense patchlike structures but not to the cables.
BioInfer.d81.s0.p1	P	As expected from immunofluorescence experiments, PROTEIN2 , PROTEIN1 , and PROTEIN colocalized in immuno-EM to the dense patchlike structures but not to the cables.
BioInfer.d81.s0.p2	P	As expected from immunofluorescence experiments, PROTEIN2 , PROTEIN , and PROTEIN1 colocalized in immuno-EM to the dense patchlike structures but not to the cables.
BioInfer.d81.s1.p0	P	Immuno-EM double-labeling experiments were conducted with antibodies to PROTEIN together with antibodies to the PROTEIN2  PROTEIN and PROTEIN1 .
BioInfer.d81.s1.p1	N	Immuno-EM double-labeling experiments were conducted with antibodies to PROTEIN together with antibodies to the PROTEIN  PROTEIN2 and PROTEIN1 .
BioInfer.d81.s1.p2	N	Immuno-EM double-labeling experiments were conducted with antibodies to PROTEIN2 together with antibodies to the PROTEIN  PROTEIN and PROTEIN1 .
BioInfer.d81.s1.p3	P	Immuno-EM double-labeling experiments were conducted with antibodies to PROTEIN together with antibodies to the PROTEIN1  PROTEIN2 and PROTEIN .
BioInfer.d81.s1.p4	N	Immuno-EM double-labeling experiments were conducted with antibodies to PROTEIN2 together with antibodies to the PROTEIN1  PROTEIN and PROTEIN .
BioInfer.d81.s1.p5	N	Immuno-EM double-labeling experiments were conducted with antibodies to PROTEIN2 together with antibodies to the PROTEIN  PROTEIN1 and PROTEIN .
BioInfer.d82.s0.p0	P	A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the PROTEIN locus, a gene that encodes a Drosophila member of the PROTEIN2 family of PROTEIN1 -severing proteins.
BioInfer.d82.s0.p1	N	A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the PROTEIN2 locus, a gene that encodes a Drosophila member of the PROTEIN family of PROTEIN1 -severing proteins.
BioInfer.d82.s0.p2	P	A similar phenotype was seen in testes treated with cytochalasin B and has been noted previously in mutants at the PROTEIN2 locus, a gene that encodes a Drosophila member of the PROTEIN1 family of PROTEIN -severing proteins.
BioInfer.d83.s0.p0	P	As previous studies indicated that the PROTEIN1 and PROTEIN2 gene products of Saccharomyces cerevisiae seem to be involved in the same cellular function, we considered the possibility of a complex between the proteins encoded by these two genes.
BioInfer.d84.s0.p0	N	As shown by in situ hybridization with cloned probes and analysis of in vitro translation products, M. occulta embryos do not accumulate high levels of PROTEIN2 or PROTEIN1 mRNA.
BioInfer.d84.s1.p0	N	In contrast, PROTEIN2 and PROTEIN1 mRNA accumulation was not enhanced in hybrid embryos.
BioInfer.d85.s0.p0	N	Associations of PROTEIN with PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 proteins in a yeast two-hybrid system.
BioInfer.d85.s0.p1	N	Associations of PROTEIN with PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN proteins in a yeast two-hybrid system.
BioInfer.d85.s0.p2	P	Associations of PROTEIN2 with PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN proteins in a yeast two-hybrid system.
BioInfer.d85.s0.p3	N	Associations of PROTEIN with PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN proteins in a yeast two-hybrid system.
BioInfer.d85.s0.p4	N	Associations of PROTEIN with PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 proteins in a yeast two-hybrid system.
BioInfer.d85.s0.p5	P	Associations of PROTEIN2 with PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 proteins in a yeast two-hybrid system.
BioInfer.d85.s0.p6	N	Associations of PROTEIN with PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 proteins in a yeast two-hybrid system.
BioInfer.d85.s0.p7	P	Associations of PROTEIN2 with PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN proteins in a yeast two-hybrid system.
BioInfer.d85.s0.p8	N	Associations of PROTEIN with PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN proteins in a yeast two-hybrid system.
BioInfer.d85.s0.p9	P	Associations of PROTEIN1 with PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN proteins in a yeast two-hybrid system.
BioInfer.d86.s0.p0	P	At least one element of the PROTEIN2 -binding region of human PROTEIN1 is an alpha-helix.
BioInfer.d87.s0.p0	P	A truncated PROTEIN2 disrupts the interaction between PROTEIN1 and PROTEIN : a cause of loss of intercellular adhesiveness in human cancer cell lines.
BioInfer.d87.s0.p1	P	A truncated PROTEIN disrupts the interaction between PROTEIN1 and PROTEIN2 : a cause of loss of intercellular adhesiveness in human cancer cell lines.
BioInfer.d87.s0.p2	P	A truncated PROTEIN1 disrupts the interaction between PROTEIN and PROTEIN2 : a cause of loss of intercellular adhesiveness in human cancer cell lines.
BioInfer.d87.s1.p0	N	However, the recombinant fusion protein containing wild-type PROTEIN1 precipitated PROTEIN2 from these cells.
BioInfer.d87.s2.p0	P	These results suggest that the dysfunction of PROTEIN2 in these cell lines is due primarily to its failure to interact with PROTEIN , and that this defect results from the mutation in PROTEIN1 .
BioInfer.d87.s2.p1	P	These results suggest that the dysfunction of PROTEIN in these cell lines is due primarily to its failure to interact with PROTEIN2 , and that this defect results from the mutation in PROTEIN1 .
BioInfer.d87.s2.p2	P	These results suggest that the dysfunction of PROTEIN1 in these cell lines is due primarily to its failure to interact with PROTEIN2 , and that this defect results from the mutation in PROTEIN .
BioInfer.d87.s3.p0	P	Thus, it is most likely that the association between PROTEIN2 and PROTEIN1 is mediated by PROTEIN , and that this process is blocked by NH2-terminal deletion in PROTEIN .
BioInfer.d87.s3.p1	P	Thus, it is most likely that the association between PROTEIN and PROTEIN1 is mediated by PROTEIN2 , and that this process is blocked by NH2-terminal deletion in PROTEIN .
BioInfer.d87.s3.p2	P	Thus, it is most likely that the association between PROTEIN and PROTEIN1 is mediated by PROTEIN , and that this process is blocked by NH2-terminal deletion in PROTEIN2 .
BioInfer.d87.s3.p3	P	Thus, it is most likely that the association between PROTEIN1 and PROTEIN is mediated by PROTEIN2 , and that this process is blocked by NH2-terminal deletion in PROTEIN .
BioInfer.d87.s3.p4	P	Thus, it is most likely that the association between PROTEIN1 and PROTEIN is mediated by PROTEIN , and that this process is blocked by NH2-terminal deletion in PROTEIN2 .
BioInfer.d87.s3.p5	P	Thus, it is most likely that the association between PROTEIN and PROTEIN is mediated by PROTEIN1 , and that this process is blocked by NH2-terminal deletion in PROTEIN2 .
BioInfer.d87.s4.p0	P	While PROTEIN2 has been demonstrated to be crucial for PROTEIN1 function, the role of PROTEIN is not yet fully understood.
BioInfer.d87.s4.p1	N	While PROTEIN has been demonstrated to be crucial for PROTEIN1 function, the role of PROTEIN2 is not yet fully understood.
BioInfer.d87.s4.p2	N	While PROTEIN1 has been demonstrated to be crucial for PROTEIN function, the role of PROTEIN2 is not yet fully understood.
BioInfer.d88.s0.p0	N	At the light microscope level, brush cells can be identified by antibodies against the PROTEIN filament crosslinking proteins PROTEIN1 and PROTEIN2 that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.
BioInfer.d88.s0.p1	P	At the light microscope level, brush cells can be identified by antibodies against the PROTEIN2 filament crosslinking proteins PROTEIN1 and PROTEIN that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.
BioInfer.d88.s0.p2	P	At the light microscope level, brush cells can be identified by antibodies against the PROTEIN2 filament crosslinking proteins PROTEIN and PROTEIN1 that not only stain the apical tuft of microvilli and their rootlets, but also label projections emanating from the basolateral surface of these cells.
BioInfer.d89.s0.p0	P	BACKGROUND: Although PROTEIN2 is believed to be an essential regulator of the PROTEIN1 cytoskeleton in most cells, its precise role in mammalian cells remains unknown.
BioInfer.d90.s0.p0	N	BACKGROUND AND OBJECTIVES: Reduced expressions of cell adhesion molecules ( PROTEIN1 , PROTEIN , and PROTEIN2 ) has been reported to be associated with tumor metastasis.
BioInfer.d90.s0.p1	N	BACKGROUND AND OBJECTIVES: Reduced expressions of cell adhesion molecules ( PROTEIN1 , PROTEIN2 , and PROTEIN ) has been reported to be associated with tumor metastasis.
BioInfer.d90.s0.p2	N	BACKGROUND AND OBJECTIVES: Reduced expressions of cell adhesion molecules ( PROTEIN , PROTEIN2 , and PROTEIN1 ) has been reported to be associated with tumor metastasis.
BioInfer.d90.s1.p0	N	In this study, we evaluated the prognostic significance of PROTEIN1 , PROTEIN , and PROTEIN2 expressions in the metastatic foci of patients with colorectal carcinoma.
BioInfer.d90.s1.p1	N	In this study, we evaluated the prognostic significance of PROTEIN1 , PROTEIN2 , and PROTEIN expressions in the metastatic foci of patients with colorectal carcinoma.
BioInfer.d90.s1.p2	N	In this study, we evaluated the prognostic significance of PROTEIN , PROTEIN2 , and PROTEIN1 expressions in the metastatic foci of patients with colorectal carcinoma.
BioInfer.d90.s2.p0	N	RESULTS: Reduced normal expression of PROTEIN1 , PROTEIN , and PROTEIN2 in comparison with normal epithelium was detected in 78 primary tumors, respectively.
BioInfer.d90.s2.p1	N	RESULTS: Reduced normal expression of PROTEIN1 , PROTEIN2 , and PROTEIN in comparison with normal epithelium was detected in 78 primary tumors, respectively.
BioInfer.d90.s2.p2	N	RESULTS: Reduced normal expression of PROTEIN , PROTEIN2 , and PROTEIN1 in comparison with normal epithelium was detected in 78 primary tumors, respectively.
BioInfer.d91.s0.p0	P	BACKGROUND: PROTEIN1 ( PROTEIN ), a PROTEIN , negatively regulates the G1 phase progression of the cell cycle by binding to the PROTEIN2 / PROTEIN complex.
BioInfer.d91.s0.p1	N	BACKGROUND: PROTEIN1 ( PROTEIN2 ), a PROTEIN , negatively regulates the G1 phase progression of the cell cycle by binding to the PROTEIN / PROTEIN complex.
BioInfer.d91.s0.p2	P	BACKGROUND: PROTEIN1 ( PROTEIN ), a PROTEIN , negatively regulates the G1 phase progression of the cell cycle by binding to the PROTEIN / PROTEIN2 complex.
BioInfer.d91.s0.p3	P	BACKGROUND: PROTEIN1 ( PROTEIN ), a PROTEIN2 , negatively regulates the G1 phase progression of the cell cycle by binding to the PROTEIN / PROTEIN complex.
BioInfer.d91.s0.p4	P	BACKGROUND: PROTEIN ( PROTEIN2 ), a PROTEIN , negatively regulates the G1 phase progression of the cell cycle by binding to the PROTEIN1 / PROTEIN complex.
BioInfer.d91.s0.p5	P	BACKGROUND: PROTEIN ( PROTEIN ), a PROTEIN , negatively regulates the G1 phase progression of the cell cycle by binding to the PROTEIN1 / PROTEIN2 complex.
BioInfer.d91.s0.p6	N	BACKGROUND: PROTEIN ( PROTEIN ), a PROTEIN2 , negatively regulates the G1 phase progression of the cell cycle by binding to the PROTEIN1 / PROTEIN complex.
BioInfer.d91.s0.p7	P	BACKGROUND: PROTEIN ( PROTEIN1 ), a PROTEIN , negatively regulates the G1 phase progression of the cell cycle by binding to the PROTEIN / PROTEIN2 complex.
BioInfer.d91.s0.p8	P	BACKGROUND: PROTEIN ( PROTEIN1 ), a PROTEIN2 , negatively regulates the G1 phase progression of the cell cycle by binding to the PROTEIN / PROTEIN complex.
BioInfer.d91.s0.p9	N	BACKGROUND: PROTEIN ( PROTEIN ), a PROTEIN2 , negatively regulates the G1 phase progression of the cell cycle by binding to the PROTEIN / PROTEIN1 complex.
BioInfer.d92.s0.p0	N	Because PROTEIN1 is known to interact with PROTEIN , which binds to PROTEIN , we generated a fusion molecule consisting of the ectodomain of PROTEIN and the PROTEIN2 binding site of PROTEIN .
BioInfer.d92.s0.p1	N	Because PROTEIN1 is known to interact with PROTEIN , which binds to PROTEIN , we generated a fusion molecule consisting of the ectodomain of PROTEIN and the PROTEIN binding site of PROTEIN2 .
BioInfer.d92.s0.p2	N	Because PROTEIN1 is known to interact with PROTEIN , which binds to PROTEIN2 , we generated a fusion molecule consisting of the ectodomain of PROTEIN and the PROTEIN binding site of PROTEIN .
BioInfer.d92.s0.p3	N	Because PROTEIN1 is known to interact with PROTEIN , which binds to PROTEIN , we generated a fusion molecule consisting of the ectodomain of PROTEIN2 and the PROTEIN binding site of PROTEIN .
BioInfer.d92.s0.p4	P	Because PROTEIN1 is known to interact with PROTEIN2 , which binds to PROTEIN , we generated a fusion molecule consisting of the ectodomain of PROTEIN and the PROTEIN binding site of PROTEIN .
BioInfer.d92.s0.p5	P	Because PROTEIN is known to interact with PROTEIN , which binds to PROTEIN , we generated a fusion molecule consisting of the ectodomain of PROTEIN and the PROTEIN1 binding site of PROTEIN2 .
BioInfer.d92.s0.p6	N	Because PROTEIN is known to interact with PROTEIN , which binds to PROTEIN2 , we generated a fusion molecule consisting of the ectodomain of PROTEIN and the PROTEIN1 binding site of PROTEIN .
BioInfer.d92.s0.p7	N	Because PROTEIN is known to interact with PROTEIN , which binds to PROTEIN , we generated a fusion molecule consisting of the ectodomain of PROTEIN2 and the PROTEIN1 binding site of PROTEIN .
BioInfer.d92.s0.p8	N	Because PROTEIN is known to interact with PROTEIN2 , which binds to PROTEIN , we generated a fusion molecule consisting of the ectodomain of PROTEIN and the PROTEIN1 binding site of PROTEIN .
BioInfer.d92.s0.p9	N	Because PROTEIN is known to interact with PROTEIN , which binds to PROTEIN2 , we generated a fusion molecule consisting of the ectodomain of PROTEIN and the PROTEIN binding site of PROTEIN1 .
BioInfer.d92.s0.p10	P	Because PROTEIN is known to interact with PROTEIN , which binds to PROTEIN , we generated a fusion molecule consisting of the ectodomain of PROTEIN2 and the PROTEIN binding site of PROTEIN1 .
BioInfer.d92.s0.p11	N	Because PROTEIN is known to interact with PROTEIN2 , which binds to PROTEIN , we generated a fusion molecule consisting of the ectodomain of PROTEIN and the PROTEIN binding site of PROTEIN1 .
BioInfer.d92.s0.p12	N	Because PROTEIN is known to interact with PROTEIN , which binds to PROTEIN1 , we generated a fusion molecule consisting of the ectodomain of PROTEIN2 and the PROTEIN binding site of PROTEIN .
BioInfer.d92.s0.p13	P	Because PROTEIN is known to interact with PROTEIN2 , which binds to PROTEIN1 , we generated a fusion molecule consisting of the ectodomain of PROTEIN and the PROTEIN binding site of PROTEIN .
BioInfer.d92.s0.p14	N	Because PROTEIN is known to interact with PROTEIN2 , which binds to PROTEIN , we generated a fusion molecule consisting of the ectodomain of PROTEIN1 and the PROTEIN binding site of PROTEIN .
BioInfer.d93.s0.p0	N	Because PROTEIN  PROTEIN shares many structural features with PROTEIN  PROTEIN2 and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN1 has similar functions.
BioInfer.d93.s0.p1	N	Because PROTEIN2  PROTEIN shares many structural features with PROTEIN  PROTEIN and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN1 has similar functions.
BioInfer.d93.s0.p2	N	Because PROTEIN  PROTEIN shares many structural features with PROTEIN  PROTEIN and is intimately associated with PROTEIN2 in the assembled nucleosome, we asked whether PROTEIN1 has similar functions.
BioInfer.d93.s0.p3	N	Because PROTEIN  PROTEIN shares many structural features with PROTEIN2  PROTEIN and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN1 has similar functions.
BioInfer.d93.s0.p4	N	Because PROTEIN  PROTEIN2 shares many structural features with PROTEIN  PROTEIN and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN1 has similar functions.
BioInfer.d93.s0.p5	N	Because PROTEIN2  PROTEIN shares many structural features with PROTEIN  PROTEIN1 and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN has similar functions.
BioInfer.d93.s0.p6	N	Because PROTEIN  PROTEIN shares many structural features with PROTEIN  PROTEIN1 and is intimately associated with PROTEIN2 in the assembled nucleosome, we asked whether PROTEIN has similar functions.
BioInfer.d93.s0.p7	P	Because PROTEIN  PROTEIN shares many structural features with PROTEIN2  PROTEIN1 and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN has similar functions.
BioInfer.d93.s0.p8	P	Because PROTEIN  PROTEIN2 shares many structural features with PROTEIN  PROTEIN1 and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN has similar functions.
BioInfer.d93.s0.p9	N	Because PROTEIN1  PROTEIN shares many structural features with PROTEIN  PROTEIN and is intimately associated with PROTEIN2 in the assembled nucleosome, we asked whether PROTEIN has similar functions.
BioInfer.d93.s0.p10	N	Because PROTEIN1  PROTEIN shares many structural features with PROTEIN2  PROTEIN and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN has similar functions.
BioInfer.d93.s0.p11	P	Because PROTEIN1  PROTEIN2 shares many structural features with PROTEIN  PROTEIN and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN has similar functions.
BioInfer.d93.s0.p12	N	Because PROTEIN  PROTEIN shares many structural features with PROTEIN2  PROTEIN and is intimately associated with PROTEIN1 in the assembled nucleosome, we asked whether PROTEIN has similar functions.
BioInfer.d93.s0.p13	P	Because PROTEIN  PROTEIN2 shares many structural features with PROTEIN  PROTEIN and is intimately associated with PROTEIN1 in the assembled nucleosome, we asked whether PROTEIN has similar functions.
BioInfer.d93.s0.p14	N	Because PROTEIN  PROTEIN2 shares many structural features with PROTEIN1  PROTEIN and is intimately associated with PROTEIN in the assembled nucleosome, we asked whether PROTEIN has similar functions.
BioInfer.d94.s0.p0	P	Because both proteins exchange rapidly between PROTEIN molecules, low concentrations of PROTEIN1 can overcome the inhibitory effects of high concentrations of PROTEIN2 on the nucleotide exchange.
BioInfer.d94.s0.p1	P	Because both proteins exchange rapidly between PROTEIN2 molecules, low concentrations of PROTEIN1 can overcome the inhibitory effects of high concentrations of PROTEIN on the nucleotide exchange.
BioInfer.d94.s0.p2	P	Because both proteins exchange rapidly between PROTEIN2 molecules, low concentrations of PROTEIN can overcome the inhibitory effects of high concentrations of PROTEIN1 on the nucleotide exchange.
BioInfer.d95.s0.p0	P	Because other researchers have shown that the PROTEIN and PROTEIN proteins interact, PROTEIN1 on a high copy number plasmid was tested and found to suppress the PROTEIN allele, but PROTEIN2 , 55 and 57 did not suppress.
BioInfer.d95.s0.p3	N	Because other researchers have shown that the PROTEIN2 and PROTEIN proteins interact, PROTEIN1 on a high copy number plasmid was tested and found to suppress the PROTEIN allele, but PROTEIN , 55 and 57 did not suppress.
BioInfer.d95.s0.p4	N	Because other researchers have shown that the PROTEIN and PROTEIN2 proteins interact, PROTEIN1 on a high copy number plasmid was tested and found to suppress the PROTEIN allele, but PROTEIN , 55 and 57 did not suppress.
BioInfer.d95.s0.p5	P	Because other researchers have shown that the PROTEIN and PROTEIN proteins interact, PROTEIN1 on a high copy number plasmid was tested and found to suppress the PROTEIN2 allele, but PROTEIN , 55 and 57 did not suppress.
BioInfer.d95.s0.p8	N	Because other researchers have shown that the PROTEIN2 and PROTEIN proteins interact, PROTEIN on a high copy number plasmid was tested and found to suppress the PROTEIN allele, but PROTEIN1 , 55 and 57 did not suppress.
BioInfer.d95.s0.p9	N	Because other researchers have shown that the PROTEIN and PROTEIN2 proteins interact, PROTEIN on a high copy number plasmid was tested and found to suppress the PROTEIN allele, but PROTEIN1 , 55 and 57 did not suppress.
BioInfer.d95.s0.p10	N	Because other researchers have shown that the PROTEIN and PROTEIN proteins interact, PROTEIN on a high copy number plasmid was tested and found to suppress the PROTEIN2 allele, but PROTEIN1 , 55 and 57 did not suppress.
BioInfer.d95.s0.p18	P	Because other researchers have shown that the PROTEIN1 and PROTEIN2 proteins interact, PROTEIN on a high copy number plasmid was tested and found to suppress the PROTEIN allele, but PROTEIN , 55 and 57 did not suppress.
BioInfer.d95.s0.p19	N	Because other researchers have shown that the PROTEIN1 and PROTEIN proteins interact, PROTEIN on a high copy number plasmid was tested and found to suppress the PROTEIN2 allele, but PROTEIN , 55 and 57 did not suppress.
BioInfer.d95.s0.p20	N	Because other researchers have shown that the PROTEIN and PROTEIN1 proteins interact, PROTEIN on a high copy number plasmid was tested and found to suppress the PROTEIN2 allele, but PROTEIN , 55 and 57 did not suppress.
BioInfer.d96.s0.p0	N	Between day 1 and day 3 in culture, the specific synthetic activities of total proteins and of electrophoretically purified PROTEIN1 and PROTEIN2 ([14C] phenylalanine incorporation into protein, in disintegrations per minute per microgram protein) decreased (-19%,-32%, and -73%, respectively).
BioInfer.d97.s0.p0	P	Binding of PROTEIN2 to PROTEIN1 occurs at a maximal molar ratio of 1:3 as determined by fluorescencetitration under G-buffer conditions.
BioInfer.d97.s1.p0	P	PROTEIN1 binds to PROTEIN2 in vitro and hence is an PROTEIN .
BioInfer.d97.s1.p1	P	PROTEIN1 binds to PROTEIN in vitro and hence is an PROTEIN2 .
BioInfer.d97.s1.p2	N	PROTEIN binds to PROTEIN1 in vitro and hence is an PROTEIN2 .
BioInfer.d98.s0.p0	P	Binding to human PROTEIN2 by PROTEIN1 and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain.
BioInfer.d99.s0.p0	P	Biochemical analyses revealed a strong induction of PROTEIN1 ( PROTEIN / PROTEIN ) tyrosine-autophosphorylation by PROTEIN2 which was maximal after 5 minutes and was followed by receptor downregulation.
BioInfer.d99.s0.p1	N	Biochemical analyses revealed a strong induction of PROTEIN1 ( PROTEIN / PROTEIN2 ) tyrosine-autophosphorylation by PROTEIN which was maximal after 5 minutes and was followed by receptor downregulation.
BioInfer.d99.s0.p2	N	Biochemical analyses revealed a strong induction of PROTEIN1 ( PROTEIN2 / PROTEIN ) tyrosine-autophosphorylation by PROTEIN which was maximal after 5 minutes and was followed by receptor downregulation.
BioInfer.d99.s0.p3	P	Biochemical analyses revealed a strong induction of PROTEIN ( PROTEIN / PROTEIN2 ) tyrosine-autophosphorylation by PROTEIN1 which was maximal after 5 minutes and was followed by receptor downregulation.
BioInfer.d99.s0.p4	P	Biochemical analyses revealed a strong induction of PROTEIN ( PROTEIN2 / PROTEIN ) tyrosine-autophosphorylation by PROTEIN1 which was maximal after 5 minutes and was followed by receptor downregulation.
BioInfer.d99.s0.p5	N	Biochemical analyses revealed a strong induction of PROTEIN ( PROTEIN2 / PROTEIN1 ) tyrosine-autophosphorylation by PROTEIN which was maximal after 5 minutes and was followed by receptor downregulation.
BioInfer.d100.s0.p0	P	Biochemical complementation experiments also indicate that the PROTEIN2 and PROTEIN1 proteins interact.
BioInfer.d100.s1.p0	P	Four yeast spliceosomal proteins ( PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN ) interact to promote PROTEIN2 binding to pre-mRNA.
BioInfer.d100.s1.p1	P	Four yeast spliceosomal proteins ( PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 ) interact to promote PROTEIN binding to pre-mRNA.
BioInfer.d100.s1.p2	P	Four yeast spliceosomal proteins ( PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN ) interact to promote PROTEIN binding to pre-mRNA.
BioInfer.d100.s1.p3	P	Four yeast spliceosomal proteins ( PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN ) interact to promote PROTEIN binding to pre-mRNA.
BioInfer.d100.s1.p4	P	Four yeast spliceosomal proteins ( PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 ) interact to promote PROTEIN1 binding to pre-mRNA.
BioInfer.d100.s1.p5	P	Four yeast spliceosomal proteins ( PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN ) interact to promote PROTEIN1 binding to pre-mRNA.
BioInfer.d100.s1.p6	P	Four yeast spliceosomal proteins ( PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN ) interact to promote PROTEIN1 binding to pre-mRNA.
BioInfer.d100.s1.p7	P	Four yeast spliceosomal proteins ( PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 ) interact to promote PROTEIN binding to pre-mRNA.
BioInfer.d100.s1.p8	P	Four yeast spliceosomal proteins ( PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 ) interact to promote PROTEIN binding to pre-mRNA.
BioInfer.d100.s1.p9	P	Four yeast spliceosomal proteins ( PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN ) interact to promote PROTEIN binding to pre-mRNA.
BioInfer.d100.s2.p0	N	Here, we show that PROTEIN2 (a PROTEIN -like protein), PROTEIN1 , and PROTEIN are each required for the PROTEIN to bind to the pre-spliceosome during spliceosome assembly in vitro.
BioInfer.d100.s2.p1	N	Here, we show that PROTEIN (a PROTEIN -like protein), PROTEIN1 , and PROTEIN2 are each required for the PROTEIN to bind to the pre-spliceosome during spliceosome assembly in vitro.
BioInfer.d100.s2.p2	P	Here, we show that PROTEIN (a PROTEIN -like protein), PROTEIN1 , and PROTEIN are each required for the PROTEIN2 to bind to the pre-spliceosome during spliceosome assembly in vitro.
BioInfer.d100.s2.p3	N	Here, we show that PROTEIN (a PROTEIN2 -like protein), PROTEIN1 , and PROTEIN are each required for the PROTEIN to bind to the pre-spliceosome during spliceosome assembly in vitro.
BioInfer.d100.s2.p4	N	Here, we show that PROTEIN1 (a PROTEIN -like protein), PROTEIN , and PROTEIN2 are each required for the PROTEIN to bind to the pre-spliceosome during spliceosome assembly in vitro.
BioInfer.d100.s2.p5	P	Here, we show that PROTEIN1 (a PROTEIN -like protein), PROTEIN , and PROTEIN are each required for the PROTEIN2 to bind to the pre-spliceosome during spliceosome assembly in vitro.
BioInfer.d100.s2.p6	P	Here, we show that PROTEIN1 (a PROTEIN2 -like protein), PROTEIN , and PROTEIN are each required for the PROTEIN to bind to the pre-spliceosome during spliceosome assembly in vitro.
BioInfer.d100.s2.p7	P	Here, we show that PROTEIN (a PROTEIN -like protein), PROTEIN , and PROTEIN1 are each required for the PROTEIN2 to bind to the pre-spliceosome during spliceosome assembly in vitro.
BioInfer.d100.s2.p8	N	Here, we show that PROTEIN (a PROTEIN2 -like protein), PROTEIN , and PROTEIN1 are each required for the PROTEIN to bind to the pre-spliceosome during spliceosome assembly in vitro.
BioInfer.d100.s2.p9	N	Here, we show that PROTEIN (a PROTEIN2 -like protein), PROTEIN , and PROTEIN are each required for the PROTEIN1 to bind to the pre-spliceosome during spliceosome assembly in vitro.
BioInfer.d101.s0.p0	N	Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN isoform 6 ( PROTEIN ), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.
BioInfer.d101.s0.p1	N	Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN isoform 6 ( PROTEIN2 ), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.
BioInfer.d101.s0.p2	N	Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN isoform 6 ( PROTEIN ), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.
BioInfer.d101.s0.p3	N	Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 isoform 6 ( PROTEIN ), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.
BioInfer.d101.s0.p4	N	Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN isoform 6 ( PROTEIN2 ), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.
BioInfer.d101.s0.p5	N	Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN isoform 6 ( PROTEIN ), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.
BioInfer.d101.s0.p6	N	Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 isoform 6 ( PROTEIN ), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.
BioInfer.d101.s0.p7	N	Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN isoform 6 ( PROTEIN1 ), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.
BioInfer.d101.s0.p8	N	Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 isoform 6 ( PROTEIN1 ), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.
BioInfer.d101.s0.p9	N	Biopsies taken prior to NAC and operative specimens were subjected to immunohistochemical (IHC) staining for PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 isoform 6 ( PROTEIN ), to uncover the role of adhesion molecules as determinants of the response to NAC and disease outcome.
BioInfer.d102.s0.p0	N	Birch PROTEIN and PROTEIN1 can be copurified as a complex, and purified recombinant birch PROTEIN can be used as an affinity matrix to obtain birch PROTEIN2 .
BioInfer.d102.s0.p1	N	Birch PROTEIN and PROTEIN1 can be copurified as a complex, and purified recombinant birch PROTEIN2 can be used as an affinity matrix to obtain birch PROTEIN .
BioInfer.d102.s0.p2	P	Birch PROTEIN2 and PROTEIN1 can be copurified as a complex, and purified recombinant birch PROTEIN can be used as an affinity matrix to obtain birch PROTEIN .
BioInfer.d102.s0.p3	P	Birch PROTEIN and PROTEIN can be copurified as a complex, and purified recombinant birch PROTEIN2 can be used as an affinity matrix to obtain birch PROTEIN1 .
BioInfer.d102.s0.p4	N	Birch PROTEIN2 and PROTEIN can be copurified as a complex, and purified recombinant birch PROTEIN can be used as an affinity matrix to obtain birch PROTEIN1 .
BioInfer.d102.s0.p5	N	Birch PROTEIN2 and PROTEIN can be copurified as a complex, and purified recombinant birch PROTEIN1 can be used as an affinity matrix to obtain birch PROTEIN .
BioInfer.d102.s1.p0	P	In this study, PROTEIN1 is identified as an PROTEIN2 in higher plants which is present in monocot and dicot angiosperms.
BioInfer.d102.s2.p0	P	The binding of 125I-labeled recombinant birch pollen PROTEIN to plant and animal PROTEIN can be blocked by PROTEIN1 -specific antibodies that react with different epitopes of birch PROTEIN2 .
BioInfer.d102.s2.p1	P	The binding of 125I-labeled recombinant birch pollen PROTEIN to plant and animal PROTEIN2 can be blocked by PROTEIN1 -specific antibodies that react with different epitopes of birch PROTEIN .
BioInfer.d102.s2.p2	P	The binding of 125I-labeled recombinant birch pollen PROTEIN2 to plant and animal PROTEIN can be blocked by PROTEIN1 -specific antibodies that react with different epitopes of birch PROTEIN .
BioInfer.d102.s2.p3	N	The binding of 125I-labeled recombinant birch pollen PROTEIN to plant and animal PROTEIN2 can be blocked by PROTEIN -specific antibodies that react with different epitopes of birch PROTEIN1 .
BioInfer.d102.s2.p4	N	The binding of 125I-labeled recombinant birch pollen PROTEIN2 to plant and animal PROTEIN can be blocked by PROTEIN -specific antibodies that react with different epitopes of birch PROTEIN1 .
BioInfer.d102.s2.p5	P	The binding of 125I-labeled recombinant birch pollen PROTEIN2 to plant and animal PROTEIN1 can be blocked by PROTEIN -specific antibodies that react with different epitopes of birch PROTEIN .
BioInfer.d103.s0.p0	N	Bistratene A causes phosphorylation of PROTEIN2 and redistribution of PROTEIN1 microfilaments in fibroblasts: possible role for PROTEIN .
BioInfer.d103.s0.p1	P	Bistratene A causes phosphorylation of PROTEIN and redistribution of PROTEIN1 microfilaments in fibroblasts: possible role for PROTEIN2 .
BioInfer.d103.s0.p2	P	Bistratene A causes phosphorylation of PROTEIN1 and redistribution of PROTEIN microfilaments in fibroblasts: possible role for PROTEIN2 .
BioInfer.d104.s0.p0	N	PROTEIN appears to be more closely related to the mouse PROTEIN1 gene and other similar eukaryotic PROTEIN homologues than to the yeast gene PROTEIN and other PROTEIN2 homologues that are involved in replication repair.
BioInfer.d104.s0.p1	N	PROTEIN appears to be more closely related to the mouse PROTEIN1 gene and other similar eukaryotic PROTEIN2 homologues than to the yeast gene PROTEIN and other PROTEIN homologues that are involved in replication repair.
BioInfer.d104.s0.p2	P	PROTEIN2 appears to be more closely related to the mouse PROTEIN1 gene and other similar eukaryotic PROTEIN homologues than to the yeast gene PROTEIN and other PROTEIN homologues that are involved in replication repair.
BioInfer.d104.s0.p3	N	PROTEIN appears to be more closely related to the mouse PROTEIN1 gene and other similar eukaryotic PROTEIN homologues than to the yeast gene PROTEIN2 and other PROTEIN homologues that are involved in replication repair.
BioInfer.d104.s0.p4	N	PROTEIN appears to be more closely related to the mouse PROTEIN gene and other similar eukaryotic PROTEIN2 homologues than to the yeast gene PROTEIN and other PROTEIN1 homologues that are involved in replication repair.
BioInfer.d104.s0.p5	P	PROTEIN2 appears to be more closely related to the mouse PROTEIN gene and other similar eukaryotic PROTEIN homologues than to the yeast gene PROTEIN and other PROTEIN1 homologues that are involved in replication repair.
BioInfer.d104.s0.p6	N	PROTEIN appears to be more closely related to the mouse PROTEIN gene and other similar eukaryotic PROTEIN homologues than to the yeast gene PROTEIN2 and other PROTEIN1 homologues that are involved in replication repair.
BioInfer.d104.s0.p7	P	PROTEIN2 appears to be more closely related to the mouse PROTEIN gene and other similar eukaryotic PROTEIN1 homologues than to the yeast gene PROTEIN and other PROTEIN homologues that are involved in replication repair.
BioInfer.d104.s0.p8	N	PROTEIN appears to be more closely related to the mouse PROTEIN gene and other similar eukaryotic PROTEIN1 homologues than to the yeast gene PROTEIN2 and other PROTEIN homologues that are involved in replication repair.
BioInfer.d104.s0.p9	P	PROTEIN1 appears to be more closely related to the mouse PROTEIN gene and other similar eukaryotic PROTEIN homologues than to the yeast gene PROTEIN2 and other PROTEIN homologues that are involved in replication repair.
BioInfer.d105.s0.p0	P	PROTEIN2 is also expressed in endothelial cells and shown to bind PROTEIN ( PROTEIN1 ), a potent regulator for vasculogenesis and angiogenesis.
BioInfer.d105.s0.p1	N	PROTEIN is also expressed in endothelial cells and shown to bind PROTEIN2 ( PROTEIN1 ), a potent regulator for vasculogenesis and angiogenesis.
BioInfer.d105.s0.p2	P	PROTEIN1 is also expressed in endothelial cells and shown to bind PROTEIN2 ( PROTEIN ), a potent regulator for vasculogenesis and angiogenesis.
BioInfer.d106.s0.p0	P	PROTEIN1 is expressed by endothelial and tumor cells as an isoform-specific receptor for PROTEIN2 .
BioInfer.d107.s0.p0	N	PROTEIN mediates PROTEIN1 / PROTEIN inhibition of endothelial cell motility: functional competition of PROTEIN and PROTEIN2 .
BioInfer.d107.s0.p1	N	PROTEIN mediates PROTEIN1 / PROTEIN2 inhibition of endothelial cell motility: functional competition of PROTEIN and PROTEIN .
BioInfer.d107.s0.p2	P	PROTEIN2 mediates PROTEIN1 / PROTEIN inhibition of endothelial cell motility: functional competition of PROTEIN and PROTEIN .
BioInfer.d107.s0.p3	N	PROTEIN mediates PROTEIN1 / PROTEIN inhibition of endothelial cell motility: functional competition of PROTEIN2 and PROTEIN .
BioInfer.d107.s0.p4	N	PROTEIN mediates PROTEIN / PROTEIN2 inhibition of endothelial cell motility: functional competition of PROTEIN and PROTEIN1 .
BioInfer.d107.s0.p5	N	PROTEIN2 mediates PROTEIN / PROTEIN inhibition of endothelial cell motility: functional competition of PROTEIN and PROTEIN1 .
BioInfer.d107.s0.p6	P	PROTEIN mediates PROTEIN / PROTEIN inhibition of endothelial cell motility: functional competition of PROTEIN2 and PROTEIN1 .
BioInfer.d107.s0.p7	P	PROTEIN2 mediates PROTEIN / PROTEIN1 inhibition of endothelial cell motility: functional competition of PROTEIN and PROTEIN .
BioInfer.d107.s0.p8	N	PROTEIN mediates PROTEIN / PROTEIN1 inhibition of endothelial cell motility: functional competition of PROTEIN2 and PROTEIN .
BioInfer.d107.s0.p9	N	PROTEIN1 mediates PROTEIN / PROTEIN inhibition of endothelial cell motility: functional competition of PROTEIN2 and PROTEIN .
BioInfer.d108.s0.p0	N	PROTEIN2 ( PROTEIN1 ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p1	P	PROTEIN ( PROTEIN1 ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN ( PROTEIN2 ).
BioInfer.d108.s0.p2	P	PROTEIN ( PROTEIN1 ) is a receptor for PROTEIN2 ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p3	P	PROTEIN ( PROTEIN1 ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN2 ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p4	P	PROTEIN ( PROTEIN1 ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN2 function through PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p5	N	PROTEIN ( PROTEIN1 ) is a receptor for PROTEIN ( PROTEIN2 ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p6	N	PROTEIN ( PROTEIN1 ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN2  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p7	P	PROTEIN ( PROTEIN1 ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN2 ( PROTEIN ).
BioInfer.d108.s0.p8	P	PROTEIN1 ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN ( PROTEIN2 ).
BioInfer.d108.s0.p9	P	PROTEIN1 ( PROTEIN ) is a receptor for PROTEIN2 ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p10	P	PROTEIN1 ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN2 ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p11	P	PROTEIN1 ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN2 function through PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p12	N	PROTEIN1 ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN2 ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p13	N	PROTEIN1 ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN2  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p14	P	PROTEIN1 ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN2 ( PROTEIN ).
BioInfer.d108.s0.p15	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN2 ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN ( PROTEIN1 ).
BioInfer.d108.s0.p16	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN2 ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN ( PROTEIN1 ).
BioInfer.d108.s0.p17	P	PROTEIN ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN2 function through PROTEIN  PROTEIN ( PROTEIN1 ).
BioInfer.d108.s0.p18	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN2 ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN ( PROTEIN1 ).
BioInfer.d108.s0.p19	P	PROTEIN ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN2  PROTEIN ( PROTEIN1 ).
BioInfer.d108.s0.p20	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN2 ( PROTEIN1 ).
BioInfer.d108.s0.p21	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN1 ( PROTEIN ) 165 ( PROTEIN2 ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p22	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN1 ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN2 function through PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p23	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN1 ( PROTEIN2 ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p24	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN1 ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN2  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p25	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN1 ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN2 ( PROTEIN ).
BioInfer.d108.s0.p26	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN1 ) and acts as a coreceptor that enhances PROTEIN2 function through PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p27	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN2 ) 165 ( PROTEIN1 ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p28	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN1 ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN2  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p29	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN1 ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN2 ( PROTEIN ).
BioInfer.d108.s0.p30	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN2 ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN1 function through PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p31	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN1 function through PROTEIN2  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p32	P	PROTEIN ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN1 function through PROTEIN  PROTEIN2 ( PROTEIN ).
BioInfer.d108.s0.p33	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN1 ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN2  PROTEIN ( PROTEIN ).
BioInfer.d108.s0.p34	N	PROTEIN ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN1 ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN  PROTEIN2 ( PROTEIN ).
BioInfer.d108.s0.p35	P	PROTEIN ( PROTEIN ) is a receptor for PROTEIN ( PROTEIN ) 165 ( PROTEIN ) and acts as a coreceptor that enhances PROTEIN function through PROTEIN1  PROTEIN2 ( PROTEIN ).
BioInfer.d109.s0.p0	N	PROTEIN1 ( PROTEIN2 ) is a 130-kDa transmembrane receptor for PROTEIN , mediators of neuronal guidance, and for PROTEIN ( PROTEIN ), an angiogenesis factor.
BioInfer.d109.s0.p1	P	PROTEIN1 ( PROTEIN ) is a 130-kDa transmembrane receptor for PROTEIN2 , mediators of neuronal guidance, and for PROTEIN ( PROTEIN ), an angiogenesis factor.
BioInfer.d109.s0.p2	P	PROTEIN1 ( PROTEIN ) is a 130-kDa transmembrane receptor for PROTEIN , mediators of neuronal guidance, and for PROTEIN2 ( PROTEIN ), an angiogenesis factor.
BioInfer.d109.s0.p3	P	PROTEIN1 ( PROTEIN ) is a 130-kDa transmembrane receptor for PROTEIN , mediators of neuronal guidance, and for PROTEIN ( PROTEIN2 ), an angiogenesis factor.
BioInfer.d109.s0.p4	P	PROTEIN ( PROTEIN1 ) is a 130-kDa transmembrane receptor for PROTEIN2 , mediators of neuronal guidance, and for PROTEIN ( PROTEIN ), an angiogenesis factor.
BioInfer.d109.s0.p5	P	PROTEIN ( PROTEIN1 ) is a 130-kDa transmembrane receptor for PROTEIN , mediators of neuronal guidance, and for PROTEIN2 ( PROTEIN ), an angiogenesis factor.
BioInfer.d109.s0.p6	P	PROTEIN ( PROTEIN1 ) is a 130-kDa transmembrane receptor for PROTEIN , mediators of neuronal guidance, and for PROTEIN ( PROTEIN2 ), an angiogenesis factor.
BioInfer.d109.s0.p7	N	PROTEIN ( PROTEIN ) is a 130-kDa transmembrane receptor for PROTEIN1 , mediators of neuronal guidance, and for PROTEIN2 ( PROTEIN ), an angiogenesis factor.
BioInfer.d109.s0.p8	N	PROTEIN ( PROTEIN ) is a 130-kDa transmembrane receptor for PROTEIN1 , mediators of neuronal guidance, and for PROTEIN ( PROTEIN2 ), an angiogenesis factor.
BioInfer.d109.s0.p9	N	PROTEIN ( PROTEIN ) is a 130-kDa transmembrane receptor for PROTEIN , mediators of neuronal guidance, and for PROTEIN1 ( PROTEIN2 ), an angiogenesis factor.
BioInfer.d109.s1.p0	N	A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN1 ( PROTEIN ) isoform containing just the a/ PROTEIN2 and b/ PROTEIN homology extracellular domains of PROTEIN .
BioInfer.d109.s1.p1	N	A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN1 ( PROTEIN2 ) isoform containing just the a/ PROTEIN and b/ PROTEIN homology extracellular domains of PROTEIN .
BioInfer.d109.s1.p2	N	A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN1 ( PROTEIN ) isoform containing just the a/ PROTEIN and b/ PROTEIN2 homology extracellular domains of PROTEIN .
BioInfer.d109.s1.p3	N	A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN1 ( PROTEIN ) isoform containing just the a/ PROTEIN and b/ PROTEIN homology extracellular domains of PROTEIN2 .
BioInfer.d109.s1.p4	P	A 2.2-kb truncated PROTEIN2 cDNA was cloned that encodes a 644-aa PROTEIN1 ( PROTEIN ) isoform containing just the a/ PROTEIN and b/ PROTEIN homology extracellular domains of PROTEIN .
BioInfer.d109.s1.p6	N	A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN2 ) isoform containing just the a/ PROTEIN1 and b/ PROTEIN homology extracellular domains of PROTEIN .
BioInfer.d109.s1.p7	N	A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN ) isoform containing just the a/ PROTEIN1 and b/ PROTEIN2 homology extracellular domains of PROTEIN .
BioInfer.d109.s1.p8	P	A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN ) isoform containing just the a/ PROTEIN1 and b/ PROTEIN homology extracellular domains of PROTEIN2 .
BioInfer.d109.s1.p9	N	A 2.2-kb truncated PROTEIN2 cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN ) isoform containing just the a/ PROTEIN1 and b/ PROTEIN homology extracellular domains of PROTEIN .
BioInfer.d109.s1.p11	N	A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN1 ) isoform containing just the a/ PROTEIN and b/ PROTEIN2 homology extracellular domains of PROTEIN .
BioInfer.d109.s1.p12	N	A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN1 ) isoform containing just the a/ PROTEIN and b/ PROTEIN homology extracellular domains of PROTEIN2 .
BioInfer.d109.s1.p13	P	A 2.2-kb truncated PROTEIN2 cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN1 ) isoform containing just the a/ PROTEIN and b/ PROTEIN homology extracellular domains of PROTEIN .
BioInfer.d109.s1.p15	P	A 2.2-kb truncated PROTEIN cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN ) isoform containing just the a/ PROTEIN and b/ PROTEIN1 homology extracellular domains of PROTEIN2 .
BioInfer.d109.s1.p16	N	A 2.2-kb truncated PROTEIN2 cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN ) isoform containing just the a/ PROTEIN and b/ PROTEIN1 homology extracellular domains of PROTEIN .
BioInfer.d109.s1.p18	N	A 2.2-kb truncated PROTEIN2 cDNA was cloned that encodes a 644-aa PROTEIN ( PROTEIN ) isoform containing just the a/ PROTEIN and b/ PROTEIN homology extracellular domains of PROTEIN1 .
BioInfer.d109.s2.p0	N	PROTEIN is secreted by cells as a 90-kDa protein that binds PROTEIN2 , but not PROTEIN1 .
BioInfer.d109.s2.p1	P	PROTEIN2 is secreted by cells as a 90-kDa protein that binds PROTEIN , but not PROTEIN1 .
BioInfer.d109.s2.p2	P	PROTEIN2 is secreted by cells as a 90-kDa protein that binds PROTEIN1 , but not PROTEIN .
BioInfer.d110.s0.p0	P	Both complexes are composed of PROTEIN and PROTEIN2 which bind to either PROTEIN1 or PROTEIN in a mutually exclusive manner.
BioInfer.d110.s0.p1	N	Both complexes are composed of PROTEIN and PROTEIN which bind to either PROTEIN1 or PROTEIN2 in a mutually exclusive manner.
BioInfer.d110.s0.p2	P	Both complexes are composed of PROTEIN2 and PROTEIN which bind to either PROTEIN1 or PROTEIN in a mutually exclusive manner.
BioInfer.d110.s0.p3	P	Both complexes are composed of PROTEIN and PROTEIN1 which bind to either PROTEIN or PROTEIN2 in a mutually exclusive manner.
BioInfer.d110.s0.p4	P	Both complexes are composed of PROTEIN2 and PROTEIN1 which bind to either PROTEIN or PROTEIN in a mutually exclusive manner.
BioInfer.d110.s0.p5	P	Both complexes are composed of PROTEIN2 and PROTEIN which bind to either PROTEIN or PROTEIN1 in a mutually exclusive manner.
BioInfer.d111.s0.p0	N	Both pathway cells and superior tarsal smooth muscle cells expressed PROTEIN2 and PROTEIN1 throughout development.
BioInfer.d112.s0.p0	N	Both types of beads induced the recruitment of PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN , by lateral mobilization of preexisting cell membrane complexes.
BioInfer.d112.s0.p1	N	Both types of beads induced the recruitment of PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN , by lateral mobilization of preexisting cell membrane complexes.
BioInfer.d112.s0.p2	N	Both types of beads induced the recruitment of PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 , by lateral mobilization of preexisting cell membrane complexes.
BioInfer.d112.s0.p3	N	Both types of beads induced the recruitment of PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN , by lateral mobilization of preexisting cell membrane complexes.
BioInfer.d112.s0.p4	N	Both types of beads induced the recruitment of PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 , by lateral mobilization of preexisting cell membrane complexes.
BioInfer.d112.s0.p5	N	Both types of beads induced the recruitment of PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 , by lateral mobilization of preexisting cell membrane complexes.
BioInfer.d113.s0.p0	N	Both tyrosine phosphorylation and association of PROTEIN with PROTEIN1 were inhibited by tyrphostin, a specific inhibitor of the PROTEIN  PROTEIN , whereas dissociation of PROTEIN from PROTEIN2 was not.
BioInfer.d113.s0.p1	N	Both tyrosine phosphorylation and association of PROTEIN with PROTEIN1 were inhibited by tyrphostin, a specific inhibitor of the PROTEIN2  PROTEIN , whereas dissociation of PROTEIN from PROTEIN was not.
BioInfer.d113.s0.p2	N	Both tyrosine phosphorylation and association of PROTEIN with PROTEIN1 were inhibited by tyrphostin, a specific inhibitor of the PROTEIN  PROTEIN2 , whereas dissociation of PROTEIN from PROTEIN was not.
BioInfer.d113.s0.p3	N	Both tyrosine phosphorylation and association of PROTEIN with PROTEIN1 were inhibited by tyrphostin, a specific inhibitor of the PROTEIN  PROTEIN , whereas dissociation of PROTEIN2 from PROTEIN was not.
BioInfer.d113.s0.p4	P	Both tyrosine phosphorylation and association of PROTEIN2 with PROTEIN1 were inhibited by tyrphostin, a specific inhibitor of the PROTEIN  PROTEIN , whereas dissociation of PROTEIN from PROTEIN was not.
BioInfer.d113.s0.p5	N	Both tyrosine phosphorylation and association of PROTEIN with PROTEIN were inhibited by tyrphostin, a specific inhibitor of the PROTEIN2  PROTEIN , whereas dissociation of PROTEIN from PROTEIN1 was not.
BioInfer.d113.s0.p6	N	Both tyrosine phosphorylation and association of PROTEIN with PROTEIN were inhibited by tyrphostin, a specific inhibitor of the PROTEIN  PROTEIN2 , whereas dissociation of PROTEIN from PROTEIN1 was not.
BioInfer.d113.s0.p7	P	Both tyrosine phosphorylation and association of PROTEIN with PROTEIN were inhibited by tyrphostin, a specific inhibitor of the PROTEIN  PROTEIN , whereas dissociation of PROTEIN2 from PROTEIN1 was not.
BioInfer.d113.s0.p8	N	Both tyrosine phosphorylation and association of PROTEIN2 with PROTEIN were inhibited by tyrphostin, a specific inhibitor of the PROTEIN  PROTEIN , whereas dissociation of PROTEIN from PROTEIN1 was not.
BioInfer.d113.s0.p9	P	Both tyrosine phosphorylation and association of PROTEIN with PROTEIN were inhibited by tyrphostin, a specific inhibitor of the PROTEIN1  PROTEIN2 , whereas dissociation of PROTEIN from PROTEIN was not.
BioInfer.d113.s0.p10	N	Both tyrosine phosphorylation and association of PROTEIN with PROTEIN were inhibited by tyrphostin, a specific inhibitor of the PROTEIN1  PROTEIN , whereas dissociation of PROTEIN2 from PROTEIN was not.
BioInfer.d113.s0.p11	N	Both tyrosine phosphorylation and association of PROTEIN2 with PROTEIN were inhibited by tyrphostin, a specific inhibitor of the PROTEIN1  PROTEIN , whereas dissociation of PROTEIN from PROTEIN was not.
BioInfer.d113.s0.p12	N	Both tyrosine phosphorylation and association of PROTEIN with PROTEIN were inhibited by tyrphostin, a specific inhibitor of the PROTEIN  PROTEIN1 , whereas dissociation of PROTEIN2 from PROTEIN was not.
BioInfer.d113.s0.p13	N	Both tyrosine phosphorylation and association of PROTEIN2 with PROTEIN were inhibited by tyrphostin, a specific inhibitor of the PROTEIN  PROTEIN1 , whereas dissociation of PROTEIN from PROTEIN was not.
BioInfer.d113.s0.p14	N	Both tyrosine phosphorylation and association of PROTEIN2 with PROTEIN were inhibited by tyrphostin, a specific inhibitor of the PROTEIN  PROTEIN , whereas dissociation of PROTEIN1 from PROTEIN was not.
BioInfer.d113.s1.p0	P	The results suggest that tyrosine phosphorylation of PROTEIN2 is achieved by PROTEIN upon tryptic digestion of cells and concurrent with but independent of dissociation of PROTEIN1 from PROTEIN .
BioInfer.d113.s1.p1	N	The results suggest that tyrosine phosphorylation of PROTEIN is achieved by PROTEIN2 upon tryptic digestion of cells and concurrent with but independent of dissociation of PROTEIN1 from PROTEIN .
BioInfer.d113.s1.p2	P	The results suggest that tyrosine phosphorylation of PROTEIN is achieved by PROTEIN upon tryptic digestion of cells and concurrent with but independent of dissociation of PROTEIN1 from PROTEIN2 .
BioInfer.d113.s1.p3	P	The results suggest that tyrosine phosphorylation of PROTEIN1 is achieved by PROTEIN2 upon tryptic digestion of cells and concurrent with but independent of dissociation of PROTEIN from PROTEIN .
BioInfer.d113.s1.p4	P	The results suggest that tyrosine phosphorylation of PROTEIN1 is achieved by PROTEIN upon tryptic digestion of cells and concurrent with but independent of dissociation of PROTEIN from PROTEIN2 .
BioInfer.d113.s1.p5	N	The results suggest that tyrosine phosphorylation of PROTEIN is achieved by PROTEIN1 upon tryptic digestion of cells and concurrent with but independent of dissociation of PROTEIN from PROTEIN2 .
BioInfer.d113.s2.p0	N	Tyrosine phosphorylation of PROTEIN was concomitantly induced with association of PROTEIN with PROTEIN ( PROTEIN2 ) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of PROTEIN from PROTEIN1 .
BioInfer.d113.s2.p1	N	Tyrosine phosphorylation of PROTEIN was concomitantly induced with association of PROTEIN2 with PROTEIN ( PROTEIN ) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of PROTEIN from PROTEIN1 .
BioInfer.d113.s2.p2	N	Tyrosine phosphorylation of PROTEIN2 was concomitantly induced with association of PROTEIN with PROTEIN ( PROTEIN ) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of PROTEIN from PROTEIN1 .
BioInfer.d113.s2.p3	N	Tyrosine phosphorylation of PROTEIN was concomitantly induced with association of PROTEIN with PROTEIN2 ( PROTEIN ) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of PROTEIN from PROTEIN1 .
BioInfer.d113.s2.p4	P	Tyrosine phosphorylation of PROTEIN was concomitantly induced with association of PROTEIN with PROTEIN ( PROTEIN ) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of PROTEIN2 from PROTEIN1 .
BioInfer.d113.s2.p5	P	Tyrosine phosphorylation of PROTEIN was concomitantly induced with association of PROTEIN2 with PROTEIN ( PROTEIN1 ) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of PROTEIN from PROTEIN .
BioInfer.d113.s2.p6	P	Tyrosine phosphorylation of PROTEIN2 was concomitantly induced with association of PROTEIN with PROTEIN ( PROTEIN1 ) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of PROTEIN from PROTEIN .
BioInfer.d113.s2.p7	N	Tyrosine phosphorylation of PROTEIN was concomitantly induced with association of PROTEIN with PROTEIN2 ( PROTEIN1 ) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of PROTEIN from PROTEIN .
BioInfer.d113.s2.p8	N	Tyrosine phosphorylation of PROTEIN was concomitantly induced with association of PROTEIN with PROTEIN ( PROTEIN1 ) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of PROTEIN2 from PROTEIN .
BioInfer.d113.s2.p9	P	Tyrosine phosphorylation of PROTEIN2 was concomitantly induced with association of PROTEIN1 with PROTEIN ( PROTEIN ) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of PROTEIN from PROTEIN .
BioInfer.d113.s2.p10	P	Tyrosine phosphorylation of PROTEIN was concomitantly induced with association of PROTEIN1 with PROTEIN2 ( PROTEIN ) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of PROTEIN from PROTEIN .
BioInfer.d113.s2.p11	N	Tyrosine phosphorylation of PROTEIN was concomitantly induced with association of PROTEIN1 with PROTEIN ( PROTEIN ) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of PROTEIN2 from PROTEIN .
BioInfer.d113.s2.p12	P	Tyrosine phosphorylation of PROTEIN1 was concomitantly induced with association of PROTEIN with PROTEIN2 ( PROTEIN ) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of PROTEIN from PROTEIN .
BioInfer.d113.s2.p13	N	Tyrosine phosphorylation of PROTEIN1 was concomitantly induced with association of PROTEIN with PROTEIN ( PROTEIN ) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of PROTEIN2 from PROTEIN .
BioInfer.d113.s2.p14	N	Tyrosine phosphorylation of PROTEIN was concomitantly induced with association of PROTEIN with PROTEIN1 ( PROTEIN ) when quiescent cells at confluence were dissociated into single cells by tryptic digestion, being accompanied by dissociation of PROTEIN2 from PROTEIN .
BioInfer.d114.s0.p0	N	PROTEIN1 or PROTEIN2 recombination-deficient yeast strains stabilize otherwise unstable YACs containing ribosomal DNA or the human color vision locus (Kohno et al., 1994).
BioInfer.d115.s0.p0	P	PROTEIN1 , a new component of the yeast PROTEIN2 - PROTEIN complex that interacts with a conserved region of PROTEIN .
BioInfer.d115.s0.p1	P	PROTEIN1 , a new component of the yeast PROTEIN - PROTEIN complex that interacts with a conserved region of PROTEIN2 .
BioInfer.d115.s0.p2	P	PROTEIN1 , a new component of the yeast PROTEIN - PROTEIN2 complex that interacts with a conserved region of PROTEIN .
BioInfer.d115.s0.p3	N	PROTEIN , a new component of the yeast PROTEIN1 - PROTEIN complex that interacts with a conserved region of PROTEIN2 .
BioInfer.d115.s0.p4	P	PROTEIN , a new component of the yeast PROTEIN1 - PROTEIN2 complex that interacts with a conserved region of PROTEIN .
BioInfer.d115.s0.p5	N	PROTEIN , a new component of the yeast PROTEIN - PROTEIN2 complex that interacts with a conserved region of PROTEIN1 .
BioInfer.d115.s1.p0	N	PROTEIN interacts with PROTEIN2 in vitro and copurifies with the PROTEIN - PROTEIN1 complex from yeast cells.
BioInfer.d115.s1.p1	P	PROTEIN2 interacts with PROTEIN in vitro and copurifies with the PROTEIN - PROTEIN1 complex from yeast cells.
BioInfer.d115.s1.p2	P	PROTEIN interacts with PROTEIN in vitro and copurifies with the PROTEIN2 - PROTEIN1 complex from yeast cells.
BioInfer.d115.s1.p3	P	PROTEIN2 interacts with PROTEIN1 in vitro and copurifies with the PROTEIN - PROTEIN complex from yeast cells.
BioInfer.d115.s1.p4	N	PROTEIN interacts with PROTEIN1 in vitro and copurifies with the PROTEIN2 - PROTEIN complex from yeast cells.
BioInfer.d115.s1.p5	P	PROTEIN1 interacts with PROTEIN in vitro and copurifies with the PROTEIN2 - PROTEIN complex from yeast cells.
BioInfer.d116.s0.p0	N	Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: PROTEIN1 / PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN .
BioInfer.d116.s0.p1	N	Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: PROTEIN1 / PROTEIN , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d116.s0.p2	N	Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: PROTEIN1 / PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d116.s0.p3	N	Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: PROTEIN1 / PROTEIN , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN .
BioInfer.d116.s0.p4	N	Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: PROTEIN1 / PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d116.s0.p5	N	Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: PROTEIN / PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN and PROTEIN .
BioInfer.d116.s0.p6	N	Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: PROTEIN / PROTEIN , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 .
BioInfer.d116.s0.p7	N	Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: PROTEIN / PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 and PROTEIN .
BioInfer.d116.s0.p8	N	Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: PROTEIN / PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN .
BioInfer.d116.s0.p9	N	Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: PROTEIN / PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d116.s0.p10	N	Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: PROTEIN / PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN .
BioInfer.d116.s0.p11	N	Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: PROTEIN / PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d116.s0.p12	N	Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: PROTEIN / PROTEIN , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN1 .
BioInfer.d116.s0.p13	N	Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: PROTEIN / PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 .
BioInfer.d116.s0.p14	N	Bud-site selection directs both cell polarity and the cytoskeletal orientation during budding and is determined by at least five genes: PROTEIN / PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d117.s0.p0	N	By 1 h the cells were well spread with straight PROTEIN2 bundles many of which ended at more central sites terminating on patches containing PROTEIN and PROTEIN1 ; thus the cells assemble typical stress fibers but do not appear to polarize.
BioInfer.d117.s0.p1	P	By 1 h the cells were well spread with straight PROTEIN bundles many of which ended at more central sites terminating on patches containing PROTEIN2 and PROTEIN1 ; thus the cells assemble typical stress fibers but do not appear to polarize.
BioInfer.d117.s0.p2	N	By 1 h the cells were well spread with straight PROTEIN1 bundles many of which ended at more central sites terminating on patches containing PROTEIN2 and PROTEIN ; thus the cells assemble typical stress fibers but do not appear to polarize.
BioInfer.d118.s0.p0	N	By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes PROTEIN1 tails were shown to contain the cytoskeletal proteins PROTEIN  PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d118.s0.p1	N	By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes PROTEIN1 tails were shown to contain the cytoskeletal proteins PROTEIN  PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d118.s0.p2	N	By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes PROTEIN1 tails were shown to contain the cytoskeletal proteins PROTEIN2  PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d118.s0.p3	N	By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes PROTEIN1 tails were shown to contain the cytoskeletal proteins PROTEIN  PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d118.s0.p4	N	By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes PROTEIN tails were shown to contain the cytoskeletal proteins PROTEIN  PROTEIN , PROTEIN2 , and PROTEIN1 .
BioInfer.d118.s0.p5	N	By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes PROTEIN tails were shown to contain the cytoskeletal proteins PROTEIN2  PROTEIN , PROTEIN , and PROTEIN1 .
BioInfer.d118.s0.p6	N	By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes PROTEIN tails were shown to contain the cytoskeletal proteins PROTEIN  PROTEIN2 , PROTEIN , and PROTEIN1 .
BioInfer.d118.s0.p7	N	By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes PROTEIN tails were shown to contain the cytoskeletal proteins PROTEIN2  PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d118.s0.p8	N	By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes PROTEIN tails were shown to contain the cytoskeletal proteins PROTEIN  PROTEIN2 , PROTEIN1 , and PROTEIN .
BioInfer.d118.s0.p9	N	By indirect immunofluorescence, both R. rickettsii and Listeria monocytogenes PROTEIN tails were shown to contain the cytoskeletal proteins PROTEIN1  PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d119.s0.p0	P	By site-directed mutagenesis of PROTEIN1 from Dictyostelium discoideum the point mutations K114E and W3N were generated by PCR thus changing PROTEIN2 and poly-(L)-proline-binding activity respectively.
BioInfer.d119.s1.p0	P	The PROTEIN1 exhibited a profound decrease in its ability to interact with PROTEIN2 , whereas binding to poly-(L)-proline was essentially unchanged.
BioInfer.d120.s0.p0	N	By the use of HSV mutants for the PROTEIN2 gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the PROTEIN1 or PROTEIN gene used as control.
BioInfer.d120.s0.p1	N	By the use of HSV mutants for the PROTEIN gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the PROTEIN1 or PROTEIN2 gene used as control.
BioInfer.d120.s0.p2	N	By the use of HSV mutants for the PROTEIN1 gene we show here that HSV can induce DNA amplification in the absence of lytic viral growth in contrast to replication-negative mutants for either the PROTEIN or PROTEIN2 gene used as control.
BioInfer.d121.s0.p0	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p1	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN2 and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p2	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p3	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p4	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN2 and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p5	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN2 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p6	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p7	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN2 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p8	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p9	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p10	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences.
BioInfer.d121.s0.p11	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p12	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN2 and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p13	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN1 ( PROTEIN ) and PROTEIN2 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p14	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN1 ( PROTEIN2 ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p15	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN2 and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p16	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p17	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN2 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p18	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p19	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p20	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p21	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences.
BioInfer.d121.s0.p22	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p23	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p24	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p25	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN2 and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p26	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p27	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p28	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p29	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN2 ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p30	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN2 ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p31	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences.
BioInfer.d121.s0.p32	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p33	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN2 ) and PROTEIN1 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p34	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN2 and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p35	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p36	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN2 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p37	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p38	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p39	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p40	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences.
BioInfer.d121.s0.p41	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p42	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN2 and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p43	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p44	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN2 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p45	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p46	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p47	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p48	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences.
BioInfer.d121.s0.p49	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p50	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p51	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p52	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p53	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences; and another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p54	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences; and another, PROTEIN1 and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p55	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN1 and PROTEIN ( PROTEIN2 ) gene sequences.
BioInfer.d121.s0.p56	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN1 and PROTEIN2 ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p57	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN1 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p58	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN1 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p59	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN1 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p60	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN1 ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p61	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN1 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences.
BioInfer.d121.s0.p62	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN1 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p63	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN1 ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p64	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN1 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p65	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN1 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p66	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN1 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences.
BioInfer.d121.s0.p67	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN1 ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p68	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN1 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p69	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN1 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p70	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN1 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences.
BioInfer.d121.s0.p71	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN1 ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p72	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN2 ( PROTEIN1 ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p73	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN1 ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences.
BioInfer.d121.s0.p74	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN1 ) gene sequences; and another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p75	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN1 ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN ( PROTEIN2 ) gene sequences.
BioInfer.d121.s0.p76	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN1 ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN2 ( PROTEIN ) gene sequences.
BioInfer.d121.s0.p77	N	By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; another, PROTEIN and PROTEIN ( PROTEIN ) gene sequences; and another, PROTEIN and PROTEIN2 ( PROTEIN1 ) gene sequences.
BioInfer.d122.s0.p0	P	By two-hybrid screening we have identified two partners that directly associate with PROTEIN : PROTEIN , a previously characterized PROTEIN subunit, and a novel protein of 33 kDa ( PROTEIN2 ) which is part of the PROTEIN1 complex and has an RNA binding domain.
BioInfer.d122.s0.p1	N	By two-hybrid screening we have identified two partners that directly associate with PROTEIN : PROTEIN , a previously characterized PROTEIN2 subunit, and a novel protein of 33 kDa ( PROTEIN ) which is part of the PROTEIN1 complex and has an RNA binding domain.
BioInfer.d122.s0.p2	N	By two-hybrid screening we have identified two partners that directly associate with PROTEIN : PROTEIN2 , a previously characterized PROTEIN subunit, and a novel protein of 33 kDa ( PROTEIN ) which is part of the PROTEIN1 complex and has an RNA binding domain.
BioInfer.d122.s0.p3	N	By two-hybrid screening we have identified two partners that directly associate with PROTEIN2 : PROTEIN , a previously characterized PROTEIN subunit, and a novel protein of 33 kDa ( PROTEIN ) which is part of the PROTEIN1 complex and has an RNA binding domain.
BioInfer.d122.s0.p4	N	By two-hybrid screening we have identified two partners that directly associate with PROTEIN : PROTEIN , a previously characterized PROTEIN2 subunit, and a novel protein of 33 kDa ( PROTEIN1 ) which is part of the PROTEIN complex and has an RNA binding domain.
BioInfer.d122.s0.p5	N	By two-hybrid screening we have identified two partners that directly associate with PROTEIN : PROTEIN2 , a previously characterized PROTEIN subunit, and a novel protein of 33 kDa ( PROTEIN1 ) which is part of the PROTEIN complex and has an RNA binding domain.
BioInfer.d122.s0.p6	P	By two-hybrid screening we have identified two partners that directly associate with PROTEIN2 : PROTEIN , a previously characterized PROTEIN subunit, and a novel protein of 33 kDa ( PROTEIN1 ) which is part of the PROTEIN complex and has an RNA binding domain.
BioInfer.d122.s0.p7	P	By two-hybrid screening we have identified two partners that directly associate with PROTEIN : PROTEIN2 , a previously characterized PROTEIN1 subunit, and a novel protein of 33 kDa ( PROTEIN ) which is part of the PROTEIN complex and has an RNA binding domain.
BioInfer.d122.s0.p8	N	By two-hybrid screening we have identified two partners that directly associate with PROTEIN2 : PROTEIN , a previously characterized PROTEIN1 subunit, and a novel protein of 33 kDa ( PROTEIN ) which is part of the PROTEIN complex and has an RNA binding domain.
BioInfer.d122.s0.p9	P	By two-hybrid screening we have identified two partners that directly associate with PROTEIN2 : PROTEIN1 , a previously characterized PROTEIN subunit, and a novel protein of 33 kDa ( PROTEIN ) which is part of the PROTEIN complex and has an RNA binding domain.
BioInfer.d122.s1.p0	P	Our results provide support for both physical and functional interactions between three subunits, PROTEIN , PROTEIN1 and PROTEIN2 , in the PROTEIN complex.
BioInfer.d122.s1.p1	P	Our results provide support for both physical and functional interactions between three subunits, PROTEIN , PROTEIN1 and PROTEIN , in the PROTEIN2 complex.
BioInfer.d122.s1.p2	P	Our results provide support for both physical and functional interactions between three subunits, PROTEIN2 , PROTEIN1 and PROTEIN , in the PROTEIN complex.
BioInfer.d122.s1.p3	P	Our results provide support for both physical and functional interactions between three subunits, PROTEIN , PROTEIN and PROTEIN1 , in the PROTEIN2 complex.
BioInfer.d122.s1.p4	P	Our results provide support for both physical and functional interactions between three subunits, PROTEIN2 , PROTEIN and PROTEIN1 , in the PROTEIN complex.
BioInfer.d122.s1.p5	P	Our results provide support for both physical and functional interactions between three subunits, PROTEIN2 , PROTEIN and PROTEIN , in the PROTEIN1 complex.
BioInfer.d123.s0.p0	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN1 , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN2 / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p1	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN1 , and not PROTEIN  PROTEIN2 , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p2	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN1 , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN2 / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p3	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN1 , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN2 complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p4	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN1 , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN2 , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p5	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN1 , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN2 promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p6	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN1 , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN2 in HTLV-1-infected cells.
BioInfer.d123.s0.p7	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN1 , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN2 / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p8	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN1 , and not PROTEIN2  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p9	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN1 , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN2 in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p10	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN2  PROTEIN1 , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p11	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN2 , was acetylated from the endogenous PROTEIN1 / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p12	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN1 / PROTEIN promoter in vivo, implying that PROTEIN2 / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p13	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN1 / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN2 complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p14	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN1 / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN2 , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p15	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN1 / PROTEIN2 promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p16	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN1 / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN2 in HTLV-1-infected cells.
BioInfer.d123.s0.p17	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN1 / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN2 / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p18	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN2  PROTEIN , was acetylated from the endogenous PROTEIN1 / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p19	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN1 / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN2 in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p20	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN2  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN1 / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p21	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN1 , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN2 / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p22	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN1 , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN2 complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p23	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN1 , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN2 , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p24	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN1 , was acetylated from the endogenous PROTEIN / PROTEIN2 promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p25	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN1 , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN2 in HTLV-1-infected cells.
BioInfer.d123.s0.p26	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN1 , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN2 / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p27	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN2  PROTEIN1 , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p28	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN1 , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN2 in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p29	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN2  PROTEIN , and not PROTEIN  PROTEIN1 , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p30	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN1 / PROTEIN , and not the PROTEIN2 complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p31	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN1 / PROTEIN2 , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p32	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN2 promoter in vivo, implying that PROTEIN1 / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p33	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN1 / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN2 in HTLV-1-infected cells.
BioInfer.d123.s0.p34	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN1 / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN2 / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p35	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN2  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN1 / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p36	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN1 / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN2 in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p37	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN2  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN1 / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p38	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN2 , and not the PROTEIN1 complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p39	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN2 promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN1 complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p40	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN1 complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN2 in HTLV-1-infected cells.
BioInfer.d123.s0.p41	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN1 complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN2 / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p42	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN2  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN1 complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p43	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN1 complex, was critical in complexing with PROTEIN2 in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p44	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN2  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN1 complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p45	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN2 promoter in vivo, implying that PROTEIN / PROTEIN1 , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p46	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN1 , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN2 in HTLV-1-infected cells.
BioInfer.d123.s0.p47	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN1 , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN2 / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p48	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN2  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN1 , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p49	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN1 , and not the PROTEIN complex, was critical in complexing with PROTEIN2 in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p50	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN2  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN1 , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p51	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN1 promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN2 in HTLV-1-infected cells.
BioInfer.d123.s0.p52	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN1 promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN2 / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p53	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN2  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN1 promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p54	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN1 promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN2 in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p55	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN2  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN1 promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p56	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN2 / PROTEIN1 in HTLV-1-infected cells.
BioInfer.d123.s0.p57	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN2  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN1 in HTLV-1-infected cells.
BioInfer.d123.s0.p58	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN2 in up-regulation of PROTEIN / PROTEIN1 in HTLV-1-infected cells.
BioInfer.d123.s0.p59	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN2  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN1 in HTLV-1-infected cells.
BioInfer.d123.s0.p60	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN2  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN1 / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p61	P	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN2 in up-regulation of PROTEIN1 / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p62	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN2  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN1 / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p63	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN  PROTEIN , and not PROTEIN1  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN2 in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p64	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN2  PROTEIN , and not PROTEIN1  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d123.s0.p65	N	By using a chromatin immunoprecipitation (ChIP) assay, we observed that PROTEIN2  PROTEIN , and not PROTEIN  PROTEIN , was acetylated from the endogenous PROTEIN / PROTEIN promoter in vivo, implying that PROTEIN / PROTEIN , and not the PROTEIN complex, was critical in complexing with PROTEIN1 in up-regulation of PROTEIN / PROTEIN in HTLV-1-infected cells.
BioInfer.d124.s0.p0	P	PROTEIN2 are essential for embryonic morphogenesis since they mediate calcium-dependent cell-cell adhesion and can modulate PROTEIN1 signaling.
BioInfer.d124.s1.p0	P	PROTEIN1 links PROTEIN2 to the PROTEIN -based cytoskeleton.
BioInfer.d124.s1.p1	P	PROTEIN1 links PROTEIN to the PROTEIN2 -based cytoskeleton.
BioInfer.d124.s1.p2	P	PROTEIN links PROTEIN1 to the PROTEIN2 -based cytoskeleton.
BioInfer.d125.s0.p0	N	Calculated solution molecular masses are 213 kDa for PROTEIN1 , 73 kDa for PROTEIN2 , and 186 kDa for both.
BioInfer.d126.s0.p0	P	Calorimetric data show ternary complex formation between PROTEIN , PROTEIN2 , and PROTEIN1 .
BioInfer.d126.s0.p1	P	Calorimetric data show ternary complex formation between PROTEIN2 , PROTEIN , and PROTEIN1 .
BioInfer.d126.s0.p2	P	Calorimetric data show ternary complex formation between PROTEIN2 , PROTEIN1 , and PROTEIN .
BioInfer.d127.s0.p0	N	PROTEIN activity in vivo was determined by observing proteolysis of PROTEIN2 and PROTEIN1 , two known substrates of PROTEIN .
BioInfer.d127.s0.p1	P	PROTEIN activity in vivo was determined by observing proteolysis of PROTEIN and PROTEIN1 , two known substrates of PROTEIN2 .
BioInfer.d127.s0.p2	N	PROTEIN2 activity in vivo was determined by observing proteolysis of PROTEIN and PROTEIN1 , two known substrates of PROTEIN .
BioInfer.d127.s0.p3	P	PROTEIN activity in vivo was determined by observing proteolysis of PROTEIN1 and PROTEIN , two known substrates of PROTEIN2 .
BioInfer.d127.s0.p4	N	PROTEIN2 activity in vivo was determined by observing proteolysis of PROTEIN1 and PROTEIN , two known substrates of PROTEIN .
BioInfer.d127.s0.p5	N	PROTEIN2 activity in vivo was determined by observing proteolysis of PROTEIN and PROTEIN , two known substrates of PROTEIN1 .
BioInfer.d128.s0.p0	N	Cardiac hypertrophy and the steady state level of the "fetal" genes, PROTEIN , PROTEIN2 ( PROTEIN ), and PROTEIN ( PROTEIN1 ) mRNAs were assessed.
BioInfer.d128.s0.p1	N	Cardiac hypertrophy and the steady state level of the "fetal" genes, PROTEIN , PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN1 ) mRNAs were assessed.
BioInfer.d128.s0.p2	N	Cardiac hypertrophy and the steady state level of the "fetal" genes, PROTEIN2 , PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN1 ) mRNAs were assessed.
BioInfer.d128.s0.p3	N	Cardiac hypertrophy and the steady state level of the "fetal" genes, PROTEIN , PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN1 ) mRNAs were assessed.
BioInfer.d128.s0.p4	N	Cardiac hypertrophy and the steady state level of the "fetal" genes, PROTEIN , PROTEIN1 ( PROTEIN ), and PROTEIN2 ( PROTEIN ) mRNAs were assessed.
BioInfer.d128.s0.p5	N	Cardiac hypertrophy and the steady state level of the "fetal" genes, PROTEIN2 , PROTEIN1 ( PROTEIN ), and PROTEIN ( PROTEIN ) mRNAs were assessed.
BioInfer.d128.s0.p6	N	Cardiac hypertrophy and the steady state level of the "fetal" genes, PROTEIN , PROTEIN1 ( PROTEIN2 ), and PROTEIN ( PROTEIN ) mRNAs were assessed.
BioInfer.d128.s0.p7	N	Cardiac hypertrophy and the steady state level of the "fetal" genes, PROTEIN2 , PROTEIN ( PROTEIN ), and PROTEIN1 ( PROTEIN ) mRNAs were assessed.
BioInfer.d128.s0.p8	N	Cardiac hypertrophy and the steady state level of the "fetal" genes, PROTEIN , PROTEIN ( PROTEIN2 ), and PROTEIN1 ( PROTEIN ) mRNAs were assessed.
BioInfer.d128.s0.p9	N	Cardiac hypertrophy and the steady state level of the "fetal" genes, PROTEIN1 , PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN ) mRNAs were assessed.
BioInfer.d129.s0.p0	N	PROTEIN1 , a T cell activation Ag, also known as PROTEIN2 , is directly associated with PROTEIN ( PROTEIN ) on the surface of T cells and T cell lines.
BioInfer.d129.s0.p1	P	PROTEIN1 , a T cell activation Ag, also known as PROTEIN , is directly associated with PROTEIN ( PROTEIN2 ) on the surface of T cells and T cell lines.
BioInfer.d129.s0.p2	P	PROTEIN1 , a T cell activation Ag, also known as PROTEIN , is directly associated with PROTEIN2 ( PROTEIN ) on the surface of T cells and T cell lines.
BioInfer.d129.s0.p3	P	PROTEIN , a T cell activation Ag, also known as PROTEIN1 , is directly associated with PROTEIN ( PROTEIN2 ) on the surface of T cells and T cell lines.
BioInfer.d129.s0.p4	P	PROTEIN , a T cell activation Ag, also known as PROTEIN1 , is directly associated with PROTEIN2 ( PROTEIN ) on the surface of T cells and T cell lines.
BioInfer.d129.s0.p5	N	PROTEIN , a T cell activation Ag, also known as PROTEIN , is directly associated with PROTEIN2 ( PROTEIN1 ) on the surface of T cells and T cell lines.
BioInfer.d130.s0.p0	P	PROTEIN1 is a T cell activation antigen known to bind PROTEIN2 and have PROTEIN activity.
BioInfer.d130.s0.p1	P	PROTEIN1 is a T cell activation antigen known to bind PROTEIN and have PROTEIN2 activity.
BioInfer.d130.s0.p2	N	PROTEIN is a T cell activation antigen known to bind PROTEIN1 and have PROTEIN2 activity.
BioInfer.d131.s0.p0	N	PROTEIN is a T cell activation antigen that contains PROTEIN1 activity and is known to bind PROTEIN2 .
BioInfer.d131.s0.p1	P	PROTEIN2 is a T cell activation antigen that contains PROTEIN1 activity and is known to bind PROTEIN .
BioInfer.d131.s0.p2	P	PROTEIN2 is a T cell activation antigen that contains PROTEIN activity and is known to bind PROTEIN1 .
BioInfer.d132.s0.p0	N	Cells lacking PROTEIN2 , a protein which in many mammalian cell types is a constituent of focal complexes that link the PROTEIN1 cytoskeleton to the plasma membrane, are strongly impaired in adhesion to external surfaces.
BioInfer.d134.s0.p0	N	Changes in PROTEIN binding to PROTEIN1 or PROTEIN protein, and the ensuing effects on cell morphology and adhesion, are independent of PROTEIN binding to PROTEIN2 .
BioInfer.d134.s0.p1	P	Changes in PROTEIN2 binding to PROTEIN1 or PROTEIN protein, and the ensuing effects on cell morphology and adhesion, are independent of PROTEIN binding to PROTEIN .
BioInfer.d134.s0.p2	N	Changes in PROTEIN binding to PROTEIN1 or PROTEIN protein, and the ensuing effects on cell morphology and adhesion, are independent of PROTEIN2 binding to PROTEIN .
BioInfer.d134.s0.p3	N	Changes in PROTEIN binding to PROTEIN1 or PROTEIN2 protein, and the ensuing effects on cell morphology and adhesion, are independent of PROTEIN binding to PROTEIN .
BioInfer.d134.s0.p4	P	Changes in PROTEIN2 binding to PROTEIN or PROTEIN protein, and the ensuing effects on cell morphology and adhesion, are independent of PROTEIN binding to PROTEIN1 .
BioInfer.d134.s0.p5	P	Changes in PROTEIN binding to PROTEIN or PROTEIN protein, and the ensuing effects on cell morphology and adhesion, are independent of PROTEIN2 binding to PROTEIN1 .
BioInfer.d134.s0.p6	N	Changes in PROTEIN binding to PROTEIN or PROTEIN2 protein, and the ensuing effects on cell morphology and adhesion, are independent of PROTEIN binding to PROTEIN1 .
BioInfer.d134.s0.p7	P	Changes in PROTEIN1 binding to PROTEIN or PROTEIN protein, and the ensuing effects on cell morphology and adhesion, are independent of PROTEIN2 binding to PROTEIN .
BioInfer.d134.s0.p8	P	Changes in PROTEIN1 binding to PROTEIN or PROTEIN2 protein, and the ensuing effects on cell morphology and adhesion, are independent of PROTEIN binding to PROTEIN .
BioInfer.d134.s0.p9	N	Changes in PROTEIN binding to PROTEIN or PROTEIN2 protein, and the ensuing effects on cell morphology and adhesion, are independent of PROTEIN1 binding to PROTEIN .
BioInfer.d134.s1.p0	N	Full-length PROTEIN , PROTEIN2 mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the PROTEIN binding site, or a mutant PROTEIN1 with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.
BioInfer.d134.s1.p3	N	Full-length PROTEIN2 , PROTEIN mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the PROTEIN binding site, or a mutant PROTEIN1 with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.
BioInfer.d134.s1.p4	N	Full-length PROTEIN , PROTEIN mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the PROTEIN2 binding site, or a mutant PROTEIN1 with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.
BioInfer.d134.s1.p7	N	Full-length PROTEIN2 , PROTEIN1 mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the PROTEIN binding site, or a mutant PROTEIN with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.
BioInfer.d134.s1.p8	N	Full-length PROTEIN , PROTEIN1 mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the PROTEIN2 binding site, or a mutant PROTEIN with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.
BioInfer.d134.s1.p14	P	Full-length PROTEIN1 , PROTEIN mutant proteins with NH2-terminal deletions before (deltaN90) or after (deltaN131, deltaN151) the PROTEIN2 binding site, or a mutant PROTEIN with a COOH-terminal deletion (delta C) were expressed in MDCK cells under the control of the tetracycline-repressible transactivator.
BioInfer.d135.s0.p0	P	Characterization of PROTEIN1 and poly-L-proline binding sites of Acanthamoeba PROTEIN2 with monoclonal antibodies and by mutagenesis.
BioInfer.d135.s1.p0	P	For example, PROTEIN2 with a deletion of the eight C-terminal residues has many of the physical properties of a molten globule, yet remarkably still binds to PROTEIN1 .
BioInfer.d135.s2.p0	P	The results provide two independent lines of evidence about the binding sites for PROTEIN1 and poly-L-proline on the PROTEIN2 molecule.
BioInfer.d136.s0.p0	P	Characterization of a mutant PROTEIN1 with reduced PROTEIN2 -binding capacity: effects in vitro and in vivo.
BioInfer.d137.s0.p0	P	Characterization of PROTEIN truncates that inhibit PROTEIN2 depolymerization by severing activity of PROTEIN and PROTEIN1 .
BioInfer.d137.s0.p1	N	Characterization of PROTEIN truncates that inhibit PROTEIN depolymerization by severing activity of PROTEIN2 and PROTEIN1 .
BioInfer.d137.s0.p2	P	Characterization of PROTEIN2 truncates that inhibit PROTEIN depolymerization by severing activity of PROTEIN and PROTEIN1 .
BioInfer.d137.s0.p3	P	Characterization of PROTEIN truncates that inhibit PROTEIN1 depolymerization by severing activity of PROTEIN2 and PROTEIN .
BioInfer.d137.s0.p4	P	Characterization of PROTEIN2 truncates that inhibit PROTEIN1 depolymerization by severing activity of PROTEIN and PROTEIN .
BioInfer.d137.s0.p5	P	Characterization of PROTEIN2 truncates that inhibit PROTEIN depolymerization by severing activity of PROTEIN1 and PROTEIN .
BioInfer.d138.s0.p0	N	Characterization of PROTEIN2 and PROTEIN1 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.
BioInfer.d139.s0.p0	P	Characterization of the action of porcine PROTEIN1 on PROTEIN2 polymerization.
BioInfer.d139.s1.p0	P	Moreover, addition of PROTEIN1 to steady-state PROTEIN2 filaments causes slow depolymerization.
BioInfer.d140.s0.p0	P	Characterization of the interactions of PROTEIN2 with PROTEIN1 and PROTEIN / PROTEIN .
BioInfer.d140.s0.p1	N	Characterization of the interactions of PROTEIN with PROTEIN1 and PROTEIN / PROTEIN2 .
BioInfer.d140.s0.p2	N	Characterization of the interactions of PROTEIN with PROTEIN1 and PROTEIN2 / PROTEIN .
BioInfer.d140.s0.p3	P	Characterization of the interactions of PROTEIN1 with PROTEIN and PROTEIN / PROTEIN2 .
BioInfer.d140.s0.p4	P	Characterization of the interactions of PROTEIN1 with PROTEIN and PROTEIN2 / PROTEIN .
BioInfer.d140.s0.p5	P	Characterization of the interactions of PROTEIN with PROTEIN and PROTEIN2 / PROTEIN1 .
BioInfer.d140.s1.p0	P	In this study we have used the yeast two-hybrid system to map the domains on PROTEIN2 that allow it to associate with PROTEIN / PROTEIN1 and with PROTEIN .
BioInfer.d140.s1.p1	N	In this study we have used the yeast two-hybrid system to map the domains on PROTEIN that allow it to associate with PROTEIN2 / PROTEIN1 and with PROTEIN .
BioInfer.d140.s1.p2	N	In this study we have used the yeast two-hybrid system to map the domains on PROTEIN that allow it to associate with PROTEIN / PROTEIN1 and with PROTEIN2 .
BioInfer.d140.s1.p3	P	In this study we have used the yeast two-hybrid system to map the domains on PROTEIN1 that allow it to associate with PROTEIN2 / PROTEIN and with PROTEIN .
BioInfer.d140.s1.p4	P	In this study we have used the yeast two-hybrid system to map the domains on PROTEIN1 that allow it to associate with PROTEIN / PROTEIN and with PROTEIN2 .
BioInfer.d140.s1.p5	N	In this study we have used the yeast two-hybrid system to map the domains on PROTEIN that allow it to associate with PROTEIN1 / PROTEIN and with PROTEIN2 .
BioInfer.d140.s2.p0	P	PROTEIN or PROTEIN2 is associated directly with the PROTEIN1 ; PROTEIN binds to PROTEIN / PROTEIN and serves to link the PROTEIN / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p1	P	PROTEIN2 or PROTEIN is associated directly with the PROTEIN1 ; PROTEIN binds to PROTEIN / PROTEIN and serves to link the PROTEIN / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p2	N	PROTEIN or PROTEIN is associated directly with the PROTEIN1 ; PROTEIN binds to PROTEIN / PROTEIN and serves to link the PROTEIN2 / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p3	N	PROTEIN or PROTEIN is associated directly with the PROTEIN1 ; PROTEIN binds to PROTEIN / PROTEIN and serves to link the PROTEIN / PROTEIN2 complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p4	N	PROTEIN or PROTEIN is associated directly with the PROTEIN1 ; PROTEIN2 binds to PROTEIN / PROTEIN and serves to link the PROTEIN / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p5	N	PROTEIN or PROTEIN is associated directly with the PROTEIN1 ; PROTEIN binds to PROTEIN / PROTEIN2 and serves to link the PROTEIN / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p6	N	PROTEIN or PROTEIN is associated directly with the PROTEIN1 ; PROTEIN binds to PROTEIN / PROTEIN and serves to link the PROTEIN / PROTEIN complex to the PROTEIN2 cytoskeleton.
BioInfer.d140.s2.p7	N	PROTEIN or PROTEIN is associated directly with the PROTEIN1 ; PROTEIN binds to PROTEIN2 / PROTEIN and serves to link the PROTEIN / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p8	N	PROTEIN2 or PROTEIN1 is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN / PROTEIN and serves to link the PROTEIN / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p9	N	PROTEIN or PROTEIN1 is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN / PROTEIN and serves to link the PROTEIN2 / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p10	N	PROTEIN or PROTEIN1 is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN / PROTEIN and serves to link the PROTEIN / PROTEIN2 complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p11	N	PROTEIN or PROTEIN1 is associated directly with the PROTEIN ; PROTEIN2 binds to PROTEIN / PROTEIN and serves to link the PROTEIN / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p12	N	PROTEIN or PROTEIN1 is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN / PROTEIN2 and serves to link the PROTEIN / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p13	N	PROTEIN or PROTEIN1 is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN / PROTEIN and serves to link the PROTEIN / PROTEIN complex to the PROTEIN2 cytoskeleton.
BioInfer.d140.s2.p14	N	PROTEIN or PROTEIN1 is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN2 / PROTEIN and serves to link the PROTEIN / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p15	N	PROTEIN1 or PROTEIN is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN / PROTEIN and serves to link the PROTEIN2 / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p16	N	PROTEIN1 or PROTEIN is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN / PROTEIN and serves to link the PROTEIN / PROTEIN2 complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p17	N	PROTEIN1 or PROTEIN is associated directly with the PROTEIN ; PROTEIN2 binds to PROTEIN / PROTEIN and serves to link the PROTEIN / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p18	N	PROTEIN1 or PROTEIN is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN / PROTEIN2 and serves to link the PROTEIN / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p19	N	PROTEIN1 or PROTEIN is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN / PROTEIN and serves to link the PROTEIN / PROTEIN complex to the PROTEIN2 cytoskeleton.
BioInfer.d140.s2.p20	N	PROTEIN1 or PROTEIN is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN2 / PROTEIN and serves to link the PROTEIN / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p21	P	PROTEIN or PROTEIN is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN / PROTEIN and serves to link the PROTEIN1 / PROTEIN2 complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p22	P	PROTEIN or PROTEIN is associated directly with the PROTEIN ; PROTEIN2 binds to PROTEIN / PROTEIN and serves to link the PROTEIN1 / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p23	N	PROTEIN or PROTEIN is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN / PROTEIN2 and serves to link the PROTEIN1 / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p24	P	PROTEIN or PROTEIN is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN / PROTEIN and serves to link the PROTEIN1 / PROTEIN complex to the PROTEIN2 cytoskeleton.
BioInfer.d140.s2.p25	N	PROTEIN or PROTEIN is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN2 / PROTEIN and serves to link the PROTEIN1 / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p26	P	PROTEIN or PROTEIN is associated directly with the PROTEIN ; PROTEIN2 binds to PROTEIN / PROTEIN and serves to link the PROTEIN / PROTEIN1 complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p27	N	PROTEIN or PROTEIN is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN / PROTEIN2 and serves to link the PROTEIN / PROTEIN1 complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p28	P	PROTEIN or PROTEIN is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN / PROTEIN and serves to link the PROTEIN / PROTEIN1 complex to the PROTEIN2 cytoskeleton.
BioInfer.d140.s2.p29	N	PROTEIN or PROTEIN is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN2 / PROTEIN and serves to link the PROTEIN / PROTEIN1 complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p30	P	PROTEIN or PROTEIN is associated directly with the PROTEIN ; PROTEIN1 binds to PROTEIN / PROTEIN2 and serves to link the PROTEIN / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p31	P	PROTEIN or PROTEIN is associated directly with the PROTEIN ; PROTEIN1 binds to PROTEIN / PROTEIN and serves to link the PROTEIN / PROTEIN complex to the PROTEIN2 cytoskeleton.
BioInfer.d140.s2.p32	P	PROTEIN or PROTEIN is associated directly with the PROTEIN ; PROTEIN1 binds to PROTEIN2 / PROTEIN and serves to link the PROTEIN / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p33	N	PROTEIN or PROTEIN is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN / PROTEIN1 and serves to link the PROTEIN / PROTEIN complex to the PROTEIN2 cytoskeleton.
BioInfer.d140.s2.p34	N	PROTEIN or PROTEIN is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN2 / PROTEIN1 and serves to link the PROTEIN / PROTEIN complex to the PROTEIN cytoskeleton.
BioInfer.d140.s2.p35	N	PROTEIN or PROTEIN is associated directly with the PROTEIN ; PROTEIN binds to PROTEIN2 / PROTEIN and serves to link the PROTEIN / PROTEIN complex to the PROTEIN1 cytoskeleton.
BioInfer.d141.s0.p0	P	Chemical modification of the cysteine residue 374 of PROTEIN , both with N-ethylmaleimide and with the fluorescent probe N-(1-pyrenyl)iodoacetamide, is shown to counteract the inhibiting effect of PROTEIN1 on PROTEIN2 polymerization.
BioInfer.d141.s0.p1	P	Chemical modification of the cysteine residue 374 of PROTEIN2 , both with N-ethylmaleimide and with the fluorescent probe N-(1-pyrenyl)iodoacetamide, is shown to counteract the inhibiting effect of PROTEIN1 on PROTEIN polymerization.
BioInfer.d141.s0.p2	P	Chemical modification of the cysteine residue 374 of PROTEIN2 , both with N-ethylmaleimide and with the fluorescent probe N-(1-pyrenyl)iodoacetamide, is shown to counteract the inhibiting effect of PROTEIN on PROTEIN1 polymerization.
BioInfer.d142.s0.p0	P	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN1 monomers, PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , and PROTEIN2 ( PROTEIN ).
BioInfer.d142.s0.p1	P	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN1 monomers, PROTEIN ( PROTEIN ), PROTEIN2 , PROTEIN , and PROTEIN ( PROTEIN ).
BioInfer.d142.s0.p2	P	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN1 monomers, PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN , and PROTEIN ( PROTEIN ).
BioInfer.d142.s0.p3	P	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN1 monomers, PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , and PROTEIN ( PROTEIN2 ).
BioInfer.d142.s0.p4	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN2 and at least four proteins which can bind PROTEIN1 monomers, PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , and PROTEIN ( PROTEIN ).
BioInfer.d142.s0.p5	P	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN1 monomers, PROTEIN ( PROTEIN ), PROTEIN , PROTEIN2 , and PROTEIN ( PROTEIN ).
BioInfer.d142.s0.p6	P	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN1 monomers, PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN , and PROTEIN ( PROTEIN ).
BioInfer.d142.s0.p7	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN monomers, PROTEIN ( PROTEIN ), PROTEIN2 , PROTEIN , and PROTEIN1 ( PROTEIN ).
BioInfer.d142.s0.p8	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN monomers, PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN , and PROTEIN1 ( PROTEIN ).
BioInfer.d142.s0.p9	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN monomers, PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , and PROTEIN1 ( PROTEIN2 ).
BioInfer.d142.s0.p10	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN2 and at least four proteins which can bind PROTEIN monomers, PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , and PROTEIN1 ( PROTEIN ).
BioInfer.d142.s0.p11	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN monomers, PROTEIN ( PROTEIN ), PROTEIN , PROTEIN2 , and PROTEIN1 ( PROTEIN ).
BioInfer.d142.s0.p12	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN monomers, PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN , and PROTEIN1 ( PROTEIN ).
BioInfer.d142.s0.p13	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN monomers, PROTEIN ( PROTEIN2 ), PROTEIN1 , PROTEIN , and PROTEIN ( PROTEIN ).
BioInfer.d142.s0.p14	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN monomers, PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN , and PROTEIN ( PROTEIN2 ).
BioInfer.d142.s0.p15	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN2 and at least four proteins which can bind PROTEIN monomers, PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN , and PROTEIN ( PROTEIN ).
BioInfer.d142.s0.p16	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN monomers, PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN2 , and PROTEIN ( PROTEIN ).
BioInfer.d142.s0.p17	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN monomers, PROTEIN2 ( PROTEIN ), PROTEIN1 , PROTEIN , and PROTEIN ( PROTEIN ).
BioInfer.d142.s0.p18	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN monomers, PROTEIN ( PROTEIN1 ), PROTEIN , PROTEIN , and PROTEIN ( PROTEIN2 ).
BioInfer.d142.s0.p19	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN2 and at least four proteins which can bind PROTEIN monomers, PROTEIN ( PROTEIN1 ), PROTEIN , PROTEIN , and PROTEIN ( PROTEIN ).
BioInfer.d142.s0.p20	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN monomers, PROTEIN ( PROTEIN1 ), PROTEIN , PROTEIN2 , and PROTEIN ( PROTEIN ).
BioInfer.d142.s0.p21	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN monomers, PROTEIN2 ( PROTEIN1 ), PROTEIN , PROTEIN , and PROTEIN ( PROTEIN ).
BioInfer.d142.s0.p22	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN2 and at least four proteins which can bind PROTEIN monomers, PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , and PROTEIN ( PROTEIN1 ).
BioInfer.d142.s0.p23	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN monomers, PROTEIN ( PROTEIN ), PROTEIN , PROTEIN2 , and PROTEIN ( PROTEIN1 ).
BioInfer.d142.s0.p24	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN monomers, PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN , and PROTEIN ( PROTEIN1 ).
BioInfer.d142.s0.p25	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN1 and at least four proteins which can bind PROTEIN monomers, PROTEIN ( PROTEIN ), PROTEIN , PROTEIN2 , and PROTEIN ( PROTEIN ).
BioInfer.d142.s0.p26	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN1 and at least four proteins which can bind PROTEIN monomers, PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN , and PROTEIN ( PROTEIN ).
BioInfer.d142.s0.p27	N	Chick embryo fibroblasts contain about 75-100 microM unpolymerized PROTEIN and at least four proteins which can bind PROTEIN monomers, PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN1 , and PROTEIN ( PROTEIN ).
BioInfer.d143.s0.p0	P	PROTEIN had higher affinity for poly-l-proline and sequestered more monomeric PROTEIN2 than did PROTEIN1 .
BioInfer.d143.s0.p1	N	PROTEIN2 had higher affinity for poly-l-proline and sequestered more monomeric PROTEIN than did PROTEIN1 .
BioInfer.d143.s0.p2	P	PROTEIN2 had higher affinity for poly-l-proline and sequestered more monomeric PROTEIN1 than did PROTEIN .
BioInfer.d143.s1.p0	P	The PROTEIN2 -sequestering activity of both maize PROTEIN1 classes was found to be dependent on the concentration of free calcium.
BioInfer.d143.s2.p0	P	We propose a model in which PROTEIN1 alters cellular concentrations of PROTEIN2 polymers in response to fluctuations in cytosolic calcium concentration.
BioInfer.d144.s0.p0	P	Coexpression of the PROTEIN2 and PROTEIN1 genes in Escherichia coli was required for in vitro activity.
BioInfer.d144.s1.p0	N	Expression of the PROTEIN and PROTEIN1 genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for PROTEIN2 in specifically regulating intermediate transcription in vivo.
BioInfer.d144.s1.p1	N	Expression of the PROTEIN2 and PROTEIN1 genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for PROTEIN in specifically regulating intermediate transcription in vivo.
BioInfer.d144.s1.p2	N	Expression of the PROTEIN2 and PROTEIN genes occurred between 1 and 5 h after vaccinia virus infection and was not prevented by an inhibitor of DNA replication, consistent with a role for PROTEIN1 in specifically regulating intermediate transcription in vivo.
BioInfer.d144.s2.p0	N	We found that the 34- and 45-kDa polypeptides encoded by vaccinia virus ORFs PROTEIN1 and PROTEIN2 , respectively, were necessary to reconstitute transcription of a template with an intermediate stage promoter.
BioInfer.d145.s0.p0	N	cDNA clones of the PROTEIN2 , PROTEIN1 , and PROTEIN genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.
BioInfer.d145.s0.p1	N	cDNA clones of the PROTEIN , PROTEIN1 , and PROTEIN2 genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.
BioInfer.d145.s0.p2	N	cDNA clones of the PROTEIN1 , PROTEIN , and PROTEIN2 genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.
BioInfer.d146.s0.p0	P	PROTEIN and PROTEIN1 may also be involved in the redistribution of PROTEIN2 during myofibrillogenesis and in the process of PROTEIN disassembly in degenerating muscles.
BioInfer.d146.s0.p1	P	PROTEIN and PROTEIN1 may also be involved in the redistribution of PROTEIN during myofibrillogenesis and in the process of PROTEIN2 disassembly in degenerating muscles.
BioInfer.d146.s0.p2	N	PROTEIN2 and PROTEIN1 may also be involved in the redistribution of PROTEIN during myofibrillogenesis and in the process of PROTEIN disassembly in degenerating muscles.
BioInfer.d146.s0.p3	N	PROTEIN and PROTEIN may also be involved in the redistribution of PROTEIN1 during myofibrillogenesis and in the process of PROTEIN2 disassembly in degenerating muscles.
BioInfer.d146.s0.p4	P	PROTEIN2 and PROTEIN may also be involved in the redistribution of PROTEIN1 during myofibrillogenesis and in the process of PROTEIN disassembly in degenerating muscles.
BioInfer.d146.s0.p5	P	PROTEIN2 and PROTEIN may also be involved in the redistribution of PROTEIN during myofibrillogenesis and in the process of PROTEIN1 disassembly in degenerating muscles.
BioInfer.d147.s0.p0	N	PROTEIN1 was identified by peptide sequencing, and PROTEIN2 recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing PROTEIN filament turnover.
BioInfer.d147.s0.p1	P	PROTEIN1 was identified by peptide sequencing, and PROTEIN recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing PROTEIN2 filament turnover.
BioInfer.d147.s0.p2	N	PROTEIN was identified by peptide sequencing, and PROTEIN1 recruitment and Listeria tail length were found to be pH-dependent, in agreement with its recently reported role in enhancing PROTEIN2 filament turnover.
BioInfer.d148.s0.p0	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p1	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , and an up to twofold increase for PROTEIN and PROTEIN2 , but there was little change for PROTEIN .
BioInfer.d148.s0.p2	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p3	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p4	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p5	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p6	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p7	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN2 .
BioInfer.d148.s0.p8	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , and an up to twofold increase for PROTEIN2 and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p9	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN2 , but there was little change for PROTEIN .
BioInfer.d148.s0.p10	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p11	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p12	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p13	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p14	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p15	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN2 .
BioInfer.d148.s0.p16	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN2 and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p17	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN1 , but there was little change for PROTEIN .
BioInfer.d148.s0.p18	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN1 , but there was little change for PROTEIN .
BioInfer.d148.s0.p19	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN1 , but there was little change for PROTEIN .
BioInfer.d148.s0.p20	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN1 , but there was little change for PROTEIN .
BioInfer.d148.s0.p21	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN1 , but there was little change for PROTEIN .
BioInfer.d148.s0.p22	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN1 , but there was little change for PROTEIN2 .
BioInfer.d148.s0.p23	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN2 and PROTEIN1 , but there was little change for PROTEIN .
BioInfer.d148.s0.p24	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p25	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p26	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p27	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p28	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN2 .
BioInfer.d148.s0.p29	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , and an up to twofold increase for PROTEIN2 and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p30	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p31	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p32	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p33	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN2 .
BioInfer.d148.s0.p34	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN2 and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p35	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p36	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p37	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN2 .
BioInfer.d148.s0.p38	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN2 and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p39	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p40	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN2 .
BioInfer.d148.s0.p41	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN2 and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p42	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN and PROTEIN , but there was little change for PROTEIN2 .
BioInfer.d148.s0.p43	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN2 and PROTEIN , but there was little change for PROTEIN .
BioInfer.d148.s0.p44	N	Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and an up to twofold increase for PROTEIN2 and PROTEIN , but there was little change for PROTEIN1 .
BioInfer.d148.s1.p0	N	To detect the expression of apoptosis-related molecules, PROTEIN2 protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p1	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p2	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d148.s1.p3	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p4	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p5	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d148.s1.p6	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p7	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p8	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p9	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p10	N	To detect the expression of apoptosis-related molecules, PROTEIN1 protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p11	N	To detect the expression of apoptosis-related molecules, PROTEIN1 protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d148.s1.p12	N	To detect the expression of apoptosis-related molecules, PROTEIN1 protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p13	N	To detect the expression of apoptosis-related molecules, PROTEIN1 protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p14	N	To detect the expression of apoptosis-related molecules, PROTEIN1 protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d148.s1.p15	N	To detect the expression of apoptosis-related molecules, PROTEIN1 protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p16	N	To detect the expression of apoptosis-related molecules, PROTEIN1 protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p17	N	To detect the expression of apoptosis-related molecules, PROTEIN1 protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p18	N	To detect the expression of apoptosis-related molecules, PROTEIN1 protection assay was used with specific antisense RNA probes for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p19	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN .
BioInfer.d148.s1.p20	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p21	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p22	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 .
BioInfer.d148.s1.p23	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p24	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p25	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p26	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p27	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d148.s1.p28	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d148.s1.p29	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 .
BioInfer.d148.s1.p30	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d148.s1.p31	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d148.s1.p32	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d148.s1.p33	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d148.s1.p34	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p35	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d148.s1.p36	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p37	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p38	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p39	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p40	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d148.s1.p41	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p42	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p43	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p44	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p45	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 .
BioInfer.d148.s1.p46	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 .
BioInfer.d148.s1.p47	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 .
BioInfer.d148.s1.p48	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 .
BioInfer.d148.s1.p49	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p50	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p51	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p52	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p53	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d148.s1.p54	N	To detect the expression of apoptosis-related molecules, PROTEIN protection assay was used with specific antisense RNA probes for PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d149.s0.p0	N	Complete gene sequences for the PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN / PROTEIN2 ) have been determined and recombinant PROTEIN and PROTEIN proteins produced in baculovirus.
BioInfer.d149.s0.p1	N	Complete gene sequences for the PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN / PROTEIN ) have been determined and recombinant PROTEIN and PROTEIN2 proteins produced in baculovirus.
BioInfer.d149.s0.p2	N	Complete gene sequences for the PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN2 / PROTEIN ) have been determined and recombinant PROTEIN and PROTEIN proteins produced in baculovirus.
BioInfer.d149.s0.p3	N	Complete gene sequences for the PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN / PROTEIN ) have been determined and recombinant PROTEIN2 and PROTEIN proteins produced in baculovirus.
BioInfer.d149.s0.p4	N	Complete gene sequences for the PROTEIN ( PROTEIN1 ) and PROTEIN2 ( PROTEIN / PROTEIN ) have been determined and recombinant PROTEIN and PROTEIN proteins produced in baculovirus.
BioInfer.d149.s0.p5	N	Complete gene sequences for the PROTEIN2 ( PROTEIN1 ) and PROTEIN ( PROTEIN / PROTEIN ) have been determined and recombinant PROTEIN and PROTEIN proteins produced in baculovirus.
BioInfer.d149.s0.p6	N	Complete gene sequences for the PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN / PROTEIN1 ) have been determined and recombinant PROTEIN and PROTEIN2 proteins produced in baculovirus.
BioInfer.d149.s0.p7	N	Complete gene sequences for the PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 / PROTEIN1 ) have been determined and recombinant PROTEIN and PROTEIN proteins produced in baculovirus.
BioInfer.d149.s0.p8	N	Complete gene sequences for the PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN / PROTEIN1 ) have been determined and recombinant PROTEIN2 and PROTEIN proteins produced in baculovirus.
BioInfer.d149.s0.p9	P	Complete gene sequences for the PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN / PROTEIN1 ) have been determined and recombinant PROTEIN and PROTEIN proteins produced in baculovirus.
BioInfer.d149.s0.p10	N	Complete gene sequences for the PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN / PROTEIN1 ) have been determined and recombinant PROTEIN and PROTEIN proteins produced in baculovirus.
BioInfer.d149.s0.p11	N	Complete gene sequences for the PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 / PROTEIN ) have been determined and recombinant PROTEIN and PROTEIN1 proteins produced in baculovirus.
BioInfer.d149.s0.p12	N	Complete gene sequences for the PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN / PROTEIN ) have been determined and recombinant PROTEIN2 and PROTEIN1 proteins produced in baculovirus.
BioInfer.d149.s0.p13	N	Complete gene sequences for the PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN / PROTEIN ) have been determined and recombinant PROTEIN and PROTEIN1 proteins produced in baculovirus.
BioInfer.d149.s0.p14	N	Complete gene sequences for the PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN / PROTEIN ) have been determined and recombinant PROTEIN and PROTEIN1 proteins produced in baculovirus.
BioInfer.d149.s0.p15	N	Complete gene sequences for the PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN1 / PROTEIN ) have been determined and recombinant PROTEIN2 and PROTEIN proteins produced in baculovirus.
BioInfer.d149.s0.p16	P	Complete gene sequences for the PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN1 / PROTEIN ) have been determined and recombinant PROTEIN and PROTEIN proteins produced in baculovirus.
BioInfer.d149.s0.p17	N	Complete gene sequences for the PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN1 / PROTEIN ) have been determined and recombinant PROTEIN and PROTEIN proteins produced in baculovirus.
BioInfer.d149.s0.p18	N	Complete gene sequences for the PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN / PROTEIN ) have been determined and recombinant PROTEIN1 and PROTEIN proteins produced in baculovirus.
BioInfer.d149.s0.p19	N	Complete gene sequences for the PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN / PROTEIN ) have been determined and recombinant PROTEIN1 and PROTEIN proteins produced in baculovirus.
BioInfer.d149.s0.p20	N	Complete gene sequences for the PROTEIN2 ( PROTEIN ) and PROTEIN1 ( PROTEIN / PROTEIN ) have been determined and recombinant PROTEIN and PROTEIN proteins produced in baculovirus.
BioInfer.d150.s0.p0	N	CONCLUSIONS: The expression of PROTEIN , PROTEIN2 , and PROTEIN is related to histological type and differentiation in NSCLC, although PROTEIN1 have no independent prognostic value.
BioInfer.d150.s0.p1	N	CONCLUSIONS: The expression of PROTEIN , PROTEIN , and PROTEIN2 is related to histological type and differentiation in NSCLC, although PROTEIN1 have no independent prognostic value.
BioInfer.d150.s0.p2	N	CONCLUSIONS: The expression of PROTEIN2 , PROTEIN , and PROTEIN is related to histological type and differentiation in NSCLC, although PROTEIN1 have no independent prognostic value.
BioInfer.d150.s0.p3	N	CONCLUSIONS: The expression of PROTEIN , PROTEIN1 , and PROTEIN2 is related to histological type and differentiation in NSCLC, although PROTEIN have no independent prognostic value.
BioInfer.d150.s0.p4	N	CONCLUSIONS: The expression of PROTEIN2 , PROTEIN1 , and PROTEIN is related to histological type and differentiation in NSCLC, although PROTEIN have no independent prognostic value.
BioInfer.d150.s0.p5	N	CONCLUSIONS: The expression of PROTEIN2 , PROTEIN , and PROTEIN1 is related to histological type and differentiation in NSCLC, although PROTEIN have no independent prognostic value.
BioInfer.d150.s1.p0	N	Reduced expression of PROTEIN2 , PROTEIN , and PROTEIN1 is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.
BioInfer.d150.s1.p1	N	Reduced expression of PROTEIN , PROTEIN2 , and PROTEIN1 is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.
BioInfer.d150.s1.p2	N	Reduced expression of PROTEIN1 , PROTEIN2 , and PROTEIN is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.
BioInfer.d151.s0.p0	P	CONCLUSIONS: These results suggest the cooperative modulation of the PROTEIN cytoskeleton by PROTEIN2 and PROTEIN1 .
BioInfer.d151.s0.p1	P	CONCLUSIONS: These results suggest the cooperative modulation of the PROTEIN2 cytoskeleton by PROTEIN and PROTEIN1 .
BioInfer.d151.s0.p2	P	CONCLUSIONS: These results suggest the cooperative modulation of the PROTEIN2 cytoskeleton by PROTEIN1 and PROTEIN .
BioInfer.d151.s1.p0	P	Immunofluorescence staining of a wild-type strain using anti- PROTEIN antibodies revealed that PROTEIN was distributed in cortical PROTEIN1 patches where PROTEIN2 was also co-localized.
BioInfer.d151.s1.p1	P	Immunofluorescence staining of a wild-type strain using anti- PROTEIN antibodies revealed that PROTEIN2 was distributed in cortical PROTEIN1 patches where PROTEIN was also co-localized.
BioInfer.d151.s1.p2	N	Immunofluorescence staining of a wild-type strain using anti- PROTEIN2 antibodies revealed that PROTEIN was distributed in cortical PROTEIN1 patches where PROTEIN was also co-localized.
BioInfer.d151.s1.p3	N	Immunofluorescence staining of a wild-type strain using anti- PROTEIN antibodies revealed that PROTEIN2 was distributed in cortical PROTEIN patches where PROTEIN1 was also co-localized.
BioInfer.d151.s1.p4	N	Immunofluorescence staining of a wild-type strain using anti- PROTEIN2 antibodies revealed that PROTEIN was distributed in cortical PROTEIN patches where PROTEIN1 was also co-localized.
BioInfer.d151.s1.p5	N	Immunofluorescence staining of a wild-type strain using anti- PROTEIN2 antibodies revealed that PROTEIN1 was distributed in cortical PROTEIN patches where PROTEIN was also co-localized.
BioInfer.d152.s0.p0	P	CONCLUSION: The results show that PROTEIN1 and PROTEIN2 form a complex in vivo and suggest that they participate in epithelial cell differentiation and targeted vesicle transport processes in the developing kidney.
BioInfer.d153.s0.p0	N	Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in PROTEIN1 cytoarchitecture and the distribution of focal contact proteins PROTEIN and PROTEIN2 .
BioInfer.d153.s0.p1	N	Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in PROTEIN1 cytoarchitecture and the distribution of focal contact proteins PROTEIN2 and PROTEIN .
BioInfer.d153.s0.p2	N	Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in PROTEIN cytoarchitecture and the distribution of focal contact proteins PROTEIN2 and PROTEIN1 .
BioInfer.d154.s0.p0	P	Conversely, inhibition of PROTEIN2 's activity by expressing a dominant negative construct, PROTEIN , or expression of the constitutively active S3A PROTEIN mutant induces loss of PROTEIN1 filaments at the phagocytic cup and also inhibits phagocytosis.
BioInfer.d154.s0.p1	P	Conversely, inhibition of PROTEIN 's activity by expressing a dominant negative construct, PROTEIN , or expression of the constitutively active S3A PROTEIN2 mutant induces loss of PROTEIN1 filaments at the phagocytic cup and also inhibits phagocytosis.
BioInfer.d154.s0.p2	P	Conversely, inhibition of PROTEIN 's activity by expressing a dominant negative construct, PROTEIN2 , or expression of the constitutively active S3A PROTEIN mutant induces loss of PROTEIN1 filaments at the phagocytic cup and also inhibits phagocytosis.
BioInfer.d154.s0.p3	N	Conversely, inhibition of PROTEIN1 's activity by expressing a dominant negative construct, PROTEIN , or expression of the constitutively active S3A PROTEIN2 mutant induces loss of PROTEIN filaments at the phagocytic cup and also inhibits phagocytosis.
BioInfer.d154.s0.p4	P	Conversely, inhibition of PROTEIN1 's activity by expressing a dominant negative construct, PROTEIN2 , or expression of the constitutively active S3A PROTEIN mutant induces loss of PROTEIN filaments at the phagocytic cup and also inhibits phagocytosis.
BioInfer.d154.s0.p5	N	Conversely, inhibition of PROTEIN 's activity by expressing a dominant negative construct, PROTEIN2 , or expression of the constitutively active S3A PROTEIN1 mutant induces loss of PROTEIN filaments at the phagocytic cup and also inhibits phagocytosis.
BioInfer.d155.s0.p0	P	Co-precipitation experiments using whole cell lysates indicate that the mutant form of PROTEIN1 binds PROTEIN and PROTEIN , and can form a structural complex with PROTEIN2 via these interactions.
BioInfer.d155.s0.p1	P	Co-precipitation experiments using whole cell lysates indicate that the mutant form of PROTEIN1 binds PROTEIN2 and PROTEIN , and can form a structural complex with PROTEIN via these interactions.
BioInfer.d155.s0.p2	P	Co-precipitation experiments using whole cell lysates indicate that the mutant form of PROTEIN1 binds PROTEIN and PROTEIN2 , and can form a structural complex with PROTEIN via these interactions.
BioInfer.d155.s0.p3	P	Co-precipitation experiments using whole cell lysates indicate that the mutant form of PROTEIN binds PROTEIN2 and PROTEIN , and can form a structural complex with PROTEIN1 via these interactions.
BioInfer.d155.s0.p4	P	Co-precipitation experiments using whole cell lysates indicate that the mutant form of PROTEIN binds PROTEIN and PROTEIN2 , and can form a structural complex with PROTEIN1 via these interactions.
BioInfer.d155.s0.p5	N	Co-precipitation experiments using whole cell lysates indicate that the mutant form of PROTEIN binds PROTEIN1 and PROTEIN2 , and can form a structural complex with PROTEIN via these interactions.
BioInfer.d156.s0.p0	P	Coprecipitations revealed that transfected PROTEIN molecules are complexed with PROTEIN2 and PROTEIN1 at plasma membranes.
BioInfer.d156.s0.p1	P	Coprecipitations revealed that transfected PROTEIN2 molecules are complexed with PROTEIN and PROTEIN1 at plasma membranes.
BioInfer.d156.s0.p2	P	Coprecipitations revealed that transfected PROTEIN2 molecules are complexed with PROTEIN1 and PROTEIN at plasma membranes.
BioInfer.d157.s0.p0	N	Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV PROTEIN1 complex ( PROTEIN , PROTEIN , PROTEIN ) and the PROTEIN ( PROTEIN2 ), was already sufficient to mediate the helper effect.
BioInfer.d157.s0.p1	P	Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV PROTEIN1 complex ( PROTEIN , PROTEIN , PROTEIN2 ) and the PROTEIN ( PROTEIN ), was already sufficient to mediate the helper effect.
BioInfer.d157.s0.p2	N	Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV PROTEIN1 complex ( PROTEIN , PROTEIN , PROTEIN ) and the PROTEIN2 ( PROTEIN ), was already sufficient to mediate the helper effect.
BioInfer.d157.s0.p3	P	Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV PROTEIN1 complex ( PROTEIN2 , PROTEIN , PROTEIN ) and the PROTEIN ( PROTEIN ), was already sufficient to mediate the helper effect.
BioInfer.d157.s0.p4	P	Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV PROTEIN1 complex ( PROTEIN , PROTEIN2 , PROTEIN ) and the PROTEIN ( PROTEIN ), was already sufficient to mediate the helper effect.
BioInfer.d157.s0.p5	N	Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV PROTEIN complex ( PROTEIN , PROTEIN , PROTEIN2 ) and the PROTEIN ( PROTEIN1 ), was already sufficient to mediate the helper effect.
BioInfer.d157.s0.p6	N	Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV PROTEIN complex ( PROTEIN , PROTEIN , PROTEIN ) and the PROTEIN2 ( PROTEIN1 ), was already sufficient to mediate the helper effect.
BioInfer.d157.s0.p7	N	Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV PROTEIN complex ( PROTEIN2 , PROTEIN , PROTEIN ) and the PROTEIN ( PROTEIN1 ), was already sufficient to mediate the helper effect.
BioInfer.d157.s0.p8	N	Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV PROTEIN complex ( PROTEIN , PROTEIN2 , PROTEIN ) and the PROTEIN ( PROTEIN1 ), was already sufficient to mediate the helper effect.
BioInfer.d157.s0.p9	N	Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV PROTEIN complex ( PROTEIN , PROTEIN , PROTEIN1 ) and the PROTEIN2 ( PROTEIN ), was already sufficient to mediate the helper effect.
BioInfer.d157.s0.p10	P	Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV PROTEIN complex ( PROTEIN2 , PROTEIN , PROTEIN1 ) and the PROTEIN ( PROTEIN ), was already sufficient to mediate the helper effect.
BioInfer.d157.s0.p11	P	Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV PROTEIN complex ( PROTEIN , PROTEIN2 , PROTEIN1 ) and the PROTEIN ( PROTEIN ), was already sufficient to mediate the helper effect.
BioInfer.d157.s0.p12	N	Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV PROTEIN complex ( PROTEIN2 , PROTEIN , PROTEIN ) and the PROTEIN1 ( PROTEIN ), was already sufficient to mediate the helper effect.
BioInfer.d157.s0.p13	N	Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV PROTEIN complex ( PROTEIN , PROTEIN2 , PROTEIN ) and the PROTEIN1 ( PROTEIN ), was already sufficient to mediate the helper effect.
BioInfer.d157.s0.p14	P	Cotransfections with different combinations of these genes demonstrated that a subset of four of them, coding for the HSV PROTEIN complex ( PROTEIN1 , PROTEIN2 , PROTEIN ) and the PROTEIN ( PROTEIN ), was already sufficient to mediate the helper effect.
BioInfer.d158.s0.p0	P	Crystallization and preliminary crystallographic analysis of the N-terminal PROTEIN2 binding domain of human PROTEIN1 .
BioInfer.d159.s0.p0	N	CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN2 ), alone or together, for the expression of biologically active proteins.
BioInfer.d159.s0.p1	N	CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN ), alone or together, for the expression of biologically active proteins.
BioInfer.d159.s0.p2	N	CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the PROTEIN2 ( PROTEIN1 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ), alone or together, for the expression of biologically active proteins.
BioInfer.d159.s0.p3	N	CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN ), alone or together, for the expression of biologically active proteins.
BioInfer.d159.s0.p4	N	CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the PROTEIN ( PROTEIN1 ), PROTEIN2 ( PROTEIN ), and PROTEIN ( PROTEIN ), alone or together, for the expression of biologically active proteins.
BioInfer.d159.s0.p5	N	CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN1 ), alone or together, for the expression of biologically active proteins.
BioInfer.d159.s0.p6	N	CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN1 ), alone or together, for the expression of biologically active proteins.
BioInfer.d159.s0.p7	N	CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN1 ), alone or together, for the expression of biologically active proteins.
BioInfer.d159.s0.p8	N	CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), and PROTEIN ( PROTEIN1 ), alone or together, for the expression of biologically active proteins.
BioInfer.d159.s0.p9	N	CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN1 ( PROTEIN ), alone or together, for the expression of biologically active proteins.
BioInfer.d159.s0.p10	N	CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN1 ( PROTEIN ), alone or together, for the expression of biologically active proteins.
BioInfer.d159.s0.p11	N	CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), and PROTEIN1 ( PROTEIN ), alone or together, for the expression of biologically active proteins.
BioInfer.d159.s0.p12	N	CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN ), alone or together, for the expression of biologically active proteins.
BioInfer.d159.s0.p13	N	CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the PROTEIN1 ( PROTEIN ), PROTEIN2 ( PROTEIN ), and PROTEIN ( PROTEIN ), alone or together, for the expression of biologically active proteins.
BioInfer.d159.s0.p14	N	CV-1 cells were transfected with cloned genes from wild-type HPIV-3 encoding the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN1 ), and PROTEIN ( PROTEIN ), alone or together, for the expression of biologically active proteins.
BioInfer.d160.s0.p0	P	Cytoplasmic staining included stress fibers that colocalized with PROTEIN1 , probably as a consequence of the PROTEIN2 component of the fusion protein.
BioInfer.d161.s0.p0	P	Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that PROTEIN , PROTEIN1 , and PROTEIN2 form a ternary complex.
BioInfer.d161.s0.p1	P	Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that PROTEIN2 , PROTEIN1 , and PROTEIN form a ternary complex.
BioInfer.d161.s0.p2	P	Data from affinity chromatography, analytical ultracentrifugation, covalent cross-linking, and fluorescence anisotropy show that PROTEIN2 , PROTEIN , and PROTEIN1 form a ternary complex.
BioInfer.d161.s1.p0	P	Experiments using a peptide that corresponds to the N-terminus of PROTEIN (residues 6-22) confirm the presence of an extensive binding surface between PROTEIN and PROTEIN , and explain why PROTEIN2 and PROTEIN can bind simultaneously to PROTEIN1 .
BioInfer.d161.s1.p1	N	Experiments using a peptide that corresponds to the N-terminus of PROTEIN (residues 6-22) confirm the presence of an extensive binding surface between PROTEIN2 and PROTEIN , and explain why PROTEIN and PROTEIN can bind simultaneously to PROTEIN1 .
BioInfer.d161.s1.p2	N	Experiments using a peptide that corresponds to the N-terminus of PROTEIN2 (residues 6-22) confirm the presence of an extensive binding surface between PROTEIN and PROTEIN , and explain why PROTEIN and PROTEIN can bind simultaneously to PROTEIN1 .
BioInfer.d161.s1.p3	N	Experiments using a peptide that corresponds to the N-terminus of PROTEIN (residues 6-22) confirm the presence of an extensive binding surface between PROTEIN and PROTEIN2 , and explain why PROTEIN and PROTEIN can bind simultaneously to PROTEIN1 .
BioInfer.d161.s1.p4	P	Experiments using a peptide that corresponds to the N-terminus of PROTEIN (residues 6-22) confirm the presence of an extensive binding surface between PROTEIN and PROTEIN , and explain why PROTEIN and PROTEIN2 can bind simultaneously to PROTEIN1 .
BioInfer.d161.s1.p5	N	Experiments using a peptide that corresponds to the N-terminus of PROTEIN (residues 6-22) confirm the presence of an extensive binding surface between PROTEIN2 and PROTEIN , and explain why PROTEIN1 and PROTEIN can bind simultaneously to PROTEIN .
BioInfer.d161.s1.p6	N	Experiments using a peptide that corresponds to the N-terminus of PROTEIN2 (residues 6-22) confirm the presence of an extensive binding surface between PROTEIN and PROTEIN , and explain why PROTEIN1 and PROTEIN can bind simultaneously to PROTEIN .
BioInfer.d161.s1.p7	N	Experiments using a peptide that corresponds to the N-terminus of PROTEIN (residues 6-22) confirm the presence of an extensive binding surface between PROTEIN and PROTEIN2 , and explain why PROTEIN1 and PROTEIN can bind simultaneously to PROTEIN .
BioInfer.d161.s1.p8	P	Experiments using a peptide that corresponds to the N-terminus of PROTEIN (residues 6-22) confirm the presence of an extensive binding surface between PROTEIN and PROTEIN , and explain why PROTEIN1 and PROTEIN2 can bind simultaneously to PROTEIN .
BioInfer.d161.s1.p9	N	Experiments using a peptide that corresponds to the N-terminus of PROTEIN2 (residues 6-22) confirm the presence of an extensive binding surface between PROTEIN1 and PROTEIN , and explain why PROTEIN and PROTEIN can bind simultaneously to PROTEIN .
BioInfer.d161.s1.p10	P	Experiments using a peptide that corresponds to the N-terminus of PROTEIN (residues 6-22) confirm the presence of an extensive binding surface between PROTEIN1 and PROTEIN2 , and explain why PROTEIN and PROTEIN can bind simultaneously to PROTEIN .
BioInfer.d161.s1.p11	N	Experiments using a peptide that corresponds to the N-terminus of PROTEIN (residues 6-22) confirm the presence of an extensive binding surface between PROTEIN1 and PROTEIN , and explain why PROTEIN and PROTEIN2 can bind simultaneously to PROTEIN .
BioInfer.d161.s1.p12	N	Experiments using a peptide that corresponds to the N-terminus of PROTEIN1 (residues 6-22) confirm the presence of an extensive binding surface between PROTEIN and PROTEIN2 , and explain why PROTEIN and PROTEIN can bind simultaneously to PROTEIN .
BioInfer.d161.s1.p13	N	Experiments using a peptide that corresponds to the N-terminus of PROTEIN1 (residues 6-22) confirm the presence of an extensive binding surface between PROTEIN and PROTEIN , and explain why PROTEIN and PROTEIN2 can bind simultaneously to PROTEIN .
BioInfer.d161.s1.p14	N	Experiments using a peptide that corresponds to the N-terminus of PROTEIN (residues 6-22) confirm the presence of an extensive binding surface between PROTEIN and PROTEIN1 , and explain why PROTEIN and PROTEIN2 can bind simultaneously to PROTEIN .
BioInfer.d162.s0.p0	N	Data is presented to suggest that the G1 PROTEIN1 and the PROTEIN  PROTEIN2 may be involved in subversion of the G1/S traverse by signaling pathways activated by PROTEIN function.
BioInfer.d162.s0.p1	P	Data is presented to suggest that the G1 PROTEIN1 and the PROTEIN  PROTEIN may be involved in subversion of the G1/S traverse by signaling pathways activated by PROTEIN2 function.
BioInfer.d162.s0.p2	N	Data is presented to suggest that the G1 PROTEIN1 and the PROTEIN2  PROTEIN may be involved in subversion of the G1/S traverse by signaling pathways activated by PROTEIN function.
BioInfer.d162.s0.p3	P	Data is presented to suggest that the G1 PROTEIN and the PROTEIN  PROTEIN1 may be involved in subversion of the G1/S traverse by signaling pathways activated by PROTEIN2 function.
BioInfer.d162.s0.p4	P	Data is presented to suggest that the G1 PROTEIN and the PROTEIN2  PROTEIN1 may be involved in subversion of the G1/S traverse by signaling pathways activated by PROTEIN function.
BioInfer.d162.s0.p5	N	Data is presented to suggest that the G1 PROTEIN and the PROTEIN2  PROTEIN may be involved in subversion of the G1/S traverse by signaling pathways activated by PROTEIN1 function.
BioInfer.d163.s0.p0	N	Data presented here suggest that two of the repressed genes encode the proteins PROTEIN2 and PROTEIN1 .
BioInfer.d163.s1.p0	N	Selective repression of PROTEIN2 and PROTEIN1 expression during the programmed death of insect skeletal muscle.
BioInfer.d163.s2.p0	N	The reduction in PROTEIN2 and PROTEIN1 synthesis presumably plays a role in the rapid dissolution of the muscles.
BioInfer.d164.s0.p0	N	PROTEIN1 belong to the PROTEIN family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as PROTEIN and PROTEIN and PROTEIN such as PROTEIN2 .
BioInfer.d164.s0.p1	P	PROTEIN1 belong to the PROTEIN family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as PROTEIN2 and PROTEIN and PROTEIN such as PROTEIN .
BioInfer.d164.s0.p2	P	PROTEIN1 belong to the PROTEIN family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as PROTEIN and PROTEIN2 and PROTEIN such as PROTEIN .
BioInfer.d164.s0.p3	P	PROTEIN1 belong to the PROTEIN family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as PROTEIN and PROTEIN and PROTEIN2 such as PROTEIN .
BioInfer.d164.s0.p4	P	PROTEIN1 belong to the PROTEIN2 family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as PROTEIN and PROTEIN and PROTEIN such as PROTEIN .
BioInfer.d164.s0.p5	N	PROTEIN belong to the PROTEIN family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as PROTEIN2 and PROTEIN and PROTEIN such as PROTEIN1 .
BioInfer.d164.s0.p6	N	PROTEIN belong to the PROTEIN family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as PROTEIN and PROTEIN2 and PROTEIN such as PROTEIN1 .
BioInfer.d164.s0.p7	P	PROTEIN belong to the PROTEIN family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as PROTEIN and PROTEIN and PROTEIN2 such as PROTEIN1 .
BioInfer.d164.s0.p8	N	PROTEIN belong to the PROTEIN2 family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as PROTEIN and PROTEIN and PROTEIN such as PROTEIN1 .
BioInfer.d164.s0.p9	N	PROTEIN belong to the PROTEIN family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as PROTEIN1 and PROTEIN2 and PROTEIN such as PROTEIN .
BioInfer.d164.s0.p10	N	PROTEIN belong to the PROTEIN family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as PROTEIN1 and PROTEIN and PROTEIN2 such as PROTEIN .
BioInfer.d164.s0.p11	N	PROTEIN belong to the PROTEIN2 family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as PROTEIN1 and PROTEIN and PROTEIN such as PROTEIN .
BioInfer.d164.s0.p12	N	PROTEIN belong to the PROTEIN family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as PROTEIN and PROTEIN1 and PROTEIN2 such as PROTEIN .
BioInfer.d164.s0.p13	N	PROTEIN belong to the PROTEIN2 family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as PROTEIN and PROTEIN1 and PROTEIN such as PROTEIN .
BioInfer.d164.s0.p14	N	PROTEIN belong to the PROTEIN2 family and are characterised by an intracellular death domain that serves to recruit adapter proteins such as PROTEIN and PROTEIN and PROTEIN1 such as PROTEIN .
BioInfer.d165.s0.p0	N	Deletion and overexpression studies demonstrate that PROTEIN1 , but not PROTEIN , PROTEIN2 or PROTEIN , is required for this rDNA position effect.
BioInfer.d165.s0.p1	N	Deletion and overexpression studies demonstrate that PROTEIN1 , but not PROTEIN2 , PROTEIN or PROTEIN , is required for this rDNA position effect.
BioInfer.d165.s0.p2	N	Deletion and overexpression studies demonstrate that PROTEIN1 , but not PROTEIN , PROTEIN or PROTEIN2 , is required for this rDNA position effect.
BioInfer.d165.s0.p3	N	Deletion and overexpression studies demonstrate that PROTEIN , but not PROTEIN2 , PROTEIN1 or PROTEIN , is required for this rDNA position effect.
BioInfer.d165.s0.p4	N	Deletion and overexpression studies demonstrate that PROTEIN , but not PROTEIN , PROTEIN1 or PROTEIN2 , is required for this rDNA position effect.
BioInfer.d165.s0.p5	N	Deletion and overexpression studies demonstrate that PROTEIN , but not PROTEIN1 , PROTEIN or PROTEIN2 , is required for this rDNA position effect.
BioInfer.d166.s0.p0	N	Deletion of both PROTEIN and PROTEIN1 produces a phenotype similar to that produced by deletion of PROTEIN2 .
BioInfer.d166.s0.p1	N	Deletion of both PROTEIN2 and PROTEIN1 produces a phenotype similar to that produced by deletion of PROTEIN .
BioInfer.d166.s0.p2	N	Deletion of both PROTEIN2 and PROTEIN produces a phenotype similar to that produced by deletion of PROTEIN1 .
BioInfer.d166.s1.p0	N	PROTEIN1 mutations completely abolished the ability to generate type II survivors, while PROTEIN2 mutations decreased the growth viability of type II survivors but did not completely eliminate their appearance.
BioInfer.d167.s0.p0	P	Deletion of PROTEIN2 enhanced PROTEIN1 and PROTEIN silencing, but deletion of PROTEIN or PROTEIN did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.
BioInfer.d167.s0.p1	P	Deletion of PROTEIN enhanced PROTEIN1 and PROTEIN silencing, but deletion of PROTEIN or PROTEIN2 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.
BioInfer.d167.s0.p2	P	Deletion of PROTEIN enhanced PROTEIN1 and PROTEIN silencing, but deletion of PROTEIN2 or PROTEIN did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.
BioInfer.d167.s0.p3	N	Deletion of PROTEIN enhanced PROTEIN1 and PROTEIN2 silencing, but deletion of PROTEIN or PROTEIN did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.
BioInfer.d167.s0.p4	N	Deletion of PROTEIN1 enhanced PROTEIN and PROTEIN silencing, but deletion of PROTEIN or PROTEIN2 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.
BioInfer.d167.s0.p5	N	Deletion of PROTEIN1 enhanced PROTEIN and PROTEIN silencing, but deletion of PROTEIN2 or PROTEIN did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.
BioInfer.d167.s0.p6	P	Deletion of PROTEIN1 enhanced PROTEIN and PROTEIN2 silencing, but deletion of PROTEIN or PROTEIN did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.
BioInfer.d167.s0.p7	N	Deletion of PROTEIN enhanced PROTEIN and PROTEIN silencing, but deletion of PROTEIN2 or PROTEIN1 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.
BioInfer.d167.s0.p8	P	Deletion of PROTEIN enhanced PROTEIN and PROTEIN2 silencing, but deletion of PROTEIN or PROTEIN1 did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.
BioInfer.d167.s0.p9	P	Deletion of PROTEIN enhanced PROTEIN and PROTEIN2 silencing, but deletion of PROTEIN1 or PROTEIN did not affect silencing, indicating that the mechanism of silencing differs from that at telomeres and silent mating loci.
BioInfer.d168.s0.p0	P	Demembranated stereociliary cores consisted primarily of protein bands corresponding to PROTEIN2 and PROTEIN1 and several proteins ranging from 43 to 63 kDa.
BioInfer.d169.s0.p0	P	Depending on the nature of the divalent cation, recombinant plant (birch) PROTEIN2 exhibited two different modes of interaction with PROTEIN1 , like mammalian PROTEIN .
BioInfer.d169.s0.p1	P	Depending on the nature of the divalent cation, recombinant plant (birch) PROTEIN exhibited two different modes of interaction with PROTEIN1 , like mammalian PROTEIN2 .
BioInfer.d169.s0.p2	N	Depending on the nature of the divalent cation, recombinant plant (birch) PROTEIN1 exhibited two different modes of interaction with PROTEIN , like mammalian PROTEIN2 .
BioInfer.d169.s1.p0	P	In the presence of magnesium ions birch PROTEIN promoted the polymerization of PROTEIN2 from PROTEIN1 : PROTEIN .
BioInfer.d169.s1.p1	N	In the presence of magnesium ions birch PROTEIN2 promoted the polymerization of PROTEIN from PROTEIN1 : PROTEIN .
BioInfer.d169.s1.p2	P	In the presence of magnesium ions birch PROTEIN promoted the polymerization of PROTEIN from PROTEIN1 : PROTEIN2 .
BioInfer.d169.s1.p3	P	In the presence of magnesium ions birch PROTEIN2 promoted the polymerization of PROTEIN1 from PROTEIN : PROTEIN .
BioInfer.d169.s1.p4	P	In the presence of magnesium ions birch PROTEIN promoted the polymerization of PROTEIN1 from PROTEIN : PROTEIN2 .
BioInfer.d169.s1.p5	N	In the presence of magnesium ions birch PROTEIN1 promoted the polymerization of PROTEIN from PROTEIN : PROTEIN2 .
BioInfer.d169.s2.p4	N	Recombinant plant (birch) PROTEIN1 was analyzed for its ability to promote PROTEIN polymerization from the PROTEIN : PROTEIN2 and beta9 complex.
BioInfer.d169.s2.p5	P	Recombinant plant (birch) PROTEIN1 was analyzed for its ability to promote PROTEIN2 polymerization from the PROTEIN : PROTEIN and beta9 complex.
BioInfer.d169.s2.p6	N	Recombinant plant (birch) PROTEIN1 was analyzed for its ability to promote PROTEIN polymerization from the PROTEIN2 : PROTEIN and beta9 complex.
BioInfer.d169.s2.p7	P	Recombinant plant (birch) PROTEIN was analyzed for its ability to promote PROTEIN2 polymerization from the PROTEIN : PROTEIN1 and beta9 complex.
BioInfer.d169.s2.p8	P	Recombinant plant (birch) PROTEIN was analyzed for its ability to promote PROTEIN polymerization from the PROTEIN2 : PROTEIN1 and beta9 complex.
BioInfer.d169.s2.p9	P	Recombinant plant (birch) PROTEIN was analyzed for its ability to promote PROTEIN1 polymerization from the PROTEIN2 : PROTEIN and beta9 complex.
BioInfer.d169.s3.p0	P	These data indicated a negative co-operativity between the PROTEIN2 and PROTEIN1 binding sites on PROTEIN .
BioInfer.d169.s3.p1	P	These data indicated a negative co-operativity between the PROTEIN and PROTEIN1 binding sites on PROTEIN2 .
BioInfer.d169.s3.p2	P	These data indicated a negative co-operativity between the PROTEIN1 and PROTEIN binding sites on PROTEIN2 .
BioInfer.d170.s0.p0	P	Detection of a sequence involved in PROTEIN1 -binding and phosphoinositide-binding in the N-terminal side of PROTEIN2 .
BioInfer.d170.s1.p0	P	The truncated PROTEIN2 molecules produced in E. coli were purified and examined for their PROTEIN1 -binding and PIP2-binding ability.
BioInfer.d171.s0.p0	N	Detection of loss of heterozygosity at PROTEIN , PROTEIN2 , PROTEIN and PROTEIN and PROTEIN1 loci in breast cancer: pathological correlations.
BioInfer.d171.s0.p1	N	Detection of loss of heterozygosity at PROTEIN , PROTEIN , PROTEIN2 and PROTEIN and PROTEIN1 loci in breast cancer: pathological correlations.
BioInfer.d171.s0.p2	N	Detection of loss of heterozygosity at PROTEIN2 , PROTEIN , PROTEIN and PROTEIN and PROTEIN1 loci in breast cancer: pathological correlations.
BioInfer.d171.s0.p3	N	Detection of loss of heterozygosity at PROTEIN , PROTEIN , PROTEIN and PROTEIN2 and PROTEIN1 loci in breast cancer: pathological correlations.
BioInfer.d171.s0.p4	N	Detection of loss of heterozygosity at PROTEIN , PROTEIN1 , PROTEIN2 and PROTEIN and PROTEIN loci in breast cancer: pathological correlations.
BioInfer.d171.s0.p5	N	Detection of loss of heterozygosity at PROTEIN2 , PROTEIN1 , PROTEIN and PROTEIN and PROTEIN loci in breast cancer: pathological correlations.
BioInfer.d171.s0.p6	N	Detection of loss of heterozygosity at PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 and PROTEIN loci in breast cancer: pathological correlations.
BioInfer.d171.s0.p7	N	Detection of loss of heterozygosity at PROTEIN2 , PROTEIN , PROTEIN1 and PROTEIN and PROTEIN loci in breast cancer: pathological correlations.
BioInfer.d171.s0.p8	N	Detection of loss of heterozygosity at PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 and PROTEIN loci in breast cancer: pathological correlations.
BioInfer.d171.s0.p9	N	Detection of loss of heterozygosity at PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 and PROTEIN loci in breast cancer: pathological correlations.
BioInfer.d171.s1.p0	N	LOH was found in the PROTEIN region in 32% of tumours, in the PROTEIN2 region in 16%, in PROTEIN in 20% and in the PROTEIN and PROTEIN1 regions in 49% and 44% respectively.
BioInfer.d171.s1.p1	N	LOH was found in the PROTEIN region in 32% of tumours, in the PROTEIN region in 16%, in PROTEIN2 in 20% and in the PROTEIN and PROTEIN1 regions in 49% and 44% respectively.
BioInfer.d171.s1.p2	N	LOH was found in the PROTEIN2 region in 32% of tumours, in the PROTEIN region in 16%, in PROTEIN in 20% and in the PROTEIN and PROTEIN1 regions in 49% and 44% respectively.
BioInfer.d171.s1.p3	N	LOH was found in the PROTEIN region in 32% of tumours, in the PROTEIN region in 16%, in PROTEIN in 20% and in the PROTEIN2 and PROTEIN1 regions in 49% and 44% respectively.
BioInfer.d171.s1.p4	N	LOH was found in the PROTEIN region in 32% of tumours, in the PROTEIN1 region in 16%, in PROTEIN2 in 20% and in the PROTEIN and PROTEIN regions in 49% and 44% respectively.
BioInfer.d171.s1.p5	N	LOH was found in the PROTEIN2 region in 32% of tumours, in the PROTEIN1 region in 16%, in PROTEIN in 20% and in the PROTEIN and PROTEIN regions in 49% and 44% respectively.
BioInfer.d171.s1.p6	N	LOH was found in the PROTEIN region in 32% of tumours, in the PROTEIN1 region in 16%, in PROTEIN in 20% and in the PROTEIN2 and PROTEIN regions in 49% and 44% respectively.
BioInfer.d171.s1.p7	N	LOH was found in the PROTEIN2 region in 32% of tumours, in the PROTEIN region in 16%, in PROTEIN1 in 20% and in the PROTEIN and PROTEIN regions in 49% and 44% respectively.
BioInfer.d171.s1.p8	N	LOH was found in the PROTEIN region in 32% of tumours, in the PROTEIN region in 16%, in PROTEIN1 in 20% and in the PROTEIN2 and PROTEIN regions in 49% and 44% respectively.
BioInfer.d171.s1.p9	N	LOH was found in the PROTEIN1 region in 32% of tumours, in the PROTEIN region in 16%, in PROTEIN in 20% and in the PROTEIN2 and PROTEIN regions in 49% and 44% respectively.
BioInfer.d171.s2.p0	N	We investigate allelic losses in microsatellites of the PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.
BioInfer.d171.s2.p1	N	We investigate allelic losses in microsatellites of the PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.
BioInfer.d171.s2.p2	N	We investigate allelic losses in microsatellites of the PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.
BioInfer.d171.s2.p3	N	We investigate allelic losses in microsatellites of the PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 and PROTEIN regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.
BioInfer.d171.s2.p4	N	We investigate allelic losses in microsatellites of the PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.
BioInfer.d171.s2.p5	N	We investigate allelic losses in microsatellites of the PROTEIN , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.
BioInfer.d171.s2.p6	N	We investigate allelic losses in microsatellites of the PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN and PROTEIN regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.
BioInfer.d171.s2.p7	N	We investigate allelic losses in microsatellites of the PROTEIN1 , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.
BioInfer.d171.s2.p8	N	We investigate allelic losses in microsatellites of the PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.
BioInfer.d171.s2.p9	N	We investigate allelic losses in microsatellites of the PROTEIN , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN1 regions, and their correlations with nine pathologic parameters in 127 breast carcinomas.
BioInfer.d172.s0.p0	N	Developmental changes in PROTEIN2 and PROTEIN1 isoform expression in smooth muscle.
BioInfer.d173.s0.p0	N	Digestion of isolated myofibrils with PROTEIN resulted in the degradation of PROTEIN1 and PROTEIN2 .
BioInfer.d173.s0.p1	P	Digestion of isolated myofibrils with PROTEIN2 resulted in the degradation of PROTEIN1 and PROTEIN .
BioInfer.d173.s0.p2	P	Digestion of isolated myofibrils with PROTEIN2 resulted in the degradation of PROTEIN and PROTEIN1 .
BioInfer.d174.s0.p0	N	Direct binding of the PROTEIN1 -homology domain in PROTEIN to PROTEIN2 is essential for cytoskeletal reorganization.
BioInfer.d174.s0.p1	P	Direct binding of the PROTEIN1 -homology domain in PROTEIN2 to PROTEIN is essential for cytoskeletal reorganization.
BioInfer.d174.s0.p2	P	Direct binding of the PROTEIN -homology domain in PROTEIN2 to PROTEIN1 is essential for cytoskeletal reorganization.
BioInfer.d174.s1.p0	P	Recently, two mammalian proteins previously shown to regulate the PROTEIN cytoskeleton, PROTEIN ( PROTEIN1 ) and its homolog expressed in neurons ( PROTEIN ), were found to possess short peptide motifs homologous to one part of PROTEIN2 .
BioInfer.d174.s1.p1	P	Recently, two mammalian proteins previously shown to regulate the PROTEIN cytoskeleton, PROTEIN ( PROTEIN1 ) and its homolog expressed in neurons ( PROTEIN2 ), were found to possess short peptide motifs homologous to one part of PROTEIN .
BioInfer.d174.s1.p2	P	Recently, two mammalian proteins previously shown to regulate the PROTEIN2 cytoskeleton, PROTEIN ( PROTEIN1 ) and its homolog expressed in neurons ( PROTEIN ), were found to possess short peptide motifs homologous to one part of PROTEIN .
BioInfer.d174.s1.p3	N	Recently, two mammalian proteins previously shown to regulate the PROTEIN cytoskeleton, PROTEIN2 ( PROTEIN1 ) and its homolog expressed in neurons ( PROTEIN ), were found to possess short peptide motifs homologous to one part of PROTEIN .
BioInfer.d174.s1.p4	P	Recently, two mammalian proteins previously shown to regulate the PROTEIN cytoskeleton, PROTEIN ( PROTEIN ) and its homolog expressed in neurons ( PROTEIN2 ), were found to possess short peptide motifs homologous to one part of PROTEIN1 .
BioInfer.d174.s1.p5	N	Recently, two mammalian proteins previously shown to regulate the PROTEIN2 cytoskeleton, PROTEIN ( PROTEIN ) and its homolog expressed in neurons ( PROTEIN ), were found to possess short peptide motifs homologous to one part of PROTEIN1 .
BioInfer.d174.s1.p6	P	Recently, two mammalian proteins previously shown to regulate the PROTEIN cytoskeleton, PROTEIN2 ( PROTEIN ) and its homolog expressed in neurons ( PROTEIN ), were found to possess short peptide motifs homologous to one part of PROTEIN1 .
BioInfer.d174.s1.p7	P	Recently, two mammalian proteins previously shown to regulate the PROTEIN2 cytoskeleton, PROTEIN ( PROTEIN ) and its homolog expressed in neurons ( PROTEIN1 ), were found to possess short peptide motifs homologous to one part of PROTEIN .
BioInfer.d174.s1.p8	P	Recently, two mammalian proteins previously shown to regulate the PROTEIN cytoskeleton, PROTEIN2 ( PROTEIN ) and its homolog expressed in neurons ( PROTEIN1 ), were found to possess short peptide motifs homologous to one part of PROTEIN .
BioInfer.d174.s1.p9	P	Recently, two mammalian proteins previously shown to regulate the PROTEIN1 cytoskeleton, PROTEIN2 ( PROTEIN ) and its homolog expressed in neurons ( PROTEIN ), were found to possess short peptide motifs homologous to one part of PROTEIN .
BioInfer.d175.s0.p0	P	Discrete segments (70-150 amino acids) of PROTEIN1 and PROTEIN were found to be responsible for their binding to PROTEIN2 .
BioInfer.d175.s0.p1	N	Discrete segments (70-150 amino acids) of PROTEIN1 and PROTEIN2 were found to be responsible for their binding to PROTEIN .
BioInfer.d175.s0.p2	P	Discrete segments (70-150 amino acids) of PROTEIN and PROTEIN2 were found to be responsible for their binding to PROTEIN1 .
BioInfer.d175.s1.p0	N	The PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN proteins of Saccharomyces cerevisiae were found previously to copurify with PROTEIN ( PROTEIN ) activity.
BioInfer.d175.s1.p1	N	The PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN proteins of Saccharomyces cerevisiae were found previously to copurify with PROTEIN2 ( PROTEIN ) activity.
BioInfer.d175.s1.p2	N	The PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN proteins of Saccharomyces cerevisiae were found previously to copurify with PROTEIN ( PROTEIN ) activity.
BioInfer.d175.s1.p3	N	The PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN proteins of Saccharomyces cerevisiae were found previously to copurify with PROTEIN ( PROTEIN2 ) activity.
BioInfer.d175.s1.p4	N	The PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 proteins of Saccharomyces cerevisiae were found previously to copurify with PROTEIN ( PROTEIN ) activity.
BioInfer.d175.s1.p5	N	The PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN proteins of Saccharomyces cerevisiae were found previously to copurify with PROTEIN2 ( PROTEIN ) activity.
BioInfer.d175.s1.p6	N	The PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN proteins of Saccharomyces cerevisiae were found previously to copurify with PROTEIN ( PROTEIN ) activity.
BioInfer.d175.s1.p7	N	The PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN proteins of Saccharomyces cerevisiae were found previously to copurify with PROTEIN ( PROTEIN2 ) activity.
BioInfer.d175.s1.p8	N	The PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 proteins of Saccharomyces cerevisiae were found previously to copurify with PROTEIN ( PROTEIN ) activity.
BioInfer.d175.s1.p9	N	The PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN proteins of Saccharomyces cerevisiae were found previously to copurify with PROTEIN1 ( PROTEIN ) activity.
BioInfer.d175.s1.p10	N	The PROTEIN , PROTEIN , PROTEIN , and PROTEIN proteins of Saccharomyces cerevisiae were found previously to copurify with PROTEIN1 ( PROTEIN2 ) activity.
BioInfer.d175.s1.p11	N	The PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 proteins of Saccharomyces cerevisiae were found previously to copurify with PROTEIN1 ( PROTEIN ) activity.
BioInfer.d175.s1.p12	N	The PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN proteins of Saccharomyces cerevisiae were found previously to copurify with PROTEIN ( PROTEIN2 ) activity.
BioInfer.d175.s1.p13	N	The PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 proteins of Saccharomyces cerevisiae were found previously to copurify with PROTEIN ( PROTEIN ) activity.
BioInfer.d175.s1.p14	N	The PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 proteins of Saccharomyces cerevisiae were found previously to copurify with PROTEIN ( PROTEIN1 ) activity.
BioInfer.d176.s0.p0	N	Dispersal of PROTEIN2 from such sites by oligoproline-rich peptide inhibitors suggests that PROTEIN is directly involved in intracellular pathogen locomotion and reorganization of PROTEIN1 cytoskeleton of the host cell peripheral membrane.
BioInfer.d176.s0.p1	P	Dispersal of PROTEIN from such sites by oligoproline-rich peptide inhibitors suggests that PROTEIN2 is directly involved in intracellular pathogen locomotion and reorganization of PROTEIN1 cytoskeleton of the host cell peripheral membrane.
BioInfer.d176.s0.p2	N	Dispersal of PROTEIN1 from such sites by oligoproline-rich peptide inhibitors suggests that PROTEIN2 is directly involved in intracellular pathogen locomotion and reorganization of PROTEIN cytoskeleton of the host cell peripheral membrane.
BioInfer.d177.s0.p0	N	Disruption of the PROTEIN gene, which is homologous to PROTEIN2 / PROTEIN and which is also required for correct PROTEIN1 localization, also blocks endocytosis.
BioInfer.d177.s0.p1	N	Disruption of the PROTEIN gene, which is homologous to PROTEIN / PROTEIN2 and which is also required for correct PROTEIN1 localization, also blocks endocytosis.
BioInfer.d177.s0.p2	P	Disruption of the PROTEIN2 gene, which is homologous to PROTEIN / PROTEIN and which is also required for correct PROTEIN1 localization, also blocks endocytosis.
BioInfer.d177.s0.p3	N	Disruption of the PROTEIN gene, which is homologous to PROTEIN1 / PROTEIN2 and which is also required for correct PROTEIN localization, also blocks endocytosis.
BioInfer.d177.s0.p4	P	Disruption of the PROTEIN2 gene, which is homologous to PROTEIN1 / PROTEIN and which is also required for correct PROTEIN localization, also blocks endocytosis.
BioInfer.d177.s0.p5	P	Disruption of the PROTEIN2 gene, which is homologous to PROTEIN / PROTEIN1 and which is also required for correct PROTEIN localization, also blocks endocytosis.
BioInfer.d178.s0.p0	P	DNA sequence analysis of the PROTEIN2 gene reveals that it encodes PROTEIN1 , an PROTEIN -monomer-binding protein.
BioInfer.d178.s0.p1	P	DNA sequence analysis of the PROTEIN gene reveals that it encodes PROTEIN1 , an PROTEIN2 -monomer-binding protein.
BioInfer.d178.s0.p2	N	DNA sequence analysis of the PROTEIN1 gene reveals that it encodes PROTEIN , an PROTEIN2 -monomer-binding protein.
BioInfer.d178.s1.p0	P	We attribute these effects to potential sequestration of PROTEIN2 monomers by PROTEIN1 , when present in excess.
BioInfer.d179.s0.p0	N	Double mutants containing N-terminal domain deletions of both PROTEIN1  PROTEIN and PROTEIN  PROTEIN2 were inviable.
BioInfer.d179.s0.p1	N	Double mutants containing N-terminal domain deletions of both PROTEIN1  PROTEIN and PROTEIN2  PROTEIN were inviable.
BioInfer.d179.s0.p2	P	Double mutants containing N-terminal domain deletions of both PROTEIN1  PROTEIN2 and PROTEIN  PROTEIN were inviable.
BioInfer.d179.s0.p3	P	Double mutants containing N-terminal domain deletions of both PROTEIN  PROTEIN and PROTEIN2  PROTEIN1 were inviable.
BioInfer.d179.s0.p4	N	Double mutants containing N-terminal domain deletions of both PROTEIN  PROTEIN2 and PROTEIN  PROTEIN1 were inviable.
BioInfer.d179.s0.p5	N	Double mutants containing N-terminal domain deletions of both PROTEIN  PROTEIN2 and PROTEIN1  PROTEIN were inviable.
BioInfer.d180.s0.p0	N	PROTEIN2 signal transduction is mediated by a complex of intracellular signaling molecules including PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d180.s0.p1	P	PROTEIN signal transduction is mediated by a complex of intracellular signaling molecules including PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d180.s0.p2	P	PROTEIN signal transduction is mediated by a complex of intracellular signaling molecules including PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d180.s0.p3	P	PROTEIN signal transduction is mediated by a complex of intracellular signaling molecules including PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d180.s0.p4	N	PROTEIN1 signal transduction is mediated by a complex of intracellular signaling molecules including PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d180.s0.p5	N	PROTEIN1 signal transduction is mediated by a complex of intracellular signaling molecules including PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d180.s0.p6	N	PROTEIN1 signal transduction is mediated by a complex of intracellular signaling molecules including PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d180.s0.p7	P	PROTEIN signal transduction is mediated by a complex of intracellular signaling molecules including PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 .
BioInfer.d180.s0.p8	P	PROTEIN signal transduction is mediated by a complex of intracellular signaling molecules including PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 .
BioInfer.d180.s0.p9	P	PROTEIN signal transduction is mediated by a complex of intracellular signaling molecules including PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN .
BioInfer.d181.s0.p0	N	During apoptotic process induced by the agents, expression of PROTEIN  PROTEIN1 and PROTEIN2 increased, whereas expression of PROTEIN decreased.
BioInfer.d181.s0.p1	P	During apoptotic process induced by the agents, expression of PROTEIN2  PROTEIN1 and PROTEIN increased, whereas expression of PROTEIN decreased.
BioInfer.d181.s0.p2	N	During apoptotic process induced by the agents, expression of PROTEIN  PROTEIN1 and PROTEIN increased, whereas expression of PROTEIN2 decreased.
BioInfer.d181.s0.p3	P	During apoptotic process induced by the agents, expression of PROTEIN2  PROTEIN and PROTEIN1 increased, whereas expression of PROTEIN decreased.
BioInfer.d181.s0.p4	N	During apoptotic process induced by the agents, expression of PROTEIN  PROTEIN and PROTEIN1 increased, whereas expression of PROTEIN2 decreased.
BioInfer.d181.s0.p5	N	During apoptotic process induced by the agents, expression of PROTEIN1  PROTEIN and PROTEIN increased, whereas expression of PROTEIN2 decreased.
BioInfer.d182.s0.p0	N	During incubation of whole myofibrils at 37 degrees C, PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN suffered degradation.
BioInfer.d182.s0.p1	N	During incubation of whole myofibrils at 37 degrees C, PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN suffered degradation.
BioInfer.d182.s0.p2	N	During incubation of whole myofibrils at 37 degrees C, PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 suffered degradation.
BioInfer.d182.s0.p3	N	During incubation of whole myofibrils at 37 degrees C, PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN suffered degradation.
BioInfer.d182.s0.p4	N	During incubation of whole myofibrils at 37 degrees C, PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 suffered degradation.
BioInfer.d182.s0.p5	N	During incubation of whole myofibrils at 37 degrees C, PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 suffered degradation.
BioInfer.d183.s0.p0	P	Dynamic PROTEIN1 structures stabilized by PROTEIN2 .
BioInfer.d183.s1.p0	P	The distribution of PROTEIN1 filaments is altered by PROTEIN2 overexpression.
BioInfer.d183.s2.p0	N	While parallel PROTEIN2 bundles crossing the cells are virtually absent in cells overexpressing PROTEIN , the submembranous PROTEIN1 network of these cells is denser than in control cells.
BioInfer.d183.s2.p1	N	While parallel PROTEIN bundles crossing the cells are virtually absent in cells overexpressing PROTEIN2 , the submembranous PROTEIN1 network of these cells is denser than in control cells.
BioInfer.d183.s2.p2	N	While parallel PROTEIN1 bundles crossing the cells are virtually absent in cells overexpressing PROTEIN2 , the submembranous PROTEIN network of these cells is denser than in control cells.
BioInfer.d184.s0.p0	P	Effects of PROTEIN2 - PROTEIN association on some properties of both PROTEIN1 and PROTEIN : modification of the inhibitory activity of PROTEIN on PROTEIN polymerization and inhibition of the self-association of PROTEIN and its interactions with liposomes.
BioInfer.d184.s0.p1	P	Effects of PROTEIN - PROTEIN2 association on some properties of both PROTEIN1 and PROTEIN : modification of the inhibitory activity of PROTEIN on PROTEIN polymerization and inhibition of the self-association of PROTEIN and its interactions with liposomes.
BioInfer.d184.s0.p2	N	Effects of PROTEIN - PROTEIN association on some properties of both PROTEIN1 and PROTEIN : modification of the inhibitory activity of PROTEIN2 on PROTEIN polymerization and inhibition of the self-association of PROTEIN and its interactions with liposomes.
BioInfer.d184.s0.p3	N	Effects of PROTEIN - PROTEIN association on some properties of both PROTEIN1 and PROTEIN : modification of the inhibitory activity of PROTEIN on PROTEIN polymerization and inhibition of the self-association of PROTEIN2 and its interactions with liposomes.
BioInfer.d184.s0.p4	N	Effects of PROTEIN - PROTEIN association on some properties of both PROTEIN1 and PROTEIN : modification of the inhibitory activity of PROTEIN on PROTEIN2 polymerization and inhibition of the self-association of PROTEIN and its interactions with liposomes.
BioInfer.d184.s0.p5	N	Effects of PROTEIN - PROTEIN association on some properties of both PROTEIN1 and PROTEIN2 : modification of the inhibitory activity of PROTEIN on PROTEIN polymerization and inhibition of the self-association of PROTEIN and its interactions with liposomes.
BioInfer.d184.s0.p6	P	Effects of PROTEIN1 - PROTEIN2 association on some properties of both PROTEIN and PROTEIN : modification of the inhibitory activity of PROTEIN on PROTEIN polymerization and inhibition of the self-association of PROTEIN and its interactions with liposomes.
BioInfer.d184.s0.p7	P	Effects of PROTEIN1 - PROTEIN association on some properties of both PROTEIN and PROTEIN : modification of the inhibitory activity of PROTEIN2 on PROTEIN polymerization and inhibition of the self-association of PROTEIN and its interactions with liposomes.
BioInfer.d184.s0.p8	P	Effects of PROTEIN1 - PROTEIN association on some properties of both PROTEIN and PROTEIN : modification of the inhibitory activity of PROTEIN on PROTEIN polymerization and inhibition of the self-association of PROTEIN2 and its interactions with liposomes.
BioInfer.d184.s0.p9	P	Effects of PROTEIN1 - PROTEIN association on some properties of both PROTEIN and PROTEIN : modification of the inhibitory activity of PROTEIN on PROTEIN2 polymerization and inhibition of the self-association of PROTEIN and its interactions with liposomes.
BioInfer.d184.s0.p10	P	Effects of PROTEIN1 - PROTEIN association on some properties of both PROTEIN and PROTEIN2 : modification of the inhibitory activity of PROTEIN on PROTEIN polymerization and inhibition of the self-association of PROTEIN and its interactions with liposomes.
BioInfer.d184.s0.p11	N	Effects of PROTEIN - PROTEIN1 association on some properties of both PROTEIN and PROTEIN : modification of the inhibitory activity of PROTEIN2 on PROTEIN polymerization and inhibition of the self-association of PROTEIN and its interactions with liposomes.
BioInfer.d184.s0.p12	P	Effects of PROTEIN - PROTEIN1 association on some properties of both PROTEIN and PROTEIN : modification of the inhibitory activity of PROTEIN on PROTEIN polymerization and inhibition of the self-association of PROTEIN2 and its interactions with liposomes.
BioInfer.d184.s0.p13	P	Effects of PROTEIN - PROTEIN1 association on some properties of both PROTEIN and PROTEIN : modification of the inhibitory activity of PROTEIN on PROTEIN2 polymerization and inhibition of the self-association of PROTEIN and its interactions with liposomes.
BioInfer.d184.s0.p14	P	Effects of PROTEIN - PROTEIN1 association on some properties of both PROTEIN and PROTEIN2 : modification of the inhibitory activity of PROTEIN on PROTEIN polymerization and inhibition of the self-association of PROTEIN and its interactions with liposomes.
BioInfer.d184.s0.p15	N	Effects of PROTEIN - PROTEIN association on some properties of both PROTEIN and PROTEIN : modification of the inhibitory activity of PROTEIN1 on PROTEIN polymerization and inhibition of the self-association of PROTEIN2 and its interactions with liposomes.
BioInfer.d184.s0.p16	P	Effects of PROTEIN - PROTEIN association on some properties of both PROTEIN and PROTEIN : modification of the inhibitory activity of PROTEIN1 on PROTEIN2 polymerization and inhibition of the self-association of PROTEIN and its interactions with liposomes.
BioInfer.d184.s0.p17	N	Effects of PROTEIN - PROTEIN association on some properties of both PROTEIN and PROTEIN2 : modification of the inhibitory activity of PROTEIN1 on PROTEIN polymerization and inhibition of the self-association of PROTEIN and its interactions with liposomes.
BioInfer.d184.s0.p18	N	Effects of PROTEIN - PROTEIN association on some properties of both PROTEIN and PROTEIN : modification of the inhibitory activity of PROTEIN on PROTEIN2 polymerization and inhibition of the self-association of PROTEIN1 and its interactions with liposomes.
BioInfer.d184.s0.p19	N	Effects of PROTEIN - PROTEIN association on some properties of both PROTEIN and PROTEIN2 : modification of the inhibitory activity of PROTEIN on PROTEIN polymerization and inhibition of the self-association of PROTEIN1 and its interactions with liposomes.
BioInfer.d184.s0.p20	N	Effects of PROTEIN - PROTEIN association on some properties of both PROTEIN and PROTEIN2 : modification of the inhibitory activity of PROTEIN on PROTEIN1 polymerization and inhibition of the self-association of PROTEIN and its interactions with liposomes.
BioInfer.d185.s0.p0	N	Effects of PROTEIN on PROTEIN1 in the presence and absence of PROTEIN2 and PROTEIN .
BioInfer.d185.s0.p1	N	Effects of PROTEIN on PROTEIN1 in the presence and absence of PROTEIN and PROTEIN2 .
BioInfer.d185.s0.p2	P	Effects of PROTEIN2 on PROTEIN1 in the presence and absence of PROTEIN and PROTEIN .
BioInfer.d185.s0.p3	N	Effects of PROTEIN on PROTEIN in the presence and absence of PROTEIN1 and PROTEIN2 .
BioInfer.d185.s0.p4	N	Effects of PROTEIN2 on PROTEIN in the presence and absence of PROTEIN1 and PROTEIN .
BioInfer.d185.s0.p5	N	Effects of PROTEIN2 on PROTEIN in the presence and absence of PROTEIN and PROTEIN1 .
BioInfer.d186.s0.p0	N	Effects of mutations of PROTEIN1 , PROTEIN , PROTEIN2 , and related genes on illegitimate recombination in Saccharomyces cerevisiae.
BioInfer.d186.s0.p1	N	Effects of mutations of PROTEIN1 , PROTEIN2 , PROTEIN , and related genes on illegitimate recombination in Saccharomyces cerevisiae.
BioInfer.d186.s0.p2	N	Effects of mutations of PROTEIN , PROTEIN2 , PROTEIN1 , and related genes on illegitimate recombination in Saccharomyces cerevisiae.
BioInfer.d187.s0.p0	P	Effects of single amino acid substitutions in the PROTEIN1 -binding site on the biological activity of bovine PROTEIN2 .
BioInfer.d187.s1.p0	N	However, these mutants displayed a lower affinity for PROTEIN1 than wild-type PROTEIN , suggesting that additional putative bonds created this way cannot increase PROTEIN 's affinity for PROTEIN2 .
BioInfer.d187.s1.p1	P	However, these mutants displayed a lower affinity for PROTEIN1 than wild-type PROTEIN2 , suggesting that additional putative bonds created this way cannot increase PROTEIN 's affinity for PROTEIN .
BioInfer.d187.s1.p2	N	However, these mutants displayed a lower affinity for PROTEIN1 than wild-type PROTEIN , suggesting that additional putative bonds created this way cannot increase PROTEIN2 's affinity for PROTEIN .
BioInfer.d187.s1.p3	N	However, these mutants displayed a lower affinity for PROTEIN than wild-type PROTEIN2 , suggesting that additional putative bonds created this way cannot increase PROTEIN 's affinity for PROTEIN1 .
BioInfer.d187.s1.p4	P	However, these mutants displayed a lower affinity for PROTEIN than wild-type PROTEIN , suggesting that additional putative bonds created this way cannot increase PROTEIN2 's affinity for PROTEIN1 .
BioInfer.d187.s1.p5	N	However, these mutants displayed a lower affinity for PROTEIN than wild-type PROTEIN1 , suggesting that additional putative bonds created this way cannot increase PROTEIN2 's affinity for PROTEIN .
BioInfer.d187.s2.p0	P	These results emphasize the highly conserved biological function of PROTEIN1 with low sequence homology, and correlate specifically their PROTEIN2 -binding capacity with cell motility and proliferation.
BioInfer.d188.s0.p1	N	Electrical stimulation of cardiocyte contraction did not enhance PROTEIN2 or PROTEIN1 (alpha+beta) mRNA transcript levels relative to PROTEIN during the period of rapid growth that occurred over the first 48 hours.
BioInfer.d188.s0.p2	N	Electrical stimulation of cardiocyte contraction did not enhance PROTEIN or PROTEIN1 (alpha+beta) mRNA transcript levels relative to PROTEIN2 during the period of rapid growth that occurred over the first 48 hours.
BioInfer.d188.s0.p5	N	Electrical stimulation of cardiocyte contraction did not enhance PROTEIN1 or PROTEIN (alpha+beta) mRNA transcript levels relative to PROTEIN2 during the period of rapid growth that occurred over the first 48 hours.
BioInfer.d189.s0.p0	P	Elevation of cAMP induced morphologic alterations indicative of changes in the adhesive status of the macrophage, including cell rounding and disassembly of structures that represent points of contact with substrate containing PROTEIN1 and PROTEIN2 .
BioInfer.d190.s0.p0	N	PROTEIN encodes a proline-rich protein ( PROTEIN1 or PROTEIN2 ) required for a polarised cortical PROTEIN cytoskeleton and endocytosis [2,3].
BioInfer.d190.s0.p1	P	PROTEIN2 encodes a proline-rich protein ( PROTEIN1 or PROTEIN ) required for a polarised cortical PROTEIN cytoskeleton and endocytosis [2,3].
BioInfer.d190.s0.p2	P	PROTEIN encodes a proline-rich protein ( PROTEIN1 or PROTEIN ) required for a polarised cortical PROTEIN2 cytoskeleton and endocytosis [2,3].
BioInfer.d190.s0.p3	P	PROTEIN2 encodes a proline-rich protein ( PROTEIN or PROTEIN1 ) required for a polarised cortical PROTEIN cytoskeleton and endocytosis [2,3].
BioInfer.d190.s0.p4	P	PROTEIN encodes a proline-rich protein ( PROTEIN or PROTEIN1 ) required for a polarised cortical PROTEIN2 cytoskeleton and endocytosis [2,3].
BioInfer.d190.s0.p5	N	PROTEIN1 encodes a proline-rich protein ( PROTEIN or PROTEIN ) required for a polarised cortical PROTEIN2 cytoskeleton and endocytosis [2,3].
BioInfer.d191.s0.p0	N	Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 over a 240 h period in culture.
BioInfer.d191.s0.p1	N	Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 over a 240 h period in culture.
BioInfer.d191.s0.p2	N	Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 over a 240 h period in culture.
BioInfer.d191.s0.p3	N	Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN over a 240 h period in culture.
BioInfer.d191.s0.p4	N	Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN over a 240 h period in culture.
BioInfer.d191.s0.p5	N	Equine satellite cell clone SE-11 and ovine satellite cell clone I(1)were evaluated for expression of PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN over a 240 h period in culture.
BioInfer.d192.s0.p0	P	Essential domains of the PROTEIN1 splicing factor are implicated in the binding to PROTEIN2 and PROTEIN proteins and are conserved through evolution.
BioInfer.d192.s0.p1	P	Essential domains of the PROTEIN1 splicing factor are implicated in the binding to PROTEIN and PROTEIN2 proteins and are conserved through evolution.
BioInfer.d192.s0.p2	N	Essential domains of the PROTEIN splicing factor are implicated in the binding to PROTEIN1 and PROTEIN2 proteins and are conserved through evolution.
BioInfer.d193.s0.p0	P	Evaluation of the binding of Acanthamoeba PROTEIN1 to pyrene-labeled PROTEIN2 by fluorescence enhancement.
BioInfer.d194.s0.p0	N	Even though rates of total protein and PROTEIN1 synthesis resembled values measured in vivo, PROTEIN2 fractional rate of synthesis was only 22% of in vivo levels.
BioInfer.d195.s0.p0	P	Evidence for a conformational change in PROTEIN induced by PROTEIN1 ( PROTEIN2 ) binding.
BioInfer.d195.s0.p1	N	Evidence for a conformational change in PROTEIN2 induced by PROTEIN1 ( PROTEIN ) binding.
BioInfer.d195.s0.p2	P	Evidence for a conformational change in PROTEIN2 induced by PROTEIN ( PROTEIN1 ) binding.
BioInfer.d196.s0.p0	P	Evidence suggests that this differential recognition bears functional significance concerning the intricate roles of PROTEIN2 and inositol lipids in modulating PROTEIN1 polymerization and PtdIns(4,5)P2 turnover.
BioInfer.d197.s0.p0	N	Exclusion of PROTEIN2 and PROTEIN1 gene involvement in hypertrophic cardiomyopathy of several French families.
BioInfer.d198.s0.p0	P	Experiments performed using extracts from doubly infected cells indicated that PROTEIN could interact separately with both the PROTEIN2 and PROTEIN1 proteins.
BioInfer.d198.s0.p1	P	Experiments performed using extracts from doubly infected cells indicated that PROTEIN2 could interact separately with both the PROTEIN and PROTEIN1 proteins.
BioInfer.d198.s0.p2	P	Experiments performed using extracts from doubly infected cells indicated that PROTEIN2 could interact separately with both the PROTEIN1 and PROTEIN proteins.
BioInfer.d198.s1.p0	N	PROTEIN was shown to recognize the PROTEIN protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN1 , PROTEIN and PROTEIN2 polypeptides.
BioInfer.d198.s1.p1	N	PROTEIN was shown to recognize the PROTEIN protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN1 , PROTEIN2 and PROTEIN polypeptides.
BioInfer.d198.s1.p2	N	PROTEIN was shown to recognize the PROTEIN2 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN1 , PROTEIN and PROTEIN polypeptides.
BioInfer.d198.s1.p3	N	PROTEIN2 was shown to recognize the PROTEIN protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN1 , PROTEIN and PROTEIN polypeptides.
BioInfer.d198.s1.p4	N	PROTEIN was shown to recognize the PROTEIN protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN , PROTEIN2 and PROTEIN1 polypeptides.
BioInfer.d198.s1.p5	N	PROTEIN was shown to recognize the PROTEIN2 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN , PROTEIN and PROTEIN1 polypeptides.
BioInfer.d198.s1.p6	N	PROTEIN2 was shown to recognize the PROTEIN protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN , PROTEIN and PROTEIN1 polypeptides.
BioInfer.d198.s1.p7	N	PROTEIN was shown to recognize the PROTEIN2 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN , PROTEIN1 and PROTEIN polypeptides.
BioInfer.d198.s1.p8	N	PROTEIN2 was shown to recognize the PROTEIN protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN , PROTEIN1 and PROTEIN polypeptides.
BioInfer.d198.s1.p9	P	PROTEIN2 was shown to recognize the PROTEIN1 protein in both Western blots and immunoprecipitation assays and to co-precipitate the other two proteins in the complex from insect cells triply infected with recombinants expressing the PROTEIN , PROTEIN and PROTEIN polypeptides.
BioInfer.d199.s0.p0	N	Exposure of the cells to tumor promoter did, however, result in a loss of PROTEIN1 and PROTEIN2 -rich cell surface elaborations that resemble focal contact precursor structures.
BioInfer.d200.s0.p0	N	Exposure of the rabbit retina to a combination of an PROTEIN2 antagonist, 8-cyclopentyl-1,3 dipropylxanthine (DPCPX), and PROTEIN1 did not affect the enhancing action of DAMGO on the light-evoked release of ACh.
BioInfer.d201.s0.p0	N	Expression of PROTEIN1 and PROTEIN2 genes in skeletal, cardiac and uterine muscles of young and old rats.
BioInfer.d202.s0.p0	P	Expression of PROTEIN2 was generally weak and did not correlate with the expression of either PROTEIN or PROTEIN1 .
BioInfer.d202.s0.p1	N	Expression of PROTEIN was generally weak and did not correlate with the expression of either PROTEIN2 or PROTEIN1 .
BioInfer.d202.s0.p2	P	Expression of PROTEIN1 was generally weak and did not correlate with the expression of either PROTEIN2 or PROTEIN .
BioInfer.d203.s0.p0	N	Expression of PROTEIN2 was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of PROTEIN ( PROTEIN ) and PROTEIN1 .
BioInfer.d203.s0.p1	N	Expression of PROTEIN was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of PROTEIN ( PROTEIN2 ) and PROTEIN1 .
BioInfer.d203.s0.p2	N	Expression of PROTEIN was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of PROTEIN2 ( PROTEIN ) and PROTEIN1 .
BioInfer.d203.s0.p3	N	Expression of PROTEIN1 was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of PROTEIN ( PROTEIN2 ) and PROTEIN .
BioInfer.d203.s0.p4	N	Expression of PROTEIN1 was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of PROTEIN2 ( PROTEIN ) and PROTEIN .
BioInfer.d203.s0.p5	N	Expression of PROTEIN was investigated in normal breast tissue and 66 breast carcinomas in conjunction with expression of PROTEIN2 ( PROTEIN1 ) and PROTEIN .
BioInfer.d203.s1.p0	N	In invasive ductal carcinomas, PROTEIN1 was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of PROTEIN and PROTEIN2 was unchanged between them.
BioInfer.d203.s1.p1	N	In invasive ductal carcinomas, PROTEIN1 was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of PROTEIN2 and PROTEIN was unchanged between them.
BioInfer.d203.s1.p2	N	In invasive ductal carcinomas, PROTEIN was reduced more frequently in diffuse than in solid type tumours, whereas the level of expression of PROTEIN2 and PROTEIN1 was unchanged between them.
BioInfer.d204.s0.p0	P	Expression of PROTEIN or PROTEIN1 was sufficient to activate PROTEIN - PROTEIN2 by promoting the formation of high-molecular-weight complexes lacking the PROTEIN  PROTEIN , as has been described, following estrogen treatment.
BioInfer.d204.s0.p1	P	Expression of PROTEIN or PROTEIN1 was sufficient to activate PROTEIN2 - PROTEIN by promoting the formation of high-molecular-weight complexes lacking the PROTEIN  PROTEIN , as has been described, following estrogen treatment.
BioInfer.d204.s0.p2	N	Expression of PROTEIN or PROTEIN1 was sufficient to activate PROTEIN - PROTEIN by promoting the formation of high-molecular-weight complexes lacking the PROTEIN2  PROTEIN , as has been described, following estrogen treatment.
BioInfer.d204.s0.p3	N	Expression of PROTEIN2 or PROTEIN1 was sufficient to activate PROTEIN - PROTEIN by promoting the formation of high-molecular-weight complexes lacking the PROTEIN  PROTEIN , as has been described, following estrogen treatment.
BioInfer.d204.s0.p4	N	Expression of PROTEIN or PROTEIN1 was sufficient to activate PROTEIN - PROTEIN by promoting the formation of high-molecular-weight complexes lacking the PROTEIN  PROTEIN2 , as has been described, following estrogen treatment.
BioInfer.d204.s0.p5	P	Expression of PROTEIN or PROTEIN was sufficient to activate PROTEIN2 - PROTEIN1 by promoting the formation of high-molecular-weight complexes lacking the PROTEIN  PROTEIN , as has been described, following estrogen treatment.
BioInfer.d204.s0.p6	N	Expression of PROTEIN or PROTEIN was sufficient to activate PROTEIN - PROTEIN1 by promoting the formation of high-molecular-weight complexes lacking the PROTEIN2  PROTEIN , as has been described, following estrogen treatment.
BioInfer.d204.s0.p7	P	Expression of PROTEIN2 or PROTEIN was sufficient to activate PROTEIN - PROTEIN1 by promoting the formation of high-molecular-weight complexes lacking the PROTEIN  PROTEIN , as has been described, following estrogen treatment.
BioInfer.d204.s0.p8	N	Expression of PROTEIN or PROTEIN was sufficient to activate PROTEIN - PROTEIN1 by promoting the formation of high-molecular-weight complexes lacking the PROTEIN  PROTEIN2 , as has been described, following estrogen treatment.
BioInfer.d204.s0.p9	N	Expression of PROTEIN or PROTEIN was sufficient to activate PROTEIN1 - PROTEIN by promoting the formation of high-molecular-weight complexes lacking the PROTEIN2  PROTEIN , as has been described, following estrogen treatment.
BioInfer.d204.s0.p10	P	Expression of PROTEIN2 or PROTEIN was sufficient to activate PROTEIN1 - PROTEIN by promoting the formation of high-molecular-weight complexes lacking the PROTEIN  PROTEIN , as has been described, following estrogen treatment.
BioInfer.d204.s0.p11	N	Expression of PROTEIN or PROTEIN was sufficient to activate PROTEIN1 - PROTEIN by promoting the formation of high-molecular-weight complexes lacking the PROTEIN  PROTEIN2 , as has been described, following estrogen treatment.
BioInfer.d204.s0.p12	N	Expression of PROTEIN2 or PROTEIN was sufficient to activate PROTEIN - PROTEIN by promoting the formation of high-molecular-weight complexes lacking the PROTEIN1  PROTEIN , as has been described, following estrogen treatment.
BioInfer.d204.s0.p13	P	Expression of PROTEIN or PROTEIN was sufficient to activate PROTEIN - PROTEIN by promoting the formation of high-molecular-weight complexes lacking the PROTEIN1  PROTEIN2 , as has been described, following estrogen treatment.
BioInfer.d204.s0.p14	N	Expression of PROTEIN1 or PROTEIN was sufficient to activate PROTEIN - PROTEIN by promoting the formation of high-molecular-weight complexes lacking the PROTEIN  PROTEIN2 , as has been described, following estrogen treatment.
BioInfer.d205.s0.p0	N	Expression of PROTEIN1 , PROTEIN and PROTEIN2 in normal ovarian surface epithelium and epithelial ovarian cancers.
BioInfer.d205.s0.p1	N	Expression of PROTEIN1 , PROTEIN2 and PROTEIN in normal ovarian surface epithelium and epithelial ovarian cancers.
BioInfer.d205.s0.p2	N	Expression of PROTEIN , PROTEIN2 and PROTEIN1 in normal ovarian surface epithelium and epithelial ovarian cancers.
BioInfer.d206.s0.p1	N	Expressions of PROTEIN2 , A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by PROTEIN1  PROTEIN expression.
BioInfer.d206.s0.p3	P	Expressions of PROTEIN , A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by PROTEIN1  PROTEIN2 expression.
BioInfer.d206.s0.p8	P	Expressions of PROTEIN1 , A, and B1 in Hodgkin and Reed-Sternberg cells: not suppressed by PROTEIN  PROTEIN2 expression.
BioInfer.d207.s0.p0	N	Features studied were PROTEIN2 , microtubules, PROTEIN , and PROTEIN1 , using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.
BioInfer.d207.s0.p1	N	Features studied were PROTEIN , microtubules, PROTEIN2 , and PROTEIN1 , using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.
BioInfer.d207.s0.p2	N	Features studied were PROTEIN1 , microtubules, PROTEIN2 , and PROTEIN , using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.
BioInfer.d208.s0.p0	N	Finally, both receptors can interact with PROTEIN , PROTEIN1 , and PROTEIN2 .
BioInfer.d208.s0.p1	N	Finally, both receptors can interact with PROTEIN2 , PROTEIN1 , and PROTEIN .
BioInfer.d208.s0.p2	N	Finally, both receptors can interact with PROTEIN2 , PROTEIN , and PROTEIN1 .
BioInfer.d208.s1.p0	P	Thus, both PROTEIN and PROTEIN1 use PROTEIN , PROTEIN , and PROTEIN2 in their signal transduction pathways, and PROTEIN is the common mediator of apoptosis by all known death domain-containing receptors.
BioInfer.d208.s1.p1	P	Thus, both PROTEIN and PROTEIN1 use PROTEIN , PROTEIN2 , and PROTEIN in their signal transduction pathways, and PROTEIN is the common mediator of apoptosis by all known death domain-containing receptors.
BioInfer.d208.s1.p2	N	Thus, both PROTEIN2 and PROTEIN1 use PROTEIN , PROTEIN , and PROTEIN in their signal transduction pathways, and PROTEIN is the common mediator of apoptosis by all known death domain-containing receptors.
BioInfer.d208.s1.p3	P	Thus, both PROTEIN and PROTEIN1 use PROTEIN2 , PROTEIN , and PROTEIN in their signal transduction pathways, and PROTEIN is the common mediator of apoptosis by all known death domain-containing receptors.
BioInfer.d208.s1.p4	N	Thus, both PROTEIN and PROTEIN1 use PROTEIN , PROTEIN , and PROTEIN in their signal transduction pathways, and PROTEIN2 is the common mediator of apoptosis by all known death domain-containing receptors.
BioInfer.d208.s1.p5	N	Thus, both PROTEIN and PROTEIN use PROTEIN , PROTEIN2 , and PROTEIN1 in their signal transduction pathways, and PROTEIN is the common mediator of apoptosis by all known death domain-containing receptors.
BioInfer.d208.s1.p6	P	Thus, both PROTEIN2 and PROTEIN use PROTEIN , PROTEIN , and PROTEIN1 in their signal transduction pathways, and PROTEIN is the common mediator of apoptosis by all known death domain-containing receptors.
BioInfer.d208.s1.p7	N	Thus, both PROTEIN and PROTEIN use PROTEIN2 , PROTEIN , and PROTEIN1 in their signal transduction pathways, and PROTEIN is the common mediator of apoptosis by all known death domain-containing receptors.
BioInfer.d208.s1.p8	N	Thus, both PROTEIN and PROTEIN use PROTEIN , PROTEIN , and PROTEIN1 in their signal transduction pathways, and PROTEIN2 is the common mediator of apoptosis by all known death domain-containing receptors.
BioInfer.d208.s1.p9	P	Thus, both PROTEIN2 and PROTEIN use PROTEIN , PROTEIN1 , and PROTEIN in their signal transduction pathways, and PROTEIN is the common mediator of apoptosis by all known death domain-containing receptors.
BioInfer.d208.s1.p10	N	Thus, both PROTEIN and PROTEIN use PROTEIN2 , PROTEIN1 , and PROTEIN in their signal transduction pathways, and PROTEIN is the common mediator of apoptosis by all known death domain-containing receptors.
BioInfer.d208.s1.p11	N	Thus, both PROTEIN and PROTEIN use PROTEIN , PROTEIN1 , and PROTEIN in their signal transduction pathways, and PROTEIN2 is the common mediator of apoptosis by all known death domain-containing receptors.
BioInfer.d208.s1.p12	P	Thus, both PROTEIN1 and PROTEIN use PROTEIN2 , PROTEIN , and PROTEIN in their signal transduction pathways, and PROTEIN is the common mediator of apoptosis by all known death domain-containing receptors.
BioInfer.d208.s1.p13	N	Thus, both PROTEIN1 and PROTEIN use PROTEIN , PROTEIN , and PROTEIN in their signal transduction pathways, and PROTEIN2 is the common mediator of apoptosis by all known death domain-containing receptors.
BioInfer.d208.s1.p14	N	Thus, both PROTEIN and PROTEIN use PROTEIN1 , PROTEIN , and PROTEIN in their signal transduction pathways, and PROTEIN2 is the common mediator of apoptosis by all known death domain-containing receptors.
BioInfer.d209.s0.p0	N	Finally it was shown that the two isoforms of PROTEIN1 can be separated from each other in the absence of PROTEIN2 also by chromatography on hydroxyapatite.
BioInfer.d210.s0.p0	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN1 , and have determined that PROTEIN  PROTEIN2 is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p1	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN1 , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN2 and PROTEIN substrates.
BioInfer.d210.s0.p2	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN1 , and have determined that PROTEIN2  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p3	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN2 and the transcription factor PROTEIN1 , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p4	P	Finally, we evaluated the acetylation of three putative PROTEIN2 substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN1 , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p5	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN2 and PROTEIN and the transcription factor PROTEIN1 , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p6	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN2  PROTEIN and PROTEIN and the transcription factor PROTEIN1 , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p7	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN1 , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN2  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p8	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN1 , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN2 substrates.
BioInfer.d210.s0.p9	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN1 is significantly preferred over the PROTEIN  PROTEIN2 and PROTEIN substrates.
BioInfer.d210.s0.p10	P	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN2  PROTEIN1 is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p11	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN2 and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN1 is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p12	N	Finally, we evaluated the acetylation of three putative PROTEIN2 substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN1 is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p13	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN2 and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN1 is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p14	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN2  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN1 is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p15	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN1 is significantly preferred over the PROTEIN2  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p16	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN1 is significantly preferred over the PROTEIN  PROTEIN and PROTEIN2 substrates.
BioInfer.d210.s0.p17	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN2  PROTEIN is significantly preferred over the PROTEIN  PROTEIN1 and PROTEIN substrates.
BioInfer.d210.s0.p18	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN2 and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN1 and PROTEIN substrates.
BioInfer.d210.s0.p19	N	Finally, we evaluated the acetylation of three putative PROTEIN2 substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN1 and PROTEIN substrates.
BioInfer.d210.s0.p20	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN2 and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN1 and PROTEIN substrates.
BioInfer.d210.s0.p21	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN2  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN1 and PROTEIN substrates.
BioInfer.d210.s0.p22	P	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN2  PROTEIN1 and PROTEIN substrates.
BioInfer.d210.s0.p23	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN1 and PROTEIN2 substrates.
BioInfer.d210.s0.p24	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN2 and the transcription factor PROTEIN , and have determined that PROTEIN1  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p25	N	Finally, we evaluated the acetylation of three putative PROTEIN2 substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN1  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p26	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN2 and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN1  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p27	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN2  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN1  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p28	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN1  PROTEIN is significantly preferred over the PROTEIN2  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p29	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN1  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN2 substrates.
BioInfer.d210.s0.p30	P	Finally, we evaluated the acetylation of three putative PROTEIN2 substrates, PROTEIN  PROTEIN and PROTEIN1 and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p31	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN2 and PROTEIN1 and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p32	P	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN2  PROTEIN and PROTEIN1 and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p33	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN1 and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN2  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p34	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN1 and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN2 substrates.
BioInfer.d210.s0.p35	P	Finally, we evaluated the acetylation of three putative PROTEIN1 substrates, PROTEIN  PROTEIN2 and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p36	N	Finally, we evaluated the acetylation of three putative PROTEIN1 substrates, PROTEIN2  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p37	N	Finally, we evaluated the acetylation of three putative PROTEIN1 substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN2  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p38	N	Finally, we evaluated the acetylation of three putative PROTEIN1 substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN2 substrates.
BioInfer.d210.s0.p39	P	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN2  PROTEIN1 and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p40	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN1 and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN2  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p41	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN1 and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN2 substrates.
BioInfer.d210.s0.p42	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN1  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN2  PROTEIN and PROTEIN substrates.
BioInfer.d210.s0.p43	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN1  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN  PROTEIN and PROTEIN2 substrates.
BioInfer.d210.s0.p44	N	Finally, we evaluated the acetylation of three putative PROTEIN substrates, PROTEIN  PROTEIN and PROTEIN and the transcription factor PROTEIN , and have determined that PROTEIN  PROTEIN is significantly preferred over the PROTEIN1  PROTEIN and PROTEIN2 substrates.
BioInfer.d211.s0.p0	N	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN2 , both PROTEIN and PROTEIN1 interact with peptides encoding the PROTEIN -binding region of PROTEIN , PROTEIN / PROTEIN , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p1	P	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN and PROTEIN1 interact with peptides encoding the PROTEIN -binding region of PROTEIN , PROTEIN2 / PROTEIN , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p2	N	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN and PROTEIN1 interact with peptides encoding the PROTEIN2 -binding region of PROTEIN , PROTEIN / PROTEIN , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p3	P	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN and PROTEIN1 interact with peptides encoding the PROTEIN -binding region of PROTEIN , PROTEIN / PROTEIN2 , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p4	P	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN and PROTEIN1 interact with peptides encoding the PROTEIN -binding region of PROTEIN2 , PROTEIN / PROTEIN , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p5	P	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN and PROTEIN1 interact with peptides encoding the PROTEIN -binding region of PROTEIN , PROTEIN / PROTEIN , and the Torpedo PROTEIN2 protein.
BioInfer.d211.s0.p6	N	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN2 and PROTEIN1 interact with peptides encoding the PROTEIN -binding region of PROTEIN , PROTEIN / PROTEIN , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p7	P	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 , both PROTEIN and PROTEIN interact with peptides encoding the PROTEIN -binding region of PROTEIN , PROTEIN2 / PROTEIN , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p8	N	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 , both PROTEIN and PROTEIN interact with peptides encoding the PROTEIN2 -binding region of PROTEIN , PROTEIN / PROTEIN , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p9	P	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 , both PROTEIN and PROTEIN interact with peptides encoding the PROTEIN -binding region of PROTEIN , PROTEIN / PROTEIN2 , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p10	P	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 , both PROTEIN and PROTEIN interact with peptides encoding the PROTEIN -binding region of PROTEIN2 , PROTEIN / PROTEIN , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p11	P	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 , both PROTEIN and PROTEIN interact with peptides encoding the PROTEIN -binding region of PROTEIN , PROTEIN / PROTEIN , and the Torpedo PROTEIN2 protein.
BioInfer.d211.s0.p12	N	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN1 , both PROTEIN2 and PROTEIN interact with peptides encoding the PROTEIN -binding region of PROTEIN , PROTEIN / PROTEIN , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p13	N	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN and PROTEIN interact with peptides encoding the PROTEIN2 -binding region of PROTEIN , PROTEIN1 / PROTEIN , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p14	N	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN and PROTEIN interact with peptides encoding the PROTEIN -binding region of PROTEIN , PROTEIN1 / PROTEIN2 , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p15	N	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN and PROTEIN interact with peptides encoding the PROTEIN -binding region of PROTEIN2 , PROTEIN1 / PROTEIN , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p16	N	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN and PROTEIN interact with peptides encoding the PROTEIN -binding region of PROTEIN , PROTEIN1 / PROTEIN , and the Torpedo PROTEIN2 protein.
BioInfer.d211.s0.p17	P	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN2 and PROTEIN interact with peptides encoding the PROTEIN -binding region of PROTEIN , PROTEIN1 / PROTEIN , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p18	N	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN and PROTEIN interact with peptides encoding the PROTEIN1 -binding region of PROTEIN , PROTEIN / PROTEIN2 , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p19	P	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN and PROTEIN interact with peptides encoding the PROTEIN1 -binding region of PROTEIN2 , PROTEIN / PROTEIN , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p20	N	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN and PROTEIN interact with peptides encoding the PROTEIN1 -binding region of PROTEIN , PROTEIN / PROTEIN , and the Torpedo PROTEIN2 protein.
BioInfer.d211.s0.p21	N	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN2 and PROTEIN interact with peptides encoding the PROTEIN1 -binding region of PROTEIN , PROTEIN / PROTEIN , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p22	N	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN and PROTEIN interact with peptides encoding the PROTEIN -binding region of PROTEIN2 , PROTEIN / PROTEIN1 , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p23	N	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN and PROTEIN interact with peptides encoding the PROTEIN -binding region of PROTEIN , PROTEIN / PROTEIN1 , and the Torpedo PROTEIN2 protein.
BioInfer.d211.s0.p24	P	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN2 and PROTEIN interact with peptides encoding the PROTEIN -binding region of PROTEIN , PROTEIN / PROTEIN1 , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p25	N	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN and PROTEIN interact with peptides encoding the PROTEIN -binding region of PROTEIN1 , PROTEIN / PROTEIN , and the Torpedo PROTEIN2 protein.
BioInfer.d211.s0.p26	P	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN2 and PROTEIN interact with peptides encoding the PROTEIN -binding region of PROTEIN1 , PROTEIN / PROTEIN , and the Torpedo PROTEIN protein.
BioInfer.d211.s0.p27	P	Finally, we used in vitro translated proteins in an immunoprecipitation assay to show that, like PROTEIN , both PROTEIN2 and PROTEIN interact with peptides encoding the PROTEIN -binding region of PROTEIN , PROTEIN / PROTEIN , and the Torpedo PROTEIN1 protein.
BioInfer.d212.s0.p0	N	First, the C-terminal PROTEIN2 - PROTEIN1 -acidic domain was shown to be essential for the regulation of PROTEIN cytoskeleton.
BioInfer.d212.s0.p1	N	First, the C-terminal PROTEIN - PROTEIN1 -acidic domain was shown to be essential for the regulation of PROTEIN2 cytoskeleton.
BioInfer.d212.s0.p2	N	First, the C-terminal PROTEIN1 - PROTEIN -acidic domain was shown to be essential for the regulation of PROTEIN2 cytoskeleton.
BioInfer.d213.s0.p0	P	Fluorescent PROTEIN1 analogs with a high affinity for PROTEIN2 in vitro exhibit an enhanced gradient of assembly in living cells.
BioInfer.d213.s1.p0	P	Three-dimensional fluorescence microscopy of the fluorescent analog of PROTEIN1 with a high affinity for PROTEIN2 revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of PROTEIN assembly near the surface of the cell.
BioInfer.d213.s1.p1	N	Three-dimensional fluorescence microscopy of the fluorescent analog of PROTEIN1 with a high affinity for PROTEIN revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of PROTEIN2 assembly near the surface of the cell.
BioInfer.d213.s1.p2	N	Three-dimensional fluorescence microscopy of the fluorescent analog of PROTEIN with a high affinity for PROTEIN1 revealed that it incorporated into cortical cytoplasmic fibers and was also distributed diffusely in the non-cortical cytoplasm consistent with a bias of PROTEIN2 assembly near the surface of the cell.
BioInfer.d213.s2.p0	N	To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of PROTEIN1 that bound PROTEIN , a protein that interacts with phosphoinositides and PROTEIN2 -monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled PROTEIN (Kd > 30 microM), yet retained the ability to inhibit PROTEIN .
BioInfer.d213.s2.p1	P	To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of PROTEIN1 that bound PROTEIN2 , a protein that interacts with phosphoinositides and PROTEIN -monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled PROTEIN (Kd > 30 microM), yet retained the ability to inhibit PROTEIN .
BioInfer.d213.s2.p2	P	To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of PROTEIN1 that bound PROTEIN , a protein that interacts with phosphoinositides and PROTEIN -monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled PROTEIN (Kd > 30 microM), yet retained the ability to inhibit PROTEIN2 .
BioInfer.d213.s2.p3	N	To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of PROTEIN1 that bound PROTEIN , a protein that interacts with phosphoinositides and PROTEIN -monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled PROTEIN2 (Kd > 30 microM), yet retained the ability to inhibit PROTEIN .
BioInfer.d213.s2.p4	P	To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of PROTEIN that bound PROTEIN2 , a protein that interacts with phosphoinositides and PROTEIN1 -monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled PROTEIN (Kd > 30 microM), yet retained the ability to inhibit PROTEIN .
BioInfer.d213.s2.p5	N	To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of PROTEIN that bound PROTEIN , a protein that interacts with phosphoinositides and PROTEIN1 -monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled PROTEIN (Kd > 30 microM), yet retained the ability to inhibit PROTEIN2 .
BioInfer.d213.s2.p6	N	To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of PROTEIN that bound PROTEIN , a protein that interacts with phosphoinositides and PROTEIN1 -monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled PROTEIN2 (Kd > 30 microM), yet retained the ability to inhibit PROTEIN .
BioInfer.d213.s2.p7	N	To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of PROTEIN that bound PROTEIN1 , a protein that interacts with phosphoinositides and PROTEIN -monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled PROTEIN (Kd > 30 microM), yet retained the ability to inhibit PROTEIN2 .
BioInfer.d213.s2.p8	P	To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of PROTEIN that bound PROTEIN1 , a protein that interacts with phosphoinositides and PROTEIN -monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled PROTEIN2 (Kd > 30 microM), yet retained the ability to inhibit PROTEIN .
BioInfer.d213.s2.p9	N	To test these models in living cells using imaging techniques, we prepared a new fluorescent analog of PROTEIN that bound PROTEIN , a protein that interacts with phosphoinositides and PROTEIN -monomers in a mutually exclusive manner, with an order of magnitude greater affinity (Kd = 3.6 microM) than cys-374-labeled PROTEIN2 (Kd > 30 microM), yet retained the ability to inhibit PROTEIN1 .
BioInfer.d214.s0.p0	N	Fluorographic analysis showed that the specific activity of soluble PROTEIN was two to three times that of its particulate form and that soluble PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 were transported at similar rates in slow component b of axonal flow.
BioInfer.d214.s0.p1	N	Fluorographic analysis showed that the specific activity of soluble PROTEIN was two to three times that of its particulate form and that soluble PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN were transported at similar rates in slow component b of axonal flow.
BioInfer.d214.s0.p2	N	Fluorographic analysis showed that the specific activity of soluble PROTEIN was two to three times that of its particulate form and that soluble PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN were transported at similar rates in slow component b of axonal flow.
BioInfer.d214.s0.p3	N	Fluorographic analysis showed that the specific activity of soluble PROTEIN2 was two to three times that of its particulate form and that soluble PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN were transported at similar rates in slow component b of axonal flow.
BioInfer.d214.s0.p4	N	Fluorographic analysis showed that the specific activity of soluble PROTEIN was two to three times that of its particulate form and that soluble PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 were transported at similar rates in slow component b of axonal flow.
BioInfer.d214.s0.p5	N	Fluorographic analysis showed that the specific activity of soluble PROTEIN was two to three times that of its particulate form and that soluble PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 were transported at similar rates in slow component b of axonal flow.
BioInfer.d214.s0.p6	N	Fluorographic analysis showed that the specific activity of soluble PROTEIN2 was two to three times that of its particulate form and that soluble PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 were transported at similar rates in slow component b of axonal flow.
BioInfer.d214.s0.p7	N	Fluorographic analysis showed that the specific activity of soluble PROTEIN was two to three times that of its particulate form and that soluble PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN were transported at similar rates in slow component b of axonal flow.
BioInfer.d214.s0.p8	N	Fluorographic analysis showed that the specific activity of soluble PROTEIN2 was two to three times that of its particulate form and that soluble PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN were transported at similar rates in slow component b of axonal flow.
BioInfer.d214.s0.p9	N	Fluorographic analysis showed that the specific activity of soluble PROTEIN2 was two to three times that of its particulate form and that soluble PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN were transported at similar rates in slow component b of axonal flow.
BioInfer.d214.s1.p0	N	Our data strongly support the view that the mobile form of PROTEIN1 in slow transport is soluble and that a substantial amount of this PROTEIN may travel as a complex with PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d214.s1.p1	N	Our data strongly support the view that the mobile form of PROTEIN1 in slow transport is soluble and that a substantial amount of this PROTEIN2 may travel as a complex with PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d214.s1.p2	N	Our data strongly support the view that the mobile form of PROTEIN1 in slow transport is soluble and that a substantial amount of this PROTEIN may travel as a complex with PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d214.s1.p3	N	Our data strongly support the view that the mobile form of PROTEIN1 in slow transport is soluble and that a substantial amount of this PROTEIN may travel as a complex with PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d214.s1.p4	P	Our data strongly support the view that the mobile form of PROTEIN in slow transport is soluble and that a substantial amount of this PROTEIN2 may travel as a complex with PROTEIN1 , PROTEIN , and PROTEIN .
BioInfer.d214.s1.p5	P	Our data strongly support the view that the mobile form of PROTEIN in slow transport is soluble and that a substantial amount of this PROTEIN may travel as a complex with PROTEIN1 , PROTEIN2 , and PROTEIN .
BioInfer.d214.s1.p6	P	Our data strongly support the view that the mobile form of PROTEIN in slow transport is soluble and that a substantial amount of this PROTEIN may travel as a complex with PROTEIN1 , PROTEIN , and PROTEIN2 .
BioInfer.d214.s1.p7	P	Our data strongly support the view that the mobile form of PROTEIN in slow transport is soluble and that a substantial amount of this PROTEIN1 may travel as a complex with PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d214.s1.p8	P	Our data strongly support the view that the mobile form of PROTEIN in slow transport is soluble and that a substantial amount of this PROTEIN1 may travel as a complex with PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d214.s1.p9	P	Our data strongly support the view that the mobile form of PROTEIN in slow transport is soluble and that a substantial amount of this PROTEIN may travel as a complex with PROTEIN , PROTEIN1 , and PROTEIN2 .
BioInfer.d214.s2.p0	P	We examined the axonal transport of PROTEIN2 and its monomer binding proteins, PROTEIN , PROTEIN , and PROTEIN1 , in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.
BioInfer.d214.s2.p1	N	We examined the axonal transport of PROTEIN and its monomer binding proteins, PROTEIN2 , PROTEIN , and PROTEIN1 , in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.
BioInfer.d214.s2.p2	N	We examined the axonal transport of PROTEIN and its monomer binding proteins, PROTEIN , PROTEIN2 , and PROTEIN1 , in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.
BioInfer.d214.s2.p3	P	We examined the axonal transport of PROTEIN1 and its monomer binding proteins, PROTEIN2 , PROTEIN , and PROTEIN , in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.
BioInfer.d214.s2.p4	P	We examined the axonal transport of PROTEIN1 and its monomer binding proteins, PROTEIN , PROTEIN2 , and PROTEIN , in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.
BioInfer.d214.s2.p5	N	We examined the axonal transport of PROTEIN and its monomer binding proteins, PROTEIN1 , PROTEIN2 , and PROTEIN , in the chicken sciatic nerve following injection of [35S]methionine into the lumbar spinal cord.
BioInfer.d215.s0.p0	N	For example, it is associated with PROTEIN and PROTEIN1 ( PROTEIN2 ), and protected from PROTEIN digestion only in the presence of Ca2+, as is the case for many of classic PROTEIN .
BioInfer.d215.s0.p1	P	For example, it is associated with PROTEIN and PROTEIN1 ( PROTEIN ), and protected from PROTEIN digestion only in the presence of Ca2+, as is the case for many of classic PROTEIN2 .
BioInfer.d215.s0.p2	N	For example, it is associated with PROTEIN2 and PROTEIN1 ( PROTEIN ), and protected from PROTEIN digestion only in the presence of Ca2+, as is the case for many of classic PROTEIN .
BioInfer.d215.s0.p3	N	For example, it is associated with PROTEIN and PROTEIN1 ( PROTEIN ), and protected from PROTEIN2 digestion only in the presence of Ca2+, as is the case for many of classic PROTEIN .
BioInfer.d215.s0.p4	P	For example, it is associated with PROTEIN and PROTEIN ( PROTEIN1 ), and protected from PROTEIN digestion only in the presence of Ca2+, as is the case for many of classic PROTEIN2 .
BioInfer.d215.s0.p5	N	For example, it is associated with PROTEIN2 and PROTEIN ( PROTEIN1 ), and protected from PROTEIN digestion only in the presence of Ca2+, as is the case for many of classic PROTEIN .
BioInfer.d215.s0.p6	N	For example, it is associated with PROTEIN and PROTEIN ( PROTEIN1 ), and protected from PROTEIN2 digestion only in the presence of Ca2+, as is the case for many of classic PROTEIN .
BioInfer.d215.s0.p7	P	For example, it is associated with PROTEIN2 and PROTEIN ( PROTEIN ), and protected from PROTEIN digestion only in the presence of Ca2+, as is the case for many of classic PROTEIN1 .
BioInfer.d215.s0.p8	P	For example, it is associated with PROTEIN and PROTEIN ( PROTEIN ), and protected from PROTEIN2 digestion only in the presence of Ca2+, as is the case for many of classic PROTEIN1 .
BioInfer.d215.s0.p9	N	For example, it is associated with PROTEIN1 and PROTEIN ( PROTEIN ), and protected from PROTEIN2 digestion only in the presence of Ca2+, as is the case for many of classic PROTEIN .
BioInfer.d216.s0.p0	P	From an analysis of PROTEIN mutants, whose PROTEIN cytoskeleton is disrupted, we found that PROTEIN2 also requires PROTEIN1 filaments to associate with adhesive cell membranes in the ovary.
BioInfer.d216.s0.p1	N	From an analysis of PROTEIN2 mutants, whose PROTEIN cytoskeleton is disrupted, we found that PROTEIN also requires PROTEIN1 filaments to associate with adhesive cell membranes in the ovary.
BioInfer.d216.s0.p2	N	From an analysis of PROTEIN mutants, whose PROTEIN2 cytoskeleton is disrupted, we found that PROTEIN also requires PROTEIN1 filaments to associate with adhesive cell membranes in the ovary.
BioInfer.d216.s0.p3	N	From an analysis of PROTEIN2 mutants, whose PROTEIN cytoskeleton is disrupted, we found that PROTEIN1 also requires PROTEIN filaments to associate with adhesive cell membranes in the ovary.
BioInfer.d216.s0.p4	N	From an analysis of PROTEIN mutants, whose PROTEIN2 cytoskeleton is disrupted, we found that PROTEIN1 also requires PROTEIN filaments to associate with adhesive cell membranes in the ovary.
BioInfer.d216.s0.p5	N	From an analysis of PROTEIN1 mutants, whose PROTEIN2 cytoskeleton is disrupted, we found that PROTEIN also requires PROTEIN filaments to associate with adhesive cell membranes in the ovary.
BioInfer.d217.s0.p0	P	From previous work, the PROTEIN2 , PROTEIN , and PROTEIN gene products also appear to be involved in linking PROTEIN to the PROTEIN1 cytoskeleton.
BioInfer.d217.s0.p1	P	From previous work, the PROTEIN , PROTEIN , and PROTEIN gene products also appear to be involved in linking PROTEIN2 to the PROTEIN1 cytoskeleton.
BioInfer.d217.s0.p2	P	From previous work, the PROTEIN , PROTEIN , and PROTEIN2 gene products also appear to be involved in linking PROTEIN to the PROTEIN1 cytoskeleton.
BioInfer.d217.s0.p3	P	From previous work, the PROTEIN , PROTEIN2 , and PROTEIN gene products also appear to be involved in linking PROTEIN to the PROTEIN1 cytoskeleton.
BioInfer.d217.s0.p4	P	From previous work, the PROTEIN1 , PROTEIN , and PROTEIN gene products also appear to be involved in linking PROTEIN2 to the PROTEIN cytoskeleton.
BioInfer.d217.s0.p5	N	From previous work, the PROTEIN1 , PROTEIN , and PROTEIN2 gene products also appear to be involved in linking PROTEIN to the PROTEIN cytoskeleton.
BioInfer.d217.s0.p6	N	From previous work, the PROTEIN1 , PROTEIN2 , and PROTEIN gene products also appear to be involved in linking PROTEIN to the PROTEIN cytoskeleton.
BioInfer.d217.s0.p7	P	From previous work, the PROTEIN , PROTEIN , and PROTEIN2 gene products also appear to be involved in linking PROTEIN1 to the PROTEIN cytoskeleton.
BioInfer.d217.s0.p8	P	From previous work, the PROTEIN , PROTEIN2 , and PROTEIN gene products also appear to be involved in linking PROTEIN1 to the PROTEIN cytoskeleton.
BioInfer.d217.s0.p9	N	From previous work, the PROTEIN , PROTEIN2 , and PROTEIN1 gene products also appear to be involved in linking PROTEIN to the PROTEIN cytoskeleton.
BioInfer.d218.s0.p0	N	From these observations it is concluded that (i) PROTEIN1 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN is not required for intrachromosomal crossovers, and (iii) that PROTEIN2 and PROTEIN have different functions, or that PROTEIN has functions in addition to those of the PROTEIN / PROTEIN protein complex.
BioInfer.d218.s0.p1	N	From these observations it is concluded that (i) PROTEIN1 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN2 is not required for intrachromosomal crossovers, and (iii) that PROTEIN and PROTEIN have different functions, or that PROTEIN has functions in addition to those of the PROTEIN / PROTEIN protein complex.
BioInfer.d218.s0.p2	N	From these observations it is concluded that (i) PROTEIN1 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN is not required for intrachromosomal crossovers, and (iii) that PROTEIN and PROTEIN2 have different functions, or that PROTEIN has functions in addition to those of the PROTEIN / PROTEIN protein complex.
BioInfer.d218.s0.p3	N	From these observations it is concluded that (i) PROTEIN1 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN is not required for intrachromosomal crossovers, and (iii) that PROTEIN and PROTEIN have different functions, or that PROTEIN has functions in addition to those of the PROTEIN / PROTEIN2 protein complex.
BioInfer.d218.s0.p4	N	From these observations it is concluded that (i) PROTEIN1 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN is not required for intrachromosomal crossovers, and (iii) that PROTEIN and PROTEIN have different functions, or that PROTEIN2 has functions in addition to those of the PROTEIN / PROTEIN protein complex.
BioInfer.d218.s0.p5	N	From these observations it is concluded that (i) PROTEIN1 is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN is not required for intrachromosomal crossovers, and (iii) that PROTEIN and PROTEIN have different functions, or that PROTEIN has functions in addition to those of the PROTEIN2 / PROTEIN protein complex.
BioInfer.d218.s0.p6	N	From these observations it is concluded that (i) PROTEIN is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN2 is not required for intrachromosomal crossovers, and (iii) that PROTEIN1 and PROTEIN have different functions, or that PROTEIN has functions in addition to those of the PROTEIN / PROTEIN protein complex.
BioInfer.d218.s0.p7	P	From these observations it is concluded that (i) PROTEIN is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN is not required for intrachromosomal crossovers, and (iii) that PROTEIN1 and PROTEIN2 have different functions, or that PROTEIN has functions in addition to those of the PROTEIN / PROTEIN protein complex.
BioInfer.d218.s0.p8	N	From these observations it is concluded that (i) PROTEIN is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN is not required for intrachromosomal crossovers, and (iii) that PROTEIN1 and PROTEIN have different functions, or that PROTEIN has functions in addition to those of the PROTEIN / PROTEIN2 protein complex.
BioInfer.d218.s0.p9	N	From these observations it is concluded that (i) PROTEIN is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN is not required for intrachromosomal crossovers, and (iii) that PROTEIN1 and PROTEIN have different functions, or that PROTEIN2 has functions in addition to those of the PROTEIN / PROTEIN protein complex.
BioInfer.d218.s0.p10	N	From these observations it is concluded that (i) PROTEIN is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN is not required for intrachromosomal crossovers, and (iii) that PROTEIN1 and PROTEIN have different functions, or that PROTEIN has functions in addition to those of the PROTEIN2 / PROTEIN protein complex.
BioInfer.d218.s0.p11	N	From these observations it is concluded that (i) PROTEIN is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN1 is not required for intrachromosomal crossovers, and (iii) that PROTEIN and PROTEIN2 have different functions, or that PROTEIN has functions in addition to those of the PROTEIN / PROTEIN protein complex.
BioInfer.d218.s0.p12	N	From these observations it is concluded that (i) PROTEIN is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN1 is not required for intrachromosomal crossovers, and (iii) that PROTEIN and PROTEIN have different functions, or that PROTEIN has functions in addition to those of the PROTEIN / PROTEIN2 protein complex.
BioInfer.d218.s0.p13	N	From these observations it is concluded that (i) PROTEIN is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN1 is not required for intrachromosomal crossovers, and (iii) that PROTEIN and PROTEIN have different functions, or that PROTEIN2 has functions in addition to those of the PROTEIN / PROTEIN protein complex.
BioInfer.d218.s0.p14	N	From these observations it is concluded that (i) PROTEIN is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN1 is not required for intrachromosomal crossovers, and (iii) that PROTEIN and PROTEIN have different functions, or that PROTEIN has functions in addition to those of the PROTEIN2 / PROTEIN protein complex.
BioInfer.d218.s0.p15	N	From these observations it is concluded that (i) PROTEIN is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN is not required for intrachromosomal crossovers, and (iii) that PROTEIN and PROTEIN1 have different functions, or that PROTEIN has functions in addition to those of the PROTEIN / PROTEIN2 protein complex.
BioInfer.d218.s0.p16	N	From these observations it is concluded that (i) PROTEIN is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN is not required for intrachromosomal crossovers, and (iii) that PROTEIN and PROTEIN1 have different functions, or that PROTEIN2 has functions in addition to those of the PROTEIN / PROTEIN protein complex.
BioInfer.d218.s0.p17	N	From these observations it is concluded that (i) PROTEIN is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN is not required for intrachromosomal crossovers, and (iii) that PROTEIN and PROTEIN1 have different functions, or that PROTEIN has functions in addition to those of the PROTEIN2 / PROTEIN protein complex.
BioInfer.d218.s0.p18	N	From these observations it is concluded that (i) PROTEIN is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN is not required for intrachromosomal crossovers, and (iii) that PROTEIN and PROTEIN have different functions, or that PROTEIN2 has functions in addition to those of the PROTEIN / PROTEIN1 protein complex.
BioInfer.d218.s0.p19	P	From these observations it is concluded that (i) PROTEIN is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN is not required for intrachromosomal crossovers, and (iii) that PROTEIN and PROTEIN have different functions, or that PROTEIN has functions in addition to those of the PROTEIN2 / PROTEIN1 protein complex.
BioInfer.d218.s0.p20	N	From these observations it is concluded that (i) PROTEIN is required for high levels of both gene conversions and reciprocal crossovers, (ii) that PROTEIN is not required for intrachromosomal crossovers, and (iii) that PROTEIN and PROTEIN have different functions, or that PROTEIN1 has functions in addition to those of the PROTEIN2 / PROTEIN protein complex.
BioInfer.d219.s0.p0	N	From these we have isolated eight viable and lethal alleles of the PROTEIN1 gene, and seven viable alleles of the indirect flight muscle (IFM)-specific PROTEIN2  PROTEIN gene.
BioInfer.d219.s0.p1	N	From these we have isolated eight viable and lethal alleles of the PROTEIN1 gene, and seven viable alleles of the indirect flight muscle (IFM)-specific PROTEIN  PROTEIN2 gene.
BioInfer.d219.s0.p2	P	From these we have isolated eight viable and lethal alleles of the PROTEIN gene, and seven viable alleles of the indirect flight muscle (IFM)-specific PROTEIN1  PROTEIN2 gene.
BioInfer.d220.s0.p0	N	Frozen tissue sections, isolated cardiomyocytes, cultured neonatal cardiomyocytes and fibroblasts were hybridized with DNA probes for type-specific PROTEIN1 , PROTEIN , and PROTEIN2 .
BioInfer.d220.s0.p1	N	Frozen tissue sections, isolated cardiomyocytes, cultured neonatal cardiomyocytes and fibroblasts were hybridized with DNA probes for type-specific PROTEIN1 , PROTEIN2 , and PROTEIN .
BioInfer.d220.s0.p2	N	Frozen tissue sections, isolated cardiomyocytes, cultured neonatal cardiomyocytes and fibroblasts were hybridized with DNA probes for type-specific PROTEIN , PROTEIN2 , and PROTEIN1 .
BioInfer.d221.s0.p0	N	Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host PROTEIN family proteins: an acidic stretch, an PROTEIN2 monomer-binding region, and a PROTEIN1 homology sequence.
BioInfer.d221.s0.p1	P	Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host PROTEIN2 family proteins: an acidic stretch, an PROTEIN monomer-binding region, and a PROTEIN1 homology sequence.
BioInfer.d221.s0.p2	P	Further deletion analysis demonstrated that this fragment contains three regions, which are important for nucleation and share functional and/or limited sequence similarity with host PROTEIN2 family proteins: an acidic stretch, an PROTEIN1 monomer-binding region, and a PROTEIN homology sequence.
BioInfer.d221.s1.p0	N	The PROTEIN homology sequence is critical for stimulating PROTEIN nucleation with the PROTEIN1 /3 complex in vitro, and is essential for PROTEIN2 polymerization and motility in cells.
BioInfer.d221.s1.p2	N	The PROTEIN2 homology sequence is critical for stimulating PROTEIN nucleation with the PROTEIN1 /3 complex in vitro, and is essential for PROTEIN polymerization and motility in cells.
BioInfer.d221.s1.p3	P	The PROTEIN homology sequence is critical for stimulating PROTEIN2 nucleation with the PROTEIN1 /3 complex in vitro, and is essential for PROTEIN polymerization and motility in cells.
BioInfer.d221.s1.p5	P	The PROTEIN2 homology sequence is critical for stimulating PROTEIN nucleation with the PROTEIN /3 complex in vitro, and is essential for PROTEIN1 polymerization and motility in cells.
BioInfer.d221.s1.p6	N	The PROTEIN homology sequence is critical for stimulating PROTEIN2 nucleation with the PROTEIN /3 complex in vitro, and is essential for PROTEIN1 polymerization and motility in cells.
BioInfer.d221.s1.p9	P	The PROTEIN1 homology sequence is critical for stimulating PROTEIN2 nucleation with the PROTEIN /3 complex in vitro, and is essential for PROTEIN polymerization and motility in cells.
BioInfer.d222.s0.p0	P	Furthermore, a simultaneous expression of PROTEIN , PROTEIN2 and PROTEIN1 was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.
BioInfer.d222.s0.p1	P	Furthermore, a simultaneous expression of PROTEIN2 , PROTEIN and PROTEIN1 was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.
BioInfer.d222.s0.p2	P	Furthermore, a simultaneous expression of PROTEIN2 , PROTEIN1 and PROTEIN was observed during the regeneration of rat liver, that is, all mRNAs of these proteins showed biphasic peaks around 6 h and 48 h after partial hepatectomy.
BioInfer.d223.s0.p0	N	Furthermore, the deletion of PROTEIN suppresses the temperature-sensitive growth defect of PROTEIN2 , a mutant in yeast PROTEIN , supporting a role for PROTEIN1 family members in PROTEIN function.
BioInfer.d223.s0.p1	P	Furthermore, the deletion of PROTEIN suppresses the temperature-sensitive growth defect of PROTEIN , a mutant in yeast PROTEIN , supporting a role for PROTEIN1 family members in PROTEIN2 function.
BioInfer.d223.s0.p2	N	Furthermore, the deletion of PROTEIN suppresses the temperature-sensitive growth defect of PROTEIN , a mutant in yeast PROTEIN2 , supporting a role for PROTEIN1 family members in PROTEIN function.
BioInfer.d223.s0.p3	N	Furthermore, the deletion of PROTEIN2 suppresses the temperature-sensitive growth defect of PROTEIN , a mutant in yeast PROTEIN , supporting a role for PROTEIN1 family members in PROTEIN function.
BioInfer.d223.s0.p4	N	Furthermore, the deletion of PROTEIN suppresses the temperature-sensitive growth defect of PROTEIN1 , a mutant in yeast PROTEIN , supporting a role for PROTEIN family members in PROTEIN2 function.
BioInfer.d223.s0.p5	N	Furthermore, the deletion of PROTEIN suppresses the temperature-sensitive growth defect of PROTEIN1 , a mutant in yeast PROTEIN2 , supporting a role for PROTEIN family members in PROTEIN function.
BioInfer.d223.s0.p6	P	Furthermore, the deletion of PROTEIN2 suppresses the temperature-sensitive growth defect of PROTEIN1 , a mutant in yeast PROTEIN , supporting a role for PROTEIN family members in PROTEIN function.
BioInfer.d223.s0.p7	N	Furthermore, the deletion of PROTEIN suppresses the temperature-sensitive growth defect of PROTEIN , a mutant in yeast PROTEIN2 , supporting a role for PROTEIN family members in PROTEIN1 function.
BioInfer.d223.s0.p8	N	Furthermore, the deletion of PROTEIN2 suppresses the temperature-sensitive growth defect of PROTEIN , a mutant in yeast PROTEIN , supporting a role for PROTEIN family members in PROTEIN1 function.
BioInfer.d223.s0.p9	N	Furthermore, the deletion of PROTEIN2 suppresses the temperature-sensitive growth defect of PROTEIN , a mutant in yeast PROTEIN1 , supporting a role for PROTEIN family members in PROTEIN function.
BioInfer.d224.s0.p0	P	Furthermore, this inactivating effect of PROTEIN1 can be prevented by coexpressing a region of the cytoskeletal protein PROTEIN2 known to interact with the CO region of PROTEIN .
BioInfer.d224.s0.p1	N	Furthermore, this inactivating effect of PROTEIN1 can be prevented by coexpressing a region of the cytoskeletal protein PROTEIN known to interact with the CO region of PROTEIN2 .
BioInfer.d224.s0.p2	P	Furthermore, this inactivating effect of PROTEIN can be prevented by coexpressing a region of the cytoskeletal protein PROTEIN1 known to interact with the CO region of PROTEIN2 .
BioInfer.d225.s0.p0	N	Further, PRP incubated with PROTEIN showed a dose dependent increase in PROTEIN and PROTEIN1 secretion as measured by RIA and an increased incorporation of PROTEIN , PROTEIN , and PROTEIN2 into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.
BioInfer.d225.s0.p1	N	Further, PRP incubated with PROTEIN showed a dose dependent increase in PROTEIN2 and PROTEIN1 secretion as measured by RIA and an increased incorporation of PROTEIN , PROTEIN , and PROTEIN into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.
BioInfer.d225.s0.p2	N	Further, PRP incubated with PROTEIN showed a dose dependent increase in PROTEIN and PROTEIN1 secretion as measured by RIA and an increased incorporation of PROTEIN , PROTEIN2 , and PROTEIN into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.
BioInfer.d225.s0.p3	N	Further, PRP incubated with PROTEIN showed a dose dependent increase in PROTEIN and PROTEIN1 secretion as measured by RIA and an increased incorporation of PROTEIN2 , PROTEIN , and PROTEIN into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.
BioInfer.d225.s0.p4	P	Further, PRP incubated with PROTEIN2 showed a dose dependent increase in PROTEIN and PROTEIN1 secretion as measured by RIA and an increased incorporation of PROTEIN , PROTEIN , and PROTEIN into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.
BioInfer.d225.s0.p5	N	Further, PRP incubated with PROTEIN showed a dose dependent increase in PROTEIN2 and PROTEIN secretion as measured by RIA and an increased incorporation of PROTEIN , PROTEIN , and PROTEIN1 into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.
BioInfer.d225.s0.p6	P	Further, PRP incubated with PROTEIN showed a dose dependent increase in PROTEIN and PROTEIN secretion as measured by RIA and an increased incorporation of PROTEIN , PROTEIN2 , and PROTEIN1 into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.
BioInfer.d225.s0.p7	P	Further, PRP incubated with PROTEIN showed a dose dependent increase in PROTEIN and PROTEIN secretion as measured by RIA and an increased incorporation of PROTEIN2 , PROTEIN , and PROTEIN1 into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.
BioInfer.d225.s0.p8	N	Further, PRP incubated with PROTEIN2 showed a dose dependent increase in PROTEIN and PROTEIN secretion as measured by RIA and an increased incorporation of PROTEIN , PROTEIN , and PROTEIN1 into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.
BioInfer.d225.s0.p9	N	Further, PRP incubated with PROTEIN showed a dose dependent increase in PROTEIN1 and PROTEIN secretion as measured by RIA and an increased incorporation of PROTEIN , PROTEIN2 , and PROTEIN into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.
BioInfer.d225.s0.p10	N	Further, PRP incubated with PROTEIN showed a dose dependent increase in PROTEIN1 and PROTEIN secretion as measured by RIA and an increased incorporation of PROTEIN2 , PROTEIN , and PROTEIN into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.
BioInfer.d225.s0.p11	P	Further, PRP incubated with PROTEIN2 showed a dose dependent increase in PROTEIN1 and PROTEIN secretion as measured by RIA and an increased incorporation of PROTEIN , PROTEIN , and PROTEIN into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.
BioInfer.d225.s0.p12	P	Further, PRP incubated with PROTEIN showed a dose dependent increase in PROTEIN and PROTEIN secretion as measured by RIA and an increased incorporation of PROTEIN2 , PROTEIN1 , and PROTEIN into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.
BioInfer.d225.s0.p13	N	Further, PRP incubated with PROTEIN2 showed a dose dependent increase in PROTEIN and PROTEIN secretion as measured by RIA and an increased incorporation of PROTEIN , PROTEIN1 , and PROTEIN into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.
BioInfer.d225.s0.p14	N	Further, PRP incubated with PROTEIN2 showed a dose dependent increase in PROTEIN and PROTEIN secretion as measured by RIA and an increased incorporation of PROTEIN1 , PROTEIN , and PROTEIN into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.
BioInfer.d226.s0.p0	P	Further, we show that PROTEIN , a high molecular weight structural protein that links PROTEIN1 to the PROTEIN2 cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.
BioInfer.d226.s0.p1	P	Further, we show that PROTEIN2 , a high molecular weight structural protein that links PROTEIN1 to the PROTEIN cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.
BioInfer.d226.s0.p2	P	Further, we show that PROTEIN2 , a high molecular weight structural protein that links PROTEIN to the PROTEIN1 cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.
BioInfer.d226.s1.p0	P	Immunofluorescence microscopy of cells grown on PROTEIN confirmed the presence of PROTEIN , PROTEIN , and PROTEIN2 at the ends of PROTEIN1 stress fibers at presumptive focal contacts in melanocytes.
BioInfer.d226.s1.p1	N	Immunofluorescence microscopy of cells grown on PROTEIN2 confirmed the presence of PROTEIN , PROTEIN , and PROTEIN at the ends of PROTEIN1 stress fibers at presumptive focal contacts in melanocytes.
BioInfer.d226.s1.p2	P	Immunofluorescence microscopy of cells grown on PROTEIN confirmed the presence of PROTEIN2 , PROTEIN , and PROTEIN at the ends of PROTEIN1 stress fibers at presumptive focal contacts in melanocytes.
BioInfer.d226.s1.p3	P	Immunofluorescence microscopy of cells grown on PROTEIN confirmed the presence of PROTEIN , PROTEIN2 , and PROTEIN at the ends of PROTEIN1 stress fibers at presumptive focal contacts in melanocytes.
BioInfer.d226.s1.p4	N	Immunofluorescence microscopy of cells grown on PROTEIN2 confirmed the presence of PROTEIN , PROTEIN , and PROTEIN1 at the ends of PROTEIN stress fibers at presumptive focal contacts in melanocytes.
BioInfer.d226.s1.p5	N	Immunofluorescence microscopy of cells grown on PROTEIN confirmed the presence of PROTEIN2 , PROTEIN , and PROTEIN1 at the ends of PROTEIN stress fibers at presumptive focal contacts in melanocytes.
BioInfer.d226.s1.p6	N	Immunofluorescence microscopy of cells grown on PROTEIN confirmed the presence of PROTEIN , PROTEIN2 , and PROTEIN1 at the ends of PROTEIN stress fibers at presumptive focal contacts in melanocytes.
BioInfer.d226.s1.p7	N	Immunofluorescence microscopy of cells grown on PROTEIN1 confirmed the presence of PROTEIN2 , PROTEIN , and PROTEIN at the ends of PROTEIN stress fibers at presumptive focal contacts in melanocytes.
BioInfer.d226.s1.p8	N	Immunofluorescence microscopy of cells grown on PROTEIN1 confirmed the presence of PROTEIN , PROTEIN2 , and PROTEIN at the ends of PROTEIN stress fibers at presumptive focal contacts in melanocytes.
BioInfer.d226.s1.p9	N	Immunofluorescence microscopy of cells grown on PROTEIN confirmed the presence of PROTEIN1 , PROTEIN2 , and PROTEIN at the ends of PROTEIN stress fibers at presumptive focal contacts in melanocytes.
BioInfer.d227.s0.p0	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 that were equivalent to epithelioid cells.
BioInfer.d227.s0.p1	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 and PROTEIN that were equivalent to epithelioid cells.
BioInfer.d227.s0.p2	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN that were equivalent to epithelioid cells.
BioInfer.d227.s0.p3	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN that were equivalent to epithelioid cells.
BioInfer.d227.s0.p4	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN that were equivalent to epithelioid cells.
BioInfer.d227.s0.p5	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN that were equivalent to epithelioid cells.
BioInfer.d227.s0.p6	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN1 that were equivalent to epithelioid cells.
BioInfer.d227.s0.p7	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN1 that were equivalent to epithelioid cells.
BioInfer.d227.s0.p8	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 that were equivalent to epithelioid cells.
BioInfer.d227.s0.p9	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 that were equivalent to epithelioid cells.
BioInfer.d227.s0.p10	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 that were equivalent to epithelioid cells.
BioInfer.d227.s0.p11	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN that were equivalent to epithelioid cells.
BioInfer.d227.s0.p12	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN that were equivalent to epithelioid cells.
BioInfer.d227.s0.p13	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN that were equivalent to epithelioid cells.
BioInfer.d227.s0.p14	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN that were equivalent to epithelioid cells.
BioInfer.d227.s0.p15	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN that were equivalent to epithelioid cells.
BioInfer.d227.s0.p16	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN that were equivalent to epithelioid cells.
BioInfer.d227.s0.p17	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN that were equivalent to epithelioid cells.
BioInfer.d227.s0.p18	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN that were equivalent to epithelioid cells.
BioInfer.d227.s0.p19	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN that were equivalent to epithelioid cells.
BioInfer.d227.s0.p20	N	Fusiform RPE, however, were not deficient in these proteins, expressing amounts of PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN and PROTEIN that were equivalent to epithelioid cells.
BioInfer.d228.s0.p0	N	Fusion of the endocardial ridges of the truncus on late ED13 is accompanied by the organization of PROTEIN1 -and PROTEIN2 -positive myofibroblasts into a central whorl and the appearance of the semilunar valve anlagen at their definitive topographical position within the proximal portion of the truncus.
BioInfer.d229.s0.p0	N	Gel electrophoresis was used to measure changes in the relative amounts of PROTEIN1 or PROTEIN and of PROTEIN2 ( PROTEIN ) isoforms.
BioInfer.d229.s0.p1	N	Gel electrophoresis was used to measure changes in the relative amounts of PROTEIN1 or PROTEIN2 and of PROTEIN ( PROTEIN ) isoforms.
BioInfer.d229.s0.p2	N	Gel electrophoresis was used to measure changes in the relative amounts of PROTEIN1 or PROTEIN and of PROTEIN ( PROTEIN2 ) isoforms.
BioInfer.d229.s0.p3	N	Gel electrophoresis was used to measure changes in the relative amounts of PROTEIN or PROTEIN2 and of PROTEIN1 ( PROTEIN ) isoforms.
BioInfer.d229.s0.p4	N	Gel electrophoresis was used to measure changes in the relative amounts of PROTEIN or PROTEIN and of PROTEIN1 ( PROTEIN2 ) isoforms.
BioInfer.d229.s0.p5	N	Gel electrophoresis was used to measure changes in the relative amounts of PROTEIN or PROTEIN1 and of PROTEIN ( PROTEIN2 ) isoforms.
BioInfer.d230.s0.p0	N	Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, PROTEIN1 ( PROTEIN ), PROTEIN , and PROTEIN2 .
BioInfer.d230.s0.p1	N	Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, PROTEIN1 ( PROTEIN ), PROTEIN2 , and PROTEIN .
BioInfer.d230.s0.p2	N	Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, PROTEIN1 ( PROTEIN2 ), PROTEIN , and PROTEIN .
BioInfer.d230.s0.p3	N	Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, PROTEIN ( PROTEIN ), PROTEIN2 , and PROTEIN1 .
BioInfer.d230.s0.p4	N	Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, PROTEIN ( PROTEIN2 ), PROTEIN , and PROTEIN1 .
BioInfer.d230.s0.p5	N	Generation of these membrane microparticles was dependent on the presence of extracellular calcium and was accompanied by proteolytic degradation of the cytoskeletal proteins, PROTEIN ( PROTEIN2 ), PROTEIN1 , and PROTEIN .
BioInfer.d231.s0.p0	P	Genetic analysis suggested that this phenotype was due to PROTEIN1 sequestering PROTEIN and preventing it from interacting with PROTEIN and PROTEIN2 .
BioInfer.d231.s0.p1	P	Genetic analysis suggested that this phenotype was due to PROTEIN1 sequestering PROTEIN and preventing it from interacting with PROTEIN2 and PROTEIN .
BioInfer.d231.s0.p2	P	Genetic analysis suggested that this phenotype was due to PROTEIN1 sequestering PROTEIN2 and preventing it from interacting with PROTEIN and PROTEIN .
BioInfer.d231.s0.p3	N	Genetic analysis suggested that this phenotype was due to PROTEIN sequestering PROTEIN and preventing it from interacting with PROTEIN2 and PROTEIN1 .
BioInfer.d231.s0.p4	P	Genetic analysis suggested that this phenotype was due to PROTEIN sequestering PROTEIN2 and preventing it from interacting with PROTEIN and PROTEIN1 .
BioInfer.d231.s0.p5	P	Genetic analysis suggested that this phenotype was due to PROTEIN sequestering PROTEIN2 and preventing it from interacting with PROTEIN1 and PROTEIN .
BioInfer.d232.s0.p0	N	Genetic dissection of Drosophila myofibril formation: effects of PROTEIN1 and PROTEIN2 null alleles.
BioInfer.d232.s1.p0	N	We find that heterozygotes for PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN2 ) null alleles have complex myofibrillar defects, whereas PROTEIN -/+; PROTEIN1 -/+ double heterozygotes have nearly normal myofibrils.
BioInfer.d232.s1.p1	N	We find that heterozygotes for PROTEIN ( PROTEIN ) or PROTEIN2 ( PROTEIN ) null alleles have complex myofibrillar defects, whereas PROTEIN -/+; PROTEIN1 -/+ double heterozygotes have nearly normal myofibrils.
BioInfer.d232.s1.p2	N	We find that heterozygotes for PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) null alleles have complex myofibrillar defects, whereas PROTEIN -/+; PROTEIN1 -/+ double heterozygotes have nearly normal myofibrils.
BioInfer.d232.s1.p3	N	We find that heterozygotes for PROTEIN2 ( PROTEIN ) or PROTEIN ( PROTEIN ) null alleles have complex myofibrillar defects, whereas PROTEIN -/+; PROTEIN1 -/+ double heterozygotes have nearly normal myofibrils.
BioInfer.d232.s1.p4	N	We find that heterozygotes for PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) null alleles have complex myofibrillar defects, whereas PROTEIN2 -/+; PROTEIN1 -/+ double heterozygotes have nearly normal myofibrils.
BioInfer.d232.s1.p5	N	We find that heterozygotes for PROTEIN ( PROTEIN ) or PROTEIN2 ( PROTEIN1 ) null alleles have complex myofibrillar defects, whereas PROTEIN -/+; PROTEIN -/+ double heterozygotes have nearly normal myofibrils.
BioInfer.d232.s1.p6	N	We find that heterozygotes for PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN1 ) null alleles have complex myofibrillar defects, whereas PROTEIN -/+; PROTEIN -/+ double heterozygotes have nearly normal myofibrils.
BioInfer.d232.s1.p7	N	We find that heterozygotes for PROTEIN2 ( PROTEIN ) or PROTEIN ( PROTEIN1 ) null alleles have complex myofibrillar defects, whereas PROTEIN -/+; PROTEIN -/+ double heterozygotes have nearly normal myofibrils.
BioInfer.d232.s1.p8	N	We find that heterozygotes for PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN1 ) null alleles have complex myofibrillar defects, whereas PROTEIN2 -/+; PROTEIN -/+ double heterozygotes have nearly normal myofibrils.
BioInfer.d232.s1.p9	N	We find that heterozygotes for PROTEIN ( PROTEIN2 ) or PROTEIN1 ( PROTEIN ) null alleles have complex myofibrillar defects, whereas PROTEIN -/+; PROTEIN -/+ double heterozygotes have nearly normal myofibrils.
BioInfer.d232.s1.p10	N	We find that heterozygotes for PROTEIN2 ( PROTEIN ) or PROTEIN1 ( PROTEIN ) null alleles have complex myofibrillar defects, whereas PROTEIN -/+; PROTEIN -/+ double heterozygotes have nearly normal myofibrils.
BioInfer.d232.s1.p11	N	We find that heterozygotes for PROTEIN ( PROTEIN ) or PROTEIN1 ( PROTEIN ) null alleles have complex myofibrillar defects, whereas PROTEIN2 -/+; PROTEIN -/+ double heterozygotes have nearly normal myofibrils.
BioInfer.d232.s1.p12	N	We find that heterozygotes for PROTEIN2 ( PROTEIN1 ) or PROTEIN ( PROTEIN ) null alleles have complex myofibrillar defects, whereas PROTEIN -/+; PROTEIN -/+ double heterozygotes have nearly normal myofibrils.
BioInfer.d232.s1.p13	N	We find that heterozygotes for PROTEIN ( PROTEIN1 ) or PROTEIN ( PROTEIN ) null alleles have complex myofibrillar defects, whereas PROTEIN2 -/+; PROTEIN -/+ double heterozygotes have nearly normal myofibrils.
BioInfer.d232.s1.p14	N	We find that heterozygotes for PROTEIN1 ( PROTEIN ) or PROTEIN ( PROTEIN ) null alleles have complex myofibrillar defects, whereas PROTEIN2 -/+; PROTEIN -/+ double heterozygotes have nearly normal myofibrils.
BioInfer.d233.s0.p0	N	Germline mutations in several members of these families, PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , but not PROTEIN1 , are responsible for hereditary non-polyposis colorectal cancer.
BioInfer.d233.s0.p1	N	Germline mutations in several members of these families, PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , but not PROTEIN1 , are responsible for hereditary non-polyposis colorectal cancer.
BioInfer.d233.s0.p2	N	Germline mutations in several members of these families, PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , but not PROTEIN1 , are responsible for hereditary non-polyposis colorectal cancer.
BioInfer.d233.s0.p3	N	Germline mutations in several members of these families, PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , but not PROTEIN1 , are responsible for hereditary non-polyposis colorectal cancer.
BioInfer.d233.s0.p4	N	Germline mutations in several members of these families, PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN , but not PROTEIN , are responsible for hereditary non-polyposis colorectal cancer.
BioInfer.d233.s0.p5	N	Germline mutations in several members of these families, PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN , but not PROTEIN , are responsible for hereditary non-polyposis colorectal cancer.
BioInfer.d233.s0.p6	N	Germline mutations in several members of these families, PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 , but not PROTEIN , are responsible for hereditary non-polyposis colorectal cancer.
BioInfer.d233.s0.p7	N	Germline mutations in several members of these families, PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN , but not PROTEIN , are responsible for hereditary non-polyposis colorectal cancer.
BioInfer.d233.s0.p8	N	Germline mutations in several members of these families, PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 , but not PROTEIN , are responsible for hereditary non-polyposis colorectal cancer.
BioInfer.d233.s0.p9	N	Germline mutations in several members of these families, PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 , but not PROTEIN , are responsible for hereditary non-polyposis colorectal cancer.
BioInfer.d234.s0.p0	P	PROTEIN pull-down performed with PROTEIN deletion mutants and peptide competition have localized the site in PROTEIN2 critical for binding PROTEIN / PROTEIN1 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN binding and PROTEIN subunit dimerization.
BioInfer.d234.s0.p1	N	PROTEIN pull-down performed with PROTEIN deletion mutants and peptide competition have localized the site in PROTEIN critical for binding PROTEIN2 / PROTEIN1 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN binding and PROTEIN subunit dimerization.
BioInfer.d234.s0.p2	N	PROTEIN pull-down performed with PROTEIN deletion mutants and peptide competition have localized the site in PROTEIN critical for binding PROTEIN / PROTEIN1 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN2 binding and PROTEIN subunit dimerization.
BioInfer.d234.s0.p3	N	PROTEIN2 pull-down performed with PROTEIN deletion mutants and peptide competition have localized the site in PROTEIN critical for binding PROTEIN / PROTEIN1 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN binding and PROTEIN subunit dimerization.
BioInfer.d234.s0.p4	N	PROTEIN pull-down performed with PROTEIN deletion mutants and peptide competition have localized the site in PROTEIN critical for binding PROTEIN / PROTEIN1 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN binding and PROTEIN2 subunit dimerization.
BioInfer.d234.s0.p5	N	PROTEIN pull-down performed with PROTEIN2 deletion mutants and peptide competition have localized the site in PROTEIN critical for binding PROTEIN / PROTEIN1 to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN binding and PROTEIN subunit dimerization.
BioInfer.d234.s0.p6	P	PROTEIN pull-down performed with PROTEIN deletion mutants and peptide competition have localized the site in PROTEIN1 critical for binding PROTEIN2 / PROTEIN to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN binding and PROTEIN subunit dimerization.
BioInfer.d234.s0.p7	P	PROTEIN pull-down performed with PROTEIN deletion mutants and peptide competition have localized the site in PROTEIN1 critical for binding PROTEIN / PROTEIN to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN2 binding and PROTEIN subunit dimerization.
BioInfer.d234.s0.p8	N	PROTEIN2 pull-down performed with PROTEIN deletion mutants and peptide competition have localized the site in PROTEIN1 critical for binding PROTEIN / PROTEIN to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN binding and PROTEIN subunit dimerization.
BioInfer.d234.s0.p9	P	PROTEIN pull-down performed with PROTEIN deletion mutants and peptide competition have localized the site in PROTEIN1 critical for binding PROTEIN / PROTEIN to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN binding and PROTEIN2 subunit dimerization.
BioInfer.d234.s0.p10	N	PROTEIN pull-down performed with PROTEIN2 deletion mutants and peptide competition have localized the site in PROTEIN1 critical for binding PROTEIN / PROTEIN to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN binding and PROTEIN subunit dimerization.
BioInfer.d234.s0.p11	N	PROTEIN pull-down performed with PROTEIN deletion mutants and peptide competition have localized the site in PROTEIN critical for binding PROTEIN1 / PROTEIN to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN2 binding and PROTEIN subunit dimerization.
BioInfer.d234.s0.p12	N	PROTEIN2 pull-down performed with PROTEIN deletion mutants and peptide competition have localized the site in PROTEIN critical for binding PROTEIN1 / PROTEIN to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN binding and PROTEIN subunit dimerization.
BioInfer.d234.s0.p13	N	PROTEIN pull-down performed with PROTEIN deletion mutants and peptide competition have localized the site in PROTEIN critical for binding PROTEIN1 / PROTEIN to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN binding and PROTEIN2 subunit dimerization.
BioInfer.d234.s0.p14	N	PROTEIN pull-down performed with PROTEIN2 deletion mutants and peptide competition have localized the site in PROTEIN critical for binding PROTEIN1 / PROTEIN to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN binding and PROTEIN subunit dimerization.
BioInfer.d234.s0.p15	N	PROTEIN2 pull-down performed with PROTEIN deletion mutants and peptide competition have localized the site in PROTEIN critical for binding PROTEIN / PROTEIN to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN1 binding and PROTEIN subunit dimerization.
BioInfer.d234.s0.p16	N	PROTEIN pull-down performed with PROTEIN deletion mutants and peptide competition have localized the site in PROTEIN critical for binding PROTEIN / PROTEIN to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN1 binding and PROTEIN2 subunit dimerization.
BioInfer.d234.s0.p17	N	PROTEIN pull-down performed with PROTEIN2 deletion mutants and peptide competition have localized the site in PROTEIN critical for binding PROTEIN / PROTEIN to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN1 binding and PROTEIN subunit dimerization.
BioInfer.d234.s0.p18	N	PROTEIN1 pull-down performed with PROTEIN deletion mutants and peptide competition have localized the site in PROTEIN critical for binding PROTEIN / PROTEIN to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN binding and PROTEIN2 subunit dimerization.
BioInfer.d234.s0.p19	N	PROTEIN1 pull-down performed with PROTEIN2 deletion mutants and peptide competition have localized the site in PROTEIN critical for binding PROTEIN / PROTEIN to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN binding and PROTEIN subunit dimerization.
BioInfer.d234.s0.p20	N	PROTEIN pull-down performed with PROTEIN2 deletion mutants and peptide competition have localized the site in PROTEIN critical for binding PROTEIN / PROTEIN to a highly protease-sensitive region around amino acid residues 81 to 95 (81QRTSKTLKVLTPPIT95) which lies between the domains previously proposed to be important for PROTEIN binding and PROTEIN1 subunit dimerization.
BioInfer.d235.s0.p0	N	PROTEIN is not likely to be a PROTEIN1 , PROTEIN , PROTEIN2 , or PROTEIN based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.
BioInfer.d235.s0.p1	N	PROTEIN2 is not likely to be a PROTEIN1 , PROTEIN , PROTEIN , or PROTEIN based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.
BioInfer.d235.s0.p2	N	PROTEIN is not likely to be a PROTEIN1 , PROTEIN2 , PROTEIN , or PROTEIN based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.
BioInfer.d235.s0.p3	N	PROTEIN is not likely to be a PROTEIN1 , PROTEIN , PROTEIN , or PROTEIN2 based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.
BioInfer.d235.s0.p4	P	PROTEIN is not likely to be a PROTEIN1 , PROTEIN , PROTEIN , or PROTEIN based on the lack of reactivity of PROTEIN2 with these polypeptides in immunoblots.
BioInfer.d235.s0.p5	N	PROTEIN2 is not likely to be a PROTEIN , PROTEIN , PROTEIN1 , or PROTEIN based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.
BioInfer.d235.s0.p6	N	PROTEIN is not likely to be a PROTEIN , PROTEIN2 , PROTEIN1 , or PROTEIN based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.
BioInfer.d235.s0.p7	N	PROTEIN is not likely to be a PROTEIN , PROTEIN , PROTEIN1 , or PROTEIN2 based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.
BioInfer.d235.s0.p8	P	PROTEIN is not likely to be a PROTEIN , PROTEIN , PROTEIN1 , or PROTEIN based on the lack of reactivity of PROTEIN2 with these polypeptides in immunoblots.
BioInfer.d235.s0.p9	N	PROTEIN1 is not likely to be a PROTEIN , PROTEIN2 , PROTEIN , or PROTEIN based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.
BioInfer.d235.s0.p10	N	PROTEIN1 is not likely to be a PROTEIN , PROTEIN , PROTEIN , or PROTEIN2 based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.
BioInfer.d235.s0.p11	N	PROTEIN1 is not likely to be a PROTEIN , PROTEIN , PROTEIN , or PROTEIN based on the lack of reactivity of PROTEIN2 with these polypeptides in immunoblots.
BioInfer.d235.s0.p12	N	PROTEIN is not likely to be a PROTEIN , PROTEIN1 , PROTEIN , or PROTEIN2 based on the lack of reactivity of PROTEIN with these polypeptides in immunoblots.
BioInfer.d235.s0.p13	P	PROTEIN is not likely to be a PROTEIN , PROTEIN1 , PROTEIN , or PROTEIN based on the lack of reactivity of PROTEIN2 with these polypeptides in immunoblots.
BioInfer.d235.s0.p14	P	PROTEIN is not likely to be a PROTEIN , PROTEIN , PROTEIN , or PROTEIN1 based on the lack of reactivity of PROTEIN2 with these polypeptides in immunoblots.
BioInfer.d236.s0.p0	P	Hence, we conclude that in its dimeric form, which is used in PROTEIN1 and lipid binding, PROTEIN2 is a dumbbell-shaped molecule built of two antiparallel subunits.
BioInfer.d236.s1.p0	P	The PROTEIN1 dimer, which is crucial for PROTEIN2 and lipid binding, is built of a backbone containing the 200 kDa rod portions, at both ends of which a 47 kDa globular domain is attached.
BioInfer.d237.s0.p0	N	Here, specific interactions between human PROTEIN and PROTEIN proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with PROTEIN2 and PROTEIN1 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.
BioInfer.d237.s0.p1	N	Here, specific interactions between human PROTEIN and PROTEIN2 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with PROTEIN and PROTEIN1 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.
BioInfer.d237.s0.p2	N	Here, specific interactions between human PROTEIN2 and PROTEIN proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with PROTEIN and PROTEIN1 recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.
BioInfer.d237.s0.p3	N	Here, specific interactions between human PROTEIN and PROTEIN2 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with PROTEIN1 and PROTEIN recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.
BioInfer.d237.s0.p4	N	Here, specific interactions between human PROTEIN2 and PROTEIN proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with PROTEIN1 and PROTEIN recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.
BioInfer.d237.s0.p5	P	Here, specific interactions between human PROTEIN2 and PROTEIN1 proteins are demonstrated both in vivo, using the yeast two-hybrid system and immunoprecipitation of insect cells co-infected with PROTEIN and PROTEIN recombinant viruses, and in vitro, using affinity chromatography with purified recombinant proteins.
BioInfer.d237.s1.p0	P	Interaction of the yeast PROTEIN1 and PROTEIN2 proteins plays a crucial role in yeast DNA homologous recombination and DNA double-strand break repair.
BioInfer.d237.s2.p0	P	Specific interactions between the human PROTEIN2 and PROTEIN1 proteins.
BioInfer.d237.s3.p0	P	The PROTEIN -interacting region (amino acids 291-330) of the human PROTEIN2 protein shows no homology with the yeast PROTEIN1 protein, indicating that the interaction between PROTEIN and PROTEIN is species-specific.
BioInfer.d237.s3.p1	N	The PROTEIN -interacting region (amino acids 291-330) of the human PROTEIN protein shows no homology with the yeast PROTEIN1 protein, indicating that the interaction between PROTEIN2 and PROTEIN is species-specific.
BioInfer.d237.s3.p2	N	The PROTEIN -interacting region (amino acids 291-330) of the human PROTEIN protein shows no homology with the yeast PROTEIN1 protein, indicating that the interaction between PROTEIN and PROTEIN2 is species-specific.
BioInfer.d237.s3.p3	N	The PROTEIN2 -interacting region (amino acids 291-330) of the human PROTEIN protein shows no homology with the yeast PROTEIN1 protein, indicating that the interaction between PROTEIN and PROTEIN is species-specific.
BioInfer.d237.s3.p4	N	The PROTEIN -interacting region (amino acids 291-330) of the human PROTEIN1 protein shows no homology with the yeast PROTEIN protein, indicating that the interaction between PROTEIN2 and PROTEIN is species-specific.
BioInfer.d237.s3.p5	N	The PROTEIN -interacting region (amino acids 291-330) of the human PROTEIN1 protein shows no homology with the yeast PROTEIN protein, indicating that the interaction between PROTEIN and PROTEIN2 is species-specific.
BioInfer.d237.s3.p6	P	The PROTEIN2 -interacting region (amino acids 291-330) of the human PROTEIN1 protein shows no homology with the yeast PROTEIN protein, indicating that the interaction between PROTEIN and PROTEIN is species-specific.
BioInfer.d237.s3.p7	P	The PROTEIN -interacting region (amino acids 291-330) of the human PROTEIN protein shows no homology with the yeast PROTEIN protein, indicating that the interaction between PROTEIN1 and PROTEIN2 is species-specific.
BioInfer.d237.s3.p8	N	The PROTEIN2 -interacting region (amino acids 291-330) of the human PROTEIN protein shows no homology with the yeast PROTEIN protein, indicating that the interaction between PROTEIN1 and PROTEIN is species-specific.
BioInfer.d237.s3.p9	N	The PROTEIN2 -interacting region (amino acids 291-330) of the human PROTEIN protein shows no homology with the yeast PROTEIN protein, indicating that the interaction between PROTEIN and PROTEIN1 is species-specific.
BioInfer.d237.s4.p0	P	These results suggest that PROTEIN1 may modulate the catalytic activities of PROTEIN2 protein such as homologous pairing and strand exchange through a direct physical interaction.
BioInfer.d238.s0.p0	P	Here we demonstrate that accessory receptor triggering induces the transient association of PROTEIN2 with the PROTEIN1 cytoskeleton.
BioInfer.d238.s1.p0	P	Recently, we have shown that the small PROTEIN2 -depolymerizing protein PROTEIN1 represents a component of a co-stimulatory signaling pathway in human T cells.
BioInfer.d238.s2.p0	P	These results suggest that PROTEIN2 provides an as yet missing link between functionally crucial T cell surface receptors and rearrangements of the PROTEIN1 cytoskeleton.
BioInfer.d239.s0.p0	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN2 , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN1 ).
BioInfer.d239.s0.p1	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN2 (but not to PROTEIN / PROTEIN1 ).
BioInfer.d239.s0.p2	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN2  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN1 ).
BioInfer.d239.s0.p3	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN2 / PROTEIN (but not to PROTEIN / PROTEIN1 ).
BioInfer.d239.s0.p4	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN2 complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN1 ).
BioInfer.d239.s0.p5	P	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN2 / PROTEIN1 ).
BioInfer.d239.s0.p6	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN2 / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN1 ).
BioInfer.d239.s0.p7	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN2 with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN1 ).
BioInfer.d239.s0.p8	P	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN2 activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN1 ).
BioInfer.d239.s0.p9	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN1 , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN2 (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p10	P	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN2  PROTEIN1 , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p11	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN1 , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN2 / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p12	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN1 , enhanced association of PROTEIN with PROTEIN / PROTEIN2 complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p13	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN1 , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN2 / PROTEIN ).
BioInfer.d239.s0.p14	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN1 , enhanced association of PROTEIN with PROTEIN2 / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p15	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN1 , enhanced association of PROTEIN2 with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p16	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN1 , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN2 activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p17	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN2  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN1 (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p18	P	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN2 / PROTEIN1 (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p19	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN2 complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN1 (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p20	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN1 (but not to PROTEIN2 / PROTEIN ).
BioInfer.d239.s0.p21	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN2 / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN1 (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p22	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN2 with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN1 (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p23	P	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN2 activity associated to PROTEIN / PROTEIN1 (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p24	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN1  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN2 / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p25	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN1  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN2 complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p26	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN1  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN2 / PROTEIN ).
BioInfer.d239.s0.p27	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN1  PROTEIN , enhanced association of PROTEIN with PROTEIN2 / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p28	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN1  PROTEIN , enhanced association of PROTEIN2 with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p29	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN1  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN2 activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p30	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN2 complexes and suppression of PROTEIN activity associated to PROTEIN1 / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p31	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN1 / PROTEIN (but not to PROTEIN2 / PROTEIN ).
BioInfer.d239.s0.p32	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN2 / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN1 / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p33	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN2 with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN1 / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p34	P	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN2 activity associated to PROTEIN1 / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p35	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN1 complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN2 / PROTEIN ).
BioInfer.d239.s0.p36	P	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN2 / PROTEIN1 complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p37	P	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN2 with PROTEIN / PROTEIN1 complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p38	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN1 complexes and suppression of PROTEIN2 activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p39	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN2 / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN1 / PROTEIN ).
BioInfer.d239.s0.p40	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN2 with PROTEIN / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN1 / PROTEIN ).
BioInfer.d239.s0.p41	P	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN / PROTEIN complexes and suppression of PROTEIN2 activity associated to PROTEIN / PROTEIN (but not to PROTEIN1 / PROTEIN ).
BioInfer.d239.s0.p42	P	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN2 with PROTEIN1 / PROTEIN complexes and suppression of PROTEIN activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p43	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN with PROTEIN1 / PROTEIN complexes and suppression of PROTEIN2 activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d239.s0.p44	N	Here we demonstrate that growth arrest and differentiation of NT2/D1 cells induced by HMBA involve increased expression of the PROTEIN  PROTEIN , enhanced association of PROTEIN1 with PROTEIN / PROTEIN complexes and suppression of PROTEIN2 activity associated to PROTEIN / PROTEIN (but not to PROTEIN / PROTEIN ).
BioInfer.d240.s0.p0	P	Here we demonstrate that PROTEIN1 is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of PROTEIN stress fibers, co-localizing with the known focal adhesion components PROTEIN2 and PROTEIN .
BioInfer.d240.s0.p1	P	Here we demonstrate that PROTEIN1 is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of PROTEIN stress fibers, co-localizing with the known focal adhesion components PROTEIN and PROTEIN2 .
BioInfer.d240.s0.p2	P	Here we demonstrate that PROTEIN1 is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of PROTEIN2 stress fibers, co-localizing with the known focal adhesion components PROTEIN and PROTEIN .
BioInfer.d240.s0.p3	N	Here we demonstrate that PROTEIN is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of PROTEIN stress fibers, co-localizing with the known focal adhesion components PROTEIN1 and PROTEIN2 .
BioInfer.d240.s0.p4	N	Here we demonstrate that PROTEIN is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of PROTEIN2 stress fibers, co-localizing with the known focal adhesion components PROTEIN1 and PROTEIN .
BioInfer.d240.s0.p5	N	Here we demonstrate that PROTEIN is concentrated in cultured skin fibroblasts and several other human mesenchymal cell lines in the focal adhesions at the ends of PROTEIN2 stress fibers, co-localizing with the known focal adhesion components PROTEIN and PROTEIN1 .
BioInfer.d241.s0.p0	N	Here, we describe proline-rich proteins involved in regulating PROTEIN1 polymerization and classify them according to their role in recruiting PROTEIN2 to the membrane.
BioInfer.d242.s0.p0	N	Here we describe the PROTEIN -dependent activation of PROTEIN ( PROTEIN ) through the PROTEIN  PROTEIN -associated proteins PROTEIN1 and PROTEIN2 .
BioInfer.d242.s0.p1	N	Here we describe the PROTEIN2 -dependent activation of PROTEIN ( PROTEIN ) through the PROTEIN  PROTEIN -associated proteins PROTEIN1 and PROTEIN .
BioInfer.d242.s0.p2	P	Here we describe the PROTEIN -dependent activation of PROTEIN ( PROTEIN ) through the PROTEIN2  PROTEIN -associated proteins PROTEIN1 and PROTEIN .
BioInfer.d242.s0.p3	N	Here we describe the PROTEIN -dependent activation of PROTEIN ( PROTEIN ) through the PROTEIN  PROTEIN2 -associated proteins PROTEIN1 and PROTEIN .
BioInfer.d242.s0.p4	P	Here we describe the PROTEIN -dependent activation of PROTEIN2 ( PROTEIN ) through the PROTEIN  PROTEIN -associated proteins PROTEIN1 and PROTEIN .
BioInfer.d242.s0.p5	P	Here we describe the PROTEIN -dependent activation of PROTEIN ( PROTEIN2 ) through the PROTEIN  PROTEIN -associated proteins PROTEIN1 and PROTEIN .
BioInfer.d242.s0.p6	N	Here we describe the PROTEIN2 -dependent activation of PROTEIN ( PROTEIN ) through the PROTEIN  PROTEIN -associated proteins PROTEIN and PROTEIN1 .
BioInfer.d242.s0.p7	P	Here we describe the PROTEIN -dependent activation of PROTEIN ( PROTEIN ) through the PROTEIN2  PROTEIN -associated proteins PROTEIN and PROTEIN1 .
BioInfer.d242.s0.p8	N	Here we describe the PROTEIN -dependent activation of PROTEIN ( PROTEIN ) through the PROTEIN  PROTEIN2 -associated proteins PROTEIN and PROTEIN1 .
BioInfer.d242.s0.p9	P	Here we describe the PROTEIN -dependent activation of PROTEIN2 ( PROTEIN ) through the PROTEIN  PROTEIN -associated proteins PROTEIN and PROTEIN1 .
BioInfer.d242.s0.p10	P	Here we describe the PROTEIN -dependent activation of PROTEIN ( PROTEIN2 ) through the PROTEIN  PROTEIN -associated proteins PROTEIN and PROTEIN1 .
BioInfer.d242.s0.p11	N	Here we describe the PROTEIN1 -dependent activation of PROTEIN ( PROTEIN ) through the PROTEIN2  PROTEIN -associated proteins PROTEIN and PROTEIN .
BioInfer.d242.s0.p12	N	Here we describe the PROTEIN1 -dependent activation of PROTEIN ( PROTEIN ) through the PROTEIN  PROTEIN2 -associated proteins PROTEIN and PROTEIN .
BioInfer.d242.s0.p13	P	Here we describe the PROTEIN1 -dependent activation of PROTEIN2 ( PROTEIN ) through the PROTEIN  PROTEIN -associated proteins PROTEIN and PROTEIN .
BioInfer.d242.s0.p14	P	Here we describe the PROTEIN1 -dependent activation of PROTEIN ( PROTEIN2 ) through the PROTEIN  PROTEIN -associated proteins PROTEIN and PROTEIN .
BioInfer.d242.s0.p15	P	Here we describe the PROTEIN -dependent activation of PROTEIN ( PROTEIN ) through the PROTEIN1  PROTEIN2 -associated proteins PROTEIN and PROTEIN .
BioInfer.d242.s0.p16	N	Here we describe the PROTEIN -dependent activation of PROTEIN2 ( PROTEIN ) through the PROTEIN1  PROTEIN -associated proteins PROTEIN and PROTEIN .
BioInfer.d242.s0.p17	N	Here we describe the PROTEIN -dependent activation of PROTEIN ( PROTEIN2 ) through the PROTEIN1  PROTEIN -associated proteins PROTEIN and PROTEIN .
BioInfer.d242.s0.p18	N	Here we describe the PROTEIN -dependent activation of PROTEIN2 ( PROTEIN ) through the PROTEIN  PROTEIN1 -associated proteins PROTEIN and PROTEIN .
BioInfer.d242.s0.p19	N	Here we describe the PROTEIN -dependent activation of PROTEIN ( PROTEIN2 ) through the PROTEIN  PROTEIN1 -associated proteins PROTEIN and PROTEIN .
BioInfer.d242.s0.p20	N	Here we describe the PROTEIN -dependent activation of PROTEIN1 ( PROTEIN2 ) through the PROTEIN  PROTEIN -associated proteins PROTEIN and PROTEIN .
BioInfer.d242.s1.p0	P	PROTEIN death domain-associated proteins PROTEIN1 and PROTEIN signal activation of PROTEIN2 .
BioInfer.d242.s1.p1	N	PROTEIN death domain-associated proteins PROTEIN1 and PROTEIN2 signal activation of PROTEIN .
BioInfer.d242.s1.p2	P	PROTEIN2 death domain-associated proteins PROTEIN1 and PROTEIN signal activation of PROTEIN .
BioInfer.d242.s1.p3	P	PROTEIN death domain-associated proteins PROTEIN and PROTEIN2 signal activation of PROTEIN1 .
BioInfer.d242.s1.p4	N	PROTEIN2 death domain-associated proteins PROTEIN and PROTEIN signal activation of PROTEIN1 .
BioInfer.d242.s1.p5	P	PROTEIN2 death domain-associated proteins PROTEIN and PROTEIN1 signal activation of PROTEIN .
BioInfer.d243.s0.p0	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p1	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p2	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p3	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p4	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p5	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p6	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p7	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p8	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p9	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p10	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 , mutations that block filamentous growth.
BioInfer.d243.s0.p11	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p12	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p13	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p14	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p15	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p16	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p17	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p18	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p19	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p20	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p21	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p22	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p23	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p24	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 , mutations that block filamentous growth.
BioInfer.d243.s0.p25	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p26	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p27	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p28	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p29	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p30	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p31	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p32	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p33	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p34	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p35	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p36	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p37	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 , mutations that block filamentous growth.
BioInfer.d243.s0.p38	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p39	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p40	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p41	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p42	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p43	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p44	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p45	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p46	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p47	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p48	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p49	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 , mutations that block filamentous growth.
BioInfer.d243.s0.p50	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p51	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p52	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p53	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p54	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p55	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p56	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p57	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p58	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p59	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p60	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 , mutations that block filamentous growth.
BioInfer.d243.s0.p61	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p62	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p63	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p64	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p65	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p66	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p67	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p68	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p69	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p70	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 , mutations that block filamentous growth.
BioInfer.d243.s0.p71	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p72	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p73	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p74	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p75	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p76	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p77	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p78	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p79	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 , mutations that block filamentous growth.
BioInfer.d243.s0.p80	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p81	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p82	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p83	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p84	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p85	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p86	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p87	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 , mutations that block filamentous growth.
BioInfer.d243.s0.p88	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p89	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p90	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p91	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p92	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p93	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p94	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 , mutations that block filamentous growth.
BioInfer.d243.s0.p95	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p96	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p97	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p98	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p99	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p100	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 , mutations that block filamentous growth.
BioInfer.d243.s0.p101	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p102	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p103	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p104	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p105	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 , mutations that block filamentous growth.
BioInfer.d243.s0.p106	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p107	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p108	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p109	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p110	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN1 , mutations that block filamentous growth.
BioInfer.d243.s0.p111	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 , mutations that block filamentous growth.
BioInfer.d243.s0.p112	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 , mutations that block filamentous growth.
BioInfer.d243.s0.p113	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 , mutations that block filamentous growth.
BioInfer.d243.s0.p114	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p115	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p116	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p117	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p118	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d243.s0.p119	N	Here, we designed a genetic screen for mutant strains defective for filamentous growth (dfg) to identify novel targets of the filamentation signaling pathway, and we thereby identified 16 different genes, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN , mutations that block filamentous growth.
BioInfer.d244.s0.p0	N	Here, we have detected a polypeptide in rat rod outer segments that is recognized by PROTEIN2 antibodies and was found to possess other characteristics of conventional PROTEIN : it comigrates in SDS-PAGE with PROTEIN1 ; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified PROTEIN filaments in the absence of ATP.
BioInfer.d244.s0.p1	N	Here, we have detected a polypeptide in rat rod outer segments that is recognized by PROTEIN antibodies and was found to possess other characteristics of conventional PROTEIN2 : it comigrates in SDS-PAGE with PROTEIN1 ; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified PROTEIN filaments in the absence of ATP.
BioInfer.d244.s0.p2	N	Here, we have detected a polypeptide in rat rod outer segments that is recognized by PROTEIN antibodies and was found to possess other characteristics of conventional PROTEIN : it comigrates in SDS-PAGE with PROTEIN1 ; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified PROTEIN2 filaments in the absence of ATP.
BioInfer.d244.s0.p3	N	Here, we have detected a polypeptide in rat rod outer segments that is recognized by PROTEIN1 antibodies and was found to possess other characteristics of conventional PROTEIN2 : it comigrates in SDS-PAGE with PROTEIN ; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified PROTEIN filaments in the absence of ATP.
BioInfer.d244.s0.p4	N	Here, we have detected a polypeptide in rat rod outer segments that is recognized by PROTEIN1 antibodies and was found to possess other characteristics of conventional PROTEIN : it comigrates in SDS-PAGE with PROTEIN ; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified PROTEIN2 filaments in the absence of ATP.
BioInfer.d244.s0.p5	P	Here, we have detected a polypeptide in rat rod outer segments that is recognized by PROTEIN antibodies and was found to possess other characteristics of conventional PROTEIN1 : it comigrates in SDS-PAGE with PROTEIN ; it associates with the cytoskeleton of rod outer segments in an ATP-sensitive manner; and it binds to purified PROTEIN2 filaments in the absence of ATP.
BioInfer.d245.s0.p0	P	Here we have now identified the reciprocal complementary binding site in PROTEIN1 which mediates its interaction with PROTEIN2 and PROTEIN .
BioInfer.d245.s0.p1	P	Here we have now identified the reciprocal complementary binding site in PROTEIN1 which mediates its interaction with PROTEIN and PROTEIN2 .
BioInfer.d245.s0.p2	N	Here we have now identified the reciprocal complementary binding site in PROTEIN which mediates its interaction with PROTEIN1 and PROTEIN2 .
BioInfer.d245.s1.p0	P	It is well established that the cytoplasmic domain of PROTEIN binds either PROTEIN or PROTEIN1 , which both can assemble PROTEIN2 into the complex.
BioInfer.d245.s1.p1	N	It is well established that the cytoplasmic domain of PROTEIN binds either PROTEIN2 or PROTEIN1 , which both can assemble PROTEIN into the complex.
BioInfer.d245.s1.p2	P	It is well established that the cytoplasmic domain of PROTEIN2 binds either PROTEIN or PROTEIN1 , which both can assemble PROTEIN into the complex.
BioInfer.d245.s1.p3	P	It is well established that the cytoplasmic domain of PROTEIN binds either PROTEIN2 or PROTEIN , which both can assemble PROTEIN1 into the complex.
BioInfer.d245.s1.p4	P	It is well established that the cytoplasmic domain of PROTEIN2 binds either PROTEIN or PROTEIN , which both can assemble PROTEIN1 into the complex.
BioInfer.d245.s1.p5	P	It is well established that the cytoplasmic domain of PROTEIN2 binds either PROTEIN1 or PROTEIN , which both can assemble PROTEIN into the complex.
BioInfer.d245.s2.p0	P	Recently we have identified an PROTEIN1 binding site in PROTEIN2 and PROTEIN and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.
BioInfer.d245.s2.p1	P	Recently we have identified an PROTEIN1 binding site in PROTEIN and PROTEIN2 and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.
BioInfer.d245.s2.p2	N	Recently we have identified an PROTEIN binding site in PROTEIN1 and PROTEIN2 and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.
BioInfer.d246.s0.p0	P	Here we identify a pathway for the regulation of PROTEIN1 , a ubiquitous PROTEIN2 that is essential for effective depolymerization of PROTEIN filaments.
BioInfer.d246.s0.p1	P	Here we identify a pathway for the regulation of PROTEIN1 , a ubiquitous PROTEIN that is essential for effective depolymerization of PROTEIN2 filaments.
BioInfer.d246.s0.p2	N	Here we identify a pathway for the regulation of PROTEIN , a ubiquitous PROTEIN1 that is essential for effective depolymerization of PROTEIN2 filaments.
BioInfer.d246.s1.p0	N	Our results define a mechanism for the regulation of PROTEIN2 and hence of PROTEIN1 dynamics in vivo.
BioInfer.d246.s2.p0	P	Phosphorylation by PROTEIN inactivates PROTEIN2 , leading to accumulation of PROTEIN1 filaments.
BioInfer.d246.s2.p1	P	Phosphorylation by PROTEIN2 inactivates PROTEIN , leading to accumulation of PROTEIN1 filaments.
BioInfer.d246.s2.p2	P	Phosphorylation by PROTEIN2 inactivates PROTEIN1 , leading to accumulation of PROTEIN filaments.
BioInfer.d246.s3.p0	P	Regulation of PROTEIN1 dynamics through phosphorylation of PROTEIN2 by PROTEIN .
BioInfer.d246.s3.p1	P	Regulation of PROTEIN1 dynamics through phosphorylation of PROTEIN by PROTEIN2 .
BioInfer.d246.s3.p2	P	Regulation of PROTEIN dynamics through phosphorylation of PROTEIN1 by PROTEIN2 .
BioInfer.d247.s0.p0	P	Here, we prepared a PROTEIN1 mutant (H119E) defective in PROTEIN2 binding, but retaining the ability to bind to other proteins.
BioInfer.d247.s1.p0	P	The essential role of PROTEIN2 in the assembly of PROTEIN1 for microspike formation.
BioInfer.d247.s2.p0	P	These findings provide the first evidence that PROTEIN2 is a key molecule linking a signaling network to rapid PROTEIN1 polymerization in microspike formation.
BioInfer.d247.s3.p0	P	This mutant PROTEIN1 suppresses PROTEIN polymerization in microspike formation induced by PROTEIN2 , the essential factor in microspike formation.
BioInfer.d247.s3.p1	P	This mutant PROTEIN1 suppresses PROTEIN2 polymerization in microspike formation induced by PROTEIN , the essential factor in microspike formation.
BioInfer.d247.s3.p2	P	This mutant PROTEIN suppresses PROTEIN2 polymerization in microspike formation induced by PROTEIN1 , the essential factor in microspike formation.
BioInfer.d248.s0.p0	P	Here we report that PROTEIN2 associates with a complex containing PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d248.s0.p1	P	Here we report that PROTEIN associates with a complex containing PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d248.s0.p2	P	Here we report that PROTEIN associates with a complex containing PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d248.s0.p3	P	Here we report that PROTEIN associates with a complex containing PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d248.s0.p4	P	Here we report that PROTEIN1 associates with a complex containing PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d248.s0.p5	P	Here we report that PROTEIN1 associates with a complex containing PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d248.s0.p6	P	Here we report that PROTEIN1 associates with a complex containing PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d248.s0.p7	P	Here we report that PROTEIN associates with a complex containing PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 .
BioInfer.d248.s0.p8	P	Here we report that PROTEIN associates with a complex containing PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN .
BioInfer.d248.s0.p9	P	Here we report that PROTEIN associates with a complex containing PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 .
BioInfer.d249.s0.p0	N	Here we report the functional importance of PROTEIN2 in various PROTEIN -mediated morphological changes using PROTEIN1 mutant profilin I, which is deficient only in PROTEIN binding.
BioInfer.d249.s0.p1	N	Here we report the functional importance of PROTEIN in various PROTEIN2 -mediated morphological changes using PROTEIN1 mutant profilin I, which is deficient only in PROTEIN binding.
BioInfer.d249.s0.p2	P	Here we report the functional importance of PROTEIN in various PROTEIN -mediated morphological changes using PROTEIN1 mutant profilin I, which is deficient only in PROTEIN2 binding.
BioInfer.d249.s0.p3	N	Here we report the functional importance of PROTEIN1 in various PROTEIN2 -mediated morphological changes using PROTEIN mutant profilin I, which is deficient only in PROTEIN binding.
BioInfer.d249.s0.p4	N	Here we report the functional importance of PROTEIN1 in various PROTEIN -mediated morphological changes using PROTEIN mutant profilin I, which is deficient only in PROTEIN2 binding.
BioInfer.d249.s0.p5	N	Here we report the functional importance of PROTEIN in various PROTEIN1 -mediated morphological changes using PROTEIN mutant profilin I, which is deficient only in PROTEIN2 binding.
BioInfer.d250.s0.p0	N	Here we show that PROTEIN1 is a member of a family of proteins including Drosophila PROTEIN , Saccharomyces cerevisiae PROTEIN , and S. pombe PROTEIN2 , which are involved in cytokinesis or other PROTEIN -mediated processes.
BioInfer.d250.s0.p1	N	Here we show that PROTEIN1 is a member of a family of proteins including Drosophila PROTEIN , Saccharomyces cerevisiae PROTEIN , and S. pombe PROTEIN , which are involved in cytokinesis or other PROTEIN2 -mediated processes.
BioInfer.d250.s0.p2	N	Here we show that PROTEIN1 is a member of a family of proteins including Drosophila PROTEIN , Saccharomyces cerevisiae PROTEIN2 , and S. pombe PROTEIN , which are involved in cytokinesis or other PROTEIN -mediated processes.
BioInfer.d250.s0.p3	N	Here we show that PROTEIN1 is a member of a family of proteins including Drosophila PROTEIN2 , Saccharomyces cerevisiae PROTEIN , and S. pombe PROTEIN , which are involved in cytokinesis or other PROTEIN -mediated processes.
BioInfer.d250.s0.p4	N	Here we show that PROTEIN is a member of a family of proteins including Drosophila PROTEIN , Saccharomyces cerevisiae PROTEIN , and S. pombe PROTEIN1 , which are involved in cytokinesis or other PROTEIN2 -mediated processes.
BioInfer.d250.s0.p5	N	Here we show that PROTEIN is a member of a family of proteins including Drosophila PROTEIN , Saccharomyces cerevisiae PROTEIN2 , and S. pombe PROTEIN1 , which are involved in cytokinesis or other PROTEIN -mediated processes.
BioInfer.d250.s0.p6	N	Here we show that PROTEIN is a member of a family of proteins including Drosophila PROTEIN2 , Saccharomyces cerevisiae PROTEIN , and S. pombe PROTEIN1 , which are involved in cytokinesis or other PROTEIN -mediated processes.
BioInfer.d250.s0.p7	N	Here we show that PROTEIN is a member of a family of proteins including Drosophila PROTEIN , Saccharomyces cerevisiae PROTEIN2 , and S. pombe PROTEIN , which are involved in cytokinesis or other PROTEIN1 -mediated processes.
BioInfer.d250.s0.p8	N	Here we show that PROTEIN is a member of a family of proteins including Drosophila PROTEIN2 , Saccharomyces cerevisiae PROTEIN , and S. pombe PROTEIN , which are involved in cytokinesis or other PROTEIN1 -mediated processes.
BioInfer.d250.s0.p9	N	Here we show that PROTEIN is a member of a family of proteins including Drosophila PROTEIN2 , Saccharomyces cerevisiae PROTEIN1 , and S. pombe PROTEIN , which are involved in cytokinesis or other PROTEIN -mediated processes.
BioInfer.d251.s0.p0	P	Here, we show that PROTEIN is a potent inhibitor of differentiation and link this activity to its ability to inhibit PROTEIN1 (and the highly related molecule, PROTEIN , or PROTEIN ) PROTEIN2 acetylation activity.
BioInfer.d251.s0.p1	P	Here, we show that PROTEIN is a potent inhibitor of differentiation and link this activity to its ability to inhibit PROTEIN1 (and the highly related molecule, PROTEIN2 , or PROTEIN ) PROTEIN acetylation activity.
BioInfer.d251.s0.p2	P	Here, we show that PROTEIN is a potent inhibitor of differentiation and link this activity to its ability to inhibit PROTEIN1 (and the highly related molecule, PROTEIN , or PROTEIN2 ) PROTEIN acetylation activity.
BioInfer.d251.s0.p3	N	Here, we show that PROTEIN2 is a potent inhibitor of differentiation and link this activity to its ability to inhibit PROTEIN1 (and the highly related molecule, PROTEIN , or PROTEIN ) PROTEIN acetylation activity.
BioInfer.d251.s0.p4	P	Here, we show that PROTEIN is a potent inhibitor of differentiation and link this activity to its ability to inhibit PROTEIN (and the highly related molecule, PROTEIN2 , or PROTEIN ) PROTEIN1 acetylation activity.
BioInfer.d251.s0.p5	P	Here, we show that PROTEIN is a potent inhibitor of differentiation and link this activity to its ability to inhibit PROTEIN (and the highly related molecule, PROTEIN , or PROTEIN2 ) PROTEIN1 acetylation activity.
BioInfer.d251.s0.p6	P	Here, we show that PROTEIN2 is a potent inhibitor of differentiation and link this activity to its ability to inhibit PROTEIN (and the highly related molecule, PROTEIN , or PROTEIN ) PROTEIN1 acetylation activity.
BioInfer.d251.s0.p7	N	Here, we show that PROTEIN is a potent inhibitor of differentiation and link this activity to its ability to inhibit PROTEIN (and the highly related molecule, PROTEIN1 , or PROTEIN2 ) PROTEIN acetylation activity.
BioInfer.d251.s0.p8	N	Here, we show that PROTEIN2 is a potent inhibitor of differentiation and link this activity to its ability to inhibit PROTEIN (and the highly related molecule, PROTEIN1 , or PROTEIN ) PROTEIN acetylation activity.
BioInfer.d251.s0.p9	N	Here, we show that PROTEIN2 is a potent inhibitor of differentiation and link this activity to its ability to inhibit PROTEIN (and the highly related molecule, PROTEIN , or PROTEIN1 ) PROTEIN acetylation activity.
BioInfer.d252.s0.p0	N	Here we show that the N-terminal domain of PROTEIN binds one PROTEIN monomer, in a PROTEIN1 -like fashion, and PROTEIN2 /3 complex and mimics the C-terminal domain of PROTEIN family proteins in catalyzing filament barbed end branching by PROTEIN /3 complex.
BioInfer.d252.s0.p1	N	Here we show that the N-terminal domain of PROTEIN binds one PROTEIN monomer, in a PROTEIN1 -like fashion, and PROTEIN /3 complex and mimics the C-terminal domain of PROTEIN family proteins in catalyzing filament barbed end branching by PROTEIN2 /3 complex.
BioInfer.d252.s0.p2	N	Here we show that the N-terminal domain of PROTEIN binds one PROTEIN2 monomer, in a PROTEIN1 -like fashion, and PROTEIN /3 complex and mimics the C-terminal domain of PROTEIN family proteins in catalyzing filament barbed end branching by PROTEIN /3 complex.
BioInfer.d252.s0.p5	N	Here we show that the N-terminal domain of PROTEIN binds one PROTEIN monomer, in a PROTEIN1 -like fashion, and PROTEIN /3 complex and mimics the C-terminal domain of PROTEIN2 family proteins in catalyzing filament barbed end branching by PROTEIN /3 complex.
BioInfer.d252.s0.p6	P	Here we show that the N-terminal domain of PROTEIN2 binds one PROTEIN monomer, in a PROTEIN1 -like fashion, and PROTEIN /3 complex and mimics the C-terminal domain of PROTEIN family proteins in catalyzing filament barbed end branching by PROTEIN /3 complex.
BioInfer.d252.s0.p7	N	Here we show that the N-terminal domain of PROTEIN binds one PROTEIN monomer, in a PROTEIN -like fashion, and PROTEIN1 /3 complex and mimics the C-terminal domain of PROTEIN family proteins in catalyzing filament barbed end branching by PROTEIN2 /3 complex.
BioInfer.d252.s0.p8	N	Here we show that the N-terminal domain of PROTEIN binds one PROTEIN2 monomer, in a PROTEIN -like fashion, and PROTEIN1 /3 complex and mimics the C-terminal domain of PROTEIN family proteins in catalyzing filament barbed end branching by PROTEIN /3 complex.
BioInfer.d252.s0.p11	N	Here we show that the N-terminal domain of PROTEIN binds one PROTEIN monomer, in a PROTEIN -like fashion, and PROTEIN1 /3 complex and mimics the C-terminal domain of PROTEIN2 family proteins in catalyzing filament barbed end branching by PROTEIN /3 complex.
BioInfer.d252.s0.p12	P	Here we show that the N-terminal domain of PROTEIN2 binds one PROTEIN monomer, in a PROTEIN -like fashion, and PROTEIN1 /3 complex and mimics the C-terminal domain of PROTEIN family proteins in catalyzing filament barbed end branching by PROTEIN /3 complex.
BioInfer.d252.s0.p13	N	Here we show that the N-terminal domain of PROTEIN binds one PROTEIN2 monomer, in a PROTEIN -like fashion, and PROTEIN /3 complex and mimics the C-terminal domain of PROTEIN family proteins in catalyzing filament barbed end branching by PROTEIN1 /3 complex.
BioInfer.d252.s0.p16	N	Here we show that the N-terminal domain of PROTEIN binds one PROTEIN monomer, in a PROTEIN -like fashion, and PROTEIN /3 complex and mimics the C-terminal domain of PROTEIN2 family proteins in catalyzing filament barbed end branching by PROTEIN1 /3 complex.
BioInfer.d252.s0.p17	N	Here we show that the N-terminal domain of PROTEIN2 binds one PROTEIN monomer, in a PROTEIN -like fashion, and PROTEIN /3 complex and mimics the C-terminal domain of PROTEIN family proteins in catalyzing filament barbed end branching by PROTEIN1 /3 complex.
BioInfer.d252.s0.p20	N	Here we show that the N-terminal domain of PROTEIN binds one PROTEIN1 monomer, in a PROTEIN -like fashion, and PROTEIN /3 complex and mimics the C-terminal domain of PROTEIN2 family proteins in catalyzing filament barbed end branching by PROTEIN /3 complex.
BioInfer.d252.s0.p21	P	Here we show that the N-terminal domain of PROTEIN2 binds one PROTEIN1 monomer, in a PROTEIN -like fashion, and PROTEIN /3 complex and mimics the C-terminal domain of PROTEIN family proteins in catalyzing filament barbed end branching by PROTEIN /3 complex.
BioInfer.d252.s0.p27	N	Here we show that the N-terminal domain of PROTEIN2 binds one PROTEIN monomer, in a PROTEIN -like fashion, and PROTEIN /3 complex and mimics the C-terminal domain of PROTEIN1 family proteins in catalyzing filament barbed end branching by PROTEIN /3 complex.
BioInfer.d253.s0.p0	P	Here we show that the PROTEIN1 -dependent proteolysis system is involved in the regulation of PROTEIN2 turnover.
BioInfer.d253.s1.p0	N	PROTEIN , but not PROTEIN2 , PROTEIN ( PROTEIN ) or PROTEIN , becomes stabilized when PROTEIN -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN1 .
BioInfer.d253.s1.p1	N	PROTEIN , but not PROTEIN , PROTEIN2 ( PROTEIN ) or PROTEIN , becomes stabilized when PROTEIN -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN1 .
BioInfer.d253.s1.p2	N	PROTEIN2 , but not PROTEIN , PROTEIN ( PROTEIN ) or PROTEIN , becomes stabilized when PROTEIN -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN1 .
BioInfer.d253.s1.p3	N	PROTEIN , but not PROTEIN , PROTEIN ( PROTEIN2 ) or PROTEIN , becomes stabilized when PROTEIN -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN1 .
BioInfer.d253.s1.p4	N	PROTEIN , but not PROTEIN , PROTEIN ( PROTEIN ) or PROTEIN , becomes stabilized when PROTEIN2 -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN1 .
BioInfer.d253.s1.p5	N	PROTEIN , but not PROTEIN , PROTEIN ( PROTEIN ) or PROTEIN2 , becomes stabilized when PROTEIN -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN1 .
BioInfer.d253.s1.p6	N	PROTEIN , but not PROTEIN1 , PROTEIN2 ( PROTEIN ) or PROTEIN , becomes stabilized when PROTEIN -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN .
BioInfer.d253.s1.p7	N	PROTEIN2 , but not PROTEIN1 , PROTEIN ( PROTEIN ) or PROTEIN , becomes stabilized when PROTEIN -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN .
BioInfer.d253.s1.p8	N	PROTEIN , but not PROTEIN1 , PROTEIN ( PROTEIN2 ) or PROTEIN , becomes stabilized when PROTEIN -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN .
BioInfer.d253.s1.p9	N	PROTEIN , but not PROTEIN1 , PROTEIN ( PROTEIN ) or PROTEIN , becomes stabilized when PROTEIN2 -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN .
BioInfer.d253.s1.p10	N	PROTEIN , but not PROTEIN1 , PROTEIN ( PROTEIN ) or PROTEIN2 , becomes stabilized when PROTEIN -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN .
BioInfer.d253.s1.p11	N	PROTEIN2 , but not PROTEIN , PROTEIN1 ( PROTEIN ) or PROTEIN , becomes stabilized when PROTEIN -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN .
BioInfer.d253.s1.p12	N	PROTEIN , but not PROTEIN , PROTEIN1 ( PROTEIN2 ) or PROTEIN , becomes stabilized when PROTEIN -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN .
BioInfer.d253.s1.p13	N	PROTEIN , but not PROTEIN , PROTEIN1 ( PROTEIN ) or PROTEIN , becomes stabilized when PROTEIN2 -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN .
BioInfer.d253.s1.p14	N	PROTEIN , but not PROTEIN , PROTEIN1 ( PROTEIN ) or PROTEIN2 , becomes stabilized when PROTEIN -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN .
BioInfer.d253.s1.p15	N	PROTEIN1 , but not PROTEIN , PROTEIN ( PROTEIN2 ) or PROTEIN , becomes stabilized when PROTEIN -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN .
BioInfer.d253.s1.p16	N	PROTEIN1 , but not PROTEIN , PROTEIN ( PROTEIN ) or PROTEIN , becomes stabilized when PROTEIN2 -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN .
BioInfer.d253.s1.p17	N	PROTEIN1 , but not PROTEIN , PROTEIN ( PROTEIN ) or PROTEIN2 , becomes stabilized when PROTEIN -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN .
BioInfer.d253.s1.p18	N	PROTEIN , but not PROTEIN , PROTEIN ( PROTEIN1 ) or PROTEIN , becomes stabilized when PROTEIN2 -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN .
BioInfer.d253.s1.p19	N	PROTEIN , but not PROTEIN , PROTEIN ( PROTEIN1 ) or PROTEIN2 , becomes stabilized when PROTEIN -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN .
BioInfer.d253.s1.p20	N	PROTEIN , but not PROTEIN , PROTEIN ( PROTEIN ) or PROTEIN2 , becomes stabilized when PROTEIN1 -mediated proteolysis is inhibited and this leads to the accumulation of multi-ubiquitinated forms of PROTEIN .
BioInfer.d254.s0.p0	N	Here, we show that the x-ray sensitivity of PROTEIN and PROTEIN1 mutant strains is suppressible by overexpression of PROTEIN2 or PROTEIN .
BioInfer.d254.s0.p1	N	Here, we show that the x-ray sensitivity of PROTEIN2 and PROTEIN1 mutant strains is suppressible by overexpression of PROTEIN or PROTEIN .
BioInfer.d254.s0.p2	N	Here, we show that the x-ray sensitivity of PROTEIN and PROTEIN1 mutant strains is suppressible by overexpression of PROTEIN or PROTEIN2 .
BioInfer.d254.s0.p3	N	Here, we show that the x-ray sensitivity of PROTEIN2 and PROTEIN mutant strains is suppressible by overexpression of PROTEIN1 or PROTEIN .
BioInfer.d254.s0.p4	N	Here, we show that the x-ray sensitivity of PROTEIN and PROTEIN mutant strains is suppressible by overexpression of PROTEIN1 or PROTEIN2 .
BioInfer.d254.s0.p5	N	Here, we show that the x-ray sensitivity of PROTEIN1 and PROTEIN mutant strains is suppressible by overexpression of PROTEIN or PROTEIN2 .
BioInfer.d255.s0.p0	P	PROTEIN2 binds to predicted alpha-helical coiled-coil regions of PROTEIN1 and PROTEIN , shown previously to be engaged in their direct interaction.
BioInfer.d255.s0.p1	P	PROTEIN binds to predicted alpha-helical coiled-coil regions of PROTEIN1 and PROTEIN2 , shown previously to be engaged in their direct interaction.
BioInfer.d255.s0.p2	P	PROTEIN1 binds to predicted alpha-helical coiled-coil regions of PROTEIN and PROTEIN2 , shown previously to be engaged in their direct interaction.
BioInfer.d256.s0.p0	N	Here, we sought to determine the spatial distributions of PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN , and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.
BioInfer.d256.s0.p1	N	Here, we sought to determine the spatial distributions of PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN , and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.
BioInfer.d256.s0.p2	N	Here, we sought to determine the spatial distributions of PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 , and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.
BioInfer.d256.s0.p3	N	Here, we sought to determine the spatial distributions of PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN , and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.
BioInfer.d256.s0.p4	N	Here, we sought to determine the spatial distributions of PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 , and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.
BioInfer.d256.s0.p5	N	Here, we sought to determine the spatial distributions of PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 , and whether different complexes of these proteins accumulate at steady state in polarized Madin-Darby canine kidney cells.
BioInfer.d257.s0.p0	P	Herpes simplex virus type 1 encodes a heterotrimeric PROTEIN2 complex that is composed of the products of the PROTEIN , PROTEIN1 , and PROTEIN genes.
BioInfer.d257.s0.p1	P	Herpes simplex virus type 1 encodes a heterotrimeric PROTEIN complex that is composed of the products of the PROTEIN2 , PROTEIN1 , and PROTEIN genes.
BioInfer.d257.s0.p2	P	Herpes simplex virus type 1 encodes a heterotrimeric PROTEIN complex that is composed of the products of the PROTEIN , PROTEIN1 , and PROTEIN2 genes.
BioInfer.d257.s0.p3	P	Herpes simplex virus type 1 encodes a heterotrimeric PROTEIN1 complex that is composed of the products of the PROTEIN2 , PROTEIN , and PROTEIN genes.
BioInfer.d257.s0.p4	P	Herpes simplex virus type 1 encodes a heterotrimeric PROTEIN1 complex that is composed of the products of the PROTEIN , PROTEIN , and PROTEIN2 genes.
BioInfer.d257.s0.p5	P	Herpes simplex virus type 1 encodes a heterotrimeric PROTEIN complex that is composed of the products of the PROTEIN1 , PROTEIN , and PROTEIN2 genes.
BioInfer.d258.s0.p0	N	Herpes simplex virus type 1 expresses a heterotrimeric PROTEIN , the subunits of which are encoded by the viral PROTEIN2 , PROTEIN1 and PROTEIN genes.
BioInfer.d258.s0.p1	P	Herpes simplex virus type 1 expresses a heterotrimeric PROTEIN2 , the subunits of which are encoded by the viral PROTEIN , PROTEIN1 and PROTEIN genes.
BioInfer.d258.s0.p2	N	Herpes simplex virus type 1 expresses a heterotrimeric PROTEIN , the subunits of which are encoded by the viral PROTEIN , PROTEIN1 and PROTEIN2 genes.
BioInfer.d258.s0.p3	P	Herpes simplex virus type 1 expresses a heterotrimeric PROTEIN2 , the subunits of which are encoded by the viral PROTEIN1 , PROTEIN and PROTEIN genes.
BioInfer.d258.s0.p4	N	Herpes simplex virus type 1 expresses a heterotrimeric PROTEIN , the subunits of which are encoded by the viral PROTEIN1 , PROTEIN and PROTEIN2 genes.
BioInfer.d258.s0.p5	P	Herpes simplex virus type 1 expresses a heterotrimeric PROTEIN1 , the subunits of which are encoded by the viral PROTEIN , PROTEIN and PROTEIN2 genes.
BioInfer.d258.s1.p0	N	The interactions of the PROTEIN protein with the PROTEIN2 and PROTEIN1 proteins were analysed by using the yeast two-hybrid system.
BioInfer.d258.s1.p1	P	The interactions of the PROTEIN2 protein with the PROTEIN and PROTEIN1 proteins were analysed by using the yeast two-hybrid system.
BioInfer.d258.s1.p2	P	The interactions of the PROTEIN2 protein with the PROTEIN1 and PROTEIN proteins were analysed by using the yeast two-hybrid system.
BioInfer.d259.s0.p0	P	Herpes simplex virus type 1 (HSV-1) encodes a PROTEIN that consists of the products of the PROTEIN , PROTEIN1 , and PROTEIN2 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).
BioInfer.d259.s0.p1	P	Herpes simplex virus type 1 (HSV-1) encodes a PROTEIN2 that consists of the products of the PROTEIN , PROTEIN1 , and PROTEIN genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).
BioInfer.d259.s0.p2	P	Herpes simplex virus type 1 (HSV-1) encodes a PROTEIN that consists of the products of the PROTEIN2 , PROTEIN1 , and PROTEIN genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).
BioInfer.d259.s0.p3	P	Herpes simplex virus type 1 (HSV-1) encodes a PROTEIN2 that consists of the products of the PROTEIN , PROTEIN , and PROTEIN1 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).
BioInfer.d259.s0.p4	P	Herpes simplex virus type 1 (HSV-1) encodes a PROTEIN that consists of the products of the PROTEIN2 , PROTEIN , and PROTEIN1 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).
BioInfer.d259.s0.p5	P	Herpes simplex virus type 1 (HSV-1) encodes a PROTEIN1 that consists of the products of the PROTEIN2 , PROTEIN , and PROTEIN genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).
BioInfer.d260.s0.p0	P	Herpes simplex virus type 1 (HSV-1) encodes a PROTEIN1 that consists of three polypeptides encoded by the PROTEIN , PROTEIN2 , and PROTEIN genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.
BioInfer.d260.s0.p1	P	Herpes simplex virus type 1 (HSV-1) encodes a PROTEIN1 that consists of three polypeptides encoded by the PROTEIN2 , PROTEIN , and PROTEIN genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.
BioInfer.d260.s0.p2	P	Herpes simplex virus type 1 (HSV-1) encodes a PROTEIN1 that consists of three polypeptides encoded by the PROTEIN , PROTEIN , and PROTEIN2 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.
BioInfer.d260.s0.p3	N	Herpes simplex virus type 1 (HSV-1) encodes a PROTEIN that consists of three polypeptides encoded by the PROTEIN2 , PROTEIN1 , and PROTEIN genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.
BioInfer.d260.s0.p4	N	Herpes simplex virus type 1 (HSV-1) encodes a PROTEIN that consists of three polypeptides encoded by the PROTEIN , PROTEIN1 , and PROTEIN2 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.
BioInfer.d260.s0.p5	N	Herpes simplex virus type 1 (HSV-1) encodes a PROTEIN that consists of three polypeptides encoded by the PROTEIN1 , PROTEIN , and PROTEIN2 genes (Crute, J.J., Tsurumi, T., Zhu, L., Weller, S.K., Olivo, P.D., Challberg, M.D., Mocarski, E.S., and Lehman, I.R. (1989) Proc. Natl.
BioInfer.d261.s0.p0	P	Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric PROTEIN2 composed of the products of the three DNA replication-specific genes PROTEIN , PROTEIN1 , and PROTEIN (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).
BioInfer.d261.s0.p1	P	Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric PROTEIN composed of the products of the three DNA replication-specific genes PROTEIN2 , PROTEIN1 , and PROTEIN (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).
BioInfer.d261.s0.p2	P	Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric PROTEIN composed of the products of the three DNA replication-specific genes PROTEIN , PROTEIN1 , and PROTEIN2 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).
BioInfer.d261.s0.p3	P	Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric PROTEIN1 composed of the products of the three DNA replication-specific genes PROTEIN2 , PROTEIN , and PROTEIN (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).
BioInfer.d261.s0.p4	P	Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric PROTEIN1 composed of the products of the three DNA replication-specific genes PROTEIN , PROTEIN , and PROTEIN2 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).
BioInfer.d261.s0.p5	P	Herpes simplex virus type 1 (HSV-1) encodes a heterotrimeric PROTEIN composed of the products of the three DNA replication-specific genes PROTEIN1 , PROTEIN , and PROTEIN2 (Crute, J. J., and Lehman, I. R. (1991) J. Biol. Chem. 266, 4484-4488).
BioInfer.d262.s0.p0	N	PROTEIN / PROTEIN1 treatment of LoVo reduced the amount of PROTEIN2 complexed with PROTEIN more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of PROTEIN , suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.
BioInfer.d262.s0.p1	N	PROTEIN / PROTEIN1 treatment of LoVo reduced the amount of PROTEIN complexed with PROTEIN2 more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of PROTEIN , suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.
BioInfer.d262.s0.p2	N	PROTEIN2 / PROTEIN1 treatment of LoVo reduced the amount of PROTEIN complexed with PROTEIN more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of PROTEIN , suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.
BioInfer.d262.s0.p3	N	PROTEIN / PROTEIN1 treatment of LoVo reduced the amount of PROTEIN complexed with PROTEIN more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of PROTEIN2 , suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.
BioInfer.d262.s0.p4	P	PROTEIN / PROTEIN treatment of LoVo reduced the amount of PROTEIN1 complexed with PROTEIN2 more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of PROTEIN , suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.
BioInfer.d262.s0.p5	N	PROTEIN2 / PROTEIN treatment of LoVo reduced the amount of PROTEIN1 complexed with PROTEIN more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of PROTEIN , suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.
BioInfer.d262.s0.p6	N	PROTEIN / PROTEIN treatment of LoVo reduced the amount of PROTEIN1 complexed with PROTEIN more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of PROTEIN2 , suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.
BioInfer.d262.s0.p7	N	PROTEIN2 / PROTEIN treatment of LoVo reduced the amount of PROTEIN complexed with PROTEIN1 more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of PROTEIN , suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.
BioInfer.d262.s0.p8	N	PROTEIN / PROTEIN treatment of LoVo reduced the amount of PROTEIN complexed with PROTEIN1 more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of PROTEIN2 , suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.
BioInfer.d262.s0.p9	N	PROTEIN1 / PROTEIN treatment of LoVo reduced the amount of PROTEIN complexed with PROTEIN more markedly than in L-10, but in both cell lines this reduction was not accompanied by increased tyrosine phosphorylation of PROTEIN2 , suggesting the presence of a mechanism other than phosphorylation for release from cell-cell adhesion during cell motility.
BioInfer.d263.s0.p0	P	High levels of PROTEIN1 suppress the lethality caused by overproduction of PROTEIN2 in yeast cells.
BioInfer.d263.s1.p0	P	In contrast, overexpression of the PROTEIN gene, PROTEIN2 , encoding an PROTEIN1 , leads to no very obvious phenotype.
BioInfer.d263.s1.p1	P	In contrast, overexpression of the PROTEIN2 gene, PROTEIN , encoding an PROTEIN1 , leads to no very obvious phenotype.
BioInfer.d263.s1.p2	N	In contrast, overexpression of the PROTEIN2 gene, PROTEIN1 , encoding an PROTEIN , leads to no very obvious phenotype.
BioInfer.d263.s2.p0	P	Interestingly, PROTEIN overproduction can compensate for the deleterious effects of too much PROTEIN1 in a PROTEIN2 concentration-dependent manner.
BioInfer.d263.s2.p1	P	Interestingly, PROTEIN2 overproduction can compensate for the deleterious effects of too much PROTEIN1 in a PROTEIN concentration-dependent manner.
BioInfer.d263.s2.p2	N	Interestingly, PROTEIN2 overproduction can compensate for the deleterious effects of too much PROTEIN in a PROTEIN1 concentration-dependent manner.
BioInfer.d264.s0.p0	N	PROTEIN2  PROTEIN showed at least seven sites of acetylation, PROTEIN  PROTEIN had six sites and PROTEIN1  PROTEIN had five sites.
BioInfer.d264.s0.p1	N	PROTEIN  PROTEIN showed at least seven sites of acetylation, PROTEIN  PROTEIN2 had six sites and PROTEIN1  PROTEIN had five sites.
BioInfer.d264.s0.p2	N	PROTEIN  PROTEIN showed at least seven sites of acetylation, PROTEIN2  PROTEIN had six sites and PROTEIN1  PROTEIN had five sites.
BioInfer.d264.s0.p3	P	PROTEIN  PROTEIN showed at least seven sites of acetylation, PROTEIN  PROTEIN had six sites and PROTEIN1  PROTEIN2 had five sites.
BioInfer.d264.s0.p4	N	PROTEIN  PROTEIN2 showed at least seven sites of acetylation, PROTEIN  PROTEIN had six sites and PROTEIN1  PROTEIN had five sites.
BioInfer.d264.s0.p5	N	PROTEIN1  PROTEIN showed at least seven sites of acetylation, PROTEIN  PROTEIN2 had six sites and PROTEIN  PROTEIN had five sites.
BioInfer.d264.s0.p6	N	PROTEIN1  PROTEIN showed at least seven sites of acetylation, PROTEIN2  PROTEIN had six sites and PROTEIN  PROTEIN had five sites.
BioInfer.d264.s0.p7	N	PROTEIN1  PROTEIN showed at least seven sites of acetylation, PROTEIN  PROTEIN had six sites and PROTEIN  PROTEIN2 had five sites.
BioInfer.d264.s0.p8	P	PROTEIN1  PROTEIN2 showed at least seven sites of acetylation, PROTEIN  PROTEIN had six sites and PROTEIN  PROTEIN had five sites.
BioInfer.d264.s0.p9	P	PROTEIN  PROTEIN showed at least seven sites of acetylation, PROTEIN2  PROTEIN1 had six sites and PROTEIN  PROTEIN had five sites.
BioInfer.d264.s0.p10	N	PROTEIN  PROTEIN showed at least seven sites of acetylation, PROTEIN  PROTEIN1 had six sites and PROTEIN  PROTEIN2 had five sites.
BioInfer.d264.s0.p11	N	PROTEIN  PROTEIN2 showed at least seven sites of acetylation, PROTEIN  PROTEIN1 had six sites and PROTEIN  PROTEIN had five sites.
BioInfer.d264.s0.p12	N	PROTEIN  PROTEIN showed at least seven sites of acetylation, PROTEIN1  PROTEIN had six sites and PROTEIN  PROTEIN2 had five sites.
BioInfer.d264.s0.p13	N	PROTEIN  PROTEIN2 showed at least seven sites of acetylation, PROTEIN1  PROTEIN had six sites and PROTEIN  PROTEIN had five sites.
BioInfer.d264.s0.p14	N	PROTEIN  PROTEIN2 showed at least seven sites of acetylation, PROTEIN  PROTEIN had six sites and PROTEIN  PROTEIN1 had five sites.
BioInfer.d265.s0.p0	P	How PROTEIN1 /barbed-end synergy controls PROTEIN2 polymerization: a kinetic model of the ATP hydrolysis circuit.
BioInfer.d265.s1.p0	N	In particular, both PROTEIN1 and free filament barbed ends have been shown to play major roles in the processing of ATP by PROTEIN2 .
BioInfer.d265.s2.p0	P	We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized PROTEIN and the flux of PROTEIN2 subunits through filaments are controlled by PROTEIN1 and free filament barbed ends through their interaction with ATP.
BioInfer.d265.s2.p1	P	We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized PROTEIN2 and the flux of PROTEIN subunits through filaments are controlled by PROTEIN1 and free filament barbed ends through their interaction with ATP.
BioInfer.d265.s2.p2	N	We have developed a new integrated kinetic model to examine how the maintenance of the pool of unpolymerized PROTEIN2 and the flux of PROTEIN1 subunits through filaments are controlled by PROTEIN and free filament barbed ends through their interaction with ATP.
BioInfer.d266.s0.p0	N	However, although expression of PROTEIN alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN with PROTEIN allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN1 ( PROTEIN2 ).
BioInfer.d266.s0.p1	N	However, although expression of PROTEIN alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN with PROTEIN2 allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN1 ( PROTEIN ).
BioInfer.d266.s0.p2	N	However, although expression of PROTEIN alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN2 with PROTEIN allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN1 ( PROTEIN ).
BioInfer.d266.s0.p3	N	However, although expression of PROTEIN alone will not induce G1 PROTEIN2 activity or S phase, coexpression of PROTEIN with PROTEIN allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN1 ( PROTEIN ).
BioInfer.d266.s0.p4	N	However, although expression of PROTEIN2 alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN with PROTEIN allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN1 ( PROTEIN ).
BioInfer.d266.s0.p5	P	However, although expression of PROTEIN alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN with PROTEIN allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN2  PROTEIN1 ( PROTEIN ).
BioInfer.d266.s0.p6	N	However, although expression of PROTEIN alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN with PROTEIN allows the generation of PROTEIN2 activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN1 ( PROTEIN ).
BioInfer.d266.s0.p7	N	However, although expression of PROTEIN alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN with PROTEIN2 allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN ( PROTEIN1 ).
BioInfer.d266.s0.p8	N	However, although expression of PROTEIN alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN2 with PROTEIN allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN ( PROTEIN1 ).
BioInfer.d266.s0.p9	N	However, although expression of PROTEIN alone will not induce G1 PROTEIN2 activity or S phase, coexpression of PROTEIN with PROTEIN allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN ( PROTEIN1 ).
BioInfer.d266.s0.p10	N	However, although expression of PROTEIN2 alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN with PROTEIN allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN ( PROTEIN1 ).
BioInfer.d266.s0.p11	P	However, although expression of PROTEIN alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN with PROTEIN allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN2  PROTEIN ( PROTEIN1 ).
BioInfer.d266.s0.p12	N	However, although expression of PROTEIN alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN with PROTEIN allows the generation of PROTEIN2 activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN ( PROTEIN1 ).
BioInfer.d266.s0.p13	P	However, although expression of PROTEIN alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN2 with PROTEIN1 allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d266.s0.p14	N	However, although expression of PROTEIN alone will not induce G1 PROTEIN2 activity or S phase, coexpression of PROTEIN with PROTEIN1 allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d266.s0.p15	N	However, although expression of PROTEIN2 alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN with PROTEIN1 allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d266.s0.p16	N	However, although expression of PROTEIN alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN with PROTEIN1 allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN2  PROTEIN ( PROTEIN ).
BioInfer.d266.s0.p17	P	However, although expression of PROTEIN alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN with PROTEIN1 allows the generation of PROTEIN2 activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d266.s0.p18	N	However, although expression of PROTEIN alone will not induce G1 PROTEIN2 activity or S phase, coexpression of PROTEIN1 with PROTEIN allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d266.s0.p19	N	However, although expression of PROTEIN2 alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN1 with PROTEIN allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d266.s0.p20	N	However, although expression of PROTEIN alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN1 with PROTEIN allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN2  PROTEIN ( PROTEIN ).
BioInfer.d266.s0.p21	P	However, although expression of PROTEIN alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN1 with PROTEIN allows the generation of PROTEIN2 activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d266.s0.p22	P	However, although expression of PROTEIN2 alone will not induce G1 PROTEIN1 activity or S phase, coexpression of PROTEIN with PROTEIN allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d266.s0.p23	N	However, although expression of PROTEIN alone will not induce G1 PROTEIN1 activity or S phase, coexpression of PROTEIN with PROTEIN allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN2  PROTEIN ( PROTEIN ).
BioInfer.d266.s0.p24	N	However, although expression of PROTEIN alone will not induce G1 PROTEIN1 activity or S phase, coexpression of PROTEIN with PROTEIN allows the generation of PROTEIN2 activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d266.s0.p25	N	However, although expression of PROTEIN1 alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN with PROTEIN allows the generation of PROTEIN activity and the induction of S phase, coincident with the loss of the PROTEIN2  PROTEIN ( PROTEIN ).
BioInfer.d266.s0.p26	N	However, although expression of PROTEIN1 alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN with PROTEIN allows the generation of PROTEIN2 activity and the induction of S phase, coincident with the loss of the PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d266.s0.p27	P	However, although expression of PROTEIN alone will not induce G1 PROTEIN activity or S phase, coexpression of PROTEIN with PROTEIN allows the generation of PROTEIN2 activity and the induction of S phase, coincident with the loss of the PROTEIN1  PROTEIN ( PROTEIN ).
BioInfer.d267.s0.p0	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN ( PROTEIN2 ), mouse PROTEIN , and the PROTEIN / PROTEIN and PROTEIN subunits of PROTEIN1 .
BioInfer.d267.s0.p1	P	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN ( PROTEIN ), mouse PROTEIN , and the PROTEIN2 / PROTEIN and PROTEIN subunits of PROTEIN1 .
BioInfer.d267.s0.p2	P	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN ( PROTEIN ), mouse PROTEIN , and the PROTEIN / PROTEIN2 and PROTEIN subunits of PROTEIN1 .
BioInfer.d267.s0.p3	P	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN ( PROTEIN ), mouse PROTEIN , and the PROTEIN / PROTEIN and PROTEIN2 subunits of PROTEIN1 .
BioInfer.d267.s0.p4	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN2 , PROTEIN ( PROTEIN ), mouse PROTEIN , and the PROTEIN / PROTEIN and PROTEIN subunits of PROTEIN1 .
BioInfer.d267.s0.p5	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN2 ( PROTEIN ), mouse PROTEIN , and the PROTEIN / PROTEIN and PROTEIN subunits of PROTEIN1 .
BioInfer.d267.s0.p6	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN ( PROTEIN ), mouse PROTEIN2 , and the PROTEIN / PROTEIN and PROTEIN subunits of PROTEIN1 .
BioInfer.d267.s0.p7	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN ( PROTEIN1 ), mouse PROTEIN , and the PROTEIN2 / PROTEIN and PROTEIN subunits of PROTEIN .
BioInfer.d267.s0.p8	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN ( PROTEIN1 ), mouse PROTEIN , and the PROTEIN / PROTEIN2 and PROTEIN subunits of PROTEIN .
BioInfer.d267.s0.p9	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN ( PROTEIN1 ), mouse PROTEIN , and the PROTEIN / PROTEIN and PROTEIN2 subunits of PROTEIN .
BioInfer.d267.s0.p10	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN2 , PROTEIN ( PROTEIN1 ), mouse PROTEIN , and the PROTEIN / PROTEIN and PROTEIN subunits of PROTEIN .
BioInfer.d267.s0.p11	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN2 ( PROTEIN1 ), mouse PROTEIN , and the PROTEIN / PROTEIN and PROTEIN subunits of PROTEIN .
BioInfer.d267.s0.p12	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN ( PROTEIN1 ), mouse PROTEIN2 , and the PROTEIN / PROTEIN and PROTEIN subunits of PROTEIN .
BioInfer.d267.s0.p13	P	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN ( PROTEIN ), mouse PROTEIN , and the PROTEIN1 / PROTEIN2 and PROTEIN subunits of PROTEIN .
BioInfer.d267.s0.p14	P	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN ( PROTEIN ), mouse PROTEIN , and the PROTEIN1 / PROTEIN and PROTEIN2 subunits of PROTEIN .
BioInfer.d267.s0.p15	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN2 , PROTEIN ( PROTEIN ), mouse PROTEIN , and the PROTEIN1 / PROTEIN and PROTEIN subunits of PROTEIN .
BioInfer.d267.s0.p16	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN2 ( PROTEIN ), mouse PROTEIN , and the PROTEIN1 / PROTEIN and PROTEIN subunits of PROTEIN .
BioInfer.d267.s0.p17	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN ( PROTEIN ), mouse PROTEIN2 , and the PROTEIN1 / PROTEIN and PROTEIN subunits of PROTEIN .
BioInfer.d267.s0.p18	P	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN ( PROTEIN ), mouse PROTEIN , and the PROTEIN / PROTEIN1 and PROTEIN2 subunits of PROTEIN .
BioInfer.d267.s0.p19	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN2 , PROTEIN ( PROTEIN ), mouse PROTEIN , and the PROTEIN / PROTEIN1 and PROTEIN subunits of PROTEIN .
BioInfer.d267.s0.p20	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN2 ( PROTEIN ), mouse PROTEIN , and the PROTEIN / PROTEIN1 and PROTEIN subunits of PROTEIN .
BioInfer.d267.s0.p21	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN ( PROTEIN ), mouse PROTEIN2 , and the PROTEIN / PROTEIN1 and PROTEIN subunits of PROTEIN .
BioInfer.d267.s0.p22	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN2 , PROTEIN ( PROTEIN ), mouse PROTEIN , and the PROTEIN / PROTEIN and PROTEIN1 subunits of PROTEIN .
BioInfer.d267.s0.p23	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN2 ( PROTEIN ), mouse PROTEIN , and the PROTEIN / PROTEIN and PROTEIN1 subunits of PROTEIN .
BioInfer.d267.s0.p24	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN ( PROTEIN ), mouse PROTEIN2 , and the PROTEIN / PROTEIN and PROTEIN1 subunits of PROTEIN .
BioInfer.d267.s0.p25	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN1 , PROTEIN2 ( PROTEIN ), mouse PROTEIN , and the PROTEIN / PROTEIN and PROTEIN subunits of PROTEIN .
BioInfer.d267.s0.p26	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN1 , PROTEIN ( PROTEIN ), mouse PROTEIN2 , and the PROTEIN / PROTEIN and PROTEIN subunits of PROTEIN .
BioInfer.d267.s0.p27	N	However, a number of mammalian DNA repair proteins lack NLS clusters; these proteins include PROTEIN , PROTEIN1 ( PROTEIN ), mouse PROTEIN2 , and the PROTEIN / PROTEIN and PROTEIN subunits of PROTEIN .
BioInfer.d267.s1.p0	N	NLS-less S.cerevisiae proteins include both PROTEIN and PROTEIN2 that function in the recombination and in the repair of double-strand breaks as well as the PROTEIN and PROTEIN1 molecules.
BioInfer.d267.s1.p1	N	NLS-less S.cerevisiae proteins include both PROTEIN and PROTEIN that function in the recombination and in the repair of double-strand breaks as well as the PROTEIN2 and PROTEIN1 molecules.
BioInfer.d267.s1.p2	N	NLS-less S.cerevisiae proteins include both PROTEIN2 and PROTEIN that function in the recombination and in the repair of double-strand breaks as well as the PROTEIN and PROTEIN1 molecules.
BioInfer.d267.s1.p3	N	NLS-less S.cerevisiae proteins include both PROTEIN and PROTEIN1 that function in the recombination and in the repair of double-strand breaks as well as the PROTEIN2 and PROTEIN molecules.
BioInfer.d267.s1.p4	N	NLS-less S.cerevisiae proteins include both PROTEIN2 and PROTEIN1 that function in the recombination and in the repair of double-strand breaks as well as the PROTEIN and PROTEIN molecules.
BioInfer.d267.s1.p5	N	NLS-less S.cerevisiae proteins include both PROTEIN2 and PROTEIN that function in the recombination and in the repair of double-strand breaks as well as the PROTEIN1 and PROTEIN molecules.
BioInfer.d268.s0.p0	P	However, disassembly of the PROTEIN cytoskeleton using Latrunculin-A does not alter PROTEIN 's location, indicating that PROTEIN1 establishes and maintains its location independent of the PROTEIN2 cytoskeleton.
BioInfer.d268.s0.p1	N	However, disassembly of the PROTEIN cytoskeleton using Latrunculin-A does not alter PROTEIN2 's location, indicating that PROTEIN1 establishes and maintains its location independent of the PROTEIN cytoskeleton.
BioInfer.d268.s0.p2	N	However, disassembly of the PROTEIN2 cytoskeleton using Latrunculin-A does not alter PROTEIN 's location, indicating that PROTEIN1 establishes and maintains its location independent of the PROTEIN cytoskeleton.
BioInfer.d268.s0.p3	N	However, disassembly of the PROTEIN cytoskeleton using Latrunculin-A does not alter PROTEIN2 's location, indicating that PROTEIN establishes and maintains its location independent of the PROTEIN1 cytoskeleton.
BioInfer.d268.s0.p4	N	However, disassembly of the PROTEIN2 cytoskeleton using Latrunculin-A does not alter PROTEIN 's location, indicating that PROTEIN establishes and maintains its location independent of the PROTEIN1 cytoskeleton.
BioInfer.d268.s0.p5	P	However, disassembly of the PROTEIN2 cytoskeleton using Latrunculin-A does not alter PROTEIN1 's location, indicating that PROTEIN establishes and maintains its location independent of the PROTEIN cytoskeleton.
BioInfer.d268.s1.p0	P	Using the two-hybrid system, we show that PROTEIN1 binds PROTEIN2 .
BioInfer.d269.s0.p0	N	However, immunofluorescence staining revealed a similar organisation of PROTEIN2 microfilaments, PROTEIN1 and phosphotyrosyl-containing proteins on both substrates.
BioInfer.d270.s0.p0	N	However, increases were also selective in nature, with increases in certain individual proteins, including PROTEIN1 (twofold to threefold), PROTEIN (2.5-fold to sevenfold), PROTEIN2 (threefold to sixfold), and PROTEIN , far exceeding overall increases in cellular protein content (20-40%).
BioInfer.d270.s0.p1	N	However, increases were also selective in nature, with increases in certain individual proteins, including PROTEIN1 (twofold to threefold), PROTEIN2 (2.5-fold to sevenfold), PROTEIN (threefold to sixfold), and PROTEIN , far exceeding overall increases in cellular protein content (20-40%).
BioInfer.d270.s0.p2	N	However, increases were also selective in nature, with increases in certain individual proteins, including PROTEIN1 (twofold to threefold), PROTEIN (2.5-fold to sevenfold), PROTEIN (threefold to sixfold), and PROTEIN2 , far exceeding overall increases in cellular protein content (20-40%).
BioInfer.d270.s0.p3	N	However, increases were also selective in nature, with increases in certain individual proteins, including PROTEIN (twofold to threefold), PROTEIN2 (2.5-fold to sevenfold), PROTEIN1 (threefold to sixfold), and PROTEIN , far exceeding overall increases in cellular protein content (20-40%).
BioInfer.d270.s0.p4	N	However, increases were also selective in nature, with increases in certain individual proteins, including PROTEIN (twofold to threefold), PROTEIN (2.5-fold to sevenfold), PROTEIN1 (threefold to sixfold), and PROTEIN2 , far exceeding overall increases in cellular protein content (20-40%).
BioInfer.d270.s0.p5	N	However, increases were also selective in nature, with increases in certain individual proteins, including PROTEIN (twofold to threefold), PROTEIN1 (2.5-fold to sevenfold), PROTEIN (threefold to sixfold), and PROTEIN2 , far exceeding overall increases in cellular protein content (20-40%).
BioInfer.d271.s0.p0	N	However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN  PROTEIN2 ( PROTEIN1 ), and the associated inhibition of PROTEIN - PROTEIN .
BioInfer.d271.s0.p1	P	However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN2  PROTEIN ( PROTEIN1 ), and the associated inhibition of PROTEIN - PROTEIN .
BioInfer.d271.s0.p2	N	However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN  PROTEIN ( PROTEIN1 ), and the associated inhibition of PROTEIN - PROTEIN2 .
BioInfer.d271.s0.p3	N	However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN  PROTEIN ( PROTEIN1 ), and the associated inhibition of PROTEIN2 - PROTEIN .
BioInfer.d271.s0.p4	P	However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN2  PROTEIN1 ( PROTEIN ), and the associated inhibition of PROTEIN - PROTEIN .
BioInfer.d271.s0.p5	N	However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN  PROTEIN1 ( PROTEIN ), and the associated inhibition of PROTEIN - PROTEIN2 .
BioInfer.d271.s0.p6	N	However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN  PROTEIN1 ( PROTEIN ), and the associated inhibition of PROTEIN2 - PROTEIN .
BioInfer.d271.s0.p7	P	However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN1  PROTEIN ( PROTEIN ), and the associated inhibition of PROTEIN - PROTEIN2 .
BioInfer.d271.s0.p8	P	However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN1  PROTEIN ( PROTEIN ), and the associated inhibition of PROTEIN2 - PROTEIN .
BioInfer.d271.s0.p9	P	However, in non-adherent cells no molecular mechanism has yet been proposed for the cell adhesion-dependent up-regulation of the PROTEIN  PROTEIN ( PROTEIN ), and the associated inhibition of PROTEIN2 - PROTEIN1 .
BioInfer.d272.s0.p4	N	However, once initiated, the synthesis of PROTEIN1 mRNA continued in the presence of cycloheximide, while the expression of PROTEIN2 , myosin heavy chain, and myogenin mRNA was abolished.
BioInfer.d272.s1.p0	N	These results suggest that muscle-specific processing of PROTEIN transcripts can continue to occur in the absence of PROTEIN2 expression unlike the expression of PROTEIN1 and PROTEIN mRNAs.
BioInfer.d272.s1.p1	N	These results suggest that muscle-specific processing of PROTEIN transcripts can continue to occur in the absence of PROTEIN expression unlike the expression of PROTEIN1 and PROTEIN2 mRNAs.
BioInfer.d272.s1.p2	N	These results suggest that muscle-specific processing of PROTEIN2 transcripts can continue to occur in the absence of PROTEIN expression unlike the expression of PROTEIN1 and PROTEIN mRNAs.
BioInfer.d272.s1.p3	N	These results suggest that muscle-specific processing of PROTEIN transcripts can continue to occur in the absence of PROTEIN1 expression unlike the expression of PROTEIN and PROTEIN2 mRNAs.
BioInfer.d272.s1.p4	P	These results suggest that muscle-specific processing of PROTEIN2 transcripts can continue to occur in the absence of PROTEIN1 expression unlike the expression of PROTEIN and PROTEIN mRNAs.
BioInfer.d272.s1.p5	N	These results suggest that muscle-specific processing of PROTEIN2 transcripts can continue to occur in the absence of PROTEIN expression unlike the expression of PROTEIN and PROTEIN1 mRNAs.
BioInfer.d273.s0.p0	N	However, regulation of PROTEIN1 function is generally unknown and controversy exists regarding PROTEIN effects on PROTEIN2 polymerization.
BioInfer.d273.s0.p1	N	However, regulation of PROTEIN1 function is generally unknown and controversy exists regarding PROTEIN2 effects on PROTEIN polymerization.
BioInfer.d273.s0.p2	P	However, regulation of PROTEIN function is generally unknown and controversy exists regarding PROTEIN2 effects on PROTEIN1 polymerization.
BioInfer.d274.s0.p0	N	However, similar to PROTEIN , PROTEIN1 is only present at the neuromuscular junction in mdx mouse muscle in which PROTEIN2 is absent.
BioInfer.d274.s0.p1	P	However, similar to PROTEIN2 , PROTEIN1 is only present at the neuromuscular junction in mdx mouse muscle in which PROTEIN is absent.
BioInfer.d274.s0.p2	N	However, similar to PROTEIN2 , PROTEIN is only present at the neuromuscular junction in mdx mouse muscle in which PROTEIN1 is absent.
BioInfer.d274.s1.p0	P	Identification of PROTEIN1 binding to PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d274.s1.p1	P	Identification of PROTEIN1 binding to PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d274.s1.p2	P	Identification of PROTEIN1 binding to PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d274.s1.p3	N	Identification of PROTEIN binding to PROTEIN2 , PROTEIN1 , and PROTEIN .
BioInfer.d274.s1.p4	N	Identification of PROTEIN binding to PROTEIN , PROTEIN1 , and PROTEIN2 .
BioInfer.d274.s1.p5	N	Identification of PROTEIN binding to PROTEIN1 , PROTEIN , and PROTEIN2 .
BioInfer.d275.s0.p0	N	However, smooth muscle contents of PROTEIN2 (26.0 +/- 1.8 vs. 19.1 +/- 2.2 micrograms/mg wet wt) and PROTEIN1 (5.5 +/- 0.4 vs. 2.0 +/- 0.3 microgram/mg wet wt) were greater (P < 0.04) in myometrium from late-pregnant vs. nonpregnant ewes.
BioInfer.d276.s0.p0	N	However, some proteins (e.g., PROTEIN1 ) and other agents (e.g., cytochalasin D) that bind to PROTEIN are affected by the presence of fluorescent labels, making PROTEIN2 intrinsic fluorescence potentially useful in investigating the interaction of these agents with PROTEIN , and in validating data obtained using labeled PROTEIN .
BioInfer.d276.s0.p1	N	However, some proteins (e.g., PROTEIN1 ) and other agents (e.g., cytochalasin D) that bind to PROTEIN are affected by the presence of fluorescent labels, making PROTEIN intrinsic fluorescence potentially useful in investigating the interaction of these agents with PROTEIN , and in validating data obtained using labeled PROTEIN2 .
BioInfer.d276.s0.p2	P	However, some proteins (e.g., PROTEIN1 ) and other agents (e.g., cytochalasin D) that bind to PROTEIN are affected by the presence of fluorescent labels, making PROTEIN intrinsic fluorescence potentially useful in investigating the interaction of these agents with PROTEIN2 , and in validating data obtained using labeled PROTEIN .
BioInfer.d276.s0.p3	P	However, some proteins (e.g., PROTEIN1 ) and other agents (e.g., cytochalasin D) that bind to PROTEIN2 are affected by the presence of fluorescent labels, making PROTEIN intrinsic fluorescence potentially useful in investigating the interaction of these agents with PROTEIN , and in validating data obtained using labeled PROTEIN .
BioInfer.d276.s0.p4	N	However, some proteins (e.g., PROTEIN ) and other agents (e.g., cytochalasin D) that bind to PROTEIN are affected by the presence of fluorescent labels, making PROTEIN1 intrinsic fluorescence potentially useful in investigating the interaction of these agents with PROTEIN , and in validating data obtained using labeled PROTEIN2 .
BioInfer.d276.s0.p5	N	However, some proteins (e.g., PROTEIN ) and other agents (e.g., cytochalasin D) that bind to PROTEIN are affected by the presence of fluorescent labels, making PROTEIN1 intrinsic fluorescence potentially useful in investigating the interaction of these agents with PROTEIN2 , and in validating data obtained using labeled PROTEIN .
BioInfer.d276.s0.p6	N	However, some proteins (e.g., PROTEIN ) and other agents (e.g., cytochalasin D) that bind to PROTEIN2 are affected by the presence of fluorescent labels, making PROTEIN1 intrinsic fluorescence potentially useful in investigating the interaction of these agents with PROTEIN , and in validating data obtained using labeled PROTEIN .
BioInfer.d276.s0.p7	N	However, some proteins (e.g., PROTEIN ) and other agents (e.g., cytochalasin D) that bind to PROTEIN are affected by the presence of fluorescent labels, making PROTEIN intrinsic fluorescence potentially useful in investigating the interaction of these agents with PROTEIN2 , and in validating data obtained using labeled PROTEIN1 .
BioInfer.d276.s0.p8	N	However, some proteins (e.g., PROTEIN ) and other agents (e.g., cytochalasin D) that bind to PROTEIN2 are affected by the presence of fluorescent labels, making PROTEIN intrinsic fluorescence potentially useful in investigating the interaction of these agents with PROTEIN , and in validating data obtained using labeled PROTEIN1 .
BioInfer.d276.s0.p9	N	However, some proteins (e.g., PROTEIN ) and other agents (e.g., cytochalasin D) that bind to PROTEIN2 are affected by the presence of fluorescent labels, making PROTEIN intrinsic fluorescence potentially useful in investigating the interaction of these agents with PROTEIN1 , and in validating data obtained using labeled PROTEIN .
BioInfer.d277.s0.p0	N	However, there were no changes in the expression of PROTEIN1 , PROTEIN , and PROTEIN2 .
BioInfer.d277.s0.p1	N	However, there were no changes in the expression of PROTEIN1 , PROTEIN2 , and PROTEIN .
BioInfer.d277.s0.p2	N	However, there were no changes in the expression of PROTEIN , PROTEIN2 , and PROTEIN1 .
BioInfer.d278.s0.p0	N	However, these rod structures were not observed in response to PROTEIN , forskolin, or TPA, suggesting that dephosphorylation of PROTEIN correlates with the reorganization of PROTEIN1 microfilaments but not with the nuclear transport of PROTEIN2 .
BioInfer.d278.s0.p1	N	However, these rod structures were not observed in response to PROTEIN2 , forskolin, or TPA, suggesting that dephosphorylation of PROTEIN correlates with the reorganization of PROTEIN1 microfilaments but not with the nuclear transport of PROTEIN .
BioInfer.d278.s0.p2	P	However, these rod structures were not observed in response to PROTEIN , forskolin, or TPA, suggesting that dephosphorylation of PROTEIN2 correlates with the reorganization of PROTEIN1 microfilaments but not with the nuclear transport of PROTEIN .
BioInfer.d278.s0.p3	N	However, these rod structures were not observed in response to PROTEIN2 , forskolin, or TPA, suggesting that dephosphorylation of PROTEIN correlates with the reorganization of PROTEIN microfilaments but not with the nuclear transport of PROTEIN1 .
BioInfer.d278.s0.p4	P	However, these rod structures were not observed in response to PROTEIN , forskolin, or TPA, suggesting that dephosphorylation of PROTEIN2 correlates with the reorganization of PROTEIN microfilaments but not with the nuclear transport of PROTEIN1 .
BioInfer.d278.s0.p5	N	However, these rod structures were not observed in response to PROTEIN1 , forskolin, or TPA, suggesting that dephosphorylation of PROTEIN2 correlates with the reorganization of PROTEIN microfilaments but not with the nuclear transport of PROTEIN .
BioInfer.d278.s1.p0	P	This suggests that dephosphorylation of PROTEIN and PROTEIN / PROTEIN1 by PROTEIN2 could be implicated in the disruption of PROTEIN -containing stress fibers and in the reorganization of microfilaments induced by this hormone.
BioInfer.d278.s1.p1	P	This suggests that dephosphorylation of PROTEIN and PROTEIN / PROTEIN1 by PROTEIN could be implicated in the disruption of PROTEIN2 -containing stress fibers and in the reorganization of microfilaments induced by this hormone.
BioInfer.d278.s1.p2	N	This suggests that dephosphorylation of PROTEIN and PROTEIN2 / PROTEIN1 by PROTEIN could be implicated in the disruption of PROTEIN -containing stress fibers and in the reorganization of microfilaments induced by this hormone.
BioInfer.d278.s1.p3	N	This suggests that dephosphorylation of PROTEIN2 and PROTEIN / PROTEIN1 by PROTEIN could be implicated in the disruption of PROTEIN -containing stress fibers and in the reorganization of microfilaments induced by this hormone.
BioInfer.d278.s1.p4	P	This suggests that dephosphorylation of PROTEIN and PROTEIN / PROTEIN by PROTEIN1 could be implicated in the disruption of PROTEIN2 -containing stress fibers and in the reorganization of microfilaments induced by this hormone.
BioInfer.d278.s1.p5	P	This suggests that dephosphorylation of PROTEIN and PROTEIN2 / PROTEIN by PROTEIN1 could be implicated in the disruption of PROTEIN -containing stress fibers and in the reorganization of microfilaments induced by this hormone.
BioInfer.d278.s1.p6	P	This suggests that dephosphorylation of PROTEIN2 and PROTEIN / PROTEIN by PROTEIN1 could be implicated in the disruption of PROTEIN -containing stress fibers and in the reorganization of microfilaments induced by this hormone.
BioInfer.d278.s1.p7	P	This suggests that dephosphorylation of PROTEIN and PROTEIN2 / PROTEIN by PROTEIN could be implicated in the disruption of PROTEIN1 -containing stress fibers and in the reorganization of microfilaments induced by this hormone.
BioInfer.d278.s1.p8	P	This suggests that dephosphorylation of PROTEIN2 and PROTEIN / PROTEIN by PROTEIN could be implicated in the disruption of PROTEIN1 -containing stress fibers and in the reorganization of microfilaments induced by this hormone.
BioInfer.d278.s1.p9	N	This suggests that dephosphorylation of PROTEIN2 and PROTEIN1 / PROTEIN by PROTEIN could be implicated in the disruption of PROTEIN -containing stress fibers and in the reorganization of microfilaments induced by this hormone.
BioInfer.d279.s0.p0	N	However, upon treatment with DMSO, cytoplasmic PROTEIN filaments were disrupted and intranuclear rod structures containing PROTEIN2 and PROTEIN were apparently larger and thicker in cells overexpressing PROTEIN1 than in normal cells.
BioInfer.d279.s0.p1	N	However, upon treatment with DMSO, cytoplasmic PROTEIN filaments were disrupted and intranuclear rod structures containing PROTEIN and PROTEIN2 were apparently larger and thicker in cells overexpressing PROTEIN1 than in normal cells.
BioInfer.d279.s0.p2	N	However, upon treatment with DMSO, cytoplasmic PROTEIN2 filaments were disrupted and intranuclear rod structures containing PROTEIN and PROTEIN were apparently larger and thicker in cells overexpressing PROTEIN1 than in normal cells.
BioInfer.d279.s0.p3	P	However, upon treatment with DMSO, cytoplasmic PROTEIN filaments were disrupted and intranuclear rod structures containing PROTEIN1 and PROTEIN2 were apparently larger and thicker in cells overexpressing PROTEIN than in normal cells.
BioInfer.d279.s0.p4	N	However, upon treatment with DMSO, cytoplasmic PROTEIN2 filaments were disrupted and intranuclear rod structures containing PROTEIN1 and PROTEIN were apparently larger and thicker in cells overexpressing PROTEIN than in normal cells.
BioInfer.d279.s0.p5	N	However, upon treatment with DMSO, cytoplasmic PROTEIN2 filaments were disrupted and intranuclear rod structures containing PROTEIN and PROTEIN1 were apparently larger and thicker in cells overexpressing PROTEIN than in normal cells.
BioInfer.d279.s1.p0	P	In cultured cells, PROTEIN , as well as PROTEIN1 , translocates from the cytoplasm into the nucleus together with PROTEIN2 and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.
BioInfer.d279.s1.p1	N	In cultured cells, PROTEIN2 , as well as PROTEIN1 , translocates from the cytoplasm into the nucleus together with PROTEIN and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.
BioInfer.d279.s1.p2	P	In cultured cells, PROTEIN2 , as well as PROTEIN , translocates from the cytoplasm into the nucleus together with PROTEIN1 and forms rod-like structures in response to heat shock or dimethylsulfoxide (DMSO) treatment.
BioInfer.d279.s2.p0	P	Stimulus-dependent disorganization of PROTEIN1 filaments induced by overexpression of PROTEIN2 in C2 myoblasts.
BioInfer.d280.s0.p0	N	However, when all of the four proteins ( PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN ) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.
BioInfer.d280.s0.p1	N	However, when all of the four proteins ( PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 ) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.
BioInfer.d280.s0.p2	N	However, when all of the four proteins ( PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN ) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.
BioInfer.d280.s0.p3	N	However, when all of the four proteins ( PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 ) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.
BioInfer.d280.s0.p4	N	However, when all of the four proteins ( PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN ) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.
BioInfer.d280.s0.p5	N	However, when all of the four proteins ( PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 ) were analysed as one group, a significant association was seen between reduction in immunoreactivity of at least one of these four proteins and the presence of metastases.
BioInfer.d280.s1.p0	N	Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for PROTEIN , in 50 (55.6 per cent) for PROTEIN1 , and in 50 (55.6 per cent) for PROTEIN2 .
BioInfer.d280.s1.p1	N	Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for PROTEIN2 , in 50 (55.6 per cent) for PROTEIN1 , and in 50 (55.6 per cent) for PROTEIN .
BioInfer.d280.s1.p2	N	Reduced or absent immunoreactivity in the tumour tissue was seen in 63 (70.0 per cent) for PROTEIN2 , in 50 (55.6 per cent) for PROTEIN , and in 50 (55.6 per cent) for PROTEIN1 .
BioInfer.d281.s0.p0	P	Human PROTEIN2 are multifunctional, single-domain proteins which directly link the PROTEIN1 microfilament system to a variety of signalling pathways via two spatially distinct binding sites.
BioInfer.d282.s0.p0	P	Human PROTEIN2 , a PROTEIN -like PROTEIN1 , binds selectively to mixed lipid bilayers.
BioInfer.d282.s0.p1	N	Human PROTEIN , a PROTEIN2 -like PROTEIN1 , binds selectively to mixed lipid bilayers.
BioInfer.d282.s0.p2	P	Human PROTEIN1 , a PROTEIN2 -like PROTEIN , binds selectively to mixed lipid bilayers.
BioInfer.d283.s0.p0	P	Human platelets contain PROTEIN2 , a potential regulator of PROTEIN1 polymerisability.
BioInfer.d284.s0.p0	N	Hypertonicity provoked PROTEIN -dependent tyrosine phosphorylation in PROTEIN2 , PROTEIN , and PROTEIN ( PROTEIN1 ) and caused the dissociation of PROTEIN from the contacts.
BioInfer.d284.s0.p1	N	Hypertonicity provoked PROTEIN -dependent tyrosine phosphorylation in PROTEIN , PROTEIN , and PROTEIN2 ( PROTEIN1 ) and caused the dissociation of PROTEIN from the contacts.
BioInfer.d284.s0.p2	P	Hypertonicity provoked PROTEIN2 -dependent tyrosine phosphorylation in PROTEIN , PROTEIN , and PROTEIN ( PROTEIN1 ) and caused the dissociation of PROTEIN from the contacts.
BioInfer.d284.s0.p3	N	Hypertonicity provoked PROTEIN -dependent tyrosine phosphorylation in PROTEIN , PROTEIN2 , and PROTEIN ( PROTEIN1 ) and caused the dissociation of PROTEIN from the contacts.
BioInfer.d284.s0.p4	N	Hypertonicity provoked PROTEIN -dependent tyrosine phosphorylation in PROTEIN , PROTEIN , and PROTEIN ( PROTEIN1 ) and caused the dissociation of PROTEIN2 from the contacts.
BioInfer.d284.s0.p5	N	Hypertonicity provoked PROTEIN -dependent tyrosine phosphorylation in PROTEIN1 , PROTEIN , and PROTEIN2 ( PROTEIN ) and caused the dissociation of PROTEIN from the contacts.
BioInfer.d284.s0.p6	P	Hypertonicity provoked PROTEIN2 -dependent tyrosine phosphorylation in PROTEIN1 , PROTEIN , and PROTEIN ( PROTEIN ) and caused the dissociation of PROTEIN from the contacts.
BioInfer.d284.s0.p7	N	Hypertonicity provoked PROTEIN -dependent tyrosine phosphorylation in PROTEIN1 , PROTEIN2 , and PROTEIN ( PROTEIN ) and caused the dissociation of PROTEIN from the contacts.
BioInfer.d284.s0.p8	N	Hypertonicity provoked PROTEIN -dependent tyrosine phosphorylation in PROTEIN1 , PROTEIN , and PROTEIN ( PROTEIN ) and caused the dissociation of PROTEIN2 from the contacts.
BioInfer.d284.s0.p9	P	Hypertonicity provoked PROTEIN2 -dependent tyrosine phosphorylation in PROTEIN , PROTEIN , and PROTEIN1 ( PROTEIN ) and caused the dissociation of PROTEIN from the contacts.
BioInfer.d284.s0.p10	N	Hypertonicity provoked PROTEIN -dependent tyrosine phosphorylation in PROTEIN , PROTEIN2 , and PROTEIN1 ( PROTEIN ) and caused the dissociation of PROTEIN from the contacts.
BioInfer.d284.s0.p11	N	Hypertonicity provoked PROTEIN -dependent tyrosine phosphorylation in PROTEIN , PROTEIN , and PROTEIN1 ( PROTEIN ) and caused the dissociation of PROTEIN2 from the contacts.
BioInfer.d284.s0.p12	P	Hypertonicity provoked PROTEIN1 -dependent tyrosine phosphorylation in PROTEIN , PROTEIN2 , and PROTEIN ( PROTEIN ) and caused the dissociation of PROTEIN from the contacts.
BioInfer.d284.s0.p13	N	Hypertonicity provoked PROTEIN1 -dependent tyrosine phosphorylation in PROTEIN , PROTEIN , and PROTEIN ( PROTEIN ) and caused the dissociation of PROTEIN2 from the contacts.
BioInfer.d284.s0.p14	N	Hypertonicity provoked PROTEIN -dependent tyrosine phosphorylation in PROTEIN , PROTEIN1 , and PROTEIN ( PROTEIN ) and caused the dissociation of PROTEIN2 from the contacts.
BioInfer.d285.s0.p0	P	Immediately after synthesis, PROTEIN , PROTEIN1 , and PROTEIN2 cosedimented as complexes.
BioInfer.d285.s0.p1	P	Immediately after synthesis, PROTEIN2 , PROTEIN1 , and PROTEIN cosedimented as complexes.
BioInfer.d285.s0.p2	P	Immediately after synthesis, PROTEIN2 , PROTEIN , and PROTEIN1 cosedimented as complexes.
BioInfer.d285.s1.p0	P	PROTEIN was not associated with these complexes after synthesis, but a subpopulation of PROTEIN2 joined the complex at a time coincident with the arrival of PROTEIN1 at the plasma membrane.
BioInfer.d285.s1.p1	N	PROTEIN2 was not associated with these complexes after synthesis, but a subpopulation of PROTEIN joined the complex at a time coincident with the arrival of PROTEIN1 at the plasma membrane.
BioInfer.d285.s1.p2	N	PROTEIN2 was not associated with these complexes after synthesis, but a subpopulation of PROTEIN1 joined the complex at a time coincident with the arrival of PROTEIN at the plasma membrane.
BioInfer.d286.s0.p0	N	Immunoblot and Northern blot analyses also revealed the presence of PROTEIN , PROTEIN1 , and PROTEIN ( PROTEIN2 ) in these cell lines.
BioInfer.d286.s0.p1	N	Immunoblot and Northern blot analyses also revealed the presence of PROTEIN2 , PROTEIN1 , and PROTEIN ( PROTEIN ) in these cell lines.
BioInfer.d286.s0.p2	N	Immunoblot and Northern blot analyses also revealed the presence of PROTEIN , PROTEIN1 , and PROTEIN2 ( PROTEIN ) in these cell lines.
BioInfer.d286.s0.p3	N	Immunoblot and Northern blot analyses also revealed the presence of PROTEIN2 , PROTEIN , and PROTEIN ( PROTEIN1 ) in these cell lines.
BioInfer.d286.s0.p4	N	Immunoblot and Northern blot analyses also revealed the presence of PROTEIN , PROTEIN , and PROTEIN2 ( PROTEIN1 ) in these cell lines.
BioInfer.d286.s0.p5	N	Immunoblot and Northern blot analyses also revealed the presence of PROTEIN1 , PROTEIN , and PROTEIN2 ( PROTEIN ) in these cell lines.
BioInfer.d287.s0.p0	N	Immunocytochemical localisation of PROTEIN1 and PROTEIN2 in the generative cell of angiosperm pollen: TEM studies on high-pressure frozen and freeze-substituted Ledebouria socialis Roth (Hyacinthaceae).
BioInfer.d287.s1.p0	N	We attribute the detection of PROTEIN1 and PROTEIN2 to the applied cryomethods which yield a much better preservation of ultrastructure and antigenicity of delicate cytoskeletal constituents than conventional fixation techniques.
BioInfer.d288.s0.p0	P	Immunofluorescence experiments showed that, like PROTEIN1 , PROTEIN is associated with the membrane PROTEIN2 cytoskeleton.
BioInfer.d288.s0.p1	N	Immunofluorescence experiments showed that, like PROTEIN1 , PROTEIN2 is associated with the membrane PROTEIN cytoskeleton.
BioInfer.d288.s0.p2	P	Immunofluorescence experiments showed that, like PROTEIN , PROTEIN2 is associated with the membrane PROTEIN1 cytoskeleton.
BioInfer.d288.s1.p0	N	In this study, we demonstrate using viscosity, sedimentation, and PROTEIN2 assembly rate assays that yeast PROTEIN1 (16 kD) possesses all of these properties.
BioInfer.d288.s2.p0	P	The NH2-terminal 16kD of PROTEIN1 , a 65-kD yeast protein identified by its ability to bind to PROTEIN filaments, is 23% identical to yeast PROTEIN2 .
BioInfer.d288.s2.p1	P	The NH2-terminal 16kD of PROTEIN1 , a 65-kD yeast protein identified by its ability to bind to PROTEIN2 filaments, is 23% identical to yeast PROTEIN .
BioInfer.d288.s2.p2	N	The NH2-terminal 16kD of PROTEIN , a 65-kD yeast protein identified by its ability to bind to PROTEIN2 filaments, is 23% identical to yeast PROTEIN1 .
BioInfer.d288.s3.p0	P	We have biochemically identified the Saccharomyces cerevisiae homologue of the mammalian PROTEIN1  PROTEIN2 .
BioInfer.d289.s0.p0	N	Immunofluorescence microscopy of monolayers between 2 and 3 h post- PROTEIN1 showed that PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.
BioInfer.d289.s0.p1	N	Immunofluorescence microscopy of monolayers between 2 and 3 h post- PROTEIN1 showed that PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.
BioInfer.d289.s0.p2	N	Immunofluorescence microscopy of monolayers between 2 and 3 h post- PROTEIN1 showed that PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.
BioInfer.d289.s0.p3	N	Immunofluorescence microscopy of monolayers between 2 and 3 h post- PROTEIN1 showed that PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.
BioInfer.d289.s0.p4	P	Immunofluorescence microscopy of monolayers between 2 and 3 h post- PROTEIN showed that PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.
BioInfer.d289.s0.p5	P	Immunofluorescence microscopy of monolayers between 2 and 3 h post- PROTEIN showed that PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.
BioInfer.d289.s0.p6	P	Immunofluorescence microscopy of monolayers between 2 and 3 h post- PROTEIN showed that PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.
BioInfer.d289.s0.p7	P	Immunofluorescence microscopy of monolayers between 2 and 3 h post- PROTEIN showed that PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.
BioInfer.d289.s0.p8	P	Immunofluorescence microscopy of monolayers between 2 and 3 h post- PROTEIN showed that PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.
BioInfer.d289.s0.p9	P	Immunofluorescence microscopy of monolayers between 2 and 3 h post- PROTEIN showed that PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 were colocalized both at the cell periphery and in newly formed bands that are perpendicular to the cell-cell border.
BioInfer.d290.s0.p0	N	Immunofluorescence studies with these antibodies showed PROTEIN1 to be distributed throughout the Acanthamoeba cytoplasm, except for lamellipodia, with the highest fluorescence intensity in cortical regions in which monomeric PROTEIN also was present, as shown by labeling with fluorescent PROTEIN2 .
BioInfer.d290.s0.p1	P	Immunofluorescence studies with these antibodies showed PROTEIN1 to be distributed throughout the Acanthamoeba cytoplasm, except for lamellipodia, with the highest fluorescence intensity in cortical regions in which monomeric PROTEIN2 also was present, as shown by labeling with fluorescent PROTEIN .
BioInfer.d290.s0.p2	N	Immunofluorescence studies with these antibodies showed PROTEIN to be distributed throughout the Acanthamoeba cytoplasm, except for lamellipodia, with the highest fluorescence intensity in cortical regions in which monomeric PROTEIN2 also was present, as shown by labeling with fluorescent PROTEIN1 .
BioInfer.d290.s1.p0	N	The differential localization of the three PROTEIN2 monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN functions predominantly as an PROTEIN1 monomer-binding protein; (2) PROTEIN regulates, or is regulated by, PIP2; and (3) PROTEIN inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.
BioInfer.d290.s1.p1	P	The differential localization of the three PROTEIN monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN2 functions predominantly as an PROTEIN1 monomer-binding protein; (2) PROTEIN regulates, or is regulated by, PIP2; and (3) PROTEIN inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.
BioInfer.d290.s1.p2	N	The differential localization of the three PROTEIN monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN functions predominantly as an PROTEIN1 monomer-binding protein; (2) PROTEIN2 regulates, or is regulated by, PIP2; and (3) PROTEIN inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.
BioInfer.d290.s1.p3	N	The differential localization of the three PROTEIN monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN functions predominantly as an PROTEIN1 monomer-binding protein; (2) PROTEIN regulates, or is regulated by, PIP2; and (3) PROTEIN2 inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.
BioInfer.d290.s1.p4	P	The differential localization of the three PROTEIN1 monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN2 functions predominantly as an PROTEIN monomer-binding protein; (2) PROTEIN regulates, or is regulated by, PIP2; and (3) PROTEIN inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.
BioInfer.d290.s1.p5	P	The differential localization of the three PROTEIN1 monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN functions predominantly as an PROTEIN monomer-binding protein; (2) PROTEIN2 regulates, or is regulated by, PIP2; and (3) PROTEIN inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.
BioInfer.d290.s1.p6	P	The differential localization of the three PROTEIN1 monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN functions predominantly as an PROTEIN monomer-binding protein; (2) PROTEIN regulates, or is regulated by, PIP2; and (3) PROTEIN2 inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.
BioInfer.d290.s1.p7	N	The differential localization of the three PROTEIN monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN1 functions predominantly as an PROTEIN monomer-binding protein; (2) PROTEIN2 regulates, or is regulated by, PIP2; and (3) PROTEIN inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.
BioInfer.d290.s1.p8	N	The differential localization of the three PROTEIN monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN1 functions predominantly as an PROTEIN monomer-binding protein; (2) PROTEIN regulates, or is regulated by, PIP2; and (3) PROTEIN2 inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.
BioInfer.d290.s1.p9	N	The differential localization of the three PROTEIN monomer-binding proteins suggests that they have different biologic functions in Acanthamoeba and is consistent with the hypotheses that (1) PROTEIN functions predominantly as an PROTEIN monomer-binding protein; (2) PROTEIN1 regulates, or is regulated by, PIP2; and (3) PROTEIN2 inhibits nucleation of new filaments and facilitates elongation of existing polarized filaments in actively motile regions.
BioInfer.d291.s0.p0	N	Immunohistochemical identification and localization of PROTEIN1 and PROTEIN2 in vestibular hair cells in the normal guinea pig and in a strain of the waltzing guinea pig.
BioInfer.d292.s0.p0	P	Immunohistochemical investigation of PROTEIN1 -anchoring proteins PROTEIN , PROTEIN and PROTEIN2 in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.
BioInfer.d292.s0.p1	P	Immunohistochemical investigation of PROTEIN1 -anchoring proteins PROTEIN , PROTEIN2 and PROTEIN in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.
BioInfer.d292.s0.p2	P	Immunohistochemical investigation of PROTEIN1 -anchoring proteins PROTEIN2 , PROTEIN and PROTEIN in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.
BioInfer.d292.s0.p3	N	Immunohistochemical investigation of PROTEIN -anchoring proteins PROTEIN , PROTEIN2 and PROTEIN1 in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.
BioInfer.d292.s0.p4	N	Immunohistochemical investigation of PROTEIN -anchoring proteins PROTEIN2 , PROTEIN and PROTEIN1 in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.
BioInfer.d292.s0.p5	N	Immunohistochemical investigation of PROTEIN -anchoring proteins PROTEIN2 , PROTEIN1 and PROTEIN in rat brain following lesion: a moderate reaction, confined to the astroglia of brain tracts.
BioInfer.d293.s0.p0	N	Immunohistochemical studies showed a strong reactivity of most LAM cells for PROTEIN2 and PROTEIN and a weak to moderate reactivity of a lesser number of cells for PROTEIN1 and PROTEIN .
BioInfer.d293.s0.p1	N	Immunohistochemical studies showed a strong reactivity of most LAM cells for PROTEIN and PROTEIN and a weak to moderate reactivity of a lesser number of cells for PROTEIN1 and PROTEIN2 .
BioInfer.d293.s0.p2	N	Immunohistochemical studies showed a strong reactivity of most LAM cells for PROTEIN and PROTEIN2 and a weak to moderate reactivity of a lesser number of cells for PROTEIN1 and PROTEIN .
BioInfer.d293.s0.p3	N	Immunohistochemical studies showed a strong reactivity of most LAM cells for PROTEIN1 and PROTEIN and a weak to moderate reactivity of a lesser number of cells for PROTEIN and PROTEIN2 .
BioInfer.d293.s0.p4	N	Immunohistochemical studies showed a strong reactivity of most LAM cells for PROTEIN1 and PROTEIN2 and a weak to moderate reactivity of a lesser number of cells for PROTEIN and PROTEIN .
BioInfer.d293.s0.p5	N	Immunohistochemical studies showed a strong reactivity of most LAM cells for PROTEIN and PROTEIN2 and a weak to moderate reactivity of a lesser number of cells for PROTEIN and PROTEIN1 .
BioInfer.d294.s0.p1	N	Immunohistochemistry for a variety of PROTEIN1 ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN2 protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p2	N	Immunohistochemistry for a variety of PROTEIN1 ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 was performed.
BioInfer.d294.s0.p3	N	Immunohistochemistry for a variety of PROTEIN1 ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN2 ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p4	N	Immunohistochemistry for a variety of PROTEIN1 ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN2 ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p5	N	Immunohistochemistry for a variety of PROTEIN1 ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p6	N	Immunohistochemistry for a variety of PROTEIN1 ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN2  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p7	N	Immunohistochemistry for a variety of PROTEIN1 ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p8	N	Immunohistochemistry for a variety of PROTEIN1 ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p9	N	Immunohistochemistry for a variety of PROTEIN1 ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p12	N	Immunohistochemistry for a variety of PROTEIN1 ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN was performed.
BioInfer.d294.s0.p13	N	Immunohistochemistry for a variety of PROTEIN1 ( PROTEIN2 ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p31	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN1 protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 was performed.
BioInfer.d294.s0.p32	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN2 ), PROTEIN1 protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p33	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN2 ( PROTEIN ), PROTEIN1 protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p34	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN1 protein, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p35	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN1 protein, PROTEIN2  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p36	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN1 protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p37	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN1 protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p38	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN1 protein, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p41	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN1 protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN was performed.
BioInfer.d294.s0.p42	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN2 ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN1 protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p45	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN2 ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 was performed.
BioInfer.d294.s0.p46	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN2 ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 was performed.
BioInfer.d294.s0.p47	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 was performed.
BioInfer.d294.s0.p48	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN2  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 was performed.
BioInfer.d294.s0.p49	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 was performed.
BioInfer.d294.s0.p50	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 was performed.
BioInfer.d294.s0.p51	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 was performed.
BioInfer.d294.s0.p54	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 was performed.
BioInfer.d294.s0.p55	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN2 ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 was performed.
BioInfer.d294.s0.p58	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN2 ( PROTEIN1 ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p59	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN1 ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p60	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN1 ), PROTEIN protein, PROTEIN2  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p61	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN1 ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p62	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN1 ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p63	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN1 ), PROTEIN protein, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p66	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN1 ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN was performed.
BioInfer.d294.s0.p67	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN2 ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN1 ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p70	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN1 ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p71	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN1 ( PROTEIN ), PROTEIN protein, PROTEIN2  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p72	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN1 ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p73	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN1 ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p74	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN1 ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p77	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN1 ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN was performed.
BioInfer.d294.s0.p78	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN2 ) (8/18, 1/10, 7, and 20), PROTEIN1 ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p81	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN2  PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p82	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p83	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p84	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p87	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN was performed.
BioInfer.d294.s0.p88	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN2 ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p91	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN1  PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p92	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN1  PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p93	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN1  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p96	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN1  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN was performed.
BioInfer.d294.s0.p97	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN2 ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN1  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p100	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p101	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p104	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN was performed.
BioInfer.d294.s0.p105	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN2 ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p108	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p111	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN was performed.
BioInfer.d294.s0.p112	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN2 ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p117	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN was performed.
BioInfer.d294.s0.p118	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN2 ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was performed.
BioInfer.d294.s0.p130	N	Immunohistochemistry for a variety of PROTEIN ( PROTEIN2 ) (8/18, 1/10, 7, and 20), PROTEIN ( PROTEIN ), PROTEIN protein, PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN was performed.
BioInfer.d295.s0.p0	N	Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to PROTEIN1 , PROTEIN and PROTEIN2 (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to PROTEIN ('-' and '+').
BioInfer.d295.s0.p1	N	Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to PROTEIN1 , PROTEIN2 and PROTEIN (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to PROTEIN ('-' and '+').
BioInfer.d295.s0.p2	N	Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to PROTEIN1 , PROTEIN and PROTEIN (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to PROTEIN2 ('-' and '+').
BioInfer.d295.s0.p3	N	Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to PROTEIN , PROTEIN2 and PROTEIN1 (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to PROTEIN ('-' and '+').
BioInfer.d295.s0.p4	N	Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to PROTEIN , PROTEIN and PROTEIN1 (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to PROTEIN2 ('-' and '+').
BioInfer.d295.s0.p5	N	Immunohistochemistry revealed that arteries had three distinct populations of cells in respect to PROTEIN , PROTEIN1 and PROTEIN (staining intensities '-', '+' or '++' for each protein), but only two populations in respect to PROTEIN2 ('-' and '+').
BioInfer.d296.s0.p0	N	Immunolocalization of PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN1 , and PROTEIN has rarely been investigated in human cholangiocarcinoma (CC).
BioInfer.d296.s0.p1	N	Immunolocalization of PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN1 , and PROTEIN has rarely been investigated in human cholangiocarcinoma (CC).
BioInfer.d296.s0.p2	N	Immunolocalization of PROTEIN ( PROTEIN ), PROTEIN2 , PROTEIN1 , and PROTEIN has rarely been investigated in human cholangiocarcinoma (CC).
BioInfer.d296.s0.p3	N	Immunolocalization of PROTEIN ( PROTEIN ), PROTEIN , PROTEIN1 , and PROTEIN2 has rarely been investigated in human cholangiocarcinoma (CC).
BioInfer.d296.s0.p4	N	Immunolocalization of PROTEIN1 ( PROTEIN2 ), PROTEIN , PROTEIN , and PROTEIN has rarely been investigated in human cholangiocarcinoma (CC).
BioInfer.d296.s0.p5	N	Immunolocalization of PROTEIN1 ( PROTEIN ), PROTEIN2 , PROTEIN , and PROTEIN has rarely been investigated in human cholangiocarcinoma (CC).
BioInfer.d296.s0.p6	N	Immunolocalization of PROTEIN1 ( PROTEIN ), PROTEIN , PROTEIN , and PROTEIN2 has rarely been investigated in human cholangiocarcinoma (CC).
BioInfer.d296.s0.p7	N	Immunolocalization of PROTEIN ( PROTEIN1 ), PROTEIN2 , PROTEIN , and PROTEIN has rarely been investigated in human cholangiocarcinoma (CC).
BioInfer.d296.s0.p8	N	Immunolocalization of PROTEIN ( PROTEIN1 ), PROTEIN , PROTEIN , and PROTEIN2 has rarely been investigated in human cholangiocarcinoma (CC).
BioInfer.d296.s0.p9	N	Immunolocalization of PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN , and PROTEIN2 has rarely been investigated in human cholangiocarcinoma (CC).
BioInfer.d296.s1.p0	N	In CC, membranous expression of PROTEIN1 , PROTEIN , and PROTEIN2 was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.
BioInfer.d296.s1.p1	N	In CC, membranous expression of PROTEIN1 , PROTEIN2 , and PROTEIN was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.
BioInfer.d296.s1.p2	N	In CC, membranous expression of PROTEIN , PROTEIN2 , and PROTEIN1 was the same or reduced when compared with non-cancerous bile ducts in the majority of CC.
BioInfer.d296.s2.p0	P	In normal livers, PROTEIN , PROTEIN and PROTEIN1 , but not PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p1	P	In normal livers, PROTEIN , PROTEIN and PROTEIN1 , but not PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p2	P	In normal livers, PROTEIN , PROTEIN and PROTEIN1 , but not PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p3	P	In normal livers, PROTEIN2 , PROTEIN and PROTEIN1 , but not PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p4	P	In normal livers, PROTEIN , PROTEIN and PROTEIN1 , but not PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p5	P	In normal livers, PROTEIN , PROTEIN2 and PROTEIN1 , but not PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p6	P	In normal livers, PROTEIN , PROTEIN and PROTEIN1 , but not PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p7	N	In normal livers, PROTEIN , PROTEIN and PROTEIN , but not PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p8	N	In normal livers, PROTEIN , PROTEIN and PROTEIN , but not PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p9	P	In normal livers, PROTEIN2 , PROTEIN and PROTEIN , but not PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p10	N	In normal livers, PROTEIN , PROTEIN and PROTEIN , but not PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p11	P	In normal livers, PROTEIN , PROTEIN2 and PROTEIN , but not PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p12	N	In normal livers, PROTEIN , PROTEIN and PROTEIN , but not PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p13	N	In normal livers, PROTEIN , PROTEIN and PROTEIN , but not PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p14	P	In normal livers, PROTEIN2 , PROTEIN and PROTEIN , but not PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p15	N	In normal livers, PROTEIN , PROTEIN and PROTEIN , but not PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p16	P	In normal livers, PROTEIN , PROTEIN2 and PROTEIN , but not PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p17	N	In normal livers, PROTEIN , PROTEIN and PROTEIN , but not PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p18	P	In normal livers, PROTEIN2 , PROTEIN and PROTEIN , but not PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p19	N	In normal livers, PROTEIN , PROTEIN and PROTEIN , but not PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p20	P	In normal livers, PROTEIN , PROTEIN2 and PROTEIN , but not PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p21	N	In normal livers, PROTEIN , PROTEIN and PROTEIN , but not PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p22	P	In normal livers, PROTEIN1 , PROTEIN and PROTEIN , but not PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p23	P	In normal livers, PROTEIN1 , PROTEIN2 and PROTEIN , but not PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p24	P	In normal livers, PROTEIN1 , PROTEIN and PROTEIN , but not PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p25	P	In normal livers, PROTEIN , PROTEIN2 and PROTEIN , but not PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p26	N	In normal livers, PROTEIN , PROTEIN and PROTEIN , but not PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s2.p27	P	In normal livers, PROTEIN , PROTEIN1 and PROTEIN , but not PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , were expressed at the cell membrane of normal intrahepatic bile ducts.
BioInfer.d296.s3.p0	N	We found that the down-regulation of PROTEIN2 , PROTEIN , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN labeling, or PROTEIN expression, except for PROTEIN1 , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p1	N	We found that the down-regulation of PROTEIN , PROTEIN , and PROTEIN2 expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN labeling, or PROTEIN expression, except for PROTEIN1 , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p2	N	We found that the down-regulation of PROTEIN , PROTEIN , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN labeling, or PROTEIN2 expression, except for PROTEIN1 , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p3	N	We found that the down-regulation of PROTEIN , PROTEIN , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN2 expression, PROTEIN labeling, or PROTEIN expression, except for PROTEIN1 , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p4	P	We found that the down-regulation of PROTEIN , PROTEIN , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN labeling, or PROTEIN expression, except for PROTEIN1 , the down-regulation of which was associated with PROTEIN2 down-regulation.
BioInfer.d296.s3.p5	N	We found that the down-regulation of PROTEIN , PROTEIN2 , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN labeling, or PROTEIN expression, except for PROTEIN1 , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p6	N	We found that the down-regulation of PROTEIN , PROTEIN , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN2 labeling, or PROTEIN expression, except for PROTEIN1 , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p7	N	We found that the down-regulation of PROTEIN1 , PROTEIN , and PROTEIN2 expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN labeling, or PROTEIN expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p8	P	We found that the down-regulation of PROTEIN1 , PROTEIN , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN labeling, or PROTEIN2 expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p9	P	We found that the down-regulation of PROTEIN1 , PROTEIN , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN2 expression, PROTEIN labeling, or PROTEIN expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p10	N	We found that the down-regulation of PROTEIN1 , PROTEIN , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN labeling, or PROTEIN expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN2 down-regulation.
BioInfer.d296.s3.p11	N	We found that the down-regulation of PROTEIN1 , PROTEIN2 , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN labeling, or PROTEIN expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p12	N	We found that the down-regulation of PROTEIN1 , PROTEIN , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN2 labeling, or PROTEIN expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p13	P	We found that the down-regulation of PROTEIN , PROTEIN , and PROTEIN1 expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN labeling, or PROTEIN2 expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p14	P	We found that the down-regulation of PROTEIN , PROTEIN , and PROTEIN1 expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN2 expression, PROTEIN labeling, or PROTEIN expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p15	N	We found that the down-regulation of PROTEIN , PROTEIN , and PROTEIN1 expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN labeling, or PROTEIN expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN2 down-regulation.
BioInfer.d296.s3.p16	N	We found that the down-regulation of PROTEIN , PROTEIN2 , and PROTEIN1 expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN labeling, or PROTEIN expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p17	N	We found that the down-regulation of PROTEIN , PROTEIN , and PROTEIN1 expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN2 labeling, or PROTEIN expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p18	N	We found that the down-regulation of PROTEIN , PROTEIN , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN2 expression, PROTEIN labeling, or PROTEIN1 expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p19	N	We found that the down-regulation of PROTEIN , PROTEIN , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN labeling, or PROTEIN1 expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN2 down-regulation.
BioInfer.d296.s3.p20	P	We found that the down-regulation of PROTEIN , PROTEIN2 , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN labeling, or PROTEIN1 expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p21	N	We found that the down-regulation of PROTEIN , PROTEIN , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN2 labeling, or PROTEIN1 expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p22	N	We found that the down-regulation of PROTEIN , PROTEIN , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN1 expression, PROTEIN labeling, or PROTEIN expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN2 down-regulation.
BioInfer.d296.s3.p23	P	We found that the down-regulation of PROTEIN , PROTEIN2 , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN1 expression, PROTEIN labeling, or PROTEIN expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p24	N	We found that the down-regulation of PROTEIN , PROTEIN , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN1 expression, PROTEIN2 labeling, or PROTEIN expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d296.s3.p25	N	We found that the down-regulation of PROTEIN , PROTEIN2 , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN labeling, or PROTEIN expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN1 down-regulation.
BioInfer.d296.s3.p26	N	We found that the down-regulation of PROTEIN , PROTEIN , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN2 labeling, or PROTEIN expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN1 down-regulation.
BioInfer.d296.s3.p27	N	We found that the down-regulation of PROTEIN , PROTEIN1 , and PROTEIN expression significantly correlated with tumor high grade, but not with vascular invasion, metastasis, PROTEIN expression, PROTEIN2 labeling, or PROTEIN expression, except for PROTEIN , the down-regulation of which was associated with PROTEIN down-regulation.
BioInfer.d297.s0.p0	N	Immunoprecipitation of PROTEIN1 was increased in response to both doses of CdCl2, while the immunoprecipitation of PROTEIN2 was little changed by either cadmium dose.
BioInfer.d298.s0.p0	N	Immunoprecipitation of metabolically labeled proteins with PROTEIN revealed three bands corresponding to PROTEIN , PROTEIN , and PROTEIN and a 79-kDa band which was apparently smaller than that of normal PROTEIN2 , indicating truncated PROTEIN1 .
BioInfer.d298.s0.p1	P	Immunoprecipitation of metabolically labeled proteins with PROTEIN2 revealed three bands corresponding to PROTEIN , PROTEIN , and PROTEIN and a 79-kDa band which was apparently smaller than that of normal PROTEIN , indicating truncated PROTEIN1 .
BioInfer.d298.s0.p2	N	Immunoprecipitation of metabolically labeled proteins with PROTEIN revealed three bands corresponding to PROTEIN2 , PROTEIN , and PROTEIN and a 79-kDa band which was apparently smaller than that of normal PROTEIN , indicating truncated PROTEIN1 .
BioInfer.d298.s0.p3	N	Immunoprecipitation of metabolically labeled proteins with PROTEIN revealed three bands corresponding to PROTEIN , PROTEIN2 , and PROTEIN and a 79-kDa band which was apparently smaller than that of normal PROTEIN , indicating truncated PROTEIN1 .
BioInfer.d298.s0.p4	N	Immunoprecipitation of metabolically labeled proteins with PROTEIN revealed three bands corresponding to PROTEIN , PROTEIN , and PROTEIN2 and a 79-kDa band which was apparently smaller than that of normal PROTEIN , indicating truncated PROTEIN1 .
BioInfer.d298.s0.p5	N	Immunoprecipitation of metabolically labeled proteins with PROTEIN2 revealed three bands corresponding to PROTEIN , PROTEIN , and PROTEIN and a 79-kDa band which was apparently smaller than that of normal PROTEIN1 , indicating truncated PROTEIN .
BioInfer.d298.s0.p6	N	Immunoprecipitation of metabolically labeled proteins with PROTEIN revealed three bands corresponding to PROTEIN2 , PROTEIN , and PROTEIN and a 79-kDa band which was apparently smaller than that of normal PROTEIN1 , indicating truncated PROTEIN .
BioInfer.d298.s0.p7	N	Immunoprecipitation of metabolically labeled proteins with PROTEIN revealed three bands corresponding to PROTEIN , PROTEIN2 , and PROTEIN and a 79-kDa band which was apparently smaller than that of normal PROTEIN1 , indicating truncated PROTEIN .
BioInfer.d298.s0.p8	N	Immunoprecipitation of metabolically labeled proteins with PROTEIN revealed three bands corresponding to PROTEIN , PROTEIN , and PROTEIN2 and a 79-kDa band which was apparently smaller than that of normal PROTEIN1 , indicating truncated PROTEIN .
BioInfer.d298.s0.p9	P	Immunoprecipitation of metabolically labeled proteins with PROTEIN1 revealed three bands corresponding to PROTEIN2 , PROTEIN , and PROTEIN and a 79-kDa band which was apparently smaller than that of normal PROTEIN , indicating truncated PROTEIN .
BioInfer.d298.s0.p10	P	Immunoprecipitation of metabolically labeled proteins with PROTEIN1 revealed three bands corresponding to PROTEIN , PROTEIN2 , and PROTEIN and a 79-kDa band which was apparently smaller than that of normal PROTEIN , indicating truncated PROTEIN .
BioInfer.d298.s0.p11	P	Immunoprecipitation of metabolically labeled proteins with PROTEIN1 revealed three bands corresponding to PROTEIN , PROTEIN , and PROTEIN2 and a 79-kDa band which was apparently smaller than that of normal PROTEIN , indicating truncated PROTEIN .
BioInfer.d298.s0.p12	N	Immunoprecipitation of metabolically labeled proteins with PROTEIN revealed three bands corresponding to PROTEIN1 , PROTEIN2 , and PROTEIN and a 79-kDa band which was apparently smaller than that of normal PROTEIN , indicating truncated PROTEIN .
BioInfer.d298.s0.p13	N	Immunoprecipitation of metabolically labeled proteins with PROTEIN revealed three bands corresponding to PROTEIN1 , PROTEIN , and PROTEIN2 and a 79-kDa band which was apparently smaller than that of normal PROTEIN , indicating truncated PROTEIN .
BioInfer.d298.s0.p14	N	Immunoprecipitation of metabolically labeled proteins with PROTEIN revealed three bands corresponding to PROTEIN , PROTEIN1 , and PROTEIN2 and a 79-kDa band which was apparently smaller than that of normal PROTEIN , indicating truncated PROTEIN .
BioInfer.d299.s0.p0	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN2 complexes, one composed of PROTEIN , PROTEIN and PROTEIN1 , and the other of PROTEIN , PROTEIN and PROTEIN .
BioInfer.d299.s0.p1	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN2 - PROTEIN complexes, one composed of PROTEIN , PROTEIN and PROTEIN1 , and the other of PROTEIN , PROTEIN and PROTEIN .
BioInfer.d299.s0.p2	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN complexes, one composed of PROTEIN , PROTEIN and PROTEIN1 , and the other of PROTEIN2 , PROTEIN and PROTEIN .
BioInfer.d299.s0.p3	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN complexes, one composed of PROTEIN , PROTEIN and PROTEIN1 , and the other of PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d299.s0.p4	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN complexes, one composed of PROTEIN , PROTEIN and PROTEIN1 , and the other of PROTEIN , PROTEIN2 and PROTEIN .
BioInfer.d299.s0.p5	P	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN complexes, one composed of PROTEIN2 , PROTEIN and PROTEIN1 , and the other of PROTEIN , PROTEIN and PROTEIN .
BioInfer.d299.s0.p6	P	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN complexes, one composed of PROTEIN , PROTEIN2 and PROTEIN1 , and the other of PROTEIN , PROTEIN and PROTEIN .
BioInfer.d299.s0.p7	P	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN2 - PROTEIN1 complexes, one composed of PROTEIN , PROTEIN and PROTEIN , and the other of PROTEIN , PROTEIN and PROTEIN .
BioInfer.d299.s0.p8	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN1 complexes, one composed of PROTEIN , PROTEIN and PROTEIN , and the other of PROTEIN2 , PROTEIN and PROTEIN .
BioInfer.d299.s0.p9	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN1 complexes, one composed of PROTEIN , PROTEIN and PROTEIN , and the other of PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d299.s0.p10	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN1 complexes, one composed of PROTEIN , PROTEIN and PROTEIN , and the other of PROTEIN , PROTEIN2 and PROTEIN .
BioInfer.d299.s0.p11	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN1 complexes, one composed of PROTEIN2 , PROTEIN and PROTEIN , and the other of PROTEIN , PROTEIN and PROTEIN .
BioInfer.d299.s0.p12	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN1 complexes, one composed of PROTEIN , PROTEIN2 and PROTEIN , and the other of PROTEIN , PROTEIN and PROTEIN .
BioInfer.d299.s0.p13	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN1 - PROTEIN complexes, one composed of PROTEIN , PROTEIN and PROTEIN , and the other of PROTEIN2 , PROTEIN and PROTEIN .
BioInfer.d299.s0.p14	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN1 - PROTEIN complexes, one composed of PROTEIN , PROTEIN and PROTEIN , and the other of PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d299.s0.p15	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN1 - PROTEIN complexes, one composed of PROTEIN , PROTEIN and PROTEIN , and the other of PROTEIN , PROTEIN2 and PROTEIN .
BioInfer.d299.s0.p16	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN1 - PROTEIN complexes, one composed of PROTEIN2 , PROTEIN and PROTEIN , and the other of PROTEIN , PROTEIN and PROTEIN .
BioInfer.d299.s0.p17	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN1 - PROTEIN complexes, one composed of PROTEIN , PROTEIN2 and PROTEIN , and the other of PROTEIN , PROTEIN and PROTEIN .
BioInfer.d299.s0.p18	P	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN complexes, one composed of PROTEIN , PROTEIN and PROTEIN , and the other of PROTEIN1 , PROTEIN and PROTEIN2 .
BioInfer.d299.s0.p19	P	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN complexes, one composed of PROTEIN , PROTEIN and PROTEIN , and the other of PROTEIN1 , PROTEIN2 and PROTEIN .
BioInfer.d299.s0.p20	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN complexes, one composed of PROTEIN2 , PROTEIN and PROTEIN , and the other of PROTEIN1 , PROTEIN and PROTEIN .
BioInfer.d299.s0.p21	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN complexes, one composed of PROTEIN , PROTEIN2 and PROTEIN , and the other of PROTEIN1 , PROTEIN and PROTEIN .
BioInfer.d299.s0.p22	P	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN complexes, one composed of PROTEIN , PROTEIN and PROTEIN , and the other of PROTEIN , PROTEIN2 and PROTEIN1 .
BioInfer.d299.s0.p23	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN complexes, one composed of PROTEIN2 , PROTEIN and PROTEIN , and the other of PROTEIN , PROTEIN and PROTEIN1 .
BioInfer.d299.s0.p24	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN complexes, one composed of PROTEIN , PROTEIN2 and PROTEIN , and the other of PROTEIN , PROTEIN and PROTEIN1 .
BioInfer.d299.s0.p25	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN complexes, one composed of PROTEIN2 , PROTEIN and PROTEIN , and the other of PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d299.s0.p26	N	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN complexes, one composed of PROTEIN , PROTEIN2 and PROTEIN , and the other of PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d299.s0.p27	P	Immunoprecipitations showed in both cell lines the presence of two different PROTEIN - PROTEIN complexes, one composed of PROTEIN1 , PROTEIN2 and PROTEIN , and the other of PROTEIN , PROTEIN and PROTEIN .
BioInfer.d300.s0.p0	N	Immunoprecipitation with an PROTEIN1 mAb, which is known to co-precipitate the PROTEIN , demonstrated that the three poorly differentiated cell lines expressing PROTEIN did not co-precipitate PROTEIN , although all of the moderately-well differentiated cell lines expressed both PROTEIN and PROTEIN2 .
BioInfer.d300.s0.p1	N	Immunoprecipitation with an PROTEIN1 mAb, which is known to co-precipitate the PROTEIN , demonstrated that the three poorly differentiated cell lines expressing PROTEIN did not co-precipitate PROTEIN2 , although all of the moderately-well differentiated cell lines expressed both PROTEIN and PROTEIN .
BioInfer.d300.s0.p2	N	Immunoprecipitation with an PROTEIN1 mAb, which is known to co-precipitate the PROTEIN , demonstrated that the three poorly differentiated cell lines expressing PROTEIN did not co-precipitate PROTEIN , although all of the moderately-well differentiated cell lines expressed both PROTEIN2 and PROTEIN .
BioInfer.d300.s0.p3	P	Immunoprecipitation with an PROTEIN1 mAb, which is known to co-precipitate the PROTEIN2 , demonstrated that the three poorly differentiated cell lines expressing PROTEIN did not co-precipitate PROTEIN , although all of the moderately-well differentiated cell lines expressed both PROTEIN and PROTEIN .
BioInfer.d300.s0.p4	N	Immunoprecipitation with an PROTEIN1 mAb, which is known to co-precipitate the PROTEIN , demonstrated that the three poorly differentiated cell lines expressing PROTEIN2 did not co-precipitate PROTEIN , although all of the moderately-well differentiated cell lines expressed both PROTEIN and PROTEIN .
BioInfer.d300.s0.p5	N	Immunoprecipitation with an PROTEIN mAb, which is known to co-precipitate the PROTEIN , demonstrated that the three poorly differentiated cell lines expressing PROTEIN did not co-precipitate PROTEIN2 , although all of the moderately-well differentiated cell lines expressed both PROTEIN and PROTEIN1 .
BioInfer.d300.s0.p6	N	Immunoprecipitation with an PROTEIN mAb, which is known to co-precipitate the PROTEIN , demonstrated that the three poorly differentiated cell lines expressing PROTEIN did not co-precipitate PROTEIN , although all of the moderately-well differentiated cell lines expressed both PROTEIN2 and PROTEIN1 .
BioInfer.d300.s0.p7	N	Immunoprecipitation with an PROTEIN mAb, which is known to co-precipitate the PROTEIN2 , demonstrated that the three poorly differentiated cell lines expressing PROTEIN did not co-precipitate PROTEIN , although all of the moderately-well differentiated cell lines expressed both PROTEIN and PROTEIN1 .
BioInfer.d300.s0.p8	N	Immunoprecipitation with an PROTEIN mAb, which is known to co-precipitate the PROTEIN , demonstrated that the three poorly differentiated cell lines expressing PROTEIN2 did not co-precipitate PROTEIN , although all of the moderately-well differentiated cell lines expressed both PROTEIN and PROTEIN1 .
BioInfer.d300.s0.p9	N	Immunoprecipitation with an PROTEIN mAb, which is known to co-precipitate the PROTEIN , demonstrated that the three poorly differentiated cell lines expressing PROTEIN did not co-precipitate PROTEIN1 , although all of the moderately-well differentiated cell lines expressed both PROTEIN2 and PROTEIN .
BioInfer.d300.s0.p10	N	Immunoprecipitation with an PROTEIN mAb, which is known to co-precipitate the PROTEIN2 , demonstrated that the three poorly differentiated cell lines expressing PROTEIN did not co-precipitate PROTEIN1 , although all of the moderately-well differentiated cell lines expressed both PROTEIN and PROTEIN .
BioInfer.d300.s0.p11	P	Immunoprecipitation with an PROTEIN mAb, which is known to co-precipitate the PROTEIN , demonstrated that the three poorly differentiated cell lines expressing PROTEIN2 did not co-precipitate PROTEIN1 , although all of the moderately-well differentiated cell lines expressed both PROTEIN and PROTEIN .
BioInfer.d300.s0.p12	N	Immunoprecipitation with an PROTEIN mAb, which is known to co-precipitate the PROTEIN2 , demonstrated that the three poorly differentiated cell lines expressing PROTEIN did not co-precipitate PROTEIN , although all of the moderately-well differentiated cell lines expressed both PROTEIN1 and PROTEIN .
BioInfer.d300.s0.p13	N	Immunoprecipitation with an PROTEIN mAb, which is known to co-precipitate the PROTEIN , demonstrated that the three poorly differentiated cell lines expressing PROTEIN2 did not co-precipitate PROTEIN , although all of the moderately-well differentiated cell lines expressed both PROTEIN1 and PROTEIN .
BioInfer.d300.s0.p14	N	Immunoprecipitation with an PROTEIN mAb, which is known to co-precipitate the PROTEIN1 , demonstrated that the three poorly differentiated cell lines expressing PROTEIN2 did not co-precipitate PROTEIN , although all of the moderately-well differentiated cell lines expressed both PROTEIN and PROTEIN .
BioInfer.d301.s0.p0	N	Immunoreactive PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
BioInfer.d301.s0.p1	N	Immunoreactive PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
BioInfer.d301.s0.p2	N	Immunoreactive PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
BioInfer.d301.s0.p3	N	Immunoreactive PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
BioInfer.d301.s0.p4	N	Immunoreactive PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
BioInfer.d301.s0.p5	N	Immunoreactive PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival.
BioInfer.d302.s0.p0	N	Immunoreactivity for PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN was observed in all 15 specimens.
BioInfer.d302.s0.p1	N	Immunoreactivity for PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 was observed in all 15 specimens.
BioInfer.d302.s0.p2	N	Immunoreactivity for PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN was observed in all 15 specimens.
BioInfer.d302.s0.p3	N	Immunoreactivity for PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN was observed in all 15 specimens.
BioInfer.d302.s0.p4	N	Immunoreactivity for PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 was observed in all 15 specimens.
BioInfer.d302.s0.p5	N	Immunoreactivity for PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN was observed in all 15 specimens.
BioInfer.d302.s0.p6	N	Immunoreactivity for PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN was observed in all 15 specimens.
BioInfer.d302.s0.p7	N	Immunoreactivity for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 was observed in all 15 specimens.
BioInfer.d302.s0.p8	N	Immunoreactivity for PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 was observed in all 15 specimens.
BioInfer.d302.s0.p9	N	Immunoreactivity for PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN was observed in all 15 specimens.
BioInfer.d303.s0.p0	P	Immunostaining showed that APBs also contain PROTEIN , PROTEIN1 , and PROTEIN2 , proteins involved in DNA synthesis and recombination.
BioInfer.d303.s0.p1	P	Immunostaining showed that APBs also contain PROTEIN2 , PROTEIN1 , and PROTEIN , proteins involved in DNA synthesis and recombination.
BioInfer.d303.s0.p2	P	Immunostaining showed that APBs also contain PROTEIN2 , PROTEIN , and PROTEIN1 , proteins involved in DNA synthesis and recombination.
BioInfer.d304.s0.p0	N	Impact of PROTEIN1 on PROTEIN2 -bound nucleotide exchange and PROTEIN polymerization dynamics.
BioInfer.d304.s0.p1	P	Impact of PROTEIN1 on PROTEIN -bound nucleotide exchange and PROTEIN2 polymerization dynamics.
BioInfer.d304.s0.p2	N	Impact of PROTEIN on PROTEIN1 -bound nucleotide exchange and PROTEIN2 polymerization dynamics.
BioInfer.d305.s0.p0	P	In 50 mM KCl, high concentrations of Acanthamoeba PROTEIN1 inhibit the elongation rate of PROTEIN2 filaments measured directly by electron microscopy, but the effect is minimal in KCl with 2 MgCl2.
BioInfer.d306.s0.p0	P	In a blot overlay experiment, purified 125I-labeled recombinant PROTEIN1 bound not only to plant PROTEIN2 , but also to mammalian PROTEIN , demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.
BioInfer.d306.s0.p1	P	In a blot overlay experiment, purified 125I-labeled recombinant PROTEIN1 bound not only to plant PROTEIN , but also to mammalian PROTEIN2 , demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.
BioInfer.d306.s0.p2	N	In a blot overlay experiment, purified 125I-labeled recombinant PROTEIN bound not only to plant PROTEIN1 , but also to mammalian PROTEIN2 , demonstrating that cytoskeletal components from distantly related organisms with divergent primary structures can be compatible.
BioInfer.d307.s0.p0	N	In Acanthamoeba PROTEIN polymerization is regulated, at least in part, by PROTEIN , which binds to PROTEIN2 monomers, and by PROTEIN1 , which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.
BioInfer.d307.s0.p1	N	In Acanthamoeba PROTEIN polymerization is regulated, at least in part, by PROTEIN2 , which binds to PROTEIN monomers, and by PROTEIN1 , which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.
BioInfer.d307.s0.p2	P	In Acanthamoeba PROTEIN2 polymerization is regulated, at least in part, by PROTEIN , which binds to PROTEIN monomers, and by PROTEIN1 , which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.
BioInfer.d307.s0.p3	P	In Acanthamoeba PROTEIN polymerization is regulated, at least in part, by PROTEIN2 , which binds to PROTEIN1 monomers, and by PROTEIN , which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.
BioInfer.d307.s0.p4	N	In Acanthamoeba PROTEIN2 polymerization is regulated, at least in part, by PROTEIN , which binds to PROTEIN1 monomers, and by PROTEIN , which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.
BioInfer.d307.s0.p5	P	In Acanthamoeba PROTEIN2 polymerization is regulated, at least in part, by PROTEIN1 , which binds to PROTEIN monomers, and by PROTEIN , which both nucleates polymerization and blocks monomer addition at the 'barbed' end of the filament.
BioInfer.d308.s0.p0	P	In Acanthamoeba, the two isoforms of PROTEIN2 may have specialized functions on the basis of their identical (approximately 10 microM) affinities for PROTEIN1 monomers and different affinities for PIP2.
BioInfer.d309.s0.p0	N	Inactivation of the PROTEIN pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the PROTEIN  PROTEIN ( PROTEIN1 ) and/or up-regulation of PROTEIN2 .
BioInfer.d309.s0.p1	P	Inactivation of the PROTEIN pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the PROTEIN2  PROTEIN ( PROTEIN1 ) and/or up-regulation of PROTEIN .
BioInfer.d309.s0.p2	N	Inactivation of the PROTEIN pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the PROTEIN  PROTEIN2 ( PROTEIN1 ) and/or up-regulation of PROTEIN .
BioInfer.d309.s0.p3	P	Inactivation of the PROTEIN2 pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the PROTEIN  PROTEIN ( PROTEIN1 ) and/or up-regulation of PROTEIN .
BioInfer.d309.s0.p4	N	Inactivation of the PROTEIN pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the PROTEIN2  PROTEIN ( PROTEIN ) and/or up-regulation of PROTEIN1 .
BioInfer.d309.s0.p5	N	Inactivation of the PROTEIN pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the PROTEIN  PROTEIN2 ( PROTEIN ) and/or up-regulation of PROTEIN1 .
BioInfer.d309.s0.p6	P	Inactivation of the PROTEIN2 pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the PROTEIN  PROTEIN ( PROTEIN ) and/or up-regulation of PROTEIN1 .
BioInfer.d309.s0.p7	P	Inactivation of the PROTEIN pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the PROTEIN1  PROTEIN2 ( PROTEIN ) and/or up-regulation of PROTEIN .
BioInfer.d309.s0.p8	N	Inactivation of the PROTEIN2 pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the PROTEIN1  PROTEIN ( PROTEIN ) and/or up-regulation of PROTEIN .
BioInfer.d309.s0.p9	P	Inactivation of the PROTEIN2 pathway in non-small cell lung carcinoma (NSCLC) occurs mostly through inactivation of the PROTEIN  PROTEIN1 ( PROTEIN ) and/or up-regulation of PROTEIN .
BioInfer.d310.s0.p0	P	In addition, interactions with components of the phosphatidylinositol cycle and the PROTEIN1 pathway in yeast implicate PROTEIN2 as an important link through which the PROTEIN cytoskeleton is able to communicate with major signaling pathways.
BioInfer.d310.s0.p1	N	In addition, interactions with components of the phosphatidylinositol cycle and the PROTEIN1 pathway in yeast implicate PROTEIN as an important link through which the PROTEIN2 cytoskeleton is able to communicate with major signaling pathways.
BioInfer.d310.s0.p2	P	In addition, interactions with components of the phosphatidylinositol cycle and the PROTEIN pathway in yeast implicate PROTEIN1 as an important link through which the PROTEIN2 cytoskeleton is able to communicate with major signaling pathways.
BioInfer.d310.s1.p0	P	So far, three ligands for PROTEIN2 have been well-characterized in vitro: PROTEIN1 monomers, membrane polyphosphoinositides and poly-L-proline.
BioInfer.d311.s0.p0	N	In addition to their role in mismatch repair (MMR), the PROTEIN1 and PROTEIN2 gene products are required to remove 3' nonhomologous DNA tails during genetic recombination.
BioInfer.d312.s0.p0	N	In addition to the PROTEIN -induced increase in the general protein synthesis, stimulation with PROTEIN led to a 2.4-fold increase in net PROTEIN2 protein synthesis and a 3.3-fold increase in net PROTEIN1 synthesis.
BioInfer.d312.s0.p1	N	In addition to the PROTEIN2 -induced increase in the general protein synthesis, stimulation with PROTEIN led to a 2.4-fold increase in net PROTEIN protein synthesis and a 3.3-fold increase in net PROTEIN1 synthesis.
BioInfer.d312.s0.p2	P	In addition to the PROTEIN -induced increase in the general protein synthesis, stimulation with PROTEIN2 led to a 2.4-fold increase in net PROTEIN protein synthesis and a 3.3-fold increase in net PROTEIN1 synthesis.
BioInfer.d312.s0.p3	N	In addition to the PROTEIN2 -induced increase in the general protein synthesis, stimulation with PROTEIN led to a 2.4-fold increase in net PROTEIN1 protein synthesis and a 3.3-fold increase in net PROTEIN synthesis.
BioInfer.d312.s0.p4	P	In addition to the PROTEIN -induced increase in the general protein synthesis, stimulation with PROTEIN2 led to a 2.4-fold increase in net PROTEIN1 protein synthesis and a 3.3-fold increase in net PROTEIN synthesis.
BioInfer.d312.s0.p5	N	In addition to the PROTEIN1 -induced increase in the general protein synthesis, stimulation with PROTEIN2 led to a 2.4-fold increase in net PROTEIN protein synthesis and a 3.3-fold increase in net PROTEIN synthesis.
BioInfer.d313.s0.p0	N	In addition, we also provide new evidence to suggest that PROTEIN stimulation of the PROTEIN promoter involves increased physical interactions with acetylated PROTEIN  PROTEIN2 and PROTEIN1  PROTEIN .
BioInfer.d313.s0.p1	N	In addition, we also provide new evidence to suggest that PROTEIN stimulation of the PROTEIN2 promoter involves increased physical interactions with acetylated PROTEIN  PROTEIN and PROTEIN1  PROTEIN .
BioInfer.d313.s0.p2	N	In addition, we also provide new evidence to suggest that PROTEIN2 stimulation of the PROTEIN promoter involves increased physical interactions with acetylated PROTEIN  PROTEIN and PROTEIN1  PROTEIN .
BioInfer.d313.s0.p3	N	In addition, we also provide new evidence to suggest that PROTEIN stimulation of the PROTEIN promoter involves increased physical interactions with acetylated PROTEIN2  PROTEIN and PROTEIN1  PROTEIN .
BioInfer.d313.s0.p4	P	In addition, we also provide new evidence to suggest that PROTEIN stimulation of the PROTEIN promoter involves increased physical interactions with acetylated PROTEIN  PROTEIN and PROTEIN1  PROTEIN2 .
BioInfer.d313.s0.p5	P	In addition, we also provide new evidence to suggest that PROTEIN stimulation of the PROTEIN2 promoter involves increased physical interactions with acetylated PROTEIN  PROTEIN1 and PROTEIN  PROTEIN .
BioInfer.d313.s0.p6	P	In addition, we also provide new evidence to suggest that PROTEIN2 stimulation of the PROTEIN promoter involves increased physical interactions with acetylated PROTEIN  PROTEIN1 and PROTEIN  PROTEIN .
BioInfer.d313.s0.p7	P	In addition, we also provide new evidence to suggest that PROTEIN stimulation of the PROTEIN promoter involves increased physical interactions with acetylated PROTEIN2  PROTEIN1 and PROTEIN  PROTEIN .
BioInfer.d313.s0.p8	N	In addition, we also provide new evidence to suggest that PROTEIN stimulation of the PROTEIN promoter involves increased physical interactions with acetylated PROTEIN  PROTEIN1 and PROTEIN  PROTEIN2 .
BioInfer.d313.s0.p9	P	In addition, we also provide new evidence to suggest that PROTEIN2 stimulation of the PROTEIN1 promoter involves increased physical interactions with acetylated PROTEIN  PROTEIN and PROTEIN  PROTEIN .
BioInfer.d313.s0.p10	N	In addition, we also provide new evidence to suggest that PROTEIN stimulation of the PROTEIN1 promoter involves increased physical interactions with acetylated PROTEIN2  PROTEIN and PROTEIN  PROTEIN .
BioInfer.d313.s0.p11	P	In addition, we also provide new evidence to suggest that PROTEIN stimulation of the PROTEIN1 promoter involves increased physical interactions with acetylated PROTEIN  PROTEIN and PROTEIN  PROTEIN2 .
BioInfer.d313.s0.p12	N	In addition, we also provide new evidence to suggest that PROTEIN1 stimulation of the PROTEIN promoter involves increased physical interactions with acetylated PROTEIN2  PROTEIN and PROTEIN  PROTEIN .
BioInfer.d313.s0.p13	P	In addition, we also provide new evidence to suggest that PROTEIN1 stimulation of the PROTEIN promoter involves increased physical interactions with acetylated PROTEIN  PROTEIN and PROTEIN  PROTEIN2 .
BioInfer.d313.s0.p14	N	In addition, we also provide new evidence to suggest that PROTEIN stimulation of the PROTEIN promoter involves increased physical interactions with acetylated PROTEIN1  PROTEIN and PROTEIN  PROTEIN2 .
BioInfer.d314.s0.p0	P	In addition, we demonstrate that PROTEIN2 and its PROTEIN1 binding peptide compete with PROTEIN segments 2-3 for binding to PROTEIN filaments.
BioInfer.d314.s0.p1	N	In addition, we demonstrate that PROTEIN and its PROTEIN1 binding peptide compete with PROTEIN segments 2-3 for binding to PROTEIN2 filaments.
BioInfer.d314.s0.p2	N	In addition, we demonstrate that PROTEIN and its PROTEIN1 binding peptide compete with PROTEIN2 segments 2-3 for binding to PROTEIN filaments.
BioInfer.d314.s0.p3	P	In addition, we demonstrate that PROTEIN1 and its PROTEIN binding peptide compete with PROTEIN segments 2-3 for binding to PROTEIN2 filaments.
BioInfer.d314.s0.p4	N	In addition, we demonstrate that PROTEIN1 and its PROTEIN binding peptide compete with PROTEIN2 segments 2-3 for binding to PROTEIN filaments.
BioInfer.d314.s0.p5	P	In addition, we demonstrate that PROTEIN and its PROTEIN binding peptide compete with PROTEIN2 segments 2-3 for binding to PROTEIN1 filaments.
BioInfer.d315.s0.p0	P	In addition, we have demonstrated that increased gene dosage of either PROTEIN or PROTEIN1 , two other factors required for silencing, suppresses the silencing defect of the PROTEIN2 mutants.
BioInfer.d315.s0.p1	N	In addition, we have demonstrated that increased gene dosage of either PROTEIN2 or PROTEIN1 , two other factors required for silencing, suppresses the silencing defect of the PROTEIN mutants.
BioInfer.d315.s0.p2	P	In addition, we have demonstrated that increased gene dosage of either PROTEIN2 or PROTEIN , two other factors required for silencing, suppresses the silencing defect of the PROTEIN1 mutants.
BioInfer.d316.s0.p0	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 .
BioInfer.d316.s0.p1	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d316.s0.p2	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN .
BioInfer.d316.s0.p3	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d316.s0.p4	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d316.s0.p5	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN2 mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d316.s0.p6	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d316.s0.p7	N	In addition, we performed immunohistochemistry on sectioned PROTEIN2 and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d316.s0.p8	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN1 .
BioInfer.d316.s0.p9	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN1 .
BioInfer.d316.s0.p10	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 .
BioInfer.d316.s0.p11	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 .
BioInfer.d316.s0.p12	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN2 mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 .
BioInfer.d316.s0.p13	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 .
BioInfer.d316.s0.p14	N	In addition, we performed immunohistochemistry on sectioned PROTEIN2 and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 .
BioInfer.d316.s0.p15	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN .
BioInfer.d316.s0.p16	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d316.s0.p17	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d316.s0.p18	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN2 mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d316.s0.p19	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d316.s0.p20	N	In addition, we performed immunohistochemistry on sectioned PROTEIN2 and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d316.s0.p21	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN .
BioInfer.d316.s0.p22	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN .
BioInfer.d316.s0.p23	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN2 mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN .
BioInfer.d316.s0.p24	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN .
BioInfer.d316.s0.p25	N	In addition, we performed immunohistochemistry on sectioned PROTEIN2 and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN .
BioInfer.d316.s0.p26	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d316.s0.p27	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN2 mutant embryos with antibodies reactive with PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d316.s0.p28	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d316.s0.p29	N	In addition, we performed immunohistochemistry on sectioned PROTEIN2 and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d316.s0.p30	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN2 mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d316.s0.p31	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN mutant embryos with antibodies reactive with PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d316.s0.p32	N	In addition, we performed immunohistochemistry on sectioned PROTEIN2 and PROTEIN mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d316.s0.p33	N	In addition, we performed immunohistochemistry on sectioned PROTEIN and PROTEIN1 mutant embryos with antibodies reactive with PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d316.s0.p34	N	In addition, we performed immunohistochemistry on sectioned PROTEIN2 and PROTEIN1 mutant embryos with antibodies reactive with PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d316.s0.p35	N	In addition, we performed immunohistochemistry on sectioned PROTEIN2 and PROTEIN mutant embryos with antibodies reactive with PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d317.s0.p0	N	In addition, we report that radiation induced transient activation of PROTEIN1 / PROTEIN2 ( PROTEIN / PROTEIN ) activation and the transcription factor, PROTEIN .
BioInfer.d317.s0.p1	N	In addition, we report that radiation induced transient activation of PROTEIN1 / PROTEIN ( PROTEIN / PROTEIN ) activation and the transcription factor, PROTEIN2 .
BioInfer.d317.s0.p2	N	In addition, we report that radiation induced transient activation of PROTEIN1 / PROTEIN ( PROTEIN2 / PROTEIN ) activation and the transcription factor, PROTEIN .
BioInfer.d317.s0.p3	N	In addition, we report that radiation induced transient activation of PROTEIN1 / PROTEIN ( PROTEIN / PROTEIN2 ) activation and the transcription factor, PROTEIN .
BioInfer.d317.s0.p4	N	In addition, we report that radiation induced transient activation of PROTEIN / PROTEIN1 ( PROTEIN / PROTEIN ) activation and the transcription factor, PROTEIN2 .
BioInfer.d317.s0.p5	N	In addition, we report that radiation induced transient activation of PROTEIN / PROTEIN1 ( PROTEIN2 / PROTEIN ) activation and the transcription factor, PROTEIN .
BioInfer.d317.s0.p6	N	In addition, we report that radiation induced transient activation of PROTEIN / PROTEIN1 ( PROTEIN / PROTEIN2 ) activation and the transcription factor, PROTEIN .
BioInfer.d317.s0.p7	N	In addition, we report that radiation induced transient activation of PROTEIN / PROTEIN ( PROTEIN2 / PROTEIN ) activation and the transcription factor, PROTEIN1 .
BioInfer.d317.s0.p8	N	In addition, we report that radiation induced transient activation of PROTEIN / PROTEIN ( PROTEIN / PROTEIN2 ) activation and the transcription factor, PROTEIN1 .
BioInfer.d317.s0.p9	N	In addition, we report that radiation induced transient activation of PROTEIN / PROTEIN ( PROTEIN1 / PROTEIN2 ) activation and the transcription factor, PROTEIN .
BioInfer.d318.s0.p0	P	In adherens junctions, the cytoplasmic domain of PROTEIN bind to PROTEIN2 , which in turn binds to the PROTEIN -associated protein PROTEIN1 .
BioInfer.d318.s0.p1	N	In adherens junctions, the cytoplasmic domain of PROTEIN2 bind to PROTEIN , which in turn binds to the PROTEIN -associated protein PROTEIN1 .
BioInfer.d318.s0.p2	P	In adherens junctions, the cytoplasmic domain of PROTEIN bind to PROTEIN , which in turn binds to the PROTEIN2 -associated protein PROTEIN1 .
BioInfer.d318.s0.p3	P	In adherens junctions, the cytoplasmic domain of PROTEIN2 bind to PROTEIN1 , which in turn binds to the PROTEIN -associated protein PROTEIN .
BioInfer.d318.s0.p4	N	In adherens junctions, the cytoplasmic domain of PROTEIN bind to PROTEIN1 , which in turn binds to the PROTEIN2 -associated protein PROTEIN .
BioInfer.d318.s0.p5	N	In adherens junctions, the cytoplasmic domain of PROTEIN1 bind to PROTEIN , which in turn binds to the PROTEIN2 -associated protein PROTEIN .
BioInfer.d319.s0.p0	P	In a model system, the interacting proteins recruiting PROTEIN2 to DNA were PROTEIN and PROTEIN1 or PROTEIN and PROTEIN .
BioInfer.d319.s0.p1	N	In a model system, the interacting proteins recruiting PROTEIN to DNA were PROTEIN and PROTEIN1 or PROTEIN2 and PROTEIN .
BioInfer.d319.s0.p2	N	In a model system, the interacting proteins recruiting PROTEIN to DNA were PROTEIN and PROTEIN1 or PROTEIN and PROTEIN2 .
BioInfer.d319.s0.p3	P	In a model system, the interacting proteins recruiting PROTEIN to DNA were PROTEIN2 and PROTEIN1 or PROTEIN and PROTEIN .
BioInfer.d319.s0.p4	P	In a model system, the interacting proteins recruiting PROTEIN1 to DNA were PROTEIN and PROTEIN or PROTEIN2 and PROTEIN .
BioInfer.d319.s0.p5	P	In a model system, the interacting proteins recruiting PROTEIN1 to DNA were PROTEIN and PROTEIN or PROTEIN and PROTEIN2 .
BioInfer.d319.s0.p6	P	In a model system, the interacting proteins recruiting PROTEIN1 to DNA were PROTEIN2 and PROTEIN or PROTEIN and PROTEIN .
BioInfer.d319.s0.p7	P	In a model system, the interacting proteins recruiting PROTEIN to DNA were PROTEIN and PROTEIN or PROTEIN1 and PROTEIN2 .
BioInfer.d319.s0.p8	N	In a model system, the interacting proteins recruiting PROTEIN to DNA were PROTEIN2 and PROTEIN or PROTEIN1 and PROTEIN .
BioInfer.d319.s0.p9	N	In a model system, the interacting proteins recruiting PROTEIN to DNA were PROTEIN2 and PROTEIN or PROTEIN and PROTEIN1 .
BioInfer.d320.s0.p0	N	In brush cells, PROTEIN2 and PROTEIN1 are not only present in the PROTEIN filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.
BioInfer.d320.s0.p1	P	In brush cells, PROTEIN and PROTEIN1 are not only present in the PROTEIN2 filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.
BioInfer.d320.s0.p2	P	In brush cells, PROTEIN1 and PROTEIN are not only present in the PROTEIN2 filament core bundles of apical microvilli and their long rootlets but, in addition, both proteins are also associated with microvilli extending from the basolateral cell surface of the brush cells.
BioInfer.d320.s1.p0	P	In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against PROTEIN1 and PROTEIN , two proteins that crosslink PROTEIN2 filaments to form bundles.
BioInfer.d320.s1.p1	N	In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against PROTEIN1 and PROTEIN2 , two proteins that crosslink PROTEIN filaments to form bundles.
BioInfer.d320.s1.p2	P	In the present study we show that brush cells can be identified in tissue sections even at the light microscopic level by immunostaining with antibodies against PROTEIN and PROTEIN2 , two proteins that crosslink PROTEIN1 filaments to form bundles.
BioInfer.d321.s0.p0	N	In cancerous tissues, the frequency of reduced expression of PROTEIN (28 of 86, 33%) was similar to that of PROTEIN1 (19 of 86, 22%), but less than that of PROTEIN2 (47 of 86, 55%).
BioInfer.d321.s0.p1	N	In cancerous tissues, the frequency of reduced expression of PROTEIN2 (28 of 86, 33%) was similar to that of PROTEIN1 (19 of 86, 22%), but less than that of PROTEIN (47 of 86, 55%).
BioInfer.d321.s0.p2	N	In cancerous tissues, the frequency of reduced expression of PROTEIN2 (28 of 86, 33%) was similar to that of PROTEIN (19 of 86, 22%), but less than that of PROTEIN1 (47 of 86, 55%).
BioInfer.d321.s1.p0	N	In this study, we immunohistochemically investigated the expression of PROTEIN1 as well as PROTEIN and PROTEIN2 in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.
BioInfer.d321.s1.p1	N	In this study, we immunohistochemically investigated the expression of PROTEIN1 as well as PROTEIN2 and PROTEIN in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.
BioInfer.d321.s1.p2	N	In this study, we immunohistochemically investigated the expression of PROTEIN as well as PROTEIN2 and PROTEIN1 in 86 human colorectal cancers, and we analysed their coexpression pattern and relationship to clinicopathological factors.
BioInfer.d322.s0.p0	P	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN1  PROTEIN ( PROTEIN2 / PROTEIN ) and rescued by the addition of PROTEIN , arguing for the involvement of PROTEIN ( PROTEIN ) delta in the conversion reaction.
BioInfer.d322.s0.p1	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN1  PROTEIN ( PROTEIN / PROTEIN ) and rescued by the addition of PROTEIN2 , arguing for the involvement of PROTEIN ( PROTEIN ) delta in the conversion reaction.
BioInfer.d322.s0.p2	P	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN1  PROTEIN ( PROTEIN / PROTEIN2 ) and rescued by the addition of PROTEIN , arguing for the involvement of PROTEIN ( PROTEIN ) delta in the conversion reaction.
BioInfer.d322.s0.p3	P	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN1  PROTEIN2 ( PROTEIN / PROTEIN ) and rescued by the addition of PROTEIN , arguing for the involvement of PROTEIN ( PROTEIN ) delta in the conversion reaction.
BioInfer.d322.s0.p4	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN1  PROTEIN ( PROTEIN / PROTEIN ) and rescued by the addition of PROTEIN , arguing for the involvement of PROTEIN2 ( PROTEIN ) delta in the conversion reaction.
BioInfer.d322.s0.p5	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN1  PROTEIN ( PROTEIN / PROTEIN ) and rescued by the addition of PROTEIN , arguing for the involvement of PROTEIN ( PROTEIN2 ) delta in the conversion reaction.
BioInfer.d322.s0.p6	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN  PROTEIN ( PROTEIN1 / PROTEIN ) and rescued by the addition of PROTEIN2 , arguing for the involvement of PROTEIN ( PROTEIN ) delta in the conversion reaction.
BioInfer.d322.s0.p7	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN  PROTEIN ( PROTEIN1 / PROTEIN2 ) and rescued by the addition of PROTEIN , arguing for the involvement of PROTEIN ( PROTEIN ) delta in the conversion reaction.
BioInfer.d322.s0.p8	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN  PROTEIN2 ( PROTEIN1 / PROTEIN ) and rescued by the addition of PROTEIN , arguing for the involvement of PROTEIN ( PROTEIN ) delta in the conversion reaction.
BioInfer.d322.s0.p9	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN  PROTEIN ( PROTEIN1 / PROTEIN ) and rescued by the addition of PROTEIN , arguing for the involvement of PROTEIN2 ( PROTEIN ) delta in the conversion reaction.
BioInfer.d322.s0.p10	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN  PROTEIN ( PROTEIN1 / PROTEIN ) and rescued by the addition of PROTEIN , arguing for the involvement of PROTEIN ( PROTEIN2 ) delta in the conversion reaction.
BioInfer.d322.s0.p11	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN  PROTEIN ( PROTEIN / PROTEIN2 ) and rescued by the addition of PROTEIN1 , arguing for the involvement of PROTEIN ( PROTEIN ) delta in the conversion reaction.
BioInfer.d322.s0.p12	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN  PROTEIN2 ( PROTEIN / PROTEIN ) and rescued by the addition of PROTEIN1 , arguing for the involvement of PROTEIN ( PROTEIN ) delta in the conversion reaction.
BioInfer.d322.s0.p13	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN  PROTEIN ( PROTEIN / PROTEIN ) and rescued by the addition of PROTEIN1 , arguing for the involvement of PROTEIN2 ( PROTEIN ) delta in the conversion reaction.
BioInfer.d322.s0.p14	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN  PROTEIN ( PROTEIN / PROTEIN ) and rescued by the addition of PROTEIN1 , arguing for the involvement of PROTEIN ( PROTEIN2 ) delta in the conversion reaction.
BioInfer.d322.s0.p15	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN  PROTEIN2 ( PROTEIN / PROTEIN1 ) and rescued by the addition of PROTEIN , arguing for the involvement of PROTEIN ( PROTEIN ) delta in the conversion reaction.
BioInfer.d322.s0.p16	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN  PROTEIN ( PROTEIN / PROTEIN1 ) and rescued by the addition of PROTEIN , arguing for the involvement of PROTEIN2 ( PROTEIN ) delta in the conversion reaction.
BioInfer.d322.s0.p17	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN  PROTEIN ( PROTEIN / PROTEIN1 ) and rescued by the addition of PROTEIN , arguing for the involvement of PROTEIN ( PROTEIN2 ) delta in the conversion reaction.
BioInfer.d322.s0.p18	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN  PROTEIN1 ( PROTEIN / PROTEIN ) and rescued by the addition of PROTEIN , arguing for the involvement of PROTEIN2 ( PROTEIN ) delta in the conversion reaction.
BioInfer.d322.s0.p19	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN  PROTEIN1 ( PROTEIN / PROTEIN ) and rescued by the addition of PROTEIN , arguing for the involvement of PROTEIN ( PROTEIN2 ) delta in the conversion reaction.
BioInfer.d322.s0.p20	N	In cell extracts, we found that complementary strand synthesis was inhibited by the PROTEIN  PROTEIN ( PROTEIN / PROTEIN ) and rescued by the addition of PROTEIN , arguing for the involvement of PROTEIN1 ( PROTEIN2 ) delta in the conversion reaction.
BioInfer.d323.s0.p0	N	In cells lacking the PROTEIN1 , the bundles, which were induced by an over-expression of PROTEIN2 , shortened and became straight following hyperosmotic stress, forming a polygonal structure.
BioInfer.d324.s0.p0	N	In contrast, PROTEIN partially suppresses the temperature sensitivity of a PROTEIN1 mutant, and the loss of cytoplasmic cables seen in PROTEIN , PROTEIN2 , and PROTEIN null mutants, suggesting filament stabilizing functions for these PROTEIN -binding proteins.
BioInfer.d324.s0.p1	N	In contrast, PROTEIN partially suppresses the temperature sensitivity of a PROTEIN1 mutant, and the loss of cytoplasmic cables seen in PROTEIN2 , PROTEIN , and PROTEIN null mutants, suggesting filament stabilizing functions for these PROTEIN -binding proteins.
BioInfer.d324.s0.p2	P	In contrast, PROTEIN2 partially suppresses the temperature sensitivity of a PROTEIN1 mutant, and the loss of cytoplasmic cables seen in PROTEIN , PROTEIN , and PROTEIN null mutants, suggesting filament stabilizing functions for these PROTEIN -binding proteins.
BioInfer.d324.s0.p3	P	In contrast, PROTEIN partially suppresses the temperature sensitivity of a PROTEIN1 mutant, and the loss of cytoplasmic cables seen in PROTEIN , PROTEIN , and PROTEIN null mutants, suggesting filament stabilizing functions for these PROTEIN2 -binding proteins.
BioInfer.d324.s0.p4	N	In contrast, PROTEIN partially suppresses the temperature sensitivity of a PROTEIN1 mutant, and the loss of cytoplasmic cables seen in PROTEIN , PROTEIN , and PROTEIN2 null mutants, suggesting filament stabilizing functions for these PROTEIN -binding proteins.
BioInfer.d324.s0.p5	N	In contrast, PROTEIN partially suppresses the temperature sensitivity of a PROTEIN mutant, and the loss of cytoplasmic cables seen in PROTEIN2 , PROTEIN1 , and PROTEIN null mutants, suggesting filament stabilizing functions for these PROTEIN -binding proteins.
BioInfer.d324.s0.p6	P	In contrast, PROTEIN2 partially suppresses the temperature sensitivity of a PROTEIN mutant, and the loss of cytoplasmic cables seen in PROTEIN , PROTEIN1 , and PROTEIN null mutants, suggesting filament stabilizing functions for these PROTEIN -binding proteins.
BioInfer.d324.s0.p7	P	In contrast, PROTEIN partially suppresses the temperature sensitivity of a PROTEIN mutant, and the loss of cytoplasmic cables seen in PROTEIN , PROTEIN1 , and PROTEIN null mutants, suggesting filament stabilizing functions for these PROTEIN2 -binding proteins.
BioInfer.d324.s0.p8	N	In contrast, PROTEIN partially suppresses the temperature sensitivity of a PROTEIN mutant, and the loss of cytoplasmic cables seen in PROTEIN , PROTEIN1 , and PROTEIN2 null mutants, suggesting filament stabilizing functions for these PROTEIN -binding proteins.
BioInfer.d324.s0.p9	P	In contrast, PROTEIN2 partially suppresses the temperature sensitivity of a PROTEIN mutant, and the loss of cytoplasmic cables seen in PROTEIN1 , PROTEIN , and PROTEIN null mutants, suggesting filament stabilizing functions for these PROTEIN -binding proteins.
BioInfer.d324.s0.p10	P	In contrast, PROTEIN partially suppresses the temperature sensitivity of a PROTEIN mutant, and the loss of cytoplasmic cables seen in PROTEIN1 , PROTEIN , and PROTEIN null mutants, suggesting filament stabilizing functions for these PROTEIN2 -binding proteins.
BioInfer.d324.s0.p11	N	In contrast, PROTEIN partially suppresses the temperature sensitivity of a PROTEIN mutant, and the loss of cytoplasmic cables seen in PROTEIN1 , PROTEIN , and PROTEIN2 null mutants, suggesting filament stabilizing functions for these PROTEIN -binding proteins.
BioInfer.d324.s0.p12	N	In contrast, PROTEIN1 partially suppresses the temperature sensitivity of a PROTEIN mutant, and the loss of cytoplasmic cables seen in PROTEIN , PROTEIN , and PROTEIN null mutants, suggesting filament stabilizing functions for these PROTEIN2 -binding proteins.
BioInfer.d324.s0.p13	P	In contrast, PROTEIN1 partially suppresses the temperature sensitivity of a PROTEIN mutant, and the loss of cytoplasmic cables seen in PROTEIN , PROTEIN , and PROTEIN2 null mutants, suggesting filament stabilizing functions for these PROTEIN -binding proteins.
BioInfer.d324.s0.p14	P	In contrast, PROTEIN partially suppresses the temperature sensitivity of a PROTEIN mutant, and the loss of cytoplasmic cables seen in PROTEIN , PROTEIN , and PROTEIN2 null mutants, suggesting filament stabilizing functions for these PROTEIN1 -binding proteins.
BioInfer.d325.s0.p0	N	In contrast, PROTEIN , another putative PROTEIN -membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken PROTEIN , which reacted with human PROTEIN2 and PROTEIN1 .
BioInfer.d325.s0.p1	N	In contrast, PROTEIN2 , another putative PROTEIN -membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken PROTEIN , which reacted with human PROTEIN and PROTEIN1 .
BioInfer.d325.s0.p2	N	In contrast, PROTEIN , another putative PROTEIN2 -membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken PROTEIN , which reacted with human PROTEIN and PROTEIN1 .
BioInfer.d325.s0.p3	N	In contrast, PROTEIN , another putative PROTEIN -membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken PROTEIN2 , which reacted with human PROTEIN and PROTEIN1 .
BioInfer.d325.s0.p4	N	In contrast, PROTEIN2 , another putative PROTEIN -membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken PROTEIN , which reacted with human PROTEIN1 and PROTEIN .
BioInfer.d325.s0.p5	N	In contrast, PROTEIN , another putative PROTEIN2 -membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken PROTEIN , which reacted with human PROTEIN1 and PROTEIN .
BioInfer.d325.s0.p6	N	In contrast, PROTEIN , another putative PROTEIN -membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken PROTEIN2 , which reacted with human PROTEIN1 and PROTEIN .
BioInfer.d325.s0.p7	P	In contrast, PROTEIN1 , another putative PROTEIN2 -membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken PROTEIN , which reacted with human PROTEIN and PROTEIN .
BioInfer.d325.s0.p8	N	In contrast, PROTEIN1 , another putative PROTEIN -membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken PROTEIN2 , which reacted with human PROTEIN and PROTEIN .
BioInfer.d325.s0.p9	N	In contrast, PROTEIN , another putative PROTEIN1 -membrane linker protein, could not be detected in significant amounts in human neutrophils using a polyclonal antibody raised against chicken PROTEIN2 , which reacted with human PROTEIN and PROTEIN .
BioInfer.d326.s0.p0	N	In contrast, EC located immediately behind the migrating front retained junctional PROTEIN , PROTEIN2 , and PROTEIN while PROTEIN1 was absent from these sites.
BioInfer.d326.s0.p1	N	In contrast, EC located immediately behind the migrating front retained junctional PROTEIN , PROTEIN , and PROTEIN2 while PROTEIN1 was absent from these sites.
BioInfer.d326.s0.p2	N	In contrast, EC located immediately behind the migrating front retained junctional PROTEIN2 , PROTEIN , and PROTEIN while PROTEIN1 was absent from these sites.
BioInfer.d326.s0.p3	N	In contrast, EC located immediately behind the migrating front retained junctional PROTEIN , PROTEIN1 , and PROTEIN2 while PROTEIN was absent from these sites.
BioInfer.d326.s0.p4	N	In contrast, EC located immediately behind the migrating front retained junctional PROTEIN2 , PROTEIN1 , and PROTEIN while PROTEIN was absent from these sites.
BioInfer.d326.s0.p5	N	In contrast, EC located immediately behind the migrating front retained junctional PROTEIN2 , PROTEIN , and PROTEIN1 while PROTEIN was absent from these sites.
BioInfer.d327.s0.p0	N	In contrast, the PROTEIN2 and PROTEIN1 genes are essential for homothallic mating-type switching.
BioInfer.d328.s0.p0	N	In contrast to the PROTEIN (Min/+) enterocytes, PROTEIN2 (Min/-) adenomas displayed increased expression and association of PROTEIN , PROTEIN , and PROTEIN relative to PROTEIN1 (+/+) controls.
BioInfer.d328.s0.p1	N	In contrast to the PROTEIN2 (Min/+) enterocytes, PROTEIN (Min/-) adenomas displayed increased expression and association of PROTEIN , PROTEIN , and PROTEIN relative to PROTEIN1 (+/+) controls.
BioInfer.d328.s0.p2	N	In contrast to the PROTEIN (Min/+) enterocytes, PROTEIN (Min/-) adenomas displayed increased expression and association of PROTEIN , PROTEIN2 , and PROTEIN relative to PROTEIN1 (+/+) controls.
BioInfer.d328.s0.p3	N	In contrast to the PROTEIN (Min/+) enterocytes, PROTEIN (Min/-) adenomas displayed increased expression and association of PROTEIN2 , PROTEIN , and PROTEIN relative to PROTEIN1 (+/+) controls.
BioInfer.d328.s0.p4	N	In contrast to the PROTEIN (Min/+) enterocytes, PROTEIN (Min/-) adenomas displayed increased expression and association of PROTEIN , PROTEIN , and PROTEIN2 relative to PROTEIN1 (+/+) controls.
BioInfer.d328.s0.p5	N	In contrast to the PROTEIN2 (Min/+) enterocytes, PROTEIN1 (Min/-) adenomas displayed increased expression and association of PROTEIN , PROTEIN , and PROTEIN relative to PROTEIN (+/+) controls.
BioInfer.d328.s0.p6	N	In contrast to the PROTEIN (Min/+) enterocytes, PROTEIN1 (Min/-) adenomas displayed increased expression and association of PROTEIN , PROTEIN2 , and PROTEIN relative to PROTEIN (+/+) controls.
BioInfer.d328.s0.p7	N	In contrast to the PROTEIN (Min/+) enterocytes, PROTEIN1 (Min/-) adenomas displayed increased expression and association of PROTEIN2 , PROTEIN , and PROTEIN relative to PROTEIN (+/+) controls.
BioInfer.d328.s0.p8	N	In contrast to the PROTEIN (Min/+) enterocytes, PROTEIN1 (Min/-) adenomas displayed increased expression and association of PROTEIN , PROTEIN , and PROTEIN2 relative to PROTEIN (+/+) controls.
BioInfer.d328.s0.p9	N	In contrast to the PROTEIN1 (Min/+) enterocytes, PROTEIN (Min/-) adenomas displayed increased expression and association of PROTEIN , PROTEIN2 , and PROTEIN relative to PROTEIN (+/+) controls.
BioInfer.d328.s0.p10	N	In contrast to the PROTEIN1 (Min/+) enterocytes, PROTEIN (Min/-) adenomas displayed increased expression and association of PROTEIN2 , PROTEIN , and PROTEIN relative to PROTEIN (+/+) controls.
BioInfer.d328.s0.p11	N	In contrast to the PROTEIN1 (Min/+) enterocytes, PROTEIN (Min/-) adenomas displayed increased expression and association of PROTEIN , PROTEIN , and PROTEIN2 relative to PROTEIN (+/+) controls.
BioInfer.d328.s0.p12	P	In contrast to the PROTEIN (Min/+) enterocytes, PROTEIN (Min/-) adenomas displayed increased expression and association of PROTEIN2 , PROTEIN1 , and PROTEIN relative to PROTEIN (+/+) controls.
BioInfer.d328.s0.p13	P	In contrast to the PROTEIN (Min/+) enterocytes, PROTEIN (Min/-) adenomas displayed increased expression and association of PROTEIN , PROTEIN1 , and PROTEIN2 relative to PROTEIN (+/+) controls.
BioInfer.d328.s0.p14	P	In contrast to the PROTEIN (Min/+) enterocytes, PROTEIN (Min/-) adenomas displayed increased expression and association of PROTEIN1 , PROTEIN , and PROTEIN2 relative to PROTEIN (+/+) controls.
BioInfer.d329.s0.p0	N	In contrast to the model of PROTEIN binding proposed for PROTEIN2 , the PROTEIN  PROTEIN -binding domain appears to associate with PROTEIN1 in an extended conformation.
BioInfer.d329.s0.p1	N	In contrast to the model of PROTEIN binding proposed for PROTEIN , the PROTEIN  PROTEIN2 -binding domain appears to associate with PROTEIN1 in an extended conformation.
BioInfer.d329.s0.p2	P	In contrast to the model of PROTEIN binding proposed for PROTEIN , the PROTEIN2  PROTEIN -binding domain appears to associate with PROTEIN1 in an extended conformation.
BioInfer.d329.s0.p3	N	In contrast to the model of PROTEIN2 binding proposed for PROTEIN , the PROTEIN  PROTEIN -binding domain appears to associate with PROTEIN1 in an extended conformation.
BioInfer.d329.s0.p4	N	In contrast to the model of PROTEIN binding proposed for PROTEIN1 , the PROTEIN  PROTEIN2 -binding domain appears to associate with PROTEIN in an extended conformation.
BioInfer.d329.s0.p5	N	In contrast to the model of PROTEIN binding proposed for PROTEIN1 , the PROTEIN2  PROTEIN -binding domain appears to associate with PROTEIN in an extended conformation.
BioInfer.d329.s0.p6	P	In contrast to the model of PROTEIN2 binding proposed for PROTEIN1 , the PROTEIN  PROTEIN -binding domain appears to associate with PROTEIN in an extended conformation.
BioInfer.d329.s0.p7	P	In contrast to the model of PROTEIN binding proposed for PROTEIN , the PROTEIN2  PROTEIN1 -binding domain appears to associate with PROTEIN in an extended conformation.
BioInfer.d329.s0.p8	N	In contrast to the model of PROTEIN2 binding proposed for PROTEIN , the PROTEIN  PROTEIN1 -binding domain appears to associate with PROTEIN in an extended conformation.
BioInfer.d329.s0.p9	N	In contrast to the model of PROTEIN2 binding proposed for PROTEIN , the PROTEIN1  PROTEIN -binding domain appears to associate with PROTEIN in an extended conformation.
BioInfer.d330.s0.p0	N	In COS-7 cells overexpressing a PROTEIN mutant lacking the proline-rich domain (Deltap) unable to interact with PROTEIN2 , the PROTEIN1 tail formation of intracellular Shigella was inhibited.
BioInfer.d330.s0.p1	N	In COS-7 cells overexpressing a PROTEIN2 mutant lacking the proline-rich domain (Deltap) unable to interact with PROTEIN , the PROTEIN1 tail formation of intracellular Shigella was inhibited.
BioInfer.d330.s0.p2	P	In COS-7 cells overexpressing a PROTEIN2 mutant lacking the proline-rich domain (Deltap) unable to interact with PROTEIN1 , the PROTEIN tail formation of intracellular Shigella was inhibited.
BioInfer.d331.s0.p0	P	Increased interaction of PROTEIN2 with the PROTEIN cytoskeleton is consistent with and might be mediated by its enhanced binding to PROTEIN1 .
BioInfer.d331.s0.p1	P	Increased interaction of PROTEIN with the PROTEIN2 cytoskeleton is consistent with and might be mediated by its enhanced binding to PROTEIN1 .
BioInfer.d331.s0.p2	P	Increased interaction of PROTEIN1 with the PROTEIN2 cytoskeleton is consistent with and might be mediated by its enhanced binding to PROTEIN .
BioInfer.d332.s0.p0	P	Increasing the ionic strength within a relatively narrow range significantly decreased ability of PROTEIN1 to bind to PROTEIN2 , regardless of pH.
BioInfer.d332.s1.p0	P	Interaction of PROTEIN1 with PROTEIN2 : sensitive modulation of filament crosslinking activity.
BioInfer.d333.s0.p0	N	In enriched cell lines and in a pure myocyte cell strain, PROTEIN inhibited increases in immunoreactive PROTEIN1 and PROTEIN ( PROTEIN2 ) normally seen after serum withdrawal.
BioInfer.d333.s0.p1	P	In enriched cell lines and in a pure myocyte cell strain, PROTEIN2 inhibited increases in immunoreactive PROTEIN1 and PROTEIN ( PROTEIN ) normally seen after serum withdrawal.
BioInfer.d333.s0.p2	N	In enriched cell lines and in a pure myocyte cell strain, PROTEIN inhibited increases in immunoreactive PROTEIN1 and PROTEIN2 ( PROTEIN ) normally seen after serum withdrawal.
BioInfer.d333.s0.p3	P	In enriched cell lines and in a pure myocyte cell strain, PROTEIN2 inhibited increases in immunoreactive PROTEIN and PROTEIN ( PROTEIN1 ) normally seen after serum withdrawal.
BioInfer.d333.s0.p4	N	In enriched cell lines and in a pure myocyte cell strain, PROTEIN inhibited increases in immunoreactive PROTEIN and PROTEIN2 ( PROTEIN1 ) normally seen after serum withdrawal.
BioInfer.d333.s0.p5	P	In enriched cell lines and in a pure myocyte cell strain, PROTEIN1 inhibited increases in immunoreactive PROTEIN and PROTEIN2 ( PROTEIN ) normally seen after serum withdrawal.
BioInfer.d334.s0.p0	N	In extracts from mouse brain, PROTEIN2 and PROTEIN can form complexes with regulators of endocytosis, synaptic vesicle recycling and PROTEIN1 assembly.
BioInfer.d334.s0.p1	N	In extracts from mouse brain, PROTEIN and PROTEIN2 can form complexes with regulators of endocytosis, synaptic vesicle recycling and PROTEIN1 assembly.
BioInfer.d334.s0.p2	N	In extracts from mouse brain, PROTEIN1 and PROTEIN2 can form complexes with regulators of endocytosis, synaptic vesicle recycling and PROTEIN assembly.
BioInfer.d334.s1.p0	N	In mouse brain PROTEIN and PROTEIN1 associate with regulators of the endocytic pathway and PROTEIN2 assembly.
BioInfer.d334.s1.p1	N	In mouse brain PROTEIN2 and PROTEIN1 associate with regulators of the endocytic pathway and PROTEIN assembly.
BioInfer.d334.s1.p2	N	In mouse brain PROTEIN2 and PROTEIN associate with regulators of the endocytic pathway and PROTEIN1 assembly.
BioInfer.d334.s2.p0	N	Our findings strongly suggest that in brain PROTEIN and PROTEIN complexes link the PROTEIN cytoskeleton and endocytic membrane flow, directing PROTEIN1 and PROTEIN2 assembly to distinct membrane domains.
BioInfer.d334.s2.p1	P	Our findings strongly suggest that in brain PROTEIN and PROTEIN complexes link the PROTEIN2 cytoskeleton and endocytic membrane flow, directing PROTEIN1 and PROTEIN assembly to distinct membrane domains.
BioInfer.d334.s2.p2	P	Our findings strongly suggest that in brain PROTEIN and PROTEIN2 complexes link the PROTEIN cytoskeleton and endocytic membrane flow, directing PROTEIN1 and PROTEIN assembly to distinct membrane domains.
BioInfer.d334.s2.p3	P	Our findings strongly suggest that in brain PROTEIN2 and PROTEIN complexes link the PROTEIN cytoskeleton and endocytic membrane flow, directing PROTEIN1 and PROTEIN assembly to distinct membrane domains.
BioInfer.d334.s2.p4	P	Our findings strongly suggest that in brain PROTEIN and PROTEIN complexes link the PROTEIN2 cytoskeleton and endocytic membrane flow, directing PROTEIN and PROTEIN1 assembly to distinct membrane domains.
BioInfer.d334.s2.p5	P	Our findings strongly suggest that in brain PROTEIN and PROTEIN2 complexes link the PROTEIN cytoskeleton and endocytic membrane flow, directing PROTEIN and PROTEIN1 assembly to distinct membrane domains.
BioInfer.d334.s2.p6	P	Our findings strongly suggest that in brain PROTEIN2 and PROTEIN complexes link the PROTEIN cytoskeleton and endocytic membrane flow, directing PROTEIN and PROTEIN1 assembly to distinct membrane domains.
BioInfer.d334.s2.p7	P	Our findings strongly suggest that in brain PROTEIN and PROTEIN2 complexes link the PROTEIN1 cytoskeleton and endocytic membrane flow, directing PROTEIN and PROTEIN assembly to distinct membrane domains.
BioInfer.d334.s2.p8	P	Our findings strongly suggest that in brain PROTEIN2 and PROTEIN complexes link the PROTEIN1 cytoskeleton and endocytic membrane flow, directing PROTEIN and PROTEIN assembly to distinct membrane domains.
BioInfer.d334.s2.p9	N	Our findings strongly suggest that in brain PROTEIN2 and PROTEIN1 complexes link the PROTEIN cytoskeleton and endocytic membrane flow, directing PROTEIN and PROTEIN assembly to distinct membrane domains.
BioInfer.d335.s0.p0	P	In flattened cells under starvation stress, PROTEIN2 localized at dramatically reorganizing PROTEIN -cytoskeletons in ruffling membranes of the leading edge, but not at rigid PROTEIN1 meshwork in focal adhesion plaques.
BioInfer.d335.s0.p1	N	In flattened cells under starvation stress, PROTEIN localized at dramatically reorganizing PROTEIN2 -cytoskeletons in ruffling membranes of the leading edge, but not at rigid PROTEIN1 meshwork in focal adhesion plaques.
BioInfer.d335.s0.p2	P	In flattened cells under starvation stress, PROTEIN1 localized at dramatically reorganizing PROTEIN2 -cytoskeletons in ruffling membranes of the leading edge, but not at rigid PROTEIN meshwork in focal adhesion plaques.
BioInfer.d335.s1.p0	P	These results suggest that PROTEIN2 may be involved in dynamic reorganization of membranous PROTEIN1 cytoskeletons.
BioInfer.d336.s0.p0	N	In growth cones, PROTEIN1 was most concentrated in the margin bordering the thickened, organelle-rich central region and the thin, PROTEIN2 -rich peripheral region.
BioInfer.d336.s1.p0	P	PROTEIN2 staining was dimmer and its colocalization with filamentous PROTEIN1 bundles in growth cones was less striking than that of PROTEIN .
BioInfer.d336.s1.p1	P	PROTEIN staining was dimmer and its colocalization with filamentous PROTEIN1 bundles in growth cones was less striking than that of PROTEIN2 .
BioInfer.d336.s1.p2	N	PROTEIN1 staining was dimmer and its colocalization with filamentous PROTEIN bundles in growth cones was less striking than that of PROTEIN2 .
BioInfer.d337.s0.p0	N	Inhibition of 12P-CRE binding was also observed in the presence of an antibody to PROTEIN1 (265-kDa PROTEIN2 ), an integrator and coactivator of cAMP-responsive genes.
BioInfer.d338.s0.p0	N	Inhibition of PROTEIN1 polymerization by a synthetic dodecapeptide patterned on the sequence around the PROTEIN2 -binding site of PROTEIN .
BioInfer.d338.s0.p1	N	Inhibition of PROTEIN1 polymerization by a synthetic dodecapeptide patterned on the sequence around the PROTEIN -binding site of PROTEIN2 .
BioInfer.d338.s0.p2	P	Inhibition of PROTEIN polymerization by a synthetic dodecapeptide patterned on the sequence around the PROTEIN1 -binding site of PROTEIN2 .
BioInfer.d339.s0.p0	P	Inhibition of PROTEIN2 polymerization in KCl was stronger than that of the parental PROTEIN1 , and the Kd value of its interaction with rabbit PROTEIN , as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine PROTEIN ).
BioInfer.d339.s0.p1	N	Inhibition of PROTEIN polymerization in KCl was stronger than that of the parental PROTEIN1 , and the Kd value of its interaction with rabbit PROTEIN , as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine PROTEIN2 ).
BioInfer.d339.s0.p2	N	Inhibition of PROTEIN polymerization in KCl was stronger than that of the parental PROTEIN1 , and the Kd value of its interaction with rabbit PROTEIN2 , as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine PROTEIN ).
BioInfer.d339.s0.p3	N	Inhibition of PROTEIN1 polymerization in KCl was stronger than that of the parental PROTEIN , and the Kd value of its interaction with rabbit PROTEIN , as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine PROTEIN2 ).
BioInfer.d339.s0.p4	N	Inhibition of PROTEIN1 polymerization in KCl was stronger than that of the parental PROTEIN , and the Kd value of its interaction with rabbit PROTEIN2 , as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine PROTEIN ).
BioInfer.d339.s0.p5	P	Inhibition of PROTEIN polymerization in KCl was stronger than that of the parental PROTEIN , and the Kd value of its interaction with rabbit PROTEIN2 , as determined by falling ball viscometry, was smaller (mean value 0.5 x 10(-6) M, as compared to 1.9 x 10(-6) M for bovine PROTEIN1 ).
BioInfer.d340.s0.p0	N	Inhibition of PROTEIN1 subfragment 1 PROTEIN activity by analog peptides of the PROTEIN2 -binding site around the Cys(SH1) of PROTEIN .
BioInfer.d340.s0.p1	P	Inhibition of PROTEIN1 subfragment 1 PROTEIN2 activity by analog peptides of the PROTEIN -binding site around the Cys(SH1) of PROTEIN .
BioInfer.d340.s0.p2	P	Inhibition of PROTEIN1 subfragment 1 PROTEIN activity by analog peptides of the PROTEIN -binding site around the Cys(SH1) of PROTEIN2 .
BioInfer.d340.s0.p3	N	Inhibition of PROTEIN subfragment 1 PROTEIN2 activity by analog peptides of the PROTEIN1 -binding site around the Cys(SH1) of PROTEIN .
BioInfer.d340.s0.p4	P	Inhibition of PROTEIN subfragment 1 PROTEIN activity by analog peptides of the PROTEIN1 -binding site around the Cys(SH1) of PROTEIN2 .
BioInfer.d340.s0.p5	N	Inhibition of PROTEIN subfragment 1 PROTEIN1 activity by analog peptides of the PROTEIN -binding site around the Cys(SH1) of PROTEIN2 .
BioInfer.d341.s0.p0	P	Inhibition of PROTEIN expression or induction of PROTEIN2  PROTEIN1 expression was found in mimosine-treated lung cancer cells.
BioInfer.d341.s0.p1	N	Inhibition of PROTEIN2 expression or induction of PROTEIN  PROTEIN1 expression was found in mimosine-treated lung cancer cells.
BioInfer.d341.s0.p2	N	Inhibition of PROTEIN2 expression or induction of PROTEIN1  PROTEIN expression was found in mimosine-treated lung cancer cells.
BioInfer.d342.s0.p0	N	Inhibition of the interactions of PROTEIN1 , PROTEIN , and PROTEIN2 with PROTEIN by phosphoinositides.
BioInfer.d342.s0.p1	P	Inhibition of the interactions of PROTEIN1 , PROTEIN , and PROTEIN with PROTEIN2 by phosphoinositides.
BioInfer.d342.s0.p2	N	Inhibition of the interactions of PROTEIN1 , PROTEIN2 , and PROTEIN with PROTEIN by phosphoinositides.
BioInfer.d342.s0.p3	P	Inhibition of the interactions of PROTEIN , PROTEIN , and PROTEIN1 with PROTEIN2 by phosphoinositides.
BioInfer.d342.s0.p4	N	Inhibition of the interactions of PROTEIN , PROTEIN2 , and PROTEIN1 with PROTEIN by phosphoinositides.
BioInfer.d342.s0.p5	P	Inhibition of the interactions of PROTEIN , PROTEIN2 , and PROTEIN with PROTEIN1 by phosphoinositides.
BioInfer.d343.s0.p0	N	In higher plants, a large number of isoforms for the PROTEIN1 monomer-binding protein PROTEIN have been identified, whereas other organisms express only few PROTEIN2 .
BioInfer.d343.s0.p1	P	In higher plants, a large number of isoforms for the PROTEIN1 monomer-binding protein PROTEIN2 have been identified, whereas other organisms express only few PROTEIN .
BioInfer.d343.s0.p2	N	In higher plants, a large number of isoforms for the PROTEIN monomer-binding protein PROTEIN2 have been identified, whereas other organisms express only few PROTEIN1 .
BioInfer.d344.s0.p0	N	In infected cells, PROTEIN2 was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN1  PROTEIN and PROTEIN  PROTEIN , which were also detected with specific antisera.
BioInfer.d344.s0.p1	P	In infected cells, PROTEIN was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN1  PROTEIN2 and PROTEIN  PROTEIN , which were also detected with specific antisera.
BioInfer.d344.s0.p2	N	In infected cells, PROTEIN was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN1  PROTEIN and PROTEIN2  PROTEIN , which were also detected with specific antisera.
BioInfer.d344.s0.p3	N	In infected cells, PROTEIN was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN1  PROTEIN and PROTEIN  PROTEIN2 , which were also detected with specific antisera.
BioInfer.d344.s0.p4	P	In infected cells, PROTEIN1 was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN  PROTEIN2 and PROTEIN  PROTEIN , which were also detected with specific antisera.
BioInfer.d344.s0.p5	N	In infected cells, PROTEIN1 was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN  PROTEIN and PROTEIN2  PROTEIN , which were also detected with specific antisera.
BioInfer.d344.s0.p6	P	In infected cells, PROTEIN1 was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN  PROTEIN and PROTEIN  PROTEIN2 , which were also detected with specific antisera.
BioInfer.d344.s0.p7	N	In infected cells, PROTEIN was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN  PROTEIN1 and PROTEIN2  PROTEIN , which were also detected with specific antisera.
BioInfer.d344.s0.p8	N	In infected cells, PROTEIN was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN  PROTEIN1 and PROTEIN  PROTEIN2 , which were also detected with specific antisera.
BioInfer.d344.s0.p9	P	In infected cells, PROTEIN was detected exclusively in the cytoplasm as granular fluorescence, which coincided very well with the distribution of PROTEIN  PROTEIN and PROTEIN1  PROTEIN2 , which were also detected with specific antisera.
BioInfer.d345.s0.p0	N	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN1  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN2 activity.
BioInfer.d345.s0.p1	N	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN1  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN2 ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p2	P	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN1  PROTEIN2 ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p3	N	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN1  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN2 and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p4	N	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN2 causes a posttranscriptional accumulation of the PROTEIN1  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p5	P	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN1  PROTEIN ( PROTEIN2 ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p6	N	In investigating the mechanism by which PROTEIN2 induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN1  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p7	N	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN1  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN2 ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p8	P	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN2 ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN1 activity.
BioInfer.d345.s0.p9	P	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN2 ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN1 activity.
BioInfer.d345.s0.p10	N	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN2 and a concomitant decrease in PROTEIN1 activity.
BioInfer.d345.s0.p11	N	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN2 causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN1 activity.
BioInfer.d345.s0.p12	P	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN2 ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN1 activity.
BioInfer.d345.s0.p13	N	In investigating the mechanism by which PROTEIN2 induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN1 activity.
BioInfer.d345.s0.p14	P	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN2 ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN1 activity.
BioInfer.d345.s0.p15	P	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN2 ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN1 ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p16	P	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN1 ) specifically bound to PROTEIN2 and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p17	N	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN2 causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN1 ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p18	P	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN2 ) that is accompanied by an increase in PROTEIN ( PROTEIN1 ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p19	N	In investigating the mechanism by which PROTEIN2 induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN1 ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p20	N	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN2 ( PROTEIN1 ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p21	N	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN1 ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN2 and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p22	P	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN2 causes a posttranscriptional accumulation of the PROTEIN  PROTEIN1 ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p23	N	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN1 ( PROTEIN2 ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p24	N	In investigating the mechanism by which PROTEIN2 induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN1 ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p25	P	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN1 ( PROTEIN ) that is accompanied by an increase in PROTEIN2 ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p26	N	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN2 causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN1 and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p27	N	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN2 ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN1 and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p28	N	In investigating the mechanism by which PROTEIN2 induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN1 and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p29	P	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN2 ( PROTEIN ) specifically bound to PROTEIN1 and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p30	P	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN1 causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN2 ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p31	N	In investigating the mechanism by which PROTEIN2 induces senescence, we have found that PROTEIN1 causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p32	N	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN1 causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN2 ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p33	N	In investigating the mechanism by which PROTEIN2 induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN1 ) that is accompanied by an increase in PROTEIN ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p34	P	In investigating the mechanism by which PROTEIN induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN1 ) that is accompanied by an increase in PROTEIN2 ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d345.s0.p35	N	In investigating the mechanism by which PROTEIN1 induces senescence, we have found that PROTEIN causes a posttranscriptional accumulation of the PROTEIN  PROTEIN ( PROTEIN ) that is accompanied by an increase in PROTEIN2 ( PROTEIN ) specifically bound to PROTEIN and a concomitant decrease in PROTEIN activity.
BioInfer.d346.s0.p0	N	In isolated hearts, PD 81,723 alone produced only a small stimulus to His bundle (S-H) interval prolongation of 1.5 to 4 msec, which was completely reversed by the PROTEIN2 antagonist 8-cyclopentyltheophylline and PROTEIN1 .
BioInfer.d347.s0.p0	N	In localization studies with mammalian cells, all fusion proteins showed the localization expected for PROTEIN1 in areas of high PROTEIN dynamics, such as leading lamellae and ruffles induced by PROTEIN2 .
BioInfer.d347.s0.p1	N	In localization studies with mammalian cells, all fusion proteins showed the localization expected for PROTEIN1 in areas of high PROTEIN2 dynamics, such as leading lamellae and ruffles induced by PROTEIN .
BioInfer.d347.s0.p2	N	In localization studies with mammalian cells, all fusion proteins showed the localization expected for PROTEIN in areas of high PROTEIN2 dynamics, such as leading lamellae and ruffles induced by PROTEIN1 .
BioInfer.d348.s0.p0	P	In order to clarify PROTEIN2 -dependent regulation of PROTEIN1 assembly in muscle cells, PROTEIN tagged with fluorescence dyes was introduced into C2 myoblasts by a micro injection method.
BioInfer.d348.s0.p1	N	In order to clarify PROTEIN -dependent regulation of PROTEIN1 assembly in muscle cells, PROTEIN2 tagged with fluorescence dyes was introduced into C2 myoblasts by a micro injection method.
BioInfer.d348.s0.p2	N	In order to clarify PROTEIN1 -dependent regulation of PROTEIN assembly in muscle cells, PROTEIN2 tagged with fluorescence dyes was introduced into C2 myoblasts by a micro injection method.
BioInfer.d348.s1.p0	N	The exogeneous PROTEIN1 , but not PROTEIN2 , caused quick disassembly of PROTEIN filaments and accumulated in furrow region of dividing cells.
BioInfer.d348.s1.p1	P	The exogeneous PROTEIN1 , but not PROTEIN , caused quick disassembly of PROTEIN2 filaments and accumulated in furrow region of dividing cells.
BioInfer.d348.s1.p2	P	The exogeneous PROTEIN , but not PROTEIN1 , caused quick disassembly of PROTEIN2 filaments and accumulated in furrow region of dividing cells.
BioInfer.d348.s2.p0	P	These results suggest that the subcellular distribution of PROTEIN2 as well as its interaction with PROTEIN1 in vivo is regulated by its phosphorylation and dephosphorylation.
BioInfer.d349.s0.p0	N	In order to determine possible changes in the cytoskeleton organization and function during these processes, we have studied the in situ distribution of two major cytoskeleton-associated elements involved in the membrane anchorage of PROTEIN microfilaments, i.e. PROTEIN1 and PROTEIN2 , during the ontogeny of the neural crest and its derivatives in the avian embryo.
BioInfer.d349.s0.p1	P	In order to determine possible changes in the cytoskeleton organization and function during these processes, we have studied the in situ distribution of two major cytoskeleton-associated elements involved in the membrane anchorage of PROTEIN2 microfilaments, i.e. PROTEIN1 and PROTEIN , during the ontogeny of the neural crest and its derivatives in the avian embryo.
BioInfer.d349.s0.p2	P	In order to determine possible changes in the cytoskeleton organization and function during these processes, we have studied the in situ distribution of two major cytoskeleton-associated elements involved in the membrane anchorage of PROTEIN2 microfilaments, i.e. PROTEIN and PROTEIN1 , during the ontogeny of the neural crest and its derivatives in the avian embryo.
BioInfer.d350.s0.p0	N	In order to help explain the apparent beneficial effects of PROTEIN over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the PROTEIN1  PROTEIN , which blocks the activating effects of PROTEIN2 .
BioInfer.d350.s0.p1	N	In order to help explain the apparent beneficial effects of PROTEIN2 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the PROTEIN1  PROTEIN , which blocks the activating effects of PROTEIN .
BioInfer.d350.s0.p2	P	In order to help explain the apparent beneficial effects of PROTEIN over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the PROTEIN1  PROTEIN2 , which blocks the activating effects of PROTEIN .
BioInfer.d350.s0.p3	N	In order to help explain the apparent beneficial effects of PROTEIN2 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the PROTEIN  PROTEIN , which blocks the activating effects of PROTEIN1 .
BioInfer.d350.s0.p4	N	In order to help explain the apparent beneficial effects of PROTEIN over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the PROTEIN  PROTEIN2 , which blocks the activating effects of PROTEIN1 .
BioInfer.d350.s0.p5	N	In order to help explain the apparent beneficial effects of PROTEIN1 over-expression, a number of closely associated cell cycle proteins have also been evaluated, including the PROTEIN  PROTEIN2 , which blocks the activating effects of PROTEIN .
BioInfer.d351.s0.p0	P	In reconstitution experiments, PROTEIN2 filaments incubated in EGTA with purified PROTEIN1 and PROTEIN form smooth-sided bundles containing an apparently random number of filaments.
BioInfer.d351.s0.p1	N	In reconstitution experiments, PROTEIN filaments incubated in EGTA with purified PROTEIN1 and PROTEIN2 form smooth-sided bundles containing an apparently random number of filaments.
BioInfer.d351.s0.p2	P	In reconstitution experiments, PROTEIN1 filaments incubated in EGTA with purified PROTEIN and PROTEIN2 form smooth-sided bundles containing an apparently random number of filaments.
BioInfer.d352.s0.p0	P	In resting leukocytes, PROTEIN2 are constitutively linked to the PROTEIN1 cytoskeleton via the protein PROTEIN .
BioInfer.d352.s0.p1	P	In resting leukocytes, PROTEIN are constitutively linked to the PROTEIN1 cytoskeleton via the protein PROTEIN2 .
BioInfer.d352.s0.p2	P	In resting leukocytes, PROTEIN1 are constitutively linked to the PROTEIN cytoskeleton via the protein PROTEIN2 .
BioInfer.d353.s0.p0	N	In search for genes which might participate in chicken PROTEIN gene conversion, we have identified chicken counterparts of the yeast PROTEIN2 , PROTEIN , and PROTEIN1 genes.
BioInfer.d353.s0.p1	N	In search for genes which might participate in chicken PROTEIN gene conversion, we have identified chicken counterparts of the yeast PROTEIN , PROTEIN2 , and PROTEIN1 genes.
BioInfer.d353.s0.p2	N	In search for genes which might participate in chicken PROTEIN2 gene conversion, we have identified chicken counterparts of the yeast PROTEIN , PROTEIN , and PROTEIN1 genes.
BioInfer.d353.s0.p3	N	In search for genes which might participate in chicken PROTEIN gene conversion, we have identified chicken counterparts of the yeast PROTEIN1 , PROTEIN2 , and PROTEIN genes.
BioInfer.d353.s0.p4	N	In search for genes which might participate in chicken PROTEIN2 gene conversion, we have identified chicken counterparts of the yeast PROTEIN1 , PROTEIN , and PROTEIN genes.
BioInfer.d353.s0.p5	N	In search for genes which might participate in chicken PROTEIN2 gene conversion, we have identified chicken counterparts of the yeast PROTEIN , PROTEIN1 , and PROTEIN genes.
BioInfer.d354.s0.p0	N	PROTEIN2 , PROTEIN1 , and PROTEIN messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.
BioInfer.d354.s0.p1	N	PROTEIN , PROTEIN1 , and PROTEIN2 messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.
BioInfer.d354.s0.p2	N	PROTEIN1 , PROTEIN , and PROTEIN2 messenger RNAs in skeletal muscle after an injection of growth hormone in subjects over 60 years old.
BioInfer.d355.s0.p0	N	PROTEIN stimulates PROTEIN1 and PROTEIN2 synthesis in the awake rat.
BioInfer.d355.s0.p1	P	PROTEIN2 stimulates PROTEIN1 and PROTEIN synthesis in the awake rat.
BioInfer.d355.s0.p2	P	PROTEIN2 stimulates PROTEIN and PROTEIN1 synthesis in the awake rat.
BioInfer.d355.s1.p0	N	To determine the effect of PROTEIN ( PROTEIN ) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into PROTEIN2 and PROTEIN1 during intravenous infusions (4 h) of either saline or PROTEIN (1 microgram. kg-1. min-1) in awake rats.
BioInfer.d355.s1.p1	N	To determine the effect of PROTEIN2 ( PROTEIN ) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into PROTEIN and PROTEIN1 during intravenous infusions (4 h) of either saline or PROTEIN (1 microgram. kg-1. min-1) in awake rats.
BioInfer.d355.s1.p2	N	To determine the effect of PROTEIN ( PROTEIN ) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into PROTEIN and PROTEIN1 during intravenous infusions (4 h) of either saline or PROTEIN2 (1 microgram. kg-1. min-1) in awake rats.
BioInfer.d355.s1.p3	N	To determine the effect of PROTEIN ( PROTEIN2 ) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into PROTEIN and PROTEIN1 during intravenous infusions (4 h) of either saline or PROTEIN (1 microgram. kg-1. min-1) in awake rats.
BioInfer.d355.s1.p4	N	To determine the effect of PROTEIN2 ( PROTEIN ) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into PROTEIN1 and PROTEIN during intravenous infusions (4 h) of either saline or PROTEIN (1 microgram. kg-1. min-1) in awake rats.
BioInfer.d355.s1.p5	N	To determine the effect of PROTEIN ( PROTEIN ) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into PROTEIN1 and PROTEIN during intravenous infusions (4 h) of either saline or PROTEIN2 (1 microgram. kg-1. min-1) in awake rats.
BioInfer.d355.s1.p6	N	To determine the effect of PROTEIN ( PROTEIN2 ) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into PROTEIN1 and PROTEIN during intravenous infusions (4 h) of either saline or PROTEIN (1 microgram. kg-1. min-1) in awake rats.
BioInfer.d355.s1.p7	N	To determine the effect of PROTEIN1 ( PROTEIN ) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into PROTEIN and PROTEIN during intravenous infusions (4 h) of either saline or PROTEIN2 (1 microgram. kg-1. min-1) in awake rats.
BioInfer.d355.s1.p8	N	To determine the effect of PROTEIN1 ( PROTEIN2 ) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into PROTEIN and PROTEIN during intravenous infusions (4 h) of either saline or PROTEIN (1 microgram. kg-1. min-1) in awake rats.
BioInfer.d355.s1.p9	N	To determine the effect of PROTEIN ( PROTEIN2 ) on cardiac contractile protein synthesis in vivo, we measured L-[ring-2, 6-3H]phenylalanine incorporation into PROTEIN and PROTEIN during intravenous infusions (4 h) of either saline or PROTEIN1 (1 microgram. kg-1. min-1) in awake rats.
BioInfer.d356.s0.p0	P	Integrating the PROTEIN2 and PROTEIN1 cytoskeletons.
BioInfer.d357.s0.p0	P	PROTEIN1 (beta) chains, for example, interact with PROTEIN2 (e.g. PROTEIN and PROTEIN ), which form mechanical links to the cytoskeleton.
BioInfer.d357.s0.p1	N	PROTEIN1 (beta) chains, for example, interact with PROTEIN (e.g. PROTEIN2 and PROTEIN ), which form mechanical links to the cytoskeleton.
BioInfer.d357.s0.p2	N	PROTEIN1 (beta) chains, for example, interact with PROTEIN (e.g. PROTEIN and PROTEIN2 ), which form mechanical links to the cytoskeleton.
BioInfer.d357.s0.p3	P	PROTEIN (beta) chains, for example, interact with PROTEIN1 (e.g. PROTEIN2 and PROTEIN ), which form mechanical links to the cytoskeleton.
BioInfer.d357.s0.p4	P	PROTEIN (beta) chains, for example, interact with PROTEIN1 (e.g. PROTEIN and PROTEIN2 ), which form mechanical links to the cytoskeleton.
BioInfer.d357.s0.p5	N	PROTEIN (beta) chains, for example, interact with PROTEIN (e.g. PROTEIN1 and PROTEIN2 ), which form mechanical links to the cytoskeleton.
BioInfer.d358.s0.p0	P	PROTEIN binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of PROTEIN or cleavage of linking protein PROTEIN1 by PROTEIN2 .
BioInfer.d358.s0.p1	N	PROTEIN binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of PROTEIN2 or cleavage of linking protein PROTEIN1 by PROTEIN .
BioInfer.d358.s0.p2	N	PROTEIN2 binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of PROTEIN or cleavage of linking protein PROTEIN1 by PROTEIN .
BioInfer.d358.s0.p3	N	PROTEIN binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of PROTEIN2 or cleavage of linking protein PROTEIN by PROTEIN1 .
BioInfer.d358.s0.p4	N	PROTEIN2 binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of PROTEIN or cleavage of linking protein PROTEIN by PROTEIN1 .
BioInfer.d358.s0.p5	N	PROTEIN2 binding may be promoted by disruption of links to the cytoskeleton, effected through depolymerisation of PROTEIN1 or cleavage of linking protein PROTEIN by PROTEIN .
BioInfer.d359.s0.p0	N	Interaction between PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) of human parainfluenza virus type 2: one of the two PROTEIN2 binding sites on PROTEIN is essential for granule formation.
BioInfer.d359.s0.p1	P	Interaction between PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN2 ) of human parainfluenza virus type 2: one of the two PROTEIN binding sites on PROTEIN is essential for granule formation.
BioInfer.d359.s0.p2	P	Interaction between PROTEIN ( PROTEIN1 ) and PROTEIN2 ( PROTEIN ) of human parainfluenza virus type 2: one of the two PROTEIN binding sites on PROTEIN is essential for granule formation.
BioInfer.d359.s0.p3	N	Interaction between PROTEIN2 ( PROTEIN1 ) and PROTEIN ( PROTEIN ) of human parainfluenza virus type 2: one of the two PROTEIN binding sites on PROTEIN is essential for granule formation.
BioInfer.d359.s0.p4	N	Interaction between PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) of human parainfluenza virus type 2: one of the two PROTEIN binding sites on PROTEIN2 is essential for granule formation.
BioInfer.d359.s0.p5	N	Interaction between PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) of human parainfluenza virus type 2: one of the two PROTEIN1 binding sites on PROTEIN is essential for granule formation.
BioInfer.d359.s0.p6	N	Interaction between PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN ) of human parainfluenza virus type 2: one of the two PROTEIN1 binding sites on PROTEIN is essential for granule formation.
BioInfer.d359.s0.p7	N	Interaction between PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN ) of human parainfluenza virus type 2: one of the two PROTEIN1 binding sites on PROTEIN is essential for granule formation.
BioInfer.d359.s0.p8	P	Interaction between PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) of human parainfluenza virus type 2: one of the two PROTEIN1 binding sites on PROTEIN2 is essential for granule formation.
BioInfer.d359.s0.p9	N	Interaction between PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN1 ) of human parainfluenza virus type 2: one of the two PROTEIN binding sites on PROTEIN is essential for granule formation.
BioInfer.d359.s0.p10	P	Interaction between PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN1 ) of human parainfluenza virus type 2: one of the two PROTEIN binding sites on PROTEIN is essential for granule formation.
BioInfer.d359.s0.p11	N	Interaction between PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN1 ) of human parainfluenza virus type 2: one of the two PROTEIN binding sites on PROTEIN2 is essential for granule formation.
BioInfer.d359.s0.p12	P	Interaction between PROTEIN2 ( PROTEIN ) and PROTEIN1 ( PROTEIN ) of human parainfluenza virus type 2: one of the two PROTEIN binding sites on PROTEIN is essential for granule formation.
BioInfer.d359.s0.p13	N	Interaction between PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) of human parainfluenza virus type 2: one of the two PROTEIN binding sites on PROTEIN2 is essential for granule formation.
BioInfer.d359.s0.p14	N	Interaction between PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) of human parainfluenza virus type 2: one of the two PROTEIN binding sites on PROTEIN2 is essential for granule formation.
BioInfer.d360.s0.p0	P	Interaction of PROTEIN1 with PROTEIN2 controls the association of apical PROTEIN in epithelial cells.
BioInfer.d360.s0.p1	P	Interaction of PROTEIN1 with PROTEIN controls the association of apical PROTEIN2 in epithelial cells.
BioInfer.d360.s0.p2	P	Interaction of PROTEIN with PROTEIN1 controls the association of apical PROTEIN2 in epithelial cells.
BioInfer.d360.s1.p0	P	The quantity of the complex is reduced by treatment of Caco-2 cells with the alkylating agent N-ethylmaleimide which also has an inhibitory effect on the ability of PROTEIN1 to associate with PROTEIN2 in vitro.
BioInfer.d361.s0.p6	N	Interactions of PROTEIN2 / PROTEIN1 , PROTEIN /3 complex, PROTEIN and PROTEIN in remodeling of branched PROTEIN filament networks.
BioInfer.d361.s0.p7	P	Interactions of PROTEIN / PROTEIN1 , PROTEIN /3 complex, PROTEIN and PROTEIN in remodeling of branched PROTEIN2 filament networks.
BioInfer.d361.s0.p8	P	Interactions of PROTEIN / PROTEIN1 , PROTEIN /3 complex, PROTEIN2 and PROTEIN in remodeling of branched PROTEIN filament networks.
BioInfer.d361.s0.p9	P	Interactions of PROTEIN / PROTEIN1 , PROTEIN2 /3 complex, PROTEIN and PROTEIN in remodeling of branched PROTEIN filament networks.
BioInfer.d361.s0.p10	P	Interactions of PROTEIN / PROTEIN1 , PROTEIN /3 complex, PROTEIN and PROTEIN2 in remodeling of branched PROTEIN filament networks.
BioInfer.d361.s0.p11	P	Interactions of PROTEIN1 / PROTEIN , PROTEIN /3 complex, PROTEIN and PROTEIN in remodeling of branched PROTEIN2 filament networks.
BioInfer.d361.s0.p12	P	Interactions of PROTEIN1 / PROTEIN , PROTEIN /3 complex, PROTEIN2 and PROTEIN in remodeling of branched PROTEIN filament networks.
BioInfer.d361.s0.p13	P	Interactions of PROTEIN1 / PROTEIN , PROTEIN2 /3 complex, PROTEIN and PROTEIN in remodeling of branched PROTEIN filament networks.
BioInfer.d361.s0.p14	P	Interactions of PROTEIN1 / PROTEIN , PROTEIN /3 complex, PROTEIN and PROTEIN2 in remodeling of branched PROTEIN filament networks.
BioInfer.d361.s0.p15	P	Interactions of PROTEIN / PROTEIN , PROTEIN /3 complex, PROTEIN2 and PROTEIN in remodeling of branched PROTEIN1 filament networks.
BioInfer.d361.s0.p16	P	Interactions of PROTEIN / PROTEIN , PROTEIN2 /3 complex, PROTEIN and PROTEIN in remodeling of branched PROTEIN1 filament networks.
BioInfer.d361.s0.p17	P	Interactions of PROTEIN / PROTEIN , PROTEIN /3 complex, PROTEIN and PROTEIN2 in remodeling of branched PROTEIN1 filament networks.
BioInfer.d361.s0.p18	P	Interactions of PROTEIN / PROTEIN , PROTEIN2 /3 complex, PROTEIN1 and PROTEIN in remodeling of branched PROTEIN filament networks.
BioInfer.d361.s0.p19	P	Interactions of PROTEIN / PROTEIN , PROTEIN /3 complex, PROTEIN1 and PROTEIN2 in remodeling of branched PROTEIN filament networks.
BioInfer.d361.s0.p20	P	Interactions of PROTEIN / PROTEIN , PROTEIN1 /3 complex, PROTEIN and PROTEIN2 in remodeling of branched PROTEIN filament networks.
BioInfer.d362.s0.p0	P	Interestingly, the regions that show the most structural diversity are located at or near the PROTEIN2 -binding site of PROTEIN1 .
BioInfer.d363.s0.p0	P	Interestingly, two major PROTEIN1 found in brain, PROTEIN and PROTEIN2 , specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.
BioInfer.d363.s0.p1	P	Interestingly, two major PROTEIN1 found in brain, PROTEIN2 and PROTEIN , specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.
BioInfer.d363.s0.p2	N	Interestingly, two major PROTEIN found in brain, PROTEIN2 and PROTEIN1 , specifically interact with phosphatidylinositol 4,5-bisphosphate, and may themselves play a role in regulating phosphoinositide turnover.
BioInfer.d364.s0.p0	N	In the PROTEIN assay system, silencing depends completely upon the function of the PROTEIN genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two PROTEIN genes, PROTEIN2 and PROTEIN1 .
BioInfer.d364.s0.p1	N	In the PROTEIN assay system, silencing depends completely upon the function of the PROTEIN2 genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two PROTEIN genes, PROTEIN and PROTEIN1 .
BioInfer.d364.s0.p2	N	In the PROTEIN2 assay system, silencing depends completely upon the function of the PROTEIN genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two PROTEIN genes, PROTEIN and PROTEIN1 .
BioInfer.d364.s0.p3	P	In the PROTEIN assay system, silencing depends completely upon the function of the PROTEIN genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two PROTEIN2 genes, PROTEIN and PROTEIN1 .
BioInfer.d364.s0.p4	N	In the PROTEIN assay system, silencing depends completely upon the function of the PROTEIN2 genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two PROTEIN genes, PROTEIN1 and PROTEIN .
BioInfer.d364.s0.p5	N	In the PROTEIN2 assay system, silencing depends completely upon the function of the PROTEIN genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two PROTEIN genes, PROTEIN1 and PROTEIN .
BioInfer.d364.s0.p6	P	In the PROTEIN assay system, silencing depends completely upon the function of the PROTEIN genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two PROTEIN2 genes, PROTEIN1 and PROTEIN .
BioInfer.d364.s0.p7	N	In the PROTEIN2 assay system, silencing depends completely upon the function of the PROTEIN1 genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two PROTEIN genes, PROTEIN and PROTEIN .
BioInfer.d364.s0.p8	N	In the PROTEIN assay system, silencing depends completely upon the function of the PROTEIN1 genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two PROTEIN2 genes, PROTEIN and PROTEIN .
BioInfer.d364.s0.p9	N	In the PROTEIN1 assay system, silencing depends completely upon the function of the PROTEIN genes, known trans-acting regulators of the silent loci, and is sensitive to the gene dosage of two PROTEIN2 genes, PROTEIN and PROTEIN .
BioInfer.d365.s0.p0	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN , PROTEIN , and PROTEIN , but not with antibodies to PROTEIN2 , PROTEIN , or with PROTEIN and PROTEIN1 antibodies.
BioInfer.d365.s0.p1	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN , PROTEIN , and PROTEIN , but not with antibodies to PROTEIN , PROTEIN , or with PROTEIN2 and PROTEIN1 antibodies.
BioInfer.d365.s0.p2	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN , PROTEIN , and PROTEIN2 , but not with antibodies to PROTEIN , PROTEIN , or with PROTEIN and PROTEIN1 antibodies.
BioInfer.d365.s0.p3	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN2 , PROTEIN , and PROTEIN , but not with antibodies to PROTEIN , PROTEIN , or with PROTEIN and PROTEIN1 antibodies.
BioInfer.d365.s0.p4	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN , PROTEIN , and PROTEIN , but not with antibodies to PROTEIN , PROTEIN2 , or with PROTEIN and PROTEIN1 antibodies.
BioInfer.d365.s0.p5	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN , PROTEIN2 , and PROTEIN , but not with antibodies to PROTEIN , PROTEIN , or with PROTEIN and PROTEIN1 antibodies.
BioInfer.d365.s0.p6	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN , PROTEIN , and PROTEIN , but not with antibodies to PROTEIN1 , PROTEIN , or with PROTEIN2 and PROTEIN antibodies.
BioInfer.d365.s0.p7	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN , PROTEIN , and PROTEIN2 , but not with antibodies to PROTEIN1 , PROTEIN , or with PROTEIN and PROTEIN antibodies.
BioInfer.d365.s0.p8	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN2 , PROTEIN , and PROTEIN , but not with antibodies to PROTEIN1 , PROTEIN , or with PROTEIN and PROTEIN antibodies.
BioInfer.d365.s0.p9	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN , PROTEIN , and PROTEIN , but not with antibodies to PROTEIN1 , PROTEIN2 , or with PROTEIN and PROTEIN antibodies.
BioInfer.d365.s0.p10	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN , PROTEIN2 , and PROTEIN , but not with antibodies to PROTEIN1 , PROTEIN , or with PROTEIN and PROTEIN antibodies.
BioInfer.d365.s0.p11	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN , PROTEIN , and PROTEIN2 , but not with antibodies to PROTEIN , PROTEIN , or with PROTEIN1 and PROTEIN antibodies.
BioInfer.d365.s0.p12	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN2 , PROTEIN , and PROTEIN , but not with antibodies to PROTEIN , PROTEIN , or with PROTEIN1 and PROTEIN antibodies.
BioInfer.d365.s0.p13	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN , PROTEIN , and PROTEIN , but not with antibodies to PROTEIN , PROTEIN2 , or with PROTEIN1 and PROTEIN antibodies.
BioInfer.d365.s0.p14	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN , PROTEIN2 , and PROTEIN , but not with antibodies to PROTEIN , PROTEIN , or with PROTEIN1 and PROTEIN antibodies.
BioInfer.d365.s0.p15	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN2 , PROTEIN , and PROTEIN1 , but not with antibodies to PROTEIN , PROTEIN , or with PROTEIN and PROTEIN antibodies.
BioInfer.d365.s0.p16	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN , PROTEIN , and PROTEIN1 , but not with antibodies to PROTEIN , PROTEIN2 , or with PROTEIN and PROTEIN antibodies.
BioInfer.d365.s0.p17	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN , PROTEIN2 , and PROTEIN1 , but not with antibodies to PROTEIN , PROTEIN , or with PROTEIN and PROTEIN antibodies.
BioInfer.d365.s0.p18	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN1 , PROTEIN , and PROTEIN , but not with antibodies to PROTEIN , PROTEIN2 , or with PROTEIN and PROTEIN antibodies.
BioInfer.d365.s0.p19	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN1 , PROTEIN2 , and PROTEIN , but not with antibodies to PROTEIN , PROTEIN , or with PROTEIN and PROTEIN antibodies.
BioInfer.d365.s0.p20	N	In the basal layer, patches of brightly labeled cells were detected with antibodies to PROTEIN , PROTEIN2 , and PROTEIN , but not with antibodies to PROTEIN , PROTEIN1 , or with PROTEIN and PROTEIN antibodies.
BioInfer.d366.s0.p0	N	In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d366.s0.p1	N	In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d366.s0.p2	N	In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d366.s0.p3	N	In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 .
BioInfer.d366.s0.p4	N	In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN .
BioInfer.d366.s0.p5	N	In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d366.s0.p6	N	In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d366.s0.p7	N	In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d366.s0.p8	N	In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN .
BioInfer.d366.s0.p9	N	In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d366.s0.p10	N	In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d366.s0.p11	N	In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN .
BioInfer.d366.s0.p12	N	In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d366.s0.p13	N	In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN .
BioInfer.d366.s0.p14	N	In the budding yeast Saccharomyces cerevisiae, the DNA damage-induced G2 arrest requires the checkpoint control genes PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN1 .
BioInfer.d367.s0.p0	P	In the cytoplasm, PROTEIN was shown to stimulate the PROTEIN1 - PROTEIN - PROTEIN ( PROTEIN2 ) cascade, which is essential for activation of transcription factor PROTEIN .
BioInfer.d367.s0.p1	N	In the cytoplasm, PROTEIN2 was shown to stimulate the PROTEIN1 - PROTEIN - PROTEIN ( PROTEIN ) cascade, which is essential for activation of transcription factor PROTEIN .
BioInfer.d367.s0.p2	P	In the cytoplasm, PROTEIN was shown to stimulate the PROTEIN1 - PROTEIN - PROTEIN ( PROTEIN ) cascade, which is essential for activation of transcription factor PROTEIN2 .
BioInfer.d367.s0.p3	P	In the cytoplasm, PROTEIN was shown to stimulate the PROTEIN1 - PROTEIN - PROTEIN2 ( PROTEIN ) cascade, which is essential for activation of transcription factor PROTEIN .
BioInfer.d367.s0.p4	P	In the cytoplasm, PROTEIN was shown to stimulate the PROTEIN1 - PROTEIN2 - PROTEIN ( PROTEIN ) cascade, which is essential for activation of transcription factor PROTEIN .
BioInfer.d367.s0.p5	N	In the cytoplasm, PROTEIN2 was shown to stimulate the PROTEIN - PROTEIN - PROTEIN ( PROTEIN1 ) cascade, which is essential for activation of transcription factor PROTEIN .
BioInfer.d367.s0.p6	P	In the cytoplasm, PROTEIN was shown to stimulate the PROTEIN - PROTEIN - PROTEIN ( PROTEIN1 ) cascade, which is essential for activation of transcription factor PROTEIN2 .
BioInfer.d367.s0.p7	P	In the cytoplasm, PROTEIN was shown to stimulate the PROTEIN - PROTEIN - PROTEIN2 ( PROTEIN1 ) cascade, which is essential for activation of transcription factor PROTEIN .
BioInfer.d367.s0.p8	P	In the cytoplasm, PROTEIN was shown to stimulate the PROTEIN - PROTEIN2 - PROTEIN ( PROTEIN1 ) cascade, which is essential for activation of transcription factor PROTEIN .
BioInfer.d367.s0.p9	N	In the cytoplasm, PROTEIN1 was shown to stimulate the PROTEIN - PROTEIN - PROTEIN ( PROTEIN ) cascade, which is essential for activation of transcription factor PROTEIN2 .
BioInfer.d367.s0.p10	N	In the cytoplasm, PROTEIN1 was shown to stimulate the PROTEIN - PROTEIN - PROTEIN2 ( PROTEIN ) cascade, which is essential for activation of transcription factor PROTEIN .
BioInfer.d367.s0.p11	N	In the cytoplasm, PROTEIN1 was shown to stimulate the PROTEIN - PROTEIN2 - PROTEIN ( PROTEIN ) cascade, which is essential for activation of transcription factor PROTEIN .
BioInfer.d367.s0.p12	P	In the cytoplasm, PROTEIN was shown to stimulate the PROTEIN - PROTEIN - PROTEIN2 ( PROTEIN ) cascade, which is essential for activation of transcription factor PROTEIN1 .
BioInfer.d367.s0.p13	P	In the cytoplasm, PROTEIN was shown to stimulate the PROTEIN - PROTEIN2 - PROTEIN ( PROTEIN ) cascade, which is essential for activation of transcription factor PROTEIN1 .
BioInfer.d367.s0.p14	P	In the cytoplasm, PROTEIN was shown to stimulate the PROTEIN - PROTEIN2 - PROTEIN1 ( PROTEIN ) cascade, which is essential for activation of transcription factor PROTEIN .
BioInfer.d368.s0.p0	N	In the hippocampus, ATP gamma S, an ATP analogue more resistant to catabolism than ATP, was virtually devoid of effect on tritium release, and the effect of ATP was prevented by the PROTEIN2 inhibitor alpha,beta-methylene ADP (100 microM), by PROTEIN1 (2 U/ml) and by the PROTEIN antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 20 nM).
BioInfer.d368.s0.p1	N	In the hippocampus, ATP gamma S, an ATP analogue more resistant to catabolism than ATP, was virtually devoid of effect on tritium release, and the effect of ATP was prevented by the PROTEIN inhibitor alpha,beta-methylene ADP (100 microM), by PROTEIN1 (2 U/ml) and by the PROTEIN2 antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 20 nM).
BioInfer.d368.s0.p2	N	In the hippocampus, ATP gamma S, an ATP analogue more resistant to catabolism than ATP, was virtually devoid of effect on tritium release, and the effect of ATP was prevented by the PROTEIN1 inhibitor alpha,beta-methylene ADP (100 microM), by PROTEIN (2 U/ml) and by the PROTEIN2 antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 20 nM).
BioInfer.d369.s0.p0	N	In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN1 -associated protein PROTEIN / PROTEIN or the PROTEIN -associated protein PROTEIN2 [2-4].
BioInfer.d369.s0.p1	N	In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN1 -associated protein PROTEIN / PROTEIN or the PROTEIN2 -associated protein PROTEIN [2-4].
BioInfer.d369.s0.p2	P	In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN1 -associated protein PROTEIN / PROTEIN2 or the PROTEIN -associated protein PROTEIN [2-4].
BioInfer.d369.s0.p3	P	In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN1 -associated protein PROTEIN2 / PROTEIN or the PROTEIN -associated protein PROTEIN [2-4].
BioInfer.d369.s0.p4	P	In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN -associated protein PROTEIN / PROTEIN or the PROTEIN2 -associated protein PROTEIN1 [2-4].
BioInfer.d369.s0.p5	N	In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN -associated protein PROTEIN / PROTEIN2 or the PROTEIN -associated protein PROTEIN1 [2-4].
BioInfer.d369.s0.p6	N	In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN -associated protein PROTEIN2 / PROTEIN or the PROTEIN -associated protein PROTEIN1 [2-4].
BioInfer.d369.s0.p7	N	In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN -associated protein PROTEIN / PROTEIN2 or the PROTEIN1 -associated protein PROTEIN [2-4].
BioInfer.d369.s0.p8	N	In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN -associated protein PROTEIN2 / PROTEIN or the PROTEIN1 -associated protein PROTEIN [2-4].
BioInfer.d369.s0.p9	N	In their cytoplasmic region, some of these receptors share a conserved sequence motif - the 'death domain' - which is required for transduction of the apoptotic signal by recruiting other death-domain-containing adaptor molecules like the PROTEIN -associated protein PROTEIN2 / PROTEIN1 or the PROTEIN -associated protein PROTEIN [2-4].
BioInfer.d370.s0.p0	N	In the present paper, using indirect immunofluorescence, we found that PMN adhesion to PROTEIN -activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: PROTEIN (VE)-cadherin, PROTEIN , PROTEIN2 , and PROTEIN1 .
BioInfer.d370.s0.p1	N	In the present paper, using indirect immunofluorescence, we found that PMN adhesion to PROTEIN -activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: PROTEIN (VE)-cadherin, PROTEIN2 , PROTEIN , and PROTEIN1 .
BioInfer.d370.s0.p2	N	In the present paper, using indirect immunofluorescence, we found that PMN adhesion to PROTEIN -activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: PROTEIN2 (VE)-cadherin, PROTEIN , PROTEIN , and PROTEIN1 .
BioInfer.d370.s0.p3	N	In the present paper, using indirect immunofluorescence, we found that PMN adhesion to PROTEIN2 -activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: PROTEIN (VE)-cadherin, PROTEIN , PROTEIN , and PROTEIN1 .
BioInfer.d370.s0.p4	N	In the present paper, using indirect immunofluorescence, we found that PMN adhesion to PROTEIN -activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: PROTEIN (VE)-cadherin, PROTEIN2 , PROTEIN1 , and PROTEIN .
BioInfer.d370.s0.p5	N	In the present paper, using indirect immunofluorescence, we found that PMN adhesion to PROTEIN -activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: PROTEIN2 (VE)-cadherin, PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d370.s0.p6	N	In the present paper, using indirect immunofluorescence, we found that PMN adhesion to PROTEIN2 -activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: PROTEIN (VE)-cadherin, PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d370.s0.p7	N	In the present paper, using indirect immunofluorescence, we found that PMN adhesion to PROTEIN -activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: PROTEIN2 (VE)-cadherin, PROTEIN1 , PROTEIN , and PROTEIN .
BioInfer.d370.s0.p8	N	In the present paper, using indirect immunofluorescence, we found that PMN adhesion to PROTEIN2 -activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: PROTEIN (VE)-cadherin, PROTEIN1 , PROTEIN , and PROTEIN .
BioInfer.d370.s0.p9	N	In the present paper, using indirect immunofluorescence, we found that PMN adhesion to PROTEIN2 -activated endothelial cells (EC) induced the disappearance from endothelial cell-to-cell contacts of adherens junction (AJ) components: PROTEIN1 (VE)-cadherin, PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d371.s0.p0	N	In the present work we have used PROTEIN1 and PROTEIN injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb PROTEIN2 microfilament structure and assembly in an attempt to answer this question.
BioInfer.d371.s0.p1	N	In the present work we have used PROTEIN1 and PROTEIN2 injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb PROTEIN microfilament structure and assembly in an attempt to answer this question.
BioInfer.d371.s0.p2	N	In the present work we have used PROTEIN and PROTEIN2 injections, as well as latrunculin B and cytochalasin D treatments, under quantitatively controlled conditions, to perturb PROTEIN1 microfilament structure and assembly in an attempt to answer this question.
BioInfer.d372.s0.p0	P	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN (the PROTEIN ), to the PROTEIN or PROTEIN1 promoter is the molecular mechanism of transcriptional activation by PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d372.s0.p1	P	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN (the PROTEIN2 ), to the PROTEIN or PROTEIN1 promoter is the molecular mechanism of transcriptional activation by PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d372.s0.p2	P	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN (the PROTEIN ), to the PROTEIN or PROTEIN1 promoter is the molecular mechanism of transcriptional activation by PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d372.s0.p3	P	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN (the PROTEIN ), to the PROTEIN or PROTEIN1 promoter is the molecular mechanism of transcriptional activation by PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d372.s0.p4	P	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN2 (the PROTEIN ), to the PROTEIN or PROTEIN1 promoter is the molecular mechanism of transcriptional activation by PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d372.s0.p5	N	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN (the PROTEIN ), to the PROTEIN2 or PROTEIN1 promoter is the molecular mechanism of transcriptional activation by PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d372.s0.p6	N	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN (the PROTEIN2 ), to the PROTEIN or PROTEIN promoter is the molecular mechanism of transcriptional activation by PROTEIN , PROTEIN , and PROTEIN1 .
BioInfer.d372.s0.p7	N	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN (the PROTEIN ), to the PROTEIN or PROTEIN promoter is the molecular mechanism of transcriptional activation by PROTEIN2 , PROTEIN , and PROTEIN1 .
BioInfer.d372.s0.p8	N	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN (the PROTEIN ), to the PROTEIN or PROTEIN promoter is the molecular mechanism of transcriptional activation by PROTEIN , PROTEIN2 , and PROTEIN1 .
BioInfer.d372.s0.p9	N	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN2 (the PROTEIN ), to the PROTEIN or PROTEIN promoter is the molecular mechanism of transcriptional activation by PROTEIN , PROTEIN , and PROTEIN1 .
BioInfer.d372.s0.p10	P	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN (the PROTEIN ), to the PROTEIN2 or PROTEIN promoter is the molecular mechanism of transcriptional activation by PROTEIN , PROTEIN , and PROTEIN1 .
BioInfer.d372.s0.p11	N	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN (the PROTEIN1 ), to the PROTEIN or PROTEIN promoter is the molecular mechanism of transcriptional activation by PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d372.s0.p12	N	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN (the PROTEIN1 ), to the PROTEIN or PROTEIN promoter is the molecular mechanism of transcriptional activation by PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d372.s0.p13	N	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN2 (the PROTEIN1 ), to the PROTEIN or PROTEIN promoter is the molecular mechanism of transcriptional activation by PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d372.s0.p14	P	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN (the PROTEIN1 ), to the PROTEIN2 or PROTEIN promoter is the molecular mechanism of transcriptional activation by PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d372.s0.p15	N	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN (the PROTEIN ), to the PROTEIN or PROTEIN promoter is the molecular mechanism of transcriptional activation by PROTEIN1 , PROTEIN2 , and PROTEIN .
BioInfer.d372.s0.p16	N	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN2 (the PROTEIN ), to the PROTEIN or PROTEIN promoter is the molecular mechanism of transcriptional activation by PROTEIN1 , PROTEIN , and PROTEIN .
BioInfer.d372.s0.p17	P	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN (the PROTEIN ), to the PROTEIN2 or PROTEIN promoter is the molecular mechanism of transcriptional activation by PROTEIN1 , PROTEIN , and PROTEIN .
BioInfer.d372.s0.p18	N	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN2 (the PROTEIN ), to the PROTEIN or PROTEIN promoter is the molecular mechanism of transcriptional activation by PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d372.s0.p19	P	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN (the PROTEIN ), to the PROTEIN2 or PROTEIN promoter is the molecular mechanism of transcriptional activation by PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d372.s0.p20	P	In these investigations, we determine that recruitment of a coactivator protein, PROTEIN1 (the PROTEIN ), to the PROTEIN2 or PROTEIN promoter is the molecular mechanism of transcriptional activation by PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d373.s0.p0	P	In this PROTEIN clustering, PROTEIN1 , a monomeric PROTEIN that has been suggested to be involved in PROTEIN2 polymerization, was shown to be essential.
BioInfer.d373.s0.p1	P	In this PROTEIN2 clustering, PROTEIN1 , a monomeric PROTEIN that has been suggested to be involved in PROTEIN polymerization, was shown to be essential.
BioInfer.d373.s0.p2	P	In this PROTEIN clustering, PROTEIN1 , a monomeric PROTEIN2 that has been suggested to be involved in PROTEIN polymerization, was shown to be essential.
BioInfer.d373.s0.p3	N	In this PROTEIN2 clustering, PROTEIN , a monomeric PROTEIN that has been suggested to be involved in PROTEIN1 polymerization, was shown to be essential.
BioInfer.d373.s0.p4	N	In this PROTEIN clustering, PROTEIN , a monomeric PROTEIN2 that has been suggested to be involved in PROTEIN1 polymerization, was shown to be essential.
BioInfer.d373.s0.p5	N	In this PROTEIN1 clustering, PROTEIN , a monomeric PROTEIN2 that has been suggested to be involved in PROTEIN polymerization, was shown to be essential.
BioInfer.d374.s0.p0	N	In this case, efficient repair does not require PROTEIN2 and PROTEIN1 , consistent with our previous observations.
BioInfer.d375.s0.p0	P	In this model, PROTEIN1 can bind both to PROTEIN2 monomers with a Kd of about 5 microM and to the barbed end of PROTEIN filaments with a Kd of about 50-100 microM.
BioInfer.d375.s0.p1	P	In this model, PROTEIN1 can bind both to PROTEIN monomers with a Kd of about 5 microM and to the barbed end of PROTEIN2 filaments with a Kd of about 50-100 microM.
BioInfer.d375.s0.p2	N	In this model, PROTEIN can bind both to PROTEIN1 monomers with a Kd of about 5 microM and to the barbed end of PROTEIN2 filaments with a Kd of about 50-100 microM.
BioInfer.d375.s1.p0	P	Quantitative analysis of the effect of Acanthamoeba PROTEIN1 on PROTEIN2 filament nucleation and elongation.
BioInfer.d375.s2.p0	P	The current view of the mechanism of action of Acanthamoeba PROTEIN2 is that it binds to PROTEIN1 monomers, forming a complex that cannot polymerize [Tobacman, L. S., & Korn, E. D. (1982) J. Biol. Chem. 257, 4166-4170; Tseng, P., & Pollard, T. D. (1982) J. Cell Biol. 94, 213-218; Tobacman, L. S., Brenner, S. L., & Korn, E. D. (1983) J. Biol. Chem. 258, 8806-8812].
BioInfer.d375.s3.p0	N	This model includes two different Kd's--one for PROTEIN1 bound to PROTEIN monomers and one for PROTEIN2 bound to an PROTEIN molecule at the barbed end of a filament.
BioInfer.d375.s3.p1	P	This model includes two different Kd's--one for PROTEIN1 bound to PROTEIN2 monomers and one for PROTEIN bound to an PROTEIN molecule at the barbed end of a filament.
BioInfer.d375.s3.p2	N	This model includes two different Kd's--one for PROTEIN1 bound to PROTEIN monomers and one for PROTEIN bound to an PROTEIN2 molecule at the barbed end of a filament.
BioInfer.d375.s3.p3	N	This model includes two different Kd's--one for PROTEIN bound to PROTEIN2 monomers and one for PROTEIN1 bound to an PROTEIN molecule at the barbed end of a filament.
BioInfer.d375.s3.p4	P	This model includes two different Kd's--one for PROTEIN bound to PROTEIN monomers and one for PROTEIN1 bound to an PROTEIN2 molecule at the barbed end of a filament.
BioInfer.d375.s3.p5	N	This model includes two different Kd's--one for PROTEIN bound to PROTEIN1 monomers and one for PROTEIN bound to an PROTEIN2 molecule at the barbed end of a filament.
BioInfer.d376.s0.p0	N	In this recombinant expression system, the PROTEIN relatives, human PROTEIN2 ( PROTEIN1 or PROTEIN ) and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN .
BioInfer.d376.s0.p1	N	In this recombinant expression system, the PROTEIN relatives, human PROTEIN ( PROTEIN1 or PROTEIN ) and the PROTEIN2 from Torpedo electric organ, also bind to translated PROTEIN .
BioInfer.d376.s0.p2	N	In this recombinant expression system, the PROTEIN relatives, human PROTEIN ( PROTEIN1 or PROTEIN2 ) and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN .
BioInfer.d376.s0.p3	P	In this recombinant expression system, the PROTEIN relatives, human PROTEIN ( PROTEIN1 or PROTEIN ) and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN2 .
BioInfer.d376.s0.p4	P	In this recombinant expression system, the PROTEIN2 relatives, human PROTEIN ( PROTEIN1 or PROTEIN ) and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN .
BioInfer.d376.s0.p5	N	In this recombinant expression system, the PROTEIN relatives, human PROTEIN1 ( PROTEIN or PROTEIN ) and the PROTEIN2 from Torpedo electric organ, also bind to translated PROTEIN .
BioInfer.d376.s0.p6	N	In this recombinant expression system, the PROTEIN relatives, human PROTEIN1 ( PROTEIN or PROTEIN2 ) and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN .
BioInfer.d376.s0.p7	P	In this recombinant expression system, the PROTEIN relatives, human PROTEIN1 ( PROTEIN or PROTEIN ) and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN2 .
BioInfer.d376.s0.p8	P	In this recombinant expression system, the PROTEIN2 relatives, human PROTEIN1 ( PROTEIN or PROTEIN ) and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN .
BioInfer.d376.s0.p9	N	In this recombinant expression system, the PROTEIN relatives, human PROTEIN ( PROTEIN or PROTEIN2 ) and the PROTEIN1 from Torpedo electric organ, also bind to translated PROTEIN .
BioInfer.d376.s0.p10	P	In this recombinant expression system, the PROTEIN relatives, human PROTEIN ( PROTEIN or PROTEIN ) and the PROTEIN1 from Torpedo electric organ, also bind to translated PROTEIN2 .
BioInfer.d376.s0.p11	P	In this recombinant expression system, the PROTEIN2 relatives, human PROTEIN ( PROTEIN or PROTEIN ) and the PROTEIN1 from Torpedo electric organ, also bind to translated PROTEIN .
BioInfer.d376.s0.p12	P	In this recombinant expression system, the PROTEIN relatives, human PROTEIN ( PROTEIN or PROTEIN1 ) and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN2 .
BioInfer.d376.s0.p13	P	In this recombinant expression system, the PROTEIN2 relatives, human PROTEIN ( PROTEIN or PROTEIN1 ) and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN .
BioInfer.d376.s0.p14	N	In this recombinant expression system, the PROTEIN2 relatives, human PROTEIN ( PROTEIN or PROTEIN ) and the PROTEIN from Torpedo electric organ, also bind to translated PROTEIN1 .
BioInfer.d377.s0.p0	P	In this study, by immunoprecipitation and affinity chromatography it is shown that PROTEIN2 and PROTEIN1 interact in pig brain cortical membranes.
BioInfer.d378.s0.p0	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN , PROTEIN , PROTEIN1 and the PROTEIN isoforms of PROTEIN and PROTEIN2 ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN chain reaction (RT-PCR).
BioInfer.d378.s0.p1	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN2 , PROTEIN , PROTEIN1 and the PROTEIN isoforms of PROTEIN and PROTEIN ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN chain reaction (RT-PCR).
BioInfer.d378.s0.p2	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN , PROTEIN , PROTEIN1 and the PROTEIN isoforms of PROTEIN and PROTEIN ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN2 chain reaction (RT-PCR).
BioInfer.d378.s0.p3	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN , PROTEIN , PROTEIN1 and the PROTEIN2 isoforms of PROTEIN and PROTEIN ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN chain reaction (RT-PCR).
BioInfer.d378.s0.p4	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN , PROTEIN2 , PROTEIN1 and the PROTEIN isoforms of PROTEIN and PROTEIN ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN chain reaction (RT-PCR).
BioInfer.d378.s0.p5	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN , PROTEIN , PROTEIN1 and the PROTEIN isoforms of PROTEIN2 and PROTEIN ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN chain reaction (RT-PCR).
BioInfer.d378.s0.p6	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN2 , PROTEIN , PROTEIN and the PROTEIN isoforms of PROTEIN and PROTEIN1 ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN chain reaction (RT-PCR).
BioInfer.d378.s0.p7	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN , PROTEIN , PROTEIN and the PROTEIN isoforms of PROTEIN and PROTEIN1 ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN2 chain reaction (RT-PCR).
BioInfer.d378.s0.p8	P	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN , PROTEIN , PROTEIN and the PROTEIN2 isoforms of PROTEIN and PROTEIN1 ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN chain reaction (RT-PCR).
BioInfer.d378.s0.p9	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN , PROTEIN2 , PROTEIN and the PROTEIN isoforms of PROTEIN and PROTEIN1 ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN chain reaction (RT-PCR).
BioInfer.d378.s0.p10	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN , PROTEIN , PROTEIN and the PROTEIN isoforms of PROTEIN2 and PROTEIN1 ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN chain reaction (RT-PCR).
BioInfer.d378.s0.p11	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN1 , PROTEIN , PROTEIN and the PROTEIN isoforms of PROTEIN and PROTEIN ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN2 chain reaction (RT-PCR).
BioInfer.d378.s0.p12	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN1 , PROTEIN , PROTEIN and the PROTEIN2 isoforms of PROTEIN and PROTEIN ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN chain reaction (RT-PCR).
BioInfer.d378.s0.p13	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN1 , PROTEIN2 , PROTEIN and the PROTEIN isoforms of PROTEIN and PROTEIN ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN chain reaction (RT-PCR).
BioInfer.d378.s0.p14	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN1 , PROTEIN , PROTEIN and the PROTEIN isoforms of PROTEIN2 and PROTEIN ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN chain reaction (RT-PCR).
BioInfer.d378.s0.p15	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN , PROTEIN , PROTEIN and the PROTEIN2 isoforms of PROTEIN and PROTEIN ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN1 chain reaction (RT-PCR).
BioInfer.d378.s0.p16	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN , PROTEIN2 , PROTEIN and the PROTEIN isoforms of PROTEIN and PROTEIN ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN1 chain reaction (RT-PCR).
BioInfer.d378.s0.p17	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN , PROTEIN , PROTEIN and the PROTEIN isoforms of PROTEIN2 and PROTEIN ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN1 chain reaction (RT-PCR).
BioInfer.d378.s0.p18	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN , PROTEIN2 , PROTEIN and the PROTEIN1 isoforms of PROTEIN and PROTEIN ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN chain reaction (RT-PCR).
BioInfer.d378.s0.p19	P	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN , PROTEIN , PROTEIN and the PROTEIN1 isoforms of PROTEIN2 and PROTEIN ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN chain reaction (RT-PCR).
BioInfer.d378.s0.p20	N	In this study, the expressions of smooth muscle-specific proteins ( PROTEIN , PROTEIN1 , PROTEIN and the PROTEIN isoforms of PROTEIN2 and PROTEIN ) in three parent and four cloned neuroblastoma cell lines, composed of S-type cells, were examined by indirect immunofluorescence, Western blot and/or by reverse transcription- PROTEIN chain reaction (RT-PCR).
BioInfer.d379.s0.p0	P	In this study the role of PROTEIN , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN1 protein and the PROTEIN and PROTEIN2 proteins.
BioInfer.d379.s0.p1	P	In this study the role of PROTEIN , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN1 protein and the PROTEIN2 and PROTEIN proteins.
BioInfer.d379.s0.p2	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN2 , and PROTEIN mutations and by studying the physical interaction between the PROTEIN1 protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p3	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN2 , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN1 protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p4	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN2 mutations and by studying the physical interaction between the PROTEIN1 protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p5	N	In this study the role of PROTEIN2 , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN1 protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p6	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN2 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN1 protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p7	N	In this study the role of PROTEIN , PROTEIN2 , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN1 protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p8	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN2 and PROTEIN1 proteins.
BioInfer.d379.s0.p9	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN2 , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN1 proteins.
BioInfer.d379.s0.p10	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN2 , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN1 proteins.
BioInfer.d379.s0.p11	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN2 mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN1 proteins.
BioInfer.d379.s0.p12	N	In this study the role of PROTEIN2 , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN1 proteins.
BioInfer.d379.s0.p13	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN2 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN1 proteins.
BioInfer.d379.s0.p14	N	In this study the role of PROTEIN , PROTEIN2 , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN1 proteins.
BioInfer.d379.s0.p15	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN2 , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN1 and PROTEIN proteins.
BioInfer.d379.s0.p16	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN2 , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN1 and PROTEIN proteins.
BioInfer.d379.s0.p17	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN2 mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN1 and PROTEIN proteins.
BioInfer.d379.s0.p18	N	In this study the role of PROTEIN2 , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN1 and PROTEIN proteins.
BioInfer.d379.s0.p19	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN2 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN1 and PROTEIN proteins.
BioInfer.d379.s0.p20	N	In this study the role of PROTEIN , PROTEIN2 , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN1 and PROTEIN proteins.
BioInfer.d379.s0.p21	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN2 , PROTEIN1 , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p22	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN1 , and PROTEIN2 mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p23	N	In this study the role of PROTEIN2 , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN1 , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p24	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN2 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN1 , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p25	N	In this study the role of PROTEIN , PROTEIN2 , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN1 , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p26	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN1 , PROTEIN , and PROTEIN2 mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p27	N	In this study the role of PROTEIN2 , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN1 , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p28	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN2 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN1 , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p29	N	In this study the role of PROTEIN , PROTEIN2 , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN1 , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p30	N	In this study the role of PROTEIN2 , PROTEIN , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN1 mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p31	N	In this study the role of PROTEIN , PROTEIN , and PROTEIN2 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN1 mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p32	N	In this study the role of PROTEIN , PROTEIN2 , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN1 mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p33	N	In this study the role of PROTEIN1 , PROTEIN , and PROTEIN2 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p34	N	In this study the role of PROTEIN1 , PROTEIN2 , and PROTEIN in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s0.p35	N	In this study the role of PROTEIN , PROTEIN2 , and PROTEIN1 in mismatch repair has been examined by measuring the rate of accumulating mutations and mutation spectrum in strains containing different combinations of PROTEIN , PROTEIN , and PROTEIN mutations and by studying the physical interaction between the PROTEIN protein and the PROTEIN and PROTEIN proteins.
BioInfer.d379.s1.p0	N	Redundancy of Saccharomyces cerevisiae PROTEIN2 and PROTEIN in PROTEIN1 -dependent mismatch repair.
BioInfer.d379.s1.p1	N	Redundancy of Saccharomyces cerevisiae PROTEIN and PROTEIN2 in PROTEIN1 -dependent mismatch repair.
BioInfer.d379.s1.p2	N	Redundancy of Saccharomyces cerevisiae PROTEIN1 and PROTEIN2 in PROTEIN -dependent mismatch repair.
BioInfer.d379.s2.p0	N	The results indicate that S. cerevisiae has two pathways of PROTEIN -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN and PROTEIN , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN2 and PROTEIN or PROTEIN1 and PROTEIN .
BioInfer.d379.s2.p1	N	The results indicate that S. cerevisiae has two pathways of PROTEIN -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN and PROTEIN , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN and PROTEIN2 or PROTEIN1 and PROTEIN .
BioInfer.d379.s2.p2	N	The results indicate that S. cerevisiae has two pathways of PROTEIN -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN and PROTEIN , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN and PROTEIN or PROTEIN1 and PROTEIN2 .
BioInfer.d379.s2.p3	N	The results indicate that S. cerevisiae has two pathways of PROTEIN -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN2 and PROTEIN , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN and PROTEIN or PROTEIN1 and PROTEIN .
BioInfer.d379.s2.p4	N	The results indicate that S. cerevisiae has two pathways of PROTEIN -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN and PROTEIN2 , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN and PROTEIN or PROTEIN1 and PROTEIN .
BioInfer.d379.s2.p5	P	The results indicate that S. cerevisiae has two pathways of PROTEIN2 -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN and PROTEIN , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN and PROTEIN or PROTEIN1 and PROTEIN .
BioInfer.d379.s2.p6	N	The results indicate that S. cerevisiae has two pathways of PROTEIN -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN and PROTEIN , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN1 and PROTEIN2 or PROTEIN and PROTEIN .
BioInfer.d379.s2.p7	N	The results indicate that S. cerevisiae has two pathways of PROTEIN -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN and PROTEIN , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN1 and PROTEIN or PROTEIN and PROTEIN2 .
BioInfer.d379.s2.p8	N	The results indicate that S. cerevisiae has two pathways of PROTEIN -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN2 and PROTEIN , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN1 and PROTEIN or PROTEIN and PROTEIN .
BioInfer.d379.s2.p9	N	The results indicate that S. cerevisiae has two pathways of PROTEIN -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN and PROTEIN2 , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN1 and PROTEIN or PROTEIN and PROTEIN .
BioInfer.d379.s2.p10	P	The results indicate that S. cerevisiae has two pathways of PROTEIN2 -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN and PROTEIN , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN1 and PROTEIN or PROTEIN and PROTEIN .
BioInfer.d379.s2.p11	N	The results indicate that S. cerevisiae has two pathways of PROTEIN -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN and PROTEIN , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN and PROTEIN1 or PROTEIN and PROTEIN2 .
BioInfer.d379.s2.p12	N	The results indicate that S. cerevisiae has two pathways of PROTEIN -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN2 and PROTEIN , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN and PROTEIN1 or PROTEIN and PROTEIN .
BioInfer.d379.s2.p13	N	The results indicate that S. cerevisiae has two pathways of PROTEIN -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN and PROTEIN2 , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN and PROTEIN1 or PROTEIN and PROTEIN .
BioInfer.d379.s2.p14	P	The results indicate that S. cerevisiae has two pathways of PROTEIN2 -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN and PROTEIN , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN and PROTEIN1 or PROTEIN and PROTEIN .
BioInfer.d379.s2.p15	N	The results indicate that S. cerevisiae has two pathways of PROTEIN -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN2 and PROTEIN , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN and PROTEIN or PROTEIN and PROTEIN1 .
BioInfer.d379.s2.p16	N	The results indicate that S. cerevisiae has two pathways of PROTEIN -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN and PROTEIN2 , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN and PROTEIN or PROTEIN and PROTEIN1 .
BioInfer.d379.s2.p17	P	The results indicate that S. cerevisiae has two pathways of PROTEIN2 -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN and PROTEIN , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN and PROTEIN or PROTEIN and PROTEIN1 .
BioInfer.d379.s2.p18	N	The results indicate that S. cerevisiae has two pathways of PROTEIN -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN1 and PROTEIN2 , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN and PROTEIN or PROTEIN and PROTEIN .
BioInfer.d379.s2.p19	P	The results indicate that S. cerevisiae has two pathways of PROTEIN2 -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN1 and PROTEIN , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN and PROTEIN or PROTEIN and PROTEIN .
BioInfer.d379.s2.p20	P	The results indicate that S. cerevisiae has two pathways of PROTEIN2 -dependent mismatch repair: one that recognized single-base mispairs and requires PROTEIN and PROTEIN1 , and a second that recognizes insertion/deletion mispairs and requires a combination of either PROTEIN and PROTEIN or PROTEIN and PROTEIN .
BioInfer.d380.s0.p0	N	In this study we aimed to determine which type of expression abnormalities for PROTEIN1 , PROTEIN and PROTEIN2 correlate with clinico-pathological features and survival in gastric cancer.
BioInfer.d380.s0.p1	N	In this study we aimed to determine which type of expression abnormalities for PROTEIN1 , PROTEIN2 and PROTEIN correlate with clinico-pathological features and survival in gastric cancer.
BioInfer.d380.s0.p2	N	In this study we aimed to determine which type of expression abnormalities for PROTEIN , PROTEIN2 and PROTEIN1 correlate with clinico-pathological features and survival in gastric cancer.
BioInfer.d381.s0.p0	N	In this study we demonstrate that PROTEIN1  PROTEIN and PROTEIN  PROTEIN2 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.
BioInfer.d381.s0.p1	P	In this study we demonstrate that PROTEIN1  PROTEIN2 and PROTEIN  PROTEIN synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.
BioInfer.d381.s0.p2	N	In this study we demonstrate that PROTEIN1  PROTEIN and PROTEIN2  PROTEIN synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.
BioInfer.d381.s0.p3	P	In this study we demonstrate that PROTEIN  PROTEIN2 and PROTEIN  PROTEIN1 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.
BioInfer.d381.s0.p4	P	In this study we demonstrate that PROTEIN  PROTEIN and PROTEIN2  PROTEIN1 synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.
BioInfer.d381.s0.p5	N	In this study we demonstrate that PROTEIN  PROTEIN1 and PROTEIN2  PROTEIN synthesized in young (5 hr) conjugating Tetrahymena are deposited into micronuclei in acetylated forms.
BioInfer.d382.s0.p0	N	In this study, we demonstrate that PROTEIN isoforms expressed in a single cell can have different effects on PROTEIN2 in living cells and that the poly-L-proline binding function of PROTEIN1 may have important consequences for the regulation of PROTEIN cytoskeletal dynamics in plant cells.
BioInfer.d382.s0.p1	N	In this study, we demonstrate that PROTEIN2 isoforms expressed in a single cell can have different effects on PROTEIN in living cells and that the poly-L-proline binding function of PROTEIN1 may have important consequences for the regulation of PROTEIN cytoskeletal dynamics in plant cells.
BioInfer.d382.s0.p2	P	In this study, we demonstrate that PROTEIN isoforms expressed in a single cell can have different effects on PROTEIN in living cells and that the poly-L-proline binding function of PROTEIN1 may have important consequences for the regulation of PROTEIN2 cytoskeletal dynamics in plant cells.
BioInfer.d382.s0.p3	P	In this study, we demonstrate that PROTEIN2 isoforms expressed in a single cell can have different effects on PROTEIN1 in living cells and that the poly-L-proline binding function of PROTEIN may have important consequences for the regulation of PROTEIN cytoskeletal dynamics in plant cells.
BioInfer.d382.s0.p4	N	In this study, we demonstrate that PROTEIN isoforms expressed in a single cell can have different effects on PROTEIN1 in living cells and that the poly-L-proline binding function of PROTEIN may have important consequences for the regulation of PROTEIN2 cytoskeletal dynamics in plant cells.
BioInfer.d382.s0.p5	N	In this study, we demonstrate that PROTEIN1 isoforms expressed in a single cell can have different effects on PROTEIN in living cells and that the poly-L-proline binding function of PROTEIN may have important consequences for the regulation of PROTEIN2 cytoskeletal dynamics in plant cells.
BioInfer.d382.s1.p0	P	Recently, we characterized several PROTEIN2 isoforms from maize pollen for their ability to alter cytoarchitecture when microinjected into living plant cells and for their association with poly-L-proline and monomeric PROTEIN1 from maize pollen.
BioInfer.d382.s2.p0	P	The affinity of PROTEIN1 for monomeric PROTEIN2 , which was measured by two independent methods, is similar to that of the three PROTEIN isoforms previously identified in pollen.
BioInfer.d382.s2.p1	N	The affinity of PROTEIN1 for monomeric PROTEIN , which was measured by two independent methods, is similar to that of the three PROTEIN2 isoforms previously identified in pollen.
BioInfer.d382.s2.p2	P	The affinity of PROTEIN for monomeric PROTEIN1 , which was measured by two independent methods, is similar to that of the three PROTEIN2 isoforms previously identified in pollen.
BioInfer.d382.s3.p0	P	When PROTEIN was microinjected into plant cells, the effect on PROTEIN2 -dependent nuclear position was significantly more rapid than that of another pollen PROTEIN isoform, PROTEIN1 .
BioInfer.d382.s3.p1	N	When PROTEIN2 was microinjected into plant cells, the effect on PROTEIN -dependent nuclear position was significantly more rapid than that of another pollen PROTEIN isoform, PROTEIN1 .
BioInfer.d382.s3.p2	P	When PROTEIN was microinjected into plant cells, the effect on PROTEIN -dependent nuclear position was significantly more rapid than that of another pollen PROTEIN2 isoform, PROTEIN1 .
BioInfer.d382.s3.p3	P	When PROTEIN2 was microinjected into plant cells, the effect on PROTEIN1 -dependent nuclear position was significantly more rapid than that of another pollen PROTEIN isoform, PROTEIN .
BioInfer.d382.s3.p4	N	When PROTEIN was microinjected into plant cells, the effect on PROTEIN1 -dependent nuclear position was significantly more rapid than that of another pollen PROTEIN2 isoform, PROTEIN .
BioInfer.d382.s3.p5	N	When PROTEIN1 was microinjected into plant cells, the effect on PROTEIN -dependent nuclear position was significantly more rapid than that of another pollen PROTEIN2 isoform, PROTEIN .
BioInfer.d383.s0.p0	N	In this work we report that the Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN1 checkpoint genes are required for efficient non-homologous end joining (NHEJ).
BioInfer.d383.s0.p1	N	In this work we report that the Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN and PROTEIN1 checkpoint genes are required for efficient non-homologous end joining (NHEJ).
BioInfer.d383.s0.p2	N	In this work we report that the Saccharomyces cerevisiae PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 checkpoint genes are required for efficient non-homologous end joining (NHEJ).
BioInfer.d383.s0.p3	N	In this work we report that the Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN1 checkpoint genes are required for efficient non-homologous end joining (NHEJ).
BioInfer.d383.s0.p4	N	In this work we report that the Saccharomyces cerevisiae PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 checkpoint genes are required for efficient non-homologous end joining (NHEJ).
BioInfer.d383.s0.p5	N	In this work we report that the Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).
BioInfer.d383.s0.p6	N	In this work we report that the Saccharomyces cerevisiae PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).
BioInfer.d383.s0.p7	N	In this work we report that the Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).
BioInfer.d383.s0.p8	N	In this work we report that the Saccharomyces cerevisiae PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).
BioInfer.d383.s0.p9	N	In this work we report that the Saccharomyces cerevisiae PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).
BioInfer.d383.s0.p10	N	In this work we report that the Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).
BioInfer.d383.s0.p11	N	In this work we report that the Saccharomyces cerevisiae PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).
BioInfer.d383.s0.p12	N	In this work we report that the Saccharomyces cerevisiae PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).
BioInfer.d383.s0.p13	N	In this work we report that the Saccharomyces cerevisiae PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).
BioInfer.d383.s0.p14	N	In this work we report that the Saccharomyces cerevisiae PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN checkpoint genes are required for efficient non-homologous end joining (NHEJ).
BioInfer.d384.s0.p0	N	In three of the cell lines with PROTEIN mutations, complexes of PROTEIN with PROTEIN2 and PROTEIN1 were detectable.
BioInfer.d384.s0.p1	P	In three of the cell lines with PROTEIN mutations, complexes of PROTEIN2 with PROTEIN and PROTEIN1 were detectable.
BioInfer.d384.s0.p2	N	In three of the cell lines with PROTEIN2 mutations, complexes of PROTEIN with PROTEIN and PROTEIN1 were detectable.
BioInfer.d384.s0.p3	P	In three of the cell lines with PROTEIN mutations, complexes of PROTEIN2 with PROTEIN1 and PROTEIN were detectable.
BioInfer.d384.s0.p4	N	In three of the cell lines with PROTEIN2 mutations, complexes of PROTEIN with PROTEIN1 and PROTEIN were detectable.
BioInfer.d384.s0.p5	N	In three of the cell lines with PROTEIN2 mutations, complexes of PROTEIN1 with PROTEIN and PROTEIN were detectable.
BioInfer.d385.s0.p0	P	Introduction of high concentrations of PROTEIN1 (estimated injected intracellular concentration 11-22 microM) into infected PtK2 cells causes a marked slowing of PROTEIN2 tail elongation and bacterial migration.
BioInfer.d386.s0.p0	P	In vitro, PROTEIN1 purified from some of these mutants is defective in polymerization or binding PROTEIN2 .
BioInfer.d387.s0.p1	N	In vitro studies indicated that suramin completely blocked PROTEIN1 activation or phosphorylation stimulated by PROTEIN , inhibited activation of PROTEIN ( PROTEIN ) kinases ( PROTEIN /2) and PROTEIN /2, and abrogated transcription factor PROTEIN2 DNA-binding activity.
BioInfer.d387.s0.p2	N	In vitro studies indicated that suramin completely blocked PROTEIN1 activation or phosphorylation stimulated by PROTEIN , inhibited activation of PROTEIN ( PROTEIN2 ) kinases ( PROTEIN /2) and PROTEIN /2, and abrogated transcription factor PROTEIN DNA-binding activity.
BioInfer.d387.s0.p4	N	In vitro studies indicated that suramin completely blocked PROTEIN1 activation or phosphorylation stimulated by PROTEIN , inhibited activation of PROTEIN ( PROTEIN ) kinases ( PROTEIN2 /2) and PROTEIN /2, and abrogated transcription factor PROTEIN DNA-binding activity.
BioInfer.d387.s0.p5	P	In vitro studies indicated that suramin completely blocked PROTEIN1 activation or phosphorylation stimulated by PROTEIN2 , inhibited activation of PROTEIN ( PROTEIN ) kinases ( PROTEIN /2) and PROTEIN /2, and abrogated transcription factor PROTEIN DNA-binding activity.
BioInfer.d387.s0.p6	N	In vitro studies indicated that suramin completely blocked PROTEIN1 activation or phosphorylation stimulated by PROTEIN , inhibited activation of PROTEIN ( PROTEIN ) kinases ( PROTEIN /2) and PROTEIN2 /2, and abrogated transcription factor PROTEIN DNA-binding activity.
BioInfer.d387.s0.p7	N	In vitro studies indicated that suramin completely blocked PROTEIN1 activation or phosphorylation stimulated by PROTEIN , inhibited activation of PROTEIN2 ( PROTEIN ) kinases ( PROTEIN /2) and PROTEIN /2, and abrogated transcription factor PROTEIN DNA-binding activity.
BioInfer.d387.s0.p15	N	In vitro studies indicated that suramin completely blocked PROTEIN activation or phosphorylation stimulated by PROTEIN , inhibited activation of PROTEIN ( PROTEIN2 ) kinases ( PROTEIN /2) and PROTEIN /2, and abrogated transcription factor PROTEIN1 DNA-binding activity.
BioInfer.d387.s0.p17	N	In vitro studies indicated that suramin completely blocked PROTEIN activation or phosphorylation stimulated by PROTEIN , inhibited activation of PROTEIN ( PROTEIN ) kinases ( PROTEIN2 /2) and PROTEIN /2, and abrogated transcription factor PROTEIN1 DNA-binding activity.
BioInfer.d387.s0.p18	N	In vitro studies indicated that suramin completely blocked PROTEIN activation or phosphorylation stimulated by PROTEIN2 , inhibited activation of PROTEIN ( PROTEIN ) kinases ( PROTEIN /2) and PROTEIN /2, and abrogated transcription factor PROTEIN1 DNA-binding activity.
BioInfer.d387.s0.p19	N	In vitro studies indicated that suramin completely blocked PROTEIN activation or phosphorylation stimulated by PROTEIN , inhibited activation of PROTEIN ( PROTEIN ) kinases ( PROTEIN /2) and PROTEIN2 /2, and abrogated transcription factor PROTEIN1 DNA-binding activity.
BioInfer.d387.s0.p20	N	In vitro studies indicated that suramin completely blocked PROTEIN activation or phosphorylation stimulated by PROTEIN , inhibited activation of PROTEIN2 ( PROTEIN ) kinases ( PROTEIN /2) and PROTEIN /2, and abrogated transcription factor PROTEIN1 DNA-binding activity.
BioInfer.d387.s0.p22	N	In vitro studies indicated that suramin completely blocked PROTEIN activation or phosphorylation stimulated by PROTEIN , inhibited activation of PROTEIN ( PROTEIN1 ) kinases ( PROTEIN2 /2) and PROTEIN /2, and abrogated transcription factor PROTEIN DNA-binding activity.
BioInfer.d387.s0.p23	N	In vitro studies indicated that suramin completely blocked PROTEIN activation or phosphorylation stimulated by PROTEIN2 , inhibited activation of PROTEIN ( PROTEIN1 ) kinases ( PROTEIN /2) and PROTEIN /2, and abrogated transcription factor PROTEIN DNA-binding activity.
BioInfer.d387.s0.p24	N	In vitro studies indicated that suramin completely blocked PROTEIN activation or phosphorylation stimulated by PROTEIN , inhibited activation of PROTEIN ( PROTEIN1 ) kinases ( PROTEIN /2) and PROTEIN2 /2, and abrogated transcription factor PROTEIN DNA-binding activity.
BioInfer.d387.s0.p25	N	In vitro studies indicated that suramin completely blocked PROTEIN activation or phosphorylation stimulated by PROTEIN , inhibited activation of PROTEIN2 ( PROTEIN1 ) kinases ( PROTEIN /2) and PROTEIN /2, and abrogated transcription factor PROTEIN DNA-binding activity.
BioInfer.d387.s0.p30	N	In vitro studies indicated that suramin completely blocked PROTEIN activation or phosphorylation stimulated by PROTEIN2 , inhibited activation of PROTEIN ( PROTEIN ) kinases ( PROTEIN1 /2) and PROTEIN /2, and abrogated transcription factor PROTEIN DNA-binding activity.
BioInfer.d387.s0.p31	N	In vitro studies indicated that suramin completely blocked PROTEIN activation or phosphorylation stimulated by PROTEIN , inhibited activation of PROTEIN ( PROTEIN ) kinases ( PROTEIN1 /2) and PROTEIN2 /2, and abrogated transcription factor PROTEIN DNA-binding activity.
BioInfer.d387.s0.p32	P	In vitro studies indicated that suramin completely blocked PROTEIN activation or phosphorylation stimulated by PROTEIN , inhibited activation of PROTEIN2 ( PROTEIN ) kinases ( PROTEIN1 /2) and PROTEIN /2, and abrogated transcription factor PROTEIN DNA-binding activity.
BioInfer.d387.s0.p33	N	In vitro studies indicated that suramin completely blocked PROTEIN activation or phosphorylation stimulated by PROTEIN1 , inhibited activation of PROTEIN ( PROTEIN ) kinases ( PROTEIN /2) and PROTEIN2 /2, and abrogated transcription factor PROTEIN DNA-binding activity.
BioInfer.d387.s0.p34	N	In vitro studies indicated that suramin completely blocked PROTEIN activation or phosphorylation stimulated by PROTEIN1 , inhibited activation of PROTEIN2 ( PROTEIN ) kinases ( PROTEIN /2) and PROTEIN /2, and abrogated transcription factor PROTEIN DNA-binding activity.
BioInfer.d387.s0.p35	N	In vitro studies indicated that suramin completely blocked PROTEIN activation or phosphorylation stimulated by PROTEIN , inhibited activation of PROTEIN2 ( PROTEIN ) kinases ( PROTEIN /2) and PROTEIN1 /2, and abrogated transcription factor PROTEIN DNA-binding activity.
BioInfer.d388.s0.p0	P	In vivo importance of PROTEIN1 nucleotide exchange catalyzed by PROTEIN2 .
BioInfer.d388.s1.p0	P	PROTEIN2 , an PROTEIN mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN organization, cell growth, and fluid-phase endocytosis of PROTEIN1 , a PROTEIN mutant defective in PROTEIN binding.
BioInfer.d388.s1.p1	N	PROTEIN , an PROTEIN mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN organization, cell growth, and fluid-phase endocytosis of PROTEIN1 , a PROTEIN2 mutant defective in PROTEIN binding.
BioInfer.d388.s1.p2	P	PROTEIN , an PROTEIN2 mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN organization, cell growth, and fluid-phase endocytosis of PROTEIN1 , a PROTEIN mutant defective in PROTEIN binding.
BioInfer.d388.s1.p3	N	PROTEIN , an PROTEIN mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN2 organization, cell growth, and fluid-phase endocytosis of PROTEIN1 , a PROTEIN mutant defective in PROTEIN binding.
BioInfer.d388.s1.p4	P	PROTEIN , an PROTEIN mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN organization, cell growth, and fluid-phase endocytosis of PROTEIN1 , a PROTEIN mutant defective in PROTEIN2 binding.
BioInfer.d388.s1.p5	P	PROTEIN1 , an PROTEIN mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN organization, cell growth, and fluid-phase endocytosis of PROTEIN , a PROTEIN2 mutant defective in PROTEIN binding.
BioInfer.d388.s1.p6	N	PROTEIN1 , an PROTEIN2 mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN organization, cell growth, and fluid-phase endocytosis of PROTEIN , a PROTEIN mutant defective in PROTEIN binding.
BioInfer.d388.s1.p7	P	PROTEIN1 , an PROTEIN mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN2 organization, cell growth, and fluid-phase endocytosis of PROTEIN , a PROTEIN mutant defective in PROTEIN binding.
BioInfer.d388.s1.p8	N	PROTEIN1 , an PROTEIN mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN organization, cell growth, and fluid-phase endocytosis of PROTEIN , a PROTEIN mutant defective in PROTEIN2 binding.
BioInfer.d388.s1.p9	P	PROTEIN , an PROTEIN2 mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN organization, cell growth, and fluid-phase endocytosis of PROTEIN , a PROTEIN1 mutant defective in PROTEIN binding.
BioInfer.d388.s1.p10	N	PROTEIN , an PROTEIN mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN2 organization, cell growth, and fluid-phase endocytosis of PROTEIN , a PROTEIN1 mutant defective in PROTEIN binding.
BioInfer.d388.s1.p11	P	PROTEIN , an PROTEIN mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN organization, cell growth, and fluid-phase endocytosis of PROTEIN , a PROTEIN1 mutant defective in PROTEIN2 binding.
BioInfer.d388.s1.p12	P	PROTEIN , an PROTEIN1 mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN2 organization, cell growth, and fluid-phase endocytosis of PROTEIN , a PROTEIN mutant defective in PROTEIN binding.
BioInfer.d388.s1.p13	N	PROTEIN , an PROTEIN1 mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN organization, cell growth, and fluid-phase endocytosis of PROTEIN , a PROTEIN mutant defective in PROTEIN2 binding.
BioInfer.d388.s1.p14	N	PROTEIN , an PROTEIN mutant with an increased intrinsic rate of nucleotide exchange, suppressed defects in PROTEIN1 organization, cell growth, and fluid-phase endocytosis of PROTEIN , a PROTEIN mutant defective in PROTEIN2 binding.
BioInfer.d388.s2.p0	N	The PROTEIN1 monomer-binding protein, PROTEIN , influences the dynamics of PROTEIN filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on PROTEIN2 , and promoting barbed-end assembly.
BioInfer.d388.s2.p1	N	The PROTEIN1 monomer-binding protein, PROTEIN , influences the dynamics of PROTEIN2 filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on PROTEIN , and promoting barbed-end assembly.
BioInfer.d388.s2.p2	P	The PROTEIN1 monomer-binding protein, PROTEIN2 , influences the dynamics of PROTEIN filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on PROTEIN , and promoting barbed-end assembly.
BioInfer.d388.s2.p3	P	The PROTEIN monomer-binding protein, PROTEIN , influences the dynamics of PROTEIN2 filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on PROTEIN1 , and promoting barbed-end assembly.
BioInfer.d388.s2.p4	P	The PROTEIN monomer-binding protein, PROTEIN2 , influences the dynamics of PROTEIN filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on PROTEIN1 , and promoting barbed-end assembly.
BioInfer.d388.s2.p5	P	The PROTEIN monomer-binding protein, PROTEIN2 , influences the dynamics of PROTEIN1 filaments in vitro by suppressing nucleation, enhancing nucleotide exchange on PROTEIN , and promoting barbed-end assembly.
BioInfer.d388.s3.p0	N	To study PROTEIN2 function, we extensively mutagenized the Saccharomyces cerevisiae PROTEIN gene ( PROTEIN ) and examined the consequences of specific point mutations on growth and PROTEIN1 organization.
BioInfer.d388.s3.p1	P	To study PROTEIN function, we extensively mutagenized the Saccharomyces cerevisiae PROTEIN2 gene ( PROTEIN ) and examined the consequences of specific point mutations on growth and PROTEIN1 organization.
BioInfer.d388.s3.p2	P	To study PROTEIN function, we extensively mutagenized the Saccharomyces cerevisiae PROTEIN gene ( PROTEIN2 ) and examined the consequences of specific point mutations on growth and PROTEIN1 organization.
BioInfer.d388.s3.p3	N	To study PROTEIN1 function, we extensively mutagenized the Saccharomyces cerevisiae PROTEIN2 gene ( PROTEIN ) and examined the consequences of specific point mutations on growth and PROTEIN organization.
BioInfer.d388.s3.p4	N	To study PROTEIN1 function, we extensively mutagenized the Saccharomyces cerevisiae PROTEIN gene ( PROTEIN2 ) and examined the consequences of specific point mutations on growth and PROTEIN organization.
BioInfer.d388.s3.p5	N	To study PROTEIN function, we extensively mutagenized the Saccharomyces cerevisiae PROTEIN1 gene ( PROTEIN2 ) and examined the consequences of specific point mutations on growth and PROTEIN organization.
BioInfer.d389.s0.p0	P	Involvement of PROTEIN2 in the PROTEIN1 -based motility of L. monocytogenes in cells and in cell-free extracts.
BioInfer.d390.s0.p0	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN / PROTEIN2 , PROTEIN ) and PROTEIN1 domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p1	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN2 / PROTEIN , PROTEIN ) and PROTEIN1 domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p2	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN1 domain-containing proteins ( PROTEIN , PROTEIN2 , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p3	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN1 domain-containing proteins ( PROTEIN2 , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p4	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN1 domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN2 ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p5	N	Isolation and characterization of death domain ( PROTEIN2 , PROTEIN , PROTEIN , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN1 domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p6	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN2 , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN1 domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p7	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN2 , PROTEIN , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN1 domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p8	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN / PROTEIN , PROTEIN2 ) and PROTEIN1 domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p9	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN2 / PROTEIN1 , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p10	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN / PROTEIN1 , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN2 , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p11	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN / PROTEIN1 , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN2 , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p12	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN / PROTEIN1 , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN2 ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p13	N	Isolation and characterization of death domain ( PROTEIN2 , PROTEIN , PROTEIN , PROTEIN / PROTEIN1 , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p14	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN2 , PROTEIN / PROTEIN1 , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p15	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN2 , PROTEIN , PROTEIN / PROTEIN1 , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p16	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN / PROTEIN1 , PROTEIN2 ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p17	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN1 / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN2 , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p18	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN1 / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN2 , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p19	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN1 / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN2 ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p20	N	Isolation and characterization of death domain ( PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p21	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p22	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p23	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN1 / PROTEIN , PROTEIN2 ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p24	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN2 , PROTEIN1 , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p25	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN1 , PROTEIN2 ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p26	N	Isolation and characterization of death domain ( PROTEIN2 , PROTEIN , PROTEIN , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN1 , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p27	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN2 , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN1 , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p28	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN2 , PROTEIN , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN1 , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p29	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN / PROTEIN , PROTEIN2 ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN1 , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p30	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN1 , PROTEIN , PROTEIN2 ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p31	N	Isolation and characterization of death domain ( PROTEIN2 , PROTEIN , PROTEIN , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN1 , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p32	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN2 , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN1 , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p33	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN2 , PROTEIN , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN1 , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p34	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN / PROTEIN , PROTEIN2 ) and PROTEIN domain-containing proteins ( PROTEIN1 , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p35	N	Isolation and characterization of death domain ( PROTEIN2 , PROTEIN , PROTEIN , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN1 ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p36	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN2 , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN1 ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p37	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN2 , PROTEIN , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN1 ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p38	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN , PROTEIN / PROTEIN , PROTEIN2 ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN1 ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p39	N	Isolation and characterization of death domain ( PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p40	N	Isolation and characterization of death domain ( PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p41	N	Isolation and characterization of death domain ( PROTEIN1 , PROTEIN , PROTEIN , PROTEIN / PROTEIN , PROTEIN2 ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p42	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN / PROTEIN , PROTEIN ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p43	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN , PROTEIN1 , PROTEIN / PROTEIN , PROTEIN2 ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d390.s0.p44	N	Isolation and characterization of death domain ( PROTEIN , PROTEIN1 , PROTEIN , PROTEIN / PROTEIN , PROTEIN2 ) and PROTEIN domain-containing proteins ( PROTEIN , PROTEIN , PROTEIN ) have partially bridged a large molecular gap within one of several signaling pathways which originate at the plasma membrane and terminate in the nucleus.
BioInfer.d391.s0.p0	P	Isolation of PROTEIN2 from embryonic chicken skeletal muscle and evaluation of its interaction with different PROTEIN1 isoforms.
BioInfer.d391.s1.p0	P	These results indicate that the assembly of PROTEIN and PROTEIN2 is regulated differently by PROTEIN1 in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.
BioInfer.d391.s1.p1	P	These results indicate that the assembly of PROTEIN2 and PROTEIN is regulated differently by PROTEIN1 in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.
BioInfer.d391.s1.p2	N	These results indicate that the assembly of PROTEIN2 and PROTEIN1 is regulated differently by PROTEIN in the developing skeletal muscle, and that the former may not be involved in myofibril assembly.
BioInfer.d392.s0.p0	P	Isolation of human PROTEIN2 and its binding specificity with PROTEIN1 .
BioInfer.d393.s0.p0	N	Isolation of human PROTEIN2 and PROTEIN1 for measurement of fractional synthesis rates.
BioInfer.d393.s1.p0	N	Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate PROTEIN2 ( PROTEIN ) and PROTEIN1 from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.
BioInfer.d393.s1.p1	N	Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate PROTEIN ( PROTEIN2 ) and PROTEIN1 from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.
BioInfer.d393.s1.p2	N	Using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), we have developed a simple method to isolate PROTEIN1 ( PROTEIN2 ) and PROTEIN from small (60-80 mg) human skeletal muscle samples for the determination of their fractional synthesis rates.
BioInfer.d394.s0.p0	N	It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G PROTEIN from PROTEIN1 or promoting the cross-linking of PROTEIN2 or its anchorage to the plasma membrane.
BioInfer.d394.s0.p1	P	It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G PROTEIN2 from PROTEIN1 or promoting the cross-linking of PROTEIN or its anchorage to the plasma membrane.
BioInfer.d394.s0.p2	N	It is also possible that PtdIns-4,5-P2 has other roles, such as promoting the release of G PROTEIN2 from PROTEIN or promoting the cross-linking of PROTEIN1 or its anchorage to the plasma membrane.
BioInfer.d395.s0.p0	N	It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of PROTEIN1 , 120 molecules of PROTEIN  PROTEIN , and 60 molecules each of PROTEIN2 and PROTEIN .
BioInfer.d395.s0.p1	N	It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of PROTEIN1 , 120 molecules of PROTEIN2  PROTEIN , and 60 molecules each of PROTEIN and PROTEIN .
BioInfer.d395.s0.p2	N	It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of PROTEIN1 , 120 molecules of PROTEIN  PROTEIN2 , and 60 molecules each of PROTEIN and PROTEIN .
BioInfer.d395.s0.p3	N	It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of PROTEIN1 , 120 molecules of PROTEIN  PROTEIN , and 60 molecules each of PROTEIN and PROTEIN2 .
BioInfer.d395.s0.p4	N	It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of PROTEIN , 120 molecules of PROTEIN2  PROTEIN , and 60 molecules each of PROTEIN1 and PROTEIN .
BioInfer.d395.s0.p5	N	It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of PROTEIN , 120 molecules of PROTEIN  PROTEIN2 , and 60 molecules each of PROTEIN1 and PROTEIN .
BioInfer.d395.s0.p6	N	It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of PROTEIN , 120 molecules of PROTEIN  PROTEIN , and 60 molecules each of PROTEIN1 and PROTEIN2 .
BioInfer.d395.s0.p7	P	It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of PROTEIN , 120 molecules of PROTEIN1  PROTEIN2 , and 60 molecules each of PROTEIN and PROTEIN .
BioInfer.d395.s0.p8	N	It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of PROTEIN , 120 molecules of PROTEIN1  PROTEIN , and 60 molecules each of PROTEIN and PROTEIN2 .
BioInfer.d395.s0.p9	N	It is estimated that at optimal levels of transcription, every molecule of viral genomic RNA associates with approximately the following number of protein molecules: 30 molecules of PROTEIN , 120 molecules of PROTEIN  PROTEIN1 , and 60 molecules each of PROTEIN and PROTEIN2 .
BioInfer.d395.s1.p0	P	Native PROTEIN2 , purified from extracts of lung epithelial cells by affinity binding to a poly-L-proline matrix, stimulated the PROTEIN1 -saturated RSV transcription by 2.5- to 3-fold.
BioInfer.d396.s0.p0	N	It reduced the rate of PROTEIN2 polymerization as reported in the cases of PROTEIN1 from other organisms.
BioInfer.d397.s0.p0	P	It therefore appears that PROTEIN1 and PROTEIN2 multigene families are both expressed in a species specific fashion but are independently regulated within a species.
BioInfer.d397.s1.p0	N	Regulation of PROTEIN2 and PROTEIN1 isogenes expression during cardiac growth.
BioInfer.d397.s2.p0	N	The PROTEIN2 phenotype is developmentally and hormonally regulated, but less is known concerning the PROTEIN1 phenotype.
BioInfer.d398.s0.p0	P	Kinetic measurements indicate that PROTEIN2 binding to PROTEIN weakens the affinity of PROTEIN1 for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.
BioInfer.d398.s0.p1	P	Kinetic measurements indicate that PROTEIN binding to PROTEIN2 weakens the affinity of PROTEIN1 for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.
BioInfer.d398.s0.p2	P	Kinetic measurements indicate that PROTEIN1 binding to PROTEIN2 weakens the affinity of PROTEIN for nucleotides primarily due to an increased nucleotide dissociation rate constant, but the nucleotide association rate constant is also increased about 2-fold.
BioInfer.d398.s1.p0	P	The data suggest that PROTEIN binding to PROTEIN2 weakens nucleotide binding to PROTEIN by disrupting Mg(2+) coordination in the PROTEIN1 central cleft.
BioInfer.d398.s1.p1	P	The data suggest that PROTEIN binding to PROTEIN weakens nucleotide binding to PROTEIN2 by disrupting Mg(2+) coordination in the PROTEIN1 central cleft.
BioInfer.d398.s1.p2	P	The data suggest that PROTEIN2 binding to PROTEIN weakens nucleotide binding to PROTEIN by disrupting Mg(2+) coordination in the PROTEIN1 central cleft.
BioInfer.d398.s1.p3	P	The data suggest that PROTEIN binding to PROTEIN1 weakens nucleotide binding to PROTEIN2 by disrupting Mg(2+) coordination in the PROTEIN central cleft.
BioInfer.d398.s1.p4	P	The data suggest that PROTEIN2 binding to PROTEIN1 weakens nucleotide binding to PROTEIN by disrupting Mg(2+) coordination in the PROTEIN central cleft.
BioInfer.d398.s1.p5	P	The data suggest that PROTEIN2 binding to PROTEIN weakens nucleotide binding to PROTEIN1 by disrupting Mg(2+) coordination in the PROTEIN central cleft.
BioInfer.d399.s0.p0	P	Kinetic studies on the effect of yeast PROTEIN1 on yeast PROTEIN2 polymerization.
BioInfer.d399.s1.p0	P	The results suggest some cooperativity with respect to PROTEIN2 binding to filamentous PROTEIN1 which may be pH dependent.
BioInfer.d400.s0.p0	N	Lack of detection in these preparations of a constituent that binds RBC PROTEIN antibody plus the presence of significant quantities of PROTEIN2 , further suggests that the principal membrane skeletal element is PROTEIN with perhaps smaller quantities of a 240-kd component, identified by others as the protein PROTEIN1 .
BioInfer.d400.s0.p1	N	Lack of detection in these preparations of a constituent that binds RBC PROTEIN antibody plus the presence of significant quantities of PROTEIN , further suggests that the principal membrane skeletal element is PROTEIN2 with perhaps smaller quantities of a 240-kd component, identified by others as the protein PROTEIN1 .
BioInfer.d400.s0.p2	N	Lack of detection in these preparations of a constituent that binds RBC PROTEIN2 antibody plus the presence of significant quantities of PROTEIN , further suggests that the principal membrane skeletal element is PROTEIN with perhaps smaller quantities of a 240-kd component, identified by others as the protein PROTEIN1 .
BioInfer.d400.s0.p3	N	Lack of detection in these preparations of a constituent that binds RBC PROTEIN antibody plus the presence of significant quantities of PROTEIN1 , further suggests that the principal membrane skeletal element is PROTEIN2 with perhaps smaller quantities of a 240-kd component, identified by others as the protein PROTEIN .
BioInfer.d400.s0.p4	N	Lack of detection in these preparations of a constituent that binds RBC PROTEIN2 antibody plus the presence of significant quantities of PROTEIN1 , further suggests that the principal membrane skeletal element is PROTEIN with perhaps smaller quantities of a 240-kd component, identified by others as the protein PROTEIN .
BioInfer.d400.s0.p5	N	Lack of detection in these preparations of a constituent that binds RBC PROTEIN2 antibody plus the presence of significant quantities of PROTEIN , further suggests that the principal membrane skeletal element is PROTEIN1 with perhaps smaller quantities of a 240-kd component, identified by others as the protein PROTEIN .
BioInfer.d401.s0.p0	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN1  PROTEIN2 and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p1	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , indicating that the PROTEIN1  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p2	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN1  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p3	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , indicating that the PROTEIN1  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p4	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , indicating that the PROTEIN1  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p5	N	Lethality of the PROTEIN2  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN1  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p6	N	Lethality of the PROTEIN  PROTEIN2 and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN1  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p7	N	Lethality of the PROTEIN  PROTEIN and PROTEIN2  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN1  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p8	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN1  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p9	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN1  PROTEIN and PROTEIN2  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p10	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN1  PROTEIN and PROTEIN  PROTEIN2 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p11	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , indicating that the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p12	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p13	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , indicating that the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p14	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p15	N	Lethality of the PROTEIN2  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p16	N	Lethality of the PROTEIN  PROTEIN2 and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p17	N	Lethality of the PROTEIN  PROTEIN and PROTEIN2  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p18	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p19	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN1 and PROTEIN2  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p20	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN2 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p21	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p22	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p23	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p24	N	Lethality of the PROTEIN2  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p25	N	Lethality of the PROTEIN  PROTEIN2 and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p26	N	Lethality of the PROTEIN  PROTEIN and PROTEIN2  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p27	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p28	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN2  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p29	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p30	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p31	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p32	N	Lethality of the PROTEIN2  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p33	N	Lethality of the PROTEIN  PROTEIN2 and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p34	N	Lethality of the PROTEIN  PROTEIN and PROTEIN2  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p35	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p36	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN2  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p37	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p38	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p39	N	Lethality of the PROTEIN2  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p40	N	Lethality of the PROTEIN  PROTEIN2 and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p41	N	Lethality of the PROTEIN  PROTEIN and PROTEIN2  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p42	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p43	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , indicating that the PROTEIN  PROTEIN and PROTEIN2  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p44	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p45	N	Lethality of the PROTEIN2  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p46	N	Lethality of the PROTEIN  PROTEIN2 and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p47	N	Lethality of the PROTEIN  PROTEIN and PROTEIN2  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p48	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p49	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN2  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p50	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p51	N	Lethality of the PROTEIN1  PROTEIN2 and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p52	N	Lethality of the PROTEIN1  PROTEIN and PROTEIN2  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p53	N	Lethality of the PROTEIN1  PROTEIN and PROTEIN  PROTEIN2 double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p54	N	Lethality of the PROTEIN1  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN2  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p55	N	Lethality of the PROTEIN1  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p56	N	Lethality of the PROTEIN  PROTEIN1 and PROTEIN2  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p57	N	Lethality of the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN2 double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p58	N	Lethality of the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN2  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p59	N	Lethality of the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p60	N	Lethality of the PROTEIN  PROTEIN and PROTEIN1  PROTEIN2 double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p61	N	Lethality of the PROTEIN  PROTEIN and PROTEIN1  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN2  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p62	N	Lethality of the PROTEIN  PROTEIN and PROTEIN1  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p63	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN1 double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN2  PROTEIN mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p64	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN1 double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d401.s0.p65	N	Lethality of the PROTEIN  PROTEIN and PROTEIN  PROTEIN double mutants can also be rescued by mutations in the DNA damage checkpoint functions PROTEIN , PROTEIN , PROTEIN , and PROTEIN , indicating that the PROTEIN  PROTEIN and PROTEIN1  PROTEIN2 mutant combinations lead to an intermediate that is sensed by these checkpoint functions.
BioInfer.d402.s0.p0	P	Like PROTEIN , the PROTEIN -associated proteins PROTEIN , PROTEIN2 and the PROTEIN1 were also found to accumulate around entering bacteria.
BioInfer.d402.s0.p1	P	Like PROTEIN , the PROTEIN -associated proteins PROTEIN2 , PROTEIN and the PROTEIN1 were also found to accumulate around entering bacteria.
BioInfer.d402.s0.p2	P	Like PROTEIN , the PROTEIN2 -associated proteins PROTEIN , PROTEIN and the PROTEIN1 were also found to accumulate around entering bacteria.
BioInfer.d402.s0.p3	P	Like PROTEIN2 , the PROTEIN -associated proteins PROTEIN , PROTEIN and the PROTEIN1 were also found to accumulate around entering bacteria.
BioInfer.d402.s0.p4	P	Like PROTEIN , the PROTEIN -associated proteins PROTEIN2 , PROTEIN1 and the PROTEIN were also found to accumulate around entering bacteria.
BioInfer.d402.s0.p5	P	Like PROTEIN , the PROTEIN2 -associated proteins PROTEIN , PROTEIN1 and the PROTEIN were also found to accumulate around entering bacteria.
BioInfer.d402.s0.p6	P	Like PROTEIN2 , the PROTEIN -associated proteins PROTEIN , PROTEIN1 and the PROTEIN were also found to accumulate around entering bacteria.
BioInfer.d402.s0.p7	P	Like PROTEIN , the PROTEIN2 -associated proteins PROTEIN1 , PROTEIN and the PROTEIN were also found to accumulate around entering bacteria.
BioInfer.d402.s0.p8	P	Like PROTEIN2 , the PROTEIN -associated proteins PROTEIN1 , PROTEIN and the PROTEIN were also found to accumulate around entering bacteria.
BioInfer.d402.s0.p9	N	Like PROTEIN2 , the PROTEIN1 -associated proteins PROTEIN , PROTEIN and the PROTEIN were also found to accumulate around entering bacteria.
BioInfer.d403.s0.p0	P	Like PROTEIN , PROTEIN2 phosphorylated PROTEIN specifically at Ser-3 and induced formation of PROTEIN1 stress fibers and focal adhesions.
BioInfer.d403.s0.p1	N	Like PROTEIN , PROTEIN phosphorylated PROTEIN2 specifically at Ser-3 and induced formation of PROTEIN1 stress fibers and focal adhesions.
BioInfer.d403.s0.p2	P	Like PROTEIN2 , PROTEIN phosphorylated PROTEIN specifically at Ser-3 and induced formation of PROTEIN1 stress fibers and focal adhesions.
BioInfer.d403.s0.p3	P	Like PROTEIN , PROTEIN1 phosphorylated PROTEIN2 specifically at Ser-3 and induced formation of PROTEIN stress fibers and focal adhesions.
BioInfer.d403.s0.p4	N	Like PROTEIN2 , PROTEIN1 phosphorylated PROTEIN specifically at Ser-3 and induced formation of PROTEIN stress fibers and focal adhesions.
BioInfer.d403.s0.p5	P	Like PROTEIN2 , PROTEIN phosphorylated PROTEIN1 specifically at Ser-3 and induced formation of PROTEIN stress fibers and focal adhesions.
BioInfer.d404.s0.p0	N	Like the PROTEIN2 , the major central part of the PROTEIN1 is made up of repeat units of 106 amino-acids.
BioInfer.d405.s0.p0	N	PROTEIN ( PROTEIN ) phosphorylates PROTEIN , an PROTEIN2 , and regulates PROTEIN1 cytoskeletal reorganization.
BioInfer.d405.s0.p1	N	PROTEIN ( PROTEIN ) phosphorylates PROTEIN2 , an PROTEIN , and regulates PROTEIN1 cytoskeletal reorganization.
BioInfer.d405.s0.p2	P	PROTEIN ( PROTEIN2 ) phosphorylates PROTEIN , an PROTEIN , and regulates PROTEIN1 cytoskeletal reorganization.
BioInfer.d405.s0.p3	P	PROTEIN2 ( PROTEIN ) phosphorylates PROTEIN , an PROTEIN , and regulates PROTEIN1 cytoskeletal reorganization.
BioInfer.d405.s0.p4	P	PROTEIN ( PROTEIN ) phosphorylates PROTEIN2 , an PROTEIN1 , and regulates PROTEIN cytoskeletal reorganization.
BioInfer.d405.s0.p5	N	PROTEIN ( PROTEIN2 ) phosphorylates PROTEIN , an PROTEIN1 , and regulates PROTEIN cytoskeletal reorganization.
BioInfer.d405.s0.p6	N	PROTEIN2 ( PROTEIN ) phosphorylates PROTEIN , an PROTEIN1 , and regulates PROTEIN cytoskeletal reorganization.
BioInfer.d405.s0.p7	P	PROTEIN ( PROTEIN2 ) phosphorylates PROTEIN1 , an PROTEIN , and regulates PROTEIN cytoskeletal reorganization.
BioInfer.d405.s0.p8	P	PROTEIN2 ( PROTEIN ) phosphorylates PROTEIN1 , an PROTEIN , and regulates PROTEIN cytoskeletal reorganization.
BioInfer.d405.s0.p9	N	PROTEIN2 ( PROTEIN1 ) phosphorylates PROTEIN , an PROTEIN , and regulates PROTEIN cytoskeletal reorganization.
BioInfer.d406.s0.p0	N	Linkage between cancer susceptibility and the candidate DNA mismatch repair genes PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 ( PROTEIN ) was investigated.
BioInfer.d406.s0.p1	N	Linkage between cancer susceptibility and the candidate DNA mismatch repair genes PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 ( PROTEIN ) was investigated.
BioInfer.d406.s0.p2	N	Linkage between cancer susceptibility and the candidate DNA mismatch repair genes PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 ( PROTEIN ) was investigated.
BioInfer.d406.s0.p3	N	Linkage between cancer susceptibility and the candidate DNA mismatch repair genes PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 ( PROTEIN2 ) was investigated.
BioInfer.d406.s0.p4	N	Linkage between cancer susceptibility and the candidate DNA mismatch repair genes PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN ( PROTEIN ) was investigated.
BioInfer.d406.s0.p5	N	Linkage between cancer susceptibility and the candidate DNA mismatch repair genes PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN ( PROTEIN ) was investigated.
BioInfer.d406.s0.p6	N	Linkage between cancer susceptibility and the candidate DNA mismatch repair genes PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN ( PROTEIN2 ) was investigated.
BioInfer.d406.s0.p7	N	Linkage between cancer susceptibility and the candidate DNA mismatch repair genes PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN ( PROTEIN ) was investigated.
BioInfer.d406.s0.p8	N	Linkage between cancer susceptibility and the candidate DNA mismatch repair genes PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN ( PROTEIN2 ) was investigated.
BioInfer.d406.s0.p9	N	Linkage between cancer susceptibility and the candidate DNA mismatch repair genes PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN ( PROTEIN2 ) was investigated.
BioInfer.d407.s0.p0	P	Live dynamics of Dictyostelium PROTEIN2 suggests a role in remodeling PROTEIN1 latticework into bundles.
BioInfer.d407.s1.p0	P	These results demonstrate that PROTEIN2 plays a crucial role in vivo in rapid remodeling of the cortical PROTEIN1 meshwork into bundles.
BioInfer.d408.s0.p0	P	Localization of PROTEIN to the leading edge of a migrating cell can lead to local accumulation of PROTEIN1 , which in turn can supply PROTEIN2 monomers to growing filament ends.
BioInfer.d408.s0.p1	P	Localization of PROTEIN2 to the leading edge of a migrating cell can lead to local accumulation of PROTEIN1 , which in turn can supply PROTEIN monomers to growing filament ends.
BioInfer.d408.s0.p2	N	Localization of PROTEIN2 to the leading edge of a migrating cell can lead to local accumulation of PROTEIN , which in turn can supply PROTEIN1 monomers to growing filament ends.
BioInfer.d409.s0.p0	N	Location of PROTEIN1 at presynaptic sites in the cerebellar cortex; implication for the regulation of the PROTEIN2 -polymerization state during axonal elongation and synaptogenesis.
BioInfer.d410.s0.p0	N	Loss of memberanous expression of PROTEIN1 , PROTEIN and PROTEIN2 was demonstrated in 52%, 85% and 40% of tumours respectively.
BioInfer.d410.s0.p1	N	Loss of memberanous expression of PROTEIN1 , PROTEIN2 and PROTEIN was demonstrated in 52%, 85% and 40% of tumours respectively.
BioInfer.d410.s0.p2	N	Loss of memberanous expression of PROTEIN , PROTEIN2 and PROTEIN1 was demonstrated in 52%, 85% and 40% of tumours respectively.
BioInfer.d410.s1.p0	N	There was a trend towards an association between advanced tumour stage and loss of membranous expression of PROTEIN1 or PROTEIN2 , although these associations were not statistically significant.
BioInfer.d411.s0.p0	N	Mammalian homologues of two important yeast genes involved in DNA double-strand break repair and recombination, PROTEIN2 and PROTEIN1 , have been isolated.
BioInfer.d412.s0.p0	P	Mammalian PROTEIN ( PROTEIN2 ) phosphorylate PROTEIN and induce PROTEIN1 cytoskeletal reorganization.
BioInfer.d412.s0.p1	P	Mammalian PROTEIN2 ( PROTEIN ) phosphorylate PROTEIN and induce PROTEIN1 cytoskeletal reorganization.
BioInfer.d412.s0.p2	N	Mammalian PROTEIN ( PROTEIN ) phosphorylate PROTEIN2 and induce PROTEIN1 cytoskeletal reorganization.
BioInfer.d412.s0.p3	N	Mammalian PROTEIN2 ( PROTEIN1 ) phosphorylate PROTEIN and induce PROTEIN cytoskeletal reorganization.
BioInfer.d412.s0.p4	P	Mammalian PROTEIN ( PROTEIN1 ) phosphorylate PROTEIN2 and induce PROTEIN cytoskeletal reorganization.
BioInfer.d412.s0.p5	P	Mammalian PROTEIN1 ( PROTEIN ) phosphorylate PROTEIN2 and induce PROTEIN cytoskeletal reorganization.
BioInfer.d413.s0.p0	P	MATERIALS AND METHODS: A mutation in the PROTEIN ( PROTEIN ) predicted to interfere strongly with PROTEIN1 's binding to PROTEIN2 was designed and used to create an animal model for HCM.
BioInfer.d413.s0.p1	P	MATERIALS AND METHODS: A mutation in the PROTEIN2 ( PROTEIN ) predicted to interfere strongly with PROTEIN1 's binding to PROTEIN was designed and used to create an animal model for HCM.
BioInfer.d413.s0.p2	P	MATERIALS AND METHODS: A mutation in the PROTEIN ( PROTEIN2 ) predicted to interfere strongly with PROTEIN1 's binding to PROTEIN was designed and used to create an animal model for HCM.
BioInfer.d413.s0.p3	P	MATERIALS AND METHODS: A mutation in the PROTEIN2 ( PROTEIN ) predicted to interfere strongly with PROTEIN 's binding to PROTEIN1 was designed and used to create an animal model for HCM.
BioInfer.d413.s0.p4	P	MATERIALS AND METHODS: A mutation in the PROTEIN ( PROTEIN2 ) predicted to interfere strongly with PROTEIN 's binding to PROTEIN1 was designed and used to create an animal model for HCM.
BioInfer.d413.s0.p5	N	MATERIALS AND METHODS: A mutation in the PROTEIN1 ( PROTEIN2 ) predicted to interfere strongly with PROTEIN 's binding to PROTEIN was designed and used to create an animal model for HCM.
BioInfer.d414.s0.p0	N	PROTEIN and PROTEIN inhibited both PROTEIN1 - and PROTEIN -induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN2 .
BioInfer.d414.s0.p1	N	PROTEIN and PROTEIN inhibited both PROTEIN1 - and PROTEIN2 -induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN .
BioInfer.d414.s0.p2	N	PROTEIN and PROTEIN inhibited both PROTEIN1 - and PROTEIN -induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN2 and PROTEIN .
BioInfer.d414.s0.p3	N	PROTEIN2 and PROTEIN inhibited both PROTEIN1 - and PROTEIN -induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN .
BioInfer.d414.s0.p4	N	PROTEIN and PROTEIN2 inhibited both PROTEIN1 - and PROTEIN -induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN .
BioInfer.d414.s0.p5	N	PROTEIN and PROTEIN inhibited both PROTEIN - and PROTEIN2 -induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN1 .
BioInfer.d414.s0.p6	N	PROTEIN and PROTEIN inhibited both PROTEIN - and PROTEIN -induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN2 and PROTEIN1 .
BioInfer.d414.s0.p7	N	PROTEIN2 and PROTEIN inhibited both PROTEIN - and PROTEIN -induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN1 .
BioInfer.d414.s0.p8	N	PROTEIN and PROTEIN2 inhibited both PROTEIN - and PROTEIN -induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN1 .
BioInfer.d414.s0.p9	N	PROTEIN and PROTEIN inhibited both PROTEIN - and PROTEIN1 -induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN2 and PROTEIN .
BioInfer.d414.s0.p10	N	PROTEIN2 and PROTEIN inhibited both PROTEIN - and PROTEIN1 -induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN .
BioInfer.d414.s0.p11	N	PROTEIN and PROTEIN2 inhibited both PROTEIN - and PROTEIN1 -induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN .
BioInfer.d414.s0.p12	N	PROTEIN2 and PROTEIN inhibited both PROTEIN - and PROTEIN -induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN1 and PROTEIN .
BioInfer.d414.s0.p13	N	PROTEIN and PROTEIN2 inhibited both PROTEIN - and PROTEIN -induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN1 and PROTEIN .
BioInfer.d414.s0.p14	N	PROTEIN1 and PROTEIN2 inhibited both PROTEIN - and PROTEIN -induced apoptosis as well as killing mediated by overexpression of the downstream adaptors PROTEIN and PROTEIN .
BioInfer.d415.s0.p0	N	PROTEIN is the previously identified PROTEIN2 , which encodes PROTEIN , required for proper organization of the PROTEIN1 cytoskeleton.
BioInfer.d415.s0.p1	N	PROTEIN2 is the previously identified PROTEIN , which encodes PROTEIN , required for proper organization of the PROTEIN1 cytoskeleton.
BioInfer.d415.s0.p2	P	PROTEIN is the previously identified PROTEIN , which encodes PROTEIN2 , required for proper organization of the PROTEIN1 cytoskeleton.
BioInfer.d415.s0.p3	N	PROTEIN2 is the previously identified PROTEIN1 , which encodes PROTEIN , required for proper organization of the PROTEIN cytoskeleton.
BioInfer.d415.s0.p4	P	PROTEIN is the previously identified PROTEIN1 , which encodes PROTEIN2 , required for proper organization of the PROTEIN cytoskeleton.
BioInfer.d415.s0.p5	N	PROTEIN1 is the previously identified PROTEIN , which encodes PROTEIN2 , required for proper organization of the PROTEIN cytoskeleton.
BioInfer.d416.s0.p0	N	Mechanism of inhibition of PROTEIN1 -dependent DNA synthesis by the PROTEIN  PROTEIN2 .
BioInfer.d416.s0.p1	N	Mechanism of inhibition of PROTEIN1 -dependent DNA synthesis by the PROTEIN2  PROTEIN .
BioInfer.d416.s0.p2	P	Mechanism of inhibition of PROTEIN -dependent DNA synthesis by the PROTEIN2  PROTEIN1 .
BioInfer.d417.s0.p0	P	Mechanism of regulation of PROTEIN2 polymerization by Physarum PROTEIN1 .
BioInfer.d417.s1.p0	P	The apparent critical concentration for polymerization of PROTEIN1 is increased by the addition of PROTEIN2 .
BioInfer.d418.s0.p0	P	Membranous staining and concomitant cytoplasmic localization of PROTEIN , PROTEIN2 and PROTEIN1 were seen in one case with abnormal PROTEIN immunoreactivity.
BioInfer.d418.s0.p1	P	Membranous staining and concomitant cytoplasmic localization of PROTEIN2 , PROTEIN and PROTEIN1 were seen in one case with abnormal PROTEIN immunoreactivity.
BioInfer.d418.s0.p2	N	Membranous staining and concomitant cytoplasmic localization of PROTEIN , PROTEIN and PROTEIN1 were seen in one case with abnormal PROTEIN2 immunoreactivity.
BioInfer.d418.s0.p3	P	Membranous staining and concomitant cytoplasmic localization of PROTEIN2 , PROTEIN1 and PROTEIN were seen in one case with abnormal PROTEIN immunoreactivity.
BioInfer.d418.s0.p4	N	Membranous staining and concomitant cytoplasmic localization of PROTEIN , PROTEIN1 and PROTEIN were seen in one case with abnormal PROTEIN2 immunoreactivity.
BioInfer.d418.s0.p5	N	Membranous staining and concomitant cytoplasmic localization of PROTEIN1 , PROTEIN and PROTEIN were seen in one case with abnormal PROTEIN2 immunoreactivity.
BioInfer.d419.s0.p0	N	METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of PROTEIN2 ), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of PROTEIN ), draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the PROTEIN1 binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.
BioInfer.d419.s0.p1	N	METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of PROTEIN ), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of PROTEIN2 ), draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the PROTEIN1 binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.
BioInfer.d419.s0.p2	N	METHODS AND RESULTS: The frequency-dependent effects of iodotubercidin (ITU, an inhibitor of PROTEIN1 ), erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA, an inhibitor of PROTEIN2 ), draflazine (a nucleoside transport blocker), and PD81,723 (an allosteric enhancer of the PROTEIN binding) on the stimulus-to-His bundle (SH) interval, a measure of AV nodal conduction, were determined in guinea pig hearts and compared with those of adenosine and diltiazem.
BioInfer.d419.s1.p0	N	The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the PROTEIN2 antagonist 8-cyclopentyltheophylline and PROTEIN1 , implicating endogenous adenosine acting at the PROTEIN .
BioInfer.d419.s1.p1	N	The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the PROTEIN antagonist 8-cyclopentyltheophylline and PROTEIN1 , implicating endogenous adenosine acting at the PROTEIN2 .
BioInfer.d419.s1.p2	N	The AV nodal effects of draflazine, ITU, EHNA, and PD81,723 were reversed by the PROTEIN1 antagonist 8-cyclopentyltheophylline and PROTEIN , implicating endogenous adenosine acting at the PROTEIN2 .
BioInfer.d420.s0.p0	N	METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against PROTEIN , PROTEIN1 and PROTEIN and a polyclonal antibody against PROTEIN2 .
BioInfer.d420.s0.p1	N	METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against PROTEIN2 , PROTEIN1 and PROTEIN and a polyclonal antibody against PROTEIN .
BioInfer.d420.s0.p2	N	METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against PROTEIN , PROTEIN1 and PROTEIN2 and a polyclonal antibody against PROTEIN .
BioInfer.d420.s0.p3	N	METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against PROTEIN2 , PROTEIN and PROTEIN and a polyclonal antibody against PROTEIN1 .
BioInfer.d420.s0.p4	N	METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against PROTEIN , PROTEIN and PROTEIN2 and a polyclonal antibody against PROTEIN1 .
BioInfer.d420.s0.p5	N	METHODS: Ileal and colonic biopsy specimens from 19 SpA patients with subclinical inflammatory gut lesions and from seven controls were stained with monoclonal antibodies against PROTEIN1 , PROTEIN and PROTEIN2 and a polyclonal antibody against PROTEIN .
BioInfer.d421.s0.p0	N	METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to PROTEIN ( PROTEIN1 ), PROTEIN2 , and PROTEIN , a novel marker for contractile VSMC phenotype.
BioInfer.d421.s0.p1	N	METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to PROTEIN ( PROTEIN1 ), PROTEIN , and PROTEIN2 , a novel marker for contractile VSMC phenotype.
BioInfer.d421.s0.p2	N	METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to PROTEIN2 ( PROTEIN1 ), PROTEIN , and PROTEIN , a novel marker for contractile VSMC phenotype.
BioInfer.d421.s0.p3	N	METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to PROTEIN ( PROTEIN ), PROTEIN1 , and PROTEIN2 , a novel marker for contractile VSMC phenotype.
BioInfer.d421.s0.p4	N	METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to PROTEIN2 ( PROTEIN ), PROTEIN1 , and PROTEIN , a novel marker for contractile VSMC phenotype.
BioInfer.d421.s0.p5	N	METHODS: Paraffin-embedded sections of five AVMs, CCMs, and control brain tissues were stained immunohistochemically with antibodies to PROTEIN2 ( PROTEIN ), PROTEIN , and PROTEIN1 , a novel marker for contractile VSMC phenotype.
BioInfer.d422.s0.p0	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN2 ; and the PROTEIN1 of PROTEIN and PROTEIN .
BioInfer.d422.s0.p1	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN1 of PROTEIN and PROTEIN .
BioInfer.d422.s0.p2	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN1 of PROTEIN and PROTEIN .
BioInfer.d422.s0.p3	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN1 of PROTEIN and PROTEIN .
BioInfer.d422.s0.p4	P	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN1 of PROTEIN2 and PROTEIN .
BioInfer.d422.s0.p5	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN2 , PROTEIN , and PROTEIN ; and the PROTEIN1 of PROTEIN and PROTEIN .
BioInfer.d422.s0.p6	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN2 , and PROTEIN ; and the PROTEIN1 of PROTEIN and PROTEIN .
BioInfer.d422.s0.p7	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN1 of PROTEIN and PROTEIN .
BioInfer.d422.s0.p8	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN1 of PROTEIN and PROTEIN .
BioInfer.d422.s0.p9	P	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN1 of PROTEIN and PROTEIN2 .
BioInfer.d422.s0.p10	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN1 ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p11	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN1 ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p12	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN1 ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p13	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN1 ; and the PROTEIN of PROTEIN2 and PROTEIN .
BioInfer.d422.s0.p14	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN2 , PROTEIN , and PROTEIN1 ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p15	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN2 , and PROTEIN1 ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p16	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN1 ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p17	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN1 ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p18	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN1 ; and the PROTEIN of PROTEIN and PROTEIN2 .
BioInfer.d422.s0.p19	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p20	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p21	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN2 and PROTEIN .
BioInfer.d422.s0.p22	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 ; the cell-cell adhesion molecules of PROTEIN2 , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p23	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 ; the cell-cell adhesion molecules of PROTEIN , PROTEIN2 , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p24	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p25	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p26	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN2 .
BioInfer.d422.s0.p27	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p28	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN2 and PROTEIN .
BioInfer.d422.s0.p29	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN2 , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p30	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN2 , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p31	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p32	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p33	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN2 .
BioInfer.d422.s0.p34	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN2 and PROTEIN .
BioInfer.d422.s0.p35	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN2 , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p36	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN2 , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p37	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p38	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p39	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN2 .
BioInfer.d422.s0.p40	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN2 , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN1 and PROTEIN .
BioInfer.d422.s0.p41	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN2 , and PROTEIN ; and the PROTEIN of PROTEIN1 and PROTEIN .
BioInfer.d422.s0.p42	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN1 and PROTEIN .
BioInfer.d422.s0.p43	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN1 and PROTEIN .
BioInfer.d422.s0.p44	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN1 and PROTEIN2 .
BioInfer.d422.s0.p45	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN1 , PROTEIN2 , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p46	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN1 , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p47	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN1 , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p48	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN1 , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN2 .
BioInfer.d422.s0.p49	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN1 , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p50	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN1 , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p51	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN1 , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN2 .
BioInfer.d422.s0.p52	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN .
BioInfer.d422.s0.p53	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN2 .
BioInfer.d422.s0.p54	N	METHODS: Tumor samples from 77 patients with squamous cell carcinoma of the esophagus were immunohistochemically evaluated for the expression of 10 molecules: the cell cycle-related molecules of PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN ; the cell-cell adhesion molecules of PROTEIN , PROTEIN , and PROTEIN ; and the PROTEIN of PROTEIN and PROTEIN2 .
BioInfer.d423.s0.p0	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN2 ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p1	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN2 ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p2	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ) isoforms, PROTEIN2 ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p3	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p4	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN2 ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p5	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN2 ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p6	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p7	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN2 ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p8	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN1 ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p9	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN2 and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p10	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN2 ), PROTEIN and PROTEIN ( PROTEIN1 ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p11	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN2 ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN1 ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p12	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN1 ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p13	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN2 ( PROTEIN1 ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p14	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN1 ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p15	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN1 ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p16	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN1 ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p17	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN1 ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p18	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN2 and PROTEIN ( PROTEIN1 ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p19	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN2 ( PROTEIN1 ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p20	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN1 ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p21	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN1 ), PROTEIN and PROTEIN2 ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p22	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) isoforms, PROTEIN ( PROTEIN1 ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p23	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN1 ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p24	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) isoforms, PROTEIN ( PROTEIN1 ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p25	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN1 ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p26	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN1 ), PROTEIN2 and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p27	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN1 ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p28	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN1 ( PROTEIN ), PROTEIN and PROTEIN2 ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p29	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) isoforms, PROTEIN1 ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p30	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN1 ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p31	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) isoforms, PROTEIN1 ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p32	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN1 ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p33	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN1 ( PROTEIN ), PROTEIN2 and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p34	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN2 ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p35	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p36	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN2 ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p37	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p38	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN1 ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p39	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN2 and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p40	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN1 ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p41	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN1 ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p42	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN1 ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p43	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN1 ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p44	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN2 and PROTEIN1 ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p45	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p46	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN1 ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p47	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN1 ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p48	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ) isoforms, PROTEIN ( PROTEIN ), PROTEIN2 and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p49	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p50	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN1 ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p51	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN2 and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p52	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN1 ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p53	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN2 and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d423.s0.p54	N	METHODS: We have performed a detailed study of the pattern of expression of PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) isoforms, PROTEIN ( PROTEIN ), PROTEIN2 and PROTEIN ( PROTEIN ), in the ventricular conduction system of normal and congenitally malformed mouse hearts (iv background) from embryonic day 14.5 to 19.5.
BioInfer.d424.s0.p0	N	METHODS: We immunohistochemically investigated the expression of PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.
BioInfer.d424.s0.p1	N	METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN1 ( PROTEIN ) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.
BioInfer.d424.s0.p2	N	METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) and PROTEIN1 ( PROTEIN ) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.
BioInfer.d424.s0.p3	N	METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN2 ) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.
BioInfer.d424.s0.p4	N	METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.
BioInfer.d424.s0.p5	N	METHODS: We immunohistochemically investigated the expression of PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN ) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.
BioInfer.d424.s0.p6	N	METHODS: We immunohistochemically investigated the expression of PROTEIN1 ( PROTEIN ), PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN ) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.
BioInfer.d424.s0.p7	N	METHODS: We immunohistochemically investigated the expression of PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.
BioInfer.d424.s0.p8	N	METHODS: We immunohistochemically investigated the expression of PROTEIN1 ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.
BioInfer.d424.s0.p9	N	METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN1 ) and PROTEIN ( PROTEIN ) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.
BioInfer.d424.s0.p10	N	METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN2 ) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.
BioInfer.d424.s0.p11	N	METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.
BioInfer.d424.s0.p12	N	METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN2 ) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.
BioInfer.d424.s0.p13	N	METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN2 ), PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.
BioInfer.d424.s0.p14	N	METHODS: We immunohistochemically investigated the expression of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN1 ) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.
BioInfer.d425.s0.p0	N	Microinjection or stable expression of PROTEIN into keratinocytes promotes the loss of PROTEIN2 and PROTEIN and relocalization of PROTEIN1 to the cytoplasm and nucleus.
BioInfer.d425.s0.p1	N	Microinjection or stable expression of PROTEIN into keratinocytes promotes the loss of PROTEIN and PROTEIN2 and relocalization of PROTEIN1 to the cytoplasm and nucleus.
BioInfer.d425.s0.p2	P	Microinjection or stable expression of PROTEIN2 into keratinocytes promotes the loss of PROTEIN and PROTEIN and relocalization of PROTEIN1 to the cytoplasm and nucleus.
BioInfer.d425.s0.p3	N	Microinjection or stable expression of PROTEIN into keratinocytes promotes the loss of PROTEIN1 and PROTEIN2 and relocalization of PROTEIN to the cytoplasm and nucleus.
BioInfer.d425.s0.p4	P	Microinjection or stable expression of PROTEIN2 into keratinocytes promotes the loss of PROTEIN1 and PROTEIN and relocalization of PROTEIN to the cytoplasm and nucleus.
BioInfer.d425.s0.p5	P	Microinjection or stable expression of PROTEIN2 into keratinocytes promotes the loss of PROTEIN and PROTEIN1 and relocalization of PROTEIN to the cytoplasm and nucleus.
BioInfer.d426.s0.p0	N	Mitochondrial genes (16.2%), PROTEIN1 genes (9%) and the PROTEIN2 gene (9%) were the most abundant transcripts.
BioInfer.d427.s0.p0	N	PROTEIN1 is fused in-frame to a different exon of PROTEIN2 in two patients producing chimeric proteins containing the AT-hooks, PROTEIN homology domain, and transcriptional repression domain of PROTEIN fused to the PROTEIN binding domain or to the bromodomain of PROTEIN .
BioInfer.d427.s0.p1	N	PROTEIN1 is fused in-frame to a different exon of PROTEIN in two patients producing chimeric proteins containing the AT-hooks, PROTEIN homology domain, and transcriptional repression domain of PROTEIN fused to the PROTEIN binding domain or to the bromodomain of PROTEIN2 .
BioInfer.d427.s0.p2	N	PROTEIN1 is fused in-frame to a different exon of PROTEIN in two patients producing chimeric proteins containing the AT-hooks, PROTEIN homology domain, and transcriptional repression domain of PROTEIN fused to the PROTEIN2 binding domain or to the bromodomain of PROTEIN .
BioInfer.d427.s0.p3	N	PROTEIN1 is fused in-frame to a different exon of PROTEIN in two patients producing chimeric proteins containing the AT-hooks, PROTEIN homology domain, and transcriptional repression domain of PROTEIN2 fused to the PROTEIN binding domain or to the bromodomain of PROTEIN .
BioInfer.d427.s0.p4	N	PROTEIN1 is fused in-frame to a different exon of PROTEIN in two patients producing chimeric proteins containing the AT-hooks, PROTEIN2 homology domain, and transcriptional repression domain of PROTEIN fused to the PROTEIN binding domain or to the bromodomain of PROTEIN .
BioInfer.d427.s0.p5	N	PROTEIN is fused in-frame to a different exon of PROTEIN1 in two patients producing chimeric proteins containing the AT-hooks, PROTEIN homology domain, and transcriptional repression domain of PROTEIN fused to the PROTEIN binding domain or to the bromodomain of PROTEIN2 .
BioInfer.d427.s0.p6	N	PROTEIN is fused in-frame to a different exon of PROTEIN1 in two patients producing chimeric proteins containing the AT-hooks, PROTEIN homology domain, and transcriptional repression domain of PROTEIN fused to the PROTEIN2 binding domain or to the bromodomain of PROTEIN .
BioInfer.d427.s0.p7	N	PROTEIN is fused in-frame to a different exon of PROTEIN1 in two patients producing chimeric proteins containing the AT-hooks, PROTEIN homology domain, and transcriptional repression domain of PROTEIN2 fused to the PROTEIN binding domain or to the bromodomain of PROTEIN .
BioInfer.d427.s0.p8	N	PROTEIN is fused in-frame to a different exon of PROTEIN1 in two patients producing chimeric proteins containing the AT-hooks, PROTEIN2 homology domain, and transcriptional repression domain of PROTEIN fused to the PROTEIN binding domain or to the bromodomain of PROTEIN .
BioInfer.d427.s0.p9	P	PROTEIN is fused in-frame to a different exon of PROTEIN in two patients producing chimeric proteins containing the AT-hooks, PROTEIN homology domain, and transcriptional repression domain of PROTEIN fused to the PROTEIN2 binding domain or to the bromodomain of PROTEIN1 .
BioInfer.d427.s0.p10	N	PROTEIN is fused in-frame to a different exon of PROTEIN in two patients producing chimeric proteins containing the AT-hooks, PROTEIN homology domain, and transcriptional repression domain of PROTEIN2 fused to the PROTEIN binding domain or to the bromodomain of PROTEIN1 .
BioInfer.d427.s0.p11	N	PROTEIN is fused in-frame to a different exon of PROTEIN in two patients producing chimeric proteins containing the AT-hooks, PROTEIN2 homology domain, and transcriptional repression domain of PROTEIN fused to the PROTEIN binding domain or to the bromodomain of PROTEIN1 .
BioInfer.d427.s0.p12	N	PROTEIN is fused in-frame to a different exon of PROTEIN in two patients producing chimeric proteins containing the AT-hooks, PROTEIN homology domain, and transcriptional repression domain of PROTEIN2 fused to the PROTEIN1 binding domain or to the bromodomain of PROTEIN .
BioInfer.d427.s0.p13	N	PROTEIN is fused in-frame to a different exon of PROTEIN in two patients producing chimeric proteins containing the AT-hooks, PROTEIN2 homology domain, and transcriptional repression domain of PROTEIN fused to the PROTEIN1 binding domain or to the bromodomain of PROTEIN .
BioInfer.d427.s0.p14	P	PROTEIN is fused in-frame to a different exon of PROTEIN in two patients producing chimeric proteins containing the AT-hooks, PROTEIN2 homology domain, and transcriptional repression domain of PROTEIN1 fused to the PROTEIN binding domain or to the bromodomain of PROTEIN .
BioInfer.d428.s0.p0	P	Modifying preselected sites on proteins: the stretch of residues 633-642 of the PROTEIN2 is part of the PROTEIN1 -binding site.
BioInfer.d429.s0.p0	P	Molecular analysis of the PROTEIN2 - PROTEIN complex elucidated the central role of PROTEIN1 in this adhesion complex, as it binds to the cytoplasmic domain of PROTEIN and to PROTEIN .
BioInfer.d429.s0.p1	P	Molecular analysis of the PROTEIN - PROTEIN2 complex elucidated the central role of PROTEIN1 in this adhesion complex, as it binds to the cytoplasmic domain of PROTEIN and to PROTEIN .
BioInfer.d429.s0.p2	P	Molecular analysis of the PROTEIN - PROTEIN complex elucidated the central role of PROTEIN1 in this adhesion complex, as it binds to the cytoplasmic domain of PROTEIN and to PROTEIN2 .
BioInfer.d429.s0.p3	P	Molecular analysis of the PROTEIN - PROTEIN complex elucidated the central role of PROTEIN1 in this adhesion complex, as it binds to the cytoplasmic domain of PROTEIN2 and to PROTEIN .
BioInfer.d429.s0.p4	P	Molecular analysis of the PROTEIN1 - PROTEIN2 complex elucidated the central role of PROTEIN in this adhesion complex, as it binds to the cytoplasmic domain of PROTEIN and to PROTEIN .
BioInfer.d429.s0.p5	N	Molecular analysis of the PROTEIN1 - PROTEIN complex elucidated the central role of PROTEIN in this adhesion complex, as it binds to the cytoplasmic domain of PROTEIN and to PROTEIN2 .
BioInfer.d429.s0.p6	N	Molecular analysis of the PROTEIN1 - PROTEIN complex elucidated the central role of PROTEIN in this adhesion complex, as it binds to the cytoplasmic domain of PROTEIN2 and to PROTEIN .
BioInfer.d429.s0.p7	N	Molecular analysis of the PROTEIN - PROTEIN1 complex elucidated the central role of PROTEIN in this adhesion complex, as it binds to the cytoplasmic domain of PROTEIN and to PROTEIN2 .
BioInfer.d429.s0.p8	N	Molecular analysis of the PROTEIN - PROTEIN1 complex elucidated the central role of PROTEIN in this adhesion complex, as it binds to the cytoplasmic domain of PROTEIN2 and to PROTEIN .
BioInfer.d429.s0.p9	N	Molecular analysis of the PROTEIN - PROTEIN complex elucidated the central role of PROTEIN in this adhesion complex, as it binds to the cytoplasmic domain of PROTEIN2 and to PROTEIN1 .
BioInfer.d429.s1.p0	P	PROTEIN2 may also function in signalling pathways, given its homology to the gene product of the Drosophila segment polarity gene PROTEIN1 , which is known to be involved in the wingless signalling cascade.
BioInfer.d430.s0.p0	N	Molecular cloning and primary structure analysis demonstrated that PROTEIN is homologous to PROTEIN and the PROTEIN is homologous to human PROTEIN1 and the Drosophila gene product PROTEIN2 .
BioInfer.d430.s0.p1	N	Molecular cloning and primary structure analysis demonstrated that PROTEIN is homologous to PROTEIN2 and the PROTEIN is homologous to human PROTEIN1 and the Drosophila gene product PROTEIN .
BioInfer.d430.s0.p2	P	Molecular cloning and primary structure analysis demonstrated that PROTEIN is homologous to PROTEIN and the PROTEIN2 is homologous to human PROTEIN1 and the Drosophila gene product PROTEIN .
BioInfer.d430.s0.p3	N	Molecular cloning and primary structure analysis demonstrated that PROTEIN2 is homologous to PROTEIN and the PROTEIN is homologous to human PROTEIN1 and the Drosophila gene product PROTEIN .
BioInfer.d430.s0.p4	N	Molecular cloning and primary structure analysis demonstrated that PROTEIN is homologous to PROTEIN2 and the PROTEIN is homologous to human PROTEIN and the Drosophila gene product PROTEIN1 .
BioInfer.d430.s0.p5	P	Molecular cloning and primary structure analysis demonstrated that PROTEIN is homologous to PROTEIN and the PROTEIN2 is homologous to human PROTEIN and the Drosophila gene product PROTEIN1 .
BioInfer.d430.s0.p6	N	Molecular cloning and primary structure analysis demonstrated that PROTEIN2 is homologous to PROTEIN and the PROTEIN is homologous to human PROTEIN and the Drosophila gene product PROTEIN1 .
BioInfer.d430.s0.p7	N	Molecular cloning and primary structure analysis demonstrated that PROTEIN is homologous to PROTEIN1 and the PROTEIN2 is homologous to human PROTEIN and the Drosophila gene product PROTEIN .
BioInfer.d430.s0.p8	P	Molecular cloning and primary structure analysis demonstrated that PROTEIN2 is homologous to PROTEIN1 and the PROTEIN is homologous to human PROTEIN and the Drosophila gene product PROTEIN .
BioInfer.d430.s0.p9	N	Molecular cloning and primary structure analysis demonstrated that PROTEIN2 is homologous to PROTEIN and the PROTEIN1 is homologous to human PROTEIN and the Drosophila gene product PROTEIN .
BioInfer.d430.s1.p0	P	One complex is composed of PROTEIN , PROTEIN and PROTEIN , the other of PROTEIN1 , PROTEIN and PROTEIN2 .
BioInfer.d430.s1.p1	N	One complex is composed of PROTEIN , PROTEIN2 and PROTEIN , the other of PROTEIN1 , PROTEIN and PROTEIN .
BioInfer.d430.s1.p2	P	One complex is composed of PROTEIN , PROTEIN and PROTEIN , the other of PROTEIN1 , PROTEIN2 and PROTEIN .
BioInfer.d430.s1.p3	N	One complex is composed of PROTEIN2 , PROTEIN and PROTEIN , the other of PROTEIN1 , PROTEIN and PROTEIN .
BioInfer.d430.s1.p4	N	One complex is composed of PROTEIN , PROTEIN and PROTEIN2 , the other of PROTEIN1 , PROTEIN and PROTEIN .
BioInfer.d430.s1.p5	N	One complex is composed of PROTEIN , PROTEIN2 and PROTEIN , the other of PROTEIN , PROTEIN and PROTEIN1 .
BioInfer.d430.s1.p6	P	One complex is composed of PROTEIN , PROTEIN and PROTEIN , the other of PROTEIN , PROTEIN2 and PROTEIN1 .
BioInfer.d430.s1.p7	N	One complex is composed of PROTEIN2 , PROTEIN and PROTEIN , the other of PROTEIN , PROTEIN and PROTEIN1 .
BioInfer.d430.s1.p8	N	One complex is composed of PROTEIN , PROTEIN and PROTEIN2 , the other of PROTEIN , PROTEIN and PROTEIN1 .
BioInfer.d430.s1.p9	N	One complex is composed of PROTEIN , PROTEIN1 and PROTEIN , the other of PROTEIN , PROTEIN2 and PROTEIN .
BioInfer.d430.s1.p10	P	One complex is composed of PROTEIN2 , PROTEIN1 and PROTEIN , the other of PROTEIN , PROTEIN and PROTEIN .
BioInfer.d430.s1.p11	P	One complex is composed of PROTEIN , PROTEIN1 and PROTEIN2 , the other of PROTEIN , PROTEIN and PROTEIN .
BioInfer.d430.s1.p12	N	One complex is composed of PROTEIN2 , PROTEIN and PROTEIN , the other of PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d430.s1.p13	N	One complex is composed of PROTEIN , PROTEIN and PROTEIN2 , the other of PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d430.s1.p14	P	One complex is composed of PROTEIN1 , PROTEIN and PROTEIN2 , the other of PROTEIN , PROTEIN and PROTEIN .
BioInfer.d431.s0.p0	P	[Molecular functions of PROTEIN2 which regulates reorganization of PROTEIN1 cytoskeleton].
BioInfer.d432.s0.p0	N	Molecules known to link PROTEIN filaments to membrane were also examined, including PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN , but none was identified at the host-parasite junction.
BioInfer.d432.s0.p1	N	Molecules known to link PROTEIN filaments to membrane were also examined, including PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 , but none was identified at the host-parasite junction.
BioInfer.d432.s0.p2	P	Molecules known to link PROTEIN2 filaments to membrane were also examined, including PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , but none was identified at the host-parasite junction.
BioInfer.d432.s0.p3	N	Molecules known to link PROTEIN filaments to membrane were also examined, including PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN , but none was identified at the host-parasite junction.
BioInfer.d432.s0.p4	N	Molecules known to link PROTEIN filaments to membrane were also examined, including PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 , but none was identified at the host-parasite junction.
BioInfer.d432.s0.p5	P	Molecules known to link PROTEIN2 filaments to membrane were also examined, including PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , but none was identified at the host-parasite junction.
BioInfer.d432.s0.p6	N	Molecules known to link PROTEIN filaments to membrane were also examined, including PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN , but none was identified at the host-parasite junction.
BioInfer.d432.s0.p7	P	Molecules known to link PROTEIN2 filaments to membrane were also examined, including PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , but none was identified at the host-parasite junction.
BioInfer.d432.s0.p8	N	Molecules known to link PROTEIN filaments to membrane were also examined, including PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 , but none was identified at the host-parasite junction.
BioInfer.d432.s0.p9	P	Molecules known to link PROTEIN1 filaments to membrane were also examined, including PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , but none was identified at the host-parasite junction.
BioInfer.d432.s1.p0	P	Other PROTEIN2 -associated proteins, including PROTEIN1 , PROTEIN , and PROTEIN , are not present.
BioInfer.d432.s1.p1	N	Other PROTEIN -associated proteins, including PROTEIN1 , PROTEIN , and PROTEIN2 , are not present.
BioInfer.d432.s1.p2	N	Other PROTEIN -associated proteins, including PROTEIN1 , PROTEIN2 , and PROTEIN , are not present.
BioInfer.d432.s1.p3	P	Other PROTEIN1 -associated proteins, including PROTEIN , PROTEIN , and PROTEIN2 , are not present.
BioInfer.d432.s1.p4	P	Other PROTEIN1 -associated proteins, including PROTEIN , PROTEIN2 , and PROTEIN , are not present.
BioInfer.d432.s1.p5	N	Other PROTEIN -associated proteins, including PROTEIN , PROTEIN2 , and PROTEIN1 , are not present.
BioInfer.d433.s0.p0	P	Monoclonal antibodies recognizing the N- and C-terminal regions of PROTEIN1 disrupt PROTEIN2 stress fibers when microinjected into human fibroblasts.
BioInfer.d433.s1.p0	P	These results show that the C-terminal PROTEIN -binding site is distinct from the region recognized by the anti-functional antibody PROTEIN2 , raising the possibility that it binds to a novel functionally important ligand-binding site in the PROTEIN1 molecule.
BioInfer.d433.s1.p1	P	These results show that the C-terminal PROTEIN2 -binding site is distinct from the region recognized by the anti-functional antibody PROTEIN , raising the possibility that it binds to a novel functionally important ligand-binding site in the PROTEIN1 molecule.
BioInfer.d433.s1.p2	N	These results show that the C-terminal PROTEIN2 -binding site is distinct from the region recognized by the anti-functional antibody PROTEIN1 , raising the possibility that it binds to a novel functionally important ligand-binding site in the PROTEIN molecule.
BioInfer.d433.s2.p0	P	To investigate the possibility that PROTEIN2 disrupts PROTEIN stress fibers by binding directly to the C-terminal PROTEIN binding site, additional PROTEIN1 fusion proteins were generated and analyzed for PROTEIN and PROTEIN binding.
BioInfer.d433.s2.p1	P	To investigate the possibility that PROTEIN disrupts PROTEIN stress fibers by binding directly to the C-terminal PROTEIN2 binding site, additional PROTEIN1 fusion proteins were generated and analyzed for PROTEIN and PROTEIN binding.
BioInfer.d433.s2.p2	P	To investigate the possibility that PROTEIN disrupts PROTEIN stress fibers by binding directly to the C-terminal PROTEIN binding site, additional PROTEIN1 fusion proteins were generated and analyzed for PROTEIN and PROTEIN2 binding.
BioInfer.d433.s2.p3	P	To investigate the possibility that PROTEIN disrupts PROTEIN stress fibers by binding directly to the C-terminal PROTEIN binding site, additional PROTEIN1 fusion proteins were generated and analyzed for PROTEIN2 and PROTEIN binding.
BioInfer.d433.s2.p4	P	To investigate the possibility that PROTEIN disrupts PROTEIN2 stress fibers by binding directly to the C-terminal PROTEIN binding site, additional PROTEIN1 fusion proteins were generated and analyzed for PROTEIN and PROTEIN binding.
BioInfer.d433.s2.p5	N	To investigate the possibility that PROTEIN1 disrupts PROTEIN stress fibers by binding directly to the C-terminal PROTEIN2 binding site, additional PROTEIN fusion proteins were generated and analyzed for PROTEIN and PROTEIN binding.
BioInfer.d433.s2.p6	N	To investigate the possibility that PROTEIN1 disrupts PROTEIN stress fibers by binding directly to the C-terminal PROTEIN binding site, additional PROTEIN fusion proteins were generated and analyzed for PROTEIN and PROTEIN2 binding.
BioInfer.d433.s2.p7	N	To investigate the possibility that PROTEIN1 disrupts PROTEIN stress fibers by binding directly to the C-terminal PROTEIN binding site, additional PROTEIN fusion proteins were generated and analyzed for PROTEIN2 and PROTEIN binding.
BioInfer.d433.s2.p8	P	To investigate the possibility that PROTEIN1 disrupts PROTEIN2 stress fibers by binding directly to the C-terminal PROTEIN binding site, additional PROTEIN fusion proteins were generated and analyzed for PROTEIN and PROTEIN binding.
BioInfer.d433.s2.p9	N	To investigate the possibility that PROTEIN disrupts PROTEIN stress fibers by binding directly to the C-terminal PROTEIN1 binding site, additional PROTEIN fusion proteins were generated and analyzed for PROTEIN and PROTEIN2 binding.
BioInfer.d433.s2.p10	N	To investigate the possibility that PROTEIN disrupts PROTEIN stress fibers by binding directly to the C-terminal PROTEIN1 binding site, additional PROTEIN fusion proteins were generated and analyzed for PROTEIN2 and PROTEIN binding.
BioInfer.d433.s2.p11	N	To investigate the possibility that PROTEIN disrupts PROTEIN2 stress fibers by binding directly to the C-terminal PROTEIN1 binding site, additional PROTEIN fusion proteins were generated and analyzed for PROTEIN and PROTEIN binding.
BioInfer.d433.s2.p12	N	To investigate the possibility that PROTEIN disrupts PROTEIN stress fibers by binding directly to the C-terminal PROTEIN binding site, additional PROTEIN fusion proteins were generated and analyzed for PROTEIN2 and PROTEIN1 binding.
BioInfer.d433.s2.p13	N	To investigate the possibility that PROTEIN disrupts PROTEIN2 stress fibers by binding directly to the C-terminal PROTEIN binding site, additional PROTEIN fusion proteins were generated and analyzed for PROTEIN and PROTEIN1 binding.
BioInfer.d433.s2.p14	N	To investigate the possibility that PROTEIN disrupts PROTEIN2 stress fibers by binding directly to the C-terminal PROTEIN binding site, additional PROTEIN fusion proteins were generated and analyzed for PROTEIN1 and PROTEIN binding.
BioInfer.d434.s0.p0	N	Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 during transendothelial migration under physiological flow conditions.
BioInfer.d434.s0.p1	N	Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 during transendothelial migration under physiological flow conditions.
BioInfer.d434.s0.p2	N	Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 during transendothelial migration under physiological flow conditions.
BioInfer.d434.s0.p3	N	Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN during transendothelial migration under physiological flow conditions.
BioInfer.d434.s0.p4	N	Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN during transendothelial migration under physiological flow conditions.
BioInfer.d434.s0.p5	N	Monocytes and in vitro differentiated U937 cells induce focal loss in the staining of PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN during transendothelial migration under physiological flow conditions.
BioInfer.d435.s0.p0	P	Moreover, PROTEIN , but not PROTEIN2 or PROTEIN , appears to co-localize with PROTEIN1 microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following PROTEIN cross-linking.
BioInfer.d435.s0.p1	P	Moreover, PROTEIN , but not PROTEIN or PROTEIN2 , appears to co-localize with PROTEIN1 microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following PROTEIN cross-linking.
BioInfer.d435.s0.p2	P	Moreover, PROTEIN2 , but not PROTEIN or PROTEIN , appears to co-localize with PROTEIN1 microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following PROTEIN cross-linking.
BioInfer.d435.s0.p3	N	Moreover, PROTEIN , but not PROTEIN or PROTEIN , appears to co-localize with PROTEIN1 microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following PROTEIN2 cross-linking.
BioInfer.d435.s0.p4	N	Moreover, PROTEIN , but not PROTEIN1 or PROTEIN2 , appears to co-localize with PROTEIN microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following PROTEIN cross-linking.
BioInfer.d435.s0.p5	N	Moreover, PROTEIN2 , but not PROTEIN1 or PROTEIN , appears to co-localize with PROTEIN microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following PROTEIN cross-linking.
BioInfer.d435.s0.p6	N	Moreover, PROTEIN , but not PROTEIN1 or PROTEIN , appears to co-localize with PROTEIN microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following PROTEIN2 cross-linking.
BioInfer.d435.s0.p7	N	Moreover, PROTEIN2 , but not PROTEIN or PROTEIN1 , appears to co-localize with PROTEIN microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following PROTEIN cross-linking.
BioInfer.d435.s0.p8	N	Moreover, PROTEIN , but not PROTEIN or PROTEIN1 , appears to co-localize with PROTEIN microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following PROTEIN2 cross-linking.
BioInfer.d435.s0.p9	N	Moreover, PROTEIN1 , but not PROTEIN or PROTEIN , appears to co-localize with PROTEIN microfilaments in the membrane ruffles of NK cells that undergo cytoskeleton rearrangement following PROTEIN2 cross-linking.
BioInfer.d436.s0.p0	N	Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN1 -dependent manner, and this is inhibited by coexpression of the PROTEIN ( PROTEIN ) PROTEIN2 .
BioInfer.d436.s0.p1	N	Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN1 -dependent manner, and this is inhibited by coexpression of the PROTEIN2 ( PROTEIN ) PROTEIN .
BioInfer.d436.s0.p2	N	Moreover, ectopic expression of PROTEIN and PROTEIN2 can stimulate the PROTEIN promoter in an PROTEIN1 -dependent manner, and this is inhibited by coexpression of the PROTEIN ( PROTEIN ) PROTEIN .
BioInfer.d436.s0.p3	P	Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN2 promoter in an PROTEIN1 -dependent manner, and this is inhibited by coexpression of the PROTEIN ( PROTEIN ) PROTEIN .
BioInfer.d436.s0.p4	N	Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN1 -dependent manner, and this is inhibited by coexpression of the PROTEIN ( PROTEIN2 ) PROTEIN .
BioInfer.d436.s0.p5	N	Moreover, ectopic expression of PROTEIN2 and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN1 -dependent manner, and this is inhibited by coexpression of the PROTEIN ( PROTEIN ) PROTEIN .
BioInfer.d436.s0.p6	P	Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN -dependent manner, and this is inhibited by coexpression of the PROTEIN2 ( PROTEIN ) PROTEIN1 .
BioInfer.d436.s0.p7	N	Moreover, ectopic expression of PROTEIN and PROTEIN2 can stimulate the PROTEIN promoter in an PROTEIN -dependent manner, and this is inhibited by coexpression of the PROTEIN ( PROTEIN ) PROTEIN1 .
BioInfer.d436.s0.p8	N	Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN2 promoter in an PROTEIN -dependent manner, and this is inhibited by coexpression of the PROTEIN ( PROTEIN ) PROTEIN1 .
BioInfer.d436.s0.p9	P	Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN -dependent manner, and this is inhibited by coexpression of the PROTEIN ( PROTEIN2 ) PROTEIN1 .
BioInfer.d436.s0.p10	N	Moreover, ectopic expression of PROTEIN2 and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN -dependent manner, and this is inhibited by coexpression of the PROTEIN ( PROTEIN ) PROTEIN1 .
BioInfer.d436.s0.p11	P	Moreover, ectopic expression of PROTEIN and PROTEIN2 can stimulate the PROTEIN promoter in an PROTEIN -dependent manner, and this is inhibited by coexpression of the PROTEIN1 ( PROTEIN ) PROTEIN .
BioInfer.d436.s0.p12	P	Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN2 promoter in an PROTEIN -dependent manner, and this is inhibited by coexpression of the PROTEIN1 ( PROTEIN ) PROTEIN .
BioInfer.d436.s0.p13	N	Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN -dependent manner, and this is inhibited by coexpression of the PROTEIN1 ( PROTEIN2 ) PROTEIN .
BioInfer.d436.s0.p14	P	Moreover, ectopic expression of PROTEIN2 and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN -dependent manner, and this is inhibited by coexpression of the PROTEIN1 ( PROTEIN ) PROTEIN .
BioInfer.d436.s0.p15	P	Moreover, ectopic expression of PROTEIN and PROTEIN1 can stimulate the PROTEIN2 promoter in an PROTEIN -dependent manner, and this is inhibited by coexpression of the PROTEIN ( PROTEIN ) PROTEIN .
BioInfer.d436.s0.p16	P	Moreover, ectopic expression of PROTEIN and PROTEIN1 can stimulate the PROTEIN promoter in an PROTEIN -dependent manner, and this is inhibited by coexpression of the PROTEIN ( PROTEIN2 ) PROTEIN .
BioInfer.d436.s0.p17	N	Moreover, ectopic expression of PROTEIN2 and PROTEIN1 can stimulate the PROTEIN promoter in an PROTEIN -dependent manner, and this is inhibited by coexpression of the PROTEIN ( PROTEIN ) PROTEIN .
BioInfer.d436.s0.p18	P	Moreover, ectopic expression of PROTEIN and PROTEIN can stimulate the PROTEIN1 promoter in an PROTEIN -dependent manner, and this is inhibited by coexpression of the PROTEIN ( PROTEIN2 ) PROTEIN .
BioInfer.d436.s0.p19	P	Moreover, ectopic expression of PROTEIN2 and PROTEIN can stimulate the PROTEIN1 promoter in an PROTEIN -dependent manner, and this is inhibited by coexpression of the PROTEIN ( PROTEIN ) PROTEIN .
BioInfer.d436.s0.p20	P	Moreover, ectopic expression of PROTEIN2 and PROTEIN can stimulate the PROTEIN promoter in an PROTEIN -dependent manner, and this is inhibited by coexpression of the PROTEIN ( PROTEIN1 ) PROTEIN .
BioInfer.d437.s0.p0	N	Moreover, in the presence of PROTEIN2 , rapid interconversion of monomeric and polymeric forms of PROTEIN1 can be induced by simply changing the pH of the medium.
BioInfer.d437.s1.p0	P	pH control of PROTEIN2 polymerization by PROTEIN1 .
BioInfer.d438.s0.p0	N	Moreover, the virus-encoded PROTEIN1 homolog was not required for PROTEIN2 -associated events, including intracellular virus movement to the periphery of the cell, formation of specialized microvilli, or release of mature virions, as shown by electron microscopy and yields of infectious intra- and extracellular virus.
BioInfer.d439.s0.p0	P	Most of these PROTEIN1 , with their intracellular domains, interact with the PROTEIN -containing cytoskeleton, via linking proteins such as PROTEIN and PROTEIN2 , while one of them interacts with the PROTEIN filaments, via an as yet unknown linking molecule(s).
BioInfer.d439.s0.p1	P	Most of these PROTEIN1 , with their intracellular domains, interact with the PROTEIN -containing cytoskeleton, via linking proteins such as PROTEIN2 and PROTEIN , while one of them interacts with the PROTEIN filaments, via an as yet unknown linking molecule(s).
BioInfer.d439.s0.p2	P	Most of these PROTEIN1 , with their intracellular domains, interact with the PROTEIN2 -containing cytoskeleton, via linking proteins such as PROTEIN and PROTEIN , while one of them interacts with the PROTEIN filaments, via an as yet unknown linking molecule(s).
BioInfer.d439.s0.p3	P	Most of these PROTEIN1 , with their intracellular domains, interact with the PROTEIN -containing cytoskeleton, via linking proteins such as PROTEIN and PROTEIN , while one of them interacts with the PROTEIN2 filaments, via an as yet unknown linking molecule(s).
BioInfer.d439.s0.p4	N	Most of these PROTEIN , with their intracellular domains, interact with the PROTEIN -containing cytoskeleton, via linking proteins such as PROTEIN2 and PROTEIN1 , while one of them interacts with the PROTEIN filaments, via an as yet unknown linking molecule(s).
BioInfer.d439.s0.p5	P	Most of these PROTEIN , with their intracellular domains, interact with the PROTEIN2 -containing cytoskeleton, via linking proteins such as PROTEIN and PROTEIN1 , while one of them interacts with the PROTEIN filaments, via an as yet unknown linking molecule(s).
BioInfer.d439.s0.p6	N	Most of these PROTEIN , with their intracellular domains, interact with the PROTEIN -containing cytoskeleton, via linking proteins such as PROTEIN and PROTEIN1 , while one of them interacts with the PROTEIN2 filaments, via an as yet unknown linking molecule(s).
BioInfer.d439.s0.p7	P	Most of these PROTEIN , with their intracellular domains, interact with the PROTEIN2 -containing cytoskeleton, via linking proteins such as PROTEIN1 and PROTEIN , while one of them interacts with the PROTEIN filaments, via an as yet unknown linking molecule(s).
BioInfer.d439.s0.p8	N	Most of these PROTEIN , with their intracellular domains, interact with the PROTEIN -containing cytoskeleton, via linking proteins such as PROTEIN1 and PROTEIN , while one of them interacts with the PROTEIN2 filaments, via an as yet unknown linking molecule(s).
BioInfer.d439.s0.p9	N	Most of these PROTEIN , with their intracellular domains, interact with the PROTEIN1 -containing cytoskeleton, via linking proteins such as PROTEIN and PROTEIN , while one of them interacts with the PROTEIN2 filaments, via an as yet unknown linking molecule(s).
BioInfer.d440.s0.p0	P	Most previous studies have focused on PROTEIN1 itself rather than its complex with PROTEIN2 .
BioInfer.d441.s0.p0	N	Motile areas of leech neurites are rich in microfilaments and two PROTEIN : PROTEIN1 and PROTEIN2 .
BioInfer.d441.s0.p1	P	Motile areas of leech neurites are rich in microfilaments and two PROTEIN2 : PROTEIN1 and PROTEIN .
BioInfer.d441.s0.p2	P	Motile areas of leech neurites are rich in microfilaments and two PROTEIN2 : PROTEIN and PROTEIN1 .
BioInfer.d441.s1.p0	P	The colocalization of PROTEIN and PROTEIN1 in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the PROTEIN2 dynamics that underlie neurite growth.
BioInfer.d441.s1.p1	P	The colocalization of PROTEIN2 and PROTEIN1 in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the PROTEIN dynamics that underlie neurite growth.
BioInfer.d441.s1.p2	P	The colocalization of PROTEIN2 and PROTEIN in motile, microfilament-rich areas supports the hypothesis that they synergistically regulate the PROTEIN1 dynamics that underlie neurite growth.
BioInfer.d442.s0.p0	N	Mutants of PROTEIN2 and PROTEIN , which encode PROTEIN and PROTEIN1 respectively, display disorganized PROTEIN patches in all cells.
BioInfer.d442.s0.p1	N	Mutants of PROTEIN and PROTEIN , which encode PROTEIN2 and PROTEIN1 respectively, display disorganized PROTEIN patches in all cells.
BioInfer.d442.s0.p2	P	Mutants of PROTEIN and PROTEIN2 , which encode PROTEIN and PROTEIN1 respectively, display disorganized PROTEIN patches in all cells.
BioInfer.d442.s0.p3	N	Mutants of PROTEIN and PROTEIN , which encode PROTEIN and PROTEIN1 respectively, display disorganized PROTEIN2 patches in all cells.
BioInfer.d442.s0.p4	P	Mutants of PROTEIN1 and PROTEIN , which encode PROTEIN2 and PROTEIN respectively, display disorganized PROTEIN patches in all cells.
BioInfer.d442.s0.p5	N	Mutants of PROTEIN1 and PROTEIN2 , which encode PROTEIN and PROTEIN respectively, display disorganized PROTEIN patches in all cells.
BioInfer.d442.s0.p6	N	Mutants of PROTEIN1 and PROTEIN , which encode PROTEIN and PROTEIN respectively, display disorganized PROTEIN2 patches in all cells.
BioInfer.d442.s0.p7	N	Mutants of PROTEIN and PROTEIN2 , which encode PROTEIN1 and PROTEIN respectively, display disorganized PROTEIN patches in all cells.
BioInfer.d442.s0.p8	N	Mutants of PROTEIN and PROTEIN , which encode PROTEIN1 and PROTEIN respectively, display disorganized PROTEIN2 patches in all cells.
BioInfer.d442.s0.p9	N	Mutants of PROTEIN and PROTEIN1 , which encode PROTEIN and PROTEIN respectively, display disorganized PROTEIN2 patches in all cells.
BioInfer.d443.s0.p0	N	Mutations in PROTEIN , PROTEIN1 , and PROTEIN2 cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).
BioInfer.d443.s0.p1	N	Mutations in PROTEIN2 , PROTEIN1 , and PROTEIN cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).
BioInfer.d443.s0.p2	N	Mutations in PROTEIN2 , PROTEIN , and PROTEIN1 cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).
BioInfer.d444.s0.p0	P	Mutations in PROTEIN and PROTEIN1 , the two yeast PROTEIN2 homologs, cause very similar growth phenotypes, a depolarized PROTEIN cytoskeleton, and a defect in the internalization step of endocytosis.
BioInfer.d444.s0.p1	P	Mutations in PROTEIN and PROTEIN1 , the two yeast PROTEIN homologs, cause very similar growth phenotypes, a depolarized PROTEIN2 cytoskeleton, and a defect in the internalization step of endocytosis.
BioInfer.d444.s0.p2	N	Mutations in PROTEIN2 and PROTEIN1 , the two yeast PROTEIN homologs, cause very similar growth phenotypes, a depolarized PROTEIN cytoskeleton, and a defect in the internalization step of endocytosis.
BioInfer.d444.s0.p3	N	Mutations in PROTEIN and PROTEIN , the two yeast PROTEIN1 homologs, cause very similar growth phenotypes, a depolarized PROTEIN2 cytoskeleton, and a defect in the internalization step of endocytosis.
BioInfer.d444.s0.p4	P	Mutations in PROTEIN2 and PROTEIN , the two yeast PROTEIN1 homologs, cause very similar growth phenotypes, a depolarized PROTEIN cytoskeleton, and a defect in the internalization step of endocytosis.
BioInfer.d444.s0.p5	P	Mutations in PROTEIN2 and PROTEIN , the two yeast PROTEIN homologs, cause very similar growth phenotypes, a depolarized PROTEIN1 cytoskeleton, and a defect in the internalization step of endocytosis.
BioInfer.d445.s0.p0	N	Mutations in PROTEIN2 cause increased rates of mitotic crossing over and are lethal in combination with mutations in PROTEIN1 and PROTEIN .
BioInfer.d445.s0.p1	N	Mutations in PROTEIN cause increased rates of mitotic crossing over and are lethal in combination with mutations in PROTEIN1 and PROTEIN2 .
BioInfer.d445.s0.p2	N	Mutations in PROTEIN1 cause increased rates of mitotic crossing over and are lethal in combination with mutations in PROTEIN and PROTEIN2 .
BioInfer.d446.s0.p0	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p1	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p2	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p3	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p4	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p5	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p6	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p7	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p8	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p9	N	Mutations in Saccharomyces cerevisiae PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p10	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN1  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p11	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN had little effect.
BioInfer.d446.s0.p12	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 had little effect.
BioInfer.d446.s0.p13	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p14	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p15	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p16	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p17	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p18	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p19	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN2 , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p20	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN2 , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p21	N	Mutations in Saccharomyces cerevisiae PROTEIN2 , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p22	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p23	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN had little effect.
BioInfer.d446.s0.p24	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 had little effect.
BioInfer.d446.s0.p25	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p26	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p27	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p28	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p29	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p30	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN2 , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p31	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN2 , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p32	N	Mutations in Saccharomyces cerevisiae PROTEIN2 , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p33	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p34	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN had little effect.
BioInfer.d446.s0.p35	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 had little effect.
BioInfer.d446.s0.p36	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p37	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p38	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p39	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p40	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN2 , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p41	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN2 , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p42	N	Mutations in Saccharomyces cerevisiae PROTEIN2 , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p43	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p44	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN had little effect.
BioInfer.d446.s0.p45	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 had little effect.
BioInfer.d446.s0.p46	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p47	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p48	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p49	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN2 , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p50	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN2 , PROTEIN  PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p51	N	Mutations in Saccharomyces cerevisiae PROTEIN2 , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p52	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p53	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN had little effect.
BioInfer.d446.s0.p54	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 had little effect.
BioInfer.d446.s0.p55	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p56	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p57	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN2 , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p58	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN2 , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p59	N	Mutations in Saccharomyces cerevisiae PROTEIN2 , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p60	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p61	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN had little effect.
BioInfer.d446.s0.p62	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 had little effect.
BioInfer.d446.s0.p63	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p64	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN2 , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p65	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN2 , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p66	N	Mutations in Saccharomyces cerevisiae PROTEIN2 , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p67	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p68	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN had little effect.
BioInfer.d446.s0.p69	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 had little effect.
BioInfer.d446.s0.p70	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN2 , PROTEIN , PROTEIN  PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p71	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN2 , PROTEIN  PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p72	N	Mutations in Saccharomyces cerevisiae PROTEIN2 , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p73	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p74	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN had little effect.
BioInfer.d446.s0.p75	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 had little effect.
BioInfer.d446.s0.p76	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p77	N	Mutations in Saccharomyces cerevisiae PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p78	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN1 , PROTEIN , PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p79	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN1 , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN had little effect.
BioInfer.d446.s0.p80	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN1 , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 had little effect.
BioInfer.d446.s0.p81	N	Mutations in Saccharomyces cerevisiae PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p82	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN1 , PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p83	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN1 , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN had little effect.
BioInfer.d446.s0.p84	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN1 , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 had little effect.
BioInfer.d446.s0.p85	N	Mutations in Saccharomyces cerevisiae PROTEIN1 , PROTEIN , PROTEIN , PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN had little effect.
BioInfer.d446.s0.p86	N	Mutations in Saccharomyces cerevisiae PROTEIN1 , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN had little effect.
BioInfer.d446.s0.p87	N	Mutations in Saccharomyces cerevisiae PROTEIN1 , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 had little effect.
BioInfer.d446.s0.p88	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN had little effect.
BioInfer.d446.s0.p89	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 had little effect.
BioInfer.d446.s0.p90	N	Mutations in Saccharomyces cerevisiae PROTEIN , PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN increased the rate of genome rearrangements up to 200-fold whereas mutations in PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 had little effect.
BioInfer.d447.s0.p0	P	Mutations that alter putative RNA-binding residues of either PROTEIN RRM are lethal in vivo, but do not prevent binding to PROTEIN in vitro, suggesting that the predicted RNA-binding surfaces of PROTEIN2 are not required for interaction with PROTEIN1 .
BioInfer.d447.s0.p1	N	Mutations that alter putative RNA-binding residues of either PROTEIN RRM are lethal in vivo, but do not prevent binding to PROTEIN2 in vitro, suggesting that the predicted RNA-binding surfaces of PROTEIN are not required for interaction with PROTEIN1 .
BioInfer.d447.s0.p2	N	Mutations that alter putative RNA-binding residues of either PROTEIN2 RRM are lethal in vivo, but do not prevent binding to PROTEIN in vitro, suggesting that the predicted RNA-binding surfaces of PROTEIN are not required for interaction with PROTEIN1 .
BioInfer.d447.s0.p3	N	Mutations that alter putative RNA-binding residues of either PROTEIN RRM are lethal in vivo, but do not prevent binding to PROTEIN2 in vitro, suggesting that the predicted RNA-binding surfaces of PROTEIN1 are not required for interaction with PROTEIN .
BioInfer.d447.s0.p4	N	Mutations that alter putative RNA-binding residues of either PROTEIN2 RRM are lethal in vivo, but do not prevent binding to PROTEIN in vitro, suggesting that the predicted RNA-binding surfaces of PROTEIN1 are not required for interaction with PROTEIN .
BioInfer.d447.s0.p5	P	Mutations that alter putative RNA-binding residues of either PROTEIN2 RRM are lethal in vivo, but do not prevent binding to PROTEIN1 in vitro, suggesting that the predicted RNA-binding surfaces of PROTEIN are not required for interaction with PROTEIN .
BioInfer.d447.s1.p0	P	Recombinant PROTEIN2 protein has a general RNA-binding activity that does not require PROTEIN1 .
BioInfer.d448.s0.p0	P	PROTEIN2 shows homology to the head domains and the coiledcoil tail of the conventional PROTEIN and carries putative binding sites for ATP and PROTEIN1 .
BioInfer.d448.s0.p1	N	PROTEIN shows homology to the head domains and the coiledcoil tail of the conventional PROTEIN2 and carries putative binding sites for ATP and PROTEIN1 .
BioInfer.d448.s0.p2	P	PROTEIN1 shows homology to the head domains and the coiledcoil tail of the conventional PROTEIN2 and carries putative binding sites for ATP and PROTEIN .
BioInfer.d449.s1.p0	N	PROTEIN1 and PROTEIN2 mRNAs were detected precociously, before the young myotube stage.
BioInfer.d450.s0.p0	P	Neither can PROTEIN1 , in the presence of the peptide, promote PROTEIN2 polymerization during its early phase consistent with a lower affinity.
BioInfer.d450.s1.p0	P	The resulting PROTEIN -peptide complex overcomes the combined capacity of PROTEIN and PROTEIN2 to inhibit PROTEIN1 nucleation and restores the extent of filament formation.
BioInfer.d450.s1.p1	P	The resulting PROTEIN -peptide complex overcomes the combined capacity of PROTEIN2 and PROTEIN to inhibit PROTEIN1 nucleation and restores the extent of filament formation.
BioInfer.d450.s1.p2	P	The resulting PROTEIN2 -peptide complex overcomes the combined capacity of PROTEIN and PROTEIN to inhibit PROTEIN1 nucleation and restores the extent of filament formation.
BioInfer.d450.s1.p3	N	The resulting PROTEIN -peptide complex overcomes the combined capacity of PROTEIN2 and PROTEIN1 to inhibit PROTEIN nucleation and restores the extent of filament formation.
BioInfer.d450.s1.p4	N	The resulting PROTEIN2 -peptide complex overcomes the combined capacity of PROTEIN and PROTEIN1 to inhibit PROTEIN nucleation and restores the extent of filament formation.
BioInfer.d450.s1.p5	N	The resulting PROTEIN2 -peptide complex overcomes the combined capacity of PROTEIN1 and PROTEIN to inhibit PROTEIN nucleation and restores the extent of filament formation.
BioInfer.d451.s0.p0	N	Newly disclosed interactions between PROTEIN , exchange factors for PROTEIN2 of the PROTEIN1 and PROTEIN families, the translational regulator PROTEIN , and PROTEIN like PROTEIN might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p2	N	Newly disclosed interactions between PROTEIN , exchange factors for PROTEIN of the PROTEIN1 and PROTEIN families, the translational regulator PROTEIN2 , and PROTEIN like PROTEIN might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p3	N	Newly disclosed interactions between PROTEIN , exchange factors for PROTEIN of the PROTEIN1 and PROTEIN families, the translational regulator PROTEIN , and PROTEIN like PROTEIN2 might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p4	N	Newly disclosed interactions between PROTEIN , exchange factors for PROTEIN of the PROTEIN1 and PROTEIN families, the translational regulator PROTEIN , and PROTEIN2 like PROTEIN might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p5	N	Newly disclosed interactions between PROTEIN2 , exchange factors for PROTEIN of the PROTEIN1 and PROTEIN families, the translational regulator PROTEIN , and PROTEIN like PROTEIN might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p6	N	Newly disclosed interactions between PROTEIN , exchange factors for PROTEIN of the PROTEIN1 and PROTEIN2 families, the translational regulator PROTEIN , and PROTEIN like PROTEIN might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p8	N	Newly disclosed interactions between PROTEIN , exchange factors for PROTEIN1 of the PROTEIN and PROTEIN families, the translational regulator PROTEIN2 , and PROTEIN like PROTEIN might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p9	N	Newly disclosed interactions between PROTEIN , exchange factors for PROTEIN1 of the PROTEIN and PROTEIN families, the translational regulator PROTEIN , and PROTEIN like PROTEIN2 might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p10	N	Newly disclosed interactions between PROTEIN , exchange factors for PROTEIN1 of the PROTEIN and PROTEIN families, the translational regulator PROTEIN , and PROTEIN2 like PROTEIN might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p11	N	Newly disclosed interactions between PROTEIN2 , exchange factors for PROTEIN1 of the PROTEIN and PROTEIN families, the translational regulator PROTEIN , and PROTEIN like PROTEIN might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p12	N	Newly disclosed interactions between PROTEIN , exchange factors for PROTEIN1 of the PROTEIN and PROTEIN2 families, the translational regulator PROTEIN , and PROTEIN like PROTEIN might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p18	N	Newly disclosed interactions between PROTEIN , exchange factors for PROTEIN of the PROTEIN and PROTEIN families, the translational regulator PROTEIN1 , and PROTEIN like PROTEIN2 might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p19	P	Newly disclosed interactions between PROTEIN , exchange factors for PROTEIN of the PROTEIN and PROTEIN families, the translational regulator PROTEIN1 , and PROTEIN2 like PROTEIN might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p20	P	Newly disclosed interactions between PROTEIN2 , exchange factors for PROTEIN of the PROTEIN and PROTEIN families, the translational regulator PROTEIN1 , and PROTEIN like PROTEIN might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p21	N	Newly disclosed interactions between PROTEIN , exchange factors for PROTEIN of the PROTEIN and PROTEIN2 families, the translational regulator PROTEIN1 , and PROTEIN like PROTEIN might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p22	P	Newly disclosed interactions between PROTEIN , exchange factors for PROTEIN of the PROTEIN and PROTEIN families, the translational regulator PROTEIN , and PROTEIN2 like PROTEIN1 might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p23	N	Newly disclosed interactions between PROTEIN2 , exchange factors for PROTEIN of the PROTEIN and PROTEIN families, the translational regulator PROTEIN , and PROTEIN like PROTEIN1 might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p24	N	Newly disclosed interactions between PROTEIN , exchange factors for PROTEIN of the PROTEIN and PROTEIN2 families, the translational regulator PROTEIN , and PROTEIN like PROTEIN1 might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p25	P	Newly disclosed interactions between PROTEIN2 , exchange factors for PROTEIN of the PROTEIN and PROTEIN families, the translational regulator PROTEIN , and PROTEIN1 like PROTEIN might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p26	N	Newly disclosed interactions between PROTEIN , exchange factors for PROTEIN of the PROTEIN and PROTEIN2 families, the translational regulator PROTEIN , and PROTEIN1 like PROTEIN might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d451.s0.p27	N	Newly disclosed interactions between PROTEIN1 , exchange factors for PROTEIN of the PROTEIN and PROTEIN2 families, the translational regulator PROTEIN , and PROTEIN like PROTEIN might integrate activity-dependent and trophic-factor-mediated signals at developing postsynaptic sites.
BioInfer.d452.s0.p0	P	N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of PROTEIN assembly through its association with the PROTEIN1 , PROTEIN2 , and PROTEIN .
BioInfer.d452.s0.p1	N	N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of PROTEIN2 assembly through its association with the PROTEIN1 , PROTEIN , and PROTEIN .
BioInfer.d452.s0.p2	P	N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of PROTEIN assembly through its association with the PROTEIN1 , PROTEIN , and PROTEIN2 .
BioInfer.d452.s0.p3	P	N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of PROTEIN2 assembly through its association with the PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d452.s0.p4	N	N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of PROTEIN assembly through its association with the PROTEIN , PROTEIN1 , and PROTEIN2 .
BioInfer.d452.s0.p5	P	N-formyl peptide chemoattractants in neutrophils stimulate the formation of phosphatidylinositol-4,5-bisphosphate (PIP2), a reservoir for second messenger molecules and regulator of PROTEIN1 assembly through its association with the PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d453.s0.p0	N	No evidence for the surface expression of the PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN2 ) proteins was found.
BioInfer.d453.s0.p1	N	No evidence for the surface expression of the PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ) or PROTEIN2 ( PROTEIN ) proteins was found.
BioInfer.d453.s0.p2	N	No evidence for the surface expression of the PROTEIN2 ( PROTEIN1 ), PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN ) proteins was found.
BioInfer.d453.s0.p3	N	No evidence for the surface expression of the PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) proteins was found.
BioInfer.d453.s0.p4	N	No evidence for the surface expression of the PROTEIN ( PROTEIN1 ), PROTEIN2 ( PROTEIN ) or PROTEIN ( PROTEIN ) proteins was found.
BioInfer.d453.s0.p5	N	No evidence for the surface expression of the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) or PROTEIN2 ( PROTEIN1 ) proteins was found.
BioInfer.d453.s0.p6	N	No evidence for the surface expression of the PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) or PROTEIN ( PROTEIN1 ) proteins was found.
BioInfer.d453.s0.p7	N	No evidence for the surface expression of the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN1 ) proteins was found.
BioInfer.d453.s0.p8	N	No evidence for the surface expression of the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) or PROTEIN ( PROTEIN1 ) proteins was found.
BioInfer.d453.s0.p9	N	No evidence for the surface expression of the PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) or PROTEIN1 ( PROTEIN ) proteins was found.
BioInfer.d453.s0.p10	N	No evidence for the surface expression of the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) or PROTEIN1 ( PROTEIN ) proteins was found.
BioInfer.d453.s0.p11	N	No evidence for the surface expression of the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) or PROTEIN1 ( PROTEIN ) proteins was found.
BioInfer.d453.s0.p12	N	No evidence for the surface expression of the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN2 ) or PROTEIN ( PROTEIN ) proteins was found.
BioInfer.d453.s0.p13	N	No evidence for the surface expression of the PROTEIN1 ( PROTEIN ), PROTEIN2 ( PROTEIN ) or PROTEIN ( PROTEIN ) proteins was found.
BioInfer.d453.s0.p14	N	No evidence for the surface expression of the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN1 ) or PROTEIN ( PROTEIN ) proteins was found.
BioInfer.d454.s0.p0	N	No significant changes in glomerular PROTEIN2 , PROTEIN , PROTEIN1 , or total PROTEIN expression occurred at any time point during disease development.
BioInfer.d454.s0.p1	N	No significant changes in glomerular PROTEIN , PROTEIN , PROTEIN1 , or total PROTEIN2 expression occurred at any time point during disease development.
BioInfer.d454.s0.p2	N	No significant changes in glomerular PROTEIN , PROTEIN2 , PROTEIN1 , or total PROTEIN expression occurred at any time point during disease development.
BioInfer.d454.s0.p3	N	No significant changes in glomerular PROTEIN1 , PROTEIN , PROTEIN , or total PROTEIN2 expression occurred at any time point during disease development.
BioInfer.d454.s0.p4	N	No significant changes in glomerular PROTEIN1 , PROTEIN2 , PROTEIN , or total PROTEIN expression occurred at any time point during disease development.
BioInfer.d454.s0.p5	N	No significant changes in glomerular PROTEIN , PROTEIN2 , PROTEIN , or total PROTEIN1 expression occurred at any time point during disease development.
BioInfer.d455.s0.p0	N	Notably, the two pro-apoptotic adapter proteins PROTEIN2 and PROTEIN1 are also involved in the activation of PROTEIN .
BioInfer.d455.s0.p1	P	Notably, the two pro-apoptotic adapter proteins PROTEIN and PROTEIN1 are also involved in the activation of PROTEIN2 .
BioInfer.d455.s0.p2	P	Notably, the two pro-apoptotic adapter proteins PROTEIN1 and PROTEIN are also involved in the activation of PROTEIN2 .
BioInfer.d456.s0.p0	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN1 ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN2 expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p1	N	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN2 can mimic the effects of PROTEIN1 ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p2	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN1 ( PROTEIN ) in acting synergistically with PROTEIN2 ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p3	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN1 ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN2 ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p4	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN1 ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN2 breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p5	N	OBJECTIVE: To determine whether other PROTEIN2 ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN1 ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p6	N	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN1 ( PROTEIN2 ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p7	N	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN2 ) binding PROTEIN can mimic the effects of PROTEIN1 ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p8	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN2 can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN1 expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p9	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN2 ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN1 expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p10	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN2 ) to induce cartilage PROTEIN breakdown and PROTEIN1 expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p11	N	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN2 breakdown and PROTEIN1 expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p12	N	OBJECTIVE: To determine whether other PROTEIN2 ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN1 expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p13	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN2 ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN1 expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p14	N	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN2 ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN1 expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p15	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN1 can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN2 ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p16	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN1 can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN2 ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p17	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN1 can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN2 breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p18	P	OBJECTIVE: To determine whether other PROTEIN2 ( PROTEIN ) binding PROTEIN1 can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p19	N	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN1 can mimic the effects of PROTEIN ( PROTEIN2 ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p20	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN2 ) binding PROTEIN1 can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p21	N	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN1 ( PROTEIN2 ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p22	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN1 ( PROTEIN ) to induce cartilage PROTEIN2 breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p23	N	OBJECTIVE: To determine whether other PROTEIN2 ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN1 ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p24	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN2 ) in acting synergistically with PROTEIN1 ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p25	N	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN2 ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN1 ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p26	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN1 ) to induce cartilage PROTEIN2 breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p27	N	OBJECTIVE: To determine whether other PROTEIN2 ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN1 ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p28	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN2 ) in acting synergistically with PROTEIN ( PROTEIN1 ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p29	N	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN2 ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN1 ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p30	N	OBJECTIVE: To determine whether other PROTEIN2 ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN1 breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p31	P	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN2 ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN1 breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p32	N	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN2 ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN1 breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p33	N	OBJECTIVE: To determine whether other PROTEIN1 ( PROTEIN ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN2 ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p34	N	OBJECTIVE: To determine whether other PROTEIN1 ( PROTEIN2 ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d456.s0.p35	N	OBJECTIVE: To determine whether other PROTEIN ( PROTEIN2 ) binding PROTEIN can mimic the effects of PROTEIN ( PROTEIN1 ) in acting synergistically with PROTEIN ( PROTEIN ) to induce cartilage PROTEIN breakdown and PROTEIN expression, and to determine which receptors mediate these effects.
BioInfer.d457.s0.p0	N	Of the five major structural proteins of MV, only PROTEIN1 ( PROTEIN2 ) protein and PROTEIN ( PROTEIN ) were consistently detected in diseased brain areas.
BioInfer.d457.s0.p1	N	Of the five major structural proteins of MV, only PROTEIN1 ( PROTEIN ) protein and PROTEIN2 ( PROTEIN ) were consistently detected in diseased brain areas.
BioInfer.d457.s0.p2	N	Of the five major structural proteins of MV, only PROTEIN1 ( PROTEIN ) protein and PROTEIN ( PROTEIN2 ) were consistently detected in diseased brain areas.
BioInfer.d457.s0.p3	N	Of the five major structural proteins of MV, only PROTEIN ( PROTEIN1 ) protein and PROTEIN2 ( PROTEIN ) were consistently detected in diseased brain areas.
BioInfer.d457.s0.p4	N	Of the five major structural proteins of MV, only PROTEIN ( PROTEIN1 ) protein and PROTEIN ( PROTEIN2 ) were consistently detected in diseased brain areas.
BioInfer.d457.s0.p5	N	Of the five major structural proteins of MV, only PROTEIN ( PROTEIN ) protein and PROTEIN1 ( PROTEIN2 ) were consistently detected in diseased brain areas.
BioInfer.d458.s0.p0	P	PROTEIN and PROTEIN were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN2  PROTEIN1 , and PROTEIN was released.
BioInfer.d458.s0.p1	P	PROTEIN2 and PROTEIN were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN  PROTEIN1 , and PROTEIN was released.
BioInfer.d458.s0.p2	N	PROTEIN and PROTEIN were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN  PROTEIN1 , and PROTEIN2 was released.
BioInfer.d458.s0.p3	P	PROTEIN and PROTEIN2 were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN  PROTEIN1 , and PROTEIN was released.
BioInfer.d458.s0.p4	N	PROTEIN2 and PROTEIN were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN1  PROTEIN , and PROTEIN was released.
BioInfer.d458.s0.p5	N	PROTEIN and PROTEIN were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN1  PROTEIN , and PROTEIN2 was released.
BioInfer.d458.s0.p6	N	PROTEIN and PROTEIN2 were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN1  PROTEIN , and PROTEIN was released.
BioInfer.d458.s0.p7	N	PROTEIN1 and PROTEIN were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN  PROTEIN , and PROTEIN2 was released.
BioInfer.d458.s0.p8	N	PROTEIN1 and PROTEIN2 were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN  PROTEIN , and PROTEIN was released.
BioInfer.d458.s0.p9	N	PROTEIN and PROTEIN2 were phosphorylated before the infected myotubes entered S phase, despite the high expression of the PROTEIN  PROTEIN , and PROTEIN1 was released.
BioInfer.d459.s0.p0	P	Once the PROTEIN monomer is bound to the filament, the PROTEIN2 is released, and is available to bind to additional PROTEIN1 monomers.
BioInfer.d459.s0.p1	N	Once the PROTEIN2 monomer is bound to the filament, the PROTEIN is released, and is available to bind to additional PROTEIN1 monomers.
BioInfer.d459.s0.p2	N	Once the PROTEIN2 monomer is bound to the filament, the PROTEIN1 is released, and is available to bind to additional PROTEIN monomers.
BioInfer.d460.s0.p0	P	One involves PROTEIN1 , which has recently been shown to bind PROTEIN2 directly.
BioInfer.d461.s0.p0	N	One, PROTEIN2 (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN1 ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p1	P	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN2 , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN1 ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p2	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN2 ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN1 ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p3	N	One, PROTEIN (also called PROTEIN2 ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN1 ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p4	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN2 but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN1 ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p5	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN2 / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN1 ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p6	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN2 but not to PROTEIN / PROTEIN1 ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p7	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN1 ; and the third, PROTEIN2 , binds weakly to both receptors.
BioInfer.d461.s0.p8	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN2 / PROTEIN1 ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p9	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN2  PROTEIN but not to PROTEIN / PROTEIN1 ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p10	N	One, PROTEIN1 (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN2 , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p11	P	One, PROTEIN1 (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN2 ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p12	N	One, PROTEIN1 (also called PROTEIN2 ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p13	P	One, PROTEIN1 (also called PROTEIN ), binds to PROTEIN / PROTEIN2 but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p14	P	One, PROTEIN1 (also called PROTEIN ), binds to PROTEIN2 / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p15	N	One, PROTEIN1 (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN2 but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p16	N	One, PROTEIN1 (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN2 , binds weakly to both receptors.
BioInfer.d461.s0.p17	N	One, PROTEIN1 (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN2 / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p18	N	One, PROTEIN1 (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN2  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p19	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN2 ; another, PROTEIN1 , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p20	N	One, PROTEIN (also called PROTEIN2 ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN1 , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p21	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN2 but not to PROTEIN ; another, PROTEIN1 , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p22	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN2 / PROTEIN but not to PROTEIN ; another, PROTEIN1 , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p23	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN1 , binds to the PROTEIN  PROTEIN2 but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p24	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN1 , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN2 , binds weakly to both receptors.
BioInfer.d461.s0.p25	P	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN1 , binds to the PROTEIN  PROTEIN but not to PROTEIN2 / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p26	P	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN1 , binds to the PROTEIN2  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p27	P	One, PROTEIN (also called PROTEIN2 ), binds to PROTEIN / PROTEIN but not to PROTEIN1 ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p28	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN2 but not to PROTEIN1 ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p29	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN2 / PROTEIN but not to PROTEIN1 ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p30	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN1 ; another, PROTEIN , binds to the PROTEIN  PROTEIN2 but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p31	P	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN1 ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN2 , binds weakly to both receptors.
BioInfer.d461.s0.p32	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN1 ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN2 / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p33	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN1 ; another, PROTEIN , binds to the PROTEIN2  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p34	P	One, PROTEIN (also called PROTEIN1 ), binds to PROTEIN / PROTEIN2 but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p35	P	One, PROTEIN (also called PROTEIN1 ), binds to PROTEIN2 / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p36	N	One, PROTEIN (also called PROTEIN1 ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN2 but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p37	N	One, PROTEIN (also called PROTEIN1 ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN2 , binds weakly to both receptors.
BioInfer.d461.s0.p38	N	One, PROTEIN (also called PROTEIN1 ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN2 / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p39	N	One, PROTEIN (also called PROTEIN1 ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN2  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p40	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN2 / PROTEIN1 but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p41	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN1 but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN2 but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p42	P	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN1 but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN2 , binds weakly to both receptors.
BioInfer.d461.s0.p43	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN1 but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN2 / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p44	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN1 but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN2  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p45	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN1 / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN2 but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p46	P	One, PROTEIN (also called PROTEIN ), binds to PROTEIN1 / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN2 , binds weakly to both receptors.
BioInfer.d461.s0.p47	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN1 / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN2 / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p48	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN1 / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN2  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p49	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN1 but not to PROTEIN / PROTEIN ; and the third, PROTEIN2 , binds weakly to both receptors.
BioInfer.d461.s0.p50	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN1 but not to PROTEIN2 / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p51	P	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN2  PROTEIN1 but not to PROTEIN / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d461.s0.p52	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN  PROTEIN but not to PROTEIN2 / PROTEIN ; and the third, PROTEIN1 , binds weakly to both receptors.
BioInfer.d461.s0.p53	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN2  PROTEIN but not to PROTEIN / PROTEIN ; and the third, PROTEIN1 , binds weakly to both receptors.
BioInfer.d461.s0.p54	N	One, PROTEIN (also called PROTEIN ), binds to PROTEIN / PROTEIN but not to PROTEIN ; another, PROTEIN , binds to the PROTEIN2  PROTEIN but not to PROTEIN1 / PROTEIN ; and the third, PROTEIN , binds weakly to both receptors.
BioInfer.d462.s0.p0	N	One mutation, PROTEIN , is in the gene encoding PROTEIN , another PROTEIN1 , which was expected because null mutations in PROTEIN and PROTEIN2 are known to be synthetic-lethal.
BioInfer.d462.s0.p1	P	One mutation, PROTEIN , is in the gene encoding PROTEIN2 , another PROTEIN1 , which was expected because null mutations in PROTEIN and PROTEIN are known to be synthetic-lethal.
BioInfer.d462.s0.p2	N	One mutation, PROTEIN2 , is in the gene encoding PROTEIN , another PROTEIN1 , which was expected because null mutations in PROTEIN and PROTEIN are known to be synthetic-lethal.
BioInfer.d462.s0.p3	N	One mutation, PROTEIN , is in the gene encoding PROTEIN , another PROTEIN1 , which was expected because null mutations in PROTEIN2 and PROTEIN are known to be synthetic-lethal.
BioInfer.d462.s0.p4	N	One mutation, PROTEIN , is in the gene encoding PROTEIN2 , another PROTEIN , which was expected because null mutations in PROTEIN and PROTEIN1 are known to be synthetic-lethal.
BioInfer.d462.s0.p5	N	One mutation, PROTEIN2 , is in the gene encoding PROTEIN , another PROTEIN , which was expected because null mutations in PROTEIN and PROTEIN1 are known to be synthetic-lethal.
BioInfer.d462.s0.p6	N	One mutation, PROTEIN , is in the gene encoding PROTEIN , another PROTEIN , which was expected because null mutations in PROTEIN2 and PROTEIN1 are known to be synthetic-lethal.
BioInfer.d462.s0.p7	N	One mutation, PROTEIN2 , is in the gene encoding PROTEIN1 , another PROTEIN , which was expected because null mutations in PROTEIN and PROTEIN are known to be synthetic-lethal.
BioInfer.d462.s0.p8	N	One mutation, PROTEIN , is in the gene encoding PROTEIN1 , another PROTEIN , which was expected because null mutations in PROTEIN2 and PROTEIN are known to be synthetic-lethal.
BioInfer.d462.s0.p9	N	One mutation, PROTEIN1 , is in the gene encoding PROTEIN , another PROTEIN , which was expected because null mutations in PROTEIN2 and PROTEIN are known to be synthetic-lethal.
BioInfer.d463.s0.p0	P	One such protein is the yeast PROTEIN1  PROTEIN2 , which is homologous to vertebrate PROTEIN (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).
BioInfer.d463.s0.p1	N	One such protein is the yeast PROTEIN1  PROTEIN , which is homologous to vertebrate PROTEIN2 (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).
BioInfer.d463.s0.p2	P	One such protein is the yeast PROTEIN  PROTEIN1 , which is homologous to vertebrate PROTEIN2 (Adams, A. E. M., D. Botstein, and D. G. Drubin. 1991. Nature (Lond.). 354:404-408.).
BioInfer.d464.s0.p0	N	Only the unphosphorylated form of PROTEIN is an active form that binds PROTEIN2 , whereas the regulatory mechanisms of PROTEIN1 have not been elucidated.
BioInfer.d464.s0.p1	N	Only the unphosphorylated form of PROTEIN2 is an active form that binds PROTEIN , whereas the regulatory mechanisms of PROTEIN1 have not been elucidated.
BioInfer.d464.s0.p2	P	Only the unphosphorylated form of PROTEIN2 is an active form that binds PROTEIN1 , whereas the regulatory mechanisms of PROTEIN have not been elucidated.
BioInfer.d465.s0.p0	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN , PROTEIN , and PROTEIN1 ), the PROTEIN ( PROTEIN2 ), and the viral PROTEIN ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p1	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN , PROTEIN , and PROTEIN1 ), the PROTEIN ( PROTEIN ), and the viral PROTEIN ( PROTEIN2 ) assemble together to initiate the process.
BioInfer.d465.s0.p2	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN2 components ( PROTEIN , PROTEIN , and PROTEIN1 ), the PROTEIN ( PROTEIN ), and the viral PROTEIN ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p3	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN , PROTEIN , and PROTEIN1 ), the PROTEIN ( PROTEIN ), and the viral PROTEIN2 ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p4	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN2 , PROTEIN , and PROTEIN1 ), the PROTEIN ( PROTEIN ), and the viral PROTEIN ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p5	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN , PROTEIN2 , and PROTEIN1 ), the PROTEIN ( PROTEIN ), and the viral PROTEIN ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p6	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN , PROTEIN , and PROTEIN1 ), the PROTEIN2 ( PROTEIN ), and the viral PROTEIN ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p7	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN , PROTEIN , and PROTEIN ), the PROTEIN ( PROTEIN1 ), and the viral PROTEIN ( PROTEIN2 ) assemble together to initiate the process.
BioInfer.d465.s0.p8	N	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN2 components ( PROTEIN , PROTEIN , and PROTEIN ), the PROTEIN ( PROTEIN1 ), and the viral PROTEIN ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p9	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN , PROTEIN , and PROTEIN ), the PROTEIN ( PROTEIN1 ), and the viral PROTEIN2 ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p10	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN2 , PROTEIN , and PROTEIN ), the PROTEIN ( PROTEIN1 ), and the viral PROTEIN ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p11	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN , PROTEIN2 , and PROTEIN ), the PROTEIN ( PROTEIN1 ), and the viral PROTEIN ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p12	N	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN , PROTEIN , and PROTEIN ), the PROTEIN2 ( PROTEIN1 ), and the viral PROTEIN ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p13	N	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN2 components ( PROTEIN , PROTEIN , and PROTEIN ), the PROTEIN ( PROTEIN ), and the viral PROTEIN ( PROTEIN1 ) assemble together to initiate the process.
BioInfer.d465.s0.p14	N	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN , PROTEIN , and PROTEIN ), the PROTEIN ( PROTEIN ), and the viral PROTEIN2 ( PROTEIN1 ) assemble together to initiate the process.
BioInfer.d465.s0.p15	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN2 , PROTEIN , and PROTEIN ), the PROTEIN ( PROTEIN ), and the viral PROTEIN ( PROTEIN1 ) assemble together to initiate the process.
BioInfer.d465.s0.p16	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN , PROTEIN2 , and PROTEIN ), the PROTEIN ( PROTEIN ), and the viral PROTEIN ( PROTEIN1 ) assemble together to initiate the process.
BioInfer.d465.s0.p17	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN , PROTEIN , and PROTEIN ), the PROTEIN2 ( PROTEIN ), and the viral PROTEIN ( PROTEIN1 ) assemble together to initiate the process.
BioInfer.d465.s0.p18	N	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN1 components ( PROTEIN , PROTEIN , and PROTEIN ), the PROTEIN ( PROTEIN ), and the viral PROTEIN2 ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p19	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN1 components ( PROTEIN2 , PROTEIN , and PROTEIN ), the PROTEIN ( PROTEIN ), and the viral PROTEIN ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p20	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN1 components ( PROTEIN , PROTEIN2 , and PROTEIN ), the PROTEIN ( PROTEIN ), and the viral PROTEIN ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p21	N	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN1 components ( PROTEIN , PROTEIN , and PROTEIN ), the PROTEIN2 ( PROTEIN ), and the viral PROTEIN ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p22	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN2 , PROTEIN , and PROTEIN ), the PROTEIN ( PROTEIN ), and the viral PROTEIN1 ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p23	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN , PROTEIN2 , and PROTEIN ), the PROTEIN ( PROTEIN ), and the viral PROTEIN1 ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p24	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN , PROTEIN , and PROTEIN ), the PROTEIN2 ( PROTEIN ), and the viral PROTEIN1 ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p25	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN1 , PROTEIN2 , and PROTEIN ), the PROTEIN ( PROTEIN ), and the viral PROTEIN ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p26	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN1 , PROTEIN , and PROTEIN ), the PROTEIN2 ( PROTEIN ), and the viral PROTEIN ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s0.p27	P	On the basis of these results, we present a model for prereplicative site formation in infected cells in which the PROTEIN components ( PROTEIN , PROTEIN1 , and PROTEIN ), the PROTEIN2 ( PROTEIN ), and the viral PROTEIN ( PROTEIN ) assemble together to initiate the process.
BioInfer.d465.s1.p0	N	We observed that four replication proteins, PROTEIN , PROTEIN  PROTEIN , and PROTEIN , are necessary for the localization of PROTEIN1 ( PROTEIN2 ) to prereplicative sites natural infection conditions.
BioInfer.d465.s1.p1	P	We observed that four replication proteins, PROTEIN , PROTEIN  PROTEIN , and PROTEIN2 , are necessary for the localization of PROTEIN1 ( PROTEIN ) to prereplicative sites natural infection conditions.
BioInfer.d465.s1.p2	P	We observed that four replication proteins, PROTEIN , PROTEIN  PROTEIN2 , and PROTEIN , are necessary for the localization of PROTEIN1 ( PROTEIN ) to prereplicative sites natural infection conditions.
BioInfer.d465.s1.p3	P	We observed that four replication proteins, PROTEIN , PROTEIN2  PROTEIN , and PROTEIN , are necessary for the localization of PROTEIN1 ( PROTEIN ) to prereplicative sites natural infection conditions.
BioInfer.d465.s1.p4	P	We observed that four replication proteins, PROTEIN2 , PROTEIN  PROTEIN , and PROTEIN , are necessary for the localization of PROTEIN1 ( PROTEIN ) to prereplicative sites natural infection conditions.
BioInfer.d465.s1.p5	P	We observed that four replication proteins, PROTEIN , PROTEIN  PROTEIN , and PROTEIN2 , are necessary for the localization of PROTEIN ( PROTEIN1 ) to prereplicative sites natural infection conditions.
BioInfer.d465.s1.p6	P	We observed that four replication proteins, PROTEIN , PROTEIN  PROTEIN2 , and PROTEIN , are necessary for the localization of PROTEIN ( PROTEIN1 ) to prereplicative sites natural infection conditions.
BioInfer.d465.s1.p7	P	We observed that four replication proteins, PROTEIN , PROTEIN2  PROTEIN , and PROTEIN , are necessary for the localization of PROTEIN ( PROTEIN1 ) to prereplicative sites natural infection conditions.
BioInfer.d465.s1.p8	P	We observed that four replication proteins, PROTEIN2 , PROTEIN  PROTEIN , and PROTEIN , are necessary for the localization of PROTEIN ( PROTEIN1 ) to prereplicative sites natural infection conditions.
BioInfer.d465.s1.p9	N	We observed that four replication proteins, PROTEIN , PROTEIN  PROTEIN2 , and PROTEIN1 , are necessary for the localization of PROTEIN ( PROTEIN ) to prereplicative sites natural infection conditions.
BioInfer.d465.s1.p10	N	We observed that four replication proteins, PROTEIN , PROTEIN2  PROTEIN , and PROTEIN1 , are necessary for the localization of PROTEIN ( PROTEIN ) to prereplicative sites natural infection conditions.
BioInfer.d465.s1.p11	N	We observed that four replication proteins, PROTEIN2 , PROTEIN  PROTEIN , and PROTEIN1 , are necessary for the localization of PROTEIN ( PROTEIN ) to prereplicative sites natural infection conditions.
BioInfer.d465.s1.p12	N	We observed that four replication proteins, PROTEIN , PROTEIN2  PROTEIN1 , and PROTEIN , are necessary for the localization of PROTEIN ( PROTEIN ) to prereplicative sites natural infection conditions.
BioInfer.d465.s1.p13	N	We observed that four replication proteins, PROTEIN2 , PROTEIN  PROTEIN1 , and PROTEIN , are necessary for the localization of PROTEIN ( PROTEIN ) to prereplicative sites natural infection conditions.
BioInfer.d465.s1.p14	N	We observed that four replication proteins, PROTEIN2 , PROTEIN1  PROTEIN , and PROTEIN , are necessary for the localization of PROTEIN ( PROTEIN ) to prereplicative sites natural infection conditions.
BioInfer.d466.s0.p0	N	On the internal (cytoplasmic) side of focal contacts, several proteins, including PROTEIN2 and PROTEIN1 , mediate interactions with the PROTEIN filament bundles of the cytoskeleton.
BioInfer.d466.s0.p1	N	On the internal (cytoplasmic) side of focal contacts, several proteins, including PROTEIN and PROTEIN1 , mediate interactions with the PROTEIN2 filament bundles of the cytoskeleton.
BioInfer.d466.s0.p2	N	On the internal (cytoplasmic) side of focal contacts, several proteins, including PROTEIN1 and PROTEIN , mediate interactions with the PROTEIN2 filament bundles of the cytoskeleton.
BioInfer.d467.s0.p0	P	On the other hand, we have recently proposed the importance of PROTEIN2 , an PROTEIN1 -binding phosphoprotein, in phagocyte functions through dephosphorylation and translocation to the plasma membrane regions.
BioInfer.d468.s0.p0	N	Opposite effects of PROTEIN and PROTEIN1 from porcine brain on rate of exchange of PROTEIN2 -bound adenosine 5'-triphosphate.
BioInfer.d468.s0.p1	N	Opposite effects of PROTEIN2 and PROTEIN1 from porcine brain on rate of exchange of PROTEIN -bound adenosine 5'-triphosphate.
BioInfer.d468.s0.p2	N	Opposite effects of PROTEIN2 and PROTEIN from porcine brain on rate of exchange of PROTEIN1 -bound adenosine 5'-triphosphate.
BioInfer.d469.s0.p0	N	Other mammalian PROTEIN such as PROTEIN and PROTEIN1 but also PROTEIN2 from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN ( PROTEIN ) phosphorylation.
BioInfer.d469.s0.p1	P	Other mammalian PROTEIN such as PROTEIN and PROTEIN1 but also PROTEIN from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN2 ( PROTEIN ) phosphorylation.
BioInfer.d469.s0.p2	P	Other mammalian PROTEIN such as PROTEIN and PROTEIN1 but also PROTEIN from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN ( PROTEIN2 ) phosphorylation.
BioInfer.d469.s0.p3	P	Other mammalian PROTEIN2 such as PROTEIN and PROTEIN1 but also PROTEIN from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN ( PROTEIN ) phosphorylation.
BioInfer.d469.s0.p4	N	Other mammalian PROTEIN such as PROTEIN2 and PROTEIN1 but also PROTEIN from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN ( PROTEIN ) phosphorylation.
BioInfer.d469.s0.p5	P	Other mammalian PROTEIN such as PROTEIN and PROTEIN but also PROTEIN1 from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN2 ( PROTEIN ) phosphorylation.
BioInfer.d469.s0.p6	P	Other mammalian PROTEIN such as PROTEIN and PROTEIN but also PROTEIN1 from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN ( PROTEIN2 ) phosphorylation.
BioInfer.d469.s0.p7	P	Other mammalian PROTEIN2 such as PROTEIN and PROTEIN but also PROTEIN1 from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN ( PROTEIN ) phosphorylation.
BioInfer.d469.s0.p8	N	Other mammalian PROTEIN such as PROTEIN2 and PROTEIN but also PROTEIN1 from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN ( PROTEIN ) phosphorylation.
BioInfer.d469.s0.p9	N	Other mammalian PROTEIN such as PROTEIN and PROTEIN but also PROTEIN from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN1 ( PROTEIN2 ) phosphorylation.
BioInfer.d469.s0.p10	N	Other mammalian PROTEIN2 such as PROTEIN and PROTEIN but also PROTEIN from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN1 ( PROTEIN ) phosphorylation.
BioInfer.d469.s0.p11	P	Other mammalian PROTEIN such as PROTEIN2 and PROTEIN but also PROTEIN from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN1 ( PROTEIN ) phosphorylation.
BioInfer.d469.s0.p12	N	Other mammalian PROTEIN2 such as PROTEIN and PROTEIN but also PROTEIN from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN ( PROTEIN1 ) phosphorylation.
BioInfer.d469.s0.p13	P	Other mammalian PROTEIN such as PROTEIN2 and PROTEIN but also PROTEIN from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN ( PROTEIN1 ) phosphorylation.
BioInfer.d469.s0.p14	P	Other mammalian PROTEIN1 such as PROTEIN2 and PROTEIN but also PROTEIN from Physarum polycephalum are similar targets for PIP2-stimulated PROTEIN ( PROTEIN ) phosphorylation.
BioInfer.d470.s0.p0	N	PROTEIN1 -mediated cell injury exhibited proteolysis of the PROTEIN2 protein substrate PROTEIN without appreciable breakdown of PROTEIN .
BioInfer.d470.s0.p1	N	PROTEIN1 -mediated cell injury exhibited proteolysis of the PROTEIN protein substrate PROTEIN without appreciable breakdown of PROTEIN2 .
BioInfer.d470.s0.p2	N	PROTEIN1 -mediated cell injury exhibited proteolysis of the PROTEIN protein substrate PROTEIN2 without appreciable breakdown of PROTEIN .
BioInfer.d470.s0.p3	N	PROTEIN -mediated cell injury exhibited proteolysis of the PROTEIN1 protein substrate PROTEIN without appreciable breakdown of PROTEIN2 .
BioInfer.d470.s0.p4	N	PROTEIN -mediated cell injury exhibited proteolysis of the PROTEIN1 protein substrate PROTEIN2 without appreciable breakdown of PROTEIN .
BioInfer.d470.s0.p5	N	PROTEIN -mediated cell injury exhibited proteolysis of the PROTEIN protein substrate PROTEIN2 without appreciable breakdown of PROTEIN1 .
BioInfer.d471.s0.p0	P	Other than monomeric PROTEIN1 , no major PROTEIN2 ligands are detected in crude extracts.
BioInfer.d471.s1.p0	P	Our results show that the major pool of polymerizable PROTEIN2 monomers is complexed with PROTEIN1 and spread throughout the cytoplasm.
BioInfer.d471.s2.p0	P	Selective monoclonal antibodies confirm that most of the PROTEIN1 is bound to PROTEIN2 : 65% in extract immunoadsorption assays and 74-89% by fluorescent antibody staining.
BioInfer.d471.s3.p0	P	We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much PROTEIN2 is bound to its known ligands: PROTEIN , membrane PIP(2), PROTEIN1 /3 complex and polyproline sequences.
BioInfer.d471.s3.p1	N	We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much PROTEIN is bound to its known ligands: PROTEIN2 , membrane PIP(2), PROTEIN1 /3 complex and polyproline sequences.
BioInfer.d471.s3.p3	P	We used biochemical fractionation, immunoassays and microscopy of live and fixed Acanthamoeba to determine how much PROTEIN1 is bound to its known ligands: PROTEIN2 , membrane PIP(2), PROTEIN /3 complex and polyproline sequences.
BioInfer.d472.s0.p0	N	Our data indicate that even PROTEIN2 of highly distant evolutionary origin can functionally substitute for each other and support the hypothesis that in animal cells, PROTEIN1 are engaged in regulating either the stability or the kinetic properties of PROTEIN filaments.
BioInfer.d472.s0.p1	P	Our data indicate that even PROTEIN of highly distant evolutionary origin can functionally substitute for each other and support the hypothesis that in animal cells, PROTEIN1 are engaged in regulating either the stability or the kinetic properties of PROTEIN2 filaments.
BioInfer.d472.s0.p2	N	Our data indicate that even PROTEIN1 of highly distant evolutionary origin can functionally substitute for each other and support the hypothesis that in animal cells, PROTEIN are engaged in regulating either the stability or the kinetic properties of PROTEIN2 filaments.
BioInfer.d473.s0.p0	N	Our data, which suggest that pollen PROTEIN2 can regulate PROTEIN1 -based cytoskeletal protein assembly and PROTEIN or phosphatase activity, indicate a possible role for the involvement of PROTEIN in signaling pathways that may regulate pollen tube growth.
BioInfer.d473.s0.p1	N	Our data, which suggest that pollen PROTEIN can regulate PROTEIN1 -based cytoskeletal protein assembly and PROTEIN or phosphatase activity, indicate a possible role for the involvement of PROTEIN2 in signaling pathways that may regulate pollen tube growth.
BioInfer.d473.s0.p2	N	Our data, which suggest that pollen PROTEIN can regulate PROTEIN1 -based cytoskeletal protein assembly and PROTEIN2 or phosphatase activity, indicate a possible role for the involvement of PROTEIN in signaling pathways that may regulate pollen tube growth.
BioInfer.d473.s0.p4	N	Our data, which suggest that pollen PROTEIN1 can regulate PROTEIN -based cytoskeletal protein assembly and PROTEIN or phosphatase activity, indicate a possible role for the involvement of PROTEIN2 in signaling pathways that may regulate pollen tube growth.
BioInfer.d473.s0.p5	P	Our data, which suggest that pollen PROTEIN1 can regulate PROTEIN -based cytoskeletal protein assembly and PROTEIN2 or phosphatase activity, indicate a possible role for the involvement of PROTEIN in signaling pathways that may regulate pollen tube growth.
BioInfer.d473.s0.p7	N	Our data, which suggest that pollen PROTEIN can regulate PROTEIN -based cytoskeletal protein assembly and PROTEIN2 or phosphatase activity, indicate a possible role for the involvement of PROTEIN1 in signaling pathways that may regulate pollen tube growth.
BioInfer.d474.s0.p0	P	Our in vitro recombinant protein-protein interaction studies demonstrated that PROTEIN1 could directly interact with PROTEIN and PROTEIN2 but not with PROTEIN .
BioInfer.d474.s0.p1	P	Our in vitro recombinant protein-protein interaction studies demonstrated that PROTEIN1 could directly interact with PROTEIN2 and PROTEIN but not with PROTEIN .
BioInfer.d474.s0.p2	P	Our in vitro recombinant protein-protein interaction studies demonstrated that PROTEIN1 could directly interact with PROTEIN and PROTEIN but not with PROTEIN2 .
BioInfer.d474.s0.p3	N	Our in vitro recombinant protein-protein interaction studies demonstrated that PROTEIN could directly interact with PROTEIN2 and PROTEIN1 but not with PROTEIN .
BioInfer.d474.s0.p4	N	Our in vitro recombinant protein-protein interaction studies demonstrated that PROTEIN could directly interact with PROTEIN and PROTEIN1 but not with PROTEIN2 .
BioInfer.d474.s0.p5	N	Our in vitro recombinant protein-protein interaction studies demonstrated that PROTEIN could directly interact with PROTEIN1 and PROTEIN but not with PROTEIN2 .
BioInfer.d475.s0.p0	N	Our results showed that cell morphology, cell adhesion pattern, PROTEIN organization, and distribution of PROTEIN1 subunits, PROTEIN , PROTEIN2 , and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN .
BioInfer.d475.s0.p1	N	Our results showed that cell morphology, cell adhesion pattern, PROTEIN organization, and distribution of PROTEIN1 subunits, PROTEIN2 , PROTEIN , and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN .
BioInfer.d475.s0.p2	P	Our results showed that cell morphology, cell adhesion pattern, PROTEIN organization, and distribution of PROTEIN1 subunits, PROTEIN , PROTEIN , and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN2 .
BioInfer.d475.s0.p3	N	Our results showed that cell morphology, cell adhesion pattern, PROTEIN2 organization, and distribution of PROTEIN1 subunits, PROTEIN , PROTEIN , and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN .
BioInfer.d475.s0.p4	N	Our results showed that cell morphology, cell adhesion pattern, PROTEIN organization, and distribution of PROTEIN subunits, PROTEIN2 , PROTEIN1 , and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN .
BioInfer.d475.s0.p5	P	Our results showed that cell morphology, cell adhesion pattern, PROTEIN organization, and distribution of PROTEIN subunits, PROTEIN , PROTEIN1 , and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN2 .
BioInfer.d475.s0.p6	N	Our results showed that cell morphology, cell adhesion pattern, PROTEIN2 organization, and distribution of PROTEIN subunits, PROTEIN , PROTEIN1 , and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN .
BioInfer.d475.s0.p7	P	Our results showed that cell morphology, cell adhesion pattern, PROTEIN organization, and distribution of PROTEIN subunits, PROTEIN1 , PROTEIN , and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN2 .
BioInfer.d475.s0.p8	N	Our results showed that cell morphology, cell adhesion pattern, PROTEIN2 organization, and distribution of PROTEIN subunits, PROTEIN1 , PROTEIN , and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN .
BioInfer.d475.s0.p9	P	Our results showed that cell morphology, cell adhesion pattern, PROTEIN2 organization, and distribution of PROTEIN subunits, PROTEIN , PROTEIN , and phosphotyrosine-containing proteins are dependent on the supramolecular organization of the PROTEIN1 .
BioInfer.d476.s0.p0	P	Overexpression of a gene fragment encoding the PROTEIN binding domain of PROTEIN2 stimulates transcription from the PROTEIN1 gene promoter.
BioInfer.d476.s0.p1	N	Overexpression of a gene fragment encoding the PROTEIN2 binding domain of PROTEIN stimulates transcription from the PROTEIN1 gene promoter.
BioInfer.d476.s0.p2	P	Overexpression of a gene fragment encoding the PROTEIN2 binding domain of PROTEIN1 stimulates transcription from the PROTEIN gene promoter.
BioInfer.d477.s0.p0	P	Overexpression of PROTEIN2 stimulates bundling of PROTEIN1 filaments, membrane ruffling, and cell movement in Dictyostelium.
BioInfer.d478.s0.p0	P	Overexpression of PROTEIN and PROTEIN1 ( PROTEIN2 ): effect on cell cycle regulation in HeLa cells.
BioInfer.d478.s0.p1	N	Overexpression of PROTEIN2 and PROTEIN1 ( PROTEIN ): effect on cell cycle regulation in HeLa cells.
BioInfer.d478.s0.p2	N	Overexpression of PROTEIN2 and PROTEIN ( PROTEIN1 ): effect on cell cycle regulation in HeLa cells.
BioInfer.d479.s0.p0	P	PROTEIN1 ( PROTEIN / PROTEIN ), a PROTEIN , induces G1 arrest and can inhibit the activity of the PROTEIN ( PROTEIN2 ).
BioInfer.d479.s0.p1	N	PROTEIN1 ( PROTEIN / PROTEIN2 ), a PROTEIN , induces G1 arrest and can inhibit the activity of the PROTEIN ( PROTEIN ).
BioInfer.d479.s0.p2	N	PROTEIN1 ( PROTEIN2 / PROTEIN ), a PROTEIN , induces G1 arrest and can inhibit the activity of the PROTEIN ( PROTEIN ).
BioInfer.d479.s0.p3	P	PROTEIN1 ( PROTEIN / PROTEIN ), a PROTEIN , induces G1 arrest and can inhibit the activity of the PROTEIN2 ( PROTEIN ).
BioInfer.d479.s0.p4	P	PROTEIN1 ( PROTEIN / PROTEIN ), a PROTEIN2 , induces G1 arrest and can inhibit the activity of the PROTEIN ( PROTEIN ).
BioInfer.d479.s0.p5	P	PROTEIN ( PROTEIN / PROTEIN2 ), a PROTEIN , induces G1 arrest and can inhibit the activity of the PROTEIN ( PROTEIN1 ).
BioInfer.d479.s0.p6	P	PROTEIN ( PROTEIN2 / PROTEIN ), a PROTEIN , induces G1 arrest and can inhibit the activity of the PROTEIN ( PROTEIN1 ).
BioInfer.d479.s0.p7	N	PROTEIN ( PROTEIN / PROTEIN ), a PROTEIN , induces G1 arrest and can inhibit the activity of the PROTEIN2 ( PROTEIN1 ).
BioInfer.d479.s0.p8	N	PROTEIN ( PROTEIN / PROTEIN ), a PROTEIN2 , induces G1 arrest and can inhibit the activity of the PROTEIN ( PROTEIN1 ).
BioInfer.d479.s0.p9	N	PROTEIN ( PROTEIN2 / PROTEIN1 ), a PROTEIN , induces G1 arrest and can inhibit the activity of the PROTEIN ( PROTEIN ).
BioInfer.d479.s0.p10	P	PROTEIN ( PROTEIN / PROTEIN1 ), a PROTEIN , induces G1 arrest and can inhibit the activity of the PROTEIN2 ( PROTEIN ).
BioInfer.d479.s0.p11	P	PROTEIN ( PROTEIN / PROTEIN1 ), a PROTEIN2 , induces G1 arrest and can inhibit the activity of the PROTEIN ( PROTEIN ).
BioInfer.d479.s0.p12	P	PROTEIN ( PROTEIN1 / PROTEIN ), a PROTEIN , induces G1 arrest and can inhibit the activity of the PROTEIN2 ( PROTEIN ).
BioInfer.d479.s0.p13	P	PROTEIN ( PROTEIN1 / PROTEIN ), a PROTEIN2 , induces G1 arrest and can inhibit the activity of the PROTEIN ( PROTEIN ).
BioInfer.d479.s0.p14	N	PROTEIN ( PROTEIN / PROTEIN ), a PROTEIN2 , induces G1 arrest and can inhibit the activity of the PROTEIN1 ( PROTEIN ).
BioInfer.d480.s0.p0	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN1 and PROTEIN of CDV were employed.
BioInfer.d480.s0.p1	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN1 and PROTEIN of CDV were employed.
BioInfer.d480.s0.p2	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN1 and PROTEIN of CDV were employed.
BioInfer.d480.s0.p3	N	Panels of six to 31 MAbs against the PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN1 and PROTEIN of CDV were employed.
BioInfer.d480.s0.p4	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN1 and PROTEIN of CDV were employed.
BioInfer.d480.s0.p5	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN2 , PROTEIN , PROTEIN1 and PROTEIN of CDV were employed.
BioInfer.d480.s0.p6	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 of CDV were employed.
BioInfer.d480.s0.p7	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN1 and PROTEIN of CDV were employed.
BioInfer.d480.s0.p8	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN of CDV were employed.
BioInfer.d480.s0.p9	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN1 and PROTEIN of CDV were employed.
BioInfer.d480.s0.p10	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN1 and PROTEIN of CDV were employed.
BioInfer.d480.s0.p11	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN1 and PROTEIN of CDV were employed.
BioInfer.d480.s0.p12	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN1 and PROTEIN of CDV were employed.
BioInfer.d480.s0.p13	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p14	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p15	N	Panels of six to 31 MAbs against the PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p16	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p17	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN2 , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p18	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN2 of CDV were employed.
BioInfer.d480.s0.p19	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p20	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN2 , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p21	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p22	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p23	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p24	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p25	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p26	N	Panels of six to 31 MAbs against the PROTEIN2 ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p27	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p28	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN2 , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p29	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN2 of CDV were employed.
BioInfer.d480.s0.p30	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p31	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN2 , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p32	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN2 ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p33	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p34	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p35	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p36	N	Panels of six to 31 MAbs against the PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p37	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p38	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) proteins of MV and the PROTEIN2 , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p39	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN2 of CDV were employed.
BioInfer.d480.s0.p40	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) and PROTEIN1 ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p41	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN2 , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p42	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p43	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN1 ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p44	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p45	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN2 ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p46	N	Panels of six to 31 MAbs against the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p47	N	Panels of six to 31 MAbs against the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN2 , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p48	N	Panels of six to 31 MAbs against the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN2 of CDV were employed.
BioInfer.d480.s0.p49	N	Panels of six to 31 MAbs against the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p50	N	Panels of six to 31 MAbs against the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN2 , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p51	N	Panels of six to 31 MAbs against the PROTEIN1 ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p52	N	Panels of six to 31 MAbs against the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p53	N	Panels of six to 31 MAbs against the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p54	N	Panels of six to 31 MAbs against the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p55	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN2 , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p56	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN2 of CDV were employed.
BioInfer.d480.s0.p57	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p58	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN2 , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p59	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p60	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p61	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p62	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p63	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 of CDV were employed.
BioInfer.d480.s0.p64	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN1 , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p65	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p66	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN1 , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p67	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN1 , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p68	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN1 , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p69	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) proteins of MV and the PROTEIN1 , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p70	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN1 of CDV were employed.
BioInfer.d480.s0.p71	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN2 , PROTEIN and PROTEIN1 of CDV were employed.
BioInfer.d480.s0.p72	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN1 of CDV were employed.
BioInfer.d480.s0.p73	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN1 of CDV were employed.
BioInfer.d480.s0.p74	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN1 of CDV were employed.
BioInfer.d480.s0.p75	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN1 of CDV were employed.
BioInfer.d480.s0.p76	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN2 , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p77	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p78	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN2 ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p79	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p80	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN2 ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p81	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN1 , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p82	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN1 , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p83	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN1 , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p84	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) proteins of MV and the PROTEIN , PROTEIN1 , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p85	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p86	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p87	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p88	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p89	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN2 ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d480.s0.p90	N	Panels of six to 31 MAbs against the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) proteins of MV and the PROTEIN , PROTEIN , PROTEIN and PROTEIN of CDV were employed.
BioInfer.d481.s0.p0	N	Particle aggregates associated with this array of PROTEIN1 microfilaments also labeled with antibodies to PROTEIN , PROTEIN2 and PROTEIN .
BioInfer.d481.s0.p1	N	Particle aggregates associated with this array of PROTEIN1 microfilaments also labeled with antibodies to PROTEIN2 , PROTEIN and PROTEIN .
BioInfer.d481.s0.p2	N	Particle aggregates associated with this array of PROTEIN1 microfilaments also labeled with antibodies to PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d481.s0.p3	N	Particle aggregates associated with this array of PROTEIN microfilaments also labeled with antibodies to PROTEIN2 , PROTEIN1 and PROTEIN .
BioInfer.d481.s0.p4	N	Particle aggregates associated with this array of PROTEIN microfilaments also labeled with antibodies to PROTEIN , PROTEIN1 and PROTEIN2 .
BioInfer.d481.s0.p5	N	Particle aggregates associated with this array of PROTEIN microfilaments also labeled with antibodies to PROTEIN1 , PROTEIN and PROTEIN2 .
BioInfer.d482.s0.p0	N	PROTEIN expression is a better indicator of clinical outcome than alterations in the expression of PROTEIN2 , PROTEIN , PROTEIN1 , or PROTEIN .
BioInfer.d482.s0.p1	N	PROTEIN expression is a better indicator of clinical outcome than alterations in the expression of PROTEIN , PROTEIN , PROTEIN1 , or PROTEIN2 .
BioInfer.d482.s0.p2	N	PROTEIN2 expression is a better indicator of clinical outcome than alterations in the expression of PROTEIN , PROTEIN , PROTEIN1 , or PROTEIN .
BioInfer.d482.s0.p3	N	PROTEIN expression is a better indicator of clinical outcome than alterations in the expression of PROTEIN , PROTEIN2 , PROTEIN1 , or PROTEIN .
BioInfer.d482.s0.p4	N	PROTEIN expression is a better indicator of clinical outcome than alterations in the expression of PROTEIN1 , PROTEIN , PROTEIN , or PROTEIN2 .
BioInfer.d482.s0.p5	N	PROTEIN2 expression is a better indicator of clinical outcome than alterations in the expression of PROTEIN1 , PROTEIN , PROTEIN , or PROTEIN .
BioInfer.d482.s0.p6	N	PROTEIN expression is a better indicator of clinical outcome than alterations in the expression of PROTEIN1 , PROTEIN2 , PROTEIN , or PROTEIN .
BioInfer.d482.s0.p7	N	PROTEIN2 expression is a better indicator of clinical outcome than alterations in the expression of PROTEIN , PROTEIN , PROTEIN , or PROTEIN1 .
BioInfer.d482.s0.p8	N	PROTEIN expression is a better indicator of clinical outcome than alterations in the expression of PROTEIN , PROTEIN2 , PROTEIN , or PROTEIN1 .
BioInfer.d482.s0.p9	N	PROTEIN1 expression is a better indicator of clinical outcome than alterations in the expression of PROTEIN , PROTEIN2 , PROTEIN , or PROTEIN .
BioInfer.d483.s0.p0	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN1 , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN2 or PROTEIN distribution.
BioInfer.d483.s0.p1	N	PROTEIN treatment had no effect on PROTEIN2 , PROTEIN1 , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p2	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN1 , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN2 distribution.
BioInfer.d483.s0.p3	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN1 , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN2 also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p4	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN1 , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN2 , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p5	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN1 , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN2 ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p6	N	PROTEIN2 treatment had no effect on PROTEIN , PROTEIN1 , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p7	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN1 , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN2 ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p8	N	PROTEIN treatment had no effect on PROTEIN2 , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN1 or PROTEIN distribution.
BioInfer.d483.s0.p9	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN1 or PROTEIN2 distribution.
BioInfer.d483.s0.p10	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN2 also had no effect on PROTEIN1 or PROTEIN distribution.
BioInfer.d483.s0.p11	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN2 , or 10 microM PROTEIN also had no effect on PROTEIN1 or PROTEIN distribution.
BioInfer.d483.s0.p12	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN2 ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN1 or PROTEIN distribution.
BioInfer.d483.s0.p13	N	PROTEIN2 treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN1 or PROTEIN distribution.
BioInfer.d483.s0.p14	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN2 ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN1 or PROTEIN distribution.
BioInfer.d483.s0.p15	N	PROTEIN treatment had no effect on PROTEIN1 , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN2 distribution.
BioInfer.d483.s0.p16	N	PROTEIN treatment had no effect on PROTEIN1 , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN2 also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p17	N	PROTEIN treatment had no effect on PROTEIN1 , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN2 , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p18	N	PROTEIN treatment had no effect on PROTEIN1 , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN2 ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p19	N	PROTEIN2 treatment had no effect on PROTEIN1 , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p20	N	PROTEIN treatment had no effect on PROTEIN1 , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN2 ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p21	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN2 also had no effect on PROTEIN or PROTEIN1 distribution.
BioInfer.d483.s0.p22	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN2 , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN1 distribution.
BioInfer.d483.s0.p23	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN2 ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN1 distribution.
BioInfer.d483.s0.p24	N	PROTEIN2 treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN1 distribution.
BioInfer.d483.s0.p25	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN2 ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN1 distribution.
BioInfer.d483.s0.p26	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN2 , or 10 microM PROTEIN1 also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p27	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN2 ), 30 ng/ml PROTEIN , or 10 microM PROTEIN1 also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p28	N	PROTEIN2 treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN1 also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p29	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN2 ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN1 also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p30	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN2 ), 30 ng/ml PROTEIN1 , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p31	N	PROTEIN2 treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN ), 30 ng/ml PROTEIN1 , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p32	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN2 ( PROTEIN ), 30 ng/ml PROTEIN1 , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p33	N	PROTEIN2 treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN ( PROTEIN1 ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p34	N	PROTEIN treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN2 ( PROTEIN1 ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d483.s0.p35	N	PROTEIN1 treatment had no effect on PROTEIN , PROTEIN , or microtubule distribution in BALB/c-3T3 cells; in addition, exposure of cells to 5% platelet-poor plasma (PPP), 0.1% PPP, 30 ng/ml PROTEIN2 ( PROTEIN ), 30 ng/ml PROTEIN , or 10 microM PROTEIN also had no effect on PROTEIN or PROTEIN distribution.
BioInfer.d484.s0.p0	N	Pervanadate caused a dramatic augmentation of the phosphorylation of PROTEIN2 , PROTEIN , and PROTEIN1 ( PROTEIN ), but PROTEIN was not detectably phosphorylated.
BioInfer.d484.s0.p1	N	Pervanadate caused a dramatic augmentation of the phosphorylation of PROTEIN , PROTEIN , and PROTEIN1 ( PROTEIN2 ), but PROTEIN was not detectably phosphorylated.
BioInfer.d484.s0.p2	N	Pervanadate caused a dramatic augmentation of the phosphorylation of PROTEIN , PROTEIN2 , and PROTEIN1 ( PROTEIN ), but PROTEIN was not detectably phosphorylated.
BioInfer.d484.s0.p3	N	Pervanadate caused a dramatic augmentation of the phosphorylation of PROTEIN , PROTEIN , and PROTEIN1 ( PROTEIN ), but PROTEIN2 was not detectably phosphorylated.
BioInfer.d484.s0.p4	N	Pervanadate caused a dramatic augmentation of the phosphorylation of PROTEIN1 , PROTEIN , and PROTEIN ( PROTEIN2 ), but PROTEIN was not detectably phosphorylated.
BioInfer.d484.s0.p5	N	Pervanadate caused a dramatic augmentation of the phosphorylation of PROTEIN1 , PROTEIN2 , and PROTEIN ( PROTEIN ), but PROTEIN was not detectably phosphorylated.
BioInfer.d484.s0.p6	N	Pervanadate caused a dramatic augmentation of the phosphorylation of PROTEIN1 , PROTEIN , and PROTEIN ( PROTEIN ), but PROTEIN2 was not detectably phosphorylated.
BioInfer.d484.s0.p7	N	Pervanadate caused a dramatic augmentation of the phosphorylation of PROTEIN , PROTEIN2 , and PROTEIN ( PROTEIN1 ), but PROTEIN was not detectably phosphorylated.
BioInfer.d484.s0.p8	N	Pervanadate caused a dramatic augmentation of the phosphorylation of PROTEIN , PROTEIN , and PROTEIN ( PROTEIN1 ), but PROTEIN2 was not detectably phosphorylated.
BioInfer.d484.s0.p9	N	Pervanadate caused a dramatic augmentation of the phosphorylation of PROTEIN , PROTEIN1 , and PROTEIN ( PROTEIN ), but PROTEIN2 was not detectably phosphorylated.
BioInfer.d485.s0.p0	P	PROTEIN -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN1 , PROTEIN ( PROTEIN2 / PROTEIN ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p1	N	PROTEIN -dependent downregulation of PROTEIN - PROTEIN2 activity was associated with increased binding of the PROTEIN1 , PROTEIN ( PROTEIN / PROTEIN ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p2	N	PROTEIN -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN1 , PROTEIN ( PROTEIN / PROTEIN ), to the PROTEIN2 - PROTEIN complex.
BioInfer.d485.s0.p3	P	PROTEIN -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN1 , PROTEIN ( PROTEIN / PROTEIN2 ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p4	N	PROTEIN -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN1 , PROTEIN ( PROTEIN / PROTEIN ), to the PROTEIN - PROTEIN2 complex.
BioInfer.d485.s0.p5	N	PROTEIN2 -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN1 , PROTEIN ( PROTEIN / PROTEIN ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p6	N	PROTEIN -dependent downregulation of PROTEIN2 - PROTEIN activity was associated with increased binding of the PROTEIN1 , PROTEIN ( PROTEIN / PROTEIN ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p7	P	PROTEIN -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN1 , PROTEIN2 ( PROTEIN / PROTEIN ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p8	P	PROTEIN -dependent downregulation of PROTEIN - PROTEIN2 activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN1 / PROTEIN ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p9	P	PROTEIN -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN1 / PROTEIN ), to the PROTEIN2 - PROTEIN complex.
BioInfer.d485.s0.p10	N	PROTEIN -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN1 / PROTEIN2 ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p11	P	PROTEIN -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN1 / PROTEIN ), to the PROTEIN - PROTEIN2 complex.
BioInfer.d485.s0.p12	N	PROTEIN2 -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN1 / PROTEIN ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p13	P	PROTEIN -dependent downregulation of PROTEIN2 - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN1 / PROTEIN ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p14	N	PROTEIN -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN2 ( PROTEIN1 / PROTEIN ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p15	P	PROTEIN -dependent downregulation of PROTEIN - PROTEIN1 activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN / PROTEIN ), to the PROTEIN2 - PROTEIN complex.
BioInfer.d485.s0.p16	P	PROTEIN -dependent downregulation of PROTEIN - PROTEIN1 activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN / PROTEIN2 ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p17	P	PROTEIN -dependent downregulation of PROTEIN - PROTEIN1 activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN / PROTEIN ), to the PROTEIN - PROTEIN2 complex.
BioInfer.d485.s0.p18	P	PROTEIN2 -dependent downregulation of PROTEIN - PROTEIN1 activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN / PROTEIN ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p19	P	PROTEIN -dependent downregulation of PROTEIN2 - PROTEIN1 activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN / PROTEIN ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p20	P	PROTEIN -dependent downregulation of PROTEIN - PROTEIN1 activity was associated with increased binding of the PROTEIN , PROTEIN2 ( PROTEIN / PROTEIN ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p21	P	PROTEIN -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN / PROTEIN2 ), to the PROTEIN1 - PROTEIN complex.
BioInfer.d485.s0.p22	P	PROTEIN -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN / PROTEIN ), to the PROTEIN1 - PROTEIN2 complex.
BioInfer.d485.s0.p23	N	PROTEIN2 -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN / PROTEIN ), to the PROTEIN1 - PROTEIN complex.
BioInfer.d485.s0.p24	P	PROTEIN -dependent downregulation of PROTEIN2 - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN / PROTEIN ), to the PROTEIN1 - PROTEIN complex.
BioInfer.d485.s0.p25	P	PROTEIN -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN2 ( PROTEIN / PROTEIN ), to the PROTEIN1 - PROTEIN complex.
BioInfer.d485.s0.p26	P	PROTEIN -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN / PROTEIN1 ), to the PROTEIN - PROTEIN2 complex.
BioInfer.d485.s0.p27	N	PROTEIN2 -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN / PROTEIN1 ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p28	P	PROTEIN -dependent downregulation of PROTEIN2 - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN / PROTEIN1 ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p29	N	PROTEIN -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN2 ( PROTEIN / PROTEIN1 ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p30	N	PROTEIN2 -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN / PROTEIN ), to the PROTEIN - PROTEIN1 complex.
BioInfer.d485.s0.p31	P	PROTEIN -dependent downregulation of PROTEIN2 - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN / PROTEIN ), to the PROTEIN - PROTEIN1 complex.
BioInfer.d485.s0.p32	P	PROTEIN -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN2 ( PROTEIN / PROTEIN ), to the PROTEIN - PROTEIN1 complex.
BioInfer.d485.s0.p33	P	PROTEIN1 -dependent downregulation of PROTEIN2 - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN ( PROTEIN / PROTEIN ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p34	N	PROTEIN1 -dependent downregulation of PROTEIN - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN2 ( PROTEIN / PROTEIN ), to the PROTEIN - PROTEIN complex.
BioInfer.d485.s0.p35	P	PROTEIN -dependent downregulation of PROTEIN1 - PROTEIN activity was associated with increased binding of the PROTEIN , PROTEIN2 ( PROTEIN / PROTEIN ), to the PROTEIN - PROTEIN complex.
BioInfer.d486.s0.p0	N	Phosphoinositides bind to PROTEIN2 and regulate PROTEIN1 -based cytoskeletal protein assembly.
BioInfer.d486.s1.p0	P	Phosphorylation of PROTEIN2 by PROTEIN was not affected by the presence of various concentrations of PROTEIN1 .
BioInfer.d486.s1.p1	P	Phosphorylation of PROTEIN by PROTEIN2 was not affected by the presence of various concentrations of PROTEIN1 .
BioInfer.d486.s1.p2	P	Phosphorylation of PROTEIN1 by PROTEIN2 was not affected by the presence of various concentrations of PROTEIN .
BioInfer.d487.s0.p0	P	Phosphorylation of the headpiece domain could regulate the PROTEIN1 binding and bundling properties of PROTEIN2 , or it could regulate the interaction of PROTEIN with other proteins.
BioInfer.d487.s0.p1	N	Phosphorylation of the headpiece domain could regulate the PROTEIN1 binding and bundling properties of PROTEIN , or it could regulate the interaction of PROTEIN2 with other proteins.
BioInfer.d487.s0.p2	P	Phosphorylation of the headpiece domain could regulate the PROTEIN binding and bundling properties of PROTEIN1 , or it could regulate the interaction of PROTEIN2 with other proteins.
BioInfer.d488.s0.p0	P	Photochemical cleavage of PROTEIN2 and the effect on the interaction with PROTEIN1 .
BioInfer.d489.s0.p0	N	PROTEIN is one of a complex of genes encoding DNA repair proteins that includes PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN .
BioInfer.d489.s0.p1	N	PROTEIN is one of a complex of genes encoding DNA repair proteins that includes PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN .
BioInfer.d489.s0.p2	N	PROTEIN2 is one of a complex of genes encoding DNA repair proteins that includes PROTEIN1 , PROTEIN , PROTEIN and PROTEIN .
BioInfer.d489.s0.p3	N	PROTEIN is one of a complex of genes encoding DNA repair proteins that includes PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d489.s0.p4	N	PROTEIN is one of a complex of genes encoding DNA repair proteins that includes PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN .
BioInfer.d489.s0.p5	N	PROTEIN2 is one of a complex of genes encoding DNA repair proteins that includes PROTEIN , PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d489.s0.p6	N	PROTEIN is one of a complex of genes encoding DNA repair proteins that includes PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 .
BioInfer.d489.s0.p7	N	PROTEIN2 is one of a complex of genes encoding DNA repair proteins that includes PROTEIN , PROTEIN1 , PROTEIN and PROTEIN .
BioInfer.d489.s0.p8	N	PROTEIN is one of a complex of genes encoding DNA repair proteins that includes PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 .
BioInfer.d489.s0.p9	N	PROTEIN1 is one of a complex of genes encoding DNA repair proteins that includes PROTEIN , PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d490.s0.p0	N	Polyacrylamide gels of platelets heated at 45 degrees C for 90 minutes showed an increase in PROTEIN2 incorporation into heated platelet cytoskeletons but no increase in filamentous PROTEIN1 .
BioInfer.d491.s0.p0	N	Porcine arterial SMCs in culture not only express high levels of PROTEIN (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of PROTEIN isoforms 1 and 2, PROTEIN1 , and PROTEIN2 , a recently described late differentiation marker of vascular SMCs.
BioInfer.d491.s0.p1	N	Porcine arterial SMCs in culture not only express high levels of PROTEIN (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of PROTEIN2 isoforms 1 and 2, PROTEIN1 , and PROTEIN , a recently described late differentiation marker of vascular SMCs.
BioInfer.d491.s0.p3	N	Porcine arterial SMCs in culture not only express high levels of PROTEIN2 (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of PROTEIN isoforms 1 and 2, PROTEIN1 , and PROTEIN , a recently described late differentiation marker of vascular SMCs.
BioInfer.d491.s0.p4	N	Porcine arterial SMCs in culture not only express high levels of PROTEIN (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of PROTEIN2 isoforms 1 and 2, PROTEIN , and PROTEIN1 , a recently described late differentiation marker of vascular SMCs.
BioInfer.d491.s0.p6	N	Porcine arterial SMCs in culture not only express high levels of PROTEIN2 (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of PROTEIN isoforms 1 and 2, PROTEIN , and PROTEIN1 , a recently described late differentiation marker of vascular SMCs.
BioInfer.d491.s0.p8	N	Porcine arterial SMCs in culture not only express high levels of PROTEIN2 (SM) actin but, contrary to rodent SMCs, also maintain an appreciable expression of PROTEIN1 isoforms 1 and 2, PROTEIN , and PROTEIN , a recently described late differentiation marker of vascular SMCs.
BioInfer.d492.s0.p0	N	Previously, we have shown that in the absence of PROTEIN1 , repair is nearly absent and diploid cells lose the broken chromosome; however, in cells lacking PROTEIN2 , gene conversion is absent but cells can repair the DSB by BIR.
BioInfer.d493.s0.p0	P	Previous studies have yielded conflicting results concerning the physiological role of PROTEIN1 , a 12-15-kD PROTEIN2 - and phosphoinositide-binding protein, as a regulator of PROTEIN polymerization.
BioInfer.d493.s0.p1	P	Previous studies have yielded conflicting results concerning the physiological role of PROTEIN1 , a 12-15-kD PROTEIN - and phosphoinositide-binding protein, as a regulator of PROTEIN2 polymerization.
BioInfer.d493.s0.p2	N	Previous studies have yielded conflicting results concerning the physiological role of PROTEIN , a 12-15-kD PROTEIN1 - and phosphoinositide-binding protein, as a regulator of PROTEIN2 polymerization.
BioInfer.d494.s0.p0	P	Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of PROTEIN2 and PROTEIN with PROTEIN1 .
BioInfer.d494.s0.p1	P	Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of PROTEIN and PROTEIN2 with PROTEIN1 .
BioInfer.d494.s0.p2	N	Production of PIP and PIP2 may be important downstream signals since these polyphosphoinositides are able to regulate the interaction of PROTEIN1 and PROTEIN2 with PROTEIN .
BioInfer.d495.s0.p0	P	PROTEIN and PROTEIN2 have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric PROTEIN1 to the same extent.
BioInfer.d495.s0.p1	P	PROTEIN2 and PROTEIN have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric PROTEIN1 to the same extent.
BioInfer.d495.s0.p2	P	PROTEIN2 and PROTEIN1 have similar affinities for PtdIns(4,5)P2 and poly(L-proline), and both accelerate nucleotide exchange on monomeric PROTEIN to the same extent.
BioInfer.d496.s0.p0	N	PROTEIN2 binds PROTEIN with a similar affinity to that of PROTEIN1 , although it inhibits PROTEIN polymerization more strongly than PROTEIN under non-equilibrium conditions.
BioInfer.d496.s0.p1	N	PROTEIN binds PROTEIN with a similar affinity to that of PROTEIN1 , although it inhibits PROTEIN polymerization more strongly than PROTEIN2 under non-equilibrium conditions.
BioInfer.d496.s0.p2	P	PROTEIN binds PROTEIN2 with a similar affinity to that of PROTEIN1 , although it inhibits PROTEIN polymerization more strongly than PROTEIN under non-equilibrium conditions.
BioInfer.d496.s0.p3	N	PROTEIN binds PROTEIN with a similar affinity to that of PROTEIN1 , although it inhibits PROTEIN2 polymerization more strongly than PROTEIN under non-equilibrium conditions.
BioInfer.d496.s0.p4	N	PROTEIN1 binds PROTEIN with a similar affinity to that of PROTEIN , although it inhibits PROTEIN polymerization more strongly than PROTEIN2 under non-equilibrium conditions.
BioInfer.d496.s0.p5	P	PROTEIN1 binds PROTEIN2 with a similar affinity to that of PROTEIN , although it inhibits PROTEIN polymerization more strongly than PROTEIN under non-equilibrium conditions.
BioInfer.d496.s0.p6	P	PROTEIN1 binds PROTEIN with a similar affinity to that of PROTEIN , although it inhibits PROTEIN2 polymerization more strongly than PROTEIN under non-equilibrium conditions.
BioInfer.d496.s0.p7	N	PROTEIN binds PROTEIN2 with a similar affinity to that of PROTEIN , although it inhibits PROTEIN polymerization more strongly than PROTEIN1 under non-equilibrium conditions.
BioInfer.d496.s0.p8	P	PROTEIN binds PROTEIN with a similar affinity to that of PROTEIN , although it inhibits PROTEIN2 polymerization more strongly than PROTEIN1 under non-equilibrium conditions.
BioInfer.d496.s0.p9	N	PROTEIN binds PROTEIN1 with a similar affinity to that of PROTEIN , although it inhibits PROTEIN2 polymerization more strongly than PROTEIN under non-equilibrium conditions.
BioInfer.d496.s1.p0	P	Since functional characteristics for PROTEIN1 are lacking, we assayed the PROTEIN2 , the phosphatidylinositol 4,5-bisphosphate and the poly(L-proline) binding properties of this isoform.
BioInfer.d497.s0.p0	N	PROTEIN2 is generally thought to regulate PROTEIN polymerization, but the observation that acidic phospholipids dissociate the complex of PROTEIN and PROTEIN1 raised the possibility that PROTEIN might also regulate lipid metabolism.
BioInfer.d497.s0.p1	P	PROTEIN is generally thought to regulate PROTEIN polymerization, but the observation that acidic phospholipids dissociate the complex of PROTEIN2 and PROTEIN1 raised the possibility that PROTEIN might also regulate lipid metabolism.
BioInfer.d497.s0.p2	N	PROTEIN is generally thought to regulate PROTEIN2 polymerization, but the observation that acidic phospholipids dissociate the complex of PROTEIN and PROTEIN1 raised the possibility that PROTEIN might also regulate lipid metabolism.
BioInfer.d497.s0.p3	N	PROTEIN is generally thought to regulate PROTEIN polymerization, but the observation that acidic phospholipids dissociate the complex of PROTEIN and PROTEIN1 raised the possibility that PROTEIN2 might also regulate lipid metabolism.
BioInfer.d497.s0.p4	N	PROTEIN1 is generally thought to regulate PROTEIN polymerization, but the observation that acidic phospholipids dissociate the complex of PROTEIN2 and PROTEIN raised the possibility that PROTEIN might also regulate lipid metabolism.
BioInfer.d497.s0.p5	P	PROTEIN1 is generally thought to regulate PROTEIN2 polymerization, but the observation that acidic phospholipids dissociate the complex of PROTEIN and PROTEIN raised the possibility that PROTEIN might also regulate lipid metabolism.
BioInfer.d497.s0.p6	N	PROTEIN1 is generally thought to regulate PROTEIN polymerization, but the observation that acidic phospholipids dissociate the complex of PROTEIN and PROTEIN raised the possibility that PROTEIN2 might also regulate lipid metabolism.
BioInfer.d497.s0.p7	N	PROTEIN is generally thought to regulate PROTEIN2 polymerization, but the observation that acidic phospholipids dissociate the complex of PROTEIN1 and PROTEIN raised the possibility that PROTEIN might also regulate lipid metabolism.
BioInfer.d497.s0.p8	N	PROTEIN is generally thought to regulate PROTEIN polymerization, but the observation that acidic phospholipids dissociate the complex of PROTEIN1 and PROTEIN raised the possibility that PROTEIN2 might also regulate lipid metabolism.
BioInfer.d497.s0.p9	N	PROTEIN is generally thought to regulate PROTEIN1 polymerization, but the observation that acidic phospholipids dissociate the complex of PROTEIN and PROTEIN raised the possibility that PROTEIN2 might also regulate lipid metabolism.
BioInfer.d497.s1.p0	P	The PROTEIN1  PROTEIN2 binds to PIP2 and inhibits its hydrolysis by PROTEIN .
BioInfer.d497.s1.p1	N	The PROTEIN1  PROTEIN binds to PIP2 and inhibits its hydrolysis by PROTEIN2 .
BioInfer.d497.s1.p2	N	The PROTEIN  PROTEIN1 binds to PIP2 and inhibits its hydrolysis by PROTEIN2 .
BioInfer.d497.s2.p0	P	The cellular concentrations and binding characteristics of these molecules are consistent with PROTEIN2 being a negative regulator of the phosphoinositide signaling pathway in addition to its established function as an inhibitor of PROTEIN1 polymerization.
BioInfer.d498.s0.p0	P	PROTEIN also bind polyphosphoinositides, which can disrupt the PROTEIN2 - PROTEIN1 complex, and proline-rich ligands which localize PROTEIN to sites requiring extensive PROTEIN filament accumulation.
BioInfer.d498.s0.p1	N	PROTEIN also bind polyphosphoinositides, which can disrupt the PROTEIN - PROTEIN1 complex, and proline-rich ligands which localize PROTEIN to sites requiring extensive PROTEIN2 filament accumulation.
BioInfer.d498.s0.p2	P	PROTEIN2 also bind polyphosphoinositides, which can disrupt the PROTEIN - PROTEIN1 complex, and proline-rich ligands which localize PROTEIN to sites requiring extensive PROTEIN filament accumulation.
BioInfer.d498.s0.p3	N	PROTEIN also bind polyphosphoinositides, which can disrupt the PROTEIN - PROTEIN1 complex, and proline-rich ligands which localize PROTEIN2 to sites requiring extensive PROTEIN filament accumulation.
BioInfer.d498.s0.p4	N	PROTEIN also bind polyphosphoinositides, which can disrupt the PROTEIN1 - PROTEIN complex, and proline-rich ligands which localize PROTEIN to sites requiring extensive PROTEIN2 filament accumulation.
BioInfer.d498.s0.p5	P	PROTEIN2 also bind polyphosphoinositides, which can disrupt the PROTEIN1 - PROTEIN complex, and proline-rich ligands which localize PROTEIN to sites requiring extensive PROTEIN filament accumulation.
BioInfer.d498.s0.p6	N	PROTEIN also bind polyphosphoinositides, which can disrupt the PROTEIN1 - PROTEIN complex, and proline-rich ligands which localize PROTEIN2 to sites requiring extensive PROTEIN filament accumulation.
BioInfer.d498.s0.p7	N	PROTEIN2 also bind polyphosphoinositides, which can disrupt the PROTEIN - PROTEIN complex, and proline-rich ligands which localize PROTEIN to sites requiring extensive PROTEIN1 filament accumulation.
BioInfer.d498.s0.p8	N	PROTEIN also bind polyphosphoinositides, which can disrupt the PROTEIN - PROTEIN complex, and proline-rich ligands which localize PROTEIN2 to sites requiring extensive PROTEIN1 filament accumulation.
BioInfer.d498.s0.p9	N	PROTEIN1 also bind polyphosphoinositides, which can disrupt the PROTEIN - PROTEIN complex, and proline-rich ligands which localize PROTEIN2 to sites requiring extensive PROTEIN filament accumulation.
BioInfer.d499.s0.p0	P	Protein phosphorylation of PROTEIN1 , an PROTEIN2 that depolymerizes PROTEIN filaments, suppresses its function.
BioInfer.d499.s0.p1	P	Protein phosphorylation of PROTEIN1 , an PROTEIN that depolymerizes PROTEIN2 filaments, suppresses its function.
BioInfer.d499.s0.p2	N	Protein phosphorylation of PROTEIN , an PROTEIN1 that depolymerizes PROTEIN2 filaments, suppresses its function.
BioInfer.d500.s0.p0	N	Proteolytic activity was not detected with PROTEIN , PROTEIN1 , or PROTEIN2 substrates.
BioInfer.d500.s0.p1	N	Proteolytic activity was not detected with PROTEIN2 , PROTEIN1 , or PROTEIN substrates.
BioInfer.d500.s0.p2	N	Proteolytic activity was not detected with PROTEIN2 , PROTEIN , or PROTEIN1 substrates.
BioInfer.d501.s0.p0	P	PROTEIN1 fragments form complexes with PROTEIN , PROTEIN2 , and PROTEIN , all components of adherens junctions.
BioInfer.d501.s0.p1	P	PROTEIN1 fragments form complexes with PROTEIN2 , PROTEIN , and PROTEIN , all components of adherens junctions.
BioInfer.d501.s0.p2	P	PROTEIN1 fragments form complexes with PROTEIN , PROTEIN , and PROTEIN2 , all components of adherens junctions.
BioInfer.d501.s0.p3	P	PROTEIN fragments form complexes with PROTEIN2 , PROTEIN1 , and PROTEIN , all components of adherens junctions.
BioInfer.d501.s0.p4	P	PROTEIN fragments form complexes with PROTEIN , PROTEIN1 , and PROTEIN2 , all components of adherens junctions.
BioInfer.d501.s0.p5	P	PROTEIN fragments form complexes with PROTEIN1 , PROTEIN , and PROTEIN2 , all components of adherens junctions.
BioInfer.d502.s0.p0	N	PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN in order to follow the assembly of the contractile proteins into the cleavage furrows.
BioInfer.d502.s0.p1	N	PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 in order to follow the assembly of the contractile proteins into the cleavage furrows.
BioInfer.d502.s0.p2	N	PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN in order to follow the assembly of the contractile proteins into the cleavage furrows.
BioInfer.d502.s0.p3	N	PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 in order to follow the assembly of the contractile proteins into the cleavage furrows.
BioInfer.d502.s0.p4	N	PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN in order to follow the assembly of the contractile proteins into the cleavage furrows.
BioInfer.d502.s0.p5	N	PtK2 cells of exceptionally large size were microinjected with fluorescently labeled probes for PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 in order to follow the assembly of the contractile proteins into the cleavage furrows.
BioInfer.d502.s1.p0	P	The presence of PROTEIN in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a PROTEIN2 mediated mechanism for the attachment of PROTEIN1 filaments to the cell surfaces in the cleavage furrow.
BioInfer.d502.s1.p1	N	The presence of PROTEIN2 in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a PROTEIN mediated mechanism for the attachment of PROTEIN1 filaments to the cell surfaces in the cleavage furrow.
BioInfer.d502.s1.p2	N	The presence of PROTEIN2 in the cleavage furrows also suggests the possibility of an overlapping mechanism in addition to that of a PROTEIN1 mediated mechanism for the attachment of PROTEIN filaments to the cell surfaces in the cleavage furrow.
BioInfer.d503.s0.p0	N	Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, PROTEIN ( PROTEIN2 ), and PROTEIN1 , but not PROTEIN .
BioInfer.d503.s0.p1	N	Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, PROTEIN2 ( PROTEIN ), and PROTEIN1 , but not PROTEIN .
BioInfer.d503.s0.p2	N	Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, PROTEIN ( PROTEIN ), and PROTEIN1 , but not PROTEIN2 .
BioInfer.d503.s0.p3	N	Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, PROTEIN2 ( PROTEIN1 ), and PROTEIN , but not PROTEIN .
BioInfer.d503.s0.p4	N	Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, PROTEIN ( PROTEIN1 ), and PROTEIN , but not PROTEIN2 .
BioInfer.d503.s0.p5	N	Pulse-chase biosynthetic labeling experiments demonstrated that contractile arrest accelerated the loss of isotopic tracer from the total myofibrillar protein fraction, PROTEIN1 ( PROTEIN ), and PROTEIN , but not PROTEIN2 .
BioInfer.d504.s0.p0	N	Purification of a cortical complex containing two unconventional PROTEIN2 from Acanthamoeba by affinity chromatography on PROTEIN1 -agarose.
BioInfer.d505.s0.p0	P	Pyrenyliodoacetamide labeling of cysteine 374 of PROTEIN1 reduces the affinity for PROTEIN2 10-fold.
BioInfer.d505.s1.p0	P	Replacement of serine 38 with cysteine created a unique site where labeling with rhodamine did not alter the affinity of PROTEIN2 for PROTEIN1 .
BioInfer.d505.s2.p0	N	Three methods, fluorescence anisotropy of rhodamine-labeled PROTEIN2 , intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba PROTEIN binding amoeba PROTEIN1 monomers with bound Mg-ATP.
BioInfer.d505.s2.p1	P	Three methods, fluorescence anisotropy of rhodamine-labeled PROTEIN , intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba PROTEIN2 binding amoeba PROTEIN1 monomers with bound Mg-ATP.
BioInfer.d505.s2.p2	N	Three methods, fluorescence anisotropy of rhodamine-labeled PROTEIN1 , intrinsic fluorescence and nucleotide exchange, give the same affinity, Kd = 0.1 microM, for Acanthamoeba PROTEIN2 binding amoeba PROTEIN monomers with bound Mg-ATP.
BioInfer.d506.s0.p0	P	Quantitation of the appearance of PROTEIN banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d506.s0.p1	P	Quantitation of the appearance of PROTEIN banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d506.s0.p2	N	Quantitation of the appearance of PROTEIN2 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d506.s0.p3	P	Quantitation of the appearance of PROTEIN banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 .
BioInfer.d506.s0.p4	P	Quantitation of the appearance of PROTEIN banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN .
BioInfer.d506.s0.p5	P	Quantitation of the appearance of PROTEIN banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d506.s0.p6	N	Quantitation of the appearance of PROTEIN2 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d506.s0.p7	P	Quantitation of the appearance of PROTEIN banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d506.s0.p8	P	Quantitation of the appearance of PROTEIN banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d506.s0.p9	N	Quantitation of the appearance of PROTEIN2 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d506.s0.p10	P	Quantitation of the appearance of PROTEIN banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d506.s0.p11	P	Quantitation of the appearance of PROTEIN banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d506.s0.p12	N	Quantitation of the appearance of PROTEIN1 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d506.s0.p13	N	Quantitation of the appearance of PROTEIN1 banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d506.s0.p14	P	Quantitation of the appearance of PROTEIN banding in primary cultures of myotubes indicates that it precedes that of other myofibrillar proteins and that assembly takes place in the following order: PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 .
BioInfer.d507.s0.p0	P	Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana PROTEIN ( PROTEIN ) is a member of the PROTEIN1 family of PROTEIN2 filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].
BioInfer.d507.s0.p1	P	Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana PROTEIN2 ( PROTEIN ) is a member of the PROTEIN1 family of PROTEIN filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].
BioInfer.d507.s0.p2	P	Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana PROTEIN ( PROTEIN2 ) is a member of the PROTEIN1 family of PROTEIN filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].
BioInfer.d507.s0.p3	N	Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana PROTEIN2 ( PROTEIN ) is a member of the PROTEIN family of PROTEIN1 filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].
BioInfer.d507.s0.p4	N	Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana PROTEIN ( PROTEIN2 ) is a member of the PROTEIN family of PROTEIN1 filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].
BioInfer.d507.s0.p5	N	Recently it has been established, through a detailed biochemical analysis, that recombinant Arabidopsis thaliana PROTEIN1 ( PROTEIN2 ) is a member of the PROTEIN family of PROTEIN filament bundling or cross-linking proteins [D.R. Kovar et al. (2000) Plant J 24:625-636].
BioInfer.d508.s0.p0	P	Recently we reported that the isolated 23 kDa N-terminal fragment of PROTEIN2 , which contains the 'consensus' ATP binding site, binds to PROTEIN1 in an ATP-sensitive manner (Muhlrad, A. (1989) Biochemistry 28, 4002).
BioInfer.d509.s0.p0	P	Recombinant human PROTEIN1 can simultaneously bind to the PROTEIN / PROTEIN complex but does not bind PROTEIN2 directly.
BioInfer.d509.s0.p1	P	Recombinant human PROTEIN1 can simultaneously bind to the PROTEIN / PROTEIN2 complex but does not bind PROTEIN directly.
BioInfer.d509.s0.p2	P	Recombinant human PROTEIN1 can simultaneously bind to the PROTEIN2 / PROTEIN complex but does not bind PROTEIN directly.
BioInfer.d509.s0.p3	N	Recombinant human PROTEIN can simultaneously bind to the PROTEIN / PROTEIN2 complex but does not bind PROTEIN1 directly.
BioInfer.d509.s0.p4	N	Recombinant human PROTEIN can simultaneously bind to the PROTEIN2 / PROTEIN complex but does not bind PROTEIN1 directly.
BioInfer.d509.s0.p5	P	Recombinant human PROTEIN can simultaneously bind to the PROTEIN2 / PROTEIN1 complex but does not bind PROTEIN directly.
BioInfer.d510.s0.p0	P	Recruitment of a PROTEIN2 to PROTEIN1 -rich protrusions in Dictyostelium.
BioInfer.d511.s0.p0	N	Redistribution of PROTEIN1 , PROTEIN2 and phosphatidylinositol-4, 5-bisphosphate in growing and maturing root hairs
BioInfer.d512.s0.p0	N	Reduced PROTEIN , PROTEIN2 , PROTEIN and PROTEIN1 expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).
BioInfer.d512.s0.p1	N	Reduced PROTEIN , PROTEIN , PROTEIN2 and PROTEIN1 expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).
BioInfer.d512.s0.p2	N	Reduced PROTEIN2 , PROTEIN , PROTEIN and PROTEIN1 expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).
BioInfer.d512.s0.p3	N	Reduced PROTEIN , PROTEIN1 , PROTEIN2 and PROTEIN expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).
BioInfer.d512.s0.p4	N	Reduced PROTEIN2 , PROTEIN1 , PROTEIN and PROTEIN expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).
BioInfer.d512.s0.p5	N	Reduced PROTEIN2 , PROTEIN , PROTEIN1 and PROTEIN expression correlated closely with the differentiation grade of the esophageal squamous cell carcinoma (p < 0.05).
BioInfer.d513.s0.p0	N	Reduced expression of PROTEIN1 , PROTEIN , and PROTEIN2 was observed in 64% (87 of 135), 50% (43 of 86), and 58% (50 of 86) of the specimens tested, respectively.
BioInfer.d513.s0.p1	N	Reduced expression of PROTEIN1 , PROTEIN2 , and PROTEIN was observed in 64% (87 of 135), 50% (43 of 86), and 58% (50 of 86) of the specimens tested, respectively.
BioInfer.d513.s0.p2	N	Reduced expression of PROTEIN , PROTEIN2 , and PROTEIN1 was observed in 64% (87 of 135), 50% (43 of 86), and 58% (50 of 86) of the specimens tested, respectively.
BioInfer.d514.s0.p0	N	Reduced expression of PROTEIN and PROTEIN2 , as well as mutations in the PROTEIN gene, have been found in various carcinomas, whereas mutations in the PROTEIN1 and PROTEIN genes have been described only in carcinoma cell lines.
BioInfer.d514.s0.p1	N	Reduced expression of PROTEIN and PROTEIN , as well as mutations in the PROTEIN gene, have been found in various carcinomas, whereas mutations in the PROTEIN1 and PROTEIN2 genes have been described only in carcinoma cell lines.
BioInfer.d514.s0.p2	N	Reduced expression of PROTEIN2 and PROTEIN , as well as mutations in the PROTEIN gene, have been found in various carcinomas, whereas mutations in the PROTEIN1 and PROTEIN genes have been described only in carcinoma cell lines.
BioInfer.d514.s0.p3	N	Reduced expression of PROTEIN and PROTEIN , as well as mutations in the PROTEIN2 gene, have been found in various carcinomas, whereas mutations in the PROTEIN1 and PROTEIN genes have been described only in carcinoma cell lines.
BioInfer.d514.s0.p4	N	Reduced expression of PROTEIN and PROTEIN1 , as well as mutations in the PROTEIN gene, have been found in various carcinomas, whereas mutations in the PROTEIN and PROTEIN2 genes have been described only in carcinoma cell lines.
BioInfer.d514.s0.p5	N	Reduced expression of PROTEIN2 and PROTEIN1 , as well as mutations in the PROTEIN gene, have been found in various carcinomas, whereas mutations in the PROTEIN and PROTEIN genes have been described only in carcinoma cell lines.
BioInfer.d514.s0.p6	N	Reduced expression of PROTEIN and PROTEIN1 , as well as mutations in the PROTEIN2 gene, have been found in various carcinomas, whereas mutations in the PROTEIN and PROTEIN genes have been described only in carcinoma cell lines.
BioInfer.d514.s0.p7	N	Reduced expression of PROTEIN2 and PROTEIN , as well as mutations in the PROTEIN gene, have been found in various carcinomas, whereas mutations in the PROTEIN and PROTEIN1 genes have been described only in carcinoma cell lines.
BioInfer.d514.s0.p8	N	Reduced expression of PROTEIN and PROTEIN , as well as mutations in the PROTEIN2 gene, have been found in various carcinomas, whereas mutations in the PROTEIN and PROTEIN1 genes have been described only in carcinoma cell lines.
BioInfer.d514.s0.p9	N	Reduced expression of PROTEIN1 and PROTEIN , as well as mutations in the PROTEIN2 gene, have been found in various carcinomas, whereas mutations in the PROTEIN and PROTEIN genes have been described only in carcinoma cell lines.
BioInfer.d515.s0.p0	N	Regulation of PROTEIN1 and PROTEIN2 isogenes during cardiac growth and hypertrophy.
BioInfer.d516.s0.p0	P	Reinvestigation of the inhibition of PROTEIN1 polymerization by PROTEIN2 .
BioInfer.d516.s1.p0	N	The very much lower affinity of PROTEIN for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN2 and the apparently weak inhibition by PROTEIN1 of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN .
BioInfer.d516.s1.p1	N	The very much lower affinity of PROTEIN for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN and the apparently weak inhibition by PROTEIN1 of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN2 .
BioInfer.d516.s1.p2	N	The very much lower affinity of PROTEIN for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN2 in the presence of PROTEIN and the apparently weak inhibition by PROTEIN1 of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN .
BioInfer.d516.s1.p3	N	The very much lower affinity of PROTEIN for modified PROTEIN2 explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN and the apparently weak inhibition by PROTEIN1 of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN .
BioInfer.d516.s1.p4	N	The very much lower affinity of PROTEIN2 for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN and the apparently weak inhibition by PROTEIN1 of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN .
BioInfer.d516.s1.p5	N	The very much lower affinity of PROTEIN for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN1 and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN2 .
BioInfer.d516.s1.p6	N	The very much lower affinity of PROTEIN for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN2 in the presence of PROTEIN1 and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN .
BioInfer.d516.s1.p7	N	The very much lower affinity of PROTEIN for modified PROTEIN2 explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN1 and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN .
BioInfer.d516.s1.p8	N	The very much lower affinity of PROTEIN2 for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN1 and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN .
BioInfer.d516.s1.p9	N	The very much lower affinity of PROTEIN for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN2 in the presence of PROTEIN and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN1 .
BioInfer.d516.s1.p10	N	The very much lower affinity of PROTEIN for modified PROTEIN2 explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN1 .
BioInfer.d516.s1.p11	N	The very much lower affinity of PROTEIN2 for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN1 .
BioInfer.d516.s1.p12	N	The very much lower affinity of PROTEIN for modified PROTEIN2 explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN1 in the presence of PROTEIN and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN .
BioInfer.d516.s1.p13	N	The very much lower affinity of PROTEIN2 for modified PROTEIN explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN1 in the presence of PROTEIN and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN .
BioInfer.d516.s1.p14	P	The very much lower affinity of PROTEIN2 for modified PROTEIN1 explains the anomalous critical concentrations curves obtained for 5-10% pyrenyl-labeled PROTEIN in the presence of PROTEIN and the apparently weak inhibition by PROTEIN of the rate of filament elongation when polymerization is quantified by the increase in fluorescence of pyrenyl-labeled PROTEIN .
BioInfer.d517.s0.p0	N	Removal of one nonhomologous DNA end during gene conversion by a PROTEIN1 - and PROTEIN2 -independent pathway.
BioInfer.d518.s0.p0	P	Removal of the amino-terminal tails of either PROTEIN  PROTEIN or PROTEIN2  PROTEIN1 allowed these polyamides to bind.
BioInfer.d518.s0.p1	N	Removal of the amino-terminal tails of either PROTEIN2  PROTEIN or PROTEIN  PROTEIN1 allowed these polyamides to bind.
BioInfer.d518.s0.p2	N	Removal of the amino-terminal tails of either PROTEIN  PROTEIN2 or PROTEIN  PROTEIN1 allowed these polyamides to bind.
BioInfer.d518.s0.p3	N	Removal of the amino-terminal tails of either PROTEIN2  PROTEIN or PROTEIN1  PROTEIN allowed these polyamides to bind.
BioInfer.d518.s0.p4	N	Removal of the amino-terminal tails of either PROTEIN  PROTEIN2 or PROTEIN1  PROTEIN allowed these polyamides to bind.
BioInfer.d518.s0.p5	P	Removal of the amino-terminal tails of either PROTEIN1  PROTEIN2 or PROTEIN  PROTEIN allowed these polyamides to bind.
BioInfer.d519.s0.p0	P	Requirement of the yeast PROTEIN and PROTEIN2 genes for PROTEIN1 -dependent genomic stability.
BioInfer.d519.s0.p1	P	Requirement of the yeast PROTEIN2 and PROTEIN genes for PROTEIN1 -dependent genomic stability.
BioInfer.d519.s0.p2	N	Requirement of the yeast PROTEIN2 and PROTEIN1 genes for PROTEIN -dependent genomic stability.
BioInfer.d519.s1.p0	P	Results from epistasis analyses indicate that PROTEIN2 functions in mismatch repair in conjunction with PROTEIN or PROTEIN1 and that PROTEIN and PROTEIN constitute alternate pathways of PROTEIN -dependent mismatch repair.
BioInfer.d519.s1.p1	N	Results from epistasis analyses indicate that PROTEIN functions in mismatch repair in conjunction with PROTEIN or PROTEIN1 and that PROTEIN and PROTEIN2 constitute alternate pathways of PROTEIN -dependent mismatch repair.
BioInfer.d519.s1.p2	N	Results from epistasis analyses indicate that PROTEIN functions in mismatch repair in conjunction with PROTEIN2 or PROTEIN1 and that PROTEIN and PROTEIN constitute alternate pathways of PROTEIN -dependent mismatch repair.
BioInfer.d519.s1.p3	N	Results from epistasis analyses indicate that PROTEIN functions in mismatch repair in conjunction with PROTEIN or PROTEIN1 and that PROTEIN and PROTEIN constitute alternate pathways of PROTEIN2 -dependent mismatch repair.
BioInfer.d519.s1.p4	N	Results from epistasis analyses indicate that PROTEIN functions in mismatch repair in conjunction with PROTEIN or PROTEIN1 and that PROTEIN2 and PROTEIN constitute alternate pathways of PROTEIN -dependent mismatch repair.
BioInfer.d519.s1.p5	N	Results from epistasis analyses indicate that PROTEIN1 functions in mismatch repair in conjunction with PROTEIN or PROTEIN and that PROTEIN and PROTEIN2 constitute alternate pathways of PROTEIN -dependent mismatch repair.
BioInfer.d519.s1.p6	P	Results from epistasis analyses indicate that PROTEIN1 functions in mismatch repair in conjunction with PROTEIN2 or PROTEIN and that PROTEIN and PROTEIN constitute alternate pathways of PROTEIN -dependent mismatch repair.
BioInfer.d519.s1.p7	N	Results from epistasis analyses indicate that PROTEIN1 functions in mismatch repair in conjunction with PROTEIN or PROTEIN and that PROTEIN and PROTEIN constitute alternate pathways of PROTEIN2 -dependent mismatch repair.
BioInfer.d519.s1.p8	N	Results from epistasis analyses indicate that PROTEIN1 functions in mismatch repair in conjunction with PROTEIN or PROTEIN and that PROTEIN2 and PROTEIN constitute alternate pathways of PROTEIN -dependent mismatch repair.
BioInfer.d519.s1.p9	N	Results from epistasis analyses indicate that PROTEIN functions in mismatch repair in conjunction with PROTEIN2 or PROTEIN and that PROTEIN and PROTEIN1 constitute alternate pathways of PROTEIN -dependent mismatch repair.
BioInfer.d519.s1.p10	P	Results from epistasis analyses indicate that PROTEIN functions in mismatch repair in conjunction with PROTEIN or PROTEIN and that PROTEIN and PROTEIN1 constitute alternate pathways of PROTEIN2 -dependent mismatch repair.
BioInfer.d519.s1.p11	N	Results from epistasis analyses indicate that PROTEIN functions in mismatch repair in conjunction with PROTEIN or PROTEIN and that PROTEIN2 and PROTEIN1 constitute alternate pathways of PROTEIN -dependent mismatch repair.
BioInfer.d519.s1.p12	N	Results from epistasis analyses indicate that PROTEIN functions in mismatch repair in conjunction with PROTEIN1 or PROTEIN and that PROTEIN and PROTEIN constitute alternate pathways of PROTEIN2 -dependent mismatch repair.
BioInfer.d519.s1.p13	N	Results from epistasis analyses indicate that PROTEIN functions in mismatch repair in conjunction with PROTEIN1 or PROTEIN and that PROTEIN2 and PROTEIN constitute alternate pathways of PROTEIN -dependent mismatch repair.
BioInfer.d519.s1.p14	P	Results from epistasis analyses indicate that PROTEIN functions in mismatch repair in conjunction with PROTEIN or PROTEIN and that PROTEIN2 and PROTEIN constitute alternate pathways of PROTEIN1 -dependent mismatch repair.
BioInfer.d520.s0.p0	P	Requirement of yeast PROTEIN2 for PROTEIN1 organization and morphogenesis in vivo.
BioInfer.d521.s0.p0	N	Resonance energy transfer determination of the following distances, using a hybrid PROTEIN2 : those between Cys-55 on the Mercenaria PROTEIN , SH-1 on the Aequipecten PROTEIN1 , and Cys-374 of PROTEIN .
BioInfer.d521.s0.p1	N	Resonance energy transfer determination of the following distances, using a hybrid PROTEIN : those between Cys-55 on the Mercenaria PROTEIN , SH-1 on the Aequipecten PROTEIN1 , and Cys-374 of PROTEIN2 .
BioInfer.d521.s0.p2	N	Resonance energy transfer determination of the following distances, using a hybrid PROTEIN : those between Cys-55 on the Mercenaria PROTEIN2 , SH-1 on the Aequipecten PROTEIN1 , and Cys-374 of PROTEIN .
BioInfer.d521.s0.p3	N	Resonance energy transfer determination of the following distances, using a hybrid PROTEIN1 : those between Cys-55 on the Mercenaria PROTEIN , SH-1 on the Aequipecten PROTEIN , and Cys-374 of PROTEIN2 .
BioInfer.d521.s0.p4	N	Resonance energy transfer determination of the following distances, using a hybrid PROTEIN1 : those between Cys-55 on the Mercenaria PROTEIN2 , SH-1 on the Aequipecten PROTEIN , and Cys-374 of PROTEIN .
BioInfer.d521.s0.p5	N	Resonance energy transfer determination of the following distances, using a hybrid PROTEIN : those between Cys-55 on the Mercenaria PROTEIN2 , SH-1 on the Aequipecten PROTEIN , and Cys-374 of PROTEIN1 .
BioInfer.d522.s0.p0	P	Reversible binding of PROTEIN2 to PROTEIN and PROTEIN1 in human platelet extracts.
BioInfer.d522.s0.p1	N	Reversible binding of PROTEIN to PROTEIN2 and PROTEIN1 in human platelet extracts.
BioInfer.d522.s0.p2	P	Reversible binding of PROTEIN1 to PROTEIN2 and PROTEIN in human platelet extracts.
BioInfer.d522.s1.p0	P	Sepharose beads coupled to either monoclonal anti- PROTEIN antibodies or to polyproline were used to extract PROTEIN and PROTEIN2 , respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to PROTEIN1 with sufficient affinity to withstand dilution (high-affinity complexes).
BioInfer.d522.s1.p1	P	Sepharose beads coupled to either monoclonal anti- PROTEIN antibodies or to polyproline were used to extract PROTEIN2 and PROTEIN , respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to PROTEIN1 with sufficient affinity to withstand dilution (high-affinity complexes).
BioInfer.d522.s1.p2	N	Sepharose beads coupled to either monoclonal anti- PROTEIN2 antibodies or to polyproline were used to extract PROTEIN and PROTEIN , respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to PROTEIN1 with sufficient affinity to withstand dilution (high-affinity complexes).
BioInfer.d522.s1.p3	N	Sepharose beads coupled to either monoclonal anti- PROTEIN antibodies or to polyproline were used to extract PROTEIN2 and PROTEIN1 , respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to PROTEIN with sufficient affinity to withstand dilution (high-affinity complexes).
BioInfer.d522.s1.p4	N	Sepharose beads coupled to either monoclonal anti- PROTEIN2 antibodies or to polyproline were used to extract PROTEIN and PROTEIN1 , respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to PROTEIN with sufficient affinity to withstand dilution (high-affinity complexes).
BioInfer.d522.s1.p5	N	Sepharose beads coupled to either monoclonal anti- PROTEIN2 antibodies or to polyproline were used to extract PROTEIN1 and PROTEIN , respectively, from EGTA-containing platelet extracts and determine the proportion of these molecules bound to PROTEIN with sufficient affinity to withstand dilution (high-affinity complexes).
BioInfer.d522.s2.p0	P	PROTEIN1 , within seconds, caused quantitative conversion of PROTEIN and gelsolin to high-affinity complexes with PROTEIN2 , but these complexes were not present 5 min after stimulation.
BioInfer.d522.s2.p1	P	PROTEIN1 , within seconds, caused quantitative conversion of PROTEIN2 and gelsolin to high-affinity complexes with PROTEIN , but these complexes were not present 5 min after stimulation.
BioInfer.d522.s2.p3	P	PROTEIN , within seconds, caused quantitative conversion of PROTEIN2 and gelsolin to high-affinity complexes with PROTEIN1 , but these complexes were not present 5 min after stimulation.
BioInfer.d523.s0.p0	N	PROTEIN , one of the cleavage products, enhanced interaction between PROTEIN and PROTEIN2 / PROTEIN and increased cells' sensitivity to PROTEIN1 .
BioInfer.d523.s0.p1	P	PROTEIN2 , one of the cleavage products, enhanced interaction between PROTEIN and PROTEIN / PROTEIN and increased cells' sensitivity to PROTEIN1 .
BioInfer.d523.s0.p2	N	PROTEIN , one of the cleavage products, enhanced interaction between PROTEIN and PROTEIN / PROTEIN2 and increased cells' sensitivity to PROTEIN1 .
BioInfer.d523.s0.p3	N	PROTEIN , one of the cleavage products, enhanced interaction between PROTEIN2 and PROTEIN / PROTEIN and increased cells' sensitivity to PROTEIN1 .
BioInfer.d523.s0.p4	P	PROTEIN2 , one of the cleavage products, enhanced interaction between PROTEIN and PROTEIN1 / PROTEIN and increased cells' sensitivity to PROTEIN .
BioInfer.d523.s0.p5	N	PROTEIN , one of the cleavage products, enhanced interaction between PROTEIN and PROTEIN1 / PROTEIN2 and increased cells' sensitivity to PROTEIN .
BioInfer.d523.s0.p6	P	PROTEIN , one of the cleavage products, enhanced interaction between PROTEIN2 and PROTEIN1 / PROTEIN and increased cells' sensitivity to PROTEIN .
BioInfer.d523.s0.p7	P	PROTEIN1 , one of the cleavage products, enhanced interaction between PROTEIN and PROTEIN / PROTEIN2 and increased cells' sensitivity to PROTEIN .
BioInfer.d523.s0.p8	P	PROTEIN1 , one of the cleavage products, enhanced interaction between PROTEIN2 and PROTEIN / PROTEIN and increased cells' sensitivity to PROTEIN .
BioInfer.d523.s0.p9	P	PROTEIN , one of the cleavage products, enhanced interaction between PROTEIN2 and PROTEIN / PROTEIN1 and increased cells' sensitivity to PROTEIN .
BioInfer.d524.s0.p0	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN1 , and PROTEIN , which bind to the PROTEIN repeats of PROTEIN , but not by coexpression of PROTEIN , although PROTEIN2 expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p1	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN1 , and PROTEIN , which bind to the PROTEIN repeats of PROTEIN , but not by coexpression of PROTEIN , although PROTEIN expression did prevent accumulation of PROTEIN2 in the nucleus.
BioInfer.d524.s0.p2	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN1 , and PROTEIN , which bind to the PROTEIN2 repeats of PROTEIN , but not by coexpression of PROTEIN , although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p3	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN1 , and PROTEIN2 , which bind to the PROTEIN repeats of PROTEIN , but not by coexpression of PROTEIN , although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p4	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN1 , and PROTEIN , which bind to the PROTEIN repeats of PROTEIN , but not by coexpression of PROTEIN2 , although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p5	N	Rod formation was prevented by coexpression of PROTEIN2 , PROTEIN1 , and PROTEIN , which bind to the PROTEIN repeats of PROTEIN , but not by coexpression of PROTEIN , although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p6	P	Rod formation was prevented by coexpression of PROTEIN , PROTEIN1 , and PROTEIN , which bind to the PROTEIN repeats of PROTEIN2 , but not by coexpression of PROTEIN , although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p7	P	Rod formation was prevented by coexpression of PROTEIN , PROTEIN , and PROTEIN , which bind to the PROTEIN repeats of PROTEIN , but not by coexpression of PROTEIN , although PROTEIN1 expression did prevent accumulation of PROTEIN2 in the nucleus.
BioInfer.d524.s0.p8	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN , and PROTEIN , which bind to the PROTEIN2 repeats of PROTEIN , but not by coexpression of PROTEIN , although PROTEIN1 expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p9	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN , and PROTEIN2 , which bind to the PROTEIN repeats of PROTEIN , but not by coexpression of PROTEIN , although PROTEIN1 expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p10	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN , and PROTEIN , which bind to the PROTEIN repeats of PROTEIN , but not by coexpression of PROTEIN2 , although PROTEIN1 expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p11	N	Rod formation was prevented by coexpression of PROTEIN2 , PROTEIN , and PROTEIN , which bind to the PROTEIN repeats of PROTEIN , but not by coexpression of PROTEIN , although PROTEIN1 expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p12	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN , and PROTEIN , which bind to the PROTEIN repeats of PROTEIN2 , but not by coexpression of PROTEIN , although PROTEIN1 expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p13	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN , and PROTEIN , which bind to the PROTEIN2 repeats of PROTEIN , but not by coexpression of PROTEIN , although PROTEIN expression did prevent accumulation of PROTEIN1 in the nucleus.
BioInfer.d524.s0.p14	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN , and PROTEIN2 , which bind to the PROTEIN repeats of PROTEIN , but not by coexpression of PROTEIN , although PROTEIN expression did prevent accumulation of PROTEIN1 in the nucleus.
BioInfer.d524.s0.p15	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN , and PROTEIN , which bind to the PROTEIN repeats of PROTEIN , but not by coexpression of PROTEIN2 , although PROTEIN expression did prevent accumulation of PROTEIN1 in the nucleus.
BioInfer.d524.s0.p16	N	Rod formation was prevented by coexpression of PROTEIN2 , PROTEIN , and PROTEIN , which bind to the PROTEIN repeats of PROTEIN , but not by coexpression of PROTEIN , although PROTEIN expression did prevent accumulation of PROTEIN1 in the nucleus.
BioInfer.d524.s0.p17	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN , and PROTEIN , which bind to the PROTEIN repeats of PROTEIN2 , but not by coexpression of PROTEIN , although PROTEIN expression did prevent accumulation of PROTEIN1 in the nucleus.
BioInfer.d524.s0.p18	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN , and PROTEIN2 , which bind to the PROTEIN1 repeats of PROTEIN , but not by coexpression of PROTEIN , although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p19	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN , and PROTEIN , which bind to the PROTEIN1 repeats of PROTEIN , but not by coexpression of PROTEIN2 , although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p20	N	Rod formation was prevented by coexpression of PROTEIN2 , PROTEIN , and PROTEIN , which bind to the PROTEIN1 repeats of PROTEIN , but not by coexpression of PROTEIN , although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p21	P	Rod formation was prevented by coexpression of PROTEIN , PROTEIN , and PROTEIN , which bind to the PROTEIN1 repeats of PROTEIN2 , but not by coexpression of PROTEIN , although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p22	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN , and PROTEIN1 , which bind to the PROTEIN repeats of PROTEIN , but not by coexpression of PROTEIN2 , although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p23	N	Rod formation was prevented by coexpression of PROTEIN2 , PROTEIN , and PROTEIN1 , which bind to the PROTEIN repeats of PROTEIN , but not by coexpression of PROTEIN , although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p24	P	Rod formation was prevented by coexpression of PROTEIN , PROTEIN , and PROTEIN1 , which bind to the PROTEIN repeats of PROTEIN2 , but not by coexpression of PROTEIN , although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p25	N	Rod formation was prevented by coexpression of PROTEIN2 , PROTEIN , and PROTEIN , which bind to the PROTEIN repeats of PROTEIN , but not by coexpression of PROTEIN1 , although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p26	N	Rod formation was prevented by coexpression of PROTEIN , PROTEIN , and PROTEIN , which bind to the PROTEIN repeats of PROTEIN2 , but not by coexpression of PROTEIN1 , although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d524.s0.p27	P	Rod formation was prevented by coexpression of PROTEIN1 , PROTEIN , and PROTEIN , which bind to the PROTEIN repeats of PROTEIN2 , but not by coexpression of PROTEIN , although PROTEIN expression did prevent accumulation of PROTEIN in the nucleus.
BioInfer.d525.s0.p0	P	Role of PROTEIN in PROTEIN1 -stimulated PROTEIN2 polymerization and lamellipod protrusion.
BioInfer.d525.s0.p1	N	Role of PROTEIN2 in PROTEIN1 -stimulated PROTEIN polymerization and lamellipod protrusion.
BioInfer.d525.s0.p2	P	Role of PROTEIN2 in PROTEIN -stimulated PROTEIN1 polymerization and lamellipod protrusion.
BioInfer.d525.s1.p0	N	These results support a model in which PROTEIN1 stimulation recruits PROTEIN to the leading edge where its severing activity is activated, leading to the generation of short PROTEIN2 filaments with free barbed ends that participate in the nucleation of PROTEIN polymerization.
BioInfer.d525.s1.p1	P	These results support a model in which PROTEIN1 stimulation recruits PROTEIN2 to the leading edge where its severing activity is activated, leading to the generation of short PROTEIN filaments with free barbed ends that participate in the nucleation of PROTEIN polymerization.
BioInfer.d525.s1.p2	N	These results support a model in which PROTEIN1 stimulation recruits PROTEIN to the leading edge where its severing activity is activated, leading to the generation of short PROTEIN filaments with free barbed ends that participate in the nucleation of PROTEIN2 polymerization.
BioInfer.d525.s1.p3	P	These results support a model in which PROTEIN stimulation recruits PROTEIN2 to the leading edge where its severing activity is activated, leading to the generation of short PROTEIN1 filaments with free barbed ends that participate in the nucleation of PROTEIN polymerization.
BioInfer.d525.s1.p4	P	These results support a model in which PROTEIN stimulation recruits PROTEIN to the leading edge where its severing activity is activated, leading to the generation of short PROTEIN1 filaments with free barbed ends that participate in the nucleation of PROTEIN2 polymerization.
BioInfer.d525.s1.p5	N	These results support a model in which PROTEIN stimulation recruits PROTEIN1 to the leading edge where its severing activity is activated, leading to the generation of short PROTEIN filaments with free barbed ends that participate in the nucleation of PROTEIN2 polymerization.
BioInfer.d525.s2.p0	N	To investigate the role of PROTEIN2 in PROTEIN -stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN1 dynamics by measuring the changes in the number of PROTEIN filaments.
BioInfer.d525.s2.p1	N	To investigate the role of PROTEIN in PROTEIN2 -stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN1 dynamics by measuring the changes in the number of PROTEIN filaments.
BioInfer.d525.s2.p2	N	To investigate the role of PROTEIN in PROTEIN -stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN1 dynamics by measuring the changes in the number of PROTEIN2 filaments.
BioInfer.d525.s2.p3	N	To investigate the role of PROTEIN in PROTEIN -stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN2 relative to free barbed ends and characterized the PROTEIN1 dynamics by measuring the changes in the number of PROTEIN filaments.
BioInfer.d525.s2.p4	N	To investigate the role of PROTEIN in PROTEIN -stimulated PROTEIN2 polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN1 dynamics by measuring the changes in the number of PROTEIN filaments.
BioInfer.d525.s2.p5	N	To investigate the role of PROTEIN1 in PROTEIN2 -stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN filaments.
BioInfer.d525.s2.p6	N	To investigate the role of PROTEIN1 in PROTEIN -stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN2 filaments.
BioInfer.d525.s2.p7	N	To investigate the role of PROTEIN1 in PROTEIN -stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN2 relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN filaments.
BioInfer.d525.s2.p8	P	To investigate the role of PROTEIN1 in PROTEIN -stimulated PROTEIN2 polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN filaments.
BioInfer.d525.s2.p9	N	To investigate the role of PROTEIN in PROTEIN1 -stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN2 filaments.
BioInfer.d525.s2.p10	N	To investigate the role of PROTEIN in PROTEIN1 -stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN2 relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN filaments.
BioInfer.d525.s2.p11	P	To investigate the role of PROTEIN in PROTEIN1 -stimulated PROTEIN2 polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN filaments.
BioInfer.d525.s2.p12	N	To investigate the role of PROTEIN in PROTEIN -stimulated PROTEIN polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN2 relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN1 filaments.
BioInfer.d525.s2.p13	N	To investigate the role of PROTEIN in PROTEIN -stimulated PROTEIN2 polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN1 filaments.
BioInfer.d525.s2.p14	N	To investigate the role of PROTEIN in PROTEIN -stimulated PROTEIN2 polymerization and lamellipod extension in MTLn3 cells, we examined in detail the temporal and spatial distribution of PROTEIN1 relative to free barbed ends and characterized the PROTEIN dynamics by measuring the changes in the number of PROTEIN filaments.
BioInfer.d526.s0.p0	P	Saccharomyces cerevisiae PROTEIN1 functions with PROTEIN2 , 2 and 4 in a pathway leading to normal microtubule stability.
BioInfer.d527.s0.p0	N	Saccharomyces cerevisiae PROTEIN2 was identified in a two-hybrid screen using PROTEIN1 as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p1	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN1 as "bait," and pairwise interactions between PROTEIN2 and PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p2	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN1 as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p3	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN1 as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p4	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN1 as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p5	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN1 as "bait," and pairwise interactions between PROTEIN and PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p6	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN1 as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p7	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN1 as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p8	N	Saccharomyces cerevisiae PROTEIN1 was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN2 and PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p9	N	Saccharomyces cerevisiae PROTEIN1 was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p10	N	Saccharomyces cerevisiae PROTEIN1 was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p11	N	Saccharomyces cerevisiae PROTEIN1 was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p12	N	Saccharomyces cerevisiae PROTEIN1 was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p13	N	Saccharomyces cerevisiae PROTEIN1 was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p14	N	Saccharomyces cerevisiae PROTEIN1 was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p15	P	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN1 and PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p16	P	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN1 and PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p17	P	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN1 and PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p18	P	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN1 and PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p19	P	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN1 and PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p20	P	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN1 and PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p21	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p22	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p23	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p24	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p25	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p26	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p27	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p28	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p29	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p30	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p31	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p32	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p33	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p34	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d527.s0.p35	N	Saccharomyces cerevisiae PROTEIN was identified in a two-hybrid screen using PROTEIN as "bait," and pairwise interactions between PROTEIN and PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN subsequently were demonstrated by two-hybrid analysis.
BioInfer.d528.s0.p0	N	SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as PROTEIN2 (43 kDa Mr), PROTEIN (195 kDa Mr), PROTEIN1 (235 and 240 kDa Mr), and PROTEIN (51-54 kDa Mr).
BioInfer.d528.s0.p1	N	SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as PROTEIN (43 kDa Mr), PROTEIN (195 kDa Mr), PROTEIN1 (235 and 240 kDa Mr), and PROTEIN2 (51-54 kDa Mr).
BioInfer.d528.s0.p2	N	SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as PROTEIN (43 kDa Mr), PROTEIN2 (195 kDa Mr), PROTEIN1 (235 and 240 kDa Mr), and PROTEIN (51-54 kDa Mr).
BioInfer.d528.s0.p3	N	SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as PROTEIN1 (43 kDa Mr), PROTEIN (195 kDa Mr), PROTEIN (235 and 240 kDa Mr), and PROTEIN2 (51-54 kDa Mr).
BioInfer.d528.s0.p4	N	SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as PROTEIN1 (43 kDa Mr), PROTEIN2 (195 kDa Mr), PROTEIN (235 and 240 kDa Mr), and PROTEIN (51-54 kDa Mr).
BioInfer.d528.s0.p5	N	SDS-PAGE analysis of growth cone cytoskeletons revealed the presence of several major bands, identified by their mobility as PROTEIN (43 kDa Mr), PROTEIN2 (195 kDa Mr), PROTEIN (235 and 240 kDa Mr), and PROTEIN1 (51-54 kDa Mr).
BioInfer.d529.s0.p0	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN ( PROTEIN2 ), PROTEIN and PROTEIN isoforms: PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d529.s0.p1	P	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN ( PROTEIN ), PROTEIN and PROTEIN2 isoforms: PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d529.s0.p2	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN2 ( PROTEIN ), PROTEIN and PROTEIN isoforms: PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d529.s0.p3	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN ( PROTEIN ), PROTEIN and PROTEIN isoforms: PROTEIN2 , PROTEIN1 and PROTEIN .
BioInfer.d529.s0.p4	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN ( PROTEIN ), PROTEIN2 and PROTEIN isoforms: PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d529.s0.p5	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN ( PROTEIN ), PROTEIN and PROTEIN isoforms: PROTEIN , PROTEIN1 and PROTEIN2 .
BioInfer.d529.s0.p6	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN ( PROTEIN1 ), PROTEIN and PROTEIN2 isoforms: PROTEIN , PROTEIN and PROTEIN .
BioInfer.d529.s0.p7	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN2 ( PROTEIN1 ), PROTEIN and PROTEIN isoforms: PROTEIN , PROTEIN and PROTEIN .
BioInfer.d529.s0.p8	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN ( PROTEIN1 ), PROTEIN and PROTEIN isoforms: PROTEIN2 , PROTEIN and PROTEIN .
BioInfer.d529.s0.p9	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN ( PROTEIN1 ), PROTEIN2 and PROTEIN isoforms: PROTEIN , PROTEIN and PROTEIN .
BioInfer.d529.s0.p10	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN ( PROTEIN1 ), PROTEIN and PROTEIN isoforms: PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d529.s0.p11	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN2 ( PROTEIN ), PROTEIN and PROTEIN1 isoforms: PROTEIN , PROTEIN and PROTEIN .
BioInfer.d529.s0.p12	P	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN ( PROTEIN ), PROTEIN and PROTEIN1 isoforms: PROTEIN2 , PROTEIN and PROTEIN .
BioInfer.d529.s0.p13	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN ( PROTEIN ), PROTEIN2 and PROTEIN1 isoforms: PROTEIN , PROTEIN and PROTEIN .
BioInfer.d529.s0.p14	P	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN ( PROTEIN ), PROTEIN and PROTEIN1 isoforms: PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d529.s0.p15	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN1 ( PROTEIN ), PROTEIN and PROTEIN isoforms: PROTEIN2 , PROTEIN and PROTEIN .
BioInfer.d529.s0.p16	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN1 ( PROTEIN ), PROTEIN2 and PROTEIN isoforms: PROTEIN , PROTEIN and PROTEIN .
BioInfer.d529.s0.p17	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN1 ( PROTEIN ), PROTEIN and PROTEIN isoforms: PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d529.s0.p18	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN ( PROTEIN ), PROTEIN2 and PROTEIN isoforms: PROTEIN1 , PROTEIN and PROTEIN .
BioInfer.d529.s0.p19	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN ( PROTEIN ), PROTEIN and PROTEIN isoforms: PROTEIN1 , PROTEIN and PROTEIN2 .
BioInfer.d529.s0.p20	N	Semiserial sections were subjected to immunohistochemical staining with antibodies to PROTEIN ( PROTEIN ), PROTEIN1 and PROTEIN isoforms: PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d530.s0.p0	N	Sequence analysis of the genes encoding the PROTEIN1 and PROTEIN ( PROTEIN ) of phocid distemper virus, and editing of the PROTEIN2 gene transcript.
BioInfer.d530.s0.p1	N	Sequence analysis of the genes encoding the PROTEIN1 and PROTEIN2 ( PROTEIN ) of phocid distemper virus, and editing of the PROTEIN gene transcript.
BioInfer.d530.s0.p2	N	Sequence analysis of the genes encoding the PROTEIN1 and PROTEIN ( PROTEIN2 ) of phocid distemper virus, and editing of the PROTEIN gene transcript.
BioInfer.d530.s0.p3	N	Sequence analysis of the genes encoding the PROTEIN and PROTEIN2 ( PROTEIN ) of phocid distemper virus, and editing of the PROTEIN1 gene transcript.
BioInfer.d530.s0.p4	N	Sequence analysis of the genes encoding the PROTEIN and PROTEIN ( PROTEIN2 ) of phocid distemper virus, and editing of the PROTEIN1 gene transcript.
BioInfer.d530.s0.p5	N	Sequence analysis of the genes encoding the PROTEIN and PROTEIN1 ( PROTEIN2 ) of phocid distemper virus, and editing of the PROTEIN gene transcript.
BioInfer.d531.s0.p0	N	Sequences upstream of the coding region for PROTEIN protein share homology with the damage response sequence element of PROTEIN , an upstream activating sequence required for damage regulation of the PROTEIN transcript, and also contain two sites for restriction enzyme PROTEIN1 ; the presence of PROTEIN2 restriction sites has been associated with cell cycle regulation.
BioInfer.d531.s0.p1	N	Sequences upstream of the coding region for PROTEIN protein share homology with the damage response sequence element of PROTEIN2 , an upstream activating sequence required for damage regulation of the PROTEIN transcript, and also contain two sites for restriction enzyme PROTEIN1 ; the presence of PROTEIN restriction sites has been associated with cell cycle regulation.
BioInfer.d531.s0.p2	N	Sequences upstream of the coding region for PROTEIN protein share homology with the damage response sequence element of PROTEIN , an upstream activating sequence required for damage regulation of the PROTEIN2 transcript, and also contain two sites for restriction enzyme PROTEIN1 ; the presence of PROTEIN restriction sites has been associated with cell cycle regulation.
BioInfer.d531.s0.p3	P	Sequences upstream of the coding region for PROTEIN2 protein share homology with the damage response sequence element of PROTEIN , an upstream activating sequence required for damage regulation of the PROTEIN transcript, and also contain two sites for restriction enzyme PROTEIN1 ; the presence of PROTEIN restriction sites has been associated with cell cycle regulation.
BioInfer.d531.s0.p4	N	Sequences upstream of the coding region for PROTEIN protein share homology with the damage response sequence element of PROTEIN2 , an upstream activating sequence required for damage regulation of the PROTEIN transcript, and also contain two sites for restriction enzyme PROTEIN ; the presence of PROTEIN1 restriction sites has been associated with cell cycle regulation.
BioInfer.d531.s0.p5	N	Sequences upstream of the coding region for PROTEIN protein share homology with the damage response sequence element of PROTEIN , an upstream activating sequence required for damage regulation of the PROTEIN2 transcript, and also contain two sites for restriction enzyme PROTEIN ; the presence of PROTEIN1 restriction sites has been associated with cell cycle regulation.
BioInfer.d531.s0.p6	N	Sequences upstream of the coding region for PROTEIN2 protein share homology with the damage response sequence element of PROTEIN , an upstream activating sequence required for damage regulation of the PROTEIN transcript, and also contain two sites for restriction enzyme PROTEIN ; the presence of PROTEIN1 restriction sites has been associated with cell cycle regulation.
BioInfer.d531.s0.p7	P	Sequences upstream of the coding region for PROTEIN protein share homology with the damage response sequence element of PROTEIN1 , an upstream activating sequence required for damage regulation of the PROTEIN2 transcript, and also contain two sites for restriction enzyme PROTEIN ; the presence of PROTEIN restriction sites has been associated with cell cycle regulation.
BioInfer.d531.s0.p8	P	Sequences upstream of the coding region for PROTEIN2 protein share homology with the damage response sequence element of PROTEIN1 , an upstream activating sequence required for damage regulation of the PROTEIN transcript, and also contain two sites for restriction enzyme PROTEIN ; the presence of PROTEIN restriction sites has been associated with cell cycle regulation.
BioInfer.d531.s0.p9	N	Sequences upstream of the coding region for PROTEIN2 protein share homology with the damage response sequence element of PROTEIN , an upstream activating sequence required for damage regulation of the PROTEIN1 transcript, and also contain two sites for restriction enzyme PROTEIN ; the presence of PROTEIN restriction sites has been associated with cell cycle regulation.
BioInfer.d532.s0.p0	P	Ser-133 phosphorylation enhances PROTEIN2 activity by promoting interaction with a 265-kDa PROTEIN referred to as PROTEIN1 (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).
BioInfer.d532.s0.p1	N	Ser-133 phosphorylation enhances PROTEIN activity by promoting interaction with a 265-kDa PROTEIN2 referred to as PROTEIN1 (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).
BioInfer.d532.s0.p2	P	Ser-133 phosphorylation enhances PROTEIN1 activity by promoting interaction with a 265-kDa PROTEIN2 referred to as PROTEIN (Arias, J., Alberts, A., Brindle, P., Claret, F., Smeal, T., Karin, M., Feramisco, J., and Montminy, M. (1994) Nature 370, 226-228; Chrivia, J. C., Kwok, R. P., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. (1993) Nature 365, 855-859).
BioInfer.d533.s0.p0	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN , PROTEIN2  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p1	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN2 , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p2	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN , PROTEIN  PROTEIN , PROTEIN2 and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p3	N	Seventeen embryonic genes were identified as PROTEIN2 , PROTEIN , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p4	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN2 , PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p5	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN2 , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p6	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN , PROTEIN  PROTEIN2 , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p7	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN2 ), PROTEIN1 , PROTEIN , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p8	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN2 ( PROTEIN ), PROTEIN1 , PROTEIN , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p9	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN2 , PROTEIN1  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p10	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN2 and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p11	N	Seventeen embryonic genes were identified as PROTEIN2 , PROTEIN , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p12	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN2 , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p13	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN2 , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p14	P	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN1  PROTEIN2 , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p15	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p16	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN1  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p17	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN1 , PROTEIN  PROTEIN , PROTEIN2 and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p18	N	Seventeen embryonic genes were identified as PROTEIN2 , PROTEIN , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN1 , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p19	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN2 , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN1 , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p20	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN2 , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN1 , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p21	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN1 , PROTEIN  PROTEIN2 , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p22	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN1 , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p23	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN1 , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p24	N	Seventeen embryonic genes were identified as PROTEIN2 , PROTEIN , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN1 and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p25	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN2 , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN1 and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p26	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN2 , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN1 and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p27	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN  PROTEIN2 , PROTEIN1 and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p28	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN1 and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p29	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN1 and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p30	N	Seventeen embryonic genes were identified as PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p31	N	Seventeen embryonic genes were identified as PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p32	N	Seventeen embryonic genes were identified as PROTEIN1 , PROTEIN , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN  PROTEIN2 , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p33	N	Seventeen embryonic genes were identified as PROTEIN1 , PROTEIN , PROTEIN , PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p34	N	Seventeen embryonic genes were identified as PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p35	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p36	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN1 , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN  PROTEIN2 , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p37	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN1 , PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p38	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p39	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN1 , PROTEIN , PROTEIN ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN  PROTEIN2 , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p40	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN1 , PROTEIN , PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p41	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p42	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN , PROTEIN  PROTEIN1 , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p43	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN , PROTEIN  PROTEIN1 , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d533.s0.p44	N	Seventeen embryonic genes were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN2 ( PROTEIN1 ), PROTEIN , PROTEIN , PROTEIN  PROTEIN , PROTEIN and nine novel sequences designated as A1-9.
BioInfer.d534.s0.p0	N	Several intracellular proteins termed PROTEIN , including PROTEIN , PROTEIN , and PROTEIN2 , are tightly associated with these PROTEIN1 and serve to link them to the cytoskeleton.
BioInfer.d534.s0.p1	P	Several intracellular proteins termed PROTEIN2 , including PROTEIN , PROTEIN , and PROTEIN , are tightly associated with these PROTEIN1 and serve to link them to the cytoskeleton.
BioInfer.d534.s0.p2	N	Several intracellular proteins termed PROTEIN , including PROTEIN2 , PROTEIN , and PROTEIN , are tightly associated with these PROTEIN1 and serve to link them to the cytoskeleton.
BioInfer.d534.s0.p3	N	Several intracellular proteins termed PROTEIN , including PROTEIN , PROTEIN2 , and PROTEIN , are tightly associated with these PROTEIN1 and serve to link them to the cytoskeleton.
BioInfer.d534.s0.p4	P	Several intracellular proteins termed PROTEIN2 , including PROTEIN , PROTEIN , and PROTEIN1 , are tightly associated with these PROTEIN and serve to link them to the cytoskeleton.
BioInfer.d534.s0.p5	N	Several intracellular proteins termed PROTEIN , including PROTEIN2 , PROTEIN , and PROTEIN1 , are tightly associated with these PROTEIN and serve to link them to the cytoskeleton.
BioInfer.d534.s0.p6	N	Several intracellular proteins termed PROTEIN , including PROTEIN , PROTEIN2 , and PROTEIN1 , are tightly associated with these PROTEIN and serve to link them to the cytoskeleton.
BioInfer.d534.s0.p7	P	Several intracellular proteins termed PROTEIN1 , including PROTEIN2 , PROTEIN , and PROTEIN , are tightly associated with these PROTEIN and serve to link them to the cytoskeleton.
BioInfer.d534.s0.p8	P	Several intracellular proteins termed PROTEIN1 , including PROTEIN , PROTEIN2 , and PROTEIN , are tightly associated with these PROTEIN and serve to link them to the cytoskeleton.
BioInfer.d534.s0.p9	N	Several intracellular proteins termed PROTEIN , including PROTEIN1 , PROTEIN2 , and PROTEIN , are tightly associated with these PROTEIN and serve to link them to the cytoskeleton.
BioInfer.d535.s0.p0	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN2 without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN1 ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p1	N	Several lines of evidence show that the PROTEIN2 fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN1 ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p2	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN2 in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN1 ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p3	P	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN2 form 3-D crystals under the same conditions as native PROTEIN1 ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p4	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN1 ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN2 ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p5	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN1 ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN2 inhibit PROTEIN polymerization.
BioInfer.d535.s0.p6	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN1 ; 3) dialyzed Acanthamoeba PROTEIN2 has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p7	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN2 rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN1 ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p8	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN1 ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN2 polymerization.
BioInfer.d535.s0.p9	N	Several lines of evidence show that the PROTEIN2 fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN1 without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p10	P	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN2 in the same way as native, conventionally purified PROTEIN1 without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p11	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN1 without urea treatment; 2) dialyzed PROTEIN2 form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p12	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN1 without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN2 ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p13	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN1 without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN2 inhibit PROTEIN polymerization.
BioInfer.d535.s0.p14	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN1 without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN2 has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p15	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN2 rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN1 without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p16	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN1 without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN2 polymerization.
BioInfer.d535.s0.p17	N	Several lines of evidence show that the PROTEIN1 fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN2 in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p18	N	Several lines of evidence show that the PROTEIN1 fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN2 form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p19	N	Several lines of evidence show that the PROTEIN1 fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN2 ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p20	N	Several lines of evidence show that the PROTEIN1 fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN2 inhibit PROTEIN polymerization.
BioInfer.d535.s0.p21	N	Several lines of evidence show that the PROTEIN1 fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN2 has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p22	N	Several lines of evidence show that the PROTEIN1 fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN2 rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p23	N	Several lines of evidence show that the PROTEIN1 fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN2 polymerization.
BioInfer.d535.s0.p24	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN1 in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN2 form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p25	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN1 in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN2 ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p26	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN1 in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN2 inhibit PROTEIN polymerization.
BioInfer.d535.s0.p27	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN1 in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN2 has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p28	P	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN2 rebind quantitatively to poly-L-proline and bind to PROTEIN1 in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p29	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN1 in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN2 polymerization.
BioInfer.d535.s0.p30	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN1 form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN2 ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p31	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN1 form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN2 inhibit PROTEIN polymerization.
BioInfer.d535.s0.p32	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN1 form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN2 has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p33	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN2 rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN1 form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p34	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN1 form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN2 polymerization.
BioInfer.d535.s0.p35	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN1 ; and 4) dialyzed human and Acanthamoeba PROTEIN2 inhibit PROTEIN polymerization.
BioInfer.d535.s0.p36	P	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN2 has an NMR spectrum identical with that of native PROTEIN1 ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p37	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN2 rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN1 ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p38	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN1 ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN2 polymerization.
BioInfer.d535.s0.p39	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN2 has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN1 inhibit PROTEIN polymerization.
BioInfer.d535.s0.p40	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN2 rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN1 inhibit PROTEIN polymerization.
BioInfer.d535.s0.p41	P	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN1 inhibit PROTEIN2 polymerization.
BioInfer.d535.s0.p42	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN2 rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN1 has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN polymerization.
BioInfer.d535.s0.p43	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN1 has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN2 polymerization.
BioInfer.d535.s0.p44	N	Several lines of evidence show that the PROTEIN fully renature after removal of the urea by dialysis: 1) dialyzed Acanthamoeba and human PROTEIN1 rebind quantitatively to poly-L-proline and bind to PROTEIN in the same way as native, conventionally purified PROTEIN without urea treatment; 2) dialyzed PROTEIN form 3-D crystals under the same conditions as native PROTEIN ; 3) dialyzed Acanthamoeba PROTEIN has an NMR spectrum identical with that of native PROTEIN ; and 4) dialyzed human and Acanthamoeba PROTEIN inhibit PROTEIN2 polymerization.
BioInfer.d536.s0.p0	N	Several proteins, such as PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 , have previously been described.
BioInfer.d536.s0.p1	N	Several proteins, such as PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , have previously been described.
BioInfer.d536.s0.p2	N	Several proteins, such as PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN , have previously been described.
BioInfer.d536.s0.p3	N	Several proteins, such as PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN , have previously been described.
BioInfer.d536.s0.p4	N	Several proteins, such as PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , have previously been described.
BioInfer.d536.s0.p5	N	Several proteins, such as PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 , have previously been described.
BioInfer.d536.s0.p6	N	Several proteins, such as PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 , have previously been described.
BioInfer.d536.s0.p7	N	Several proteins, such as PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , have previously been described.
BioInfer.d536.s0.p8	N	Several proteins, such as PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , have previously been described.
BioInfer.d536.s0.p9	N	Several proteins, such as PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN , have previously been described.
BioInfer.d537.s0.p0	P	Signaling pathways involved in dephosphorylation and localization of the PROTEIN1  PROTEIN2 in stimulated human neutrophils.
BioInfer.d537.s1.p0	P	These findings suggest a role of PROTEIN1 in stimulus-dependent PROTEIN2 remodeling in motile neutrophils.
BioInfer.d538.s0.p0	P	Significantly, those PROTEIN mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the PROTEIN1 crystal structure previously defined as the PROTEIN2 ( PROTEIN )-binding site.
BioInfer.d538.s0.p1	P	Significantly, those PROTEIN mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the PROTEIN1 crystal structure previously defined as the PROTEIN ( PROTEIN2 )-binding site.
BioInfer.d538.s0.p2	N	Significantly, those PROTEIN2 mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the PROTEIN1 crystal structure previously defined as the PROTEIN ( PROTEIN )-binding site.
BioInfer.d538.s0.p3	N	Significantly, those PROTEIN mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the PROTEIN crystal structure previously defined as the PROTEIN1 ( PROTEIN2 )-binding site.
BioInfer.d538.s0.p4	N	Significantly, those PROTEIN2 mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the PROTEIN crystal structure previously defined as the PROTEIN1 ( PROTEIN )-binding site.
BioInfer.d538.s0.p5	N	Significantly, those PROTEIN2 mutants exhibiting the most severe phenotypes in all three processes have altered residues that cluster to a small region of the PROTEIN crystal structure previously defined as the PROTEIN ( PROTEIN1 )-binding site.
BioInfer.d539.s0.p0	N	Silencing mediated by PROTEIN2 - PROTEIN requires the trans-acting factors that normally participate in repression, namely, PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN  PROTEIN .
BioInfer.d539.s0.p1	N	Silencing mediated by PROTEIN - PROTEIN2 requires the trans-acting factors that normally participate in repression, namely, PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN  PROTEIN .
BioInfer.d539.s0.p2	N	Silencing mediated by PROTEIN - PROTEIN requires the trans-acting factors that normally participate in repression, namely, PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN  PROTEIN .
BioInfer.d539.s0.p3	N	Silencing mediated by PROTEIN - PROTEIN requires the trans-acting factors that normally participate in repression, namely, PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN  PROTEIN2 .
BioInfer.d539.s0.p4	N	Silencing mediated by PROTEIN - PROTEIN requires the trans-acting factors that normally participate in repression, namely, PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN  PROTEIN .
BioInfer.d539.s0.p5	N	Silencing mediated by PROTEIN - PROTEIN requires the trans-acting factors that normally participate in repression, namely, PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2  PROTEIN .
BioInfer.d539.s0.p6	P	Silencing mediated by PROTEIN1 - PROTEIN2 requires the trans-acting factors that normally participate in repression, namely, PROTEIN , PROTEIN , PROTEIN , and PROTEIN  PROTEIN .
BioInfer.d539.s0.p7	N	Silencing mediated by PROTEIN1 - PROTEIN requires the trans-acting factors that normally participate in repression, namely, PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN  PROTEIN .
BioInfer.d539.s0.p8	N	Silencing mediated by PROTEIN1 - PROTEIN requires the trans-acting factors that normally participate in repression, namely, PROTEIN , PROTEIN , PROTEIN , and PROTEIN  PROTEIN2 .
BioInfer.d539.s0.p9	N	Silencing mediated by PROTEIN1 - PROTEIN requires the trans-acting factors that normally participate in repression, namely, PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN  PROTEIN .
BioInfer.d539.s0.p10	N	Silencing mediated by PROTEIN1 - PROTEIN requires the trans-acting factors that normally participate in repression, namely, PROTEIN , PROTEIN , PROTEIN , and PROTEIN2  PROTEIN .
BioInfer.d539.s0.p11	N	Silencing mediated by PROTEIN - PROTEIN1 requires the trans-acting factors that normally participate in repression, namely, PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN  PROTEIN .
BioInfer.d539.s0.p12	N	Silencing mediated by PROTEIN - PROTEIN1 requires the trans-acting factors that normally participate in repression, namely, PROTEIN , PROTEIN , PROTEIN , and PROTEIN  PROTEIN2 .
BioInfer.d539.s0.p13	N	Silencing mediated by PROTEIN - PROTEIN1 requires the trans-acting factors that normally participate in repression, namely, PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN  PROTEIN .
BioInfer.d539.s0.p14	N	Silencing mediated by PROTEIN - PROTEIN1 requires the trans-acting factors that normally participate in repression, namely, PROTEIN , PROTEIN , PROTEIN , and PROTEIN2  PROTEIN .
BioInfer.d539.s0.p15	N	Silencing mediated by PROTEIN - PROTEIN requires the trans-acting factors that normally participate in repression, namely, PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN  PROTEIN2 .
BioInfer.d539.s0.p16	N	Silencing mediated by PROTEIN - PROTEIN requires the trans-acting factors that normally participate in repression, namely, PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN  PROTEIN .
BioInfer.d539.s0.p17	N	Silencing mediated by PROTEIN - PROTEIN requires the trans-acting factors that normally participate in repression, namely, PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2  PROTEIN .
BioInfer.d539.s0.p18	N	Silencing mediated by PROTEIN - PROTEIN requires the trans-acting factors that normally participate in repression, namely, PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN  PROTEIN1 .
BioInfer.d539.s0.p19	P	Silencing mediated by PROTEIN - PROTEIN requires the trans-acting factors that normally participate in repression, namely, PROTEIN , PROTEIN , PROTEIN , and PROTEIN2  PROTEIN1 .
BioInfer.d539.s0.p20	N	Silencing mediated by PROTEIN - PROTEIN requires the trans-acting factors that normally participate in repression, namely, PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2  PROTEIN .
BioInfer.d540.s0.p0	N	Since PROTEIN is required for PROTEIN2 -mediated adhesion, the PROTEIN1 repeat region alone probably cannot promote cell adhesion, making it unlikely that PROTEIN induces axis duplication by increasing cell adhesion.
BioInfer.d540.s0.p1	N	Since PROTEIN is required for PROTEIN -mediated adhesion, the PROTEIN1 repeat region alone probably cannot promote cell adhesion, making it unlikely that PROTEIN2 induces axis duplication by increasing cell adhesion.
BioInfer.d540.s0.p2	N	Since PROTEIN2 is required for PROTEIN -mediated adhesion, the PROTEIN1 repeat region alone probably cannot promote cell adhesion, making it unlikely that PROTEIN induces axis duplication by increasing cell adhesion.
BioInfer.d540.s0.p3	N	Since PROTEIN is required for PROTEIN1 -mediated adhesion, the PROTEIN repeat region alone probably cannot promote cell adhesion, making it unlikely that PROTEIN2 induces axis duplication by increasing cell adhesion.
BioInfer.d540.s0.p4	N	Since PROTEIN2 is required for PROTEIN1 -mediated adhesion, the PROTEIN repeat region alone probably cannot promote cell adhesion, making it unlikely that PROTEIN induces axis duplication by increasing cell adhesion.
BioInfer.d540.s0.p5	N	Since PROTEIN2 is required for PROTEIN -mediated adhesion, the PROTEIN repeat region alone probably cannot promote cell adhesion, making it unlikely that PROTEIN1 induces axis duplication by increasing cell adhesion.
BioInfer.d541.s0.p0	P	Since both PROTEIN2 and PROTEIN1 have been found enriched in ruffling membranes of animal cells, our in vitro findings may be relevant to the regulation of PROTEIN filaments in living cells.
BioInfer.d541.s0.p1	N	Since both PROTEIN and PROTEIN1 have been found enriched in ruffling membranes of animal cells, our in vitro findings may be relevant to the regulation of PROTEIN2 filaments in living cells.
BioInfer.d541.s0.p2	N	Since both PROTEIN1 and PROTEIN have been found enriched in ruffling membranes of animal cells, our in vitro findings may be relevant to the regulation of PROTEIN2 filaments in living cells.
BioInfer.d542.s0.p0	P	Since PROTEIN2 is a recombinational protein associated with PROTEIN1 , this is the first genetic evidence that cancer arises from a defect in repair processes involving homologous recombination.
BioInfer.d543.s0.p0	P	PROTEIN2 , which consists of a full length PROTEIN and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and PROTEIN1 .
BioInfer.d543.s0.p1	N	PROTEIN , which consists of a full length PROTEIN2 and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and PROTEIN1 .
BioInfer.d543.s0.p2	P	PROTEIN1 , which consists of a full length PROTEIN2 and a tagged tail, was isolated on the basis of the affinities for Nickel agarose and PROTEIN .
BioInfer.d545.s0.p0	P	PROTEIN1 prepared from chicken gizzard binds to PROTEIN2 in vitro.
BioInfer.d546.s0.p0	N	Specific antibodies to PROTEIN isoforms ( PROTEIN1 , PROTEIN , PROTEIN ), PROTEIN , and PROTEIN2 and cDNAs for PROTEIN were used.
BioInfer.d546.s0.p1	N	Specific antibodies to PROTEIN isoforms ( PROTEIN1 , PROTEIN , PROTEIN ), PROTEIN2 , and PROTEIN and cDNAs for PROTEIN were used.
BioInfer.d546.s0.p2	N	Specific antibodies to PROTEIN isoforms ( PROTEIN1 , PROTEIN2 , PROTEIN ), PROTEIN , and PROTEIN and cDNAs for PROTEIN were used.
BioInfer.d546.s0.p3	N	Specific antibodies to PROTEIN isoforms ( PROTEIN1 , PROTEIN , PROTEIN ), PROTEIN , and PROTEIN and cDNAs for PROTEIN2 were used.
BioInfer.d546.s0.p4	N	Specific antibodies to PROTEIN isoforms ( PROTEIN1 , PROTEIN , PROTEIN2 ), PROTEIN , and PROTEIN and cDNAs for PROTEIN were used.
BioInfer.d546.s0.p5	P	Specific antibodies to PROTEIN2 isoforms ( PROTEIN1 , PROTEIN , PROTEIN ), PROTEIN , and PROTEIN and cDNAs for PROTEIN were used.
BioInfer.d546.s0.p6	N	Specific antibodies to PROTEIN isoforms ( PROTEIN , PROTEIN , PROTEIN ), PROTEIN2 , and PROTEIN1 and cDNAs for PROTEIN were used.
BioInfer.d546.s0.p7	N	Specific antibodies to PROTEIN isoforms ( PROTEIN , PROTEIN2 , PROTEIN ), PROTEIN , and PROTEIN1 and cDNAs for PROTEIN were used.
BioInfer.d546.s0.p8	N	Specific antibodies to PROTEIN isoforms ( PROTEIN , PROTEIN , PROTEIN ), PROTEIN , and PROTEIN1 and cDNAs for PROTEIN2 were used.
BioInfer.d546.s0.p9	N	Specific antibodies to PROTEIN isoforms ( PROTEIN , PROTEIN , PROTEIN2 ), PROTEIN , and PROTEIN1 and cDNAs for PROTEIN were used.
BioInfer.d546.s0.p10	N	Specific antibodies to PROTEIN2 isoforms ( PROTEIN , PROTEIN , PROTEIN ), PROTEIN , and PROTEIN1 and cDNAs for PROTEIN were used.
BioInfer.d546.s0.p11	N	Specific antibodies to PROTEIN isoforms ( PROTEIN , PROTEIN2 , PROTEIN ), PROTEIN1 , and PROTEIN and cDNAs for PROTEIN were used.
BioInfer.d546.s0.p12	N	Specific antibodies to PROTEIN isoforms ( PROTEIN , PROTEIN , PROTEIN ), PROTEIN1 , and PROTEIN and cDNAs for PROTEIN2 were used.
BioInfer.d546.s0.p13	N	Specific antibodies to PROTEIN isoforms ( PROTEIN , PROTEIN , PROTEIN2 ), PROTEIN1 , and PROTEIN and cDNAs for PROTEIN were used.
BioInfer.d546.s0.p14	N	Specific antibodies to PROTEIN2 isoforms ( PROTEIN , PROTEIN , PROTEIN ), PROTEIN1 , and PROTEIN and cDNAs for PROTEIN were used.
BioInfer.d546.s0.p15	N	Specific antibodies to PROTEIN isoforms ( PROTEIN , PROTEIN1 , PROTEIN ), PROTEIN , and PROTEIN and cDNAs for PROTEIN2 were used.
BioInfer.d546.s0.p16	N	Specific antibodies to PROTEIN isoforms ( PROTEIN , PROTEIN1 , PROTEIN2 ), PROTEIN , and PROTEIN and cDNAs for PROTEIN were used.
BioInfer.d546.s0.p17	P	Specific antibodies to PROTEIN2 isoforms ( PROTEIN , PROTEIN1 , PROTEIN ), PROTEIN , and PROTEIN and cDNAs for PROTEIN were used.
BioInfer.d546.s0.p18	N	Specific antibodies to PROTEIN isoforms ( PROTEIN , PROTEIN , PROTEIN2 ), PROTEIN , and PROTEIN and cDNAs for PROTEIN1 were used.
BioInfer.d546.s0.p19	N	Specific antibodies to PROTEIN2 isoforms ( PROTEIN , PROTEIN , PROTEIN ), PROTEIN , and PROTEIN and cDNAs for PROTEIN1 were used.
BioInfer.d546.s0.p20	P	Specific antibodies to PROTEIN2 isoforms ( PROTEIN , PROTEIN , PROTEIN1 ), PROTEIN , and PROTEIN and cDNAs for PROTEIN were used.
BioInfer.d547.s0.p0	N	Specific interaction between the PROTEIN ( PROTEIN ) and the PROTEIN2 ( PROTEIN1 ) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.
BioInfer.d547.s0.p1	P	Specific interaction between the PROTEIN2 ( PROTEIN ) and the PROTEIN ( PROTEIN1 ) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.
BioInfer.d547.s0.p2	P	Specific interaction between the PROTEIN ( PROTEIN2 ) and the PROTEIN ( PROTEIN1 ) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.
BioInfer.d547.s0.p3	P	Specific interaction between the PROTEIN2 ( PROTEIN ) and the PROTEIN1 ( PROTEIN ) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.
BioInfer.d547.s0.p4	P	Specific interaction between the PROTEIN ( PROTEIN2 ) and the PROTEIN1 ( PROTEIN ) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.
BioInfer.d547.s0.p5	N	Specific interaction between the PROTEIN1 ( PROTEIN2 ) and the PROTEIN ( PROTEIN ) of vesicular stomatitis virus (VSV), an important step in the life-cycle of the virus, was studied by using a two-hybrid system.
BioInfer.d548.s0.p0	P	Specific interactions between the PROTEIN ( PROTEIN2 ) and the PROTEIN1 ( PROTEIN ) of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.
BioInfer.d548.s0.p1	P	Specific interactions between the PROTEIN2 ( PROTEIN ) and the PROTEIN1 ( PROTEIN ) of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.
BioInfer.d548.s0.p2	N	Specific interactions between the PROTEIN ( PROTEIN ) and the PROTEIN1 ( PROTEIN2 ) of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.
BioInfer.d548.s0.p3	N	Specific interactions between the PROTEIN2 ( PROTEIN1 ) and the PROTEIN ( PROTEIN ) of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.
BioInfer.d548.s0.p4	P	Specific interactions between the PROTEIN ( PROTEIN1 ) and the PROTEIN ( PROTEIN2 ) of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.
BioInfer.d548.s0.p5	P	Specific interactions between the PROTEIN1 ( PROTEIN ) and the PROTEIN ( PROTEIN2 ) of bovine respiratory syncytial virus (BRSV) have been investigated using a yeast-based two-hybrid system.
BioInfer.d549.s0.p0	N	Spontaneous and mitomycin C-induced SCE levels were significantly reduced for chicken DT40 B cells lacking the key HR genes PROTEIN1 and PROTEIN2 but not for nonhomologous DNA end-joining (NHEJ)-defective KU70(-/-) cells.
BioInfer.d550.s0.p0	N	Stable transfection of mutant PROTEIN molecules showed that deletion of the PROTEIN1 binding domain, but not the PROTEIN2 binding domain, abolished PROTEIN downregulation.
BioInfer.d550.s0.p1	N	Stable transfection of mutant PROTEIN molecules showed that deletion of the PROTEIN1 binding domain, but not the PROTEIN binding domain, abolished PROTEIN2 downregulation.
BioInfer.d550.s0.p2	P	Stable transfection of mutant PROTEIN2 molecules showed that deletion of the PROTEIN1 binding domain, but not the PROTEIN binding domain, abolished PROTEIN downregulation.
BioInfer.d550.s0.p3	N	Stable transfection of mutant PROTEIN molecules showed that deletion of the PROTEIN binding domain, but not the PROTEIN1 binding domain, abolished PROTEIN2 downregulation.
BioInfer.d550.s0.p4	P	Stable transfection of mutant PROTEIN2 molecules showed that deletion of the PROTEIN binding domain, but not the PROTEIN1 binding domain, abolished PROTEIN downregulation.
BioInfer.d550.s0.p5	P	Stable transfection of mutant PROTEIN2 molecules showed that deletion of the PROTEIN binding domain, but not the PROTEIN binding domain, abolished PROTEIN1 downregulation.
BioInfer.d551.s0.p0	N	Structural studies on the ribbon-to-helix transition in PROTEIN1 : PROTEIN2 crystals.
BioInfer.d552.s0.p0	P	Studies on cultured cells have suggested that both PROTEIN2 and PROTEIN are important for the adhesive function of PROTEIN1 .
BioInfer.d552.s0.p1	P	Studies on cultured cells have suggested that both PROTEIN and PROTEIN2 are important for the adhesive function of PROTEIN1 .
BioInfer.d552.s0.p2	N	Studies on cultured cells have suggested that both PROTEIN1 and PROTEIN2 are important for the adhesive function of PROTEIN .
BioInfer.d553.s0.p0	P	Studies on the interaction between PROTEIN1 and PROTEIN2 purified by a new method.
BioInfer.d554.s0.p0	N	Study of mutated yeast PROTEIN and PROTEIN from Acanthamoeba suggests that the ability of PROTEIN2 to suppress PROTEIN1 cells is dependent upon a property other than, or in addition to, its ability to bind PROTEIN .
BioInfer.d554.s0.p1	N	Study of mutated yeast PROTEIN and PROTEIN from Acanthamoeba suggests that the ability of PROTEIN to suppress PROTEIN1 cells is dependent upon a property other than, or in addition to, its ability to bind PROTEIN2 .
BioInfer.d554.s0.p2	N	Study of mutated yeast PROTEIN2 and PROTEIN from Acanthamoeba suggests that the ability of PROTEIN to suppress PROTEIN1 cells is dependent upon a property other than, or in addition to, its ability to bind PROTEIN .
BioInfer.d554.s0.p3	N	Study of mutated yeast PROTEIN and PROTEIN2 from Acanthamoeba suggests that the ability of PROTEIN to suppress PROTEIN1 cells is dependent upon a property other than, or in addition to, its ability to bind PROTEIN .
BioInfer.d554.s0.p4	P	Study of mutated yeast PROTEIN and PROTEIN from Acanthamoeba suggests that the ability of PROTEIN1 to suppress PROTEIN cells is dependent upon a property other than, or in addition to, its ability to bind PROTEIN2 .
BioInfer.d554.s0.p5	N	Study of mutated yeast PROTEIN2 and PROTEIN from Acanthamoeba suggests that the ability of PROTEIN1 to suppress PROTEIN cells is dependent upon a property other than, or in addition to, its ability to bind PROTEIN .
BioInfer.d554.s0.p6	N	Study of mutated yeast PROTEIN and PROTEIN2 from Acanthamoeba suggests that the ability of PROTEIN1 to suppress PROTEIN cells is dependent upon a property other than, or in addition to, its ability to bind PROTEIN .
BioInfer.d554.s0.p7	N	Study of mutated yeast PROTEIN2 and PROTEIN from Acanthamoeba suggests that the ability of PROTEIN to suppress PROTEIN cells is dependent upon a property other than, or in addition to, its ability to bind PROTEIN1 .
BioInfer.d554.s0.p8	N	Study of mutated yeast PROTEIN and PROTEIN2 from Acanthamoeba suggests that the ability of PROTEIN to suppress PROTEIN cells is dependent upon a property other than, or in addition to, its ability to bind PROTEIN1 .
BioInfer.d554.s0.p9	N	Study of mutated yeast PROTEIN1 and PROTEIN2 from Acanthamoeba suggests that the ability of PROTEIN to suppress PROTEIN cells is dependent upon a property other than, or in addition to, its ability to bind PROTEIN .
BioInfer.d555.s0.p0	N	Such motifs are known to bind to PROTEIN2 ( PROTEIN1 ), small proteins engaged in the control of PROTEIN dynamics.
BioInfer.d555.s0.p1	P	Such motifs are known to bind to PROTEIN ( PROTEIN1 ), small proteins engaged in the control of PROTEIN2 dynamics.
BioInfer.d555.s0.p2	P	Such motifs are known to bind to PROTEIN1 ( PROTEIN ), small proteins engaged in the control of PROTEIN2 dynamics.
BioInfer.d556.s0.p0	P	Suppression of cell transformation by the PROTEIN  PROTEIN2 requires binding to PROTEIN1 .
BioInfer.d556.s0.p1	N	Suppression of cell transformation by the PROTEIN2  PROTEIN requires binding to PROTEIN1 .
BioInfer.d556.s0.p2	P	Suppression of cell transformation by the PROTEIN2  PROTEIN1 requires binding to PROTEIN .
BioInfer.d557.s0.p0	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN and PROTEIN gene but not the endogenous PROTEIN , PROTEIN , PROTEIN , the PROTEIN2 , or the PROTEIN1 genes.
BioInfer.d557.s0.p1	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN and PROTEIN gene but not the endogenous PROTEIN , PROTEIN , PROTEIN2 , the PROTEIN , or the PROTEIN1 genes.
BioInfer.d557.s0.p2	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN and PROTEIN gene but not the endogenous PROTEIN , PROTEIN2 , PROTEIN , the PROTEIN , or the PROTEIN1 genes.
BioInfer.d557.s0.p3	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN and PROTEIN gene but not the endogenous PROTEIN2 , PROTEIN , PROTEIN , the PROTEIN , or the PROTEIN1 genes.
BioInfer.d557.s0.p4	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN and PROTEIN2 gene but not the endogenous PROTEIN , PROTEIN , PROTEIN , the PROTEIN , or the PROTEIN1 genes.
BioInfer.d557.s0.p5	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN2 and PROTEIN gene but not the endogenous PROTEIN , PROTEIN , PROTEIN , the PROTEIN , or the PROTEIN1 genes.
BioInfer.d557.s0.p6	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN and PROTEIN gene but not the endogenous PROTEIN , PROTEIN , PROTEIN2 , the PROTEIN1 , or the PROTEIN genes.
BioInfer.d557.s0.p7	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN and PROTEIN gene but not the endogenous PROTEIN , PROTEIN2 , PROTEIN , the PROTEIN1 , or the PROTEIN genes.
BioInfer.d557.s0.p8	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN and PROTEIN gene but not the endogenous PROTEIN2 , PROTEIN , PROTEIN , the PROTEIN1 , or the PROTEIN genes.
BioInfer.d557.s0.p9	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN and PROTEIN2 gene but not the endogenous PROTEIN , PROTEIN , PROTEIN , the PROTEIN1 , or the PROTEIN genes.
BioInfer.d557.s0.p10	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN2 and PROTEIN gene but not the endogenous PROTEIN , PROTEIN , PROTEIN , the PROTEIN1 , or the PROTEIN genes.
BioInfer.d557.s0.p11	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN and PROTEIN gene but not the endogenous PROTEIN , PROTEIN2 , PROTEIN1 , the PROTEIN , or the PROTEIN genes.
BioInfer.d557.s0.p12	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN and PROTEIN gene but not the endogenous PROTEIN2 , PROTEIN , PROTEIN1 , the PROTEIN , or the PROTEIN genes.
BioInfer.d557.s0.p13	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN and PROTEIN2 gene but not the endogenous PROTEIN , PROTEIN , PROTEIN1 , the PROTEIN , or the PROTEIN genes.
BioInfer.d557.s0.p14	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN2 and PROTEIN gene but not the endogenous PROTEIN , PROTEIN , PROTEIN1 , the PROTEIN , or the PROTEIN genes.
BioInfer.d557.s0.p15	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN and PROTEIN gene but not the endogenous PROTEIN2 , PROTEIN1 , PROTEIN , the PROTEIN , or the PROTEIN genes.
BioInfer.d557.s0.p16	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN and PROTEIN2 gene but not the endogenous PROTEIN , PROTEIN1 , PROTEIN , the PROTEIN , or the PROTEIN genes.
BioInfer.d557.s0.p17	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN2 and PROTEIN gene but not the endogenous PROTEIN , PROTEIN1 , PROTEIN , the PROTEIN , or the PROTEIN genes.
BioInfer.d557.s0.p18	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN and PROTEIN2 gene but not the endogenous PROTEIN1 , PROTEIN , PROTEIN , the PROTEIN , or the PROTEIN genes.
BioInfer.d557.s0.p19	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN2 and PROTEIN gene but not the endogenous PROTEIN1 , PROTEIN , PROTEIN , the PROTEIN , or the PROTEIN genes.
BioInfer.d557.s0.p20	N	Surprisingly, although maintained in mitogen-rich medium, this ectopic expression was associated with a transactivation of the endogenous PROTEIN2 and PROTEIN1 gene but not the endogenous PROTEIN , PROTEIN , PROTEIN , the PROTEIN , or the PROTEIN genes.
BioInfer.d558.s1.p0	N	PROTEIN2 inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d558.s1.p1	N	PROTEIN inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against PROTEIN , PROTEIN1 , and PROTEIN2 .
BioInfer.d558.s1.p2	N	PROTEIN inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against PROTEIN2 , PROTEIN1 , and PROTEIN .
BioInfer.d558.s1.p3	N	PROTEIN1 inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d558.s1.p4	N	PROTEIN1 inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d558.s1.p5	N	PROTEIN inhibition also led to the formation of less prominent focal adhesions as revealed by immunofluorescence staining against PROTEIN2 , PROTEIN , and PROTEIN1 .
BioInfer.d559.s0.p0	P	PROTEIN ( PROTEIN2 ) is a PROTEIN highly expressed in testicular germ cells and has the potential to phosphorylate PROTEIN and induce PROTEIN1 cytoskeletal reorganization.
BioInfer.d559.s0.p1	P	PROTEIN2 ( PROTEIN ) is a PROTEIN highly expressed in testicular germ cells and has the potential to phosphorylate PROTEIN and induce PROTEIN1 cytoskeletal reorganization.
BioInfer.d559.s0.p2	N	PROTEIN ( PROTEIN ) is a PROTEIN2 highly expressed in testicular germ cells and has the potential to phosphorylate PROTEIN and induce PROTEIN1 cytoskeletal reorganization.
BioInfer.d559.s0.p3	N	PROTEIN ( PROTEIN ) is a PROTEIN highly expressed in testicular germ cells and has the potential to phosphorylate PROTEIN2 and induce PROTEIN1 cytoskeletal reorganization.
BioInfer.d559.s0.p4	N	PROTEIN2 ( PROTEIN1 ) is a PROTEIN highly expressed in testicular germ cells and has the potential to phosphorylate PROTEIN and induce PROTEIN cytoskeletal reorganization.
BioInfer.d559.s0.p5	P	PROTEIN ( PROTEIN1 ) is a PROTEIN2 highly expressed in testicular germ cells and has the potential to phosphorylate PROTEIN and induce PROTEIN cytoskeletal reorganization.
BioInfer.d559.s0.p6	P	PROTEIN ( PROTEIN1 ) is a PROTEIN highly expressed in testicular germ cells and has the potential to phosphorylate PROTEIN2 and induce PROTEIN cytoskeletal reorganization.
BioInfer.d559.s0.p7	P	PROTEIN1 ( PROTEIN ) is a PROTEIN2 highly expressed in testicular germ cells and has the potential to phosphorylate PROTEIN and induce PROTEIN cytoskeletal reorganization.
BioInfer.d559.s0.p8	P	PROTEIN1 ( PROTEIN ) is a PROTEIN highly expressed in testicular germ cells and has the potential to phosphorylate PROTEIN2 and induce PROTEIN cytoskeletal reorganization.
BioInfer.d559.s0.p9	N	PROTEIN ( PROTEIN ) is a PROTEIN1 highly expressed in testicular germ cells and has the potential to phosphorylate PROTEIN2 and induce PROTEIN cytoskeletal reorganization.
BioInfer.d560.s0.p0	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN1 , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p1	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p2	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p3	N	The 16236 nt genome encodes eight proteins, PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p4	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN2 ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p5	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p6	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN2 ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p7	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p8	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p9	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN2 ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p10	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN1 , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p11	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p12	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p13	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN2 ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p14	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p15	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p16	N	The 16236 nt genome encodes eight proteins, PROTEIN2 ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p17	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN2 ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p18	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p19	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN2 ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p20	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN2 ), PROTEIN1 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p21	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN , PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p22	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN2 ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p23	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN2 ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p24	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p25	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p26	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN2 ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p27	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN2 ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p28	N	The 16236 nt genome encodes eight proteins, PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p29	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN2 ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p30	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN2 ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p31	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN2 ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p32	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p33	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN2 ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p34	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN2 ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p35	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p36	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN2 ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p37	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN2 ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p38	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN2 ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p39	N	The 16236 nt genome encodes eight proteins, PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p40	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN2 ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p41	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p42	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) protein, PROTEIN ( PROTEIN2 ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p43	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p44	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p45	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) protein, PROTEIN2 ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p46	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p47	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN2 ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p48	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN1 ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p49	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN2 ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p50	N	The 16236 nt genome encodes eight proteins, PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN2 ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p51	N	The 16236 nt genome encodes eight proteins, PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p52	N	The 16236 nt genome encodes eight proteins, PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN2 ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p53	N	The 16236 nt genome encodes eight proteins, PROTEIN1 ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p54	N	The 16236 nt genome encodes eight proteins, PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p55	N	The 16236 nt genome encodes eight proteins, PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN2 ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p56	N	The 16236 nt genome encodes eight proteins, PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p57	N	The 16236 nt genome encodes eight proteins, PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p58	N	The 16236 nt genome encodes eight proteins, PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p59	N	The 16236 nt genome encodes eight proteins, PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN2 ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p60	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN1 ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p61	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN2 ) protein and PROTEIN1 ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p62	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN1 ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p63	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN1 ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p64	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN2 ( PROTEIN ) protein and PROTEIN1 ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p65	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN1 ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p66	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN1 ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p67	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN1 ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p68	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN1 ( PROTEIN2 ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p69	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN2 ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p70	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p71	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN2 ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p72	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN2 ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p73	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p74	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p75	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p76	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN2 ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p77	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN1 ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p78	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN1 ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p79	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN2 ( PROTEIN1 ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p80	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN1 ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p81	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) protein, PROTEIN ( PROTEIN1 ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p82	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN1 ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p83	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN1 ) protein and PROTEIN ( PROTEIN2 ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p84	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p85	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN2 ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p86	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p87	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p88	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p89	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN2 ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p90	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN2 ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p91	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p92	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p93	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p94	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN2 ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p95	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN1 ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p96	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) protein, PROTEIN1 ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p97	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) protein, PROTEIN1 ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p98	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN1 ( PROTEIN ) protein and PROTEIN ( PROTEIN2 ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p99	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p100	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p101	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN2 ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p102	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN1 ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p103	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN2 ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d560.s0.p104	N	The 16236 nt genome encodes eight proteins, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ) protein, PROTEIN ( PROTEIN ) protein and PROTEIN ( PROTEIN2 ) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.
BioInfer.d561.s0.p0	P	The PROTEIN1  PROTEIN2 was isolated from Tetrahymena thermophila by affinity chromatography, and the peptide sequence was determined for part of the protein.
BioInfer.d562.s0.p0	P	The PROTEIN1 bundle formation induced by overexpression of PROTEIN2 is accompanied with an increase in cell motility of Dictyostelium cells. 4.
BioInfer.d563.s0.p0	P	The PROTEIN1 cytoskeleton-associated protein PROTEIN2 binds to PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d563.s0.p1	N	The PROTEIN1 cytoskeleton-associated protein PROTEIN binds to PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d563.s0.p2	N	The PROTEIN1 cytoskeleton-associated protein PROTEIN binds to PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d563.s0.p3	N	The PROTEIN1 cytoskeleton-associated protein PROTEIN binds to PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d563.s0.p4	P	The PROTEIN cytoskeleton-associated protein PROTEIN1 binds to PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d563.s0.p5	P	The PROTEIN cytoskeleton-associated protein PROTEIN1 binds to PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d563.s0.p6	P	The PROTEIN cytoskeleton-associated protein PROTEIN1 binds to PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d563.s0.p7	N	The PROTEIN cytoskeleton-associated protein PROTEIN binds to PROTEIN1 , PROTEIN2 , and PROTEIN .
BioInfer.d563.s0.p8	N	The PROTEIN cytoskeleton-associated protein PROTEIN binds to PROTEIN1 , PROTEIN , and PROTEIN2 .
BioInfer.d563.s0.p9	N	The PROTEIN cytoskeleton-associated protein PROTEIN binds to PROTEIN , PROTEIN1 , and PROTEIN2 .
BioInfer.d564.s0.p0	N	The PROTEIN molecule links PROTEIN / PROTEIN2 or PROTEIN1 / PROTEIN complexes to the PROTEIN cytoskeleton.
BioInfer.d564.s0.p1	N	The PROTEIN molecule links PROTEIN2 / PROTEIN or PROTEIN1 / PROTEIN complexes to the PROTEIN cytoskeleton.
BioInfer.d564.s0.p2	P	The PROTEIN molecule links PROTEIN / PROTEIN or PROTEIN1 / PROTEIN2 complexes to the PROTEIN cytoskeleton.
BioInfer.d564.s0.p3	P	The PROTEIN2 molecule links PROTEIN / PROTEIN or PROTEIN1 / PROTEIN complexes to the PROTEIN cytoskeleton.
BioInfer.d564.s0.p4	P	The PROTEIN molecule links PROTEIN / PROTEIN or PROTEIN1 / PROTEIN complexes to the PROTEIN2 cytoskeleton.
BioInfer.d564.s0.p5	P	The PROTEIN molecule links PROTEIN2 / PROTEIN1 or PROTEIN / PROTEIN complexes to the PROTEIN cytoskeleton.
BioInfer.d564.s0.p6	N	The PROTEIN molecule links PROTEIN / PROTEIN1 or PROTEIN / PROTEIN2 complexes to the PROTEIN cytoskeleton.
BioInfer.d564.s0.p7	P	The PROTEIN2 molecule links PROTEIN / PROTEIN1 or PROTEIN / PROTEIN complexes to the PROTEIN cytoskeleton.
BioInfer.d564.s0.p8	P	The PROTEIN molecule links PROTEIN / PROTEIN1 or PROTEIN / PROTEIN complexes to the PROTEIN2 cytoskeleton.
BioInfer.d564.s0.p9	N	The PROTEIN molecule links PROTEIN1 / PROTEIN or PROTEIN / PROTEIN2 complexes to the PROTEIN cytoskeleton.
BioInfer.d564.s0.p10	P	The PROTEIN2 molecule links PROTEIN1 / PROTEIN or PROTEIN / PROTEIN complexes to the PROTEIN cytoskeleton.
BioInfer.d564.s0.p11	P	The PROTEIN molecule links PROTEIN1 / PROTEIN or PROTEIN / PROTEIN complexes to the PROTEIN2 cytoskeleton.
BioInfer.d564.s0.p12	P	The PROTEIN2 molecule links PROTEIN / PROTEIN or PROTEIN / PROTEIN1 complexes to the PROTEIN cytoskeleton.
BioInfer.d564.s0.p13	P	The PROTEIN molecule links PROTEIN / PROTEIN or PROTEIN / PROTEIN1 complexes to the PROTEIN2 cytoskeleton.
BioInfer.d564.s0.p14	P	The PROTEIN1 molecule links PROTEIN / PROTEIN or PROTEIN / PROTEIN complexes to the PROTEIN2 cytoskeleton.
BioInfer.d565.s0.p0	P	The ability of these three mutant PROTEIN proteins to form specific interactions with other members of the PROTEIN complex, PROTEIN2 and PROTEIN1 , indicates that the functional domains required for replication activity of PROTEIN are separable from domains responsible for protein-protein interactions.
BioInfer.d565.s0.p1	P	The ability of these three mutant PROTEIN2 proteins to form specific interactions with other members of the PROTEIN complex, PROTEIN and PROTEIN1 , indicates that the functional domains required for replication activity of PROTEIN are separable from domains responsible for protein-protein interactions.
BioInfer.d565.s0.p2	P	The ability of these three mutant PROTEIN proteins to form specific interactions with other members of the PROTEIN2 complex, PROTEIN and PROTEIN1 , indicates that the functional domains required for replication activity of PROTEIN are separable from domains responsible for protein-protein interactions.
BioInfer.d565.s0.p3	N	The ability of these three mutant PROTEIN proteins to form specific interactions with other members of the PROTEIN complex, PROTEIN and PROTEIN1 , indicates that the functional domains required for replication activity of PROTEIN2 are separable from domains responsible for protein-protein interactions.
BioInfer.d565.s0.p4	P	The ability of these three mutant PROTEIN2 proteins to form specific interactions with other members of the PROTEIN complex, PROTEIN1 and PROTEIN , indicates that the functional domains required for replication activity of PROTEIN are separable from domains responsible for protein-protein interactions.
BioInfer.d565.s0.p5	P	The ability of these three mutant PROTEIN proteins to form specific interactions with other members of the PROTEIN2 complex, PROTEIN1 and PROTEIN , indicates that the functional domains required for replication activity of PROTEIN are separable from domains responsible for protein-protein interactions.
BioInfer.d565.s0.p6	N	The ability of these three mutant PROTEIN proteins to form specific interactions with other members of the PROTEIN complex, PROTEIN1 and PROTEIN , indicates that the functional domains required for replication activity of PROTEIN2 are separable from domains responsible for protein-protein interactions.
BioInfer.d565.s0.p7	N	The ability of these three mutant PROTEIN1 proteins to form specific interactions with other members of the PROTEIN2 complex, PROTEIN and PROTEIN , indicates that the functional domains required for replication activity of PROTEIN are separable from domains responsible for protein-protein interactions.
BioInfer.d565.s0.p8	N	The ability of these three mutant PROTEIN1 proteins to form specific interactions with other members of the PROTEIN complex, PROTEIN and PROTEIN , indicates that the functional domains required for replication activity of PROTEIN2 are separable from domains responsible for protein-protein interactions.
BioInfer.d565.s0.p9	N	The ability of these three mutant PROTEIN proteins to form specific interactions with other members of the PROTEIN1 complex, PROTEIN and PROTEIN , indicates that the functional domains required for replication activity of PROTEIN2 are separable from domains responsible for protein-protein interactions.
BioInfer.d566.s0.p0	N	The ability of PROTEIN to replace PROTEIN is dependent on its WH2 PROTEIN2 binding domain and a putative PROTEIN1 binding domain.
BioInfer.d566.s0.p1	P	The ability of PROTEIN2 to replace PROTEIN is dependent on its WH2 PROTEIN binding domain and a putative PROTEIN1 binding domain.
BioInfer.d566.s0.p2	N	The ability of PROTEIN to replace PROTEIN2 is dependent on its WH2 PROTEIN binding domain and a putative PROTEIN1 binding domain.
BioInfer.d566.s0.p3	P	The ability of PROTEIN2 to replace PROTEIN is dependent on its WH2 PROTEIN1 binding domain and a putative PROTEIN binding domain.
BioInfer.d566.s0.p4	N	The ability of PROTEIN to replace PROTEIN2 is dependent on its WH2 PROTEIN1 binding domain and a putative PROTEIN binding domain.
BioInfer.d566.s0.p5	P	The ability of PROTEIN1 to replace PROTEIN2 is dependent on its WH2 PROTEIN binding domain and a putative PROTEIN binding domain.
BioInfer.d566.s1.p0	P	Thus, like PROTEIN1 , PROTEIN functions in yeast to link the polarity development pathway and the PROTEIN2 cytoskeleton to generate cytoskeletal asymmetry.
BioInfer.d566.s1.p1	N	Thus, like PROTEIN1 , PROTEIN2 functions in yeast to link the polarity development pathway and the PROTEIN cytoskeleton to generate cytoskeletal asymmetry.
BioInfer.d566.s1.p2	P	Thus, like PROTEIN , PROTEIN2 functions in yeast to link the polarity development pathway and the PROTEIN1 cytoskeleton to generate cytoskeletal asymmetry.
BioInfer.d567.s0.p0	P	The PROTEIN2 binding domain of PROTEIN1 is sufficient to contact to PROTEIN in vitro.
BioInfer.d567.s0.p1	P	The PROTEIN binding domain of PROTEIN1 is sufficient to contact to PROTEIN2 in vitro.
BioInfer.d567.s0.p2	N	The PROTEIN1 binding domain of PROTEIN is sufficient to contact to PROTEIN2 in vitro.
BioInfer.d568.s0.p0	P	The activation of the PROTEIN1 - PROTEIN2 protein leads to an accumulation of high levels of PROTEIN protein and a repression of the PROTEIN  PROTEIN under all culture conditions tested.
BioInfer.d568.s0.p1	P	The activation of the PROTEIN1 - PROTEIN protein leads to an accumulation of high levels of PROTEIN2 protein and a repression of the PROTEIN  PROTEIN under all culture conditions tested.
BioInfer.d568.s0.p2	N	The activation of the PROTEIN1 - PROTEIN protein leads to an accumulation of high levels of PROTEIN protein and a repression of the PROTEIN  PROTEIN2 under all culture conditions tested.
BioInfer.d568.s0.p3	P	The activation of the PROTEIN1 - PROTEIN protein leads to an accumulation of high levels of PROTEIN protein and a repression of the PROTEIN2  PROTEIN under all culture conditions tested.
BioInfer.d568.s0.p4	P	The activation of the PROTEIN - PROTEIN1 protein leads to an accumulation of high levels of PROTEIN2 protein and a repression of the PROTEIN  PROTEIN under all culture conditions tested.
BioInfer.d568.s0.p5	N	The activation of the PROTEIN - PROTEIN1 protein leads to an accumulation of high levels of PROTEIN protein and a repression of the PROTEIN  PROTEIN2 under all culture conditions tested.
BioInfer.d568.s0.p6	P	The activation of the PROTEIN - PROTEIN1 protein leads to an accumulation of high levels of PROTEIN protein and a repression of the PROTEIN2  PROTEIN under all culture conditions tested.
BioInfer.d568.s0.p7	N	The activation of the PROTEIN - PROTEIN protein leads to an accumulation of high levels of PROTEIN1 protein and a repression of the PROTEIN  PROTEIN2 under all culture conditions tested.
BioInfer.d568.s0.p8	N	The activation of the PROTEIN - PROTEIN protein leads to an accumulation of high levels of PROTEIN1 protein and a repression of the PROTEIN2  PROTEIN under all culture conditions tested.
BioInfer.d568.s0.p9	P	The activation of the PROTEIN - PROTEIN protein leads to an accumulation of high levels of PROTEIN protein and a repression of the PROTEIN2  PROTEIN1 under all culture conditions tested.
BioInfer.d569.s0.p0	N	The adventitial tissue underlying PTCA-induced lesions temporarily expressed PROTEIN , PROTEIN2 , and PROTEIN isoforms, but not PROTEIN1 .
BioInfer.d569.s0.p1	N	The adventitial tissue underlying PTCA-induced lesions temporarily expressed PROTEIN , PROTEIN , and PROTEIN2 isoforms, but not PROTEIN1 .
BioInfer.d569.s0.p2	N	The adventitial tissue underlying PTCA-induced lesions temporarily expressed PROTEIN2 , PROTEIN , and PROTEIN isoforms, but not PROTEIN1 .
BioInfer.d569.s0.p3	N	The adventitial tissue underlying PTCA-induced lesions temporarily expressed PROTEIN , PROTEIN1 , and PROTEIN2 isoforms, but not PROTEIN .
BioInfer.d569.s0.p4	N	The adventitial tissue underlying PTCA-induced lesions temporarily expressed PROTEIN2 , PROTEIN1 , and PROTEIN isoforms, but not PROTEIN .
BioInfer.d569.s0.p5	N	The adventitial tissue underlying PTCA-induced lesions temporarily expressed PROTEIN2 , PROTEIN , and PROTEIN1 isoforms, but not PROTEIN .
BioInfer.d570.s0.p0	N	The affinity of yeast PROTEIN1 for rabbit PROTEIN (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN2 for rabbit PROTEIN (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN .
BioInfer.d570.s0.p1	P	The affinity of yeast PROTEIN1 for rabbit PROTEIN2 (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN for rabbit PROTEIN (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN .
BioInfer.d570.s0.p2	N	The affinity of yeast PROTEIN1 for rabbit PROTEIN (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN for rabbit PROTEIN2 (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN .
BioInfer.d570.s0.p3	N	The affinity of yeast PROTEIN1 for rabbit PROTEIN (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN for rabbit PROTEIN (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN2 .
BioInfer.d570.s0.p4	N	The affinity of yeast PROTEIN for rabbit PROTEIN2 (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN1 for rabbit PROTEIN (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN .
BioInfer.d570.s0.p5	P	The affinity of yeast PROTEIN for rabbit PROTEIN (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN1 for rabbit PROTEIN2 (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN .
BioInfer.d570.s0.p6	N	The affinity of yeast PROTEIN for rabbit PROTEIN (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN1 for rabbit PROTEIN (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN2 .
BioInfer.d570.s0.p7	N	The affinity of yeast PROTEIN for rabbit PROTEIN1 (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN for rabbit PROTEIN2 (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN .
BioInfer.d570.s0.p8	N	The affinity of yeast PROTEIN for rabbit PROTEIN1 (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN for rabbit PROTEIN (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN2 .
BioInfer.d570.s0.p9	N	The affinity of yeast PROTEIN for rabbit PROTEIN (2.9 microM) is approximately 30-fold weaker than the affinity of human PROTEIN for rabbit PROTEIN1 (0.1 microM), and the relative contributions of entropic and enthalpic terms to the overall free energy of binding are different for the two PROTEIN2 .
BioInfer.d570.s1.p2	P	The interactions of yeast and human PROTEIN2 with rabbit PROTEIN1 were characterized by titration microcalorimetry, fluorescence titrations, and nucleotide exchange kinetics.
BioInfer.d570.s2.p0	P	The in vivo and in vitro properties of yeast PROTEIN1 mutants with altered poly-L-proline and PROTEIN2 binding sites are discussed in the context of the crystal structure.
BioInfer.d570.s3.p0	N	The titration of pyrene-labeled rabbit PROTEIN1 with human PROTEIN yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast PROTEIN and pyrene-labeled yeast PROTEIN2 .
BioInfer.d570.s3.p1	N	The titration of pyrene-labeled rabbit PROTEIN1 with human PROTEIN yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast PROTEIN2 and pyrene-labeled yeast PROTEIN .
BioInfer.d570.s3.p2	P	The titration of pyrene-labeled rabbit PROTEIN1 with human PROTEIN2 yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast PROTEIN and pyrene-labeled yeast PROTEIN .
BioInfer.d570.s3.p3	P	The titration of pyrene-labeled rabbit PROTEIN with human PROTEIN yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast PROTEIN2 and pyrene-labeled yeast PROTEIN1 .
BioInfer.d570.s3.p4	N	The titration of pyrene-labeled rabbit PROTEIN with human PROTEIN2 yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast PROTEIN and pyrene-labeled yeast PROTEIN1 .
BioInfer.d570.s3.p5	N	The titration of pyrene-labeled rabbit PROTEIN with human PROTEIN2 yielded a Kd of 2.8 microM, similar to the Kd of 2.0 microM for the interaction between yeast PROTEIN1 and pyrene-labeled yeast PROTEIN .
BioInfer.d570.s4.p0	N	Yeast PROTEIN was shown to catalyze adenine nucleotide exchange from yeast PROTEIN almost 2 orders of magnitude less efficiently than human PROTEIN2 and rabbit PROTEIN1 .
BioInfer.d570.s4.p1	N	Yeast PROTEIN2 was shown to catalyze adenine nucleotide exchange from yeast PROTEIN almost 2 orders of magnitude less efficiently than human PROTEIN and rabbit PROTEIN1 .
BioInfer.d570.s4.p2	N	Yeast PROTEIN was shown to catalyze adenine nucleotide exchange from yeast PROTEIN2 almost 2 orders of magnitude less efficiently than human PROTEIN and rabbit PROTEIN1 .
BioInfer.d570.s4.p3	N	Yeast PROTEIN2 was shown to catalyze adenine nucleotide exchange from yeast PROTEIN almost 2 orders of magnitude less efficiently than human PROTEIN1 and rabbit PROTEIN .
BioInfer.d570.s4.p4	N	Yeast PROTEIN was shown to catalyze adenine nucleotide exchange from yeast PROTEIN2 almost 2 orders of magnitude less efficiently than human PROTEIN1 and rabbit PROTEIN .
BioInfer.d570.s4.p5	N	Yeast PROTEIN1 was shown to catalyze adenine nucleotide exchange from yeast PROTEIN2 almost 2 orders of magnitude less efficiently than human PROTEIN and rabbit PROTEIN .
BioInfer.d571.s0.p0	N	The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two PROTEIN -associated proteins of the adherens junctions, such as PROTEIN1 and PROTEIN2 , and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.
BioInfer.d571.s0.p1	P	The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two PROTEIN2 -associated proteins of the adherens junctions, such as PROTEIN1 and PROTEIN , and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.
BioInfer.d571.s0.p2	P	The aim of our study on human seminiferous tubules of adolescent testes was to study the localization of two PROTEIN2 -associated proteins of the adherens junctions, such as PROTEIN and PROTEIN1 , and to verify if there were modifications in their pattern in varicocele, a frequent disease of the testis in adolescent age.
BioInfer.d572.s0.p0	N	The amino acid composition of the 15-kDa protein was similar to that of mammalian PROTEIN1 and it inhibited the salt-induced polymerization of rabbit PROTEIN2 .
BioInfer.d573.s0.p0	P	The amount of unassembled PROTEIN2 (12 microM) is accounted for by the sequestering functions of PROTEIN (20 microM) and PROTEIN1 (5 microM), the barbed ends being capped.
BioInfer.d573.s0.p1	N	The amount of unassembled PROTEIN (12 microM) is accounted for by the sequestering functions of PROTEIN2 (20 microM) and PROTEIN1 (5 microM), the barbed ends being capped.
BioInfer.d573.s0.p2	P	The amount of unassembled PROTEIN1 (12 microM) is accounted for by the sequestering functions of PROTEIN2 (20 microM) and PROTEIN (5 microM), the barbed ends being capped.
BioInfer.d574.s0.p0	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN1 ) proteins.
BioInfer.d574.s0.p1	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN1 ) proteins.
BioInfer.d574.s0.p2	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN1 ) proteins.
BioInfer.d574.s0.p3	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN1 ) proteins.
BioInfer.d574.s0.p4	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 , PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN1 ) proteins.
BioInfer.d574.s0.p5	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN1 ) proteins.
BioInfer.d574.s0.p6	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN1 ) proteins.
BioInfer.d574.s0.p7	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN1 ) proteins.
BioInfer.d574.s0.p8	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p9	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p10	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p11	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN2 , PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p12	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN2 ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p13	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN ) proteins.
BioInfer.d574.s0.p14	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN1 ), PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p15	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN , PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p16	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN1 ( PROTEIN2 ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p17	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 , PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p18	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p19	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN1 ( PROTEIN ) and PROTEIN2 ( PROTEIN ) proteins.
BioInfer.d574.s0.p20	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p21	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN , PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p22	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN2 , PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p23	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN , PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p24	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN , PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN ) proteins.
BioInfer.d574.s0.p25	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN1 ), PROTEIN , PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p26	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 , PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p27	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p28	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN1 ) and PROTEIN2 ( PROTEIN ) proteins.
BioInfer.d574.s0.p29	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p30	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p31	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 , PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN ) proteins.
BioInfer.d574.s0.p32	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN1 , PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p33	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ) and PROTEIN2 ( PROTEIN ) proteins.
BioInfer.d574.s0.p34	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN1 ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins.
BioInfer.d574.s0.p35	N	The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN , PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) proteins.
BioInfer.d575.s0.p0	N	The PROTEIN1 binding site on PROTEIN may be discontinuous since neither the carboxyl- nor amino-terminal halves of PROTEIN will independently associate with PROTEIN , although the amino-terminal half independently binds PROTEIN2 .
BioInfer.d575.s0.p1	N	The PROTEIN1 binding site on PROTEIN may be discontinuous since neither the carboxyl- nor amino-terminal halves of PROTEIN will independently associate with PROTEIN2 , although the amino-terminal half independently binds PROTEIN .
BioInfer.d575.s0.p2	P	The PROTEIN1 binding site on PROTEIN2 may be discontinuous since neither the carboxyl- nor amino-terminal halves of PROTEIN will independently associate with PROTEIN , although the amino-terminal half independently binds PROTEIN .
BioInfer.d575.s0.p3	N	The PROTEIN1 binding site on PROTEIN may be discontinuous since neither the carboxyl- nor amino-terminal halves of PROTEIN2 will independently associate with PROTEIN , although the amino-terminal half independently binds PROTEIN .
BioInfer.d575.s0.p4	N	The PROTEIN binding site on PROTEIN may be discontinuous since neither the carboxyl- nor amino-terminal halves of PROTEIN will independently associate with PROTEIN2 , although the amino-terminal half independently binds PROTEIN1 .
BioInfer.d575.s0.p5	N	The PROTEIN binding site on PROTEIN2 may be discontinuous since neither the carboxyl- nor amino-terminal halves of PROTEIN will independently associate with PROTEIN , although the amino-terminal half independently binds PROTEIN1 .
BioInfer.d575.s0.p6	P	The PROTEIN binding site on PROTEIN may be discontinuous since neither the carboxyl- nor amino-terminal halves of PROTEIN2 will independently associate with PROTEIN , although the amino-terminal half independently binds PROTEIN1 .
BioInfer.d575.s0.p7	N	The PROTEIN binding site on PROTEIN2 may be discontinuous since neither the carboxyl- nor amino-terminal halves of PROTEIN will independently associate with PROTEIN1 , although the amino-terminal half independently binds PROTEIN .
BioInfer.d575.s0.p8	P	The PROTEIN binding site on PROTEIN may be discontinuous since neither the carboxyl- nor amino-terminal halves of PROTEIN2 will independently associate with PROTEIN1 , although the amino-terminal half independently binds PROTEIN .
BioInfer.d575.s0.p9	N	The PROTEIN binding site on PROTEIN1 may be discontinuous since neither the carboxyl- nor amino-terminal halves of PROTEIN2 will independently associate with PROTEIN , although the amino-terminal half independently binds PROTEIN .
BioInfer.d575.s1.p0	P	The PROTEIN2 protein and PROTEIN1 form similar but independent complexes with PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d575.s1.p1	P	The PROTEIN protein and PROTEIN1 form similar but independent complexes with PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d575.s1.p2	P	The PROTEIN protein and PROTEIN1 form similar but independent complexes with PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d575.s1.p3	P	The PROTEIN protein and PROTEIN1 form similar but independent complexes with PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d575.s1.p4	P	The PROTEIN1 protein and PROTEIN form similar but independent complexes with PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d575.s1.p5	P	The PROTEIN1 protein and PROTEIN form similar but independent complexes with PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d575.s1.p6	P	The PROTEIN1 protein and PROTEIN form similar but independent complexes with PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d575.s1.p7	P	The PROTEIN protein and PROTEIN form similar but independent complexes with PROTEIN2 , PROTEIN , and PROTEIN1 .
BioInfer.d575.s1.p8	P	The PROTEIN protein and PROTEIN form similar but independent complexes with PROTEIN , PROTEIN2 , and PROTEIN1 .
BioInfer.d575.s1.p9	P	The PROTEIN protein and PROTEIN form similar but independent complexes with PROTEIN1 , PROTEIN2 , and PROTEIN .
BioInfer.d575.s2.p0	P	Thus, PROTEIN forms distinct heteromeric complexes containing combinations of PROTEIN2 , PROTEIN1 , and PROTEIN which are independent from the PROTEIN - PROTEIN complexes.
BioInfer.d575.s2.p1	P	Thus, PROTEIN forms distinct heteromeric complexes containing combinations of PROTEIN , PROTEIN1 , and PROTEIN2 which are independent from the PROTEIN - PROTEIN complexes.
BioInfer.d575.s2.p2	P	Thus, PROTEIN forms distinct heteromeric complexes containing combinations of PROTEIN , PROTEIN1 , and PROTEIN which are independent from the PROTEIN2 - PROTEIN complexes.
BioInfer.d575.s2.p3	P	Thus, PROTEIN2 forms distinct heteromeric complexes containing combinations of PROTEIN , PROTEIN1 , and PROTEIN which are independent from the PROTEIN - PROTEIN complexes.
BioInfer.d575.s2.p4	P	Thus, PROTEIN forms distinct heteromeric complexes containing combinations of PROTEIN , PROTEIN1 , and PROTEIN which are independent from the PROTEIN - PROTEIN2 complexes.
BioInfer.d575.s2.p5	P	Thus, PROTEIN forms distinct heteromeric complexes containing combinations of PROTEIN1 , PROTEIN , and PROTEIN2 which are independent from the PROTEIN - PROTEIN complexes.
BioInfer.d575.s2.p6	P	Thus, PROTEIN forms distinct heteromeric complexes containing combinations of PROTEIN1 , PROTEIN , and PROTEIN which are independent from the PROTEIN2 - PROTEIN complexes.
BioInfer.d575.s2.p7	P	Thus, PROTEIN2 forms distinct heteromeric complexes containing combinations of PROTEIN1 , PROTEIN , and PROTEIN which are independent from the PROTEIN - PROTEIN complexes.
BioInfer.d575.s2.p8	P	Thus, PROTEIN forms distinct heteromeric complexes containing combinations of PROTEIN1 , PROTEIN , and PROTEIN which are independent from the PROTEIN - PROTEIN2 complexes.
BioInfer.d575.s2.p9	P	Thus, PROTEIN forms distinct heteromeric complexes containing combinations of PROTEIN , PROTEIN , and PROTEIN1 which are independent from the PROTEIN2 - PROTEIN complexes.
BioInfer.d575.s2.p10	P	Thus, PROTEIN2 forms distinct heteromeric complexes containing combinations of PROTEIN , PROTEIN , and PROTEIN1 which are independent from the PROTEIN - PROTEIN complexes.
BioInfer.d575.s2.p11	P	Thus, PROTEIN forms distinct heteromeric complexes containing combinations of PROTEIN , PROTEIN , and PROTEIN1 which are independent from the PROTEIN - PROTEIN2 complexes.
BioInfer.d575.s2.p12	P	Thus, PROTEIN2 forms distinct heteromeric complexes containing combinations of PROTEIN , PROTEIN , and PROTEIN which are independent from the PROTEIN1 - PROTEIN complexes.
BioInfer.d575.s2.p13	P	Thus, PROTEIN forms distinct heteromeric complexes containing combinations of PROTEIN , PROTEIN , and PROTEIN which are independent from the PROTEIN1 - PROTEIN2 complexes.
BioInfer.d575.s2.p14	P	Thus, PROTEIN1 forms distinct heteromeric complexes containing combinations of PROTEIN , PROTEIN , and PROTEIN which are independent from the PROTEIN - PROTEIN2 complexes.
BioInfer.d576.s0.p0	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 (Machesky et al., 1994).
BioInfer.d576.s0.p1	P	The PROTEIN2 /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p3	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p4	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN2 ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p5	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p6	N	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN2 -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p7	N	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN2 , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p8	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p9	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN2 and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p10	P	The PROTEIN2 /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 (Machesky et al., 1994).
BioInfer.d576.s0.p12	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 (Machesky et al., 1994).
BioInfer.d576.s0.p13	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN2 ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 (Machesky et al., 1994).
BioInfer.d576.s0.p14	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 (Machesky et al., 1994).
BioInfer.d576.s0.p15	N	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN2 -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 (Machesky et al., 1994).
BioInfer.d576.s0.p16	N	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN2 , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 (Machesky et al., 1994).
BioInfer.d576.s0.p17	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 (Machesky et al., 1994).
BioInfer.d576.s0.p18	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN2 and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 (Machesky et al., 1994).
BioInfer.d576.s0.p20	P	The PROTEIN1 /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p21	P	The PROTEIN1 /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN2 ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p22	P	The PROTEIN1 /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p23	N	The PROTEIN1 /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN2 -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p24	N	The PROTEIN1 /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN2 , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p25	P	The PROTEIN1 /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p26	P	The PROTEIN1 /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN2 and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p34	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN2 ; and five apparently novel proteins, PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p35	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p36	N	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN2 -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p37	N	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN2 , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p38	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p39	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN2 and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p40	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN1 ; and five apparently novel proteins, PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p41	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN2 -related proteins, PROTEIN and PROTEIN1 ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p42	N	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN2 , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN1 ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p43	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN1 ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p44	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN2 and PROTEIN1 ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p45	N	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN2 -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p46	N	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN2 , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p47	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p48	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN2 and PROTEIN ; and five apparently novel proteins, PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p49	N	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN2 , consists of seven polypeptides; two PROTEIN1 -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p50	N	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN1 -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p51	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN1 -related proteins, PROTEIN2 and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p52	N	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN1 , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p53	N	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN1 , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN2 and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d576.s0.p54	P	The PROTEIN /3 complex, first isolated from Acanthamoeba castellani by affinity chromatography on PROTEIN , consists of seven polypeptides; two PROTEIN -related proteins, PROTEIN2 and PROTEIN ; and five apparently novel proteins, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN (Machesky et al., 1994).
BioInfer.d577.s0.p0	P	The PROTEIN /3 complex with full-length PROTEIN , PROTEIN containing P, W, and A domains, or PROTEIN containing W and A domains overcomes inhibition of nucleation by the PROTEIN1 monomer-binding protein PROTEIN2 , giving active nucleation over a low background of spontaneous nucleation.
BioInfer.d577.s0.p1	N	The PROTEIN /3 complex with full-length PROTEIN2 , PROTEIN containing P, W, and A domains, or PROTEIN containing W and A domains overcomes inhibition of nucleation by the PROTEIN1 monomer-binding protein PROTEIN , giving active nucleation over a low background of spontaneous nucleation.
BioInfer.d577.s0.p3	N	The PROTEIN /3 complex with full-length PROTEIN , PROTEIN2 containing P, W, and A domains, or PROTEIN containing W and A domains overcomes inhibition of nucleation by the PROTEIN1 monomer-binding protein PROTEIN , giving active nucleation over a low background of spontaneous nucleation.
BioInfer.d577.s0.p4	N	The PROTEIN /3 complex with full-length PROTEIN , PROTEIN containing P, W, and A domains, or PROTEIN2 containing W and A domains overcomes inhibition of nucleation by the PROTEIN1 monomer-binding protein PROTEIN , giving active nucleation over a low background of spontaneous nucleation.
BioInfer.d577.s0.p5	N	The PROTEIN2 /3 complex with full-length PROTEIN , PROTEIN containing P, W, and A domains, or PROTEIN containing W and A domains overcomes inhibition of nucleation by the PROTEIN1 monomer-binding protein PROTEIN , giving active nucleation over a low background of spontaneous nucleation.
BioInfer.d577.s0.p6	N	The PROTEIN /3 complex with full-length PROTEIN2 , PROTEIN containing P, W, and A domains, or PROTEIN containing W and A domains overcomes inhibition of nucleation by the PROTEIN monomer-binding protein PROTEIN1 , giving active nucleation over a low background of spontaneous nucleation.
BioInfer.d577.s0.p8	N	The PROTEIN /3 complex with full-length PROTEIN , PROTEIN2 containing P, W, and A domains, or PROTEIN containing W and A domains overcomes inhibition of nucleation by the PROTEIN monomer-binding protein PROTEIN1 , giving active nucleation over a low background of spontaneous nucleation.
BioInfer.d577.s0.p9	N	The PROTEIN /3 complex with full-length PROTEIN , PROTEIN containing P, W, and A domains, or PROTEIN2 containing W and A domains overcomes inhibition of nucleation by the PROTEIN monomer-binding protein PROTEIN1 , giving active nucleation over a low background of spontaneous nucleation.
BioInfer.d577.s0.p10	P	The PROTEIN2 /3 complex with full-length PROTEIN , PROTEIN containing P, W, and A domains, or PROTEIN containing W and A domains overcomes inhibition of nucleation by the PROTEIN monomer-binding protein PROTEIN1 , giving active nucleation over a low background of spontaneous nucleation.
BioInfer.d577.s0.p12	N	The PROTEIN /3 complex with full-length PROTEIN1 , PROTEIN2 containing P, W, and A domains, or PROTEIN containing W and A domains overcomes inhibition of nucleation by the PROTEIN monomer-binding protein PROTEIN , giving active nucleation over a low background of spontaneous nucleation.
BioInfer.d577.s0.p13	N	The PROTEIN /3 complex with full-length PROTEIN1 , PROTEIN containing P, W, and A domains, or PROTEIN2 containing W and A domains overcomes inhibition of nucleation by the PROTEIN monomer-binding protein PROTEIN , giving active nucleation over a low background of spontaneous nucleation.
BioInfer.d577.s0.p14	N	The PROTEIN2 /3 complex with full-length PROTEIN1 , PROTEIN containing P, W, and A domains, or PROTEIN containing W and A domains overcomes inhibition of nucleation by the PROTEIN monomer-binding protein PROTEIN , giving active nucleation over a low background of spontaneous nucleation.
BioInfer.d577.s0.p18	N	The PROTEIN /3 complex with full-length PROTEIN , PROTEIN1 containing P, W, and A domains, or PROTEIN2 containing W and A domains overcomes inhibition of nucleation by the PROTEIN monomer-binding protein PROTEIN , giving active nucleation over a low background of spontaneous nucleation.
BioInfer.d577.s0.p19	N	The PROTEIN2 /3 complex with full-length PROTEIN , PROTEIN1 containing P, W, and A domains, or PROTEIN containing W and A domains overcomes inhibition of nucleation by the PROTEIN monomer-binding protein PROTEIN , giving active nucleation over a low background of spontaneous nucleation.
BioInfer.d577.s0.p20	N	The PROTEIN2 /3 complex with full-length PROTEIN , PROTEIN containing P, W, and A domains, or PROTEIN1 containing W and A domains overcomes inhibition of nucleation by the PROTEIN monomer-binding protein PROTEIN , giving active nucleation over a low background of spontaneous nucleation.
BioInfer.d578.s0.p0	P	The assay detects the high-affinity binding of PROTEIN1 to PROTEIN ( PROTEIN2 ), PROTEIN or PROTEIN .
BioInfer.d578.s0.p1	P	The assay detects the high-affinity binding of PROTEIN1 to PROTEIN ( PROTEIN ), PROTEIN2 or PROTEIN .
BioInfer.d578.s0.p2	P	The assay detects the high-affinity binding of PROTEIN1 to PROTEIN2 ( PROTEIN ), PROTEIN or PROTEIN .
BioInfer.d578.s0.p3	P	The assay detects the high-affinity binding of PROTEIN1 to PROTEIN ( PROTEIN ), PROTEIN or PROTEIN2 .
BioInfer.d578.s0.p4	N	The assay detects the high-affinity binding of PROTEIN to PROTEIN ( PROTEIN1 ), PROTEIN2 or PROTEIN .
BioInfer.d578.s0.p5	N	The assay detects the high-affinity binding of PROTEIN to PROTEIN2 ( PROTEIN1 ), PROTEIN or PROTEIN .
BioInfer.d578.s0.p6	N	The assay detects the high-affinity binding of PROTEIN to PROTEIN ( PROTEIN1 ), PROTEIN or PROTEIN2 .
BioInfer.d578.s0.p7	N	The assay detects the high-affinity binding of PROTEIN to PROTEIN2 ( PROTEIN ), PROTEIN1 or PROTEIN .
BioInfer.d578.s0.p8	N	The assay detects the high-affinity binding of PROTEIN to PROTEIN ( PROTEIN ), PROTEIN1 or PROTEIN2 .
BioInfer.d578.s0.p9	N	The assay detects the high-affinity binding of PROTEIN to PROTEIN1 ( PROTEIN ), PROTEIN or PROTEIN2 .
BioInfer.d579.s0.p0	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 , that are essential for viral DNA replication.
BioInfer.d579.s0.p1	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN , that are essential for viral DNA replication.
BioInfer.d579.s0.p2	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN , that are essential for viral DNA replication.
BioInfer.d579.s0.p3	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , that are essential for viral DNA replication.
BioInfer.d579.s0.p4	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , that are essential for viral DNA replication.
BioInfer.d579.s0.p5	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , that are essential for viral DNA replication.
BioInfer.d579.s0.p6	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 , that are essential for viral DNA replication.
BioInfer.d579.s0.p7	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 , that are essential for viral DNA replication.
BioInfer.d579.s0.p8	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , that are essential for viral DNA replication.
BioInfer.d579.s0.p9	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , that are essential for viral DNA replication.
BioInfer.d579.s0.p10	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , that are essential for viral DNA replication.
BioInfer.d579.s0.p11	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN , that are essential for viral DNA replication.
BioInfer.d579.s0.p12	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , that are essential for viral DNA replication.
BioInfer.d579.s0.p13	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , that are essential for viral DNA replication.
BioInfer.d579.s0.p14	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , that are essential for viral DNA replication.
BioInfer.d579.s0.p15	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , that are essential for viral DNA replication.
BioInfer.d579.s0.p16	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , that are essential for viral DNA replication.
BioInfer.d579.s0.p17	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , that are essential for viral DNA replication.
BioInfer.d579.s0.p18	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , that are essential for viral DNA replication.
BioInfer.d579.s0.p19	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , that are essential for viral DNA replication.
BioInfer.d579.s0.p20	N	The assembly of complete HSV replication compartments and incorporation of BrdU were both abolished by treatment with phosphonoacetic acid (PAA) and by omission of any one of the seven viral replication proteins, PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , that are essential for viral DNA replication.
BioInfer.d580.s0.p0	N	The PROTEIN component of the herpes simplex virus PROTEIN2 complex stimulates primer synthesis by a subassembly of the PROTEIN and PROTEIN1 components.
BioInfer.d580.s0.p1	P	The PROTEIN2 component of the herpes simplex virus PROTEIN complex stimulates primer synthesis by a subassembly of the PROTEIN and PROTEIN1 components.
BioInfer.d580.s0.p2	P	The PROTEIN component of the herpes simplex virus PROTEIN complex stimulates primer synthesis by a subassembly of the PROTEIN2 and PROTEIN1 components.
BioInfer.d580.s0.p3	P	The PROTEIN2 component of the herpes simplex virus PROTEIN1 complex stimulates primer synthesis by a subassembly of the PROTEIN and PROTEIN components.
BioInfer.d580.s0.p4	N	The PROTEIN component of the herpes simplex virus PROTEIN1 complex stimulates primer synthesis by a subassembly of the PROTEIN2 and PROTEIN components.
BioInfer.d580.s0.p5	P	The PROTEIN1 component of the herpes simplex virus PROTEIN complex stimulates primer synthesis by a subassembly of the PROTEIN2 and PROTEIN components.
BioInfer.d580.s1.p0	P	The herpes simplex virus type 1 (HSV) PROTEIN , PROTEIN2 , and PROTEIN1 proteins form a helicase-primase complex in infected cells.
BioInfer.d580.s1.p1	P	The herpes simplex virus type 1 (HSV) PROTEIN2 , PROTEIN , and PROTEIN1 proteins form a helicase-primase complex in infected cells.
BioInfer.d580.s1.p2	P	The herpes simplex virus type 1 (HSV) PROTEIN2 , PROTEIN1 , and PROTEIN proteins form a helicase-primase complex in infected cells.
BioInfer.d581.s0.p0	N	The PROTEIN1 -binding region is distinct from major anti- PROTEIN mAb epitopes on the human PROTEIN ( PROTEIN2 ) molecule.
BioInfer.d581.s0.p1	N	The PROTEIN1 -binding region is distinct from major anti- PROTEIN2 mAb epitopes on the human PROTEIN ( PROTEIN ) molecule.
BioInfer.d581.s0.p2	N	The PROTEIN1 -binding region is distinct from major anti- PROTEIN mAb epitopes on the human PROTEIN2 ( PROTEIN ) molecule.
BioInfer.d581.s0.p3	P	The PROTEIN -binding region is distinct from major anti- PROTEIN2 mAb epitopes on the human PROTEIN ( PROTEIN1 ) molecule.
BioInfer.d581.s0.p4	N	The PROTEIN -binding region is distinct from major anti- PROTEIN mAb epitopes on the human PROTEIN2 ( PROTEIN1 ) molecule.
BioInfer.d581.s0.p5	P	The PROTEIN -binding region is distinct from major anti- PROTEIN1 mAb epitopes on the human PROTEIN2 ( PROTEIN ) molecule.
BioInfer.d582.s0.p0	N	The binding constants of Acanthamoeba PROTEIN2 to fluorescein-labeled PROTEIN from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the PROTEIN1 tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added PROTEIN concentration.
BioInfer.d582.s0.p1	N	The binding constants of Acanthamoeba PROTEIN to fluorescein-labeled PROTEIN2 from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the PROTEIN1 tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added PROTEIN concentration.
BioInfer.d582.s0.p2	N	The binding constants of Acanthamoeba PROTEIN to fluorescein-labeled PROTEIN from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the PROTEIN1 tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added PROTEIN2 concentration.
BioInfer.d582.s0.p3	P	The binding constants of Acanthamoeba PROTEIN1 to fluorescein-labeled PROTEIN2 from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the PROTEIN tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added PROTEIN concentration.
BioInfer.d582.s0.p4	N	The binding constants of Acanthamoeba PROTEIN1 to fluorescein-labeled PROTEIN from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the PROTEIN tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added PROTEIN2 concentration.
BioInfer.d582.s0.p5	N	The binding constants of Acanthamoeba PROTEIN to fluorescein-labeled PROTEIN1 from Acanthamoeba and from rabbit skeletal muscle have been determined by measuring the reduction in the PROTEIN tracer diffusion coefficients, determined by fluorescence photobleaching recovery, as a function of added PROTEIN2 concentration.
BioInfer.d582.s1.p0	P	These dissociation constants are the first to be determined from direct physical measurement; they are in agreement with values inferred from earlier studies on the effect of PROTEIN2 on the assembly of PROTEIN1 that had been fluorescently labeled or otherwise modified at Cys 374.
BioInfer.d582.s2.p0	N	These results place important restrictions on the interpretation of experiments in which fluorescently labeled PROTEIN1 is used as a probe of living cytoplasm or cytoplasmic extracts that include PROTEIN2 .
BioInfer.d583.s0.p0	P	The binding surfaces for segment 1 and PROTEIN2 are different, although they peripherally overlap on PROTEIN1 .
BioInfer.d583.s1.p0	P	This review describes three structures of PROTEIN1 complexed with different monomer-binding proteins, namely with PROTEIN2 , PROTEIN segment 1, and PROTEIN .
BioInfer.d583.s1.p1	P	This review describes three structures of PROTEIN1 complexed with different monomer-binding proteins, namely with PROTEIN , PROTEIN segment 1, and PROTEIN2 .
BioInfer.d583.s1.p2	P	This review describes three structures of PROTEIN1 complexed with different monomer-binding proteins, namely with PROTEIN , PROTEIN2 segment 1, and PROTEIN .
BioInfer.d583.s1.p3	N	This review describes three structures of PROTEIN complexed with different monomer-binding proteins, namely with PROTEIN1 , PROTEIN segment 1, and PROTEIN2 .
BioInfer.d583.s1.p4	N	This review describes three structures of PROTEIN complexed with different monomer-binding proteins, namely with PROTEIN1 , PROTEIN2 segment 1, and PROTEIN .
BioInfer.d583.s1.p5	N	This review describes three structures of PROTEIN complexed with different monomer-binding proteins, namely with PROTEIN , PROTEIN2 segment 1, and PROTEIN1 .
BioInfer.d584.s0.p0	N	The PROTEIN1 ( PROTEIN2 ) contains the PROTEIN - and ATP-binding sites and represents the molecular motor of muscle contraction.
BioInfer.d584.s0.p1	P	The PROTEIN1 ( PROTEIN ) contains the PROTEIN2 - and ATP-binding sites and represents the molecular motor of muscle contraction.
BioInfer.d584.s0.p2	P	The PROTEIN ( PROTEIN1 ) contains the PROTEIN2 - and ATP-binding sites and represents the molecular motor of muscle contraction.
BioInfer.d585.s0.p0	N	The PROTEIN ( PROTEIN ) of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN2 ] and Indiana [ PROTEIN1 ] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN  PROTEIN in vivo.
BioInfer.d585.s0.p1	P	The PROTEIN ( PROTEIN2 ) of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN ] and Indiana [ PROTEIN1 ] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN  PROTEIN in vivo.
BioInfer.d585.s0.p2	P	The PROTEIN2 ( PROTEIN ) of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN ] and Indiana [ PROTEIN1 ] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN  PROTEIN in vivo.
BioInfer.d585.s0.p3	N	The PROTEIN ( PROTEIN ) of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN ] and Indiana [ PROTEIN1 ] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN2  PROTEIN in vivo.
BioInfer.d585.s0.p4	P	The PROTEIN ( PROTEIN ) of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN ] and Indiana [ PROTEIN1 ] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN  PROTEIN2 in vivo.
BioInfer.d585.s0.p5	P	The PROTEIN ( PROTEIN2 ) of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN1 ] and Indiana [ PROTEIN ] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN  PROTEIN in vivo.
BioInfer.d585.s0.p6	P	The PROTEIN2 ( PROTEIN ) of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN1 ] and Indiana [ PROTEIN ] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN  PROTEIN in vivo.
BioInfer.d585.s0.p7	N	The PROTEIN ( PROTEIN ) of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN1 ] and Indiana [ PROTEIN ] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN2  PROTEIN in vivo.
BioInfer.d585.s0.p8	P	The PROTEIN ( PROTEIN ) of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN1 ] and Indiana [ PROTEIN ] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN  PROTEIN2 in vivo.
BioInfer.d585.s0.p9	N	The PROTEIN2 ( PROTEIN1 ) of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN ] and Indiana [ PROTEIN ] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN  PROTEIN in vivo.
BioInfer.d585.s0.p10	N	The PROTEIN ( PROTEIN1 ) of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN ] and Indiana [ PROTEIN ] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN2  PROTEIN in vivo.
BioInfer.d585.s0.p11	P	The PROTEIN ( PROTEIN1 ) of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN ] and Indiana [ PROTEIN ] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN  PROTEIN2 in vivo.
BioInfer.d585.s0.p12	N	The PROTEIN1 ( PROTEIN ) of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN ] and Indiana [ PROTEIN ] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN2  PROTEIN in vivo.
BioInfer.d585.s0.p13	P	The PROTEIN1 ( PROTEIN ) of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN ] and Indiana [ PROTEIN ] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN  PROTEIN2 in vivo.
BioInfer.d585.s0.p14	P	The PROTEIN ( PROTEIN ) of vesicular stomatitis virus (VSV) serotypes New Jersey [ PROTEIN ] and Indiana [ PROTEIN ] contains a highly conserved carboxy-terminal domain which is required for binding to the cognate N-RNA template as well as to form a soluble complex with the PROTEIN1  PROTEIN2 in vivo.
BioInfer.d586.s0.p0	N	The PROTEIN1 and PROTEIN2 genes are involved in genetic recombination and double-strand break repair in the yeast Saccharomyces cerevisiae.
BioInfer.d587.s0.p0	N	The PROTEIN2 -like central (vc) region of PROTEIN induces PROTEIN /3 complex-dependent PROTEIN1 nucleation.
BioInfer.d587.s0.p2	P	The PROTEIN -like central (vc) region of PROTEIN induces PROTEIN2 /3 complex-dependent PROTEIN1 nucleation.
BioInfer.d587.s0.p3	P	The PROTEIN -like central (vc) region of PROTEIN2 induces PROTEIN /3 complex-dependent PROTEIN1 nucleation.
BioInfer.d587.s0.p5	N	The PROTEIN1 -like central (vc) region of PROTEIN induces PROTEIN2 /3 complex-dependent PROTEIN nucleation.
BioInfer.d587.s0.p6	P	The PROTEIN1 -like central (vc) region of PROTEIN2 induces PROTEIN /3 complex-dependent PROTEIN nucleation.
BioInfer.d587.s0.p9	N	The PROTEIN -like central (vc) region of PROTEIN2 induces PROTEIN1 /3 complex-dependent PROTEIN nucleation.
BioInfer.d588.s0.p0	P	The C374S mutation had the most pronounced effect; it reduced the polymerizability of the PROTEIN1 , abolished its binding to PROTEIN2 , and filaments containing this mutation moved at reduced rates in the in vitro 'motility assay'.
BioInfer.d589.s0.p0	P	The PROTEIN1 -associated proteins, PROTEIN2 and PROTEIN , were present in both mesotheliomas and adenocarcinomas.
BioInfer.d589.s0.p1	P	The PROTEIN1 -associated proteins, PROTEIN and PROTEIN2 , were present in both mesotheliomas and adenocarcinomas.
BioInfer.d589.s0.p2	N	The PROTEIN -associated proteins, PROTEIN1 and PROTEIN2 , were present in both mesotheliomas and adenocarcinomas.
BioInfer.d590.s0.p0	P	The PROTEIN Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the PROTEIN1 - or ATP-binding capacities of two size-limited recombinant PROTEIN2 fragments.
BioInfer.d590.s0.p1	P	The PROTEIN2 Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the PROTEIN1 - or ATP-binding capacities of two size-limited recombinant PROTEIN fragments.
BioInfer.d590.s0.p2	P	The PROTEIN2 Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the PROTEIN - or ATP-binding capacities of two size-limited recombinant PROTEIN1 fragments.
BioInfer.d591.s0.p0	N	The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the PROTEIN2 , PROTEIN , PROTEIN1 and PROTEIN .
BioInfer.d591.s0.p1	N	The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 .
BioInfer.d591.s0.p2	N	The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN .
BioInfer.d591.s0.p3	N	The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d591.s0.p4	N	The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN .
BioInfer.d591.s0.p5	N	The cellular morphological changes were analyzed and correlated with the distribution of cell-substratum contacts viewed by confocal images obtained after immunostaining with antibodies raised against the PROTEIN , PROTEIN2 , PROTEIN and PROTEIN1 .
BioInfer.d592.s0.p0	P	The cellular transcription co-activators PROTEIN and the PROTEIN1  PROTEIN2 are cellular targets for transformation by the PROTEIN proteins of non-oncogenic adenovirus 5 (Ad5).
BioInfer.d592.s0.p1	N	The cellular transcription co-activators PROTEIN2 and the PROTEIN1  PROTEIN are cellular targets for transformation by the PROTEIN proteins of non-oncogenic adenovirus 5 (Ad5).
BioInfer.d592.s0.p2	N	The cellular transcription co-activators PROTEIN and the PROTEIN1  PROTEIN are cellular targets for transformation by the PROTEIN2 proteins of non-oncogenic adenovirus 5 (Ad5).
BioInfer.d592.s0.p3	N	The cellular transcription co-activators PROTEIN2 and the PROTEIN  PROTEIN1 are cellular targets for transformation by the PROTEIN proteins of non-oncogenic adenovirus 5 (Ad5).
BioInfer.d592.s0.p4	P	The cellular transcription co-activators PROTEIN and the PROTEIN  PROTEIN1 are cellular targets for transformation by the PROTEIN2 proteins of non-oncogenic adenovirus 5 (Ad5).
BioInfer.d592.s0.p5	P	The cellular transcription co-activators PROTEIN1 and the PROTEIN  PROTEIN are cellular targets for transformation by the PROTEIN2 proteins of non-oncogenic adenovirus 5 (Ad5).
BioInfer.d593.s0.p0	P	The characteristics of the PROTEIN2 and PROTEIN interactions with PROTEIN1 are similar.
BioInfer.d593.s0.p1	P	The characteristics of the PROTEIN and PROTEIN2 interactions with PROTEIN1 are similar.
BioInfer.d593.s0.p2	P	The characteristics of the PROTEIN1 and PROTEIN2 interactions with PROTEIN are similar.
BioInfer.d594.s0.p0	P	The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal PROTEIN ( PROTEIN1 ), PROTEIN2 and PROTEIN .
BioInfer.d594.s0.p1	P	The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal PROTEIN ( PROTEIN1 ), PROTEIN and PROTEIN2 .
BioInfer.d594.s0.p2	N	The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal PROTEIN2 ( PROTEIN1 ), PROTEIN and PROTEIN .
BioInfer.d594.s0.p3	N	The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal PROTEIN ( PROTEIN ), PROTEIN1 and PROTEIN2 .
BioInfer.d594.s0.p4	P	The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal PROTEIN2 ( PROTEIN ), PROTEIN1 and PROTEIN .
BioInfer.d594.s0.p5	P	The clone contains an open reading frame of 139 amino acid residues which shows greater than 40% sequence identity in a 91 amino acid overlap to animal PROTEIN2 ( PROTEIN ), PROTEIN and PROTEIN1 .
BioInfer.d595.s0.p0	P	The common denominator is impaired PROTEIN1 association with either PROTEIN2 (PaTuII) or PROTEIN (BxPc3 and T3M4).
BioInfer.d595.s0.p1	P	The common denominator is impaired PROTEIN1 association with either PROTEIN (PaTuII) or PROTEIN2 (BxPc3 and T3M4).
BioInfer.d595.s0.p2	N	The common denominator is impaired PROTEIN association with either PROTEIN1 (PaTuII) or PROTEIN2 (BxPc3 and T3M4).
BioInfer.d596.s0.p0	P	The comparison of PROTEIN1 proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d596.s0.p1	P	The comparison of PROTEIN1 proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d596.s0.p2	P	The comparison of PROTEIN1 proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d596.s0.p3	N	The comparison of PROTEIN proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with PROTEIN , PROTEIN2 , and PROTEIN1 .
BioInfer.d596.s0.p4	N	The comparison of PROTEIN proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with PROTEIN2 , PROTEIN , and PROTEIN1 .
BioInfer.d596.s0.p5	N	The comparison of PROTEIN proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with PROTEIN2 , PROTEIN1 , and PROTEIN .
BioInfer.d597.s0.p0	N	The concentration of PROTEIN2 was constant during the follicular phase, whereas the content of PROTEIN1 decreased in granulosa cells after treatment with diethylstilboestrol or hCG.
BioInfer.d597.s1.p0	N	PROTEIN2 and PROTEIN1 were present in most ovarian cells at all stages of folliculogenesis.
BioInfer.d598.s0.p0	N	The contents of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 in 125-week-old rats decreased compared with those of 12-week-old rats.
BioInfer.d598.s0.p1	N	The contents of PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 in 125-week-old rats decreased compared with those of 12-week-old rats.
BioInfer.d598.s0.p2	N	The contents of PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 in 125-week-old rats decreased compared with those of 12-week-old rats.
BioInfer.d598.s0.p3	N	The contents of PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN in 125-week-old rats decreased compared with those of 12-week-old rats.
BioInfer.d598.s0.p4	N	The contents of PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN in 125-week-old rats decreased compared with those of 12-week-old rats.
BioInfer.d598.s0.p5	N	The contents of PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN in 125-week-old rats decreased compared with those of 12-week-old rats.
BioInfer.d599.s0.p0	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN2  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN1  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p1	N	The core PROTEIN2 from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN1  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p2	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN2  PROTEIN ; PROTEIN1  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p3	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN2  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN1  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p4	P	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN1  PROTEIN and PROTEIN2 show less heterogeneity.
BioInfer.d599.s0.p5	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN2  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN1  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p6	N	The core PROTEIN from Physarum, PROTEIN2  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN1  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p7	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN2 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN1  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p8	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN1  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p9	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN2 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN1  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p10	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN2 (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN1  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p11	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN1  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p12	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN1  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p13	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN1  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p14	P	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN1  PROTEIN2 and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p15	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN2 ; PROTEIN1  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p16	N	The core PROTEIN2 from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p17	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN2  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p18	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN2  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p19	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN2 show less heterogeneity.
BioInfer.d599.s0.p20	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN2  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p21	N	The core PROTEIN from Physarum, PROTEIN2  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p22	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN2 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p23	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p24	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN2 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p25	P	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1  PROTEIN2 (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p26	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p27	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p28	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p29	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN2 and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p30	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN1  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN2 ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p31	N	The core PROTEIN1 from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN2  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p32	N	The core PROTEIN1 from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN2  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p33	N	The core PROTEIN1 from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN2 show less heterogeneity.
BioInfer.d599.s0.p34	N	The core PROTEIN1 from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN2  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p35	N	The core PROTEIN1 from Physarum, PROTEIN2  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p36	N	The core PROTEIN1 from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN2 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p37	P	The core PROTEIN1 from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p38	N	The core PROTEIN1 from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN2 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p39	N	The core PROTEIN1 from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN2 (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p40	P	The core PROTEIN1 from Physarum, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p41	P	The core PROTEIN1 from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p42	P	The core PROTEIN1 from Physarum, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p43	N	The core PROTEIN1 from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN2 and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p44	N	The core PROTEIN1 from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN2 ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p45	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN2  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN1  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p46	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN1  PROTEIN ; PROTEIN  PROTEIN and PROTEIN2 show less heterogeneity.
BioInfer.d599.s0.p47	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN2  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN1  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p48	N	The core PROTEIN from Physarum, PROTEIN2  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN1  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p49	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN2 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN1  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p50	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN1  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p51	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN2 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN1  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p52	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN2 (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN1  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p53	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN1  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p54	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN1  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p55	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN1  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p56	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN1  PROTEIN ; PROTEIN  PROTEIN2 and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p57	P	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN1  PROTEIN2 ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p58	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN1  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN2 show less heterogeneity.
BioInfer.d599.s0.p59	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN1  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN2  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p60	N	The core PROTEIN from Physarum, PROTEIN2  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN1  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p61	P	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN1  PROTEIN2 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p62	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , are rapidly acetylated; PROTEIN1  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p63	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN1  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN2 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p64	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN1  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN2 (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p65	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN1  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p66	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , are rapidly acetylated; PROTEIN1  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p67	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN1  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p68	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN1  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN2 and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p69	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN1  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN2 ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p70	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN2  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN1 show less heterogeneity.
BioInfer.d599.s0.p71	N	The core PROTEIN from Physarum, PROTEIN2  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN1 show less heterogeneity.
BioInfer.d599.s0.p72	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN2 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN1 show less heterogeneity.
BioInfer.d599.s0.p73	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN1 show less heterogeneity.
BioInfer.d599.s0.p74	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN2 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN1 show less heterogeneity.
BioInfer.d599.s0.p75	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN2 (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN1 show less heterogeneity.
BioInfer.d599.s0.p76	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN1 show less heterogeneity.
BioInfer.d599.s0.p77	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN1 show less heterogeneity.
BioInfer.d599.s0.p78	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN1 show less heterogeneity.
BioInfer.d599.s0.p79	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN2 and PROTEIN1 show less heterogeneity.
BioInfer.d599.s0.p80	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN2 ; PROTEIN  PROTEIN and PROTEIN1 show less heterogeneity.
BioInfer.d599.s0.p81	N	The core PROTEIN from Physarum, PROTEIN2  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN1  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p82	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN2 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN1  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p83	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN1  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p84	P	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN1  PROTEIN2 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p85	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN2 (containing zero to four acetyllysine residues per molecule); PROTEIN1  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p86	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN1  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p87	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN1  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p88	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN1  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p89	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN1  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN2 and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p90	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN1  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN2 ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p91	N	The core PROTEIN from Physarum, PROTEIN1  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN2 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p92	P	The core PROTEIN from Physarum, PROTEIN1  PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p93	N	The core PROTEIN from Physarum, PROTEIN1  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN2 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p94	N	The core PROTEIN from Physarum, PROTEIN1  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN2 (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p95	P	The core PROTEIN from Physarum, PROTEIN1  PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p96	P	The core PROTEIN from Physarum, PROTEIN1  PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p97	P	The core PROTEIN from Physarum, PROTEIN1  PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p98	N	The core PROTEIN from Physarum, PROTEIN1  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN2 and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p99	N	The core PROTEIN from Physarum, PROTEIN1  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN2 ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p100	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , are rapidly acetylated; PROTEIN  PROTEIN1 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p101	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN1 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN2 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p102	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN1 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN2 (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p103	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN1 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p104	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN1 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p105	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN1 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p106	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN1 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN2 and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p107	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN1 shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN2 ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p108	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN2 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p109	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN2 (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p110	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p111	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p112	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p113	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN2 and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p114	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN2 ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p115	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN2 (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN1 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p116	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN1 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p117	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN1 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p118	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN1 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p119	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN1 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN2 and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p120	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN1 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN2 ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p121	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN1 (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p122	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN1 (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p123	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN1 (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p124	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN1 (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN2 and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p125	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN1 (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN2 ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p126	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p127	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p128	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN2 and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p129	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN2 ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p130	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p131	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN2 and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p132	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN2 ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p133	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN ; PROTEIN  PROTEIN2 and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p134	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN2 ; PROTEIN  PROTEIN and PROTEIN show less heterogeneity.
BioInfer.d599.s0.p135	N	The core PROTEIN from Physarum, PROTEIN  PROTEIN , PROTEIN , PROTEIN , and PROTEIN , are rapidly acetylated; PROTEIN  PROTEIN shows five subfractions, analogous to the five subfractions of mammalian PROTEIN  PROTEIN (containing zero to four acetyllysine residues per molecule); PROTEIN  PROTEIN has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of PROTEIN  PROTEIN2 ; PROTEIN  PROTEIN1 and PROTEIN show less heterogeneity.
BioInfer.d600.s0.p0	N	The core, isolated in the absence of free Ca2+, contains five major proteins: the PROTEIN1 (Mr 43 000) that makes up the filaments, the PROTEIN (Mr 95 000) and PROTEIN2 (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide- PROTEIN complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.
BioInfer.d600.s0.p1	N	The core, isolated in the absence of free Ca2+, contains five major proteins: the PROTEIN1 (Mr 43 000) that makes up the filaments, the PROTEIN2 (Mr 95 000) and PROTEIN (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide- PROTEIN complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.
BioInfer.d600.s0.p2	N	The core, isolated in the absence of free Ca2+, contains five major proteins: the PROTEIN1 (Mr 43 000) that makes up the filaments, the PROTEIN (Mr 95 000) and PROTEIN (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide- PROTEIN2 complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.
BioInfer.d600.s0.p3	N	The core, isolated in the absence of free Ca2+, contains five major proteins: the PROTEIN (Mr 43 000) that makes up the filaments, the PROTEIN2 (Mr 95 000) and PROTEIN1 (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide- PROTEIN complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.
BioInfer.d600.s0.p4	N	The core, isolated in the absence of free Ca2+, contains five major proteins: the PROTEIN (Mr 43 000) that makes up the filaments, the PROTEIN (Mr 95 000) and PROTEIN1 (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide- PROTEIN2 complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.
BioInfer.d600.s0.p5	N	The core, isolated in the absence of free Ca2+, contains five major proteins: the PROTEIN (Mr 43 000) that makes up the filaments, the PROTEIN1 (Mr 95 000) and PROTEIN (Mr 68 000) that cross-link the filaments together, and the 110 000 Mr polypeptide- PROTEIN2 complex that makes up cross-filaments which project laterally from the core and link it to the inner surface of the microvillus membrane.
BioInfer.d601.s0.p0	N	The C-terminal of PROTEIN1 comprises the "death domain" that is responsible for association of PROTEIN and other death domain-containing proteins such as PROTEIN2 and PROTEIN .
BioInfer.d601.s0.p1	N	The C-terminal of PROTEIN1 comprises the "death domain" that is responsible for association of PROTEIN2 and other death domain-containing proteins such as PROTEIN and PROTEIN .
BioInfer.d601.s0.p2	N	The C-terminal of PROTEIN1 comprises the "death domain" that is responsible for association of PROTEIN and other death domain-containing proteins such as PROTEIN and PROTEIN2 .
BioInfer.d601.s0.p3	P	The C-terminal of PROTEIN comprises the "death domain" that is responsible for association of PROTEIN2 and other death domain-containing proteins such as PROTEIN1 and PROTEIN .
BioInfer.d601.s0.p4	N	The C-terminal of PROTEIN comprises the "death domain" that is responsible for association of PROTEIN and other death domain-containing proteins such as PROTEIN1 and PROTEIN2 .
BioInfer.d601.s0.p5	P	The C-terminal of PROTEIN comprises the "death domain" that is responsible for association of PROTEIN1 and other death domain-containing proteins such as PROTEIN and PROTEIN2 .
BioInfer.d602.s0.p0	P	The C-terminal region of PROTEIN was, however, necessary to bring PROTEIN1 and PROTEIN2 into the core complex.
BioInfer.d602.s0.p1	P	The C-terminal region of PROTEIN2 was, however, necessary to bring PROTEIN1 and PROTEIN into the core complex.
BioInfer.d602.s0.p2	P	The C-terminal region of PROTEIN2 was, however, necessary to bring PROTEIN and PROTEIN1 into the core complex.
BioInfer.d603.s0.p0	N	The cytoplasmic domain of PROTEIN cannot directly associate with PROTEIN1 but interacts with high affinity with PROTEIN , whereas the binding of PROTEIN ( PROTEIN2 ) to PROTEIN is less efficient.
BioInfer.d603.s0.p1	P	The cytoplasmic domain of PROTEIN2 cannot directly associate with PROTEIN1 but interacts with high affinity with PROTEIN , whereas the binding of PROTEIN ( PROTEIN ) to PROTEIN is less efficient.
BioInfer.d603.s0.p2	N	The cytoplasmic domain of PROTEIN cannot directly associate with PROTEIN1 but interacts with high affinity with PROTEIN , whereas the binding of PROTEIN ( PROTEIN ) to PROTEIN2 is less efficient.
BioInfer.d603.s0.p3	N	The cytoplasmic domain of PROTEIN cannot directly associate with PROTEIN1 but interacts with high affinity with PROTEIN , whereas the binding of PROTEIN2 ( PROTEIN ) to PROTEIN is less efficient.
BioInfer.d603.s0.p4	N	The cytoplasmic domain of PROTEIN cannot directly associate with PROTEIN1 but interacts with high affinity with PROTEIN2 , whereas the binding of PROTEIN ( PROTEIN ) to PROTEIN is less efficient.
BioInfer.d603.s0.p5	N	The cytoplasmic domain of PROTEIN2 cannot directly associate with PROTEIN but interacts with high affinity with PROTEIN , whereas the binding of PROTEIN ( PROTEIN1 ) to PROTEIN is less efficient.
BioInfer.d603.s0.p6	P	The cytoplasmic domain of PROTEIN cannot directly associate with PROTEIN but interacts with high affinity with PROTEIN , whereas the binding of PROTEIN ( PROTEIN1 ) to PROTEIN2 is less efficient.
BioInfer.d603.s0.p7	N	The cytoplasmic domain of PROTEIN cannot directly associate with PROTEIN but interacts with high affinity with PROTEIN , whereas the binding of PROTEIN2 ( PROTEIN1 ) to PROTEIN is less efficient.
BioInfer.d603.s0.p8	N	The cytoplasmic domain of PROTEIN cannot directly associate with PROTEIN but interacts with high affinity with PROTEIN2 , whereas the binding of PROTEIN ( PROTEIN1 ) to PROTEIN is less efficient.
BioInfer.d603.s0.p9	N	The cytoplasmic domain of PROTEIN1 cannot directly associate with PROTEIN but interacts with high affinity with PROTEIN , whereas the binding of PROTEIN ( PROTEIN ) to PROTEIN2 is less efficient.
BioInfer.d603.s0.p10	N	The cytoplasmic domain of PROTEIN1 cannot directly associate with PROTEIN but interacts with high affinity with PROTEIN , whereas the binding of PROTEIN2 ( PROTEIN ) to PROTEIN is less efficient.
BioInfer.d603.s0.p11	P	The cytoplasmic domain of PROTEIN1 cannot directly associate with PROTEIN but interacts with high affinity with PROTEIN2 , whereas the binding of PROTEIN ( PROTEIN ) to PROTEIN is less efficient.
BioInfer.d603.s0.p12	P	The cytoplasmic domain of PROTEIN cannot directly associate with PROTEIN but interacts with high affinity with PROTEIN , whereas the binding of PROTEIN2 ( PROTEIN ) to PROTEIN1 is less efficient.
BioInfer.d603.s0.p13	N	The cytoplasmic domain of PROTEIN cannot directly associate with PROTEIN but interacts with high affinity with PROTEIN2 , whereas the binding of PROTEIN ( PROTEIN ) to PROTEIN1 is less efficient.
BioInfer.d603.s0.p14	N	The cytoplasmic domain of PROTEIN cannot directly associate with PROTEIN but interacts with high affinity with PROTEIN2 , whereas the binding of PROTEIN1 ( PROTEIN ) to PROTEIN is less efficient.
BioInfer.d603.s1.p0	P	PROTEIN2 and PROTEIN1 assemble into a 1:1 heterodimeric complex.
BioInfer.d604.s0.p0	P	The deduced peptide sequence contained a nuclear localization signal and a putative PROTEIN2 -binding sequence as reported in PROTEIN1 .
BioInfer.d605.s0.p0	N	The domain consists of a mixed alpha-helical/beta-sheet fold that resembles a circular permutation of the PROTEIN1 /poly-proline binding protein, PROTEIN , and the PROTEIN2 family of regulatory modules.
BioInfer.d605.s0.p1	P	The domain consists of a mixed alpha-helical/beta-sheet fold that resembles a circular permutation of the PROTEIN1 /poly-proline binding protein, PROTEIN2 , and the PROTEIN family of regulatory modules.
BioInfer.d605.s0.p2	N	The domain consists of a mixed alpha-helical/beta-sheet fold that resembles a circular permutation of the PROTEIN /poly-proline binding protein, PROTEIN2 , and the PROTEIN1 family of regulatory modules.
BioInfer.d606.s0.p0	N	The domains in PROTEIN that are involved in PROTEIN binding and transcriptional activation are highly related to the adenoviral PROTEIN1 -associated cellular protein PROTEIN (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN and PROTEIN2 (refs 4 and 5, respectively), whose functions are unknown.
BioInfer.d606.s0.p1	P	The domains in PROTEIN that are involved in PROTEIN binding and transcriptional activation are highly related to the adenoviral PROTEIN1 -associated cellular protein PROTEIN2 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN and PROTEIN (refs 4 and 5, respectively), whose functions are unknown.
BioInfer.d606.s0.p2	N	The domains in PROTEIN that are involved in PROTEIN binding and transcriptional activation are highly related to the adenoviral PROTEIN1 -associated cellular protein PROTEIN (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN2 and PROTEIN (refs 4 and 5, respectively), whose functions are unknown.
BioInfer.d606.s0.p3	N	The domains in PROTEIN that are involved in PROTEIN2 binding and transcriptional activation are highly related to the adenoviral PROTEIN1 -associated cellular protein PROTEIN (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN and PROTEIN (refs 4 and 5, respectively), whose functions are unknown.
BioInfer.d606.s0.p4	N	The domains in PROTEIN2 that are involved in PROTEIN binding and transcriptional activation are highly related to the adenoviral PROTEIN1 -associated cellular protein PROTEIN (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN and PROTEIN (refs 4 and 5, respectively), whose functions are unknown.
BioInfer.d606.s0.p5	N	The domains in PROTEIN that are involved in PROTEIN binding and transcriptional activation are highly related to the adenoviral PROTEIN -associated cellular protein PROTEIN2 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN and PROTEIN1 (refs 4 and 5, respectively), whose functions are unknown.
BioInfer.d606.s0.p6	N	The domains in PROTEIN that are involved in PROTEIN binding and transcriptional activation are highly related to the adenoviral PROTEIN -associated cellular protein PROTEIN (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN2 and PROTEIN1 (refs 4 and 5, respectively), whose functions are unknown.
BioInfer.d606.s0.p7	N	The domains in PROTEIN that are involved in PROTEIN2 binding and transcriptional activation are highly related to the adenoviral PROTEIN -associated cellular protein PROTEIN (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN and PROTEIN1 (refs 4 and 5, respectively), whose functions are unknown.
BioInfer.d606.s0.p8	P	The domains in PROTEIN2 that are involved in PROTEIN binding and transcriptional activation are highly related to the adenoviral PROTEIN -associated cellular protein PROTEIN (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN and PROTEIN1 (refs 4 and 5, respectively), whose functions are unknown.
BioInfer.d606.s0.p9	N	The domains in PROTEIN that are involved in PROTEIN binding and transcriptional activation are highly related to the adenoviral PROTEIN -associated cellular protein PROTEIN1 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN2 and PROTEIN (refs 4 and 5, respectively), whose functions are unknown.
BioInfer.d606.s0.p10	N	The domains in PROTEIN that are involved in PROTEIN2 binding and transcriptional activation are highly related to the adenoviral PROTEIN -associated cellular protein PROTEIN1 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN and PROTEIN (refs 4 and 5, respectively), whose functions are unknown.
BioInfer.d606.s0.p11	P	The domains in PROTEIN2 that are involved in PROTEIN binding and transcriptional activation are highly related to the adenoviral PROTEIN -associated cellular protein PROTEIN1 (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN and PROTEIN (refs 4 and 5, respectively), whose functions are unknown.
BioInfer.d606.s0.p12	N	The domains in PROTEIN that are involved in PROTEIN2 binding and transcriptional activation are highly related to the adenoviral PROTEIN -associated cellular protein PROTEIN (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN1 and PROTEIN (refs 4 and 5, respectively), whose functions are unknown.
BioInfer.d606.s0.p13	P	The domains in PROTEIN2 that are involved in PROTEIN binding and transcriptional activation are highly related to the adenoviral PROTEIN -associated cellular protein PROTEIN (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN1 and PROTEIN (refs 4 and 5, respectively), whose functions are unknown.
BioInfer.d606.s0.p14	P	The domains in PROTEIN2 that are involved in PROTEIN1 binding and transcriptional activation are highly related to the adenoviral PROTEIN -associated cellular protein PROTEIN (refs 2, 3), and to two hypothetical proteins from Caenorhabditis elegans, PROTEIN and PROTEIN (refs 4 and 5, respectively), whose functions are unknown.
BioInfer.d607.s0.p0	P	The drastic effects of the exogenous PROTEIN2 on PROTEIN1 assembly were suppressed by phosphatidylinositol 4,5-bisphosphate (PIP2).
BioInfer.d607.s1.p0	P	The previous investigation (Abe et al. (1989) J. Biochem. 106, 696-702) suggested that PROTEIN2 is deeply involved in the regulation of PROTEIN1 assembly in developing skeletal muscle.
BioInfer.d608.s0.p0	N	The PROTEIN -associated proteins PROTEIN1 and PROTEIN2 were not significantly affected by treatment with PROTEIN .
BioInfer.d608.s0.p1	N	The PROTEIN -associated proteins PROTEIN1 and PROTEIN were not significantly affected by treatment with PROTEIN2 .
BioInfer.d608.s0.p2	P	The PROTEIN2 -associated proteins PROTEIN1 and PROTEIN were not significantly affected by treatment with PROTEIN .
BioInfer.d608.s0.p3	N	The PROTEIN -associated proteins PROTEIN and PROTEIN1 were not significantly affected by treatment with PROTEIN2 .
BioInfer.d608.s0.p4	P	The PROTEIN2 -associated proteins PROTEIN and PROTEIN1 were not significantly affected by treatment with PROTEIN .
BioInfer.d608.s0.p5	N	The PROTEIN2 -associated proteins PROTEIN and PROTEIN were not significantly affected by treatment with PROTEIN1 .
BioInfer.d609.s0.p0	P	The effects of two adhesion substrates (serum and PROTEIN1 ) and time in culture on the expression of genes encoding PROTEIN2 ( PROTEIN ) isoforms and PROTEIN were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.
BioInfer.d609.s0.p1	P	The effects of two adhesion substrates (serum and PROTEIN1 ) and time in culture on the expression of genes encoding PROTEIN ( PROTEIN2 ) isoforms and PROTEIN were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.
BioInfer.d609.s0.p2	P	The effects of two adhesion substrates (serum and PROTEIN1 ) and time in culture on the expression of genes encoding PROTEIN ( PROTEIN ) isoforms and PROTEIN2 were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.
BioInfer.d609.s0.p3	N	The effects of two adhesion substrates (serum and PROTEIN ) and time in culture on the expression of genes encoding PROTEIN1 ( PROTEIN2 ) isoforms and PROTEIN were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.
BioInfer.d609.s0.p4	N	The effects of two adhesion substrates (serum and PROTEIN ) and time in culture on the expression of genes encoding PROTEIN1 ( PROTEIN ) isoforms and PROTEIN2 were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.
BioInfer.d609.s0.p5	N	The effects of two adhesion substrates (serum and PROTEIN ) and time in culture on the expression of genes encoding PROTEIN ( PROTEIN1 ) isoforms and PROTEIN2 were analysed in myocytes isolated from adult rat heart and maintained in serum-free culture.
BioInfer.d610.s0.p0	N	The enzyme showed hardly any activity below 50 degrees C but considerable activity at around 60 degrees C against myofibrils, digesting PROTEIN , PROTEIN1 and PROTEIN2 .
BioInfer.d610.s0.p1	N	The enzyme showed hardly any activity below 50 degrees C but considerable activity at around 60 degrees C against myofibrils, digesting PROTEIN2 , PROTEIN1 and PROTEIN .
BioInfer.d610.s0.p2	N	The enzyme showed hardly any activity below 50 degrees C but considerable activity at around 60 degrees C against myofibrils, digesting PROTEIN2 , PROTEIN and PROTEIN1 .
BioInfer.d611.s0.p0	N	The existence of this pathway helps to explain some of the effects of PROTEIN1 and PROTEIN2 in the control of PROTEIN dynamics.
BioInfer.d611.s0.p1	P	The existence of this pathway helps to explain some of the effects of PROTEIN1 and PROTEIN in the control of PROTEIN2 dynamics.
BioInfer.d611.s0.p2	P	The existence of this pathway helps to explain some of the effects of PROTEIN and PROTEIN1 in the control of PROTEIN2 dynamics.
BioInfer.d612.s0.p0	N	The expression of PROTEIN1 , PROTEIN and PROTEIN2 also was decreased in HT29 cells, with a translocation of PROTEIN into the nucleus.
BioInfer.d612.s0.p1	N	The expression of PROTEIN1 , PROTEIN2 and PROTEIN also was decreased in HT29 cells, with a translocation of PROTEIN into the nucleus.
BioInfer.d612.s0.p2	N	The expression of PROTEIN1 , PROTEIN and PROTEIN also was decreased in HT29 cells, with a translocation of PROTEIN2 into the nucleus.
BioInfer.d612.s0.p3	N	The expression of PROTEIN , PROTEIN2 and PROTEIN1 also was decreased in HT29 cells, with a translocation of PROTEIN into the nucleus.
BioInfer.d612.s0.p4	N	The expression of PROTEIN , PROTEIN and PROTEIN1 also was decreased in HT29 cells, with a translocation of PROTEIN2 into the nucleus.
BioInfer.d612.s0.p5	N	The expression of PROTEIN , PROTEIN1 and PROTEIN also was decreased in HT29 cells, with a translocation of PROTEIN2 into the nucleus.
BioInfer.d613.s0.p0	P	The findings suggest that PROTEIN2  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN1 production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p1	N	The findings suggest that PROTEIN  PROTEIN2 are involved in PROTEIN -mediated enhancement of PROTEIN1 production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p2	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN1 production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN2 , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p3	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN1 production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN2 production.
BioInfer.d613.s0.p4	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN1 production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN2 -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p5	P	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN2 -mediated enhancement of PROTEIN1 production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p6	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN1 production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN2 , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p7	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN1 production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN2 and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p8	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN1 production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN2 )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p9	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN1 production in Jurkat cells and that the transcription factor PROTEIN2 and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p10	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN1 production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN2  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p11	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN1 production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN2 ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p12	P	The findings suggest that PROTEIN1  PROTEIN2 are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p13	N	The findings suggest that PROTEIN1  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN2 , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p14	N	The findings suggest that PROTEIN1  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN2 production.
BioInfer.d613.s0.p15	N	The findings suggest that PROTEIN1  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN2 -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p16	N	The findings suggest that PROTEIN1  PROTEIN are involved in PROTEIN2 -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p17	N	The findings suggest that PROTEIN1  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN2 , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p18	N	The findings suggest that PROTEIN1  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN2 and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p19	N	The findings suggest that PROTEIN1  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN2 )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p20	N	The findings suggest that PROTEIN1  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN2 and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p21	N	The findings suggest that PROTEIN1  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN2  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p22	N	The findings suggest that PROTEIN1  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN2 ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p23	N	The findings suggest that PROTEIN  PROTEIN1 are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN2 , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p24	N	The findings suggest that PROTEIN  PROTEIN1 are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN2 production.
BioInfer.d613.s0.p25	N	The findings suggest that PROTEIN  PROTEIN1 are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN2 -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p26	N	The findings suggest that PROTEIN  PROTEIN1 are involved in PROTEIN2 -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p27	N	The findings suggest that PROTEIN  PROTEIN1 are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN2 , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p28	N	The findings suggest that PROTEIN  PROTEIN1 are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN2 and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p29	N	The findings suggest that PROTEIN  PROTEIN1 are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN2 )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p30	N	The findings suggest that PROTEIN  PROTEIN1 are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN2 and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p31	N	The findings suggest that PROTEIN  PROTEIN1 are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN2  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p32	N	The findings suggest that PROTEIN  PROTEIN1 are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN2 ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p33	P	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN1 , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN2 production.
BioInfer.d613.s0.p34	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN1 , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN2 -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p35	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN2 -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN1 , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p36	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN1 , but not via PROTEIN  PROTEIN2 , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p37	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN2 and PROTEIN1 , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p38	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN2 )/ PROTEIN and PROTEIN1 , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p39	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN2 and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN1 , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p40	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN1 , but not via PROTEIN2  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p41	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN2 ( PROTEIN )/ PROTEIN and PROTEIN1 , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p42	P	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN2 -mediated enhancement of PROTEIN1 production.
BioInfer.d613.s0.p43	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN2 -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN1 production.
BioInfer.d613.s0.p44	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN2 , may be involved in the PROTEIN -mediated enhancement of PROTEIN1 production.
BioInfer.d613.s0.p45	P	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN2 and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN1 production.
BioInfer.d613.s0.p46	P	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN2 )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN1 production.
BioInfer.d613.s0.p47	P	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN2 and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN1 production.
BioInfer.d613.s0.p48	P	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN2  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN1 production.
BioInfer.d613.s0.p49	P	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN2 ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN1 production.
BioInfer.d613.s0.p50	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN2 -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN1 -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p51	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN2 , may be involved in the PROTEIN1 -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p52	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN2 and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN1 -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p53	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN2 )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN1 -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p54	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN2 and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN1 -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p55	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN2  PROTEIN , may be involved in the PROTEIN1 -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p56	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN2 ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN1 -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p57	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN1 -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN2 , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p58	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN1 -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN2 and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p59	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN1 -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN2 )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p60	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN1 -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN2 and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p61	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN1 -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN2  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p62	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN1 -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN2 ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p63	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN2 and PROTEIN , but not via PROTEIN  PROTEIN1 , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p64	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN2 )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN1 , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p65	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN2 and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN1 , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p66	P	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN2  PROTEIN1 , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p67	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN2 ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN1 , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p68	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN2 )/ PROTEIN1 and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p69	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN2 and pathways via PROTEIN ( PROTEIN )/ PROTEIN1 and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p70	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN )/ PROTEIN1 and PROTEIN , but not via PROTEIN2  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p71	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN2 ( PROTEIN )/ PROTEIN1 and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p72	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN2 and pathways via PROTEIN ( PROTEIN1 )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p73	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN ( PROTEIN1 )/ PROTEIN and PROTEIN , but not via PROTEIN2  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p74	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN2 ( PROTEIN1 )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p75	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN1 and pathways via PROTEIN ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN2  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p76	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN1 and pathways via PROTEIN2 ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d613.s0.p77	N	The findings suggest that PROTEIN  PROTEIN are involved in PROTEIN -mediated enhancement of PROTEIN production in Jurkat cells and that the transcription factor PROTEIN and pathways via PROTEIN2 ( PROTEIN )/ PROTEIN and PROTEIN , but not via PROTEIN1  PROTEIN , may be involved in the PROTEIN -mediated enhancement of PROTEIN production.
BioInfer.d615.s0.p0	N	The gene for the human PROTEIN , the transcriptional coactivator PROTEIN1 , is included in the RT1 cosmid, and mutations in PROTEIN2 have recently been identified in nondeleted RTS patients.
BioInfer.d615.s0.p1	N	The gene for the human PROTEIN2 , the transcriptional coactivator PROTEIN1 , is included in the RT1 cosmid, and mutations in PROTEIN have recently been identified in nondeleted RTS patients.
BioInfer.d615.s0.p2	N	The gene for the human PROTEIN2 , the transcriptional coactivator PROTEIN , is included in the RT1 cosmid, and mutations in PROTEIN1 have recently been identified in nondeleted RTS patients.
BioInfer.d616.s0.p0	N	The genes considered are those for PROTEIN2 , PROTEIN1 and PROTEIN , PROTEIN , PROTEIN /b and II, PROTEIN , IC and II, and PROTEIN .
BioInfer.d616.s0.p1	N	The genes considered are those for PROTEIN , PROTEIN1 and PROTEIN2 , PROTEIN , PROTEIN /b and II, PROTEIN , IC and II, and PROTEIN .
BioInfer.d616.s0.p2	N	The genes considered are those for PROTEIN , PROTEIN1 and PROTEIN , PROTEIN , PROTEIN2 /b and II, PROTEIN , IC and II, and PROTEIN .
BioInfer.d616.s0.p4	N	The genes considered are those for PROTEIN , PROTEIN1 and PROTEIN , PROTEIN2 , PROTEIN /b and II, PROTEIN , IC and II, and PROTEIN .
BioInfer.d616.s0.p8	N	The genes considered are those for PROTEIN , PROTEIN1 and PROTEIN , PROTEIN , PROTEIN /b and II, PROTEIN2 , IC and II, and PROTEIN .
BioInfer.d616.s0.p9	N	The genes considered are those for PROTEIN , PROTEIN1 and PROTEIN , PROTEIN , PROTEIN /b and II, PROTEIN , IC and II, and PROTEIN2 .
BioInfer.d616.s0.p10	N	The genes considered are those for PROTEIN1 , PROTEIN and PROTEIN2 , PROTEIN , PROTEIN /b and II, PROTEIN , IC and II, and PROTEIN .
BioInfer.d616.s0.p11	N	The genes considered are those for PROTEIN1 , PROTEIN and PROTEIN , PROTEIN , PROTEIN2 /b and II, PROTEIN , IC and II, and PROTEIN .
BioInfer.d616.s0.p13	N	The genes considered are those for PROTEIN1 , PROTEIN and PROTEIN , PROTEIN2 , PROTEIN /b and II, PROTEIN , IC and II, and PROTEIN .
BioInfer.d616.s0.p17	N	The genes considered are those for PROTEIN1 , PROTEIN and PROTEIN , PROTEIN , PROTEIN /b and II, PROTEIN2 , IC and II, and PROTEIN .
BioInfer.d616.s0.p18	N	The genes considered are those for PROTEIN1 , PROTEIN and PROTEIN , PROTEIN , PROTEIN /b and II, PROTEIN , IC and II, and PROTEIN2 .
BioInfer.d616.s0.p19	N	The genes considered are those for PROTEIN , PROTEIN and PROTEIN1 , PROTEIN , PROTEIN2 /b and II, PROTEIN , IC and II, and PROTEIN .
BioInfer.d616.s0.p21	N	The genes considered are those for PROTEIN , PROTEIN and PROTEIN1 , PROTEIN2 , PROTEIN /b and II, PROTEIN , IC and II, and PROTEIN .
BioInfer.d616.s0.p25	N	The genes considered are those for PROTEIN , PROTEIN and PROTEIN1 , PROTEIN , PROTEIN /b and II, PROTEIN2 , IC and II, and PROTEIN .
BioInfer.d616.s0.p26	N	The genes considered are those for PROTEIN , PROTEIN and PROTEIN1 , PROTEIN , PROTEIN /b and II, PROTEIN , IC and II, and PROTEIN2 .
BioInfer.d616.s0.p28	N	The genes considered are those for PROTEIN , PROTEIN and PROTEIN , PROTEIN2 , PROTEIN1 /b and II, PROTEIN , IC and II, and PROTEIN .
BioInfer.d616.s0.p32	N	The genes considered are those for PROTEIN , PROTEIN and PROTEIN , PROTEIN , PROTEIN1 /b and II, PROTEIN2 , IC and II, and PROTEIN .
BioInfer.d616.s0.p33	N	The genes considered are those for PROTEIN , PROTEIN and PROTEIN , PROTEIN , PROTEIN1 /b and II, PROTEIN , IC and II, and PROTEIN2 .
BioInfer.d616.s0.p43	N	The genes considered are those for PROTEIN , PROTEIN and PROTEIN , PROTEIN1 , PROTEIN /b and II, PROTEIN2 , IC and II, and PROTEIN .
BioInfer.d616.s0.p44	N	The genes considered are those for PROTEIN , PROTEIN and PROTEIN , PROTEIN1 , PROTEIN /b and II, PROTEIN , IC and II, and PROTEIN2 .
BioInfer.d616.s0.p54	N	The genes considered are those for PROTEIN , PROTEIN and PROTEIN , PROTEIN , PROTEIN /b and II, PROTEIN1 , IC and II, and PROTEIN2 .
BioInfer.d617.s0.p0	P	The head domain of PROTEIN2 thus binds to PROTEIN1 to form a link to the PROTEIN cytoskeleton and can thus regulate PROTEIN function.
BioInfer.d617.s0.p1	N	The head domain of PROTEIN thus binds to PROTEIN1 to form a link to the PROTEIN cytoskeleton and can thus regulate PROTEIN2 function.
BioInfer.d617.s0.p2	P	The head domain of PROTEIN thus binds to PROTEIN1 to form a link to the PROTEIN2 cytoskeleton and can thus regulate PROTEIN function.
BioInfer.d617.s0.p3	P	The head domain of PROTEIN1 thus binds to PROTEIN to form a link to the PROTEIN cytoskeleton and can thus regulate PROTEIN2 function.
BioInfer.d617.s0.p4	P	The head domain of PROTEIN1 thus binds to PROTEIN to form a link to the PROTEIN2 cytoskeleton and can thus regulate PROTEIN function.
BioInfer.d617.s0.p5	N	The head domain of PROTEIN thus binds to PROTEIN to form a link to the PROTEIN2 cytoskeleton and can thus regulate PROTEIN1 function.
BioInfer.d618.s0.p0	P	The herpes simplex virus PROTEIN2 complex, a heterotrimer of the PROTEIN1 , PROTEIN , and PROTEIN proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).
BioInfer.d618.s0.p1	P	The herpes simplex virus PROTEIN complex, a heterotrimer of the PROTEIN1 , PROTEIN2 , and PROTEIN proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).
BioInfer.d618.s0.p2	P	The herpes simplex virus PROTEIN complex, a heterotrimer of the PROTEIN1 , PROTEIN , and PROTEIN2 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).
BioInfer.d618.s0.p3	P	The herpes simplex virus PROTEIN1 complex, a heterotrimer of the PROTEIN , PROTEIN2 , and PROTEIN proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).
BioInfer.d618.s0.p4	P	The herpes simplex virus PROTEIN1 complex, a heterotrimer of the PROTEIN , PROTEIN , and PROTEIN2 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).
BioInfer.d618.s0.p5	P	The herpes simplex virus PROTEIN complex, a heterotrimer of the PROTEIN , PROTEIN1 , and PROTEIN2 proteins, displays a single predominant site of primer synthesis on phi X174 virion DNA (Tenney, D. J., Hurlburt, W. W., Micheletti, P. M., Bifano, M., and Hamatake, R. K. (1994) J. Biol. Chem. 269, 5030-5035).
BioInfer.d619.s0.p0	N	The herpes simplex virus type 1 PROTEIN protein influences the intracellular localization of the PROTEIN2 but not the PROTEIN1 or PROTEIN replication proteins in virus-infected cells.
BioInfer.d619.s0.p1	N	The herpes simplex virus type 1 PROTEIN protein influences the intracellular localization of the PROTEIN but not the PROTEIN1 or PROTEIN2 replication proteins in virus-infected cells.
BioInfer.d619.s0.p2	P	The herpes simplex virus type 1 PROTEIN2 protein influences the intracellular localization of the PROTEIN but not the PROTEIN1 or PROTEIN replication proteins in virus-infected cells.
BioInfer.d619.s0.p3	N	The herpes simplex virus type 1 PROTEIN protein influences the intracellular localization of the PROTEIN1 but not the PROTEIN or PROTEIN2 replication proteins in virus-infected cells.
BioInfer.d619.s0.p4	P	The herpes simplex virus type 1 PROTEIN2 protein influences the intracellular localization of the PROTEIN1 but not the PROTEIN or PROTEIN replication proteins in virus-infected cells.
BioInfer.d619.s0.p5	P	The herpes simplex virus type 1 PROTEIN2 protein influences the intracellular localization of the PROTEIN but not the PROTEIN or PROTEIN1 replication proteins in virus-infected cells.
BioInfer.d620.s0.p0	N	The herpes simplex virus type-1 PROTEIN is a heterotrimer encoded by the PROTEIN , PROTEIN1 , and PROTEIN2 genes.
BioInfer.d620.s0.p1	P	The herpes simplex virus type-1 PROTEIN2 is a heterotrimer encoded by the PROTEIN , PROTEIN1 , and PROTEIN genes.
BioInfer.d620.s0.p2	N	The herpes simplex virus type-1 PROTEIN is a heterotrimer encoded by the PROTEIN2 , PROTEIN1 , and PROTEIN genes.
BioInfer.d620.s0.p3	P	The herpes simplex virus type-1 PROTEIN2 is a heterotrimer encoded by the PROTEIN , PROTEIN , and PROTEIN1 genes.
BioInfer.d620.s0.p4	N	The herpes simplex virus type-1 PROTEIN is a heterotrimer encoded by the PROTEIN2 , PROTEIN , and PROTEIN1 genes.
BioInfer.d620.s0.p5	P	The herpes simplex virus type-1 PROTEIN1 is a heterotrimer encoded by the PROTEIN2 , PROTEIN , and PROTEIN genes.
BioInfer.d621.s0.p0	P	The Herpes simplex virus type 1 PROTEIN2 consists of three subunits that are the products of the PROTEIN1 , PROTEIN , and PROTEIN genes.
BioInfer.d621.s0.p1	P	The Herpes simplex virus type 1 PROTEIN consists of three subunits that are the products of the PROTEIN1 , PROTEIN2 , and PROTEIN genes.
BioInfer.d621.s0.p2	P	The Herpes simplex virus type 1 PROTEIN consists of three subunits that are the products of the PROTEIN1 , PROTEIN , and PROTEIN2 genes.
BioInfer.d621.s0.p3	P	The Herpes simplex virus type 1 PROTEIN1 consists of three subunits that are the products of the PROTEIN , PROTEIN2 , and PROTEIN genes.
BioInfer.d621.s0.p4	P	The Herpes simplex virus type 1 PROTEIN1 consists of three subunits that are the products of the PROTEIN , PROTEIN , and PROTEIN2 genes.
BioInfer.d621.s0.p5	P	The Herpes simplex virus type 1 PROTEIN consists of three subunits that are the products of the PROTEIN , PROTEIN1 , and PROTEIN2 genes.
BioInfer.d622.s0.p0	N	The herpes simplex virus type-1 PROTEIN2 , PROTEIN1 , and PROTEIN genes encode an essential heterotrimeric PROTEIN that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.
BioInfer.d622.s0.p1	N	The herpes simplex virus type-1 PROTEIN , PROTEIN1 , and PROTEIN2 genes encode an essential heterotrimeric PROTEIN that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.
BioInfer.d622.s0.p2	P	The herpes simplex virus type-1 PROTEIN , PROTEIN1 , and PROTEIN genes encode an essential heterotrimeric PROTEIN2 that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.
BioInfer.d622.s0.p3	N	The herpes simplex virus type-1 PROTEIN1 , PROTEIN , and PROTEIN2 genes encode an essential heterotrimeric PROTEIN that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.
BioInfer.d622.s0.p4	P	The herpes simplex virus type-1 PROTEIN1 , PROTEIN , and PROTEIN genes encode an essential heterotrimeric PROTEIN2 that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.
BioInfer.d622.s0.p5	P	The herpes simplex virus type-1 PROTEIN , PROTEIN , and PROTEIN1 genes encode an essential heterotrimeric PROTEIN2 that is responsible for concomitant DNA unwinding and primer synthesis at the viral DNA replication fork.
BioInfer.d623.s0.p0	N	The higher affinity of vaccinia PROTEIN for polyphosphoinositides (Kd = 0.2-8.5 microM) than for PROTEIN or poly(L-proline) and the concentration of vaccinia PROTEIN2 expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia PROTEIN1 binds preferentially to PIP and PIP2 in vivo.
BioInfer.d623.s0.p1	N	The higher affinity of vaccinia PROTEIN for polyphosphoinositides (Kd = 0.2-8.5 microM) than for PROTEIN2 or poly(L-proline) and the concentration of vaccinia PROTEIN expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia PROTEIN1 binds preferentially to PIP and PIP2 in vivo.
BioInfer.d623.s0.p2	N	The higher affinity of vaccinia PROTEIN2 for polyphosphoinositides (Kd = 0.2-8.5 microM) than for PROTEIN or poly(L-proline) and the concentration of vaccinia PROTEIN expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia PROTEIN1 binds preferentially to PIP and PIP2 in vivo.
BioInfer.d623.s0.p3	N	The higher affinity of vaccinia PROTEIN for polyphosphoinositides (Kd = 0.2-8.5 microM) than for PROTEIN2 or poly(L-proline) and the concentration of vaccinia PROTEIN1 expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia PROTEIN binds preferentially to PIP and PIP2 in vivo.
BioInfer.d623.s0.p4	N	The higher affinity of vaccinia PROTEIN2 for polyphosphoinositides (Kd = 0.2-8.5 microM) than for PROTEIN or poly(L-proline) and the concentration of vaccinia PROTEIN1 expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia PROTEIN binds preferentially to PIP and PIP2 in vivo.
BioInfer.d623.s0.p5	P	The higher affinity of vaccinia PROTEIN2 for polyphosphoinositides (Kd = 0.2-8.5 microM) than for PROTEIN1 or poly(L-proline) and the concentration of vaccinia PROTEIN expressed in infected HeLa cells (approximately 20 microM) suggest that vaccinia PROTEIN binds preferentially to PIP and PIP2 in vivo.
BioInfer.d623.s1.p0	N	We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate PROTEIN2 , purified the recombinant viral PROTEIN1 , and characterized its interactions with PROTEIN and polyphosphoinositides.
BioInfer.d623.s1.p1	P	We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate PROTEIN , purified the recombinant viral PROTEIN1 , and characterized its interactions with PROTEIN2 and polyphosphoinositides.
BioInfer.d623.s1.p2	N	We expressed in Escherichia coli the vaccinia virus gene for a protein similar to vertebrate PROTEIN1 , purified the recombinant viral PROTEIN , and characterized its interactions with PROTEIN2 and polyphosphoinositides.
BioInfer.d624.s0.p0	N	The high recombination levels seen in PROTEIN and PROTEIN mutants is dependent on the PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 genes.
BioInfer.d624.s0.p1	N	The high recombination levels seen in PROTEIN and PROTEIN mutants is dependent on the PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 genes.
BioInfer.d624.s0.p2	N	The high recombination levels seen in PROTEIN and PROTEIN2 mutants is dependent on the PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 genes.
BioInfer.d624.s0.p3	N	The high recombination levels seen in PROTEIN and PROTEIN mutants is dependent on the PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 genes.
BioInfer.d624.s0.p4	N	The high recombination levels seen in PROTEIN2 and PROTEIN mutants is dependent on the PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 genes.
BioInfer.d624.s0.p5	N	The high recombination levels seen in PROTEIN and PROTEIN mutants is dependent on the PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN genes.
BioInfer.d624.s0.p6	N	The high recombination levels seen in PROTEIN and PROTEIN2 mutants is dependent on the PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN genes.
BioInfer.d624.s0.p7	N	The high recombination levels seen in PROTEIN and PROTEIN mutants is dependent on the PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN genes.
BioInfer.d624.s0.p8	N	The high recombination levels seen in PROTEIN2 and PROTEIN mutants is dependent on the PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN genes.
BioInfer.d624.s0.p9	N	The high recombination levels seen in PROTEIN and PROTEIN2 mutants is dependent on the PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN genes.
BioInfer.d624.s0.p10	N	The high recombination levels seen in PROTEIN and PROTEIN mutants is dependent on the PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN genes.
BioInfer.d624.s0.p11	N	The high recombination levels seen in PROTEIN2 and PROTEIN mutants is dependent on the PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN genes.
BioInfer.d624.s0.p12	N	The high recombination levels seen in PROTEIN and PROTEIN1 mutants is dependent on the PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN genes.
BioInfer.d624.s0.p13	N	The high recombination levels seen in PROTEIN2 and PROTEIN1 mutants is dependent on the PROTEIN , PROTEIN , PROTEIN , and PROTEIN genes.
BioInfer.d624.s0.p14	N	The high recombination levels seen in PROTEIN2 and PROTEIN mutants is dependent on the PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN genes.
BioInfer.d625.s0.p0	P	The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of PROTEIN , the PROTEIN  PROTEIN and of PROTEIN and decreased expression of the PROTEIN1  PROTEIN2 .
BioInfer.d625.s0.p1	N	The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of PROTEIN , the PROTEIN  PROTEIN and of PROTEIN2 and decreased expression of the PROTEIN1  PROTEIN .
BioInfer.d625.s0.p2	N	The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of PROTEIN , the PROTEIN  PROTEIN2 and of PROTEIN and decreased expression of the PROTEIN1  PROTEIN .
BioInfer.d625.s0.p3	N	The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of PROTEIN , the PROTEIN2  PROTEIN and of PROTEIN and decreased expression of the PROTEIN1  PROTEIN .
BioInfer.d625.s0.p4	N	The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of PROTEIN2 , the PROTEIN  PROTEIN and of PROTEIN and decreased expression of the PROTEIN1  PROTEIN .
BioInfer.d625.s0.p5	N	The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of PROTEIN , the PROTEIN  PROTEIN and of PROTEIN2 and decreased expression of the PROTEIN  PROTEIN1 .
BioInfer.d625.s0.p6	N	The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of PROTEIN , the PROTEIN  PROTEIN2 and of PROTEIN and decreased expression of the PROTEIN  PROTEIN1 .
BioInfer.d625.s0.p7	N	The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of PROTEIN , the PROTEIN2  PROTEIN and of PROTEIN and decreased expression of the PROTEIN  PROTEIN1 .
BioInfer.d625.s0.p8	N	The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of PROTEIN2 , the PROTEIN  PROTEIN and of PROTEIN and decreased expression of the PROTEIN  PROTEIN1 .
BioInfer.d625.s0.p9	N	The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of PROTEIN , the PROTEIN  PROTEIN2 and of PROTEIN1 and decreased expression of the PROTEIN  PROTEIN .
BioInfer.d625.s0.p10	N	The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of PROTEIN , the PROTEIN2  PROTEIN and of PROTEIN1 and decreased expression of the PROTEIN  PROTEIN .
BioInfer.d625.s0.p11	N	The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of PROTEIN2 , the PROTEIN  PROTEIN and of PROTEIN1 and decreased expression of the PROTEIN  PROTEIN .
BioInfer.d625.s0.p12	P	The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of PROTEIN , the PROTEIN2  PROTEIN1 and of PROTEIN and decreased expression of the PROTEIN  PROTEIN .
BioInfer.d625.s0.p13	N	The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of PROTEIN2 , the PROTEIN  PROTEIN1 and of PROTEIN and decreased expression of the PROTEIN  PROTEIN .
BioInfer.d625.s0.p14	N	The hyperproliferative response observed in the gastric mucosa is secondary to this initial insult and is associated with increased expression of PROTEIN2 , the PROTEIN1  PROTEIN and of PROTEIN and decreased expression of the PROTEIN  PROTEIN .
BioInfer.d626.s0.p0	P	The I/LWEQ module is a conserved sequence that we have identified as an PROTEIN1 -binding motif in the metazoan focal adhesion protein PROTEIN2 and the yeast protein PROTEIN .
BioInfer.d626.s0.p1	P	The I/LWEQ module is a conserved sequence that we have identified as an PROTEIN1 -binding motif in the metazoan focal adhesion protein PROTEIN and the yeast protein PROTEIN2 .
BioInfer.d626.s0.p2	N	The I/LWEQ module is a conserved sequence that we have identified as an PROTEIN -binding motif in the metazoan focal adhesion protein PROTEIN1 and the yeast protein PROTEIN2 .
BioInfer.d627.s0.p0	P	The influence of these PROTEIN1 on cell morphology and the distribution pattern of PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.
BioInfer.d627.s0.p1	P	The influence of these PROTEIN1 on cell morphology and the distribution pattern of PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.
BioInfer.d627.s0.p2	P	The influence of these PROTEIN1 on cell morphology and the distribution pattern of PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.
BioInfer.d627.s0.p3	P	The influence of these PROTEIN1 on cell morphology and the distribution pattern of PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.
BioInfer.d627.s0.p4	N	The influence of these PROTEIN on cell morphology and the distribution pattern of PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.
BioInfer.d627.s0.p5	N	The influence of these PROTEIN on cell morphology and the distribution pattern of PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.
BioInfer.d627.s0.p6	N	The influence of these PROTEIN on cell morphology and the distribution pattern of PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.
BioInfer.d627.s0.p7	N	The influence of these PROTEIN on cell morphology and the distribution pattern of PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.
BioInfer.d627.s0.p8	N	The influence of these PROTEIN on cell morphology and the distribution pattern of PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.
BioInfer.d627.s0.p9	N	The influence of these PROTEIN on cell morphology and the distribution pattern of PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 was analyzed by light microscopy, conventional electron microscopy, immunofluorescence, and immunogold labeling after lysis-squirting.
BioInfer.d628.s0.p0	N	The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the PROTEIN1  PROTEIN ( PROTEIN ) but a striking inhibition of the expression of PROTEIN2 .
BioInfer.d628.s0.p1	P	The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the PROTEIN1  PROTEIN ( PROTEIN2 ) but a striking inhibition of the expression of PROTEIN .
BioInfer.d628.s0.p2	P	The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the PROTEIN1  PROTEIN2 ( PROTEIN ) but a striking inhibition of the expression of PROTEIN .
BioInfer.d628.s0.p3	N	The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the PROTEIN  PROTEIN ( PROTEIN2 ) but a striking inhibition of the expression of PROTEIN1 .
BioInfer.d628.s0.p4	N	The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the PROTEIN  PROTEIN2 ( PROTEIN ) but a striking inhibition of the expression of PROTEIN1 .
BioInfer.d628.s0.p5	N	The inhibitory effects of rapamycin on bombesin-stimulated cell cycle progression did not involve accumulation of the PROTEIN  PROTEIN2 ( PROTEIN1 ) but a striking inhibition of the expression of PROTEIN .
BioInfer.d629.s0.p0	N	The interaction between the human respiratory syncytial virus PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN2 ) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.
BioInfer.d629.s0.p1	P	The interaction between the human respiratory syncytial virus PROTEIN ( PROTEIN2 ) and PROTEIN1 ( PROTEIN ) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.
BioInfer.d629.s0.p2	P	The interaction between the human respiratory syncytial virus PROTEIN2 ( PROTEIN ) and PROTEIN1 ( PROTEIN ) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.
BioInfer.d629.s0.p3	P	The interaction between the human respiratory syncytial virus PROTEIN ( PROTEIN2 ) and PROTEIN ( PROTEIN1 ) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.
BioInfer.d629.s0.p4	P	The interaction between the human respiratory syncytial virus PROTEIN2 ( PROTEIN ) and PROTEIN ( PROTEIN1 ) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.
BioInfer.d629.s0.p5	N	The interaction between the human respiratory syncytial virus PROTEIN2 ( PROTEIN1 ) and PROTEIN ( PROTEIN ) protein has been investigated using the two hybrid system in yeast and in tissue culture cells.
BioInfer.d630.s0.p0	P	The interaction of a mouse monoclonal antibody ( PROTEIN1 ) and birch PROTEIN2 , a structurally well conserved PROTEIN - and phosphoinositide-binding protein and cross-reactive allergen, was characterized.
BioInfer.d630.s0.p1	N	The interaction of a mouse monoclonal antibody ( PROTEIN1 ) and birch PROTEIN , a structurally well conserved PROTEIN2 - and phosphoinositide-binding protein and cross-reactive allergen, was characterized.
BioInfer.d630.s0.p2	P	The interaction of a mouse monoclonal antibody ( PROTEIN ) and birch PROTEIN1 , a structurally well conserved PROTEIN2 - and phosphoinositide-binding protein and cross-reactive allergen, was characterized.
BioInfer.d631.s0.p0	N	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN ( PROTEIN ) with PROTEIN ( PROTEIN2 ) and PROTEIN1 ( PROTEIN ) proteins was investigated using an intracellular BRSV- PROTEIN minigenome replication system.
BioInfer.d631.s0.p1	N	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN ( PROTEIN ) with PROTEIN2 ( PROTEIN ) and PROTEIN1 ( PROTEIN ) proteins was investigated using an intracellular BRSV- PROTEIN minigenome replication system.
BioInfer.d631.s0.p2	P	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN2 ( PROTEIN ) with PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) proteins was investigated using an intracellular BRSV- PROTEIN minigenome replication system.
BioInfer.d631.s0.p3	P	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN ( PROTEIN2 ) with PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) proteins was investigated using an intracellular BRSV- PROTEIN minigenome replication system.
BioInfer.d631.s0.p4	N	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN ( PROTEIN ) with PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN ) proteins was investigated using an intracellular BRSV- PROTEIN2 minigenome replication system.
BioInfer.d631.s0.p5	N	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN ( PROTEIN ) with PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN2 ) proteins was investigated using an intracellular BRSV- PROTEIN minigenome replication system.
BioInfer.d631.s0.p6	N	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN ( PROTEIN ) with PROTEIN2 ( PROTEIN1 ) and PROTEIN ( PROTEIN ) proteins was investigated using an intracellular BRSV- PROTEIN minigenome replication system.
BioInfer.d631.s0.p7	P	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN2 ( PROTEIN ) with PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) proteins was investigated using an intracellular BRSV- PROTEIN minigenome replication system.
BioInfer.d631.s0.p8	P	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN ( PROTEIN2 ) with PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) proteins was investigated using an intracellular BRSV- PROTEIN minigenome replication system.
BioInfer.d631.s0.p9	N	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN ( PROTEIN ) with PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN ) proteins was investigated using an intracellular BRSV- PROTEIN2 minigenome replication system.
BioInfer.d631.s0.p10	N	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN ( PROTEIN ) with PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN2 ) proteins was investigated using an intracellular BRSV- PROTEIN minigenome replication system.
BioInfer.d631.s0.p11	P	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN2 ( PROTEIN ) with PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins was investigated using an intracellular BRSV- PROTEIN minigenome replication system.
BioInfer.d631.s0.p12	P	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN ( PROTEIN2 ) with PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins was investigated using an intracellular BRSV- PROTEIN minigenome replication system.
BioInfer.d631.s0.p13	N	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN ( PROTEIN ) with PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins was investigated using an intracellular BRSV- PROTEIN2 minigenome replication system.
BioInfer.d631.s0.p14	N	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN ( PROTEIN ) with PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN2 ) proteins was investigated using an intracellular BRSV- PROTEIN minigenome replication system.
BioInfer.d631.s0.p15	N	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN1 ( PROTEIN2 ) with PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins was investigated using an intracellular BRSV- PROTEIN minigenome replication system.
BioInfer.d631.s0.p16	N	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN1 ( PROTEIN ) with PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins was investigated using an intracellular BRSV- PROTEIN2 minigenome replication system.
BioInfer.d631.s0.p17	P	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN1 ( PROTEIN ) with PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) proteins was investigated using an intracellular BRSV- PROTEIN minigenome replication system.
BioInfer.d631.s0.p18	N	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN ( PROTEIN1 ) with PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN ) proteins was investigated using an intracellular BRSV- PROTEIN2 minigenome replication system.
BioInfer.d631.s0.p19	P	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN ( PROTEIN1 ) with PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) proteins was investigated using an intracellular BRSV- PROTEIN minigenome replication system.
BioInfer.d631.s0.p20	N	The interaction of bovine respiratory syncytial virus (BRSV) PROTEIN ( PROTEIN ) with PROTEIN ( PROTEIN ) and PROTEIN ( PROTEIN2 ) proteins was investigated using an intracellular BRSV- PROTEIN1 minigenome replication system.
BioInfer.d632.s0.p0	P	The interactions of PROTEIN1 with PROTEIN , PROTEIN2 and PROTEIN are compared.
BioInfer.d632.s0.p1	P	The interactions of PROTEIN1 with PROTEIN2 , PROTEIN and PROTEIN are compared.
BioInfer.d632.s0.p2	P	The interactions of PROTEIN1 with PROTEIN , PROTEIN and PROTEIN2 are compared.
BioInfer.d632.s0.p3	N	The interactions of PROTEIN with PROTEIN2 , PROTEIN1 and PROTEIN are compared.
BioInfer.d632.s0.p4	N	The interactions of PROTEIN with PROTEIN , PROTEIN1 and PROTEIN2 are compared.
BioInfer.d632.s0.p5	N	The interactions of PROTEIN with PROTEIN1 , PROTEIN and PROTEIN2 are compared.
BioInfer.d633.s0.p0	N	The intracellular molecules PROTEIN2 and PROTEIN1 actively regulate PROTEIN -based motility and participate in the signaling pathways used to steer growth cones.
BioInfer.d633.s0.p1	P	The intracellular molecules PROTEIN and PROTEIN1 actively regulate PROTEIN2 -based motility and participate in the signaling pathways used to steer growth cones.
BioInfer.d633.s0.p2	P	The intracellular molecules PROTEIN1 and PROTEIN actively regulate PROTEIN2 -based motility and participate in the signaling pathways used to steer growth cones.
BioInfer.d634.s0.p0	N	The involvement of the death adaptor proteins PROTEIN2 / PROTEIN , PROTEIN , and PROTEIN1 and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN and PROTEIN ) are controversial.
BioInfer.d634.s0.p1	N	The involvement of the death adaptor proteins PROTEIN / PROTEIN , PROTEIN2 , and PROTEIN1 and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN and PROTEIN ) are controversial.
BioInfer.d634.s0.p2	N	The involvement of the death adaptor proteins PROTEIN / PROTEIN2 , PROTEIN , and PROTEIN1 and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN and PROTEIN ) are controversial.
BioInfer.d634.s0.p3	P	The involvement of the death adaptor proteins PROTEIN / PROTEIN , PROTEIN , and PROTEIN1 and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN2 and PROTEIN ) are controversial.
BioInfer.d634.s0.p5	N	The involvement of the death adaptor proteins PROTEIN / PROTEIN , PROTEIN , and PROTEIN1 and the apoptosis-initiating PROTEIN2 and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN and PROTEIN ) are controversial.
BioInfer.d634.s0.p7	P	The involvement of the death adaptor proteins PROTEIN / PROTEIN , PROTEIN , and PROTEIN1 and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN2 and 2 ( PROTEIN and PROTEIN ) are controversial.
BioInfer.d634.s0.p8	P	The involvement of the death adaptor proteins PROTEIN / PROTEIN , PROTEIN , and PROTEIN1 and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN and PROTEIN2 ) are controversial.
BioInfer.d634.s0.p9	N	The involvement of the death adaptor proteins PROTEIN1 / PROTEIN , PROTEIN2 , and PROTEIN and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN and PROTEIN ) are controversial.
BioInfer.d634.s0.p10	N	The involvement of the death adaptor proteins PROTEIN1 / PROTEIN2 , PROTEIN , and PROTEIN and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN and PROTEIN ) are controversial.
BioInfer.d634.s0.p11	P	The involvement of the death adaptor proteins PROTEIN1 / PROTEIN , PROTEIN , and PROTEIN and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN2 and PROTEIN ) are controversial.
BioInfer.d634.s0.p13	N	The involvement of the death adaptor proteins PROTEIN1 / PROTEIN , PROTEIN , and PROTEIN and the apoptosis-initiating PROTEIN2 and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN and PROTEIN ) are controversial.
BioInfer.d634.s0.p15	P	The involvement of the death adaptor proteins PROTEIN1 / PROTEIN , PROTEIN , and PROTEIN and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN2 and 2 ( PROTEIN and PROTEIN ) are controversial.
BioInfer.d634.s0.p16	P	The involvement of the death adaptor proteins PROTEIN1 / PROTEIN , PROTEIN , and PROTEIN and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN and PROTEIN2 ) are controversial.
BioInfer.d634.s0.p17	N	The involvement of the death adaptor proteins PROTEIN / PROTEIN2 , PROTEIN1 , and PROTEIN and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN and PROTEIN ) are controversial.
BioInfer.d634.s0.p18	P	The involvement of the death adaptor proteins PROTEIN / PROTEIN , PROTEIN1 , and PROTEIN and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN2 and PROTEIN ) are controversial.
BioInfer.d634.s0.p20	N	The involvement of the death adaptor proteins PROTEIN / PROTEIN , PROTEIN1 , and PROTEIN and the apoptosis-initiating PROTEIN2 and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN and PROTEIN ) are controversial.
BioInfer.d634.s0.p22	P	The involvement of the death adaptor proteins PROTEIN / PROTEIN , PROTEIN1 , and PROTEIN and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN2 and 2 ( PROTEIN and PROTEIN ) are controversial.
BioInfer.d634.s0.p23	P	The involvement of the death adaptor proteins PROTEIN / PROTEIN , PROTEIN1 , and PROTEIN and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN and PROTEIN2 ) are controversial.
BioInfer.d634.s0.p24	P	The involvement of the death adaptor proteins PROTEIN / PROTEIN1 , PROTEIN , and PROTEIN and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN2 and PROTEIN ) are controversial.
BioInfer.d634.s0.p26	N	The involvement of the death adaptor proteins PROTEIN / PROTEIN1 , PROTEIN , and PROTEIN and the apoptosis-initiating PROTEIN2 and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN and PROTEIN ) are controversial.
BioInfer.d634.s0.p28	P	The involvement of the death adaptor proteins PROTEIN / PROTEIN1 , PROTEIN , and PROTEIN and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN2 and 2 ( PROTEIN and PROTEIN ) are controversial.
BioInfer.d634.s0.p29	P	The involvement of the death adaptor proteins PROTEIN / PROTEIN1 , PROTEIN , and PROTEIN and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN and PROTEIN2 ) are controversial.
BioInfer.d634.s0.p31	P	The involvement of the death adaptor proteins PROTEIN / PROTEIN , PROTEIN , and PROTEIN and the apoptosis-initiating PROTEIN2 and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN1 and PROTEIN ) are controversial.
BioInfer.d634.s0.p33	N	The involvement of the death adaptor proteins PROTEIN / PROTEIN , PROTEIN , and PROTEIN and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN2 and 2 ( PROTEIN1 and PROTEIN ) are controversial.
BioInfer.d634.s0.p34	N	The involvement of the death adaptor proteins PROTEIN / PROTEIN , PROTEIN , and PROTEIN and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN1 and PROTEIN2 ) are controversial.
BioInfer.d634.s0.p40	P	The involvement of the death adaptor proteins PROTEIN / PROTEIN , PROTEIN , and PROTEIN and the apoptosis-initiating PROTEIN1 and -10 in death signaling by the two death-inducing PROTEIN2 and 2 ( PROTEIN and PROTEIN ) are controversial.
BioInfer.d634.s0.p41	P	The involvement of the death adaptor proteins PROTEIN / PROTEIN , PROTEIN , and PROTEIN and the apoptosis-initiating PROTEIN1 and -10 in death signaling by the two death-inducing PROTEIN and 2 ( PROTEIN and PROTEIN2 ) are controversial.
BioInfer.d634.s0.p44	N	The involvement of the death adaptor proteins PROTEIN / PROTEIN , PROTEIN , and PROTEIN and the apoptosis-initiating PROTEIN and -10 in death signaling by the two death-inducing PROTEIN1 and 2 ( PROTEIN and PROTEIN2 ) are controversial.
BioInfer.d635.s0.p0	P	Their abilities to store lipids and express PROTEIN2 intermediate filaments, PROTEIN , and PROTEIN1 in contractile filaments in vitro illustrate similarities among the pulmonary LF, the hepatic lipocyte, and the contractile interstitial cell, which contribute to the repair reaction in the lung after pulmonary injury.
BioInfer.d635.s0.p1	P	Their abilities to store lipids and express PROTEIN intermediate filaments, PROTEIN2 , and PROTEIN1 in contractile filaments in vitro illustrate similarities among the pulmonary LF, the hepatic lipocyte, and the contractile interstitial cell, which contribute to the repair reaction in the lung after pulmonary injury.
BioInfer.d635.s0.p2	P	Their abilities to store lipids and express PROTEIN1 intermediate filaments, PROTEIN2 , and PROTEIN in contractile filaments in vitro illustrate similarities among the pulmonary LF, the hepatic lipocyte, and the contractile interstitial cell, which contribute to the repair reaction in the lung after pulmonary injury.
BioInfer.d636.s0.p0	P	The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 .
BioInfer.d636.s0.p1	P	The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN .
BioInfer.d636.s0.p2	P	The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN .
BioInfer.d636.s0.p3	P	The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: PROTEIN , PROTEIN2 , PROTEIN and PROTEIN1 .
BioInfer.d636.s0.p4	P	The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: PROTEIN , PROTEIN , PROTEIN2 and PROTEIN1 .
BioInfer.d636.s0.p5	P	The isolated intestinal microvillus cytoskeleton (core) consists of four major proteins: PROTEIN , PROTEIN1 , PROTEIN2 and PROTEIN .
BioInfer.d637.s0.p0	P	The junctional multidomain protein PROTEIN1 is a binding partner of the PROTEIN2  PROTEIN and associates with the PROTEIN cytoskeletal regulator PROTEIN .
BioInfer.d637.s0.p1	N	The junctional multidomain protein PROTEIN1 is a binding partner of the PROTEIN  PROTEIN and associates with the PROTEIN2 cytoskeletal regulator PROTEIN .
BioInfer.d637.s0.p2	N	The junctional multidomain protein PROTEIN1 is a binding partner of the PROTEIN  PROTEIN2 and associates with the PROTEIN cytoskeletal regulator PROTEIN .
BioInfer.d637.s0.p3	P	The junctional multidomain protein PROTEIN1 is a binding partner of the PROTEIN  PROTEIN and associates with the PROTEIN cytoskeletal regulator PROTEIN2 .
BioInfer.d637.s0.p4	N	The junctional multidomain protein PROTEIN is a binding partner of the PROTEIN1  PROTEIN and associates with the PROTEIN2 cytoskeletal regulator PROTEIN .
BioInfer.d637.s0.p5	P	The junctional multidomain protein PROTEIN is a binding partner of the PROTEIN1  PROTEIN2 and associates with the PROTEIN cytoskeletal regulator PROTEIN .
BioInfer.d637.s0.p6	N	The junctional multidomain protein PROTEIN is a binding partner of the PROTEIN1  PROTEIN and associates with the PROTEIN cytoskeletal regulator PROTEIN2 .
BioInfer.d637.s0.p7	N	The junctional multidomain protein PROTEIN is a binding partner of the PROTEIN  PROTEIN2 and associates with the PROTEIN1 cytoskeletal regulator PROTEIN .
BioInfer.d637.s0.p8	P	The junctional multidomain protein PROTEIN is a binding partner of the PROTEIN  PROTEIN and associates with the PROTEIN1 cytoskeletal regulator PROTEIN2 .
BioInfer.d637.s0.p9	N	The junctional multidomain protein PROTEIN is a binding partner of the PROTEIN  PROTEIN1 and associates with the PROTEIN cytoskeletal regulator PROTEIN2 .
BioInfer.d637.s1.p0	P	To our knowledge, PROTEIN1 is the only integral component in cell-cell junctions discovered thus far that interacts with PROTEIN2 and thus could modulate PROTEIN modeling proximal to adhesion complexes.
BioInfer.d637.s1.p1	P	To our knowledge, PROTEIN1 is the only integral component in cell-cell junctions discovered thus far that interacts with PROTEIN and thus could modulate PROTEIN2 modeling proximal to adhesion complexes.
BioInfer.d637.s1.p2	N	To our knowledge, PROTEIN is the only integral component in cell-cell junctions discovered thus far that interacts with PROTEIN1 and thus could modulate PROTEIN2 modeling proximal to adhesion complexes.
BioInfer.d638.s0.p0	N	The long repeats, which are interdigitated between the PRRs, increased the frequency with which PROTEIN1 -based motility occurred by a mechanism independent of the PRRs, PROTEIN , and PROTEIN2 .
BioInfer.d638.s0.p1	N	The long repeats, which are interdigitated between the PRRs, increased the frequency with which PROTEIN1 -based motility occurred by a mechanism independent of the PRRs, PROTEIN2 , and PROTEIN .
BioInfer.d638.s0.p2	N	The long repeats, which are interdigitated between the PRRs, increased the frequency with which PROTEIN -based motility occurred by a mechanism independent of the PRRs, PROTEIN2 , and PROTEIN1 .
BioInfer.d638.s1.p0	P	The tandem repeat domain in the Listeria monocytogenes PROTEIN2 protein controls the rate of PROTEIN -based motility, the percentage of moving bacteria, and the localization of PROTEIN and PROTEIN1 .
BioInfer.d638.s1.p1	N	The tandem repeat domain in the Listeria monocytogenes PROTEIN protein controls the rate of PROTEIN2 -based motility, the percentage of moving bacteria, and the localization of PROTEIN and PROTEIN1 .
BioInfer.d638.s1.p2	N	The tandem repeat domain in the Listeria monocytogenes PROTEIN protein controls the rate of PROTEIN -based motility, the percentage of moving bacteria, and the localization of PROTEIN2 and PROTEIN1 .
BioInfer.d638.s1.p3	P	The tandem repeat domain in the Listeria monocytogenes PROTEIN1 protein controls the rate of PROTEIN2 -based motility, the percentage of moving bacteria, and the localization of PROTEIN and PROTEIN .
BioInfer.d638.s1.p4	P	The tandem repeat domain in the Listeria monocytogenes PROTEIN1 protein controls the rate of PROTEIN -based motility, the percentage of moving bacteria, and the localization of PROTEIN2 and PROTEIN .
BioInfer.d638.s1.p5	N	The tandem repeat domain in the Listeria monocytogenes PROTEIN protein controls the rate of PROTEIN1 -based motility, the percentage of moving bacteria, and the localization of PROTEIN2 and PROTEIN .
BioInfer.d639.s0.p0	N	The main inhibitory action of PROTEIN , a PROTEIN ( PROTEIN1 ), arises from its binding with the PROTEIN / PROTEIN2 ( PROTEIN ) complex that results in G(1)-S arrest.
BioInfer.d639.s0.p1	P	The main inhibitory action of PROTEIN2 , a PROTEIN ( PROTEIN1 ), arises from its binding with the PROTEIN / PROTEIN ( PROTEIN ) complex that results in G(1)-S arrest.
BioInfer.d639.s0.p2	N	The main inhibitory action of PROTEIN , a PROTEIN ( PROTEIN1 ), arises from its binding with the PROTEIN / PROTEIN ( PROTEIN2 ) complex that results in G(1)-S arrest.
BioInfer.d639.s0.p3	N	The main inhibitory action of PROTEIN , a PROTEIN2 ( PROTEIN1 ), arises from its binding with the PROTEIN / PROTEIN ( PROTEIN ) complex that results in G(1)-S arrest.
BioInfer.d639.s0.p4	N	The main inhibitory action of PROTEIN , a PROTEIN ( PROTEIN1 ), arises from its binding with the PROTEIN2 / PROTEIN ( PROTEIN ) complex that results in G(1)-S arrest.
BioInfer.d639.s0.p5	P	The main inhibitory action of PROTEIN2 , a PROTEIN ( PROTEIN ), arises from its binding with the PROTEIN / PROTEIN1 ( PROTEIN ) complex that results in G(1)-S arrest.
BioInfer.d639.s0.p6	P	The main inhibitory action of PROTEIN , a PROTEIN ( PROTEIN ), arises from its binding with the PROTEIN / PROTEIN1 ( PROTEIN2 ) complex that results in G(1)-S arrest.
BioInfer.d639.s0.p7	N	The main inhibitory action of PROTEIN , a PROTEIN2 ( PROTEIN ), arises from its binding with the PROTEIN / PROTEIN1 ( PROTEIN ) complex that results in G(1)-S arrest.
BioInfer.d639.s0.p8	P	The main inhibitory action of PROTEIN , a PROTEIN ( PROTEIN ), arises from its binding with the PROTEIN2 / PROTEIN1 ( PROTEIN ) complex that results in G(1)-S arrest.
BioInfer.d639.s0.p9	P	The main inhibitory action of PROTEIN1 , a PROTEIN ( PROTEIN ), arises from its binding with the PROTEIN / PROTEIN ( PROTEIN2 ) complex that results in G(1)-S arrest.
BioInfer.d639.s0.p10	P	The main inhibitory action of PROTEIN1 , a PROTEIN2 ( PROTEIN ), arises from its binding with the PROTEIN / PROTEIN ( PROTEIN ) complex that results in G(1)-S arrest.
BioInfer.d639.s0.p11	P	The main inhibitory action of PROTEIN1 , a PROTEIN ( PROTEIN ), arises from its binding with the PROTEIN2 / PROTEIN ( PROTEIN ) complex that results in G(1)-S arrest.
BioInfer.d639.s0.p12	N	The main inhibitory action of PROTEIN , a PROTEIN2 ( PROTEIN ), arises from its binding with the PROTEIN / PROTEIN ( PROTEIN1 ) complex that results in G(1)-S arrest.
BioInfer.d639.s0.p13	P	The main inhibitory action of PROTEIN , a PROTEIN ( PROTEIN ), arises from its binding with the PROTEIN2 / PROTEIN ( PROTEIN1 ) complex that results in G(1)-S arrest.
BioInfer.d639.s0.p14	N	The main inhibitory action of PROTEIN , a PROTEIN1 ( PROTEIN ), arises from its binding with the PROTEIN2 / PROTEIN ( PROTEIN ) complex that results in G(1)-S arrest.
BioInfer.d640.s0.p0	N	The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for PROTEIN2 ; 86 per cent for PROTEIN1 ; 91 per cent for PROTEIN ) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.
BioInfer.d640.s0.p1	N	The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for PROTEIN ; 86 per cent for PROTEIN1 ; 91 per cent for PROTEIN2 ) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.
BioInfer.d640.s0.p2	N	The majority of cortical thymomas showed diffuse and homogenous membrane immunoreactivity for these molecules (88 per cent for PROTEIN1 ; 86 per cent for PROTEIN ; 91 per cent for PROTEIN2 ) and the remaining cases showed heterogeneous immunoreactivity, whereas almost all mixed and medullary thymomas revealed decreased expression or were negative.
BioInfer.d641.s0.p0	P	The majority of the aromatic residues in PROTEIN1 are exposed to solvent and lie in either of two hydrophobic patches, neither of which takes part in an interface with PROTEIN2 .
BioInfer.d642.s0.p0	N	The map locates the N-terminal calcium-binding domain and identifies PROTEIN2 -binding site residues on the two PROTEIN1 -homology domains of PROTEIN .
BioInfer.d642.s0.p1	P	The map locates the N-terminal calcium-binding domain and identifies PROTEIN -binding site residues on the two PROTEIN1 -homology domains of PROTEIN2 .
BioInfer.d642.s0.p2	P	The map locates the N-terminal calcium-binding domain and identifies PROTEIN1 -binding site residues on the two PROTEIN -homology domains of PROTEIN2 .
BioInfer.d643.s0.p0	P	The mechanism of PROTEIN1 -promoted PROTEIN2 polymerization has been systematically reinvestigated.
BioInfer.d643.s1.p0	P	When measured in the absence of PROTEIN , PROTEIN assembly curves over a 0.7-4 microM PROTEIN concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN1 . PROTEIN2 ).
BioInfer.d643.s1.p1	N	When measured in the absence of PROTEIN , PROTEIN2 assembly curves over a 0.7-4 microM PROTEIN concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN1 . PROTEIN ).
BioInfer.d643.s1.p2	N	When measured in the absence of PROTEIN2 , PROTEIN assembly curves over a 0.7-4 microM PROTEIN concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN1 . PROTEIN ).
BioInfer.d643.s1.p3	N	When measured in the absence of PROTEIN , PROTEIN assembly curves over a 0.7-4 microM PROTEIN2 concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN1 . PROTEIN ).
BioInfer.d643.s1.p4	N	When measured in the absence of PROTEIN , PROTEIN2 assembly curves over a 0.7-4 microM PROTEIN concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN . PROTEIN1 ).
BioInfer.d643.s1.p5	N	When measured in the absence of PROTEIN2 , PROTEIN assembly curves over a 0.7-4 microM PROTEIN concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN . PROTEIN1 ).
BioInfer.d643.s1.p6	N	When measured in the absence of PROTEIN , PROTEIN assembly curves over a 0.7-4 microM PROTEIN2 concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN . PROTEIN1 ).
BioInfer.d643.s1.p7	N	When measured in the absence of PROTEIN2 , PROTEIN1 assembly curves over a 0.7-4 microM PROTEIN concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN . PROTEIN ).
BioInfer.d643.s1.p8	N	When measured in the absence of PROTEIN , PROTEIN1 assembly curves over a 0.7-4 microM PROTEIN2 concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN . PROTEIN ).
BioInfer.d643.s1.p9	N	When measured in the absence of PROTEIN1 , PROTEIN assembly curves over a 0.7-4 microM PROTEIN2 concentration range fit a simple monomer sequestering model (1 microM K(D) for PROTEIN . PROTEIN ).
BioInfer.d643.s2.p0	N	With solutions of PROTEIN (2 microM) and PROTEIN1 (2 or 4 microM), the barbed-end assembly rate rose with increasing PROTEIN2 concentration (0.7-2 microM).
BioInfer.d643.s2.p1	N	With solutions of PROTEIN2 (2 microM) and PROTEIN1 (2 or 4 microM), the barbed-end assembly rate rose with increasing PROTEIN concentration (0.7-2 microM).
BioInfer.d643.s2.p2	N	With solutions of PROTEIN2 (2 microM) and PROTEIN (2 or 4 microM), the barbed-end assembly rate rose with increasing PROTEIN1 concentration (0.7-2 microM).
BioInfer.d644.s0.p0	P	The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, PROTEIN1 (95,000 daltons), PROTEIN (68,000 daltons), PROTEIN (43,000 daltons), and PROTEIN2 (17,000 daltons).
BioInfer.d644.s0.p1	P	The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, PROTEIN1 (95,000 daltons), PROTEIN2 (68,000 daltons), PROTEIN (43,000 daltons), and PROTEIN (17,000 daltons).
BioInfer.d644.s0.p2	P	The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, PROTEIN1 (95,000 daltons), PROTEIN (68,000 daltons), PROTEIN2 (43,000 daltons), and PROTEIN (17,000 daltons).
BioInfer.d644.s0.p3	P	The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, PROTEIN (95,000 daltons), PROTEIN2 (68,000 daltons), PROTEIN (43,000 daltons), and PROTEIN1 (17,000 daltons).
BioInfer.d644.s0.p4	P	The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, PROTEIN (95,000 daltons), PROTEIN (68,000 daltons), PROTEIN2 (43,000 daltons), and PROTEIN1 (17,000 daltons).
BioInfer.d644.s0.p5	P	The microvillus cytoskeleton, isolated from chicken intestinal epithelial cell brush borders, is known to contain five major protein components, the 110,000-dalton polypeptide, PROTEIN (95,000 daltons), PROTEIN1 (68,000 daltons), PROTEIN2 (43,000 daltons), and PROTEIN (17,000 daltons).
BioInfer.d645.s0.p0	N	The monomeric PROTEIN1 , PROTEIN , is a key regulator of PROTEIN2 -filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.
BioInfer.d645.s0.p1	P	The monomeric PROTEIN1 , PROTEIN2 , is a key regulator of PROTEIN -filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.
BioInfer.d645.s0.p2	P	The monomeric PROTEIN , PROTEIN2 , is a key regulator of PROTEIN1 -filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.
BioInfer.d646.s0.p0	N	The most significant finding was the re-expression of PROTEIN , PROTEIN2 , and PROTEIN , and increased down-regulation of PROTEIN1 , in metastatic lesions.
BioInfer.d646.s0.p1	N	The most significant finding was the re-expression of PROTEIN , PROTEIN , and PROTEIN2 , and increased down-regulation of PROTEIN1 , in metastatic lesions.
BioInfer.d646.s0.p2	N	The most significant finding was the re-expression of PROTEIN2 , PROTEIN , and PROTEIN , and increased down-regulation of PROTEIN1 , in metastatic lesions.
BioInfer.d646.s0.p3	N	The most significant finding was the re-expression of PROTEIN , PROTEIN1 , and PROTEIN2 , and increased down-regulation of PROTEIN , in metastatic lesions.
BioInfer.d646.s0.p4	N	The most significant finding was the re-expression of PROTEIN2 , PROTEIN1 , and PROTEIN , and increased down-regulation of PROTEIN , in metastatic lesions.
BioInfer.d646.s0.p5	N	The most significant finding was the re-expression of PROTEIN2 , PROTEIN , and PROTEIN1 , and increased down-regulation of PROTEIN , in metastatic lesions.
BioInfer.d647.s0.p0	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN1 versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN2  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p1	P	The most striking difference was in the relative preference for acetylation of PROTEIN2  PROTEIN1 versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p2	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN1 versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN2 , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p3	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN1 versus acetylation of PROTEIN  PROTEIN2 : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p4	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN1 versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN2 , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p5	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN1 versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN2 .
BioInfer.d647.s0.p6	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN1 versus acetylation of PROTEIN2  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p7	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN1 versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN2 in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p8	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN1 versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN2  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p9	N	The most striking difference was in the relative preference for acetylation of PROTEIN2  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN1  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p10	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN1  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN2 , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p11	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN2 : with the purified PROTEIN , PROTEIN1  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p12	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN2 , PROTEIN1  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p13	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN1  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN2 .
BioInfer.d647.s0.p14	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN2  PROTEIN : with the purified PROTEIN , PROTEIN1  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p15	P	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN1  PROTEIN2 in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p16	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN1  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN2  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p17	N	The most striking difference was in the relative preference for acetylation of PROTEIN1  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN2 , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p18	N	The most striking difference was in the relative preference for acetylation of PROTEIN1  PROTEIN versus acetylation of PROTEIN  PROTEIN2 : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p19	N	The most striking difference was in the relative preference for acetylation of PROTEIN1  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN2 , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p20	N	The most striking difference was in the relative preference for acetylation of PROTEIN1  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN2 .
BioInfer.d647.s0.p21	N	The most striking difference was in the relative preference for acetylation of PROTEIN1  PROTEIN versus acetylation of PROTEIN2  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p22	N	The most striking difference was in the relative preference for acetylation of PROTEIN1  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN2 in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p23	N	The most striking difference was in the relative preference for acetylation of PROTEIN1  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN2  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p24	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN2 : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN1 , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p25	P	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN2 , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN1 , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p26	P	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN1 , whereas the reverse preference was found with the endogenous PROTEIN2 .
BioInfer.d647.s0.p27	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN2  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN1 , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p28	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN2 in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN1 , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p29	P	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN2  PROTEIN1 , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p30	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN1 : with the purified PROTEIN2 , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p31	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN1 : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN2 .
BioInfer.d647.s0.p32	P	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN2  PROTEIN1 : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p33	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN1 : with the purified PROTEIN , PROTEIN  PROTEIN2 in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p34	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN1 : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN2  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p35	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN1 , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN2 .
BioInfer.d647.s0.p36	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN2  PROTEIN : with the purified PROTEIN1 , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p37	P	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN1 , PROTEIN  PROTEIN2 in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p38	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN1 , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN2  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p39	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN2  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN1 .
BioInfer.d647.s0.p40	P	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN2 in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN1 .
BioInfer.d647.s0.p41	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN2  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN1 .
BioInfer.d647.s0.p42	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN1  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN2 in nucleosomes was acetylated to a much greater extent than was PROTEIN  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p43	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN1  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN in nucleosomes was acetylated to a much greater extent than was PROTEIN2  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d647.s0.p44	N	The most striking difference was in the relative preference for acetylation of PROTEIN  PROTEIN versus acetylation of PROTEIN  PROTEIN : with the purified PROTEIN , PROTEIN  PROTEIN1 in nucleosomes was acetylated to a much greater extent than was PROTEIN2  PROTEIN , whereas the reverse preference was found with the endogenous PROTEIN .
BioInfer.d648.s0.p0	P	The multifunctional protein PROTEIN1 is one of the most abundant proteins in the cytoplasm and is thought to regulate PROTEIN2 assembly and the phosphoinositide signaling pathway.
BioInfer.d649.s0.p0	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p1	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p2	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p3	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p4	N	The muscle-related genes included PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p5	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p6	N	The muscle-related genes included PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p7	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p8	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p9	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN protein, and PROTEIN2 , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p10	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p11	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p12	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p13	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p14	N	The muscle-related genes included PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p15	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p16	N	The muscle-related genes included PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p17	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p18	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p19	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN2 , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p20	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p21	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p22	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p23	N	The muscle-related genes included PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p24	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p25	N	The muscle-related genes included PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p26	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p27	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p28	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN2 , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p29	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p30	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p31	N	The muscle-related genes included PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p32	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p33	N	The muscle-related genes included PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p34	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p35	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p36	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN2 , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p37	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p38	N	The muscle-related genes included PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p39	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p40	N	The muscle-related genes included PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p41	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p42	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p43	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN2 , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p44	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p45	N	The muscle-related genes included PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p46	N	The muscle-related genes included PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p47	N	The muscle-related genes included PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p48	N	The muscle-related genes included PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p49	N	The muscle-related genes included PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN2 , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p50	N	The muscle-related genes included PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p51	N	The muscle-related genes included PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p52	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p53	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p54	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN2 , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p55	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p56	N	The muscle-related genes included PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p57	N	The muscle-related genes included PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p58	N	The muscle-related genes included PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN2 , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p59	N	The muscle-related genes included PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p60	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p61	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 protein, and PROTEIN2 , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p62	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p63	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN protein, and PROTEIN2 , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p64	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN protein, and PROTEIN , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d649.s0.p65	N	The muscle-related genes included PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN protein, and PROTEIN1 , suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.
BioInfer.d650.s0.p0	N	The mutants ranged in affinity, from those that only weakly affected polymerization of PROTEIN2 to one that bound PROTEIN more strongly than wild-type PROTEIN1 .
BioInfer.d650.s0.p1	P	The mutants ranged in affinity, from those that only weakly affected polymerization of PROTEIN to one that bound PROTEIN2 more strongly than wild-type PROTEIN1 .
BioInfer.d650.s0.p2	N	The mutants ranged in affinity, from those that only weakly affected polymerization of PROTEIN1 to one that bound PROTEIN2 more strongly than wild-type PROTEIN .
BioInfer.d650.s1.p0	P	The role of PROTEIN2 in PROTEIN1 polymerization and nucleotide exchange.
BioInfer.d650.s2.p0	N	With PROTEIN1 , whose sequestering activity was low, the concentration of free PROTEIN monomers observed at steady-state of polymerization [Afree], was close to that seen with PROTEIN2 alone ([Acc], critical concentration of polymerization).
BioInfer.d650.s2.p1	N	With PROTEIN1 , whose sequestering activity was low, the concentration of free PROTEIN2 monomers observed at steady-state of polymerization [Afree], was close to that seen with PROTEIN alone ([Acc], critical concentration of polymerization).
BioInfer.d650.s2.p2	N	With PROTEIN , whose sequestering activity was low, the concentration of free PROTEIN2 monomers observed at steady-state of polymerization [Afree], was close to that seen with PROTEIN1 alone ([Acc], critical concentration of polymerization).
BioInfer.d651.s0.p0	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 protein.
BioInfer.d651.s0.p1	N	The neoplastic cells were positive for PROTEIN2 , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p2	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN2 and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p3	N	The neoplastic cells were positive for PROTEIN , PROTEIN2 , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p4	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p5	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN2 , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p6	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p7	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p8	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p9	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN protein.
BioInfer.d651.s0.p10	N	The neoplastic cells were positive for PROTEIN2 , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 protein.
BioInfer.d651.s0.p11	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN2 and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 protein.
BioInfer.d651.s0.p12	N	The neoplastic cells were positive for PROTEIN , PROTEIN2 , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 protein.
BioInfer.d651.s0.p13	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 protein.
BioInfer.d651.s0.p14	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN2 , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 protein.
BioInfer.d651.s0.p15	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 protein.
BioInfer.d651.s0.p16	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 protein.
BioInfer.d651.s0.p17	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN1 protein.
BioInfer.d651.s0.p18	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN1 protein.
BioInfer.d651.s0.p19	N	The neoplastic cells were positive for PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p20	N	The neoplastic cells were positive for PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p21	N	The neoplastic cells were positive for PROTEIN1 , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p22	N	The neoplastic cells were positive for PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p23	N	The neoplastic cells were positive for PROTEIN1 , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p24	N	The neoplastic cells were positive for PROTEIN1 , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p25	N	The neoplastic cells were positive for PROTEIN1 , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p26	N	The neoplastic cells were positive for PROTEIN1 , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN protein.
BioInfer.d651.s0.p27	N	The neoplastic cells were positive for PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p28	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , but negative for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p29	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p30	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p31	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , but negative for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p32	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p33	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN1 and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN protein.
BioInfer.d651.s0.p34	N	The neoplastic cells were positive for PROTEIN , PROTEIN1 , PROTEIN and PROTEIN , but negative for PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p35	N	The neoplastic cells were positive for PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p36	N	The neoplastic cells were positive for PROTEIN , PROTEIN1 , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p37	N	The neoplastic cells were positive for PROTEIN , PROTEIN1 , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p38	N	The neoplastic cells were positive for PROTEIN , PROTEIN1 , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p39	N	The neoplastic cells were positive for PROTEIN , PROTEIN1 , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN protein.
BioInfer.d651.s0.p40	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN2 , but negative for PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p41	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p42	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p43	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p44	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN protein.
BioInfer.d651.s0.p45	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN1 , but negative for PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p46	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN1 , but negative for PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p47	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN1 , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p48	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN1 , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN protein.
BioInfer.d651.s0.p49	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p50	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p51	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN protein.
BioInfer.d651.s0.p52	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN protein.
BioInfer.d651.s0.p53	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN protein.
BioInfer.d651.s0.p54	N	The neoplastic cells were positive for PROTEIN , PROTEIN , PROTEIN and PROTEIN , but negative for PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 and PROTEIN protein.
BioInfer.d652.s0.p0	P	The N-terminal PROTEIN1 polypeptide eventually disrupted PROTEIN2 stress fibres whereas the C-terminal polypeptide was without effect.
BioInfer.d652.s1.p0	P	The Pro1176 to Thr substitution found in PROTEIN2 from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind PROTEIN1 or PROTEIN .
BioInfer.d652.s1.p1	N	The Pro1176 to Thr substitution found in PROTEIN from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind PROTEIN1 or PROTEIN2 .
BioInfer.d652.s1.p2	P	The Pro1176 to Thr substitution found in PROTEIN1 from Wistar-Furth rats does not destroy the capacity of this region of the protein to bind PROTEIN or PROTEIN2 .
BioInfer.d653.s0.p0	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN2 : 1751-2190, PROTEIN : 3571-4057, PROTEIN1 : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p1	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN1 : 6621-7210, PROTEIN2 : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p2	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN2 ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN1 : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p3	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN2 : 3571-4057, PROTEIN1 : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p4	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN1 : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p5	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN1 : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p6	N	The nucleotide sequences of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN1 : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p7	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN1 : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p8	N	The nucleotide sequences of PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN1 : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p9	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN1 : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p10	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN1 : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p11	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN1 : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p12	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN1 : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p13	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN2 : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN1 : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p14	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN1 : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN2 : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p15	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN2 ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN1 : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p16	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN1 : 1751-2190, PROTEIN2 : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p17	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN1 : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p18	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN1 : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p19	N	The nucleotide sequences of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN1 : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p20	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN1 : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p21	N	The nucleotide sequences of PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN1 : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p22	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN1 : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p23	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN1 : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p24	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN1 : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p25	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN1 : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p26	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN2 : 1301-1700, PROTEIN1 : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p27	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN2 ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN1 : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p28	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN2 : 3571-4057, PROTEIN : 6621-7210, PROTEIN1 : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p29	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN1 : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p30	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN1 : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p31	N	The nucleotide sequences of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN1 : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p32	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN1 : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p33	N	The nucleotide sequences of PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN1 : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p34	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN1 : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p35	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN1 : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p36	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN1 : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p37	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN1 : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p38	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN2 : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN1 : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p39	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN1 ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN2 : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p40	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), and PROTEIN ( PROTEIN1 ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p41	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN1 ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p42	N	The nucleotide sequences of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN1 ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p43	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN1 ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p44	N	The nucleotide sequences of PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN1 ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p45	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN1 ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p46	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN1 ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p47	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN1 ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p48	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN1 ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p49	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN1 ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN2 : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p50	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN1 : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p51	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN1 : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p52	N	The nucleotide sequences of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN1 : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p53	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN1 : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p54	N	The nucleotide sequences of PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN1 : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p55	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN1 : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p56	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN1 : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p57	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN1 : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p58	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN1 : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p59	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN2 : 1301-1700, PROTEIN : 1751-2190, PROTEIN1 : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p60	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p61	N	The nucleotide sequences of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p62	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN2 ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p63	N	The nucleotide sequences of PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p64	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN1 ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p65	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p66	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), and PROTEIN2 ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p67	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN1 ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p68	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN2 : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p69	N	The nucleotide sequences of PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p70	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p71	N	The nucleotide sequences of PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p72	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p73	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p74	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p75	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p76	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN2 : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p77	N	The nucleotide sequences of PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p78	N	The nucleotide sequences of PROTEIN2 ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p79	N	The nucleotide sequences of PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p80	N	The nucleotide sequences of PROTEIN ( PROTEIN1 ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p81	N	The nucleotide sequences of PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p82	N	The nucleotide sequences of PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p83	N	The nucleotide sequences of PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN2 : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p84	N	The nucleotide sequences of PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p85	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN1 ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p86	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p87	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), and PROTEIN2 ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p88	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN1 ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p89	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN2 : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p90	N	The nucleotide sequences of PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p91	N	The nucleotide sequences of PROTEIN1 ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p92	N	The nucleotide sequences of PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p93	N	The nucleotide sequences of PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p94	N	The nucleotide sequences of PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN2 : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p95	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p96	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p97	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN2 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p98	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN2 : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p99	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN2 ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p100	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p101	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN2 : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p102	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), and PROTEIN1 ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p103	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), and PROTEIN1 ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN2 : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d653.s0.p104	N	The nucleotide sequences of PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), and PROTEIN ( PROTEIN ) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position PROTEIN2 : 1301-1700, PROTEIN : 1751-2190, PROTEIN : 3571-4057, PROTEIN : 6621-7210, PROTEIN : 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.
BioInfer.d654.s0.p0	N	The observed in vivo expression patterns of PROTEIN2 , PROTEIN1 , and PROTEIN suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.
BioInfer.d654.s0.p1	N	The observed in vivo expression patterns of PROTEIN , PROTEIN1 , and PROTEIN2 suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.
BioInfer.d654.s0.p2	N	The observed in vivo expression patterns of PROTEIN1 , PROTEIN , and PROTEIN2 suggest that these proteins are directly linked with the developmental regulation of cell junctions, as cardiac cells become stably committed and phenotypically differentiated to eventually form a mature myocardium.
BioInfer.d654.s1.p0	N	This study details the expression patterns of PROTEIN1 , PROTEIN , and PROTEIN2 , during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.
BioInfer.d654.s1.p1	N	This study details the expression patterns of PROTEIN1 , PROTEIN2 , and PROTEIN , during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.
BioInfer.d654.s1.p2	N	This study details the expression patterns of PROTEIN , PROTEIN2 , and PROTEIN1 , during definition of the cardiac cell population as distinct compartments in the anterior regions of the chick embryo between stages 5 and 9.
BioInfer.d655.s0.p0	P	The ordered assembly of the PROTEIN2 homologue together with PROTEIN1 and a series of other proteins is considered to play a key role in chemotactic orientation.
BioInfer.d656.s0.p0	P	The PROTEIN gene encodes a PROTEIN substrate that associates with the cell-cell adhesion protein complex containing PROTEIN and its cytoplasmic cofactors PROTEIN , PROTEIN1 , and PROTEIN2 .
BioInfer.d656.s0.p1	P	The PROTEIN gene encodes a PROTEIN substrate that associates with the cell-cell adhesion protein complex containing PROTEIN and its cytoplasmic cofactors PROTEIN2 , PROTEIN1 , and PROTEIN .
BioInfer.d656.s0.p2	P	The PROTEIN gene encodes a PROTEIN substrate that associates with the cell-cell adhesion protein complex containing PROTEIN2 and its cytoplasmic cofactors PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d656.s0.p3	N	The PROTEIN2 gene encodes a PROTEIN substrate that associates with the cell-cell adhesion protein complex containing PROTEIN and its cytoplasmic cofactors PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d656.s0.p4	N	The PROTEIN gene encodes a PROTEIN2 substrate that associates with the cell-cell adhesion protein complex containing PROTEIN and its cytoplasmic cofactors PROTEIN , PROTEIN1 , and PROTEIN .
BioInfer.d656.s0.p5	P	The PROTEIN gene encodes a PROTEIN substrate that associates with the cell-cell adhesion protein complex containing PROTEIN and its cytoplasmic cofactors PROTEIN2 , PROTEIN , and PROTEIN1 .
BioInfer.d656.s0.p6	P	The PROTEIN gene encodes a PROTEIN substrate that associates with the cell-cell adhesion protein complex containing PROTEIN2 and its cytoplasmic cofactors PROTEIN , PROTEIN , and PROTEIN1 .
BioInfer.d656.s0.p7	N	The PROTEIN2 gene encodes a PROTEIN substrate that associates with the cell-cell adhesion protein complex containing PROTEIN and its cytoplasmic cofactors PROTEIN , PROTEIN , and PROTEIN1 .
BioInfer.d656.s0.p8	N	The PROTEIN gene encodes a PROTEIN2 substrate that associates with the cell-cell adhesion protein complex containing PROTEIN and its cytoplasmic cofactors PROTEIN , PROTEIN , and PROTEIN1 .
BioInfer.d656.s0.p9	P	The PROTEIN gene encodes a PROTEIN substrate that associates with the cell-cell adhesion protein complex containing PROTEIN2 and its cytoplasmic cofactors PROTEIN1 , PROTEIN , and PROTEIN .
BioInfer.d656.s0.p10	N	The PROTEIN2 gene encodes a PROTEIN substrate that associates with the cell-cell adhesion protein complex containing PROTEIN and its cytoplasmic cofactors PROTEIN1 , PROTEIN , and PROTEIN .
BioInfer.d656.s0.p11	N	The PROTEIN gene encodes a PROTEIN2 substrate that associates with the cell-cell adhesion protein complex containing PROTEIN and its cytoplasmic cofactors PROTEIN1 , PROTEIN , and PROTEIN .
BioInfer.d656.s0.p12	N	The PROTEIN2 gene encodes a PROTEIN substrate that associates with the cell-cell adhesion protein complex containing PROTEIN1 and its cytoplasmic cofactors PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d656.s0.p13	N	The PROTEIN gene encodes a PROTEIN2 substrate that associates with the cell-cell adhesion protein complex containing PROTEIN1 and its cytoplasmic cofactors PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d656.s0.p14	N	The PROTEIN1 gene encodes a PROTEIN2 substrate that associates with the cell-cell adhesion protein complex containing PROTEIN and its cytoplasmic cofactors PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d657.s0.p0	N	PROTEIN binds to and inhibits complexes formed by PROTEIN1 - PROTEIN , PROTEIN2 - PROTEIN , and PROTEIN - PROTEIN .
BioInfer.d657.s0.p1	N	PROTEIN binds to and inhibits complexes formed by PROTEIN1 - PROTEIN , PROTEIN - PROTEIN , and PROTEIN2 - PROTEIN .
BioInfer.d657.s0.p2	N	PROTEIN binds to and inhibits complexes formed by PROTEIN1 - PROTEIN , PROTEIN - PROTEIN2 , and PROTEIN - PROTEIN .
BioInfer.d657.s0.p3	N	PROTEIN binds to and inhibits complexes formed by PROTEIN1 - PROTEIN , PROTEIN - PROTEIN , and PROTEIN - PROTEIN2 .
BioInfer.d657.s0.p4	P	PROTEIN binds to and inhibits complexes formed by PROTEIN1 - PROTEIN2 , PROTEIN - PROTEIN , and PROTEIN - PROTEIN .
BioInfer.d657.s0.p5	P	PROTEIN2 binds to and inhibits complexes formed by PROTEIN1 - PROTEIN , PROTEIN - PROTEIN , and PROTEIN - PROTEIN .
BioInfer.d657.s0.p6	N	PROTEIN binds to and inhibits complexes formed by PROTEIN - PROTEIN , PROTEIN1 - PROTEIN , and PROTEIN2 - PROTEIN .
BioInfer.d657.s0.p7	P	PROTEIN binds to and inhibits complexes formed by PROTEIN - PROTEIN , PROTEIN1 - PROTEIN2 , and PROTEIN - PROTEIN .
BioInfer.d657.s0.p8	N	PROTEIN binds to and inhibits complexes formed by PROTEIN - PROTEIN , PROTEIN1 - PROTEIN , and PROTEIN - PROTEIN2 .
BioInfer.d657.s0.p9	N	PROTEIN binds to and inhibits complexes formed by PROTEIN - PROTEIN2 , PROTEIN1 - PROTEIN , and PROTEIN - PROTEIN .
BioInfer.d657.s0.p10	P	PROTEIN2 binds to and inhibits complexes formed by PROTEIN - PROTEIN , PROTEIN1 - PROTEIN , and PROTEIN - PROTEIN .
BioInfer.d657.s0.p11	N	PROTEIN binds to and inhibits complexes formed by PROTEIN - PROTEIN , PROTEIN - PROTEIN2 , and PROTEIN1 - PROTEIN .
BioInfer.d657.s0.p12	P	PROTEIN binds to and inhibits complexes formed by PROTEIN - PROTEIN , PROTEIN - PROTEIN , and PROTEIN1 - PROTEIN2 .
BioInfer.d657.s0.p13	N	PROTEIN binds to and inhibits complexes formed by PROTEIN - PROTEIN2 , PROTEIN - PROTEIN , and PROTEIN1 - PROTEIN .
BioInfer.d657.s0.p14	P	PROTEIN2 binds to and inhibits complexes formed by PROTEIN - PROTEIN , PROTEIN - PROTEIN , and PROTEIN1 - PROTEIN .
BioInfer.d657.s0.p15	N	PROTEIN binds to and inhibits complexes formed by PROTEIN - PROTEIN , PROTEIN - PROTEIN1 , and PROTEIN - PROTEIN2 .
BioInfer.d657.s0.p16	N	PROTEIN binds to and inhibits complexes formed by PROTEIN - PROTEIN2 , PROTEIN - PROTEIN1 , and PROTEIN - PROTEIN .
BioInfer.d657.s0.p17	P	PROTEIN2 binds to and inhibits complexes formed by PROTEIN - PROTEIN , PROTEIN - PROTEIN1 , and PROTEIN - PROTEIN .
BioInfer.d657.s0.p18	N	PROTEIN binds to and inhibits complexes formed by PROTEIN - PROTEIN2 , PROTEIN - PROTEIN , and PROTEIN - PROTEIN1 .
BioInfer.d657.s0.p19	P	PROTEIN2 binds to and inhibits complexes formed by PROTEIN - PROTEIN , PROTEIN - PROTEIN , and PROTEIN - PROTEIN1 .
BioInfer.d657.s0.p20	P	PROTEIN2 binds to and inhibits complexes formed by PROTEIN - PROTEIN1 , PROTEIN - PROTEIN , and PROTEIN - PROTEIN .
BioInfer.d658.s0.p0	P	The phosphoprotein was identified as PROTEIN2 , an PROTEIN1 , and the activation-induced changes in its intracellular distribution have been described elsewhere (Suzuki et al., 1995, J Biol Chem 270:19551-19556).
BioInfer.d659.s0.p0	N	The PROTEIN gene product mediates PROTEIN1 -dependent and PROTEIN2 -dependent activation of the transcription factor PROTEIN .
BioInfer.d659.s0.p1	N	The PROTEIN2 gene product mediates PROTEIN1 -dependent and PROTEIN -dependent activation of the transcription factor PROTEIN .
BioInfer.d659.s0.p2	P	The PROTEIN gene product mediates PROTEIN1 -dependent and PROTEIN -dependent activation of the transcription factor PROTEIN2 .
BioInfer.d659.s0.p3	N	The PROTEIN2 gene product mediates PROTEIN -dependent and PROTEIN1 -dependent activation of the transcription factor PROTEIN .
BioInfer.d659.s0.p4	P	The PROTEIN gene product mediates PROTEIN -dependent and PROTEIN1 -dependent activation of the transcription factor PROTEIN2 .
BioInfer.d659.s0.p5	P	The PROTEIN1 gene product mediates PROTEIN -dependent and PROTEIN -dependent activation of the transcription factor PROTEIN2 .
BioInfer.d660.s0.p0	P	The polypeptide folds and the PROTEIN2 -binding surfaces of the amoeba PROTEIN1 are very similar to those of bovine and human PROTEIN .
BioInfer.d660.s0.p1	P	The polypeptide folds and the PROTEIN -binding surfaces of the amoeba PROTEIN1 are very similar to those of bovine and human PROTEIN2 .
BioInfer.d660.s0.p2	P	The polypeptide folds and the PROTEIN1 -binding surfaces of the amoeba PROTEIN are very similar to those of bovine and human PROTEIN2 .
BioInfer.d660.s1.p0	P	The proximity of these sites to the PROTEIN2 binding site provides an explanation for the competition between PROTEIN and lipids for binding PROTEIN1 .
BioInfer.d660.s1.p1	P	The proximity of these sites to the PROTEIN binding site provides an explanation for the competition between PROTEIN2 and lipids for binding PROTEIN1 .
BioInfer.d660.s1.p2	N	The proximity of these sites to the PROTEIN1 binding site provides an explanation for the competition between PROTEIN2 and lipids for binding PROTEIN .
BioInfer.d660.s2.p0	P	X-ray structures of isoforms of the PROTEIN2  PROTEIN1 that differ in their affinity for phosphatidylinositol phosphates.
BioInfer.d661.s0.p0	P	The position of the PROTEIN1 -binding site at the C terminal suggests that PROTEIN2 may work as a crosslinker between PROTEIN and PROTEIN .
BioInfer.d661.s0.p1	N	The position of the PROTEIN1 -binding site at the C terminal suggests that PROTEIN may work as a crosslinker between PROTEIN2 and PROTEIN .
BioInfer.d661.s0.p2	N	The position of the PROTEIN1 -binding site at the C terminal suggests that PROTEIN may work as a crosslinker between PROTEIN and PROTEIN2 .
BioInfer.d661.s0.p3	P	The position of the PROTEIN -binding site at the C terminal suggests that PROTEIN1 may work as a crosslinker between PROTEIN2 and PROTEIN .
BioInfer.d661.s0.p4	P	The position of the PROTEIN -binding site at the C terminal suggests that PROTEIN1 may work as a crosslinker between PROTEIN and PROTEIN2 .
BioInfer.d661.s0.p5	P	The position of the PROTEIN -binding site at the C terminal suggests that PROTEIN may work as a crosslinker between PROTEIN1 and PROTEIN2 .
BioInfer.d662.s0.p0	N	The posttranslational metabolism of PROTEIN1 ( PROTEIN2 ) and PROTEIN was regulated in parallel with the total contractile protein pool.
BioInfer.d662.s0.p1	N	The posttranslational metabolism of PROTEIN1 ( PROTEIN ) and PROTEIN2 was regulated in parallel with the total contractile protein pool.
BioInfer.d662.s0.p2	N	The posttranslational metabolism of PROTEIN ( PROTEIN1 ) and PROTEIN2 was regulated in parallel with the total contractile protein pool.
BioInfer.d663.s0.p0	P	The potentiating effect of PROTEIN appears to involve increases in the expression of PROTEIN and decreases in the expression of the PROTEIN1  PROTEIN ( PROTEIN2 ).
BioInfer.d663.s0.p1	N	The potentiating effect of PROTEIN appears to involve increases in the expression of PROTEIN2 and decreases in the expression of the PROTEIN1  PROTEIN ( PROTEIN ).
BioInfer.d663.s0.p2	N	The potentiating effect of PROTEIN2 appears to involve increases in the expression of PROTEIN and decreases in the expression of the PROTEIN1  PROTEIN ( PROTEIN ).
BioInfer.d663.s0.p3	P	The potentiating effect of PROTEIN appears to involve increases in the expression of PROTEIN and decreases in the expression of the PROTEIN1  PROTEIN2 ( PROTEIN ).
BioInfer.d663.s0.p4	N	The potentiating effect of PROTEIN appears to involve increases in the expression of PROTEIN2 and decreases in the expression of the PROTEIN  PROTEIN ( PROTEIN1 ).
BioInfer.d663.s0.p5	P	The potentiating effect of PROTEIN2 appears to involve increases in the expression of PROTEIN and decreases in the expression of the PROTEIN  PROTEIN ( PROTEIN1 ).
BioInfer.d663.s0.p6	N	The potentiating effect of PROTEIN appears to involve increases in the expression of PROTEIN and decreases in the expression of the PROTEIN  PROTEIN2 ( PROTEIN1 ).
BioInfer.d663.s0.p7	P	The potentiating effect of PROTEIN2 appears to involve increases in the expression of PROTEIN1 and decreases in the expression of the PROTEIN  PROTEIN ( PROTEIN ).
BioInfer.d663.s0.p8	N	The potentiating effect of PROTEIN appears to involve increases in the expression of PROTEIN1 and decreases in the expression of the PROTEIN  PROTEIN2 ( PROTEIN ).
BioInfer.d663.s0.p9	P	The potentiating effect of PROTEIN1 appears to involve increases in the expression of PROTEIN and decreases in the expression of the PROTEIN  PROTEIN2 ( PROTEIN ).
BioInfer.d664.s0.p0	N	The predicted sequence of PROTEIN shares ca. 40% identity with nonplant PROTEIN and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN2 -binding domain in PROTEIN and in a larger family of PROTEIN1 cross-linking proteins.
BioInfer.d664.s0.p1	N	The predicted sequence of PROTEIN shares ca. 40% identity with nonplant PROTEIN and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN -binding domain in PROTEIN2 and in a larger family of PROTEIN1 cross-linking proteins.
BioInfer.d664.s0.p2	N	The predicted sequence of PROTEIN shares ca. 40% identity with nonplant PROTEIN2 and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN -binding domain in PROTEIN and in a larger family of PROTEIN1 cross-linking proteins.
BioInfer.d664.s0.p3	N	The predicted sequence of PROTEIN2 shares ca. 40% identity with nonplant PROTEIN and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN -binding domain in PROTEIN and in a larger family of PROTEIN1 cross-linking proteins.
BioInfer.d664.s0.p4	P	The predicted sequence of PROTEIN shares ca. 40% identity with nonplant PROTEIN and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN1 -binding domain in PROTEIN2 and in a larger family of PROTEIN cross-linking proteins.
BioInfer.d664.s0.p5	N	The predicted sequence of PROTEIN shares ca. 40% identity with nonplant PROTEIN2 and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN1 -binding domain in PROTEIN and in a larger family of PROTEIN cross-linking proteins.
BioInfer.d664.s0.p6	P	The predicted sequence of PROTEIN2 shares ca. 40% identity with nonplant PROTEIN and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN1 -binding domain in PROTEIN and in a larger family of PROTEIN cross-linking proteins.
BioInfer.d664.s0.p7	N	The predicted sequence of PROTEIN shares ca. 40% identity with nonplant PROTEIN2 and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN -binding domain in PROTEIN1 and in a larger family of PROTEIN cross-linking proteins.
BioInfer.d664.s0.p8	N	The predicted sequence of PROTEIN2 shares ca. 40% identity with nonplant PROTEIN and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN -binding domain in PROTEIN1 and in a larger family of PROTEIN cross-linking proteins.
BioInfer.d664.s0.p9	P	The predicted sequence of PROTEIN2 shares ca. 40% identity with nonplant PROTEIN1 and contains two tandem repeats, each possessing a 27 amino acid region identified as a putative PROTEIN -binding domain in PROTEIN and in a larger family of PROTEIN cross-linking proteins.
BioInfer.d665.s0.p0	N	The presence, in varying quantities, of PROTEIN2 and PROTEIN1 isoforms of smooth muscle type in the different vessels reflected their degree of differentiation.
BioInfer.d666.s0.p0	N	The present study was designed to determine if cholesterol feeding results in alterations in the isoforms of PROTEIN2 and/or PROTEIN1 in gallbladder smooth muscle.
BioInfer.d667.s0.p0	N	The primary purpose of this study was to determine the relationship between PROTEIN ( PROTEIN2 ) and PROTEIN1 contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.
BioInfer.d667.s0.p1	N	The primary purpose of this study was to determine the relationship between PROTEIN2 ( PROTEIN ) and PROTEIN1 contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.
BioInfer.d667.s0.p2	N	The primary purpose of this study was to determine the relationship between PROTEIN2 ( PROTEIN1 ) and PROTEIN contents and maximum isometric tetanic force (Po) in mouse extensor digitorum longus (EDL) muscles following eccentric contraction-induced injury.
BioInfer.d668.s0.p0	N	The procedure allows for the simultaneous quantification of PROTEIN2 , PROTEIN , PROTEIN1 and PROTEIN from as little as 50 mg of tissue.
BioInfer.d668.s0.p1	N	The procedure allows for the simultaneous quantification of PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 from as little as 50 mg of tissue.
BioInfer.d668.s0.p2	N	The procedure allows for the simultaneous quantification of PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN from as little as 50 mg of tissue.
BioInfer.d668.s0.p3	N	The procedure allows for the simultaneous quantification of PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 from as little as 50 mg of tissue.
BioInfer.d668.s0.p4	N	The procedure allows for the simultaneous quantification of PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN from as little as 50 mg of tissue.
BioInfer.d668.s0.p5	N	The procedure allows for the simultaneous quantification of PROTEIN , PROTEIN2 , PROTEIN and PROTEIN1 from as little as 50 mg of tissue.
BioInfer.d669.s0.p0	N	The product of PROTEIN1 has been shown to be essential for capsid assembly, but no role has previously been assigned to the product of PROTEIN2 .
BioInfer.d670.s0.p0	N	The products of the yeast mismatch repair genes PROTEIN1 and PROTEIN2 participate in the inhibition of genetic recombination between homeologous (divergent) DNA sequences.
BioInfer.d670.s1.p0	N	These results suggest that PROTEIN1 and PROTEIN2 can function differentially to control homeologous exchanges.
BioInfer.d671.s0.p0	N	The prominent 125 A transverse stripping pattern characteristic of the PROTEIN1 cross-bridges in a bundle is also absent in hair borders suggesting PROTEIN2 as the component that gives rise to the transverse stripes.
BioInfer.d672.s0.p0	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN2 - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p1	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN2 -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p2	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN2 - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p3	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN2 - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p4	N	The proposed LNYV genomic map is 3'- PROTEIN2 - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p5	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN2 - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p6	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN2 is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p7	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN2 is the proposed PROTEIN gene.
BioInfer.d672.s0.p8	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN2 is the PROTEIN gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p9	P	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN2 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p10	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN2 is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p11	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN2 gene.
BioInfer.d672.s0.p12	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN2 gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p13	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN2 gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p14	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN2  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p15	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN2 and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p16	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN1 are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p17	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN2 -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p18	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN2 - PROTEIN - PROTEIN1 - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p19	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN2 - PROTEIN1 - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p20	N	The proposed LNYV genomic map is 3'- PROTEIN2 - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p21	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN2 - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p22	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN2 is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p23	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN2 is the proposed PROTEIN gene.
BioInfer.d672.s0.p24	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN -5', where PROTEIN2 is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p25	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN2 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p26	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN2 is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p27	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN2 gene.
BioInfer.d672.s0.p28	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN2 gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p29	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN -5', where PROTEIN is the PROTEIN2 gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p30	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN2  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p31	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN2 and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p32	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p33	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN2 - PROTEIN - PROTEIN - PROTEIN1 -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p34	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN2 - PROTEIN - PROTEIN1 -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p35	N	The proposed LNYV genomic map is 3'- PROTEIN2 - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p36	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN2 - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p37	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN2 is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p38	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN2 is the proposed PROTEIN gene.
BioInfer.d672.s0.p39	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 -5', where PROTEIN2 is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p40	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN2 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p41	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN2 is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p42	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN2 gene.
BioInfer.d672.s0.p43	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN2 gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p44	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 -5', where PROTEIN is the PROTEIN2 gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p45	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN2  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p46	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 -5', where PROTEIN is the PROTEIN gene; PROTEIN2 and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p47	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN1 -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p48	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN1 - PROTEIN2 - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p49	N	The proposed LNYV genomic map is 3'- PROTEIN2 - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p50	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN2 - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p51	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN2 is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p52	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN2 is the proposed PROTEIN gene.
BioInfer.d672.s0.p53	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN2 is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p54	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN2 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p55	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN2 is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p56	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN2 gene.
BioInfer.d672.s0.p57	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN2 gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p58	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN2 gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p59	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN2  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p60	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN2 and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p61	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p62	N	The proposed LNYV genomic map is 3'- PROTEIN2 - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p63	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN2 - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p64	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN2 is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p65	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN2 is the proposed PROTEIN gene.
BioInfer.d672.s0.p66	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN -5', where PROTEIN2 is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p67	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN2 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p68	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN2 is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p69	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN2 gene.
BioInfer.d672.s0.p70	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN2 gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p71	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN2 gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p72	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN2  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p73	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN2 and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p74	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN1 - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p75	N	The proposed LNYV genomic map is 3'- PROTEIN1 - PROTEIN2 - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p76	N	The proposed LNYV genomic map is 3'- PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN2 is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p77	N	The proposed LNYV genomic map is 3'- PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN2 is the proposed PROTEIN gene.
BioInfer.d672.s0.p78	N	The proposed LNYV genomic map is 3'- PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN2 is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p79	N	The proposed LNYV genomic map is 3'- PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN2 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p80	N	The proposed LNYV genomic map is 3'- PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN2 is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p81	N	The proposed LNYV genomic map is 3'- PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN2 gene.
BioInfer.d672.s0.p82	N	The proposed LNYV genomic map is 3'- PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN2 gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p83	N	The proposed LNYV genomic map is 3'- PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN2 gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p84	N	The proposed LNYV genomic map is 3'- PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN2  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p85	N	The proposed LNYV genomic map is 3'- PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN2 and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p86	N	The proposed LNYV genomic map is 3'- PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p87	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN2 is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p88	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN2 is the proposed PROTEIN gene.
BioInfer.d672.s0.p89	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN2 is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p90	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN2 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p91	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN2 is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p92	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN2 gene.
BioInfer.d672.s0.p93	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN2 gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p94	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN2 gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p95	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN2  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p96	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN2 and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p97	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN1 - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p98	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN1 is the proposed PROTEIN gene; and PROTEIN2 is the proposed PROTEIN gene.
BioInfer.d672.s0.p99	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN2 is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN1 is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p100	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN2 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN1 is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p101	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN2 is the proposed PROTEIN gene; PROTEIN1 is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p102	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN1 is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN2 gene.
BioInfer.d672.s0.p103	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN1 is the proposed PROTEIN2 gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p104	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN2 gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN1 is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p105	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN2  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN1 is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p106	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN2 and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN1 is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p107	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN1 is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p108	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN2 is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN1 is the proposed PROTEIN gene.
BioInfer.d672.s0.p109	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN2 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN1 is the proposed PROTEIN gene.
BioInfer.d672.s0.p110	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN2 is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN1 is the proposed PROTEIN gene.
BioInfer.d672.s0.p111	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN1 is the proposed PROTEIN2 gene.
BioInfer.d672.s0.p112	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN2 gene; and PROTEIN1 is the proposed PROTEIN gene.
BioInfer.d672.s0.p113	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN2 gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN1 is the proposed PROTEIN gene.
BioInfer.d672.s0.p114	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN2  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN1 is the proposed PROTEIN gene.
BioInfer.d672.s0.p115	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN2 and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN1 is the proposed PROTEIN gene.
BioInfer.d672.s0.p116	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN1 is the proposed PROTEIN gene.
BioInfer.d672.s0.p117	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN1 is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN2 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p118	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN1 is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN2 is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p119	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN1 is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN2 gene.
BioInfer.d672.s0.p120	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN1 is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN2 gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p121	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN1 is the PROTEIN2 gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p122	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN1 is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN2  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p123	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN1 is the PROTEIN gene; PROTEIN2 and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p124	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN1 is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p125	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN1 and the other for a putative protein of unknown function; PROTEIN2 is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p126	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN1 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN2 gene.
BioInfer.d672.s0.p127	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN1 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN2 gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p128	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN2 gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN1 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p129	P	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN2  PROTEIN1 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p130	P	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN2 and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN1 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p131	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN1 and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p132	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN1 is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN2 gene.
BioInfer.d672.s0.p133	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN1 is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN2 gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p134	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN2 gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN1 is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p135	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN2  PROTEIN and the other for a putative protein of unknown function; PROTEIN1 is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p136	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN2 and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN1 is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p137	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN1 is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p138	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN2 gene; and PROTEIN is the proposed PROTEIN1 gene.
BioInfer.d672.s0.p139	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN2 gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN1 gene.
BioInfer.d672.s0.p140	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN2  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN1 gene.
BioInfer.d672.s0.p141	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN2 and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN1 gene.
BioInfer.d672.s0.p142	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN1 gene.
BioInfer.d672.s0.p143	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN2 gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN1 gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p144	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN2  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN1 gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p145	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN2 and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN1 gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p146	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN1 gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p147	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN1 gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN2  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p148	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN1 gene; PROTEIN2 and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p149	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN1 gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p150	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN2 and PROTEIN are two genes, one of which codes for the proposed PROTEIN1  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p151	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN and PROTEIN are two genes, one of which codes for the proposed PROTEIN1  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d672.s0.p152	N	The proposed LNYV genomic map is 3'- PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN - PROTEIN -5', where PROTEIN is the PROTEIN gene; PROTEIN1 and PROTEIN are two genes, one of which codes for the proposed PROTEIN  PROTEIN and the other for a putative protein of unknown function; PROTEIN is the proposed PROTEIN2 gene; PROTEIN is the proposed PROTEIN gene; and PROTEIN is the proposed PROTEIN gene.
BioInfer.d673.s0.p0	P	The protein PROTEIN2 binds to both PROTEIN1 and the head groups of poly)phosphoinositide)s and may regulate both PROTEIN assembly and the phosphoinositide signaling pathway.
BioInfer.d673.s0.p1	N	The protein PROTEIN binds to both PROTEIN1 and the head groups of poly)phosphoinositide)s and may regulate both PROTEIN2 assembly and the phosphoinositide signaling pathway.
BioInfer.d673.s0.p2	P	The protein PROTEIN1 binds to both PROTEIN and the head groups of poly)phosphoinositide)s and may regulate both PROTEIN2 assembly and the phosphoinositide signaling pathway.
BioInfer.d674.s0.p0	P	The protein has the two conserved domains identified as PROTEIN2 and phosphatidylinositol 4,5-biphosphate (PIP2) binding sites found in members of the PROTEIN1 family.
BioInfer.d675.s0.p0	P	The proteins encoded by PROTEIN1 and PROTEIN2 , which display 35%, sequence identity are both located in the mitochondrial intermembrane space.
BioInfer.d676.s0.p0	N	The proximity of the semi-conserved PROTEIN1 -binding site and the binding pocket characteristic of plant PROTEIN2 suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant PROTEIN thought to be responsible for type I allergies.
BioInfer.d676.s0.p1	N	The proximity of the semi-conserved PROTEIN1 -binding site and the binding pocket characteristic of plant PROTEIN suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant PROTEIN2 thought to be responsible for type I allergies.
BioInfer.d676.s0.p2	N	The proximity of the semi-conserved PROTEIN -binding site and the binding pocket characteristic of plant PROTEIN1 suggests that epitopes encompassing both features are responsible for the cross-reactivity of antibodies between human and plant PROTEIN2 thought to be responsible for type I allergies.
BioInfer.d677.s0.p0	N	The qualitative changes involve differential expression of multigene families of contractile proteins, especially PROTEIN ( PROTEIN2 ) and PROTEIN1 .
BioInfer.d677.s0.p1	N	The qualitative changes involve differential expression of multigene families of contractile proteins, especially PROTEIN2 ( PROTEIN ) and PROTEIN1 .
BioInfer.d677.s0.p2	N	The qualitative changes involve differential expression of multigene families of contractile proteins, especially PROTEIN2 ( PROTEIN1 ) and PROTEIN .
BioInfer.d678.s0.p0	N	The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes ( PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN ).
BioInfer.d678.s0.p1	N	The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes ( PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 ).
BioInfer.d678.s0.p2	N	The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes ( PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN ).
BioInfer.d678.s0.p3	N	The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes ( PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN ).
BioInfer.d678.s0.p4	N	The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes ( PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 ).
BioInfer.d678.s0.p5	N	The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes ( PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN ).
BioInfer.d678.s0.p6	N	The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes ( PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN ).
BioInfer.d678.s0.p7	N	The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes ( PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 ).
BioInfer.d678.s0.p8	N	The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes ( PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 ).
BioInfer.d678.s0.p9	N	The radioresistant N10 and parental KB cell lines were examined for the expression of human DNA repair genes which were related to the repair of radiation-induced DNA damage by northern blot analysis using five kinds of DNA probes ( PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN ).
BioInfer.d679.s0.p0	N	The ratios PROTEIN mRNA: PROTEIN and PROTEIN1 mRNA: PROTEIN2 were unaffected by clenbuterol.
BioInfer.d679.s0.p1	N	The ratios PROTEIN2 mRNA: PROTEIN and PROTEIN1 mRNA: PROTEIN were unaffected by clenbuterol.
BioInfer.d679.s0.p2	N	The ratios PROTEIN mRNA: PROTEIN2 and PROTEIN1 mRNA: PROTEIN were unaffected by clenbuterol.
BioInfer.d679.s0.p3	N	The ratios PROTEIN2 mRNA: PROTEIN and PROTEIN mRNA: PROTEIN1 were unaffected by clenbuterol.
BioInfer.d679.s0.p4	N	The ratios PROTEIN mRNA: PROTEIN2 and PROTEIN mRNA: PROTEIN1 were unaffected by clenbuterol.
BioInfer.d679.s0.p5	N	The ratios PROTEIN1 mRNA: PROTEIN2 and PROTEIN mRNA: PROTEIN were unaffected by clenbuterol.
BioInfer.d680.s0.p0	P	There are only 14 non-conservative substitutions in the two PROTEIN1 , three of which are located in the secondary PROTEIN2 -binding loop and flanking regions and others correspond to residues so far not assigned a functional role, including two residues in the proximal S2 domain.
BioInfer.d681.s0.p0	P	There are three PROTEIN2  PROTEIN1 genes, two of which are identical; four PROTEIN  PROTEIN genes, two of which are identical, one PROTEIN  PROTEIN gene; and two PROTEIN  PROTEIN genes.
BioInfer.d681.s0.p1	N	There are three PROTEIN  PROTEIN1 genes, two of which are identical; four PROTEIN  PROTEIN genes, two of which are identical, one PROTEIN2  PROTEIN gene; and two PROTEIN  PROTEIN genes.
BioInfer.d681.s0.p2	N	There are three PROTEIN  PROTEIN1 genes, two of which are identical; four PROTEIN2  PROTEIN genes, two of which are identical, one PROTEIN  PROTEIN gene; and two PROTEIN  PROTEIN genes.
BioInfer.d681.s0.p3	N	There are three PROTEIN  PROTEIN1 genes, two of which are identical; four PROTEIN  PROTEIN genes, two of which are identical, one PROTEIN  PROTEIN gene; and two PROTEIN2  PROTEIN genes.
BioInfer.d681.s0.p4	N	There are three PROTEIN  PROTEIN1 genes, two of which are identical; four PROTEIN  PROTEIN genes, two of which are identical, one PROTEIN  PROTEIN2 gene; and two PROTEIN  PROTEIN genes.
BioInfer.d681.s0.p5	N	There are three PROTEIN  PROTEIN1 genes, two of which are identical; four PROTEIN  PROTEIN2 genes, two of which are identical, one PROTEIN  PROTEIN gene; and two PROTEIN  PROTEIN genes.
BioInfer.d681.s0.p6	N	There are three PROTEIN  PROTEIN1 genes, two of which are identical; four PROTEIN  PROTEIN genes, two of which are identical, one PROTEIN  PROTEIN gene; and two PROTEIN  PROTEIN2 genes.
BioInfer.d681.s0.p7	N	There are three PROTEIN1  PROTEIN genes, two of which are identical; four PROTEIN  PROTEIN genes, two of which are identical, one PROTEIN2  PROTEIN gene; and two PROTEIN  PROTEIN genes.
BioInfer.d681.s0.p8	N	There are three PROTEIN1  PROTEIN genes, two of which are identical; four PROTEIN2  PROTEIN genes, two of which are identical, one PROTEIN  PROTEIN gene; and two PROTEIN  PROTEIN genes.
BioInfer.d681.s0.p9	N	There are three PROTEIN1  PROTEIN genes, two of which are identical; four PROTEIN  PROTEIN genes, two of which are identical, one PROTEIN  PROTEIN gene; and two PROTEIN2  PROTEIN genes.
BioInfer.d681.s0.p10	N	There are three PROTEIN1  PROTEIN genes, two of which are identical; four PROTEIN  PROTEIN genes, two of which are identical, one PROTEIN  PROTEIN2 gene; and two PROTEIN  PROTEIN genes.
BioInfer.d681.s0.p11	N	There are three PROTEIN1  PROTEIN genes, two of which are identical; four PROTEIN  PROTEIN2 genes, two of which are identical, one PROTEIN  PROTEIN gene; and two PROTEIN  PROTEIN genes.
BioInfer.d681.s0.p12	N	There are three PROTEIN1  PROTEIN genes, two of which are identical; four PROTEIN  PROTEIN genes, two of which are identical, one PROTEIN  PROTEIN gene; and two PROTEIN  PROTEIN2 genes.
BioInfer.d681.s0.p13	N	There are three PROTEIN  PROTEIN genes, two of which are identical; four PROTEIN2  PROTEIN genes, two of which are identical, one PROTEIN1  PROTEIN gene; and two PROTEIN  PROTEIN genes.
BioInfer.d681.s0.p14	N	There are three PROTEIN  PROTEIN genes, two of which are identical; four PROTEIN  PROTEIN genes, two of which are identical, one PROTEIN1  PROTEIN gene; and two PROTEIN2  PROTEIN genes.
BioInfer.d681.s0.p15	P	There are three PROTEIN  PROTEIN genes, two of which are identical; four PROTEIN  PROTEIN genes, two of which are identical, one PROTEIN1  PROTEIN2 gene; and two PROTEIN  PROTEIN genes.
BioInfer.d681.s0.p16	N	There are three PROTEIN  PROTEIN genes, two of which are identical; four PROTEIN  PROTEIN2 genes, two of which are identical, one PROTEIN1  PROTEIN gene; and two PROTEIN  PROTEIN genes.
BioInfer.d681.s0.p17	N	There are three PROTEIN  PROTEIN genes, two of which are identical; four PROTEIN  PROTEIN genes, two of which are identical, one PROTEIN1  PROTEIN gene; and two PROTEIN  PROTEIN2 genes.
BioInfer.d681.s0.p18	N	There are three PROTEIN  PROTEIN genes, two of which are identical; four PROTEIN1  PROTEIN genes, two of which are identical, one PROTEIN  PROTEIN gene; and two PROTEIN2  PROTEIN genes.
BioInfer.d681.s0.p19	N	There are three PROTEIN  PROTEIN genes, two of which are identical; four PROTEIN1  PROTEIN genes, two of which are identical, one PROTEIN  PROTEIN2 gene; and two PROTEIN  PROTEIN genes.
BioInfer.d681.s0.p20	P	There are three PROTEIN  PROTEIN genes, two of which are identical; four PROTEIN1  PROTEIN2 genes, two of which are identical, one PROTEIN  PROTEIN gene; and two PROTEIN  PROTEIN genes.
BioInfer.d681.s0.p21	N	There are three PROTEIN  PROTEIN genes, two of which are identical; four PROTEIN1  PROTEIN genes, two of which are identical, one PROTEIN  PROTEIN gene; and two PROTEIN  PROTEIN2 genes.
BioInfer.d681.s0.p22	N	There are three PROTEIN  PROTEIN genes, two of which are identical; four PROTEIN  PROTEIN genes, two of which are identical, one PROTEIN  PROTEIN2 gene; and two PROTEIN1  PROTEIN genes.
BioInfer.d681.s0.p23	N	There are three PROTEIN  PROTEIN genes, two of which are identical; four PROTEIN  PROTEIN2 genes, two of which are identical, one PROTEIN  PROTEIN gene; and two PROTEIN1  PROTEIN genes.
BioInfer.d681.s0.p24	P	There are three PROTEIN  PROTEIN genes, two of which are identical; four PROTEIN  PROTEIN genes, two of which are identical, one PROTEIN  PROTEIN gene; and two PROTEIN1  PROTEIN2 genes.
BioInfer.d681.s0.p25	N	There are three PROTEIN  PROTEIN genes, two of which are identical; four PROTEIN  PROTEIN2 genes, two of which are identical, one PROTEIN  PROTEIN1 gene; and two PROTEIN  PROTEIN genes.
BioInfer.d681.s0.p26	N	There are three PROTEIN  PROTEIN genes, two of which are identical; four PROTEIN  PROTEIN genes, two of which are identical, one PROTEIN  PROTEIN1 gene; and two PROTEIN  PROTEIN2 genes.
BioInfer.d681.s0.p27	N	There are three PROTEIN  PROTEIN genes, two of which are identical; four PROTEIN  PROTEIN1 genes, two of which are identical, one PROTEIN  PROTEIN gene; and two PROTEIN  PROTEIN2 genes.
BioInfer.d681.s1.p0	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN1 mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN2 mRNA.
BioInfer.d681.s1.p1	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN1 mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p2	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN1 mRNA, whereas the PROTEIN2  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p3	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN1 mRNA, whereas the PROTEIN  PROTEIN2 and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p4	N	These PROTEIN  PROTEIN2 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN1 mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p5	P	These PROTEIN  PROTEIN and PROTEIN2 genes encode approximately 40% of the total PROTEIN and PROTEIN1 mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p6	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN1 mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN2 and PROTEIN mRNA.
BioInfer.d681.s1.p7	N	These PROTEIN2  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN1 mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p8	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN2 and PROTEIN1 mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p9	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN1 mRNA, whereas the PROTEIN  PROTEIN and PROTEIN2  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p10	P	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN2 genes encode < 10% of the total PROTEIN and PROTEIN1 mRNA.
BioInfer.d681.s1.p11	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN2  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN1 mRNA.
BioInfer.d681.s1.p12	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN2 and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN1 mRNA.
BioInfer.d681.s1.p13	N	These PROTEIN  PROTEIN2 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN1 mRNA.
BioInfer.d681.s1.p14	N	These PROTEIN  PROTEIN and PROTEIN2 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN1 mRNA.
BioInfer.d681.s1.p15	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN2 and PROTEIN1 mRNA.
BioInfer.d681.s1.p16	N	These PROTEIN2  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN1 mRNA.
BioInfer.d681.s1.p17	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN2 and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN1 mRNA.
BioInfer.d681.s1.p18	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN2  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN1 mRNA.
BioInfer.d681.s1.p19	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN2  PROTEIN and PROTEIN  PROTEIN1 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p20	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN2 and PROTEIN  PROTEIN1 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p21	N	These PROTEIN  PROTEIN2 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN1 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p22	N	These PROTEIN  PROTEIN and PROTEIN2 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN1 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p23	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN1 genes encode < 10% of the total PROTEIN2 and PROTEIN mRNA.
BioInfer.d681.s1.p24	N	These PROTEIN2  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN1 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p25	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN2 and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN1 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p26	P	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN2  PROTEIN1 genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p27	P	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN1  PROTEIN2 and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p28	N	These PROTEIN  PROTEIN2 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN1  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p29	N	These PROTEIN  PROTEIN and PROTEIN2 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN1  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p30	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN1  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN2 and PROTEIN mRNA.
BioInfer.d681.s1.p31	N	These PROTEIN2  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN1  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p32	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN2 and PROTEIN mRNA, whereas the PROTEIN1  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p33	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN1  PROTEIN and PROTEIN2  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p34	N	These PROTEIN  PROTEIN2 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p35	N	These PROTEIN  PROTEIN and PROTEIN2 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p36	P	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN2 and PROTEIN mRNA.
BioInfer.d681.s1.p37	N	These PROTEIN2  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p38	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN2 and PROTEIN mRNA, whereas the PROTEIN  PROTEIN1 and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p39	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN1 and PROTEIN2  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p40	N	These PROTEIN  PROTEIN1 and PROTEIN2 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p41	N	These PROTEIN  PROTEIN1 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN2 and PROTEIN mRNA.
BioInfer.d681.s1.p42	P	These PROTEIN2  PROTEIN1 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p43	P	These PROTEIN  PROTEIN1 and PROTEIN genes encode approximately 40% of the total PROTEIN2 and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p44	N	These PROTEIN  PROTEIN1 and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN2  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p45	N	These PROTEIN  PROTEIN and PROTEIN1 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN2 and PROTEIN mRNA.
BioInfer.d681.s1.p46	P	These PROTEIN2  PROTEIN and PROTEIN1 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p47	N	These PROTEIN  PROTEIN and PROTEIN1 genes encode approximately 40% of the total PROTEIN2 and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p48	N	These PROTEIN  PROTEIN and PROTEIN1 genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN2  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p49	N	These PROTEIN2  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN1 and PROTEIN mRNA.
BioInfer.d681.s1.p50	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN2 and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN1 and PROTEIN mRNA.
BioInfer.d681.s1.p51	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN2  PROTEIN genes encode < 10% of the total PROTEIN1 and PROTEIN mRNA.
BioInfer.d681.s1.p52	N	These PROTEIN1  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN2 and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p53	N	These PROTEIN1  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN2  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d681.s1.p54	N	These PROTEIN  PROTEIN and PROTEIN genes encode approximately 40% of the total PROTEIN1 and PROTEIN mRNA, whereas the PROTEIN  PROTEIN and PROTEIN2  PROTEIN genes encode < 10% of the total PROTEIN and PROTEIN mRNA.
BioInfer.d682.s0.p0	N	The recombinant material is similar to authentic PROTEIN from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, PROTEIN2 -nucleotide exchange rate and the Kd for rabbit PROTEIN1 .
BioInfer.d682.s0.p1	P	The recombinant material is similar to authentic PROTEIN2 from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, PROTEIN -nucleotide exchange rate and the Kd for rabbit PROTEIN1 .
BioInfer.d682.s0.p2	N	The recombinant material is similar to authentic PROTEIN2 from Acanthamoeba-based on fluorescence monitored urea denaturation, circular dichroism, PROTEIN1 -nucleotide exchange rate and the Kd for rabbit PROTEIN .
BioInfer.d683.s0.p0	P	The recombinant material is similar to authentic human PROTEIN2 based on the measured Kd for rabbit PROTEIN1 .
BioInfer.d684.s0.p0	P	The relatively conservative sequence of PROTEIN1 from yeast, Physarum, Acanthamoeba, echinoid eggs and mammalian cells was found in the N-terminal region, which was suggested to be a common PROTEIN2 -binding region.
BioInfer.d685.s0.p0	P	The resulting PROTEIN1 product is unable to bind PROTEIN2 that is responsible for PROTEIN filament binding and organization.
BioInfer.d685.s0.p1	N	The resulting PROTEIN1 product is unable to bind PROTEIN that is responsible for PROTEIN2 filament binding and organization.
BioInfer.d685.s0.p2	P	The resulting PROTEIN product is unable to bind PROTEIN1 that is responsible for PROTEIN2 filament binding and organization.
BioInfer.d686.s0.p0	N	The results clearly showed that the mutated PROTEIN2 possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant PROTEIN1 with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with PROTEIN .
BioInfer.d686.s0.p1	P	The results clearly showed that the mutated PROTEIN possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant PROTEIN1 with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with PROTEIN2 .
BioInfer.d686.s0.p2	N	The results clearly showed that the mutated PROTEIN1 possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant PROTEIN with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with PROTEIN2 .
BioInfer.d687.s0.p2	N	The results indicate increased fractional synthesis and degradation of PROTEIN1 and light chains, but not PROTEIN2 , in the left compared to the right ventricular free wall.
BioInfer.d687.s1.p0	N	To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 in the right and left ventricular free walls of growing, New Zealand White rabbits.
BioInfer.d687.s1.p1	N	To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN in the right and left ventricular free walls of growing, New Zealand White rabbits.
BioInfer.d687.s1.p2	N	To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN in the right and left ventricular free walls of growing, New Zealand White rabbits.
BioInfer.d687.s1.p3	N	To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 in the right and left ventricular free walls of growing, New Zealand White rabbits.
BioInfer.d687.s1.p4	N	To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 in the right and left ventricular free walls of growing, New Zealand White rabbits.
BioInfer.d687.s1.p5	N	To test for regional differences in the rates of synthesis and degradation of contractile proteins during normal physiological growth of the heart in vivo, fractional rates of protein accumulation and synthesis were assessed for total protein, PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN in the right and left ventricular free walls of growing, New Zealand White rabbits.
BioInfer.d688.s0.p0	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN2 and PROTEIN ; (b) PROTEIN1 -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p1	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN1 -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN2 , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p2	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN1 -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN2 , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p3	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN2 ; (b) PROTEIN1 -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p4	N	The results indicate that (a) PROTEIN2 and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN1 -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p5	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN1 -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN2 and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p6	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN1 -dependent transactivation is preferentially driven by PROTEIN2 ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p7	N	The results indicate that (a) PROTEIN and PROTEIN2 differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN1 -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p8	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN1 and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN2 , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p9	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN1 and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN2 , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p10	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN1 and PROTEIN2 ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p11	P	The results indicate that (a) PROTEIN2 and PROTEIN differ in their nuclear translocation and complexing with PROTEIN1 and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p12	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN1 and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN2 and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p13	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN1 and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN2 ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p14	P	The results indicate that (a) PROTEIN and PROTEIN2 differ in their nuclear translocation and complexing with PROTEIN1 and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p15	P	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN2 , PROTEIN and PROTEIN1 , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p16	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN2 ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN1 , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p17	N	The results indicate that (a) PROTEIN2 and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN1 , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p18	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN2 and PROTEIN1 , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p19	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN2 ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN1 , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p20	N	The results indicate that (a) PROTEIN and PROTEIN2 differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN1 , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p21	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN2 ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN1 , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p22	N	The results indicate that (a) PROTEIN2 and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN1 , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p23	P	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN1 , PROTEIN2 and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p24	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN2 ; and (c) the cytoplasmic partners of PROTEIN1 , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p25	N	The results indicate that (a) PROTEIN and PROTEIN2 differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN1 , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p26	P	The results indicate that (a) PROTEIN2 and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN1 ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p27	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN1 ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN2 and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p28	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN1 ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN2 ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p29	P	The results indicate that (a) PROTEIN and PROTEIN2 differ in their nuclear translocation and complexing with PROTEIN and PROTEIN1 ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p30	N	The results indicate that (a) PROTEIN1 and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN2 and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p31	N	The results indicate that (a) PROTEIN1 and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN2 ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p32	P	The results indicate that (a) PROTEIN1 and PROTEIN2 differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p33	N	The results indicate that (a) PROTEIN and PROTEIN differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN2 ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN1 and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p34	N	The results indicate that (a) PROTEIN and PROTEIN2 differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN1 and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d688.s0.p35	N	The results indicate that (a) PROTEIN and PROTEIN2 differ in their nuclear translocation and complexing with PROTEIN and PROTEIN ; (b) PROTEIN -dependent transactivation is preferentially driven by PROTEIN1 ; and (c) the cytoplasmic partners of PROTEIN , PROTEIN and PROTEIN , can sequester it to the cytoplasm and inhibit its transcriptional activity.
BioInfer.d689.s0.p0	N	The Saccharomyces cerevisiae PROTEIN1 and PROTEIN2 genes are both required for the occurrence of homologous recombination and for the repair of double-stranded DNA breaks.
BioInfer.d690.s0.p0	P	The Saccharomyces cerevisiae PROTEIN gene belongs to the PROTEIN , PROTEIN1 and PROTEIN2 epistasis group which, together with PROTEIN , is proposed to act at the beginning of the DNA damage checkpoint pathway.
BioInfer.d690.s0.p1	P	The Saccharomyces cerevisiae PROTEIN2 gene belongs to the PROTEIN , PROTEIN1 and PROTEIN epistasis group which, together with PROTEIN , is proposed to act at the beginning of the DNA damage checkpoint pathway.
BioInfer.d690.s0.p2	N	The Saccharomyces cerevisiae PROTEIN gene belongs to the PROTEIN , PROTEIN1 and PROTEIN epistasis group which, together with PROTEIN2 , is proposed to act at the beginning of the DNA damage checkpoint pathway.
BioInfer.d690.s0.p3	P	The Saccharomyces cerevisiae PROTEIN gene belongs to the PROTEIN2 , PROTEIN1 and PROTEIN epistasis group which, together with PROTEIN , is proposed to act at the beginning of the DNA damage checkpoint pathway.
BioInfer.d690.s0.p4	P	The Saccharomyces cerevisiae PROTEIN2 gene belongs to the PROTEIN , PROTEIN and PROTEIN1 epistasis group which, together with PROTEIN , is proposed to act at the beginning of the DNA damage checkpoint pathway.
BioInfer.d690.s0.p5	N	The Saccharomyces cerevisiae PROTEIN gene belongs to the PROTEIN , PROTEIN and PROTEIN1 epistasis group which, together with PROTEIN2 , is proposed to act at the beginning of the DNA damage checkpoint pathway.
BioInfer.d690.s0.p6	P	The Saccharomyces cerevisiae PROTEIN gene belongs to the PROTEIN2 , PROTEIN and PROTEIN1 epistasis group which, together with PROTEIN , is proposed to act at the beginning of the DNA damage checkpoint pathway.
BioInfer.d690.s0.p7	N	The Saccharomyces cerevisiae PROTEIN1 gene belongs to the PROTEIN , PROTEIN and PROTEIN epistasis group which, together with PROTEIN2 , is proposed to act at the beginning of the DNA damage checkpoint pathway.
BioInfer.d690.s0.p8	P	The Saccharomyces cerevisiae PROTEIN1 gene belongs to the PROTEIN2 , PROTEIN and PROTEIN epistasis group which, together with PROTEIN , is proposed to act at the beginning of the DNA damage checkpoint pathway.
BioInfer.d690.s0.p9	N	The Saccharomyces cerevisiae PROTEIN gene belongs to the PROTEIN2 , PROTEIN and PROTEIN epistasis group which, together with PROTEIN1 , is proposed to act at the beginning of the DNA damage checkpoint pathway.
BioInfer.d691.s0.p0	N	The same steady state concentrations of polymerized and nonpolymerized PROTEIN1 are reached whether PROTEIN2 is added before initiation of polymerization or after polymerization is complete.
BioInfer.d692.s0.p0	P	The Schizosaccharomyces pombe PROTEIN , PROTEIN and PROTEIN1 genes are homologous to PROTEIN , PROTEIN and PROTEIN2 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
BioInfer.d692.s0.p1	N	The Schizosaccharomyces pombe PROTEIN , PROTEIN and PROTEIN1 genes are homologous to PROTEIN2 , PROTEIN and PROTEIN respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
BioInfer.d692.s0.p2	N	The Schizosaccharomyces pombe PROTEIN , PROTEIN2 and PROTEIN1 genes are homologous to PROTEIN , PROTEIN and PROTEIN respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
BioInfer.d692.s0.p3	N	The Schizosaccharomyces pombe PROTEIN2 , PROTEIN and PROTEIN1 genes are homologous to PROTEIN , PROTEIN and PROTEIN respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
BioInfer.d692.s0.p4	N	The Schizosaccharomyces pombe PROTEIN , PROTEIN and PROTEIN1 genes are homologous to PROTEIN , PROTEIN2 and PROTEIN respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
BioInfer.d692.s0.p5	N	The Schizosaccharomyces pombe PROTEIN , PROTEIN and PROTEIN genes are homologous to PROTEIN2 , PROTEIN and PROTEIN1 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
BioInfer.d692.s0.p6	N	The Schizosaccharomyces pombe PROTEIN , PROTEIN2 and PROTEIN genes are homologous to PROTEIN , PROTEIN and PROTEIN1 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
BioInfer.d692.s0.p7	N	The Schizosaccharomyces pombe PROTEIN2 , PROTEIN and PROTEIN genes are homologous to PROTEIN , PROTEIN and PROTEIN1 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
BioInfer.d692.s0.p8	N	The Schizosaccharomyces pombe PROTEIN , PROTEIN and PROTEIN genes are homologous to PROTEIN , PROTEIN2 and PROTEIN1 respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
BioInfer.d692.s0.p9	N	The Schizosaccharomyces pombe PROTEIN , PROTEIN2 and PROTEIN genes are homologous to PROTEIN1 , PROTEIN and PROTEIN respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
BioInfer.d692.s0.p10	P	The Schizosaccharomyces pombe PROTEIN2 , PROTEIN and PROTEIN genes are homologous to PROTEIN1 , PROTEIN and PROTEIN respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
BioInfer.d692.s0.p11	N	The Schizosaccharomyces pombe PROTEIN , PROTEIN and PROTEIN genes are homologous to PROTEIN1 , PROTEIN2 and PROTEIN respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
BioInfer.d692.s0.p12	N	The Schizosaccharomyces pombe PROTEIN2 , PROTEIN1 and PROTEIN genes are homologous to PROTEIN , PROTEIN and PROTEIN respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
BioInfer.d692.s0.p13	P	The Schizosaccharomyces pombe PROTEIN , PROTEIN1 and PROTEIN genes are homologous to PROTEIN , PROTEIN2 and PROTEIN respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
BioInfer.d692.s0.p14	N	The Schizosaccharomyces pombe PROTEIN1 , PROTEIN and PROTEIN genes are homologous to PROTEIN , PROTEIN2 and PROTEIN respectively, which are indispensable in the recombinational repair of double-strand breaks (DSBs) in Saccharomyces cerevisiae.
BioInfer.d693.s0.p0	N	These cells have both PROTEIN2 and PROTEIN1 , display unusual expression of PROTEIN , and have the typical fibroblastic phenotype of transformed cells.
BioInfer.d693.s0.p1	N	These cells have both PROTEIN and PROTEIN1 , display unusual expression of PROTEIN2 , and have the typical fibroblastic phenotype of transformed cells.
BioInfer.d693.s0.p2	N	These cells have both PROTEIN1 and PROTEIN , display unusual expression of PROTEIN2 , and have the typical fibroblastic phenotype of transformed cells.
BioInfer.d694.s0.p0	P	These data strongly suggest that the head, neck, and tail domains of all PROTEIN , and light chains at least of PROTEIN1 , have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated PROTEIN -dependent PROTEIN activity of Dictyostelium PROTEIN2 requires isoform specific interactions between the heavy chain head and tail and light chains.
BioInfer.d694.s0.p1	N	These data strongly suggest that the head, neck, and tail domains of all PROTEIN , and light chains at least of PROTEIN1 , have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated PROTEIN2 -dependent PROTEIN activity of Dictyostelium PROTEIN requires isoform specific interactions between the heavy chain head and tail and light chains.
BioInfer.d694.s0.p2	N	These data strongly suggest that the head, neck, and tail domains of all PROTEIN , and light chains at least of PROTEIN1 , have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated PROTEIN -dependent PROTEIN2 activity of Dictyostelium PROTEIN requires isoform specific interactions between the heavy chain head and tail and light chains.
BioInfer.d694.s0.p3	P	These data strongly suggest that the head, neck, and tail domains of all PROTEIN2 , and light chains at least of PROTEIN1 , have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated PROTEIN -dependent PROTEIN activity of Dictyostelium PROTEIN requires isoform specific interactions between the heavy chain head and tail and light chains.
BioInfer.d694.s0.p4	P	These data strongly suggest that the head, neck, and tail domains of all PROTEIN , and light chains at least of PROTEIN , have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated PROTEIN2 -dependent PROTEIN activity of Dictyostelium PROTEIN1 requires isoform specific interactions between the heavy chain head and tail and light chains.
BioInfer.d694.s0.p5	P	These data strongly suggest that the head, neck, and tail domains of all PROTEIN , and light chains at least of PROTEIN , have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated PROTEIN -dependent PROTEIN2 activity of Dictyostelium PROTEIN1 requires isoform specific interactions between the heavy chain head and tail and light chains.
BioInfer.d694.s0.p6	P	These data strongly suggest that the head, neck, and tail domains of all PROTEIN2 , and light chains at least of PROTEIN , have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated PROTEIN -dependent PROTEIN activity of Dictyostelium PROTEIN1 requires isoform specific interactions between the heavy chain head and tail and light chains.
BioInfer.d694.s0.p7	N	These data strongly suggest that the head, neck, and tail domains of all PROTEIN , and light chains at least of PROTEIN , have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated PROTEIN1 -dependent PROTEIN2 activity of Dictyostelium PROTEIN requires isoform specific interactions between the heavy chain head and tail and light chains.
BioInfer.d694.s0.p8	N	These data strongly suggest that the head, neck, and tail domains of all PROTEIN2 , and light chains at least of PROTEIN , have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated PROTEIN1 -dependent PROTEIN activity of Dictyostelium PROTEIN requires isoform specific interactions between the heavy chain head and tail and light chains.
BioInfer.d694.s0.p9	N	These data strongly suggest that the head, neck, and tail domains of all PROTEIN2 , and light chains at least of PROTEIN , have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated PROTEIN -dependent PROTEIN1 activity of Dictyostelium PROTEIN requires isoform specific interactions between the heavy chain head and tail and light chains.
BioInfer.d695.s0.p0	P	These data suggest that nuclear PROTEIN2 can mediate a stimulus-response action on the PROTEIN1 cytoskeleton which is somehow linked to a phosphoinositide-signaling cascade.
BioInfer.d696.s0.p0	N	These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of PROTEIN2 , PROTEIN and PROTEIN1 .
BioInfer.d696.s0.p1	N	These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of PROTEIN , PROTEIN2 and PROTEIN1 .
BioInfer.d696.s0.p2	N	These differences in contractile protein profiles between single and cultured cells were collaborated with the observation of cells using immunofluorescence microscope with responsible antibodies to isoforms of PROTEIN1 , PROTEIN2 and PROTEIN .
BioInfer.d697.s0.p0	N	These findings reveal striking differences between S. cerevisiae and vertebrates in the functions of PROTEIN1 and PROTEIN2 .
BioInfer.d698.s0.p0	N	These findings suggest that this novel PROTEIN2 is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN1 and PROTEIN .
BioInfer.d698.s0.p1	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN2 activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN1 and PROTEIN .
BioInfer.d698.s0.p2	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN2 -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN1 and PROTEIN .
BioInfer.d698.s0.p3	P	These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN2 such as PROTEIN1 and PROTEIN .
BioInfer.d698.s0.p4	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN2 , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN1 and PROTEIN .
BioInfer.d698.s0.p5	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN1 and PROTEIN2 .
BioInfer.d698.s0.p6	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN2 signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN1 and PROTEIN .
BioInfer.d698.s0.p7	P	These findings suggest that this novel PROTEIN1 is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN2 activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d698.s0.p8	N	These findings suggest that this novel PROTEIN1 is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN2 -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d698.s0.p9	N	These findings suggest that this novel PROTEIN1 is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN2 such as PROTEIN and PROTEIN .
BioInfer.d698.s0.p10	P	These findings suggest that this novel PROTEIN1 is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN2 , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d698.s0.p11	N	These findings suggest that this novel PROTEIN1 is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN2 .
BioInfer.d698.s0.p12	P	These findings suggest that this novel PROTEIN1 is involved in the PROTEIN2 signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d698.s0.p13	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN1 activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN2 -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d698.s0.p14	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN1 activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN2 such as PROTEIN and PROTEIN .
BioInfer.d698.s0.p15	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN1 activation, and mediates the stimulation of PROTEIN2 , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d698.s0.p16	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN1 activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN2 .
BioInfer.d698.s0.p17	P	These findings suggest that this novel PROTEIN is involved in the PROTEIN2 signalling pathway, probably downstream of PROTEIN1 activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d698.s0.p18	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN1 -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN2 such as PROTEIN and PROTEIN .
BioInfer.d698.s0.p19	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN2 , which leads to PROTEIN1 -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d698.s0.p20	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN1 -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN2 .
BioInfer.d698.s0.p21	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN2 signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN1 -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d698.s0.p22	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN2 , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN1 such as PROTEIN and PROTEIN .
BioInfer.d698.s0.p23	P	These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN1 such as PROTEIN and PROTEIN2 .
BioInfer.d698.s0.p24	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN2 signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN1 such as PROTEIN and PROTEIN .
BioInfer.d698.s0.p25	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN1 , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN2 .
BioInfer.d698.s0.p26	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN2 signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN1 , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d698.s0.p27	N	These findings suggest that this novel PROTEIN is involved in the PROTEIN2 signalling pathway, probably downstream of PROTEIN activation, and mediates the stimulation of PROTEIN , which leads to PROTEIN -related cytoskeletal changes through the hydrolysis of PIP2, which binds to PROTEIN such as PROTEIN and PROTEIN1 .
BioInfer.d699.s0.p0	N	These genes were designated PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
BioInfer.d699.s0.p1	N	These genes were designated PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
BioInfer.d699.s0.p2	N	These genes were designated PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
BioInfer.d699.s0.p3	N	These genes were designated PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
BioInfer.d699.s0.p4	N	These genes were designated PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
BioInfer.d699.s0.p5	N	These genes were designated PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
BioInfer.d699.s0.p6	N	These genes were designated PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
BioInfer.d699.s0.p7	N	These genes were designated PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
BioInfer.d699.s0.p8	N	These genes were designated PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
BioInfer.d699.s0.p9	N	These genes were designated PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 and were predicted to encode proteins with molecular weights of, respectively, 99,000, 80,000, 94,000, 51,000, and 114,000.
BioInfer.d700.s0.p0	N	These increases were specific; DNA, total protein, PROTEIN , PROTEIN1 , and PROTEIN2 levels were unchanged in the overexpressing cells.
BioInfer.d700.s0.p1	N	These increases were specific; DNA, total protein, PROTEIN2 , PROTEIN1 , and PROTEIN levels were unchanged in the overexpressing cells.
BioInfer.d700.s0.p2	N	These increases were specific; DNA, total protein, PROTEIN2 , PROTEIN , and PROTEIN1 levels were unchanged in the overexpressing cells.
BioInfer.d701.s0.p0	N	These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the PROTEIN1 gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the PROTEIN2 and PROTEIN families are independently regulated in human heart.
BioInfer.d701.s0.p1	N	These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the PROTEIN1 gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the PROTEIN and PROTEIN2 families are independently regulated in human heart.
BioInfer.d701.s0.p2	P	These observations demonstrate that cardiac development in man, in contrast to rodent heart, is characterized by an up-regulation of the PROTEIN gene, the expression of which does not change in hypertrophied and failing hearts, and suggest that the PROTEIN1 and PROTEIN2 families are independently regulated in human heart.
BioInfer.d702.s0.p0	N	These phenotypes are similar to those of the mutant of PROTEIN1 , which encodes PROTEIN , an PROTEIN2 .
BioInfer.d702.s0.p1	P	These phenotypes are similar to those of the mutant of PROTEIN1 , which encodes PROTEIN2 , an PROTEIN .
BioInfer.d702.s0.p2	P	These phenotypes are similar to those of the mutant of PROTEIN , which encodes PROTEIN2 , an PROTEIN1 .
BioInfer.d703.s0.p0	N	These proteins also compose the essential heterotrimeric splicing factor PROTEIN , and products of yeast pre-mRNA processing genes PROTEIN2 , PROTEIN , and PROTEIN1 are their likely yeast counterparts.
BioInfer.d703.s0.p1	N	These proteins also compose the essential heterotrimeric splicing factor PROTEIN , and products of yeast pre-mRNA processing genes PROTEIN , PROTEIN2 , and PROTEIN1 are their likely yeast counterparts.
BioInfer.d703.s0.p2	N	These proteins also compose the essential heterotrimeric splicing factor PROTEIN2 , and products of yeast pre-mRNA processing genes PROTEIN , PROTEIN , and PROTEIN1 are their likely yeast counterparts.
BioInfer.d703.s0.p3	N	These proteins also compose the essential heterotrimeric splicing factor PROTEIN , and products of yeast pre-mRNA processing genes PROTEIN1 , PROTEIN2 , and PROTEIN are their likely yeast counterparts.
BioInfer.d703.s0.p4	N	These proteins also compose the essential heterotrimeric splicing factor PROTEIN2 , and products of yeast pre-mRNA processing genes PROTEIN1 , PROTEIN , and PROTEIN are their likely yeast counterparts.
BioInfer.d703.s0.p5	N	These proteins also compose the essential heterotrimeric splicing factor PROTEIN2 , and products of yeast pre-mRNA processing genes PROTEIN , PROTEIN1 , and PROTEIN are their likely yeast counterparts.
BioInfer.d704.s0.p0	N	These proteins each have a PROTEIN1 -homology (V) domain, PROTEIN -homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the PROTEIN2 /3 complex, leading to rapid PROTEIN polymerization.
BioInfer.d704.s0.p1	N	These proteins each have a PROTEIN1 -homology (V) domain, PROTEIN -homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the PROTEIN /3 complex, leading to rapid PROTEIN2 polymerization.
BioInfer.d704.s0.p2	N	These proteins each have a PROTEIN1 -homology (V) domain, PROTEIN2 -homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the PROTEIN /3 complex, leading to rapid PROTEIN polymerization.
BioInfer.d704.s0.p4	P	These proteins each have a PROTEIN -homology (V) domain, PROTEIN -homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the PROTEIN1 /3 complex, leading to rapid PROTEIN2 polymerization.
BioInfer.d704.s0.p5	N	These proteins each have a PROTEIN -homology (V) domain, PROTEIN2 -homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the PROTEIN1 /3 complex, leading to rapid PROTEIN polymerization.
BioInfer.d704.s0.p7	N	These proteins each have a PROTEIN -homology (V) domain, PROTEIN2 -homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the PROTEIN /3 complex, leading to rapid PROTEIN1 polymerization.
BioInfer.d705.s0.p0	P	The sequence of the inhibitory region is similar to that of a beta-hairpin region of the PROTEIN1  PROTEIN2 .
BioInfer.d706.s0.p0	P	The sequences of the predicted PROTEIN , PROTEIN , and PROTEIN proteins are related to the PROTEIN2  PROTEIN , PROTEIN1 / PROTEIN , and PROTEIN , respectively.
BioInfer.d706.s0.p1	N	The sequences of the predicted PROTEIN , PROTEIN , and PROTEIN proteins are related to the PROTEIN  PROTEIN2 , PROTEIN1 / PROTEIN , and PROTEIN , respectively.
BioInfer.d706.s0.p2	N	The sequences of the predicted PROTEIN , PROTEIN , and PROTEIN proteins are related to the PROTEIN  PROTEIN , PROTEIN1 / PROTEIN , and PROTEIN2 , respectively.
BioInfer.d706.s0.p3	P	The sequences of the predicted PROTEIN , PROTEIN2 , and PROTEIN proteins are related to the PROTEIN  PROTEIN , PROTEIN1 / PROTEIN , and PROTEIN , respectively.
BioInfer.d706.s0.p4	N	The sequences of the predicted PROTEIN , PROTEIN , and PROTEIN2 proteins are related to the PROTEIN  PROTEIN , PROTEIN1 / PROTEIN , and PROTEIN , respectively.
BioInfer.d706.s0.p5	N	The sequences of the predicted PROTEIN , PROTEIN , and PROTEIN proteins are related to the PROTEIN  PROTEIN , PROTEIN1 / PROTEIN2 , and PROTEIN , respectively.
BioInfer.d706.s0.p6	N	The sequences of the predicted PROTEIN2 , PROTEIN , and PROTEIN proteins are related to the PROTEIN  PROTEIN , PROTEIN1 / PROTEIN , and PROTEIN , respectively.
BioInfer.d706.s0.p7	P	The sequences of the predicted PROTEIN , PROTEIN , and PROTEIN proteins are related to the PROTEIN1  PROTEIN2 , PROTEIN / PROTEIN , and PROTEIN , respectively.
BioInfer.d706.s0.p8	P	The sequences of the predicted PROTEIN , PROTEIN , and PROTEIN proteins are related to the PROTEIN1  PROTEIN , PROTEIN / PROTEIN , and PROTEIN2 , respectively.
BioInfer.d706.s0.p9	N	The sequences of the predicted PROTEIN , PROTEIN2 , and PROTEIN proteins are related to the PROTEIN1  PROTEIN , PROTEIN / PROTEIN , and PROTEIN , respectively.
BioInfer.d706.s0.p10	N	The sequences of the predicted PROTEIN , PROTEIN , and PROTEIN2 proteins are related to the PROTEIN1  PROTEIN , PROTEIN / PROTEIN , and PROTEIN , respectively.
BioInfer.d706.s0.p11	P	The sequences of the predicted PROTEIN , PROTEIN , and PROTEIN proteins are related to the PROTEIN1  PROTEIN , PROTEIN / PROTEIN2 , and PROTEIN , respectively.
BioInfer.d706.s0.p12	N	The sequences of the predicted PROTEIN2 , PROTEIN , and PROTEIN proteins are related to the PROTEIN1  PROTEIN , PROTEIN / PROTEIN , and PROTEIN , respectively.
BioInfer.d706.s0.p13	N	The sequences of the predicted PROTEIN , PROTEIN , and PROTEIN proteins are related to the PROTEIN  PROTEIN1 , PROTEIN / PROTEIN , and PROTEIN2 , respectively.
BioInfer.d706.s0.p14	N	The sequences of the predicted PROTEIN , PROTEIN2 , and PROTEIN proteins are related to the PROTEIN  PROTEIN1 , PROTEIN / PROTEIN , and PROTEIN , respectively.
BioInfer.d706.s0.p15	N	The sequences of the predicted PROTEIN , PROTEIN , and PROTEIN2 proteins are related to the PROTEIN  PROTEIN1 , PROTEIN / PROTEIN , and PROTEIN , respectively.
BioInfer.d706.s0.p16	N	The sequences of the predicted PROTEIN , PROTEIN , and PROTEIN proteins are related to the PROTEIN  PROTEIN1 , PROTEIN / PROTEIN2 , and PROTEIN , respectively.
BioInfer.d706.s0.p17	P	The sequences of the predicted PROTEIN2 , PROTEIN , and PROTEIN proteins are related to the PROTEIN  PROTEIN1 , PROTEIN / PROTEIN , and PROTEIN , respectively.
BioInfer.d706.s0.p18	N	The sequences of the predicted PROTEIN , PROTEIN2 , and PROTEIN proteins are related to the PROTEIN  PROTEIN , PROTEIN / PROTEIN , and PROTEIN1 , respectively.
BioInfer.d706.s0.p19	P	The sequences of the predicted PROTEIN , PROTEIN , and PROTEIN2 proteins are related to the PROTEIN  PROTEIN , PROTEIN / PROTEIN , and PROTEIN1 , respectively.
BioInfer.d706.s0.p20	N	The sequences of the predicted PROTEIN , PROTEIN , and PROTEIN proteins are related to the PROTEIN  PROTEIN , PROTEIN / PROTEIN2 , and PROTEIN1 , respectively.
BioInfer.d706.s0.p21	N	The sequences of the predicted PROTEIN2 , PROTEIN , and PROTEIN proteins are related to the PROTEIN  PROTEIN , PROTEIN / PROTEIN , and PROTEIN1 , respectively.
BioInfer.d706.s0.p22	N	The sequences of the predicted PROTEIN , PROTEIN1 , and PROTEIN2 proteins are related to the PROTEIN  PROTEIN , PROTEIN / PROTEIN , and PROTEIN , respectively.
BioInfer.d706.s0.p23	P	The sequences of the predicted PROTEIN , PROTEIN1 , and PROTEIN proteins are related to the PROTEIN  PROTEIN , PROTEIN / PROTEIN2 , and PROTEIN , respectively.
BioInfer.d706.s0.p24	N	The sequences of the predicted PROTEIN2 , PROTEIN1 , and PROTEIN proteins are related to the PROTEIN  PROTEIN , PROTEIN / PROTEIN , and PROTEIN , respectively.
BioInfer.d706.s0.p25	N	The sequences of the predicted PROTEIN , PROTEIN , and PROTEIN1 proteins are related to the PROTEIN  PROTEIN , PROTEIN / PROTEIN2 , and PROTEIN , respectively.
BioInfer.d706.s0.p26	N	The sequences of the predicted PROTEIN2 , PROTEIN , and PROTEIN1 proteins are related to the PROTEIN  PROTEIN , PROTEIN / PROTEIN , and PROTEIN , respectively.
BioInfer.d706.s0.p27	N	The sequences of the predicted PROTEIN2 , PROTEIN , and PROTEIN proteins are related to the PROTEIN  PROTEIN , PROTEIN / PROTEIN1 , and PROTEIN , respectively.
BioInfer.d707.s0.p0	P	These regions also interact with the physiologically relevant ligands of PROTEIN2 , PROTEIN1 and proline-rich peptides.
BioInfer.d708.s0.p0	P	These results indicate that (i) cotranslational assembly of PROTEIN1 is developmentally regulated, (ii) structures containing PROTEIN2 and not microtubules may mediate initial association of the heavy chains with the cytoskeleton, and (iii) the site of translation dictates where a significant fraction of the heavy chains will be inserted into the cytoskeleton.
BioInfer.d709.s0.p0	N	These results indicate that phosphorylation of PROTEIN1 by PROTEIN and consequently increased phosphorylation of PROTEIN by PROTEIN2 contribute to PROTEIN -induced reorganization of the PROTEIN cytoskeleton.
BioInfer.d709.s0.p1	P	These results indicate that phosphorylation of PROTEIN1 by PROTEIN and consequently increased phosphorylation of PROTEIN2 by PROTEIN contribute to PROTEIN -induced reorganization of the PROTEIN cytoskeleton.
BioInfer.d709.s0.p2	P	These results indicate that phosphorylation of PROTEIN1 by PROTEIN and consequently increased phosphorylation of PROTEIN by PROTEIN contribute to PROTEIN -induced reorganization of the PROTEIN2 cytoskeleton.
BioInfer.d709.s0.p3	N	These results indicate that phosphorylation of PROTEIN1 by PROTEIN and consequently increased phosphorylation of PROTEIN by PROTEIN contribute to PROTEIN2 -induced reorganization of the PROTEIN cytoskeleton.
BioInfer.d709.s0.p4	P	These results indicate that phosphorylation of PROTEIN1 by PROTEIN2 and consequently increased phosphorylation of PROTEIN by PROTEIN contribute to PROTEIN -induced reorganization of the PROTEIN cytoskeleton.
BioInfer.d709.s0.p5	P	These results indicate that phosphorylation of PROTEIN by PROTEIN and consequently increased phosphorylation of PROTEIN2 by PROTEIN1 contribute to PROTEIN -induced reorganization of the PROTEIN cytoskeleton.
BioInfer.d709.s0.p6	P	These results indicate that phosphorylation of PROTEIN by PROTEIN and consequently increased phosphorylation of PROTEIN by PROTEIN1 contribute to PROTEIN -induced reorganization of the PROTEIN2 cytoskeleton.
BioInfer.d709.s0.p7	N	These results indicate that phosphorylation of PROTEIN by PROTEIN and consequently increased phosphorylation of PROTEIN by PROTEIN1 contribute to PROTEIN2 -induced reorganization of the PROTEIN cytoskeleton.
BioInfer.d709.s0.p8	N	These results indicate that phosphorylation of PROTEIN by PROTEIN2 and consequently increased phosphorylation of PROTEIN by PROTEIN1 contribute to PROTEIN -induced reorganization of the PROTEIN cytoskeleton.
BioInfer.d709.s0.p9	P	These results indicate that phosphorylation of PROTEIN by PROTEIN and consequently increased phosphorylation of PROTEIN1 by PROTEIN contribute to PROTEIN -induced reorganization of the PROTEIN2 cytoskeleton.
BioInfer.d709.s0.p10	N	These results indicate that phosphorylation of PROTEIN by PROTEIN and consequently increased phosphorylation of PROTEIN1 by PROTEIN contribute to PROTEIN2 -induced reorganization of the PROTEIN cytoskeleton.
BioInfer.d709.s0.p11	P	These results indicate that phosphorylation of PROTEIN by PROTEIN2 and consequently increased phosphorylation of PROTEIN1 by PROTEIN contribute to PROTEIN -induced reorganization of the PROTEIN cytoskeleton.
BioInfer.d709.s0.p12	P	These results indicate that phosphorylation of PROTEIN by PROTEIN and consequently increased phosphorylation of PROTEIN by PROTEIN contribute to PROTEIN2 -induced reorganization of the PROTEIN1 cytoskeleton.
BioInfer.d709.s0.p13	P	These results indicate that phosphorylation of PROTEIN by PROTEIN2 and consequently increased phosphorylation of PROTEIN by PROTEIN contribute to PROTEIN -induced reorganization of the PROTEIN1 cytoskeleton.
BioInfer.d709.s0.p14	N	These results indicate that phosphorylation of PROTEIN by PROTEIN2 and consequently increased phosphorylation of PROTEIN by PROTEIN contribute to PROTEIN1 -induced reorganization of the PROTEIN cytoskeleton.
BioInfer.d710.s0.p0	N	These results show that PROTEIN1 / PROTEIN2 is an important regulator of PROTEIN -based cell motility during Drosophila development.
BioInfer.d710.s0.p1	P	These results show that PROTEIN1 / PROTEIN is an important regulator of PROTEIN2 -based cell motility during Drosophila development.
BioInfer.d710.s0.p2	P	These results show that PROTEIN / PROTEIN1 is an important regulator of PROTEIN2 -based cell motility during Drosophila development.
BioInfer.d711.s0.p0	P	These results suggest that activation of PROTEIN precedes the activation of PROTEIN and PROTEIN and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN2 such as PROTEIN and PROTEIN1 .
BioInfer.d711.s0.p1	N	These results suggest that activation of PROTEIN precedes the activation of PROTEIN2 and PROTEIN and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN such as PROTEIN and PROTEIN1 .
BioInfer.d711.s0.p2	N	These results suggest that activation of PROTEIN2 precedes the activation of PROTEIN and PROTEIN and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN such as PROTEIN and PROTEIN1 .
BioInfer.d711.s0.p3	N	These results suggest that activation of PROTEIN precedes the activation of PROTEIN and PROTEIN2 and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN such as PROTEIN and PROTEIN1 .
BioInfer.d711.s0.p4	N	These results suggest that activation of PROTEIN precedes the activation of PROTEIN and PROTEIN and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN2 in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN such as PROTEIN and PROTEIN1 .
BioInfer.d711.s0.p5	N	These results suggest that activation of PROTEIN precedes the activation of PROTEIN and PROTEIN and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN such as PROTEIN2 and PROTEIN1 .
BioInfer.d711.s0.p6	P	These results suggest that activation of PROTEIN precedes the activation of PROTEIN2 and PROTEIN and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN1 such as PROTEIN and PROTEIN .
BioInfer.d711.s0.p7	P	These results suggest that activation of PROTEIN2 precedes the activation of PROTEIN and PROTEIN and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN1 such as PROTEIN and PROTEIN .
BioInfer.d711.s0.p8	P	These results suggest that activation of PROTEIN precedes the activation of PROTEIN and PROTEIN2 and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN1 such as PROTEIN and PROTEIN .
BioInfer.d711.s0.p9	P	These results suggest that activation of PROTEIN precedes the activation of PROTEIN and PROTEIN and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN2 in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN1 such as PROTEIN and PROTEIN .
BioInfer.d711.s0.p10	P	These results suggest that activation of PROTEIN precedes the activation of PROTEIN and PROTEIN and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN1 such as PROTEIN2 and PROTEIN .
BioInfer.d711.s0.p11	P	These results suggest that activation of PROTEIN2 precedes the activation of PROTEIN1 and PROTEIN and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d711.s0.p12	N	These results suggest that activation of PROTEIN precedes the activation of PROTEIN1 and PROTEIN2 and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d711.s0.p13	P	These results suggest that activation of PROTEIN precedes the activation of PROTEIN1 and PROTEIN and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN2 in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d711.s0.p14	N	These results suggest that activation of PROTEIN precedes the activation of PROTEIN1 and PROTEIN and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN such as PROTEIN2 and PROTEIN .
BioInfer.d711.s0.p15	P	These results suggest that activation of PROTEIN1 precedes the activation of PROTEIN and PROTEIN2 and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d711.s0.p16	P	These results suggest that activation of PROTEIN1 precedes the activation of PROTEIN and PROTEIN and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN2 in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d711.s0.p17	N	These results suggest that activation of PROTEIN1 precedes the activation of PROTEIN and PROTEIN and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN such as PROTEIN2 and PROTEIN .
BioInfer.d711.s0.p18	P	These results suggest that activation of PROTEIN precedes the activation of PROTEIN and PROTEIN1 and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN2 in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN such as PROTEIN and PROTEIN .
BioInfer.d711.s0.p19	N	These results suggest that activation of PROTEIN precedes the activation of PROTEIN and PROTEIN1 and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN such as PROTEIN2 and PROTEIN .
BioInfer.d711.s0.p20	N	These results suggest that activation of PROTEIN precedes the activation of PROTEIN and PROTEIN and that under certain circumstances activation of the kinases and the increased synthesis of PIP and PIP2 may be involved in the polymerization of PROTEIN1 in RBL cells, possibly through the interaction of the polyphosphoinositides with PROTEIN such as PROTEIN2 and PROTEIN .
BioInfer.d712.s0.p0	P	These results suggest that PROTEIN1 may be involved in the pathogenesis of glomerulonephritis by reorganizing PROTEIN2 cytoskeleton.
BioInfer.d713.s0.p0	P	These results suggest that PROTEIN2 functions downstream of the PROTEIN - PROTEIN1 signalling pathway and plays a role in reorganization of PROTEIN filaments and membrane structures, by phosphorylating PROTEIN proteins.
BioInfer.d713.s0.p1	N	These results suggest that PROTEIN functions downstream of the PROTEIN - PROTEIN1 signalling pathway and plays a role in reorganization of PROTEIN filaments and membrane structures, by phosphorylating PROTEIN2 proteins.
BioInfer.d713.s0.p2	N	These results suggest that PROTEIN functions downstream of the PROTEIN - PROTEIN1 signalling pathway and plays a role in reorganization of PROTEIN2 filaments and membrane structures, by phosphorylating PROTEIN proteins.
BioInfer.d713.s0.p3	N	These results suggest that PROTEIN functions downstream of the PROTEIN2 - PROTEIN1 signalling pathway and plays a role in reorganization of PROTEIN filaments and membrane structures, by phosphorylating PROTEIN proteins.
BioInfer.d713.s0.p4	P	These results suggest that PROTEIN1 functions downstream of the PROTEIN - PROTEIN signalling pathway and plays a role in reorganization of PROTEIN filaments and membrane structures, by phosphorylating PROTEIN2 proteins.
BioInfer.d713.s0.p5	P	These results suggest that PROTEIN1 functions downstream of the PROTEIN - PROTEIN signalling pathway and plays a role in reorganization of PROTEIN2 filaments and membrane structures, by phosphorylating PROTEIN proteins.
BioInfer.d713.s0.p6	P	These results suggest that PROTEIN1 functions downstream of the PROTEIN2 - PROTEIN signalling pathway and plays a role in reorganization of PROTEIN filaments and membrane structures, by phosphorylating PROTEIN proteins.
BioInfer.d713.s0.p7	P	These results suggest that PROTEIN functions downstream of the PROTEIN - PROTEIN signalling pathway and plays a role in reorganization of PROTEIN2 filaments and membrane structures, by phosphorylating PROTEIN1 proteins.
BioInfer.d713.s0.p8	N	These results suggest that PROTEIN functions downstream of the PROTEIN2 - PROTEIN signalling pathway and plays a role in reorganization of PROTEIN filaments and membrane structures, by phosphorylating PROTEIN1 proteins.
BioInfer.d713.s0.p9	N	These results suggest that PROTEIN functions downstream of the PROTEIN2 - PROTEIN signalling pathway and plays a role in reorganization of PROTEIN1 filaments and membrane structures, by phosphorylating PROTEIN proteins.
BioInfer.d713.s1.p0	P	We report here that PROTEIN and PROTEIN1 phosphorylate both PROTEIN and PROTEIN ( PROTEIN ) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN2 mutants as substrates.
BioInfer.d713.s1.p1	N	We report here that PROTEIN2 and PROTEIN1 phosphorylate both PROTEIN and PROTEIN ( PROTEIN ) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN mutants as substrates.
BioInfer.d713.s1.p2	P	We report here that PROTEIN and PROTEIN1 phosphorylate both PROTEIN and PROTEIN ( PROTEIN2 ) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN mutants as substrates.
BioInfer.d713.s1.p3	P	We report here that PROTEIN and PROTEIN1 phosphorylate both PROTEIN2 and PROTEIN ( PROTEIN ) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN mutants as substrates.
BioInfer.d713.s1.p4	P	We report here that PROTEIN and PROTEIN1 phosphorylate both PROTEIN and PROTEIN2 ( PROTEIN ) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN mutants as substrates.
BioInfer.d713.s1.p5	P	We report here that PROTEIN2 and PROTEIN phosphorylate both PROTEIN and PROTEIN ( PROTEIN ) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN1 mutants as substrates.
BioInfer.d713.s1.p6	N	We report here that PROTEIN and PROTEIN phosphorylate both PROTEIN and PROTEIN ( PROTEIN2 ) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN1 mutants as substrates.
BioInfer.d713.s1.p7	N	We report here that PROTEIN and PROTEIN phosphorylate both PROTEIN2 and PROTEIN ( PROTEIN ) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN1 mutants as substrates.
BioInfer.d713.s1.p8	N	We report here that PROTEIN and PROTEIN phosphorylate both PROTEIN and PROTEIN2 ( PROTEIN ) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN1 mutants as substrates.
BioInfer.d713.s1.p9	P	We report here that PROTEIN1 and PROTEIN phosphorylate both PROTEIN and PROTEIN ( PROTEIN2 ) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN mutants as substrates.
BioInfer.d713.s1.p10	P	We report here that PROTEIN1 and PROTEIN phosphorylate both PROTEIN2 and PROTEIN ( PROTEIN ) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN mutants as substrates.
BioInfer.d713.s1.p11	P	We report here that PROTEIN1 and PROTEIN phosphorylate both PROTEIN and PROTEIN2 ( PROTEIN ) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN mutants as substrates.
BioInfer.d713.s1.p12	N	We report here that PROTEIN and PROTEIN phosphorylate both PROTEIN2 and PROTEIN ( PROTEIN1 ) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN mutants as substrates.
BioInfer.d713.s1.p13	N	We report here that PROTEIN and PROTEIN phosphorylate both PROTEIN and PROTEIN2 ( PROTEIN1 ) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN mutants as substrates.
BioInfer.d713.s1.p14	N	We report here that PROTEIN and PROTEIN phosphorylate both PROTEIN1 and PROTEIN2 ( PROTEIN ) specifically at Ser-3 and exhibit partially distinct substrate specificity when tested using site-directed PROTEIN mutants as substrates.
BioInfer.d714.s0.p0	N	These results suggest that the heptapeptide sequence is specific for the interaction with PROTEIN1 and, therefore, may constitute part of the PROTEIN -binding domain of PROTEIN2 .
BioInfer.d714.s0.p1	N	These results suggest that the heptapeptide sequence is specific for the interaction with PROTEIN1 and, therefore, may constitute part of the PROTEIN2 -binding domain of PROTEIN .
BioInfer.d714.s0.p2	P	These results suggest that the heptapeptide sequence is specific for the interaction with PROTEIN and, therefore, may constitute part of the PROTEIN2 -binding domain of PROTEIN1 .
BioInfer.d715.s0.p0	P	These results suggest that PROTEIN2 can cause apoptosis in pancreatic beta cells through PROTEIN -linked apoptotic factors, PROTEIN1 , PROTEIN , and PROTEIN , and PROTEIN -induced ceramide production may be involved in the pathways.
BioInfer.d715.s0.p1	N	These results suggest that PROTEIN can cause apoptosis in pancreatic beta cells through PROTEIN -linked apoptotic factors, PROTEIN1 , PROTEIN , and PROTEIN2 , and PROTEIN -induced ceramide production may be involved in the pathways.
BioInfer.d715.s0.p2	N	These results suggest that PROTEIN can cause apoptosis in pancreatic beta cells through PROTEIN -linked apoptotic factors, PROTEIN1 , PROTEIN2 , and PROTEIN , and PROTEIN -induced ceramide production may be involved in the pathways.
BioInfer.d715.s0.p3	N	These results suggest that PROTEIN can cause apoptosis in pancreatic beta cells through PROTEIN -linked apoptotic factors, PROTEIN1 , PROTEIN , and PROTEIN , and PROTEIN2 -induced ceramide production may be involved in the pathways.
BioInfer.d715.s0.p4	P	These results suggest that PROTEIN can cause apoptosis in pancreatic beta cells through PROTEIN2 -linked apoptotic factors, PROTEIN1 , PROTEIN , and PROTEIN , and PROTEIN -induced ceramide production may be involved in the pathways.
BioInfer.d715.s0.p5	P	These results suggest that PROTEIN1 can cause apoptosis in pancreatic beta cells through PROTEIN -linked apoptotic factors, PROTEIN , PROTEIN , and PROTEIN2 , and PROTEIN -induced ceramide production may be involved in the pathways.
BioInfer.d715.s0.p6	P	These results suggest that PROTEIN1 can cause apoptosis in pancreatic beta cells through PROTEIN -linked apoptotic factors, PROTEIN , PROTEIN2 , and PROTEIN , and PROTEIN -induced ceramide production may be involved in the pathways.
BioInfer.d715.s0.p7	N	These results suggest that PROTEIN1 can cause apoptosis in pancreatic beta cells through PROTEIN -linked apoptotic factors, PROTEIN , PROTEIN , and PROTEIN , and PROTEIN2 -induced ceramide production may be involved in the pathways.
BioInfer.d715.s0.p8	N	These results suggest that PROTEIN1 can cause apoptosis in pancreatic beta cells through PROTEIN2 -linked apoptotic factors, PROTEIN , PROTEIN , and PROTEIN , and PROTEIN -induced ceramide production may be involved in the pathways.
BioInfer.d715.s0.p9	N	These results suggest that PROTEIN can cause apoptosis in pancreatic beta cells through PROTEIN -linked apoptotic factors, PROTEIN , PROTEIN2 , and PROTEIN1 , and PROTEIN -induced ceramide production may be involved in the pathways.
BioInfer.d715.s0.p10	N	These results suggest that PROTEIN can cause apoptosis in pancreatic beta cells through PROTEIN -linked apoptotic factors, PROTEIN , PROTEIN , and PROTEIN1 , and PROTEIN2 -induced ceramide production may be involved in the pathways.
BioInfer.d715.s0.p11	P	These results suggest that PROTEIN can cause apoptosis in pancreatic beta cells through PROTEIN2 -linked apoptotic factors, PROTEIN , PROTEIN , and PROTEIN1 , and PROTEIN -induced ceramide production may be involved in the pathways.
BioInfer.d715.s0.p12	N	These results suggest that PROTEIN can cause apoptosis in pancreatic beta cells through PROTEIN -linked apoptotic factors, PROTEIN , PROTEIN1 , and PROTEIN , and PROTEIN2 -induced ceramide production may be involved in the pathways.
BioInfer.d715.s0.p13	P	These results suggest that PROTEIN can cause apoptosis in pancreatic beta cells through PROTEIN2 -linked apoptotic factors, PROTEIN , PROTEIN1 , and PROTEIN , and PROTEIN -induced ceramide production may be involved in the pathways.
BioInfer.d715.s0.p14	N	These results suggest that PROTEIN can cause apoptosis in pancreatic beta cells through PROTEIN2 -linked apoptotic factors, PROTEIN , PROTEIN , and PROTEIN , and PROTEIN1 -induced ceramide production may be involved in the pathways.
BioInfer.d716.s0.p0	P	The PROTEIN  PROTEIN and PROTEIN associate with and activate the PROTEIN1  PROTEIN2 in human T lymphocytes.
BioInfer.d716.s0.p1	N	The PROTEIN  PROTEIN2 and PROTEIN associate with and activate the PROTEIN1  PROTEIN in human T lymphocytes.
BioInfer.d716.s0.p2	N	The PROTEIN  PROTEIN and PROTEIN2 associate with and activate the PROTEIN1  PROTEIN in human T lymphocytes.
BioInfer.d716.s0.p3	N	The PROTEIN2  PROTEIN and PROTEIN associate with and activate the PROTEIN1  PROTEIN in human T lymphocytes.
BioInfer.d716.s0.p4	P	The PROTEIN  PROTEIN2 and PROTEIN associate with and activate the PROTEIN  PROTEIN1 in human T lymphocytes.
BioInfer.d716.s0.p5	P	The PROTEIN  PROTEIN and PROTEIN2 associate with and activate the PROTEIN  PROTEIN1 in human T lymphocytes.
BioInfer.d716.s0.p6	N	The PROTEIN2  PROTEIN and PROTEIN associate with and activate the PROTEIN  PROTEIN1 in human T lymphocytes.
BioInfer.d716.s0.p7	N	The PROTEIN  PROTEIN1 and PROTEIN2 associate with and activate the PROTEIN  PROTEIN in human T lymphocytes.
BioInfer.d716.s0.p8	P	The PROTEIN2  PROTEIN1 and PROTEIN associate with and activate the PROTEIN  PROTEIN in human T lymphocytes.
BioInfer.d716.s0.p9	P	The PROTEIN2  PROTEIN and PROTEIN1 associate with and activate the PROTEIN  PROTEIN in human T lymphocytes.
BioInfer.d717.s0.p0	N	These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN  PROTEIN1 , the PROTEIN  PROTEIN , and the PROTEIN  PROTEIN2 .
BioInfer.d717.s0.p1	P	These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN2  PROTEIN1 , the PROTEIN  PROTEIN , and the PROTEIN  PROTEIN .
BioInfer.d717.s0.p2	N	These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN  PROTEIN1 , the PROTEIN  PROTEIN , and the PROTEIN2  PROTEIN .
BioInfer.d717.s0.p3	N	These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN  PROTEIN1 , the PROTEIN2  PROTEIN , and the PROTEIN  PROTEIN .
BioInfer.d717.s0.p4	N	These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN  PROTEIN1 , the PROTEIN  PROTEIN2 , and the PROTEIN  PROTEIN .
BioInfer.d717.s0.p5	N	These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN2  PROTEIN , the PROTEIN  PROTEIN , and the PROTEIN  PROTEIN1 .
BioInfer.d717.s0.p6	P	These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN  PROTEIN , the PROTEIN  PROTEIN , and the PROTEIN2  PROTEIN1 .
BioInfer.d717.s0.p7	N	These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN  PROTEIN , the PROTEIN2  PROTEIN , and the PROTEIN  PROTEIN1 .
BioInfer.d717.s0.p8	N	These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN  PROTEIN , the PROTEIN  PROTEIN2 , and the PROTEIN  PROTEIN1 .
BioInfer.d717.s0.p9	N	These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN1  PROTEIN , the PROTEIN  PROTEIN , and the PROTEIN2  PROTEIN .
BioInfer.d717.s0.p10	N	These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN1  PROTEIN , the PROTEIN2  PROTEIN , and the PROTEIN  PROTEIN .
BioInfer.d717.s0.p11	N	These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN1  PROTEIN , the PROTEIN  PROTEIN2 , and the PROTEIN  PROTEIN .
BioInfer.d717.s0.p12	N	These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN  PROTEIN , the PROTEIN2  PROTEIN , and the PROTEIN1  PROTEIN .
BioInfer.d717.s0.p13	N	These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN  PROTEIN , the PROTEIN  PROTEIN2 , and the PROTEIN1  PROTEIN .
BioInfer.d717.s0.p14	P	These separately encoded a complete HPIV3 genome (negative-sense), the HPIV3 PROTEIN  PROTEIN , the PROTEIN1  PROTEIN2 , and the PROTEIN  PROTEIN .
BioInfer.d718.s0.p0	N	These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive PROTEIN -depolymerizing protein, PROTEIN2 , by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for PROTEIN1 .
BioInfer.d718.s0.p1	N	These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive PROTEIN2 -depolymerizing protein, PROTEIN , by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for PROTEIN1 .
BioInfer.d718.s0.p2	P	These two proteins were identified as the phosphorylated and non-phosphorylated forms of the pH-sensitive PROTEIN2 -depolymerizing protein, PROTEIN1 , by sequencing of peptide fragments and immunoblotting with a monoclonal antibody specific for PROTEIN .
BioInfer.d719.s0.p0	N	These were identified as PROTEIN , PROTEIN1 , PROTEIN , PROTEIN ( PROTEIN )-60, an unidentified protein and PROTEIN2 , respectively.
BioInfer.d719.s0.p1	N	These were identified as PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN ( PROTEIN )-60, an unidentified protein and PROTEIN , respectively.
BioInfer.d719.s0.p2	N	These were identified as PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN ( PROTEIN )-60, an unidentified protein and PROTEIN , respectively.
BioInfer.d719.s0.p3	N	These were identified as PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 ( PROTEIN )-60, an unidentified protein and PROTEIN , respectively.
BioInfer.d719.s0.p4	N	These were identified as PROTEIN , PROTEIN1 , PROTEIN , PROTEIN ( PROTEIN2 )-60, an unidentified protein and PROTEIN , respectively.
BioInfer.d719.s0.p5	N	These were identified as PROTEIN2 , PROTEIN , PROTEIN , PROTEIN ( PROTEIN )-60, an unidentified protein and PROTEIN1 , respectively.
BioInfer.d719.s0.p6	N	These were identified as PROTEIN , PROTEIN , PROTEIN2 , PROTEIN ( PROTEIN )-60, an unidentified protein and PROTEIN1 , respectively.
BioInfer.d719.s0.p7	N	These were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN2 ( PROTEIN )-60, an unidentified protein and PROTEIN1 , respectively.
BioInfer.d719.s0.p8	N	These were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN ( PROTEIN2 )-60, an unidentified protein and PROTEIN1 , respectively.
BioInfer.d719.s0.p9	N	These were identified as PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN ( PROTEIN )-60, an unidentified protein and PROTEIN , respectively.
BioInfer.d719.s0.p10	N	These were identified as PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 ( PROTEIN )-60, an unidentified protein and PROTEIN , respectively.
BioInfer.d719.s0.p11	N	These were identified as PROTEIN1 , PROTEIN , PROTEIN , PROTEIN ( PROTEIN2 )-60, an unidentified protein and PROTEIN , respectively.
BioInfer.d719.s0.p12	N	These were identified as PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 ( PROTEIN )-60, an unidentified protein and PROTEIN , respectively.
BioInfer.d719.s0.p13	N	These were identified as PROTEIN , PROTEIN , PROTEIN1 , PROTEIN ( PROTEIN2 )-60, an unidentified protein and PROTEIN , respectively.
BioInfer.d719.s0.p14	N	These were identified as PROTEIN , PROTEIN , PROTEIN , PROTEIN1 ( PROTEIN2 )-60, an unidentified protein and PROTEIN , respectively.
BioInfer.d720.s0.p0	N	The sites on the PROTEIN that interact with PROTEIN and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the PROTEIN1 head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the PROTEIN2 head (subfragment 1, S1) in this process.
BioInfer.d720.s0.p1	N	The sites on the PROTEIN that interact with PROTEIN2 and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the PROTEIN1 head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the PROTEIN head (subfragment 1, S1) in this process.
BioInfer.d720.s0.p2	N	The sites on the PROTEIN2 that interact with PROTEIN and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the PROTEIN1 head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the PROTEIN head (subfragment 1, S1) in this process.
BioInfer.d720.s0.p3	N	The sites on the PROTEIN that interact with PROTEIN2 and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the PROTEIN head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the PROTEIN1 head (subfragment 1, S1) in this process.
BioInfer.d720.s0.p4	N	The sites on the PROTEIN2 that interact with PROTEIN and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the PROTEIN head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the PROTEIN1 head (subfragment 1, S1) in this process.
BioInfer.d720.s0.p5	P	The sites on the PROTEIN2 that interact with PROTEIN1 and are responsible for force generation are ill-defined: crosslinking and experiments with isolated domains of the PROTEIN head implicate regions in both the 50K and 20K (molecular weights in thousands) domains of the PROTEIN head (subfragment 1, S1) in this process.
BioInfer.d721.s0.p0	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN1 ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN2 ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p1	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN1 ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN2 ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p2	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN1 ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN2 ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p3	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN1 ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN2 ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p4	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN1 ; 190 kDa), PROTEIN ( PROTEIN2 ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p5	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN2 ( PROTEIN1 ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p6	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN1 ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN2 ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p7	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN1 ; 190 kDa), PROTEIN2 ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p8	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN1 ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN2 ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p9	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN1 ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN2 ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p10	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN1 ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN2 ; 35 kDa) proteins.
BioInfer.d721.s0.p11	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN1 ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN2 ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p12	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN1 ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN2 ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p13	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN2 ( PROTEIN1 ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p14	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN1 ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN2 ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p15	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN1 ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN2 ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p16	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN2 ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN1 ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p17	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN2 ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN1 ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p18	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN2 ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN1 ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p19	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN2 ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN1 ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p20	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN1 ; 63 kDa), PROTEIN2 ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p21	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN1 ; 63 kDa), PROTEIN ( PROTEIN2 ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p22	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN1 ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN2 ; 35 kDa) proteins.
BioInfer.d721.s0.p23	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN2 ; 66 kDa), PROTEIN ( PROTEIN1 ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p24	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN1 ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN2 ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p25	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN1 ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN2 ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p26	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN1 ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN2 ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p27	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN2 ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN1 ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p28	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN2 ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN1 ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p29	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN2 ( PROTEIN ; 66 kDa), PROTEIN1 ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p30	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN2 ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN1 ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p31	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN1 ( PROTEIN ; 63 kDa), PROTEIN2 ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p32	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN1 ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN2 ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p33	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN1 ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN2 ; 35 kDa) proteins.
BioInfer.d721.s0.p34	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN2 ; 66 kDa), PROTEIN1 ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p35	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN1 ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN2 ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p36	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN2 ( PROTEIN ; 43 kDa) and PROTEIN1 ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p37	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN2 ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN1 ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p38	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN2 ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN1 ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p39	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN2 ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN1 ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p40	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN2 ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN1 ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p41	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN2 ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN1 ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p42	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN2 ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN1 ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p43	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN1 ( PROTEIN2 ; 35 kDa) proteins.
BioInfer.d721.s0.p44	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN2 ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN1 ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p45	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN2 ; 43 kDa) and PROTEIN1 ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p46	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN2 ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN1 ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p47	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN2 ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN1 ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p48	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN2 ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN1 ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p49	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN2 ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN1 ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p50	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN2 ( PROTEIN ; 49 kDa), PROTEIN1 ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p51	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN2 ; 49 kDa), PROTEIN1 ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p52	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN1 ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN2 ; 35 kDa) proteins.
BioInfer.d721.s0.p53	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN2 ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN1 ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p54	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN1 ( PROTEIN2 ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p55	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN2 ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN1 ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p56	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN1 ; 74 kDa), PROTEIN2 ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p57	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN2 ( PROTEIN1 ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p58	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN1 ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN2 ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p59	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN1 ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN2 ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p60	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN1 ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN2 ; 35 kDa) proteins.
BioInfer.d721.s0.p61	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN1 ; 74 kDa), PROTEIN ( PROTEIN2 ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p62	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN1 ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN2 ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p63	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN2 ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p64	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 ( PROTEIN ; 190 kDa), PROTEIN2 ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p65	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN2 ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p66	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN2 ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p67	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN2 ; 35 kDa) proteins.
BioInfer.d721.s0.p68	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN2 ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p69	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN1 ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN2 ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p70	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN2 ( PROTEIN ; 74 kDa), PROTEIN1 ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p71	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN1 ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN2 ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p72	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN1 ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN2 ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p73	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN1 ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN2 ; 35 kDa) proteins.
BioInfer.d721.s0.p74	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN1 ( PROTEIN2 ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p75	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN1 ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN2 ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p76	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN1 ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN2 ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p77	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN1 ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN2 ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p78	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN1 ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN2 ; 35 kDa) proteins.
BioInfer.d721.s0.p79	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN1 ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN2 ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p80	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN1 ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN2 ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p81	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN1 ( PROTEIN2 ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p82	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN1 ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN2 ; 35 kDa) proteins.
BioInfer.d721.s0.p83	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN2 ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN1 ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p84	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN1 ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN2 ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p85	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN1 ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN2 ; 35 kDa) proteins.
BioInfer.d721.s0.p86	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN2 ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN1 ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p87	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN1 ; 49 kDa), PROTEIN ( PROTEIN2 ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d721.s0.p88	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN2 ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN ; 43 kDa) and PROTEIN ( PROTEIN1 ; 35 kDa) proteins.
BioInfer.d721.s0.p89	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN2 ; 43 kDa) and PROTEIN ( PROTEIN1 ; 35 kDa) proteins.
BioInfer.d721.s0.p90	N	The sizes and characteristics of each of the proteins determined from various radiolabelling experiments allowed preliminary identification of the proteins as the PROTEIN ( PROTEIN ; 190 kDa), PROTEIN ( PROTEIN ; 74 kDa), PROTEIN ( PROTEIN1 ; 66 kDa), PROTEIN ( PROTEIN ; 63 kDa), PROTEIN ( PROTEIN ; 49 kDa), PROTEIN ( PROTEIN2 ; 43 kDa) and PROTEIN ( PROTEIN ; 35 kDa) proteins.
BioInfer.d722.s0.p0	P	The PROTEIN homology domain 3 (SH3) of a yeast PROTEIN , PROTEIN2 , binds to PROTEIN1 and is required for targeting to sites of PROTEIN polarization.
BioInfer.d722.s0.p1	N	The PROTEIN homology domain 3 (SH3) of a yeast PROTEIN2 , PROTEIN , binds to PROTEIN1 and is required for targeting to sites of PROTEIN polarization.
BioInfer.d722.s0.p2	N	The PROTEIN homology domain 3 (SH3) of a yeast PROTEIN , PROTEIN , binds to PROTEIN1 and is required for targeting to sites of PROTEIN2 polarization.
BioInfer.d722.s0.p3	N	The PROTEIN2 homology domain 3 (SH3) of a yeast PROTEIN , PROTEIN , binds to PROTEIN1 and is required for targeting to sites of PROTEIN polarization.
BioInfer.d722.s0.p4	P	The PROTEIN homology domain 3 (SH3) of a yeast PROTEIN2 , PROTEIN1 , binds to PROTEIN and is required for targeting to sites of PROTEIN polarization.
BioInfer.d722.s0.p5	N	The PROTEIN homology domain 3 (SH3) of a yeast PROTEIN , PROTEIN1 , binds to PROTEIN and is required for targeting to sites of PROTEIN2 polarization.
BioInfer.d722.s0.p6	P	The PROTEIN2 homology domain 3 (SH3) of a yeast PROTEIN , PROTEIN1 , binds to PROTEIN and is required for targeting to sites of PROTEIN polarization.
BioInfer.d722.s0.p7	N	The PROTEIN homology domain 3 (SH3) of a yeast PROTEIN1 , PROTEIN , binds to PROTEIN and is required for targeting to sites of PROTEIN2 polarization.
BioInfer.d722.s0.p8	N	The PROTEIN2 homology domain 3 (SH3) of a yeast PROTEIN1 , PROTEIN , binds to PROTEIN and is required for targeting to sites of PROTEIN polarization.
BioInfer.d722.s0.p9	N	The PROTEIN2 homology domain 3 (SH3) of a yeast PROTEIN , PROTEIN , binds to PROTEIN and is required for targeting to sites of PROTEIN1 polarization.
BioInfer.d723.s0.p0	P	The structural homology between PROTEIN and PROTEIN2 segment-1 binding to PROTEIN1 was confirmed experimentally by two types of competitive binding assays.
BioInfer.d723.s0.p1	P	The structural homology between PROTEIN2 and PROTEIN segment-1 binding to PROTEIN1 was confirmed experimentally by two types of competitive binding assays.
BioInfer.d723.s0.p2	P	The structural homology between PROTEIN2 and PROTEIN1 segment-1 binding to PROTEIN was confirmed experimentally by two types of competitive binding assays.
BioInfer.d724.s0.p0	P	The structure of an PROTEIN2 -crosslinking domain from human PROTEIN1 .
BioInfer.d725.s0.p0	N	The structure of PROTEIN differed entirely from that of PROTEIN1 and resembled the overall fold of the PROTEIN2 regulatory protein, PROTEIN .
BioInfer.d725.s0.p1	P	The structure of PROTEIN2 differed entirely from that of PROTEIN1 and resembled the overall fold of the PROTEIN regulatory protein, PROTEIN .
BioInfer.d725.s0.p2	N	The structure of PROTEIN differed entirely from that of PROTEIN1 and resembled the overall fold of the PROTEIN regulatory protein, PROTEIN2 .
BioInfer.d725.s0.p3	N	The structure of PROTEIN2 differed entirely from that of PROTEIN and resembled the overall fold of the PROTEIN1 regulatory protein, PROTEIN .
BioInfer.d725.s0.p4	P	The structure of PROTEIN differed entirely from that of PROTEIN and resembled the overall fold of the PROTEIN1 regulatory protein, PROTEIN2 .
BioInfer.d725.s0.p5	P	The structure of PROTEIN1 differed entirely from that of PROTEIN and resembled the overall fold of the PROTEIN regulatory protein, PROTEIN2 .
BioInfer.d726.s0.p0	N	The Tetrahymena PROTEIN2 has two PROTEIN -binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena PROTEIN probably cross-links PROTEIN1 filaments in a Ca(2+)- insensitive manner during cytokinesis.
BioInfer.d726.s0.p1	P	The Tetrahymena PROTEIN has two PROTEIN -binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena PROTEIN2 probably cross-links PROTEIN1 filaments in a Ca(2+)- insensitive manner during cytokinesis.
BioInfer.d726.s0.p2	N	The Tetrahymena PROTEIN has two PROTEIN2 -binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena PROTEIN probably cross-links PROTEIN1 filaments in a Ca(2+)- insensitive manner during cytokinesis.
BioInfer.d726.s0.p3	N	The Tetrahymena PROTEIN1 has two PROTEIN -binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena PROTEIN2 probably cross-links PROTEIN filaments in a Ca(2+)- insensitive manner during cytokinesis.
BioInfer.d726.s0.p4	P	The Tetrahymena PROTEIN1 has two PROTEIN2 -binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena PROTEIN probably cross-links PROTEIN filaments in a Ca(2+)- insensitive manner during cytokinesis.
BioInfer.d726.s0.p5	N	The Tetrahymena PROTEIN has two PROTEIN2 -binding domains, but lacks the EF-hand Ca(2+)-binding motif, suggesting that Tetrahymena PROTEIN1 probably cross-links PROTEIN filaments in a Ca(2+)- insensitive manner during cytokinesis.
BioInfer.d727.s0.p0	P	The PROTEIN ( PROTEIN ) and the PROTEIN receptor recruit complexes formed by the interactions between PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p1	P	The PROTEIN ( PROTEIN2 ) and the PROTEIN receptor recruit complexes formed by the interactions between PROTEIN , PROTEIN1 , PROTEIN and PROTEIN - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p2	P	The PROTEIN ( PROTEIN ) and the PROTEIN2 receptor recruit complexes formed by the interactions between PROTEIN , PROTEIN1 , PROTEIN and PROTEIN - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p3	P	The PROTEIN2 ( PROTEIN ) and the PROTEIN receptor recruit complexes formed by the interactions between PROTEIN , PROTEIN1 , PROTEIN and PROTEIN - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p4	P	The PROTEIN ( PROTEIN ) and the PROTEIN receptor recruit complexes formed by the interactions between PROTEIN2 , PROTEIN1 , PROTEIN and PROTEIN - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p5	P	The PROTEIN ( PROTEIN ) and the PROTEIN receptor recruit complexes formed by the interactions between PROTEIN , PROTEIN1 , PROTEIN2 and PROTEIN - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p6	P	The PROTEIN ( PROTEIN2 ) and the PROTEIN receptor recruit complexes formed by the interactions between PROTEIN , PROTEIN , PROTEIN and PROTEIN1 - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p7	P	The PROTEIN ( PROTEIN ) and the PROTEIN2 receptor recruit complexes formed by the interactions between PROTEIN , PROTEIN , PROTEIN and PROTEIN1 - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p8	P	The PROTEIN2 ( PROTEIN ) and the PROTEIN receptor recruit complexes formed by the interactions between PROTEIN , PROTEIN , PROTEIN and PROTEIN1 - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p9	P	The PROTEIN ( PROTEIN ) and the PROTEIN receptor recruit complexes formed by the interactions between PROTEIN2 , PROTEIN , PROTEIN and PROTEIN1 - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p10	P	The PROTEIN ( PROTEIN ) and the PROTEIN receptor recruit complexes formed by the interactions between PROTEIN , PROTEIN , PROTEIN2 and PROTEIN1 - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p11	N	The PROTEIN ( PROTEIN1 ) and the PROTEIN2 receptor recruit complexes formed by the interactions between PROTEIN , PROTEIN , PROTEIN and PROTEIN - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p12	N	The PROTEIN2 ( PROTEIN1 ) and the PROTEIN receptor recruit complexes formed by the interactions between PROTEIN , PROTEIN , PROTEIN and PROTEIN - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p13	P	The PROTEIN ( PROTEIN1 ) and the PROTEIN receptor recruit complexes formed by the interactions between PROTEIN2 , PROTEIN , PROTEIN and PROTEIN - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p14	P	The PROTEIN ( PROTEIN1 ) and the PROTEIN receptor recruit complexes formed by the interactions between PROTEIN , PROTEIN , PROTEIN2 and PROTEIN - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p15	N	The PROTEIN2 ( PROTEIN ) and the PROTEIN1 receptor recruit complexes formed by the interactions between PROTEIN , PROTEIN , PROTEIN and PROTEIN - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p16	P	The PROTEIN ( PROTEIN ) and the PROTEIN1 receptor recruit complexes formed by the interactions between PROTEIN2 , PROTEIN , PROTEIN and PROTEIN - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p17	P	The PROTEIN ( PROTEIN ) and the PROTEIN1 receptor recruit complexes formed by the interactions between PROTEIN , PROTEIN , PROTEIN2 and PROTEIN - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p18	P	The PROTEIN1 ( PROTEIN ) and the PROTEIN receptor recruit complexes formed by the interactions between PROTEIN2 , PROTEIN , PROTEIN and PROTEIN - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p19	P	The PROTEIN1 ( PROTEIN ) and the PROTEIN receptor recruit complexes formed by the interactions between PROTEIN , PROTEIN , PROTEIN2 and PROTEIN - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d727.s0.p20	P	The PROTEIN ( PROTEIN ) and the PROTEIN receptor recruit complexes formed by the interactions between PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN - adaptor proteins that contain death domains - which in turn recruit other proteins to initiate signaling [1][2][3][4][5].
BioInfer.d728.s0.p0	P	The two PROTEIN isoforms, alpha and beta, differ functionally, PROTEIN exhibits higher PROTEIN -activated PROTEIN1 than does PROTEIN2 , and hearts expressing PROTEIN exhibit increased contractility relative to hearts expressing PROTEIN .
BioInfer.d728.s0.p1	P	The two PROTEIN isoforms, alpha and beta, differ functionally, PROTEIN2 exhibits higher PROTEIN -activated PROTEIN1 than does PROTEIN , and hearts expressing PROTEIN exhibit increased contractility relative to hearts expressing PROTEIN .
BioInfer.d728.s0.p2	N	The two PROTEIN isoforms, alpha and beta, differ functionally, PROTEIN exhibits higher PROTEIN -activated PROTEIN1 than does PROTEIN , and hearts expressing PROTEIN2 exhibit increased contractility relative to hearts expressing PROTEIN .
BioInfer.d728.s0.p3	N	The two PROTEIN isoforms, alpha and beta, differ functionally, PROTEIN exhibits higher PROTEIN -activated PROTEIN1 than does PROTEIN , and hearts expressing PROTEIN exhibit increased contractility relative to hearts expressing PROTEIN2 .
BioInfer.d728.s0.p4	N	The two PROTEIN2 isoforms, alpha and beta, differ functionally, PROTEIN exhibits higher PROTEIN -activated PROTEIN1 than does PROTEIN , and hearts expressing PROTEIN exhibit increased contractility relative to hearts expressing PROTEIN .
BioInfer.d728.s0.p5	P	The two PROTEIN isoforms, alpha and beta, differ functionally, PROTEIN exhibits higher PROTEIN2 -activated PROTEIN1 than does PROTEIN , and hearts expressing PROTEIN exhibit increased contractility relative to hearts expressing PROTEIN .
BioInfer.d728.s0.p7	N	The two PROTEIN isoforms, alpha and beta, differ functionally, PROTEIN2 exhibits higher PROTEIN -activated PROTEIN than does PROTEIN1 , and hearts expressing PROTEIN exhibit increased contractility relative to hearts expressing PROTEIN .
BioInfer.d728.s0.p8	N	The two PROTEIN isoforms, alpha and beta, differ functionally, PROTEIN exhibits higher PROTEIN -activated PROTEIN than does PROTEIN1 , and hearts expressing PROTEIN2 exhibit increased contractility relative to hearts expressing PROTEIN .
BioInfer.d728.s0.p9	N	The two PROTEIN isoforms, alpha and beta, differ functionally, PROTEIN exhibits higher PROTEIN -activated PROTEIN than does PROTEIN1 , and hearts expressing PROTEIN exhibit increased contractility relative to hearts expressing PROTEIN2 .
BioInfer.d728.s0.p10	N	The two PROTEIN2 isoforms, alpha and beta, differ functionally, PROTEIN exhibits higher PROTEIN -activated PROTEIN than does PROTEIN1 , and hearts expressing PROTEIN exhibit increased contractility relative to hearts expressing PROTEIN .
BioInfer.d728.s0.p11	N	The two PROTEIN isoforms, alpha and beta, differ functionally, PROTEIN exhibits higher PROTEIN2 -activated PROTEIN than does PROTEIN1 , and hearts expressing PROTEIN exhibit increased contractility relative to hearts expressing PROTEIN .
BioInfer.d728.s0.p13	N	The two PROTEIN isoforms, alpha and beta, differ functionally, PROTEIN1 exhibits higher PROTEIN -activated PROTEIN than does PROTEIN , and hearts expressing PROTEIN2 exhibit increased contractility relative to hearts expressing PROTEIN .
BioInfer.d728.s0.p14	N	The two PROTEIN isoforms, alpha and beta, differ functionally, PROTEIN1 exhibits higher PROTEIN -activated PROTEIN than does PROTEIN , and hearts expressing PROTEIN exhibit increased contractility relative to hearts expressing PROTEIN2 .
BioInfer.d728.s0.p15	N	The two PROTEIN2 isoforms, alpha and beta, differ functionally, PROTEIN1 exhibits higher PROTEIN -activated PROTEIN than does PROTEIN , and hearts expressing PROTEIN exhibit increased contractility relative to hearts expressing PROTEIN .
BioInfer.d728.s0.p16	N	The two PROTEIN isoforms, alpha and beta, differ functionally, PROTEIN1 exhibits higher PROTEIN2 -activated PROTEIN than does PROTEIN , and hearts expressing PROTEIN exhibit increased contractility relative to hearts expressing PROTEIN .
BioInfer.d728.s0.p18	N	The two PROTEIN isoforms, alpha and beta, differ functionally, PROTEIN exhibits higher PROTEIN -activated PROTEIN than does PROTEIN , and hearts expressing PROTEIN1 exhibit increased contractility relative to hearts expressing PROTEIN2 .
BioInfer.d728.s0.p19	N	The two PROTEIN2 isoforms, alpha and beta, differ functionally, PROTEIN exhibits higher PROTEIN -activated PROTEIN than does PROTEIN , and hearts expressing PROTEIN1 exhibit increased contractility relative to hearts expressing PROTEIN .
BioInfer.d728.s0.p20	N	The two PROTEIN isoforms, alpha and beta, differ functionally, PROTEIN exhibits higher PROTEIN2 -activated PROTEIN than does PROTEIN , and hearts expressing PROTEIN1 exhibit increased contractility relative to hearts expressing PROTEIN .
BioInfer.d728.s0.p22	N	The two PROTEIN2 isoforms, alpha and beta, differ functionally, PROTEIN exhibits higher PROTEIN -activated PROTEIN than does PROTEIN , and hearts expressing PROTEIN exhibit increased contractility relative to hearts expressing PROTEIN1 .
BioInfer.d728.s0.p23	N	The two PROTEIN isoforms, alpha and beta, differ functionally, PROTEIN exhibits higher PROTEIN2 -activated PROTEIN than does PROTEIN , and hearts expressing PROTEIN exhibit increased contractility relative to hearts expressing PROTEIN1 .
BioInfer.d728.s0.p25	N	The two PROTEIN1 isoforms, alpha and beta, differ functionally, PROTEIN exhibits higher PROTEIN2 -activated PROTEIN than does PROTEIN , and hearts expressing PROTEIN exhibit increased contractility relative to hearts expressing PROTEIN .
BioInfer.d729.s0.p0	P	The two proteins were found to differ in their interaction with PROTEIN , like PROTEIN2 and PROTEIN1 isolated from porcine brain.
BioInfer.d729.s0.p1	P	The two proteins were found to differ in their interaction with PROTEIN2 , like PROTEIN and PROTEIN1 isolated from porcine brain.
BioInfer.d729.s0.p2	P	The two proteins were found to differ in their interaction with PROTEIN2 , like PROTEIN1 and PROTEIN isolated from porcine brain.
BioInfer.d730.s0.p0	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN1 stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN2 -containing focal adhesions.
BioInfer.d730.s0.p1	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN1 stress fibers on PROTEIN , whereas PROTEIN2 (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p2	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN2 or PROTEIN -containing focal adhesions or PROTEIN1 stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p3	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN1 stress fibers on PROTEIN2 , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p4	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN2 and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN1 stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p5	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN2 (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN1 stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p6	N	The undifferentiated cells (a) were unable to spread on PROTEIN2 or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN1 stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p7	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN2 (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN1 stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p8	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN2 , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN1 stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p9	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN2 -containing focal adhesions or PROTEIN1 stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p10	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN2 , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN1 stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p11	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN1 stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p12	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN2 (-/-) ES cells were able to assemble PROTEIN1 -containing focal adhesions.
BioInfer.d730.s0.p13	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN2 or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN1 -containing focal adhesions.
BioInfer.d730.s0.p14	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN2 , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN1 -containing focal adhesions.
BioInfer.d730.s0.p15	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN2 and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN1 -containing focal adhesions.
BioInfer.d730.s0.p16	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN2 (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN1 -containing focal adhesions.
BioInfer.d730.s0.p17	N	The undifferentiated cells (a) were unable to spread on PROTEIN2 or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN1 -containing focal adhesions.
BioInfer.d730.s0.p18	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN2 (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN1 -containing focal adhesions.
BioInfer.d730.s0.p19	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN2 , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN1 -containing focal adhesions.
BioInfer.d730.s0.p20	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN2 -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN1 -containing focal adhesions.
BioInfer.d730.s0.p21	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN2 , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN1 -containing focal adhesions.
BioInfer.d730.s0.p22	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN1 -containing focal adhesions.
BioInfer.d730.s0.p23	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN2 or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN1 (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p24	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN2 , whereas PROTEIN1 (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p25	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN2 and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN1 (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p26	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN2 (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN1 (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p27	N	The undifferentiated cells (a) were unable to spread on PROTEIN2 or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN1 (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p28	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN2 (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN1 (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p29	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN2 , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN1 (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p30	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN2 -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN1 (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p31	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN2 , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN1 (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p32	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN1 (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p33	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN1 or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN2 , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p34	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN2 and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN1 or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p35	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN2 (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN1 or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p36	N	The undifferentiated cells (a) were unable to spread on PROTEIN2 or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN1 or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p37	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN2 (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN1 or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p38	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN2 , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN1 or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p39	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN1 or PROTEIN2 -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p40	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN2 , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN1 or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p41	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble PROTEIN1 or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p42	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN2 and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN1 , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p43	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN2 (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN1 , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p44	N	The undifferentiated cells (a) were unable to spread on PROTEIN2 or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN1 , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p45	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN2 (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN1 , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p46	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN2 , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN1 , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p47	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN2 -containing focal adhesions or PROTEIN stress fibers on PROTEIN1 , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p48	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN2 , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN1 , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p49	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN1 , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p50	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN1 and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN2 (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p51	N	The undifferentiated cells (a) were unable to spread on PROTEIN2 or PROTEIN1 and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p52	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN1 and grew as rounded colonies, although they were able to spread on PROTEIN2 (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p53	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN1 and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN2 , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p54	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN1 and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN2 -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p55	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN1 and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN2 , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p56	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN1 and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p57	N	The undifferentiated cells (a) were unable to spread on PROTEIN2 or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN1 (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p58	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN2 (b) showed reduced adhesion to PROTEIN , but not PROTEIN1 (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p59	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN1 (c) expressed much reduced levels of PROTEIN2 , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p60	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN1 (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN2 -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p61	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN2 , but not PROTEIN1 (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p62	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN1 (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p63	N	The undifferentiated cells (a) were unable to spread on PROTEIN1 or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN2 (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p64	N	The undifferentiated cells (a) were unable to spread on PROTEIN1 or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN2 , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p65	N	The undifferentiated cells (a) were unable to spread on PROTEIN1 or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN2 -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p66	N	The undifferentiated cells (a) were unable to spread on PROTEIN1 or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN2 , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p67	N	The undifferentiated cells (a) were unable to spread on PROTEIN1 or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p68	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN1 (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN2 , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p69	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN1 (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN2 -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p70	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN1 (b) showed reduced adhesion to PROTEIN2 , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p71	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN1 (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p72	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN1 , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN2 -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p73	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN2 , but not PROTEIN (c) expressed much reduced levels of PROTEIN1 , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p74	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN1 , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p75	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN2 , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN1 -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p76	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN1 -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d730.s0.p77	N	The undifferentiated cells (a) were unable to spread on PROTEIN or PROTEIN and grew as rounded colonies, although they were able to spread on PROTEIN (b) showed reduced adhesion to PROTEIN1 , but not PROTEIN (c) expressed much reduced levels of PROTEIN , although levels of alpha5 and alphaV were wild-type (d) were less polarized with increased membrane protrusions compared with a PROTEIN2 (-/-) ES cell mutant (e) were unable to assemble PROTEIN or PROTEIN -containing focal adhesions or PROTEIN stress fibers on PROTEIN , whereas PROTEIN (-/-) ES cells were able to assemble PROTEIN -containing focal adhesions.
BioInfer.d731.s0.p0	N	The vaccinia virus PROTEIN1 gene product, PROTEIN , is a dsRNA binding protein that prevents activation of the PROTEIN -induced, dsRNA-activated PROTEIN2 , PROTEIN .
BioInfer.d731.s0.p1	N	The vaccinia virus PROTEIN1 gene product, PROTEIN2 , is a dsRNA binding protein that prevents activation of the PROTEIN -induced, dsRNA-activated PROTEIN , PROTEIN .
BioInfer.d731.s0.p2	N	The vaccinia virus PROTEIN1 gene product, PROTEIN , is a dsRNA binding protein that prevents activation of the PROTEIN2 -induced, dsRNA-activated PROTEIN , PROTEIN .
BioInfer.d731.s0.p3	P	The vaccinia virus PROTEIN1 gene product, PROTEIN , is a dsRNA binding protein that prevents activation of the PROTEIN -induced, dsRNA-activated PROTEIN , PROTEIN2 .
BioInfer.d731.s0.p4	N	The vaccinia virus PROTEIN gene product, PROTEIN2 , is a dsRNA binding protein that prevents activation of the PROTEIN -induced, dsRNA-activated PROTEIN1 , PROTEIN .
BioInfer.d731.s0.p5	N	The vaccinia virus PROTEIN gene product, PROTEIN , is a dsRNA binding protein that prevents activation of the PROTEIN2 -induced, dsRNA-activated PROTEIN1 , PROTEIN .
BioInfer.d731.s0.p6	P	The vaccinia virus PROTEIN gene product, PROTEIN , is a dsRNA binding protein that prevents activation of the PROTEIN -induced, dsRNA-activated PROTEIN1 , PROTEIN2 .
BioInfer.d731.s0.p7	N	The vaccinia virus PROTEIN gene product, PROTEIN1 , is a dsRNA binding protein that prevents activation of the PROTEIN2 -induced, dsRNA-activated PROTEIN , PROTEIN .
BioInfer.d731.s0.p8	P	The vaccinia virus PROTEIN gene product, PROTEIN1 , is a dsRNA binding protein that prevents activation of the PROTEIN -induced, dsRNA-activated PROTEIN , PROTEIN2 .
BioInfer.d731.s0.p9	P	The vaccinia virus PROTEIN gene product, PROTEIN , is a dsRNA binding protein that prevents activation of the PROTEIN1 -induced, dsRNA-activated PROTEIN , PROTEIN2 .
BioInfer.d732.s0.p0	P	The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) PROTEIN2 ( PROTEIN ) and PROTEIN1 ( PROTEIN ).
BioInfer.d732.s0.p1	P	The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) PROTEIN ( PROTEIN2 ) and PROTEIN1 ( PROTEIN ).
BioInfer.d732.s0.p2	N	The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) PROTEIN ( PROTEIN ) and PROTEIN1 ( PROTEIN2 ).
BioInfer.d732.s0.p3	N	The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) PROTEIN1 ( PROTEIN2 ) and PROTEIN ( PROTEIN ).
BioInfer.d732.s0.p4	P	The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) PROTEIN1 ( PROTEIN ) and PROTEIN ( PROTEIN2 ).
BioInfer.d732.s0.p5	P	The yeast two-hybrid system was used to identify domains involved in specific in vivo interactions between the Rinderpest virus (RPV) PROTEIN ( PROTEIN1 ) and PROTEIN ( PROTEIN2 ).
BioInfer.d733.s0.p0	N	They exhibited strong synergistic increases in PROTEIN duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes PROTEIN2 , PROTEIN , and PROTEIN1 for viability.
BioInfer.d733.s0.p1	N	They exhibited strong synergistic increases in PROTEIN duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes PROTEIN , PROTEIN2 , and PROTEIN1 for viability.
BioInfer.d733.s0.p2	N	They exhibited strong synergistic increases in PROTEIN2 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes PROTEIN , PROTEIN , and PROTEIN1 for viability.
BioInfer.d733.s0.p3	N	They exhibited strong synergistic increases in PROTEIN duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes PROTEIN1 , PROTEIN2 , and PROTEIN for viability.
BioInfer.d733.s0.p4	N	They exhibited strong synergistic increases in PROTEIN2 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes PROTEIN1 , PROTEIN , and PROTEIN for viability.
BioInfer.d733.s0.p5	N	They exhibited strong synergistic increases in PROTEIN2 duplication mutations, intrachromosomal and interchromosomal recombination, and required the wild-type double-strand break repair genes PROTEIN , PROTEIN1 , and PROTEIN for viability.
BioInfer.d734.s0.p0	N	They had altered adhesive properties as measured by their ability to bind to a PROTEIN -coated glass surface, suggesting that the expression of a PROTEIN alters the assembly of PROTEIN1 receptors, PROTEIN and cytoskeletal proteins such as PROTEIN and PROTEIN2 .
BioInfer.d734.s0.p1	N	They had altered adhesive properties as measured by their ability to bind to a PROTEIN -coated glass surface, suggesting that the expression of a PROTEIN alters the assembly of PROTEIN1 receptors, PROTEIN and cytoskeletal proteins such as PROTEIN2 and PROTEIN .
BioInfer.d734.s0.p2	N	They had altered adhesive properties as measured by their ability to bind to a PROTEIN2 -coated glass surface, suggesting that the expression of a PROTEIN alters the assembly of PROTEIN1 receptors, PROTEIN and cytoskeletal proteins such as PROTEIN and PROTEIN .
BioInfer.d734.s0.p3	P	They had altered adhesive properties as measured by their ability to bind to a PROTEIN -coated glass surface, suggesting that the expression of a PROTEIN2 alters the assembly of PROTEIN1 receptors, PROTEIN and cytoskeletal proteins such as PROTEIN and PROTEIN .
BioInfer.d734.s0.p4	N	They had altered adhesive properties as measured by their ability to bind to a PROTEIN -coated glass surface, suggesting that the expression of a PROTEIN alters the assembly of PROTEIN1 receptors, PROTEIN2 and cytoskeletal proteins such as PROTEIN and PROTEIN .
BioInfer.d734.s0.p5	N	They had altered adhesive properties as measured by their ability to bind to a PROTEIN -coated glass surface, suggesting that the expression of a PROTEIN alters the assembly of PROTEIN receptors, PROTEIN and cytoskeletal proteins such as PROTEIN2 and PROTEIN1 .
BioInfer.d734.s0.p6	N	They had altered adhesive properties as measured by their ability to bind to a PROTEIN2 -coated glass surface, suggesting that the expression of a PROTEIN alters the assembly of PROTEIN receptors, PROTEIN and cytoskeletal proteins such as PROTEIN and PROTEIN1 .
BioInfer.d734.s0.p7	P	They had altered adhesive properties as measured by their ability to bind to a PROTEIN -coated glass surface, suggesting that the expression of a PROTEIN2 alters the assembly of PROTEIN receptors, PROTEIN and cytoskeletal proteins such as PROTEIN and PROTEIN1 .
BioInfer.d734.s0.p8	N	They had altered adhesive properties as measured by their ability to bind to a PROTEIN -coated glass surface, suggesting that the expression of a PROTEIN alters the assembly of PROTEIN receptors, PROTEIN2 and cytoskeletal proteins such as PROTEIN and PROTEIN1 .
BioInfer.d734.s0.p9	N	They had altered adhesive properties as measured by their ability to bind to a PROTEIN2 -coated glass surface, suggesting that the expression of a PROTEIN alters the assembly of PROTEIN receptors, PROTEIN and cytoskeletal proteins such as PROTEIN1 and PROTEIN .
BioInfer.d734.s0.p10	P	They had altered adhesive properties as measured by their ability to bind to a PROTEIN -coated glass surface, suggesting that the expression of a PROTEIN2 alters the assembly of PROTEIN receptors, PROTEIN and cytoskeletal proteins such as PROTEIN1 and PROTEIN .
BioInfer.d734.s0.p11	N	They had altered adhesive properties as measured by their ability to bind to a PROTEIN -coated glass surface, suggesting that the expression of a PROTEIN alters the assembly of PROTEIN receptors, PROTEIN2 and cytoskeletal proteins such as PROTEIN1 and PROTEIN .
BioInfer.d734.s0.p12	N	They had altered adhesive properties as measured by their ability to bind to a PROTEIN1 -coated glass surface, suggesting that the expression of a PROTEIN2 alters the assembly of PROTEIN receptors, PROTEIN and cytoskeletal proteins such as PROTEIN and PROTEIN .
BioInfer.d734.s0.p13	N	They had altered adhesive properties as measured by their ability to bind to a PROTEIN1 -coated glass surface, suggesting that the expression of a PROTEIN alters the assembly of PROTEIN receptors, PROTEIN2 and cytoskeletal proteins such as PROTEIN and PROTEIN .
BioInfer.d734.s0.p14	P	They had altered adhesive properties as measured by their ability to bind to a PROTEIN -coated glass surface, suggesting that the expression of a PROTEIN1 alters the assembly of PROTEIN receptors, PROTEIN2 and cytoskeletal proteins such as PROTEIN and PROTEIN .
BioInfer.d735.s0.p0	N	This activity is independent of PROTEIN 's ability to bind to three known interacting proteins, PROTEIN , PROTEIN or PROTEIN1 suggesting that it is distinct from PROTEIN2 's functions at activated PROTEIN .
BioInfer.d735.s0.p1	P	This activity is independent of PROTEIN 's ability to bind to three known interacting proteins, PROTEIN2 , PROTEIN or PROTEIN1 suggesting that it is distinct from PROTEIN 's functions at activated PROTEIN .
BioInfer.d735.s0.p2	P	This activity is independent of PROTEIN2 's ability to bind to three known interacting proteins, PROTEIN , PROTEIN or PROTEIN1 suggesting that it is distinct from PROTEIN 's functions at activated PROTEIN .
BioInfer.d735.s0.p3	N	This activity is independent of PROTEIN 's ability to bind to three known interacting proteins, PROTEIN , PROTEIN or PROTEIN1 suggesting that it is distinct from PROTEIN 's functions at activated PROTEIN2 .
BioInfer.d735.s0.p4	P	This activity is independent of PROTEIN 's ability to bind to three known interacting proteins, PROTEIN , PROTEIN2 or PROTEIN1 suggesting that it is distinct from PROTEIN 's functions at activated PROTEIN .
BioInfer.d735.s0.p5	N	This activity is independent of PROTEIN 's ability to bind to three known interacting proteins, PROTEIN2 , PROTEIN or PROTEIN suggesting that it is distinct from PROTEIN1 's functions at activated PROTEIN .
BioInfer.d735.s0.p6	N	This activity is independent of PROTEIN2 's ability to bind to three known interacting proteins, PROTEIN , PROTEIN or PROTEIN suggesting that it is distinct from PROTEIN1 's functions at activated PROTEIN .
BioInfer.d735.s0.p7	P	This activity is independent of PROTEIN 's ability to bind to three known interacting proteins, PROTEIN , PROTEIN or PROTEIN suggesting that it is distinct from PROTEIN1 's functions at activated PROTEIN2 .
BioInfer.d735.s0.p8	N	This activity is independent of PROTEIN 's ability to bind to three known interacting proteins, PROTEIN , PROTEIN2 or PROTEIN suggesting that it is distinct from PROTEIN1 's functions at activated PROTEIN .
BioInfer.d735.s0.p9	P	This activity is independent of PROTEIN2 's ability to bind to three known interacting proteins, PROTEIN1 , PROTEIN or PROTEIN suggesting that it is distinct from PROTEIN 's functions at activated PROTEIN .
BioInfer.d735.s0.p10	N	This activity is independent of PROTEIN 's ability to bind to three known interacting proteins, PROTEIN1 , PROTEIN or PROTEIN suggesting that it is distinct from PROTEIN 's functions at activated PROTEIN2 .
BioInfer.d735.s0.p11	P	This activity is independent of PROTEIN 's ability to bind to three known interacting proteins, PROTEIN1 , PROTEIN2 or PROTEIN suggesting that it is distinct from PROTEIN 's functions at activated PROTEIN .
BioInfer.d735.s0.p12	N	This activity is independent of PROTEIN1 's ability to bind to three known interacting proteins, PROTEIN , PROTEIN or PROTEIN suggesting that it is distinct from PROTEIN 's functions at activated PROTEIN2 .
BioInfer.d735.s0.p13	P	This activity is independent of PROTEIN1 's ability to bind to three known interacting proteins, PROTEIN , PROTEIN2 or PROTEIN suggesting that it is distinct from PROTEIN 's functions at activated PROTEIN .
BioInfer.d735.s0.p14	N	This activity is independent of PROTEIN 's ability to bind to three known interacting proteins, PROTEIN , PROTEIN2 or PROTEIN suggesting that it is distinct from PROTEIN 's functions at activated PROTEIN1 .
BioInfer.d736.s0.p0	N	This approach is based on the assumption that an PROTEIN2 mutation that specifically impairs the interaction with an PROTEIN will cause a phenotype similar to a null mutation in the gene that encodes the PROTEIN1 .
BioInfer.d736.s0.p1	N	This approach is based on the assumption that an PROTEIN mutation that specifically impairs the interaction with an PROTEIN2 will cause a phenotype similar to a null mutation in the gene that encodes the PROTEIN1 .
BioInfer.d736.s0.p2	P	This approach is based on the assumption that an PROTEIN1 mutation that specifically impairs the interaction with an PROTEIN2 will cause a phenotype similar to a null mutation in the gene that encodes the PROTEIN .
BioInfer.d736.s1.p0	N	21 PROTEIN2 mutations were analyzed in budding yeast, and specific regions of PROTEIN1 subdomain 1 were implicated in the interaction with PROTEIN , an PROTEIN filament-bundling protein.
BioInfer.d736.s1.p1	N	21 PROTEIN mutations were analyzed in budding yeast, and specific regions of PROTEIN1 subdomain 1 were implicated in the interaction with PROTEIN , an PROTEIN2 filament-bundling protein.
BioInfer.d736.s1.p2	P	21 PROTEIN mutations were analyzed in budding yeast, and specific regions of PROTEIN1 subdomain 1 were implicated in the interaction with PROTEIN2 , an PROTEIN filament-bundling protein.
BioInfer.d736.s1.p3	N	21 PROTEIN1 mutations were analyzed in budding yeast, and specific regions of PROTEIN subdomain 1 were implicated in the interaction with PROTEIN , an PROTEIN2 filament-bundling protein.
BioInfer.d736.s1.p4	N	21 PROTEIN1 mutations were analyzed in budding yeast, and specific regions of PROTEIN subdomain 1 were implicated in the interaction with PROTEIN2 , an PROTEIN filament-bundling protein.
BioInfer.d736.s1.p5	P	21 PROTEIN mutations were analyzed in budding yeast, and specific regions of PROTEIN subdomain 1 were implicated in the interaction with PROTEIN2 , an PROTEIN1 filament-bundling protein.
BioInfer.d737.s0.p0	N	This arrest can be suppressed by mutations in PROTEIN , PROTEIN , and PROTEIN , suggesting that the cell cycle defect in PROTEIN1  PROTEIN2 mutants results from inappropriate homologous recombination.
BioInfer.d737.s0.p1	N	This arrest can be suppressed by mutations in PROTEIN , PROTEIN2 , and PROTEIN , suggesting that the cell cycle defect in PROTEIN1  PROTEIN mutants results from inappropriate homologous recombination.
BioInfer.d737.s0.p2	N	This arrest can be suppressed by mutations in PROTEIN , PROTEIN , and PROTEIN2 , suggesting that the cell cycle defect in PROTEIN1  PROTEIN mutants results from inappropriate homologous recombination.
BioInfer.d737.s0.p3	N	This arrest can be suppressed by mutations in PROTEIN2 , PROTEIN , and PROTEIN , suggesting that the cell cycle defect in PROTEIN1  PROTEIN mutants results from inappropriate homologous recombination.
BioInfer.d737.s0.p4	N	This arrest can be suppressed by mutations in PROTEIN , PROTEIN2 , and PROTEIN , suggesting that the cell cycle defect in PROTEIN  PROTEIN1 mutants results from inappropriate homologous recombination.
BioInfer.d737.s0.p5	N	This arrest can be suppressed by mutations in PROTEIN , PROTEIN , and PROTEIN2 , suggesting that the cell cycle defect in PROTEIN  PROTEIN1 mutants results from inappropriate homologous recombination.
BioInfer.d737.s0.p6	N	This arrest can be suppressed by mutations in PROTEIN2 , PROTEIN , and PROTEIN , suggesting that the cell cycle defect in PROTEIN  PROTEIN1 mutants results from inappropriate homologous recombination.
BioInfer.d737.s0.p7	N	This arrest can be suppressed by mutations in PROTEIN , PROTEIN1 , and PROTEIN2 , suggesting that the cell cycle defect in PROTEIN  PROTEIN mutants results from inappropriate homologous recombination.
BioInfer.d737.s0.p8	N	This arrest can be suppressed by mutations in PROTEIN2 , PROTEIN1 , and PROTEIN , suggesting that the cell cycle defect in PROTEIN  PROTEIN mutants results from inappropriate homologous recombination.
BioInfer.d737.s0.p9	N	This arrest can be suppressed by mutations in PROTEIN2 , PROTEIN , and PROTEIN1 , suggesting that the cell cycle defect in PROTEIN  PROTEIN mutants results from inappropriate homologous recombination.
BioInfer.d738.s0.p0	P	This PROTEIN1 - PROTEIN2 complex plays an indispensable role in construction of ordered multicellular structures such as polarized epithelium.
BioInfer.d738.s1.p0	P	PROTEIN and PROTEIN2 possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified PROTEIN1 activities.
BioInfer.d738.s1.p1	P	PROTEIN2 and PROTEIN possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified PROTEIN1 activities.
BioInfer.d738.s1.p2	N	PROTEIN2 and PROTEIN1 possibly play more regulatory roles, as it was shown that their tyrosine phosphorylation correlated with modified PROTEIN activities.
BioInfer.d739.s0.p0	P	This filament growth is driven by a large storage pool of PROTEIN1 bound to the sequestering protein, PROTEIN2 .
BioInfer.d740.s0.p0	P	This is consistent with PROTEIN1 activation being required for PROTEIN2 reorganization during exocytosis.
BioInfer.d741.s0.p0	N	This is the first report describing the coexistence of PROTEIN with PROTEIN1 filaments in the division furrow, implying the possible involvement of PROTEIN2 in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.
BioInfer.d741.s0.p1	P	This is the first report describing the coexistence of PROTEIN2 with PROTEIN1 filaments in the division furrow, implying the possible involvement of PROTEIN in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.
BioInfer.d741.s0.p2	N	This is the first report describing the coexistence of PROTEIN2 with PROTEIN filaments in the division furrow, implying the possible involvement of PROTEIN1 in assembly and disassembly of contractile ring microfilaments in the process of cytokinesis.
BioInfer.d742.s0.p0	P	This novel mutation was predicted to disrupt the binding of PROTEIN2 to PROTEIN1 and may be related to the diffuse type morphology.
BioInfer.d743.s0.p0	P	This paper describes the structural and biochemical characterization of PROTEIN1 , a protein localized to various cellular sites where bundles of PROTEIN2 filaments attach to the plasma membrane.
BioInfer.d744.s0.p0	P	This process involves other PROTEIN2 , such as PROTEIN and PROTEIN1 .
BioInfer.d744.s0.p1	N	This process involves other PROTEIN , such as PROTEIN2 and PROTEIN1 .
BioInfer.d744.s0.p2	P	This process involves other PROTEIN1 , such as PROTEIN2 and PROTEIN .
BioInfer.d745.s0.p1	N	This result was supported by a high protein expression of the PROTEIN  PROTEIN1 in 44% of the tumours with high PROTEIN2 and low D1 expression, and all immunohistochemical PROTEIN defect tumours showed a high PROTEIN protein level.
BioInfer.d745.s0.p2	N	This result was supported by a high protein expression of the PROTEIN  PROTEIN1 in 44% of the tumours with high PROTEIN and low D1 expression, and all immunohistochemical PROTEIN defect tumours showed a high PROTEIN2 protein level.
BioInfer.d745.s0.p3	N	This result was supported by a high protein expression of the PROTEIN  PROTEIN1 in 44% of the tumours with high PROTEIN and low D1 expression, and all immunohistochemical PROTEIN2 defect tumours showed a high PROTEIN protein level.
BioInfer.d745.s0.p4	P	This result was supported by a high protein expression of the PROTEIN2  PROTEIN1 in 44% of the tumours with high PROTEIN and low D1 expression, and all immunohistochemical PROTEIN defect tumours showed a high PROTEIN protein level.
BioInfer.d745.s0.p9	N	This result was supported by a high protein expression of the PROTEIN  PROTEIN in 44% of the tumours with high PROTEIN1 and low D1 expression, and all immunohistochemical PROTEIN defect tumours showed a high PROTEIN2 protein level.
BioInfer.d745.s0.p10	N	This result was supported by a high protein expression of the PROTEIN  PROTEIN in 44% of the tumours with high PROTEIN1 and low D1 expression, and all immunohistochemical PROTEIN2 defect tumours showed a high PROTEIN protein level.
BioInfer.d745.s0.p11	N	This result was supported by a high protein expression of the PROTEIN2  PROTEIN in 44% of the tumours with high PROTEIN1 and low D1 expression, and all immunohistochemical PROTEIN defect tumours showed a high PROTEIN protein level.
BioInfer.d745.s0.p12	N	This result was supported by a high protein expression of the PROTEIN  PROTEIN in 44% of the tumours with high PROTEIN and low D1 expression, and all immunohistochemical PROTEIN2 defect tumours showed a high PROTEIN1 protein level.
BioInfer.d745.s0.p13	N	This result was supported by a high protein expression of the PROTEIN2  PROTEIN in 44% of the tumours with high PROTEIN and low D1 expression, and all immunohistochemical PROTEIN defect tumours showed a high PROTEIN1 protein level.
BioInfer.d745.s0.p14	N	This result was supported by a high protein expression of the PROTEIN2  PROTEIN in 44% of the tumours with high PROTEIN and low D1 expression, and all immunohistochemical PROTEIN1 defect tumours showed a high PROTEIN protein level.
BioInfer.d746.s0.p0	P	This shows that structural changes in the poly(L-proline)-binding region of PROTEIN2 can affect the distantly located PROTEIN1 -binding site.
BioInfer.d747.s0.p0	P	This technique was employed to quantify changes caused by the lack of PROTEIN , a protein that couples the PROTEIN network to the plasma membrane, or by the lack of PROTEIN2 or II, two isoforms of the PROTEIN -bundling protein PROTEIN1 .
BioInfer.d747.s0.p1	N	This technique was employed to quantify changes caused by the lack of PROTEIN2 , a protein that couples the PROTEIN network to the plasma membrane, or by the lack of PROTEIN or II, two isoforms of the PROTEIN -bundling protein PROTEIN1 .
BioInfer.d747.s0.p3	P	This technique was employed to quantify changes caused by the lack of PROTEIN , a protein that couples the PROTEIN network to the plasma membrane, or by the lack of PROTEIN or II, two isoforms of the PROTEIN2 -bundling protein PROTEIN1 .
BioInfer.d747.s0.p4	N	This technique was employed to quantify changes caused by the lack of PROTEIN , a protein that couples the PROTEIN2 network to the plasma membrane, or by the lack of PROTEIN or II, two isoforms of the PROTEIN -bundling protein PROTEIN1 .
BioInfer.d747.s0.p5	N	This technique was employed to quantify changes caused by the lack of PROTEIN2 , a protein that couples the PROTEIN network to the plasma membrane, or by the lack of PROTEIN1 or II, two isoforms of the PROTEIN -bundling protein PROTEIN .
BioInfer.d747.s0.p7	N	This technique was employed to quantify changes caused by the lack of PROTEIN , a protein that couples the PROTEIN network to the plasma membrane, or by the lack of PROTEIN1 or II, two isoforms of the PROTEIN2 -bundling protein PROTEIN .
BioInfer.d747.s0.p8	N	This technique was employed to quantify changes caused by the lack of PROTEIN , a protein that couples the PROTEIN2 network to the plasma membrane, or by the lack of PROTEIN1 or II, two isoforms of the PROTEIN -bundling protein PROTEIN .
BioInfer.d747.s0.p10	N	This technique was employed to quantify changes caused by the lack of PROTEIN1 , a protein that couples the PROTEIN network to the plasma membrane, or by the lack of PROTEIN or II, two isoforms of the PROTEIN2 -bundling protein PROTEIN .
BioInfer.d747.s0.p11	P	This technique was employed to quantify changes caused by the lack of PROTEIN1 , a protein that couples the PROTEIN2 network to the plasma membrane, or by the lack of PROTEIN or II, two isoforms of the PROTEIN -bundling protein PROTEIN .
BioInfer.d747.s0.p14	N	This technique was employed to quantify changes caused by the lack of PROTEIN , a protein that couples the PROTEIN2 network to the plasma membrane, or by the lack of PROTEIN or II, two isoforms of the PROTEIN1 -bundling protein PROTEIN .
BioInfer.d748.s0.p0	N	Those observations were extended to include a spatiotemporal immunohistochemical analyses of PROTEIN2 and PROTEIN , as well as a more detailed study of PROTEIN1 , during segmentation, compaction, and compartmentalization of the somite.
BioInfer.d748.s0.p1	N	Those observations were extended to include a spatiotemporal immunohistochemical analyses of PROTEIN and PROTEIN2 , as well as a more detailed study of PROTEIN1 , during segmentation, compaction, and compartmentalization of the somite.
BioInfer.d748.s0.p2	N	Those observations were extended to include a spatiotemporal immunohistochemical analyses of PROTEIN1 and PROTEIN2 , as well as a more detailed study of PROTEIN , during segmentation, compaction, and compartmentalization of the somite.
BioInfer.d749.s0.p0	N	Three PROTEIN -associated proteins, PROTEIN2 , PROTEIN1 , and PROTEIN , influence gelation, solation, and polymerization, respectively, of PROTEIN in vitro.
BioInfer.d749.s0.p1	P	Three PROTEIN2 -associated proteins, PROTEIN , PROTEIN1 , and PROTEIN , influence gelation, solation, and polymerization, respectively, of PROTEIN in vitro.
BioInfer.d749.s0.p2	N	Three PROTEIN -associated proteins, PROTEIN , PROTEIN1 , and PROTEIN , influence gelation, solation, and polymerization, respectively, of PROTEIN2 in vitro.
BioInfer.d749.s0.p3	N	Three PROTEIN -associated proteins, PROTEIN , PROTEIN1 , and PROTEIN2 , influence gelation, solation, and polymerization, respectively, of PROTEIN in vitro.
BioInfer.d749.s0.p4	P	Three PROTEIN2 -associated proteins, PROTEIN1 , PROTEIN , and PROTEIN , influence gelation, solation, and polymerization, respectively, of PROTEIN in vitro.
BioInfer.d749.s0.p5	N	Three PROTEIN -associated proteins, PROTEIN1 , PROTEIN , and PROTEIN , influence gelation, solation, and polymerization, respectively, of PROTEIN2 in vitro.
BioInfer.d749.s0.p6	N	Three PROTEIN -associated proteins, PROTEIN1 , PROTEIN , and PROTEIN2 , influence gelation, solation, and polymerization, respectively, of PROTEIN in vitro.
BioInfer.d749.s0.p7	N	Three PROTEIN1 -associated proteins, PROTEIN , PROTEIN , and PROTEIN , influence gelation, solation, and polymerization, respectively, of PROTEIN2 in vitro.
BioInfer.d749.s0.p8	P	Three PROTEIN1 -associated proteins, PROTEIN , PROTEIN , and PROTEIN2 , influence gelation, solation, and polymerization, respectively, of PROTEIN in vitro.
BioInfer.d749.s0.p9	P	Three PROTEIN -associated proteins, PROTEIN , PROTEIN , and PROTEIN2 , influence gelation, solation, and polymerization, respectively, of PROTEIN1 in vitro.
BioInfer.d750.s0.p0	N	Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: PROTEIN2 (homolog of PROTEIN ), Drosophila PROTEIN1 ( PROTEIN ), and PROTEIN .
BioInfer.d750.s0.p1	N	Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: PROTEIN (homolog of PROTEIN ), Drosophila PROTEIN1 ( PROTEIN ), and PROTEIN2 .
BioInfer.d750.s0.p2	N	Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: PROTEIN (homolog of PROTEIN2 ), Drosophila PROTEIN1 ( PROTEIN ), and PROTEIN .
BioInfer.d750.s0.p3	N	Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: PROTEIN (homolog of PROTEIN ), Drosophila PROTEIN1 ( PROTEIN2 ), and PROTEIN .
BioInfer.d750.s0.p4	N	Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: PROTEIN1 (homolog of PROTEIN ), Drosophila PROTEIN ( PROTEIN ), and PROTEIN2 .
BioInfer.d750.s0.p5	P	Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: PROTEIN1 (homolog of PROTEIN2 ), Drosophila PROTEIN ( PROTEIN ), and PROTEIN .
BioInfer.d750.s0.p6	N	Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: PROTEIN1 (homolog of PROTEIN ), Drosophila PROTEIN ( PROTEIN2 ), and PROTEIN .
BioInfer.d750.s0.p7	N	Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: PROTEIN (homolog of PROTEIN2 ), Drosophila PROTEIN ( PROTEIN ), and PROTEIN1 .
BioInfer.d750.s0.p8	N	Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: PROTEIN (homolog of PROTEIN ), Drosophila PROTEIN ( PROTEIN2 ), and PROTEIN1 .
BioInfer.d750.s0.p9	N	Three components of Drosophila adherens junctions, analogous to those in vertebrates, have been identified: PROTEIN (homolog of PROTEIN1 ), Drosophila PROTEIN ( PROTEIN2 ), and PROTEIN .
BioInfer.d751.s0.p0	N	Thus, PROTEIN was found in association with PROTEIN1 in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in PROTEIN2 , did not reveal PROTEIN .
BioInfer.d751.s0.p1	P	Thus, PROTEIN2 was found in association with PROTEIN1 in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in PROTEIN , did not reveal PROTEIN .
BioInfer.d751.s0.p2	N	Thus, PROTEIN was found in association with PROTEIN1 in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in PROTEIN , did not reveal PROTEIN2 .
BioInfer.d751.s0.p3	N	Thus, PROTEIN2 was found in association with PROTEIN in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in PROTEIN1 , did not reveal PROTEIN .
BioInfer.d751.s0.p4	N	Thus, PROTEIN was found in association with PROTEIN in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in PROTEIN1 , did not reveal PROTEIN2 .
BioInfer.d751.s0.p5	N	Thus, PROTEIN1 was found in association with PROTEIN in the mechanoreceptive region of hair cells, whereas supporting cells, although rich in PROTEIN , did not reveal PROTEIN2 .
BioInfer.d752.s0.p0	N	Thus, PROTEIN2 , PROTEIN , and PROTEIN1 have similar prognostic values.
BioInfer.d752.s0.p1	N	Thus, PROTEIN , PROTEIN2 , and PROTEIN1 have similar prognostic values.
BioInfer.d752.s0.p2	N	Thus, PROTEIN1 , PROTEIN2 , and PROTEIN have similar prognostic values.
BioInfer.d753.s0.p0	P	Thus, PROTEIN2 and PROTEIN1 expression are not co-regulated in all cells.
BioInfer.d754.s0.p0	P	Thus, it is likely that the both PROTEIN1 isoforms are involved in the regulation of PROTEIN2 assembly during myofibrillogenesis.
BioInfer.d755.s0.p0	N	Thus, PROTEIN contains an NH(2)-terminal domain homologous to that implicated in PROTEIN2 's endocytic function, three predicted coiled-coils, a leucine zipper, and a PROTEIN -like PROTEIN1 -binding domain at the COOH terminus.
BioInfer.d755.s0.p1	N	Thus, PROTEIN contains an NH(2)-terminal domain homologous to that implicated in PROTEIN 's endocytic function, three predicted coiled-coils, a leucine zipper, and a PROTEIN2 -like PROTEIN1 -binding domain at the COOH terminus.
BioInfer.d755.s0.p2	P	Thus, PROTEIN2 contains an NH(2)-terminal domain homologous to that implicated in PROTEIN 's endocytic function, three predicted coiled-coils, a leucine zipper, and a PROTEIN -like PROTEIN1 -binding domain at the COOH terminus.
BioInfer.d755.s0.p3	N	Thus, PROTEIN contains an NH(2)-terminal domain homologous to that implicated in PROTEIN1 's endocytic function, three predicted coiled-coils, a leucine zipper, and a PROTEIN2 -like PROTEIN -binding domain at the COOH terminus.
BioInfer.d755.s0.p4	P	Thus, PROTEIN2 contains an NH(2)-terminal domain homologous to that implicated in PROTEIN1 's endocytic function, three predicted coiled-coils, a leucine zipper, and a PROTEIN -like PROTEIN -binding domain at the COOH terminus.
BioInfer.d755.s0.p5	P	Thus, PROTEIN2 contains an NH(2)-terminal domain homologous to that implicated in PROTEIN 's endocytic function, three predicted coiled-coils, a leucine zipper, and a PROTEIN1 -like PROTEIN -binding domain at the COOH terminus.
BioInfer.d756.s0.p0	N	Thus, poly-L-proline binding, PROTEIN1 binding, and PROTEIN2 nucleotide exchange are each independent requirements for PROTEIN function in fission yeast.
BioInfer.d756.s0.p1	P	Thus, poly-L-proline binding, PROTEIN1 binding, and PROTEIN nucleotide exchange are each independent requirements for PROTEIN2 function in fission yeast.
BioInfer.d756.s0.p2	P	Thus, poly-L-proline binding, PROTEIN binding, and PROTEIN1 nucleotide exchange are each independent requirements for PROTEIN2 function in fission yeast.
BioInfer.d757.s0.p0	P	Thus, the PROTEIN1 -binding dodecapeptide sequence of PROTEIN2 may constitute a multifunctional domain in PROTEIN .
BioInfer.d757.s0.p1	N	Thus, the PROTEIN1 -binding dodecapeptide sequence of PROTEIN may constitute a multifunctional domain in PROTEIN2 .
BioInfer.d757.s0.p2	N	Thus, the PROTEIN -binding dodecapeptide sequence of PROTEIN1 may constitute a multifunctional domain in PROTEIN2 .
BioInfer.d757.s1.p0	P	We have previously shown that the synthetic dodecapeptide corresponding to Trp104-Met115 of PROTEIN1 is a potent inhibitor of PROTEIN2 polymerization (Yonezawa, N., Nishida, E., Iida, K., Kumagai, H., Yahara, I., and Sakai, H. (1991) J. Biol. Chem. 266, 10485-10489).
BioInfer.d758.s0.p0	N	PROTEIN1 also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as PROTEIN and PROTEIN2 .
BioInfer.d758.s0.p1	N	PROTEIN1 also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as PROTEIN2 and PROTEIN .
BioInfer.d758.s0.p2	N	PROTEIN also inhibited muscle differentiation as measured by several parameters, including cell fusion and the expression of other muscle-specific genes, such as PROTEIN2 and PROTEIN1 .
BioInfer.d759.s0.p0	N	To approach the problem, we have constructed a carp genomic library and isolated 28 nonoverlapping clones containing sequences of different PROTEIN ( PROTEIN2 ) isoforms along with a clone containing carp PROTEIN1 sequences.
BioInfer.d759.s0.p1	N	To approach the problem, we have constructed a carp genomic library and isolated 28 nonoverlapping clones containing sequences of different PROTEIN2 ( PROTEIN ) isoforms along with a clone containing carp PROTEIN1 sequences.
BioInfer.d759.s0.p2	N	To approach the problem, we have constructed a carp genomic library and isolated 28 nonoverlapping clones containing sequences of different PROTEIN2 ( PROTEIN1 ) isoforms along with a clone containing carp PROTEIN sequences.
BioInfer.d760.s0.p0	N	To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN ) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
BioInfer.d760.s0.p1	N	To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN ) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
BioInfer.d760.s0.p2	N	To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN ) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
BioInfer.d760.s0.p3	N	To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 ) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
BioInfer.d760.s0.p4	N	To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN ) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
BioInfer.d760.s0.p5	N	To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN ) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
BioInfer.d760.s0.p6	N	To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN ) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
BioInfer.d760.s0.p7	N	To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 ) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
BioInfer.d760.s0.p8	N	To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN ) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
BioInfer.d760.s0.p9	N	To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN ) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
BioInfer.d760.s0.p10	N	To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 ) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
BioInfer.d760.s0.p11	N	To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN ) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
BioInfer.d760.s0.p12	N	To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 ) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
BioInfer.d760.s0.p13	N	To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN ) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
BioInfer.d760.s0.p14	N	To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 ) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).
BioInfer.d761.s0.p0	N	To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of PROTEIN , PROTEIN , and PROTEIN2 ( PROTEIN ) in PROTEIN1 nephropathy.
BioInfer.d761.s0.p1	N	To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of PROTEIN2 , PROTEIN , and PROTEIN ( PROTEIN ) in PROTEIN1 nephropathy.
BioInfer.d761.s0.p2	N	To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of PROTEIN , PROTEIN , and PROTEIN ( PROTEIN2 ) in PROTEIN1 nephropathy.
BioInfer.d761.s0.p3	N	To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of PROTEIN , PROTEIN2 , and PROTEIN ( PROTEIN ) in PROTEIN1 nephropathy.
BioInfer.d761.s0.p4	N	To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of PROTEIN2 , PROTEIN , and PROTEIN1 ( PROTEIN ) in PROTEIN nephropathy.
BioInfer.d761.s0.p5	N	To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of PROTEIN , PROTEIN , and PROTEIN1 ( PROTEIN2 ) in PROTEIN nephropathy.
BioInfer.d761.s0.p6	N	To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of PROTEIN , PROTEIN2 , and PROTEIN1 ( PROTEIN ) in PROTEIN nephropathy.
BioInfer.d761.s0.p7	N	To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of PROTEIN1 , PROTEIN , and PROTEIN ( PROTEIN2 ) in PROTEIN nephropathy.
BioInfer.d761.s0.p8	N	To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of PROTEIN1 , PROTEIN2 , and PROTEIN ( PROTEIN ) in PROTEIN nephropathy.
BioInfer.d761.s0.p9	N	To characterize the phenotypic alteration in mesangial cells in human glomerulonephritis, we investigated the expression of PROTEIN , PROTEIN2 , and PROTEIN ( PROTEIN1 ) in PROTEIN nephropathy.
BioInfer.d762.s0.p0	N	To check its applicability, well characterized, commercially available antibodies (against PROTEIN , PROTEIN1 , and PROTEIN2 ) were used on sections of human small intestine.
BioInfer.d762.s0.p1	N	To check its applicability, well characterized, commercially available antibodies (against PROTEIN2 , PROTEIN1 , and PROTEIN ) were used on sections of human small intestine.
BioInfer.d762.s0.p2	N	To check its applicability, well characterized, commercially available antibodies (against PROTEIN2 , PROTEIN , and PROTEIN1 ) were used on sections of human small intestine.
BioInfer.d763.s0.p0	N	To clarify the relation between alteration of expression of PROTEIN and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , with additional reverse transcription- PROTEIN2 chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
BioInfer.d763.s0.p1	N	To clarify the relation between alteration of expression of PROTEIN and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 , with additional reverse transcription- PROTEIN chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
BioInfer.d763.s0.p2	N	To clarify the relation between alteration of expression of PROTEIN2 and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , with additional reverse transcription- PROTEIN chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
BioInfer.d763.s0.p3	N	To clarify the relation between alteration of expression of PROTEIN and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 , with additional reverse transcription- PROTEIN chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
BioInfer.d763.s0.p4	N	To clarify the relation between alteration of expression of PROTEIN and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 , with additional reverse transcription- PROTEIN chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
BioInfer.d763.s0.p5	N	To clarify the relation between alteration of expression of PROTEIN and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , with additional reverse transcription- PROTEIN1 chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
BioInfer.d763.s0.p6	N	To clarify the relation between alteration of expression of PROTEIN2 and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN , PROTEIN , PROTEIN , and PROTEIN , with additional reverse transcription- PROTEIN1 chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
BioInfer.d763.s0.p7	N	To clarify the relation between alteration of expression of PROTEIN and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , with additional reverse transcription- PROTEIN1 chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
BioInfer.d763.s0.p8	N	To clarify the relation between alteration of expression of PROTEIN and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , with additional reverse transcription- PROTEIN1 chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
BioInfer.d763.s0.p9	N	To clarify the relation between alteration of expression of PROTEIN2 and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , with additional reverse transcription- PROTEIN chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
BioInfer.d763.s0.p10	N	To clarify the relation between alteration of expression of PROTEIN and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN , with additional reverse transcription- PROTEIN chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
BioInfer.d763.s0.p11	N	To clarify the relation between alteration of expression of PROTEIN and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN , with additional reverse transcription- PROTEIN chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
BioInfer.d763.s0.p12	N	To clarify the relation between alteration of expression of PROTEIN1 and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , with additional reverse transcription- PROTEIN chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
BioInfer.d763.s0.p13	N	To clarify the relation between alteration of expression of PROTEIN1 and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , with additional reverse transcription- PROTEIN chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
BioInfer.d763.s0.p14	N	To clarify the relation between alteration of expression of PROTEIN and progression of extrahepatic bile duct carcinomas 55 cases were immunohistochemically examined for PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN , with additional reverse transcription- PROTEIN chain reaction and Southern blotting hybridization (RT-PCR/SBH) assays.
BioInfer.d764.s0.p0	N	To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti PROTEIN antibodies, PROTEIN1 and PROTEIN , and two anti- PROTEIN markers, anti- PROTEIN2 and anti- PROTEIN antibodies and related antibodies.
BioInfer.d764.s0.p1	N	To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti PROTEIN antibodies, PROTEIN1 and PROTEIN , and two anti- PROTEIN2 markers, anti- PROTEIN and anti- PROTEIN antibodies and related antibodies.
BioInfer.d764.s0.p2	N	To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti PROTEIN antibodies, PROTEIN1 and PROTEIN , and two anti- PROTEIN markers, anti- PROTEIN and anti- PROTEIN2 antibodies and related antibodies.
BioInfer.d764.s0.p3	N	To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti PROTEIN antibodies, PROTEIN1 and PROTEIN2 , and two anti- PROTEIN markers, anti- PROTEIN and anti- PROTEIN antibodies and related antibodies.
BioInfer.d764.s0.p4	P	To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti PROTEIN2 antibodies, PROTEIN1 and PROTEIN , and two anti- PROTEIN markers, anti- PROTEIN and anti- PROTEIN antibodies and related antibodies.
BioInfer.d764.s0.p5	N	To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti PROTEIN antibodies, PROTEIN and PROTEIN , and two anti- PROTEIN2 markers, anti- PROTEIN1 and anti- PROTEIN antibodies and related antibodies.
BioInfer.d764.s0.p6	N	To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti PROTEIN antibodies, PROTEIN and PROTEIN , and two anti- PROTEIN markers, anti- PROTEIN1 and anti- PROTEIN2 antibodies and related antibodies.
BioInfer.d764.s0.p7	N	To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti PROTEIN antibodies, PROTEIN and PROTEIN2 , and two anti- PROTEIN markers, anti- PROTEIN1 and anti- PROTEIN antibodies and related antibodies.
BioInfer.d764.s0.p8	N	To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti PROTEIN2 antibodies, PROTEIN and PROTEIN , and two anti- PROTEIN markers, anti- PROTEIN1 and anti- PROTEIN antibodies and related antibodies.
BioInfer.d764.s0.p9	N	To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti PROTEIN antibodies, PROTEIN and PROTEIN , and two anti- PROTEIN1 markers, anti- PROTEIN and anti- PROTEIN2 antibodies and related antibodies.
BioInfer.d764.s0.p10	N	To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti PROTEIN antibodies, PROTEIN and PROTEIN2 , and two anti- PROTEIN1 markers, anti- PROTEIN and anti- PROTEIN antibodies and related antibodies.
BioInfer.d764.s0.p11	N	To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti PROTEIN2 antibodies, PROTEIN and PROTEIN , and two anti- PROTEIN1 markers, anti- PROTEIN and anti- PROTEIN antibodies and related antibodies.
BioInfer.d764.s0.p12	N	To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti PROTEIN antibodies, PROTEIN and PROTEIN2 , and two anti- PROTEIN markers, anti- PROTEIN and anti- PROTEIN1 antibodies and related antibodies.
BioInfer.d764.s0.p13	N	To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti PROTEIN2 antibodies, PROTEIN and PROTEIN , and two anti- PROTEIN markers, anti- PROTEIN and anti- PROTEIN1 antibodies and related antibodies.
BioInfer.d764.s0.p14	P	To determine the phenotypes of smooth muscle cells (SMCs) in such lesions, the authors conducted an immunohistochemical analysis of lung tissues from two patients with PPH, using two anti PROTEIN2 antibodies, PROTEIN and PROTEIN1 , and two anti- PROTEIN markers, anti- PROTEIN and anti- PROTEIN antibodies and related antibodies.
BioInfer.d765.s0.p0	P	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN , PROTEIN , PROTEIN , the PROTEIN ( PROTEIN2 ) PROTEIN1 and PROTEIN , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p1	P	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN , PROTEIN , PROTEIN , the PROTEIN2 ( PROTEIN ) PROTEIN1 and PROTEIN , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p2	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN , PROTEIN , PROTEIN2 , the PROTEIN ( PROTEIN ) PROTEIN1 and PROTEIN , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p3	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN2 , PROTEIN , PROTEIN , the PROTEIN ( PROTEIN ) PROTEIN1 and PROTEIN , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p4	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN , PROTEIN2 , PROTEIN , the PROTEIN ( PROTEIN ) PROTEIN1 and PROTEIN , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p5	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN , PROTEIN , PROTEIN , the PROTEIN ( PROTEIN ) PROTEIN1 and PROTEIN2 , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p6	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN , PROTEIN , PROTEIN , the PROTEIN2 ( PROTEIN1 ) PROTEIN and PROTEIN , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p7	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN , PROTEIN , PROTEIN2 , the PROTEIN ( PROTEIN1 ) PROTEIN and PROTEIN , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p8	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN2 , PROTEIN , PROTEIN , the PROTEIN ( PROTEIN1 ) PROTEIN and PROTEIN , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p9	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN , PROTEIN2 , PROTEIN , the PROTEIN ( PROTEIN1 ) PROTEIN and PROTEIN , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p10	P	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN , PROTEIN , PROTEIN , the PROTEIN ( PROTEIN1 ) PROTEIN and PROTEIN2 , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p11	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN , PROTEIN , PROTEIN2 , the PROTEIN1 ( PROTEIN ) PROTEIN and PROTEIN , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p12	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN2 , PROTEIN , PROTEIN , the PROTEIN1 ( PROTEIN ) PROTEIN and PROTEIN , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p13	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN , PROTEIN2 , PROTEIN , the PROTEIN1 ( PROTEIN ) PROTEIN and PROTEIN , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p14	P	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN , PROTEIN , PROTEIN , the PROTEIN1 ( PROTEIN ) PROTEIN and PROTEIN2 , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p15	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN2 , PROTEIN , PROTEIN1 , the PROTEIN ( PROTEIN ) PROTEIN and PROTEIN , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p16	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN , PROTEIN2 , PROTEIN1 , the PROTEIN ( PROTEIN ) PROTEIN and PROTEIN , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p17	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN , PROTEIN , PROTEIN1 , the PROTEIN ( PROTEIN ) PROTEIN and PROTEIN2 , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p18	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN1 , PROTEIN2 , PROTEIN , the PROTEIN ( PROTEIN ) PROTEIN and PROTEIN , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p19	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN1 , PROTEIN , PROTEIN , the PROTEIN ( PROTEIN ) PROTEIN and PROTEIN2 , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d765.s0.p20	N	To determine the relationship between cell cycle regulation and differentiation, the spatiotemporal expression of PROTEIN , PROTEIN1 , PROTEIN , the PROTEIN ( PROTEIN ) PROTEIN and PROTEIN2 , and markers of differentiating podocytes in developing human kidneys was investigated by immunohistochemistry.
BioInfer.d766.s0.p4	N	To determine the relative importance of protein degradation in the development of starvation-induced cardiac atrophy, in vivo fractional synthetic rates of total cardiac protein, PROTEIN2 , PROTEIN1 , light chain 1, and light chain 2 were measured in fed and fasted rabbits by continuous infusion of [3H] leucine.
BioInfer.d767.s0.p0	N	To determine whether alpha 1-adrenergic stimulation produced similar effects on the turnover of myofibrillar proteins, rates of synthesis and degradation were estimated for a myofibrillar-enriched protein fraction and for PROTEIN1 and PROTEIN2 .
BioInfer.d768.s0.p0	P	Together these results indicate that PROTEIN1 regulates PROTEIN2 gene expression through an PROTEIN site and its cognate transcription factor PROTEIN , and requires the involvement of PROTEIN .
BioInfer.d768.s0.p1	P	Together these results indicate that PROTEIN1 regulates PROTEIN gene expression through an PROTEIN site and its cognate transcription factor PROTEIN2 , and requires the involvement of PROTEIN .
BioInfer.d768.s0.p2	P	Together these results indicate that PROTEIN1 regulates PROTEIN gene expression through an PROTEIN2 site and its cognate transcription factor PROTEIN , and requires the involvement of PROTEIN .
BioInfer.d768.s0.p3	P	Together these results indicate that PROTEIN1 regulates PROTEIN gene expression through an PROTEIN site and its cognate transcription factor PROTEIN , and requires the involvement of PROTEIN2 .
BioInfer.d768.s0.p4	P	Together these results indicate that PROTEIN regulates PROTEIN1 gene expression through an PROTEIN site and its cognate transcription factor PROTEIN2 , and requires the involvement of PROTEIN .
BioInfer.d768.s0.p5	P	Together these results indicate that PROTEIN regulates PROTEIN1 gene expression through an PROTEIN2 site and its cognate transcription factor PROTEIN , and requires the involvement of PROTEIN .
BioInfer.d768.s0.p6	N	Together these results indicate that PROTEIN regulates PROTEIN1 gene expression through an PROTEIN site and its cognate transcription factor PROTEIN , and requires the involvement of PROTEIN2 .
BioInfer.d768.s0.p7	P	Together these results indicate that PROTEIN regulates PROTEIN gene expression through an PROTEIN2 site and its cognate transcription factor PROTEIN1 , and requires the involvement of PROTEIN .
BioInfer.d768.s0.p8	N	Together these results indicate that PROTEIN regulates PROTEIN gene expression through an PROTEIN site and its cognate transcription factor PROTEIN1 , and requires the involvement of PROTEIN2 .
BioInfer.d768.s0.p9	N	Together these results indicate that PROTEIN regulates PROTEIN gene expression through an PROTEIN1 site and its cognate transcription factor PROTEIN , and requires the involvement of PROTEIN2 .
BioInfer.d769.s0.p0	N	To improve our ability to study these proteins, we have expressed PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN in insect cells by using the baculovirus expression system.
BioInfer.d769.s0.p1	N	To improve our ability to study these proteins, we have expressed PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN in insect cells by using the baculovirus expression system.
BioInfer.d769.s0.p2	N	To improve our ability to study these proteins, we have expressed PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 in insect cells by using the baculovirus expression system.
BioInfer.d769.s0.p3	N	To improve our ability to study these proteins, we have expressed PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN in insect cells by using the baculovirus expression system.
BioInfer.d769.s0.p4	N	To improve our ability to study these proteins, we have expressed PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 in insect cells by using the baculovirus expression system.
BioInfer.d769.s0.p5	N	To improve our ability to study these proteins, we have expressed PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 in insect cells by using the baculovirus expression system.
BioInfer.d769.s1.p0	N	Various immunological assays suggest that four of these proteins ( PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 ) are made in infected cells in very low abundance relative to the other three.
BioInfer.d769.s1.p1	N	Various immunological assays suggest that four of these proteins ( PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 ) are made in infected cells in very low abundance relative to the other three.
BioInfer.d769.s1.p2	N	Various immunological assays suggest that four of these proteins ( PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 ) are made in infected cells in very low abundance relative to the other three.
BioInfer.d769.s1.p3	N	Various immunological assays suggest that four of these proteins ( PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN ) are made in infected cells in very low abundance relative to the other three.
BioInfer.d769.s1.p4	N	Various immunological assays suggest that four of these proteins ( PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN ) are made in infected cells in very low abundance relative to the other three.
BioInfer.d769.s1.p5	N	Various immunological assays suggest that four of these proteins ( PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN ) are made in infected cells in very low abundance relative to the other three.
BioInfer.d770.s0.p0	N	Total PROTEIN2 and PROTEIN1 mRNAs, and polyadenylated RNA, were determined using slot-blot assays.
BioInfer.d771.s0.p0	N	Total protein, PROTEIN ( PROTEIN2 ), and PROTEIN1 appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.
BioInfer.d771.s0.p1	N	Total protein, PROTEIN2 ( PROTEIN ), and PROTEIN1 appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.
BioInfer.d771.s0.p2	N	Total protein, PROTEIN2 ( PROTEIN1 ), and PROTEIN appeared unchanged with SVT cardiomyopathy at the LV or myocyte level.
BioInfer.d772.s0.p0	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p1	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p2	P	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN2 -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p3	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p4	N	Transcriptional expression of PROTEIN2 ( PROTEIN ), as well as that of PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p5	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p6	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p7	N	Transcriptional expression of PROTEIN ( PROTEIN2 ), as well as that of PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p8	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p9	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p10	P	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN2 -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p11	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p12	N	Transcriptional expression of PROTEIN2 ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p13	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p14	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p15	N	Transcriptional expression of PROTEIN ( PROTEIN2 ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p16	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p17	P	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN2 -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p18	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p19	N	Transcriptional expression of PROTEIN2 ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p20	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p21	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p22	N	Transcriptional expression of PROTEIN ( PROTEIN2 ), as well as that of PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p23	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p24	P	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN1 -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p25	P	Transcriptional expression of PROTEIN2 ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN1 -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p26	P	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN1 -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p27	P	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN1 -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p28	P	Transcriptional expression of PROTEIN ( PROTEIN2 ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN1 -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p29	P	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to PROTEIN1 -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p30	N	Transcriptional expression of PROTEIN2 ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p31	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p32	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p33	N	Transcriptional expression of PROTEIN ( PROTEIN2 ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p34	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p35	N	Transcriptional expression of PROTEIN1 ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p36	N	Transcriptional expression of PROTEIN1 ( PROTEIN ), as well as that of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p37	N	Transcriptional expression of PROTEIN1 ( PROTEIN2 ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p38	N	Transcriptional expression of PROTEIN1 ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p39	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p40	N	Transcriptional expression of PROTEIN ( PROTEIN2 ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p41	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p42	N	Transcriptional expression of PROTEIN ( PROTEIN2 ), as well as that of PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p43	N	Transcriptional expression of PROTEIN ( PROTEIN ), as well as that of PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d772.s0.p44	N	Transcriptional expression of PROTEIN ( PROTEIN1 ), as well as that of PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 was similar in these cell lines, indicating that the susceptibility to PROTEIN -induced apoptosis may not be determined by the constitutive expression level of these factors.
BioInfer.d773.s0.p0	P	Transcriptional regulation in the galactose regulon of yeast is determined by an interplay between a positive regulatory protein, PROTEIN1 , and a negative regulatory protein, PROTEIN2 .
BioInfer.d774.s0.p0	N	Transfection of PROTEIN2 -deficient colon carcinoma cells recruited PROTEIN and PROTEIN1 to cell-cell contacts and functional PROTEIN -mediated cell-cell adhesion was restored in this way.
BioInfer.d774.s0.p1	N	Transfection of PROTEIN -deficient colon carcinoma cells recruited PROTEIN and PROTEIN1 to cell-cell contacts and functional PROTEIN2 -mediated cell-cell adhesion was restored in this way.
BioInfer.d774.s0.p2	N	Transfection of PROTEIN -deficient colon carcinoma cells recruited PROTEIN2 and PROTEIN1 to cell-cell contacts and functional PROTEIN -mediated cell-cell adhesion was restored in this way.
BioInfer.d774.s0.p3	N	Transfection of PROTEIN1 -deficient colon carcinoma cells recruited PROTEIN and PROTEIN to cell-cell contacts and functional PROTEIN2 -mediated cell-cell adhesion was restored in this way.
BioInfer.d774.s0.p4	N	Transfection of PROTEIN1 -deficient colon carcinoma cells recruited PROTEIN2 and PROTEIN to cell-cell contacts and functional PROTEIN -mediated cell-cell adhesion was restored in this way.
BioInfer.d774.s0.p5	N	Transfection of PROTEIN -deficient colon carcinoma cells recruited PROTEIN2 and PROTEIN to cell-cell contacts and functional PROTEIN1 -mediated cell-cell adhesion was restored in this way.
BioInfer.d775.s0.p0	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ) and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN1 gave rise to PROTEIN activity and progeny with the minigenome.
BioInfer.d775.s0.p1	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN1 gave rise to PROTEIN2 activity and progeny with the minigenome.
BioInfer.d775.s0.p2	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN1 gave rise to PROTEIN activity and progeny with the minigenome.
BioInfer.d775.s0.p3	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN1 gave rise to PROTEIN activity and progeny with the minigenome.
BioInfer.d775.s0.p4	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN2 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN1 gave rise to PROTEIN activity and progeny with the minigenome.
BioInfer.d775.s0.p5	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN1 gave rise to PROTEIN activity and progeny with the minigenome.
BioInfer.d775.s0.p6	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ) and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN2 activity and progeny with the minigenome.
BioInfer.d775.s0.p7	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN1 ) and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.
BioInfer.d775.s0.p8	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN1 ) and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.
BioInfer.d775.s0.p9	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ) and PROTEIN2 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.
BioInfer.d775.s0.p10	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN1 ) and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.
BioInfer.d775.s0.p11	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ) and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN1 activity and progeny with the minigenome.
BioInfer.d775.s0.p12	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ) and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN1 activity and progeny with the minigenome.
BioInfer.d775.s0.p13	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN2 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN1 activity and progeny with the minigenome.
BioInfer.d775.s0.p14	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN1 activity and progeny with the minigenome.
BioInfer.d775.s0.p15	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN1 ), PROTEIN2 ( PROTEIN ) and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.
BioInfer.d775.s0.p16	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ) and PROTEIN2 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.
BioInfer.d775.s0.p17	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN2 ( PROTEIN1 ), PROTEIN ( PROTEIN ) and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.
BioInfer.d775.s0.p18	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ) and PROTEIN2 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.
BioInfer.d775.s0.p19	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN2 ( PROTEIN ), PROTEIN1 ( PROTEIN ) and PROTEIN protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.
BioInfer.d775.s0.p20	N	Transfection of plasmids encoding the BRSV minigenome, PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ) and PROTEIN1 protein, each under the control of T7 promoter, into cells infected with a vaccinia virus recombinant expressing the T7 PROTEIN gave rise to PROTEIN activity and progeny with the minigenome.
BioInfer.d776.s0.p0	N	Treatment of cells with gamma linolenic acid (GLA) increased PROTEIN expression in most cell lines, while PROTEIN1 levels were reduced, and PROTEIN2 expression was unchanged.
BioInfer.d776.s0.p1	N	Treatment of cells with gamma linolenic acid (GLA) increased PROTEIN2 expression in most cell lines, while PROTEIN1 levels were reduced, and PROTEIN expression was unchanged.
BioInfer.d776.s0.p2	N	Treatment of cells with gamma linolenic acid (GLA) increased PROTEIN2 expression in most cell lines, while PROTEIN levels were reduced, and PROTEIN1 expression was unchanged.
BioInfer.d777.s0.p0	N	Treatment with HNE resulted in activation of PROTEIN  PROTEIN1 and PROTEIN2 , induction of PROTEIN and PROTEIN protein expression, and an increase in transcription factor PROTEIN DNA binding activity.
BioInfer.d777.s0.p1	N	Treatment with HNE resulted in activation of PROTEIN  PROTEIN1 and PROTEIN , induction of PROTEIN and PROTEIN protein expression, and an increase in transcription factor PROTEIN2 DNA binding activity.
BioInfer.d777.s0.p2	N	Treatment with HNE resulted in activation of PROTEIN  PROTEIN1 and PROTEIN , induction of PROTEIN and PROTEIN2 protein expression, and an increase in transcription factor PROTEIN DNA binding activity.
BioInfer.d777.s0.p3	N	Treatment with HNE resulted in activation of PROTEIN  PROTEIN1 and PROTEIN , induction of PROTEIN2 and PROTEIN protein expression, and an increase in transcription factor PROTEIN DNA binding activity.
BioInfer.d777.s0.p4	P	Treatment with HNE resulted in activation of PROTEIN2  PROTEIN1 and PROTEIN , induction of PROTEIN and PROTEIN protein expression, and an increase in transcription factor PROTEIN DNA binding activity.
BioInfer.d777.s0.p5	N	Treatment with HNE resulted in activation of PROTEIN  PROTEIN and PROTEIN1 , induction of PROTEIN and PROTEIN protein expression, and an increase in transcription factor PROTEIN2 DNA binding activity.
BioInfer.d777.s0.p6	N	Treatment with HNE resulted in activation of PROTEIN  PROTEIN and PROTEIN1 , induction of PROTEIN and PROTEIN2 protein expression, and an increase in transcription factor PROTEIN DNA binding activity.
BioInfer.d777.s0.p7	N	Treatment with HNE resulted in activation of PROTEIN  PROTEIN and PROTEIN1 , induction of PROTEIN2 and PROTEIN protein expression, and an increase in transcription factor PROTEIN DNA binding activity.
BioInfer.d777.s0.p8	P	Treatment with HNE resulted in activation of PROTEIN2  PROTEIN and PROTEIN1 , induction of PROTEIN and PROTEIN protein expression, and an increase in transcription factor PROTEIN DNA binding activity.
BioInfer.d777.s0.p9	N	Treatment with HNE resulted in activation of PROTEIN  PROTEIN and PROTEIN , induction of PROTEIN and PROTEIN2 protein expression, and an increase in transcription factor PROTEIN1 DNA binding activity.
BioInfer.d777.s0.p10	N	Treatment with HNE resulted in activation of PROTEIN  PROTEIN and PROTEIN , induction of PROTEIN2 and PROTEIN protein expression, and an increase in transcription factor PROTEIN1 DNA binding activity.
BioInfer.d777.s0.p11	N	Treatment with HNE resulted in activation of PROTEIN2  PROTEIN and PROTEIN , induction of PROTEIN and PROTEIN protein expression, and an increase in transcription factor PROTEIN1 DNA binding activity.
BioInfer.d777.s0.p12	N	Treatment with HNE resulted in activation of PROTEIN  PROTEIN and PROTEIN , induction of PROTEIN2 and PROTEIN1 protein expression, and an increase in transcription factor PROTEIN DNA binding activity.
BioInfer.d777.s0.p13	N	Treatment with HNE resulted in activation of PROTEIN2  PROTEIN and PROTEIN , induction of PROTEIN and PROTEIN1 protein expression, and an increase in transcription factor PROTEIN DNA binding activity.
BioInfer.d777.s0.p14	N	Treatment with HNE resulted in activation of PROTEIN2  PROTEIN and PROTEIN , induction of PROTEIN1 and PROTEIN protein expression, and an increase in transcription factor PROTEIN DNA binding activity.
BioInfer.d778.s0.p0	P	Two PROTEIN , PROTEIN1 and PROTEIN2 , are associated with Hirano bodies.
BioInfer.d778.s0.p1	P	Two PROTEIN2 , PROTEIN1 and PROTEIN , are associated with Hirano bodies.
BioInfer.d778.s0.p2	P	Two PROTEIN2 , PROTEIN and PROTEIN1 , are associated with Hirano bodies.
BioInfer.d779.s0.p0	N	Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick PROTEIN and 66% identical to chick PROTEIN1 ( PROTEIN2 ), two structurally and functionally related proteins.
BioInfer.d779.s0.p1	P	Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick PROTEIN2 and 66% identical to chick PROTEIN1 ( PROTEIN ), two structurally and functionally related proteins.
BioInfer.d779.s0.p2	P	Two cDNAs, isolated from a Xenopus laevis embryonic library, encode proteins of 168 amino acids, both of which are 77% identical to chick PROTEIN2 and 66% identical to chick PROTEIN ( PROTEIN1 ), two structurally and functionally related proteins.
BioInfer.d780.s0.p0	N	Two isoforms of PROTEIN ( PROTEIN2 ) are generated by alternative splicing; PROTEIN1 differs from PROTEIN by the insertion of B2 exon cassette near the PROTEIN binding region.
BioInfer.d780.s0.p1	N	Two isoforms of PROTEIN2 ( PROTEIN ) are generated by alternative splicing; PROTEIN1 differs from PROTEIN by the insertion of B2 exon cassette near the PROTEIN binding region.
BioInfer.d780.s0.p2	P	Two isoforms of PROTEIN ( PROTEIN ) are generated by alternative splicing; PROTEIN1 differs from PROTEIN2 by the insertion of B2 exon cassette near the PROTEIN binding region.
BioInfer.d780.s0.p3	P	Two isoforms of PROTEIN ( PROTEIN ) are generated by alternative splicing; PROTEIN1 differs from PROTEIN by the insertion of B2 exon cassette near the PROTEIN2 binding region.
BioInfer.d780.s0.p4	N	Two isoforms of PROTEIN2 ( PROTEIN1 ) are generated by alternative splicing; PROTEIN differs from PROTEIN by the insertion of B2 exon cassette near the PROTEIN binding region.
BioInfer.d780.s0.p5	N	Two isoforms of PROTEIN ( PROTEIN1 ) are generated by alternative splicing; PROTEIN differs from PROTEIN2 by the insertion of B2 exon cassette near the PROTEIN binding region.
BioInfer.d780.s0.p6	N	Two isoforms of PROTEIN ( PROTEIN1 ) are generated by alternative splicing; PROTEIN differs from PROTEIN by the insertion of B2 exon cassette near the PROTEIN2 binding region.
BioInfer.d780.s0.p7	N	Two isoforms of PROTEIN1 ( PROTEIN ) are generated by alternative splicing; PROTEIN differs from PROTEIN2 by the insertion of B2 exon cassette near the PROTEIN binding region.
BioInfer.d780.s0.p8	N	Two isoforms of PROTEIN1 ( PROTEIN ) are generated by alternative splicing; PROTEIN differs from PROTEIN by the insertion of B2 exon cassette near the PROTEIN2 binding region.
BioInfer.d780.s0.p9	P	Two isoforms of PROTEIN ( PROTEIN ) are generated by alternative splicing; PROTEIN differs from PROTEIN1 by the insertion of B2 exon cassette near the PROTEIN2 binding region.
BioInfer.d781.s0.p0	N	Under all conditions, platelets retained 40-50% of their total PROTEIN and greater than 70% of their PROTEIN ( PROTEIN2 ) but lost greater than 80% of PROTEIN and PROTEIN1 to the supernatant.
BioInfer.d781.s0.p1	N	Under all conditions, platelets retained 40-50% of their total PROTEIN and greater than 70% of their PROTEIN2 ( PROTEIN ) but lost greater than 80% of PROTEIN and PROTEIN1 to the supernatant.
BioInfer.d781.s0.p2	N	Under all conditions, platelets retained 40-50% of their total PROTEIN and greater than 70% of their PROTEIN ( PROTEIN ) but lost greater than 80% of PROTEIN2 and PROTEIN1 to the supernatant.
BioInfer.d781.s0.p3	N	Under all conditions, platelets retained 40-50% of their total PROTEIN2 and greater than 70% of their PROTEIN ( PROTEIN ) but lost greater than 80% of PROTEIN and PROTEIN1 to the supernatant.
BioInfer.d781.s0.p4	N	Under all conditions, platelets retained 40-50% of their total PROTEIN and greater than 70% of their PROTEIN2 ( PROTEIN1 ) but lost greater than 80% of PROTEIN and PROTEIN to the supernatant.
BioInfer.d781.s0.p5	N	Under all conditions, platelets retained 40-50% of their total PROTEIN and greater than 70% of their PROTEIN ( PROTEIN1 ) but lost greater than 80% of PROTEIN2 and PROTEIN to the supernatant.
BioInfer.d781.s0.p6	N	Under all conditions, platelets retained 40-50% of their total PROTEIN2 and greater than 70% of their PROTEIN ( PROTEIN1 ) but lost greater than 80% of PROTEIN and PROTEIN to the supernatant.
BioInfer.d781.s0.p7	N	Under all conditions, platelets retained 40-50% of their total PROTEIN and greater than 70% of their PROTEIN1 ( PROTEIN ) but lost greater than 80% of PROTEIN2 and PROTEIN to the supernatant.
BioInfer.d781.s0.p8	N	Under all conditions, platelets retained 40-50% of their total PROTEIN2 and greater than 70% of their PROTEIN1 ( PROTEIN ) but lost greater than 80% of PROTEIN and PROTEIN to the supernatant.
BioInfer.d781.s0.p9	N	Under all conditions, platelets retained 40-50% of their total PROTEIN2 and greater than 70% of their PROTEIN ( PROTEIN ) but lost greater than 80% of PROTEIN1 and PROTEIN to the supernatant.
BioInfer.d782.s0.p0	N	Unexpectedly, treatment with the PROTEIN -depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN  PROTEIN2 and PROTEIN1 also did not exhibit medial PROTEIN - PROTEIN staining.
BioInfer.d782.s0.p1	N	Unexpectedly, treatment with the PROTEIN -depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN  PROTEIN and PROTEIN1 also did not exhibit medial PROTEIN - PROTEIN2 staining.
BioInfer.d782.s0.p2	N	Unexpectedly, treatment with the PROTEIN2 -depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN  PROTEIN and PROTEIN1 also did not exhibit medial PROTEIN - PROTEIN staining.
BioInfer.d782.s0.p3	N	Unexpectedly, treatment with the PROTEIN -depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN  PROTEIN and PROTEIN1 also did not exhibit medial PROTEIN2 - PROTEIN staining.
BioInfer.d782.s0.p4	P	Unexpectedly, treatment with the PROTEIN -depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN2  PROTEIN and PROTEIN1 also did not exhibit medial PROTEIN - PROTEIN staining.
BioInfer.d782.s0.p5	N	Unexpectedly, treatment with the PROTEIN -depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN  PROTEIN1 and PROTEIN also did not exhibit medial PROTEIN - PROTEIN2 staining.
BioInfer.d782.s0.p6	N	Unexpectedly, treatment with the PROTEIN2 -depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN  PROTEIN1 and PROTEIN also did not exhibit medial PROTEIN - PROTEIN staining.
BioInfer.d782.s0.p7	N	Unexpectedly, treatment with the PROTEIN -depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN  PROTEIN1 and PROTEIN also did not exhibit medial PROTEIN2 - PROTEIN staining.
BioInfer.d782.s0.p8	P	Unexpectedly, treatment with the PROTEIN -depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN2  PROTEIN1 and PROTEIN also did not exhibit medial PROTEIN - PROTEIN staining.
BioInfer.d782.s0.p9	N	Unexpectedly, treatment with the PROTEIN2 -depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN  PROTEIN and PROTEIN also did not exhibit medial PROTEIN - PROTEIN1 staining.
BioInfer.d782.s0.p10	P	Unexpectedly, treatment with the PROTEIN -depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN  PROTEIN and PROTEIN also did not exhibit medial PROTEIN2 - PROTEIN1 staining.
BioInfer.d782.s0.p11	N	Unexpectedly, treatment with the PROTEIN -depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN2  PROTEIN and PROTEIN also did not exhibit medial PROTEIN - PROTEIN1 staining.
BioInfer.d782.s0.p12	N	Unexpectedly, treatment with the PROTEIN1 -depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN  PROTEIN and PROTEIN also did not exhibit medial PROTEIN2 - PROTEIN staining.
BioInfer.d782.s0.p13	N	Unexpectedly, treatment with the PROTEIN1 -depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN2  PROTEIN and PROTEIN also did not exhibit medial PROTEIN - PROTEIN staining.
BioInfer.d782.s0.p14	N	Unexpectedly, treatment with the PROTEIN -depolymerizing drug latrunculin-A disrupted the medial region targeting pattern, and cells deficient in the PROTEIN2  PROTEIN and PROTEIN also did not exhibit medial PROTEIN1 - PROTEIN staining.
BioInfer.d783.s0.p0	N	Unlike PROTEIN2 , PROTEIN1 's PROTEIN -bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.
BioInfer.d783.s0.p1	P	Unlike PROTEIN , PROTEIN1 's PROTEIN2 -bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.
BioInfer.d783.s0.p2	P	Unlike PROTEIN1 , PROTEIN 's PROTEIN2 -bundling action was strictly calcium-dependent: the bundles were formed at pCa 7, but not at pCa 6.
BioInfer.d784.s0.p0	P	Unmasking of this site serves as a molecular switch that initiates assembly of an PROTEIN2 -based motility complex containing PROTEIN1 and PROTEIN .
BioInfer.d784.s0.p1	P	Unmasking of this site serves as a molecular switch that initiates assembly of an PROTEIN -based motility complex containing PROTEIN1 and PROTEIN2 .
BioInfer.d784.s0.p2	P	Unmasking of this site serves as a molecular switch that initiates assembly of an PROTEIN1 -based motility complex containing PROTEIN and PROTEIN2 .
BioInfer.d785.s0.p0	N	Up to now three allergens have been identified as responsible for cross-reactivity in these associations: PROTEIN , a 14 kd protein that regulates PROTEIN1 ; PROTEIN2 , the 18 kd birch pollen allergen; and a 60-69 kd allergen.
BioInfer.d785.s0.p1	P	Up to now three allergens have been identified as responsible for cross-reactivity in these associations: PROTEIN2 , a 14 kd protein that regulates PROTEIN1 ; PROTEIN , the 18 kd birch pollen allergen; and a 60-69 kd allergen.
BioInfer.d785.s0.p2	N	Up to now three allergens have been identified as responsible for cross-reactivity in these associations: PROTEIN2 , a 14 kd protein that regulates PROTEIN ; PROTEIN1 , the 18 kd birch pollen allergen; and a 60-69 kd allergen.
BioInfer.d786.s0.p0	P	Using a complementary sequence or antipeptide to selectively neutralize the stretch of residues 633-642 of PROTEIN1 , we recently demonstrated that this segment is an PROTEIN2 binding site operating in the absence as in the presence of nucleotide and that this stretch 633-642 is not part of the nucleotide binding site [Chaussepied & Morales (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 7471-7475].
BioInfer.d787.s0.p0	N	Using ITP (a substrate for PROTEIN  PROTEIN2 ) and/or ATP gamma S (a substrate for PROTEIN [ PROTEIN1 ]), we demonstrated that phosphorylation of PROTEIN occurred at the foci within the PROTEIN network, a result that suggests that PROTEIN was localized at the foci.
BioInfer.d787.s0.p1	N	Using ITP (a substrate for PROTEIN2  PROTEIN ) and/or ATP gamma S (a substrate for PROTEIN [ PROTEIN1 ]), we demonstrated that phosphorylation of PROTEIN occurred at the foci within the PROTEIN network, a result that suggests that PROTEIN was localized at the foci.
BioInfer.d787.s0.p2	N	Using ITP (a substrate for PROTEIN  PROTEIN ) and/or ATP gamma S (a substrate for PROTEIN [ PROTEIN1 ]), we demonstrated that phosphorylation of PROTEIN occurred at the foci within the PROTEIN network, a result that suggests that PROTEIN2 was localized at the foci.
BioInfer.d787.s0.p3	N	Using ITP (a substrate for PROTEIN  PROTEIN ) and/or ATP gamma S (a substrate for PROTEIN2 [ PROTEIN1 ]), we demonstrated that phosphorylation of PROTEIN occurred at the foci within the PROTEIN network, a result that suggests that PROTEIN was localized at the foci.
BioInfer.d787.s0.p4	N	Using ITP (a substrate for PROTEIN  PROTEIN ) and/or ATP gamma S (a substrate for PROTEIN [ PROTEIN1 ]), we demonstrated that phosphorylation of PROTEIN2 occurred at the foci within the PROTEIN network, a result that suggests that PROTEIN was localized at the foci.
BioInfer.d787.s0.p5	N	Using ITP (a substrate for PROTEIN  PROTEIN ) and/or ATP gamma S (a substrate for PROTEIN [ PROTEIN1 ]), we demonstrated that phosphorylation of PROTEIN occurred at the foci within the PROTEIN2 network, a result that suggests that PROTEIN was localized at the foci.
BioInfer.d787.s0.p6	P	Using ITP (a substrate for PROTEIN2  PROTEIN1 ) and/or ATP gamma S (a substrate for PROTEIN [ PROTEIN ]), we demonstrated that phosphorylation of PROTEIN occurred at the foci within the PROTEIN network, a result that suggests that PROTEIN was localized at the foci.
BioInfer.d787.s0.p7	N	Using ITP (a substrate for PROTEIN  PROTEIN1 ) and/or ATP gamma S (a substrate for PROTEIN [ PROTEIN ]), we demonstrated that phosphorylation of PROTEIN occurred at the foci within the PROTEIN network, a result that suggests that PROTEIN2 was localized at the foci.
BioInfer.d787.s0.p8	N	Using ITP (a substrate for PROTEIN  PROTEIN1 ) and/or ATP gamma S (a substrate for PROTEIN2 [ PROTEIN ]), we demonstrated that phosphorylation of PROTEIN occurred at the foci within the PROTEIN network, a result that suggests that PROTEIN was localized at the foci.
BioInfer.d787.s0.p9	N	Using ITP (a substrate for PROTEIN  PROTEIN1 ) and/or ATP gamma S (a substrate for PROTEIN [ PROTEIN ]), we demonstrated that phosphorylation of PROTEIN2 occurred at the foci within the PROTEIN network, a result that suggests that PROTEIN was localized at the foci.
BioInfer.d787.s0.p10	N	Using ITP (a substrate for PROTEIN  PROTEIN1 ) and/or ATP gamma S (a substrate for PROTEIN [ PROTEIN ]), we demonstrated that phosphorylation of PROTEIN occurred at the foci within the PROTEIN2 network, a result that suggests that PROTEIN was localized at the foci.
BioInfer.d787.s0.p11	N	Using ITP (a substrate for PROTEIN1  PROTEIN ) and/or ATP gamma S (a substrate for PROTEIN [ PROTEIN ]), we demonstrated that phosphorylation of PROTEIN occurred at the foci within the PROTEIN network, a result that suggests that PROTEIN2 was localized at the foci.
BioInfer.d787.s0.p12	N	Using ITP (a substrate for PROTEIN1  PROTEIN ) and/or ATP gamma S (a substrate for PROTEIN2 [ PROTEIN ]), we demonstrated that phosphorylation of PROTEIN occurred at the foci within the PROTEIN network, a result that suggests that PROTEIN was localized at the foci.
BioInfer.d787.s0.p13	N	Using ITP (a substrate for PROTEIN1  PROTEIN ) and/or ATP gamma S (a substrate for PROTEIN [ PROTEIN ]), we demonstrated that phosphorylation of PROTEIN2 occurred at the foci within the PROTEIN network, a result that suggests that PROTEIN was localized at the foci.
BioInfer.d787.s0.p14	N	Using ITP (a substrate for PROTEIN1  PROTEIN ) and/or ATP gamma S (a substrate for PROTEIN [ PROTEIN ]), we demonstrated that phosphorylation of PROTEIN occurred at the foci within the PROTEIN2 network, a result that suggests that PROTEIN was localized at the foci.
BioInfer.d787.s0.p15	N	Using ITP (a substrate for PROTEIN  PROTEIN ) and/or ATP gamma S (a substrate for PROTEIN2 [ PROTEIN ]), we demonstrated that phosphorylation of PROTEIN occurred at the foci within the PROTEIN network, a result that suggests that PROTEIN1 was localized at the foci.
BioInfer.d787.s0.p16	N	Using ITP (a substrate for PROTEIN  PROTEIN ) and/or ATP gamma S (a substrate for PROTEIN [ PROTEIN ]), we demonstrated that phosphorylation of PROTEIN2 occurred at the foci within the PROTEIN network, a result that suggests that PROTEIN1 was localized at the foci.
BioInfer.d787.s0.p17	N	Using ITP (a substrate for PROTEIN  PROTEIN ) and/or ATP gamma S (a substrate for PROTEIN [ PROTEIN ]), we demonstrated that phosphorylation of PROTEIN occurred at the foci within the PROTEIN2 network, a result that suggests that PROTEIN1 was localized at the foci.
BioInfer.d787.s0.p18	N	Using ITP (a substrate for PROTEIN  PROTEIN ) and/or ATP gamma S (a substrate for PROTEIN1 [ PROTEIN ]), we demonstrated that phosphorylation of PROTEIN2 occurred at the foci within the PROTEIN network, a result that suggests that PROTEIN was localized at the foci.
BioInfer.d787.s0.p19	N	Using ITP (a substrate for PROTEIN  PROTEIN ) and/or ATP gamma S (a substrate for PROTEIN1 [ PROTEIN ]), we demonstrated that phosphorylation of PROTEIN occurred at the foci within the PROTEIN2 network, a result that suggests that PROTEIN was localized at the foci.
BioInfer.d787.s0.p20	N	Using ITP (a substrate for PROTEIN  PROTEIN ) and/or ATP gamma S (a substrate for PROTEIN [ PROTEIN ]), we demonstrated that phosphorylation of PROTEIN1 occurred at the foci within the PROTEIN2 network, a result that suggests that PROTEIN was localized at the foci.
BioInfer.d788.s0.p0	P	Using the known three-dimensional structure of the homologous PROTEIN -binding domain of PROTEIN2 , these results have enabled us to determine the likely orientation of the PROTEIN1  PROTEIN -binding domain with respect to the PROTEIN filament.
BioInfer.d788.s0.p1	P	Using the known three-dimensional structure of the homologous PROTEIN -binding domain of PROTEIN , these results have enabled us to determine the likely orientation of the PROTEIN1  PROTEIN -binding domain with respect to the PROTEIN2 filament.
BioInfer.d788.s0.p2	P	Using the known three-dimensional structure of the homologous PROTEIN -binding domain of PROTEIN , these results have enabled us to determine the likely orientation of the PROTEIN1  PROTEIN2 -binding domain with respect to the PROTEIN filament.
BioInfer.d788.s0.p3	N	Using the known three-dimensional structure of the homologous PROTEIN2 -binding domain of PROTEIN , these results have enabled us to determine the likely orientation of the PROTEIN1  PROTEIN -binding domain with respect to the PROTEIN filament.
BioInfer.d788.s0.p4	N	Using the known three-dimensional structure of the homologous PROTEIN -binding domain of PROTEIN1 , these results have enabled us to determine the likely orientation of the PROTEIN  PROTEIN -binding domain with respect to the PROTEIN2 filament.
BioInfer.d788.s0.p5	N	Using the known three-dimensional structure of the homologous PROTEIN -binding domain of PROTEIN1 , these results have enabled us to determine the likely orientation of the PROTEIN  PROTEIN2 -binding domain with respect to the PROTEIN filament.
BioInfer.d788.s0.p6	P	Using the known three-dimensional structure of the homologous PROTEIN2 -binding domain of PROTEIN1 , these results have enabled us to determine the likely orientation of the PROTEIN  PROTEIN -binding domain with respect to the PROTEIN filament.
BioInfer.d788.s0.p7	N	Using the known three-dimensional structure of the homologous PROTEIN -binding domain of PROTEIN , these results have enabled us to determine the likely orientation of the PROTEIN  PROTEIN2 -binding domain with respect to the PROTEIN1 filament.
BioInfer.d788.s0.p8	N	Using the known three-dimensional structure of the homologous PROTEIN2 -binding domain of PROTEIN , these results have enabled us to determine the likely orientation of the PROTEIN  PROTEIN -binding domain with respect to the PROTEIN1 filament.
BioInfer.d788.s0.p9	N	Using the known three-dimensional structure of the homologous PROTEIN2 -binding domain of PROTEIN , these results have enabled us to determine the likely orientation of the PROTEIN  PROTEIN1 -binding domain with respect to the PROTEIN filament.
BioInfer.d789.s0.p0	P	Using the 'nuclear displacement assay' as a measure of the integrity of the PROTEIN cytoskeleton in living stamen hair cells, we demonstrated that PROTEIN protects PROTEIN2 filaments in these cells from Z. mays PROTEIN1 ( PROTEIN )-induced depolymerization, in a dose-dependent manner.
BioInfer.d789.s0.p1	N	Using the 'nuclear displacement assay' as a measure of the integrity of the PROTEIN cytoskeleton in living stamen hair cells, we demonstrated that PROTEIN2 protects PROTEIN filaments in these cells from Z. mays PROTEIN1 ( PROTEIN )-induced depolymerization, in a dose-dependent manner.
BioInfer.d789.s0.p2	N	Using the 'nuclear displacement assay' as a measure of the integrity of the PROTEIN cytoskeleton in living stamen hair cells, we demonstrated that PROTEIN protects PROTEIN filaments in these cells from Z. mays PROTEIN1 ( PROTEIN2 )-induced depolymerization, in a dose-dependent manner.
BioInfer.d789.s0.p3	N	Using the 'nuclear displacement assay' as a measure of the integrity of the PROTEIN2 cytoskeleton in living stamen hair cells, we demonstrated that PROTEIN protects PROTEIN filaments in these cells from Z. mays PROTEIN1 ( PROTEIN )-induced depolymerization, in a dose-dependent manner.
BioInfer.d789.s0.p4	P	Using the 'nuclear displacement assay' as a measure of the integrity of the PROTEIN cytoskeleton in living stamen hair cells, we demonstrated that PROTEIN2 protects PROTEIN1 filaments in these cells from Z. mays PROTEIN ( PROTEIN )-induced depolymerization, in a dose-dependent manner.
BioInfer.d789.s0.p5	P	Using the 'nuclear displacement assay' as a measure of the integrity of the PROTEIN cytoskeleton in living stamen hair cells, we demonstrated that PROTEIN protects PROTEIN1 filaments in these cells from Z. mays PROTEIN ( PROTEIN2 )-induced depolymerization, in a dose-dependent manner.
BioInfer.d789.s0.p6	N	Using the 'nuclear displacement assay' as a measure of the integrity of the PROTEIN2 cytoskeleton in living stamen hair cells, we demonstrated that PROTEIN protects PROTEIN1 filaments in these cells from Z. mays PROTEIN ( PROTEIN )-induced depolymerization, in a dose-dependent manner.
BioInfer.d789.s0.p7	N	Using the 'nuclear displacement assay' as a measure of the integrity of the PROTEIN cytoskeleton in living stamen hair cells, we demonstrated that PROTEIN1 protects PROTEIN filaments in these cells from Z. mays PROTEIN ( PROTEIN2 )-induced depolymerization, in a dose-dependent manner.
BioInfer.d789.s0.p8	N	Using the 'nuclear displacement assay' as a measure of the integrity of the PROTEIN2 cytoskeleton in living stamen hair cells, we demonstrated that PROTEIN1 protects PROTEIN filaments in these cells from Z. mays PROTEIN ( PROTEIN )-induced depolymerization, in a dose-dependent manner.
BioInfer.d789.s0.p9	N	Using the 'nuclear displacement assay' as a measure of the integrity of the PROTEIN2 cytoskeleton in living stamen hair cells, we demonstrated that PROTEIN protects PROTEIN filaments in these cells from Z. mays PROTEIN ( PROTEIN1 )-induced depolymerization, in a dose-dependent manner.
BioInfer.d790.s0.p0	P	Using these methods, we confirm previous reports that intact PROTEIN1 induces cross-linking as well as filament shortening on PROTEIN2 networks.
BioInfer.d791.s0.p0	N	PROTEIN ( PROTEIN1 ) clusters were co-localized with PROTEIN , an important signal transduction ligand, and with PROTEIN , which is thought to link the complex to the peri-junctional PROTEIN2 .
BioInfer.d791.s0.p1	N	PROTEIN2 ( PROTEIN1 ) clusters were co-localized with PROTEIN , an important signal transduction ligand, and with PROTEIN , which is thought to link the complex to the peri-junctional PROTEIN .
BioInfer.d791.s0.p2	P	PROTEIN ( PROTEIN1 ) clusters were co-localized with PROTEIN , an important signal transduction ligand, and with PROTEIN2 , which is thought to link the complex to the peri-junctional PROTEIN .
BioInfer.d791.s0.p3	P	PROTEIN ( PROTEIN1 ) clusters were co-localized with PROTEIN2 , an important signal transduction ligand, and with PROTEIN , which is thought to link the complex to the peri-junctional PROTEIN .
BioInfer.d791.s0.p4	N	PROTEIN2 ( PROTEIN ) clusters were co-localized with PROTEIN , an important signal transduction ligand, and with PROTEIN , which is thought to link the complex to the peri-junctional PROTEIN1 .
BioInfer.d791.s0.p5	P	PROTEIN ( PROTEIN ) clusters were co-localized with PROTEIN , an important signal transduction ligand, and with PROTEIN2 , which is thought to link the complex to the peri-junctional PROTEIN1 .
BioInfer.d791.s0.p6	N	PROTEIN ( PROTEIN ) clusters were co-localized with PROTEIN2 , an important signal transduction ligand, and with PROTEIN , which is thought to link the complex to the peri-junctional PROTEIN1 .
BioInfer.d791.s0.p7	P	PROTEIN1 ( PROTEIN ) clusters were co-localized with PROTEIN , an important signal transduction ligand, and with PROTEIN2 , which is thought to link the complex to the peri-junctional PROTEIN .
BioInfer.d791.s0.p8	P	PROTEIN1 ( PROTEIN ) clusters were co-localized with PROTEIN2 , an important signal transduction ligand, and with PROTEIN , which is thought to link the complex to the peri-junctional PROTEIN .
BioInfer.d791.s0.p9	N	PROTEIN ( PROTEIN ) clusters were co-localized with PROTEIN2 , an important signal transduction ligand, and with PROTEIN1 , which is thought to link the complex to the peri-junctional PROTEIN .
BioInfer.d792.s0.p0	P	PROTEIN2 , in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding PROTEIN1 , an PROTEIN -regulatory protein that stimulates PROTEIN filament assembly.
BioInfer.d792.s0.p1	P	PROTEIN , in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding PROTEIN1 , an PROTEIN2 -regulatory protein that stimulates PROTEIN filament assembly.
BioInfer.d792.s0.p2	P	PROTEIN , in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding PROTEIN1 , an PROTEIN -regulatory protein that stimulates PROTEIN2 filament assembly.
BioInfer.d792.s0.p3	N	PROTEIN1 , in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding PROTEIN , an PROTEIN2 -regulatory protein that stimulates PROTEIN filament assembly.
BioInfer.d792.s0.p4	N	PROTEIN1 , in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding PROTEIN , an PROTEIN -regulatory protein that stimulates PROTEIN2 filament assembly.
BioInfer.d792.s0.p5	N	PROTEIN , in turn, provides the ABM-2 sequences [XPPPPP, X = G, P, L, S, A] for binding PROTEIN , an PROTEIN1 -regulatory protein that stimulates PROTEIN2 filament assembly.
BioInfer.d793.s0.p0	P	PROTEIN and PROTEIN2 are two PROTEIN that bundle PROTEIN1 filaments in the intestine and kidney brush border epithelium.
BioInfer.d793.s0.p1	P	PROTEIN2 and PROTEIN are two PROTEIN that bundle PROTEIN1 filaments in the intestine and kidney brush border epithelium.
BioInfer.d793.s0.p2	N	PROTEIN and PROTEIN are two PROTEIN2 that bundle PROTEIN1 filaments in the intestine and kidney brush border epithelium.
BioInfer.d793.s0.p3	N	PROTEIN2 and PROTEIN1 are two PROTEIN that bundle PROTEIN filaments in the intestine and kidney brush border epithelium.
BioInfer.d793.s0.p4	P	PROTEIN and PROTEIN1 are two PROTEIN2 that bundle PROTEIN filaments in the intestine and kidney brush border epithelium.
BioInfer.d793.s0.p5	P	PROTEIN1 and PROTEIN are two PROTEIN2 that bundle PROTEIN filaments in the intestine and kidney brush border epithelium.
BioInfer.d794.s0.p0	N	PROTEIN2 and PROTEIN were also up-regulated, whereas an isoform of PROTEIN1 was down-regulated.
BioInfer.d794.s0.p1	N	PROTEIN and PROTEIN2 were also up-regulated, whereas an isoform of PROTEIN1 was down-regulated.
BioInfer.d794.s0.p2	N	PROTEIN1 and PROTEIN2 were also up-regulated, whereas an isoform of PROTEIN was down-regulated.
BioInfer.d795.s0.p0	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN1 / PROTEIN2 -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p1	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN2 as well as PROTEIN1 / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p2	P	PROTEIN2 contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN1 / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p3	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN1 / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN2 - PROTEIN has been identified.
BioInfer.d795.s0.p4	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN1 / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN2 has been identified.
BioInfer.d795.s0.p5	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN1 / PROTEIN -like PROTEIN2 -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p6	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN1 / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN2 structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p7	N	PROTEIN contains a binding motif for the PROTEIN2  PROTEIN as well as PROTEIN1 / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p8	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN2 as well as PROTEIN / PROTEIN1 -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p9	P	PROTEIN2 contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN / PROTEIN1 -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p10	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN / PROTEIN1 -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN2 - PROTEIN has been identified.
BioInfer.d795.s0.p11	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN / PROTEIN1 -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN2 has been identified.
BioInfer.d795.s0.p12	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN / PROTEIN1 -like PROTEIN2 -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p13	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN / PROTEIN1 -like PROTEIN -regulatory domains, but no specific PROTEIN2 structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p14	N	PROTEIN contains a binding motif for the PROTEIN2  PROTEIN as well as PROTEIN / PROTEIN1 -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p15	P	PROTEIN2 contains a binding motif for the PROTEIN  PROTEIN1 as well as PROTEIN / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p16	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN1 as well as PROTEIN / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN2 - PROTEIN has been identified.
BioInfer.d795.s0.p17	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN1 as well as PROTEIN / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN2 has been identified.
BioInfer.d795.s0.p18	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN1 as well as PROTEIN / PROTEIN -like PROTEIN2 -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p19	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN1 as well as PROTEIN / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN2 structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p20	P	PROTEIN contains a binding motif for the PROTEIN2  PROTEIN1 as well as PROTEIN / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p21	N	PROTEIN1 contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN2 - PROTEIN has been identified.
BioInfer.d795.s0.p22	N	PROTEIN1 contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN2 has been identified.
BioInfer.d795.s0.p23	P	PROTEIN1 contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN / PROTEIN -like PROTEIN2 -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p24	N	PROTEIN1 contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN2 structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p25	N	PROTEIN1 contains a binding motif for the PROTEIN2  PROTEIN as well as PROTEIN / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p26	P	PROTEIN contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN1 - PROTEIN2 has been identified.
BioInfer.d795.s0.p27	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN / PROTEIN -like PROTEIN2 -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN1 - PROTEIN has been identified.
BioInfer.d795.s0.p28	P	PROTEIN contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN2 structure regulated by PROTEIN1 - PROTEIN has been identified.
BioInfer.d795.s0.p29	N	PROTEIN contains a binding motif for the PROTEIN2  PROTEIN as well as PROTEIN / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN1 - PROTEIN has been identified.
BioInfer.d795.s0.p30	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN / PROTEIN -like PROTEIN2 -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN1 has been identified.
BioInfer.d795.s0.p31	P	PROTEIN contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN2 structure regulated by PROTEIN - PROTEIN1 has been identified.
BioInfer.d795.s0.p32	N	PROTEIN contains a binding motif for the PROTEIN2  PROTEIN as well as PROTEIN / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN1 has been identified.
BioInfer.d795.s0.p33	N	PROTEIN contains a binding motif for the PROTEIN  PROTEIN as well as PROTEIN / PROTEIN -like PROTEIN1 -regulatory domains, but no specific PROTEIN2 structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p34	N	PROTEIN contains a binding motif for the PROTEIN2  PROTEIN as well as PROTEIN / PROTEIN -like PROTEIN1 -regulatory domains, but no specific PROTEIN structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d795.s0.p35	N	PROTEIN contains a binding motif for the PROTEIN2  PROTEIN as well as PROTEIN / PROTEIN -like PROTEIN -regulatory domains, but no specific PROTEIN1 structure regulated by PROTEIN - PROTEIN has been identified.
BioInfer.d796.s0.p0	N	We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant PROTEIN -d and two recombination mutants defective in PROTEIN and PROTEIN (homologues of S.cerevisiae PROTEIN1 and PROTEIN2 , respectively) are not affected.
BioInfer.d796.s0.p1	P	We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant PROTEIN -d and two recombination mutants defective in PROTEIN2 and PROTEIN (homologues of S.cerevisiae PROTEIN1 and PROTEIN , respectively) are not affected.
BioInfer.d796.s0.p2	N	We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant PROTEIN -d and two recombination mutants defective in PROTEIN and PROTEIN2 (homologues of S.cerevisiae PROTEIN1 and PROTEIN , respectively) are not affected.
BioInfer.d796.s0.p3	N	We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant PROTEIN2 -d and two recombination mutants defective in PROTEIN and PROTEIN (homologues of S.cerevisiae PROTEIN1 and PROTEIN , respectively) are not affected.
BioInfer.d796.s0.p4	N	We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant PROTEIN -d and two recombination mutants defective in PROTEIN2 and PROTEIN (homologues of S.cerevisiae PROTEIN and PROTEIN1 , respectively) are not affected.
BioInfer.d796.s0.p5	P	We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant PROTEIN -d and two recombination mutants defective in PROTEIN and PROTEIN2 (homologues of S.cerevisiae PROTEIN and PROTEIN1 , respectively) are not affected.
BioInfer.d796.s0.p6	N	We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant PROTEIN2 -d and two recombination mutants defective in PROTEIN and PROTEIN (homologues of S.cerevisiae PROTEIN and PROTEIN1 , respectively) are not affected.
BioInfer.d796.s0.p7	N	We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant PROTEIN -d and two recombination mutants defective in PROTEIN1 and PROTEIN2 (homologues of S.cerevisiae PROTEIN and PROTEIN , respectively) are not affected.
BioInfer.d796.s0.p8	N	We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant PROTEIN2 -d and two recombination mutants defective in PROTEIN1 and PROTEIN (homologues of S.cerevisiae PROTEIN and PROTEIN , respectively) are not affected.
BioInfer.d796.s0.p9	N	We also analysed NHEJ in other DNA damage response mutants and showed that the checkpoint mutant PROTEIN2 -d and two recombination mutants defective in PROTEIN and PROTEIN1 (homologues of S.cerevisiae PROTEIN and PROTEIN , respectively) are not affected.
BioInfer.d797.s0.p0	P	We believe that this complex may mediate the cortical functions of PROTEIN1 at PROTEIN2 patches in S. pombe.
BioInfer.d798.s0.p0	N	We conclude that germ-line involvement of PROTEIN2 and PROTEIN is rare and that other genes are likely to account for a majority of PROTEIN1 -, PROTEIN -mutation negative families with nonpolypotic colon cancer.
BioInfer.d798.s0.p1	N	We conclude that germ-line involvement of PROTEIN and PROTEIN is rare and that other genes are likely to account for a majority of PROTEIN1 -, PROTEIN2 -mutation negative families with nonpolypotic colon cancer.
BioInfer.d798.s0.p2	N	We conclude that germ-line involvement of PROTEIN and PROTEIN2 is rare and that other genes are likely to account for a majority of PROTEIN1 -, PROTEIN -mutation negative families with nonpolypotic colon cancer.
BioInfer.d798.s0.p3	N	We conclude that germ-line involvement of PROTEIN1 and PROTEIN is rare and that other genes are likely to account for a majority of PROTEIN -, PROTEIN2 -mutation negative families with nonpolypotic colon cancer.
BioInfer.d798.s0.p4	N	We conclude that germ-line involvement of PROTEIN1 and PROTEIN2 is rare and that other genes are likely to account for a majority of PROTEIN -, PROTEIN -mutation negative families with nonpolypotic colon cancer.
BioInfer.d798.s0.p5	N	We conclude that germ-line involvement of PROTEIN and PROTEIN2 is rare and that other genes are likely to account for a majority of PROTEIN -, PROTEIN1 -mutation negative families with nonpolypotic colon cancer.
BioInfer.d799.s0.p0	N	We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes ( PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN ) in the absence of any of the other proteins required for viral DNA synthesis.
BioInfer.d799.s0.p1	N	We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes ( PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN ) in the absence of any of the other proteins required for viral DNA synthesis.
BioInfer.d799.s0.p2	N	We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes ( PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 ) in the absence of any of the other proteins required for viral DNA synthesis.
BioInfer.d799.s0.p3	N	We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes ( PROTEIN , PROTEIN2 , PROTEIN1 and PROTEIN ) in the absence of any of the other proteins required for viral DNA synthesis.
BioInfer.d799.s0.p4	N	We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes ( PROTEIN , PROTEIN , PROTEIN1 and PROTEIN2 ) in the absence of any of the other proteins required for viral DNA synthesis.
BioInfer.d799.s0.p5	N	We constructed recombinant viruses based on the herpes simplex virus type 1 mutant tsK which individually were able to express the products of four viral DNA replication genes ( PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 ) in the absence of any of the other proteins required for viral DNA synthesis.
BioInfer.d800.s0.p0	N	We describe the localization of PROTEIN and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN2 " with PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and the association of these complexes with the PROTEIN1 microfilaments.
BioInfer.d800.s0.p1	N	We describe the localization of PROTEIN and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , and the association of these complexes with the PROTEIN1 microfilaments.
BioInfer.d800.s0.p2	N	We describe the localization of PROTEIN and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , and the association of these complexes with the PROTEIN1 microfilaments.
BioInfer.d800.s0.p3	N	We describe the localization of PROTEIN and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , and the association of these complexes with the PROTEIN1 microfilaments.
BioInfer.d800.s0.p4	N	We describe the localization of PROTEIN and PROTEIN2 along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and the association of these complexes with the PROTEIN1 microfilaments.
BioInfer.d800.s0.p5	N	We describe the localization of PROTEIN and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , and the association of these complexes with the PROTEIN1 microfilaments.
BioInfer.d800.s0.p6	N	We describe the localization of PROTEIN2 and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and the association of these complexes with the PROTEIN1 microfilaments.
BioInfer.d800.s0.p7	P	We describe the localization of PROTEIN and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN1 " with PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p8	P	We describe the localization of PROTEIN and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN1 " with PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p9	P	We describe the localization of PROTEIN and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN1 " with PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p10	N	We describe the localization of PROTEIN and PROTEIN2 along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN1 " with PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p11	P	We describe the localization of PROTEIN and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN1 " with PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p12	N	We describe the localization of PROTEIN2 and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN1 " with PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p13	N	We describe the localization of PROTEIN and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p14	N	We describe the localization of PROTEIN and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p15	N	We describe the localization of PROTEIN and PROTEIN2 along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p16	N	We describe the localization of PROTEIN and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p17	N	We describe the localization of PROTEIN2 and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p18	N	We describe the localization of PROTEIN and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p19	N	We describe the localization of PROTEIN and PROTEIN2 along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p20	N	We describe the localization of PROTEIN and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p21	N	We describe the localization of PROTEIN2 and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p22	N	We describe the localization of PROTEIN and PROTEIN2 along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p23	N	We describe the localization of PROTEIN and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p24	N	We describe the localization of PROTEIN2 and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p25	N	We describe the localization of PROTEIN and PROTEIN1 along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p26	N	We describe the localization of PROTEIN2 and PROTEIN1 along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN , PROTEIN , PROTEIN , and PROTEIN , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d800.s0.p27	N	We describe the localization of PROTEIN2 and PROTEIN along the cell margins of mouse osteoblast-like cells, the colocalization of " PROTEIN " with PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , and the association of these complexes with the PROTEIN microfilaments.
BioInfer.d801.s0.p0	N	We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, PROTEIN2 ( PROTEIN ), PROTEIN1 , and mixed muscle proteins in nonfrail elders and younger women and men.
BioInfer.d801.s0.p1	N	We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, PROTEIN ( PROTEIN2 ), PROTEIN1 , and mixed muscle proteins in nonfrail elders and younger women and men.
BioInfer.d801.s0.p2	N	We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, PROTEIN1 ( PROTEIN2 ), PROTEIN , and mixed muscle proteins in nonfrail elders and younger women and men.
BioInfer.d802.s0.p0	N	We examined whether levels of PROTEIN2 or PROTEIN1 correlated with PROTEIN levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.
BioInfer.d802.s0.p1	P	We examined whether levels of PROTEIN or PROTEIN1 correlated with PROTEIN2 levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.
BioInfer.d802.s0.p2	P	We examined whether levels of PROTEIN1 or PROTEIN correlated with PROTEIN2 levels in the glomeruli of rats with puromycin aminonucleoside nephrosis.
BioInfer.d803.s0.p0	N	We find that PROTEIN2 and PROTEIN1 regulate PROTEIN -filament formation throughout the cell cortex.
BioInfer.d803.s0.p1	P	We find that PROTEIN and PROTEIN1 regulate PROTEIN2 -filament formation throughout the cell cortex.
BioInfer.d803.s0.p2	P	We find that PROTEIN1 and PROTEIN regulate PROTEIN2 -filament formation throughout the cell cortex.
BioInfer.d804.s0.p0	P	We find that PROTEIN1 contributes in several ways to PROTEIN -induced nucleation of PROTEIN2 filaments in high speed supernatant of lysed neutrophils.
BioInfer.d804.s0.p1	N	We find that PROTEIN1 contributes in several ways to PROTEIN2 -induced nucleation of PROTEIN filaments in high speed supernatant of lysed neutrophils.
BioInfer.d804.s0.p2	P	We find that PROTEIN contributes in several ways to PROTEIN2 -induced nucleation of PROTEIN1 filaments in high speed supernatant of lysed neutrophils.
BioInfer.d805.s0.p0	N	We found normal levels of PROTEIN2 and PROTEIN1 in BT549 and HS578t cells; however, low levels of PROTEIN were expressed in these cells compared to those found in weakly invasive MCF-7 cells.
BioInfer.d805.s0.p1	N	We found normal levels of PROTEIN and PROTEIN1 in BT549 and HS578t cells; however, low levels of PROTEIN2 were expressed in these cells compared to those found in weakly invasive MCF-7 cells.
BioInfer.d805.s0.p2	N	We found normal levels of PROTEIN1 and PROTEIN in BT549 and HS578t cells; however, low levels of PROTEIN2 were expressed in these cells compared to those found in weakly invasive MCF-7 cells.
BioInfer.d806.s0.p0	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p1	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p2	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN2  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p3	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p4	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN2  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p5	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN2  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p7	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN2 , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p8	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p9	N	We found that the expression of all these genes, including PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p10	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p11	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p12	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN2 + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p13	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN2 , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p14	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p15	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN2 , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p16	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p17	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN2  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p18	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p19	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN2  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p20	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN2  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p22	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN2 , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p23	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p24	N	We found that the expression of all these genes, including PROTEIN2 ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p25	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN1 ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p26	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p27	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN2 + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p28	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN2 , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p29	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p30	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN2 , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p31	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN  PROTEIN , PROTEIN2  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p32	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN2  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p33	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN2  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p34	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN2  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p36	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN2 , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p37	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN1 ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p38	N	We found that the expression of all these genes, including PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p39	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p40	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p41	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN  PROTEIN , PROTEIN  PROTEIN2 + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p42	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN  PROTEIN2 , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p43	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN1 ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p44	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN2 , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p45	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2  PROTEIN , PROTEIN1  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p46	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN1  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN2  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p47	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN1  PROTEIN + 2B, PROTEIN2  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p49	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN1  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN2 , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p50	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN1  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p51	N	We found that the expression of all these genes, including PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN1  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p52	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN1  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p53	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN1  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p54	P	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN1  PROTEIN2 + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p55	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN2 , PROTEIN1  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p56	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN1  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p57	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN1  PROTEIN + 2B, PROTEIN  PROTEIN2 , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p58	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN2  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p59	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN2  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p61	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN2 , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p62	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN1  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p63	N	We found that the expression of all these genes, including PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p64	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p65	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p66	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1  PROTEIN , PROTEIN  PROTEIN2 + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p67	P	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1  PROTEIN2 , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p68	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN1  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p69	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN2 , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p70	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN2  PROTEIN , and PROTEIN1  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p72	P	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN1  PROTEIN2 , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p73	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN1  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p74	N	We found that the expression of all these genes, including PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN1  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p75	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN1  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p76	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN1  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p77	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN2 + 2B, PROTEIN  PROTEIN , and PROTEIN1  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p78	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN2 , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN1  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p79	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN1  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p80	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN2 , and PROTEIN1  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p82	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN1  PROTEIN , and PROTEIN  PROTEIN2 , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p83	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN1  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p84	N	We found that the expression of all these genes, including PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN1  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p85	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN1  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p86	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN1  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p87	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN2 + 2B, PROTEIN1  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p88	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN2 , PROTEIN  PROTEIN + 2B, PROTEIN1  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p89	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN1  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p90	P	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN1  PROTEIN2 , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p100	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN2 ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN1 , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p101	N	We found that the expression of all these genes, including PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN1 , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p102	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN1 , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p103	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN1 , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p104	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN2 + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN1 , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p105	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN2 , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN1 , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p106	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN1 , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p107	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN2 , and PROTEIN  PROTEIN1 , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p108	N	We found that the expression of all these genes, including PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p109	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p110	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p111	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN2 + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p112	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN2 , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p113	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN2 ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p114	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN1 ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN2 , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p115	N	We found that the expression of all these genes, including PROTEIN1 ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p116	N	We found that the expression of all these genes, including PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p117	N	We found that the expression of all these genes, including PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN2 + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p118	N	We found that the expression of all these genes, including PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN2 , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p119	N	We found that the expression of all these genes, including PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p120	N	We found that the expression of all these genes, including PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN2 , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p121	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p122	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN2 + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p123	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN2 , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p124	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p125	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN2 , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p126	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN2 + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p127	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN2 , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p128	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p129	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN2 , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p130	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN2 , PROTEIN  PROTEIN1 + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p131	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN1 + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p132	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN1 + 2B, PROTEIN  PROTEIN2 , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p133	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN2 ( PROTEIN ), PROTEIN  PROTEIN1 , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p134	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN  PROTEIN1 , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN2 , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d806.s0.p135	N	We found that the expression of all these genes, including PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN ( PROTEIN ), PROTEIN1 ( PROTEIN ), PROTEIN  PROTEIN , PROTEIN  PROTEIN + 2B, PROTEIN  PROTEIN2 , and PROTEIN  PROTEIN , was induced to high levels in young IMR-90 cells but not in old IMR-90 cells.
BioInfer.d807.s0.p0	N	We have analyzed the expression levels of the genes encoding PROTEIN1 , PROTEIN and PROTEIN2 in correlation to the PROTEIN expression levels in cell lines derived from human cervical carcinomas.
BioInfer.d807.s0.p1	N	We have analyzed the expression levels of the genes encoding PROTEIN1 , PROTEIN2 and PROTEIN in correlation to the PROTEIN expression levels in cell lines derived from human cervical carcinomas.
BioInfer.d807.s0.p2	N	We have analyzed the expression levels of the genes encoding PROTEIN1 , PROTEIN and PROTEIN in correlation to the PROTEIN2 expression levels in cell lines derived from human cervical carcinomas.
BioInfer.d807.s0.p3	N	We have analyzed the expression levels of the genes encoding PROTEIN , PROTEIN2 and PROTEIN1 in correlation to the PROTEIN expression levels in cell lines derived from human cervical carcinomas.
BioInfer.d807.s0.p4	N	We have analyzed the expression levels of the genes encoding PROTEIN , PROTEIN and PROTEIN1 in correlation to the PROTEIN2 expression levels in cell lines derived from human cervical carcinomas.
BioInfer.d807.s0.p5	N	We have analyzed the expression levels of the genes encoding PROTEIN , PROTEIN1 and PROTEIN in correlation to the PROTEIN2 expression levels in cell lines derived from human cervical carcinomas.
BioInfer.d808.s0.p0	P	We have characterized the interaction and nuclear localization of the PROTEIN ( PROTEIN2 ) protein and PROTEIN1 ( PROTEIN ) of sonchus yellow net nucleorhabdovirus.
BioInfer.d808.s0.p1	N	We have characterized the interaction and nuclear localization of the PROTEIN ( PROTEIN ) protein and PROTEIN1 ( PROTEIN2 ) of sonchus yellow net nucleorhabdovirus.
BioInfer.d808.s0.p2	P	We have characterized the interaction and nuclear localization of the PROTEIN2 ( PROTEIN ) protein and PROTEIN1 ( PROTEIN ) of sonchus yellow net nucleorhabdovirus.
BioInfer.d808.s0.p3	P	We have characterized the interaction and nuclear localization of the PROTEIN ( PROTEIN1 ) protein and PROTEIN ( PROTEIN2 ) of sonchus yellow net nucleorhabdovirus.
BioInfer.d808.s0.p4	N	We have characterized the interaction and nuclear localization of the PROTEIN2 ( PROTEIN1 ) protein and PROTEIN ( PROTEIN ) of sonchus yellow net nucleorhabdovirus.
BioInfer.d808.s0.p5	P	We have characterized the interaction and nuclear localization of the PROTEIN2 ( PROTEIN ) protein and PROTEIN ( PROTEIN1 ) of sonchus yellow net nucleorhabdovirus.
BioInfer.d809.s0.p0	P	We have characterized this PROTEIN1 with respect to its ability to interact with yeast PROTEIN2 and PROTEIN , the only yeast PROTEIN so far purified and characterized.
BioInfer.d809.s0.p1	N	We have characterized this PROTEIN1 with respect to its ability to interact with yeast PROTEIN and PROTEIN , the only yeast PROTEIN2 so far purified and characterized.
BioInfer.d809.s0.p2	P	We have characterized this PROTEIN1 with respect to its ability to interact with yeast PROTEIN and PROTEIN2 , the only yeast PROTEIN so far purified and characterized.
BioInfer.d809.s0.p3	P	We have characterized this PROTEIN with respect to its ability to interact with yeast PROTEIN1 and PROTEIN , the only yeast PROTEIN2 so far purified and characterized.
BioInfer.d809.s0.p4	N	We have characterized this PROTEIN with respect to its ability to interact with yeast PROTEIN1 and PROTEIN2 , the only yeast PROTEIN so far purified and characterized.
BioInfer.d809.s0.p5	P	We have characterized this PROTEIN with respect to its ability to interact with yeast PROTEIN and PROTEIN2 , the only yeast PROTEIN1 so far purified and characterized.
BioInfer.d809.s1.p0	P	Yeast PROTEIN1 can sequester yeast PROTEIN2 monomers and thereby reduce the ability of yeast PROTEIN to polymerize, whereas it has little effect on the degree of polymerization of rabbit PROTEIN .
BioInfer.d809.s1.p1	P	Yeast PROTEIN1 can sequester yeast PROTEIN monomers and thereby reduce the ability of yeast PROTEIN2 to polymerize, whereas it has little effect on the degree of polymerization of rabbit PROTEIN .
BioInfer.d809.s1.p2	P	Yeast PROTEIN1 can sequester yeast PROTEIN monomers and thereby reduce the ability of yeast PROTEIN to polymerize, whereas it has little effect on the degree of polymerization of rabbit PROTEIN2 .
BioInfer.d809.s1.p3	N	Yeast PROTEIN can sequester yeast PROTEIN1 monomers and thereby reduce the ability of yeast PROTEIN2 to polymerize, whereas it has little effect on the degree of polymerization of rabbit PROTEIN .
BioInfer.d809.s1.p4	N	Yeast PROTEIN can sequester yeast PROTEIN1 monomers and thereby reduce the ability of yeast PROTEIN to polymerize, whereas it has little effect on the degree of polymerization of rabbit PROTEIN2 .
BioInfer.d809.s1.p5	N	Yeast PROTEIN can sequester yeast PROTEIN monomers and thereby reduce the ability of yeast PROTEIN1 to polymerize, whereas it has little effect on the degree of polymerization of rabbit PROTEIN2 .
BioInfer.d810.s0.p0	P	We have cloned a Saccharomyces cerevisiae gene ( PROTEIN2 ) encoding a low-M(r) PROTEIN of 143 amino acid (aa) residues (yeast PROTEIN1 ; PROTEIN ); its aa sequence is 35% identical to porcine PROTEIN .
BioInfer.d810.s0.p1	N	We have cloned a Saccharomyces cerevisiae gene ( PROTEIN ) encoding a low-M(r) PROTEIN of 143 amino acid (aa) residues (yeast PROTEIN1 ; PROTEIN2 ); its aa sequence is 35% identical to porcine PROTEIN .
BioInfer.d810.s0.p2	P	We have cloned a Saccharomyces cerevisiae gene ( PROTEIN ) encoding a low-M(r) PROTEIN2 of 143 amino acid (aa) residues (yeast PROTEIN1 ; PROTEIN ); its aa sequence is 35% identical to porcine PROTEIN .
BioInfer.d810.s0.p3	P	We have cloned a Saccharomyces cerevisiae gene ( PROTEIN ) encoding a low-M(r) PROTEIN of 143 amino acid (aa) residues (yeast PROTEIN1 ; PROTEIN ); its aa sequence is 35% identical to porcine PROTEIN2 .
BioInfer.d810.s0.p4	P	We have cloned a Saccharomyces cerevisiae gene ( PROTEIN1 ) encoding a low-M(r) PROTEIN of 143 amino acid (aa) residues (yeast PROTEIN ; PROTEIN2 ); its aa sequence is 35% identical to porcine PROTEIN .
BioInfer.d810.s0.p5	N	We have cloned a Saccharomyces cerevisiae gene ( PROTEIN1 ) encoding a low-M(r) PROTEIN2 of 143 amino acid (aa) residues (yeast PROTEIN ; PROTEIN ); its aa sequence is 35% identical to porcine PROTEIN .
BioInfer.d810.s0.p6	N	We have cloned a Saccharomyces cerevisiae gene ( PROTEIN1 ) encoding a low-M(r) PROTEIN of 143 amino acid (aa) residues (yeast PROTEIN ; PROTEIN ); its aa sequence is 35% identical to porcine PROTEIN2 .
BioInfer.d810.s0.p7	P	We have cloned a Saccharomyces cerevisiae gene ( PROTEIN ) encoding a low-M(r) PROTEIN2 of 143 amino acid (aa) residues (yeast PROTEIN ; PROTEIN1 ); its aa sequence is 35% identical to porcine PROTEIN .
BioInfer.d810.s0.p8	P	We have cloned a Saccharomyces cerevisiae gene ( PROTEIN ) encoding a low-M(r) PROTEIN of 143 amino acid (aa) residues (yeast PROTEIN ; PROTEIN1 ); its aa sequence is 35% identical to porcine PROTEIN2 .
BioInfer.d810.s0.p9	N	We have cloned a Saccharomyces cerevisiae gene ( PROTEIN ) encoding a low-M(r) PROTEIN1 of 143 amino acid (aa) residues (yeast PROTEIN ; PROTEIN ); its aa sequence is 35% identical to porcine PROTEIN2 .
BioInfer.d811.s0.p0	N	We have established an PROTEIN2 -deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type PROTEIN and PROTEIN1 genes, to HHUA cells.
BioInfer.d811.s0.p1	N	We have established an PROTEIN -deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type PROTEIN2 and PROTEIN1 genes, to HHUA cells.
BioInfer.d811.s0.p2	N	We have established an PROTEIN1 -deficient HHUA/chr.2 cell line by introducing human chromosome 2, which carries wild-type PROTEIN2 and PROTEIN genes, to HHUA cells.
BioInfer.d812.s0.p0	N	We have examined the level of PROTEIN2 , a PROTEIN , and PROTEIN1 , a PROTEIN , in BALB/c 3T3 cells.
BioInfer.d812.s0.p1	N	We have examined the level of PROTEIN , a PROTEIN2 , and PROTEIN1 , a PROTEIN , in BALB/c 3T3 cells.
BioInfer.d812.s0.p2	P	We have examined the level of PROTEIN , a PROTEIN , and PROTEIN1 , a PROTEIN2 , in BALB/c 3T3 cells.
BioInfer.d812.s0.p3	P	We have examined the level of PROTEIN1 , a PROTEIN2 , and PROTEIN , a PROTEIN , in BALB/c 3T3 cells.
BioInfer.d812.s0.p4	N	We have examined the level of PROTEIN1 , a PROTEIN , and PROTEIN , a PROTEIN2 , in BALB/c 3T3 cells.
BioInfer.d812.s0.p5	N	We have examined the level of PROTEIN , a PROTEIN1 , and PROTEIN , a PROTEIN2 , in BALB/c 3T3 cells.
BioInfer.d813.s0.p0	P	We have found that PROTEIN1 , a 21-kDa PROTEIN2 , is a component of these rods.
BioInfer.d814.s0.p0	N	We have shown that the PROTEIN  PROTEIN and PROTEIN are potential targets of the PROTEIN2 family PROTEIN and bind to an PROTEIN , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN1 cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p1	P	We have shown that the PROTEIN  PROTEIN and PROTEIN2 are potential targets of the PROTEIN family PROTEIN and bind to an PROTEIN , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN1 cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p2	N	We have shown that the PROTEIN  PROTEIN and PROTEIN are potential targets of the PROTEIN family PROTEIN2 and bind to an PROTEIN , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN1 cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p3	P	We have shown that the PROTEIN  PROTEIN2 and PROTEIN are potential targets of the PROTEIN family PROTEIN and bind to an PROTEIN , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN1 cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p4	P	We have shown that the PROTEIN  PROTEIN and PROTEIN are potential targets of the PROTEIN family PROTEIN and bind to an PROTEIN , PROTEIN2 , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN1 cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p5	N	We have shown that the PROTEIN  PROTEIN and PROTEIN are potential targets of the PROTEIN family PROTEIN and bind to an PROTEIN2 , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN1 cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p6	N	We have shown that the PROTEIN2  PROTEIN and PROTEIN are potential targets of the PROTEIN family PROTEIN and bind to an PROTEIN , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN1 cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p7	P	We have shown that the PROTEIN  PROTEIN and PROTEIN2 are potential targets of the PROTEIN1 family PROTEIN and bind to an PROTEIN , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p8	P	We have shown that the PROTEIN  PROTEIN and PROTEIN are potential targets of the PROTEIN1 family PROTEIN2 and bind to an PROTEIN , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p9	P	We have shown that the PROTEIN  PROTEIN2 and PROTEIN are potential targets of the PROTEIN1 family PROTEIN and bind to an PROTEIN , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p10	N	We have shown that the PROTEIN  PROTEIN and PROTEIN are potential targets of the PROTEIN1 family PROTEIN and bind to an PROTEIN , PROTEIN2 , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p11	N	We have shown that the PROTEIN  PROTEIN and PROTEIN are potential targets of the PROTEIN1 family PROTEIN and bind to an PROTEIN2 , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p12	N	We have shown that the PROTEIN2  PROTEIN and PROTEIN are potential targets of the PROTEIN1 family PROTEIN and bind to an PROTEIN , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p13	P	We have shown that the PROTEIN  PROTEIN and PROTEIN1 are potential targets of the PROTEIN family PROTEIN2 and bind to an PROTEIN , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p14	N	We have shown that the PROTEIN  PROTEIN2 and PROTEIN1 are potential targets of the PROTEIN family PROTEIN and bind to an PROTEIN , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p15	P	We have shown that the PROTEIN  PROTEIN and PROTEIN1 are potential targets of the PROTEIN family PROTEIN and bind to an PROTEIN , PROTEIN2 , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p16	N	We have shown that the PROTEIN  PROTEIN and PROTEIN1 are potential targets of the PROTEIN family PROTEIN and bind to an PROTEIN2 , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p17	P	We have shown that the PROTEIN2  PROTEIN and PROTEIN1 are potential targets of the PROTEIN family PROTEIN and bind to an PROTEIN , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p18	P	We have shown that the PROTEIN  PROTEIN2 and PROTEIN are potential targets of the PROTEIN family PROTEIN1 and bind to an PROTEIN , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p19	N	We have shown that the PROTEIN  PROTEIN and PROTEIN are potential targets of the PROTEIN family PROTEIN1 and bind to an PROTEIN , PROTEIN2 , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p20	N	We have shown that the PROTEIN  PROTEIN and PROTEIN are potential targets of the PROTEIN family PROTEIN1 and bind to an PROTEIN2 , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p21	N	We have shown that the PROTEIN2  PROTEIN and PROTEIN are potential targets of the PROTEIN family PROTEIN1 and bind to an PROTEIN , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p22	P	We have shown that the PROTEIN  PROTEIN1 and PROTEIN are potential targets of the PROTEIN family PROTEIN and bind to an PROTEIN , PROTEIN2 , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p23	N	We have shown that the PROTEIN  PROTEIN1 and PROTEIN are potential targets of the PROTEIN family PROTEIN and bind to an PROTEIN2 , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p24	P	We have shown that the PROTEIN2  PROTEIN1 and PROTEIN are potential targets of the PROTEIN family PROTEIN and bind to an PROTEIN , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p25	P	We have shown that the PROTEIN  PROTEIN and PROTEIN are potential targets of the PROTEIN family PROTEIN and bind to an PROTEIN2 , PROTEIN1 , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p26	N	We have shown that the PROTEIN2  PROTEIN and PROTEIN are potential targets of the PROTEIN family PROTEIN and bind to an PROTEIN , PROTEIN1 , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d814.s0.p27	N	We have shown that the PROTEIN2  PROTEIN and PROTEIN are potential targets of the PROTEIN family PROTEIN and bind to an PROTEIN1 , PROTEIN , at their proline-rich FH1 domains to regulate reorganization of the PROTEIN cytoskeleton in the yeast Saccharomyces cerevisiae.
BioInfer.d815.s0.p0	N	We have shown that these proteins are indeed PROTEIN1 : the 14 kd is the PROTEIN  PROTEIN , the 19 kd is the PROTEIN2  PROTEIN , and the 25 kd is the sperm-specific protein PROTEIN .
BioInfer.d815.s0.p1	N	We have shown that these proteins are indeed PROTEIN1 : the 14 kd is the PROTEIN2  PROTEIN , the 19 kd is the PROTEIN  PROTEIN , and the 25 kd is the sperm-specific protein PROTEIN .
BioInfer.d815.s0.p2	P	We have shown that these proteins are indeed PROTEIN1 : the 14 kd is the PROTEIN  PROTEIN2 , the 19 kd is the PROTEIN  PROTEIN , and the 25 kd is the sperm-specific protein PROTEIN .
BioInfer.d815.s0.p3	P	We have shown that these proteins are indeed PROTEIN1 : the 14 kd is the PROTEIN  PROTEIN , the 19 kd is the PROTEIN  PROTEIN , and the 25 kd is the sperm-specific protein PROTEIN2 .
BioInfer.d815.s0.p4	P	We have shown that these proteins are indeed PROTEIN1 : the 14 kd is the PROTEIN  PROTEIN , the 19 kd is the PROTEIN  PROTEIN2 , and the 25 kd is the sperm-specific protein PROTEIN .
BioInfer.d815.s0.p5	N	We have shown that these proteins are indeed PROTEIN : the 14 kd is the PROTEIN2  PROTEIN , the 19 kd is the PROTEIN1  PROTEIN , and the 25 kd is the sperm-specific protein PROTEIN .
BioInfer.d815.s0.p6	N	We have shown that these proteins are indeed PROTEIN : the 14 kd is the PROTEIN  PROTEIN2 , the 19 kd is the PROTEIN1  PROTEIN , and the 25 kd is the sperm-specific protein PROTEIN .
BioInfer.d815.s0.p7	N	We have shown that these proteins are indeed PROTEIN : the 14 kd is the PROTEIN  PROTEIN , the 19 kd is the PROTEIN1  PROTEIN , and the 25 kd is the sperm-specific protein PROTEIN2 .
BioInfer.d815.s0.p8	P	We have shown that these proteins are indeed PROTEIN : the 14 kd is the PROTEIN  PROTEIN , the 19 kd is the PROTEIN1  PROTEIN2 , and the 25 kd is the sperm-specific protein PROTEIN .
BioInfer.d815.s0.p9	P	We have shown that these proteins are indeed PROTEIN : the 14 kd is the PROTEIN1  PROTEIN2 , the 19 kd is the PROTEIN  PROTEIN , and the 25 kd is the sperm-specific protein PROTEIN .
BioInfer.d815.s0.p10	N	We have shown that these proteins are indeed PROTEIN : the 14 kd is the PROTEIN1  PROTEIN , the 19 kd is the PROTEIN  PROTEIN , and the 25 kd is the sperm-specific protein PROTEIN2 .
BioInfer.d815.s0.p11	N	We have shown that these proteins are indeed PROTEIN : the 14 kd is the PROTEIN1  PROTEIN , the 19 kd is the PROTEIN  PROTEIN2 , and the 25 kd is the sperm-specific protein PROTEIN .
BioInfer.d815.s0.p12	N	We have shown that these proteins are indeed PROTEIN : the 14 kd is the PROTEIN  PROTEIN1 , the 19 kd is the PROTEIN  PROTEIN , and the 25 kd is the sperm-specific protein PROTEIN2 .
BioInfer.d815.s0.p13	N	We have shown that these proteins are indeed PROTEIN : the 14 kd is the PROTEIN  PROTEIN1 , the 19 kd is the PROTEIN  PROTEIN2 , and the 25 kd is the sperm-specific protein PROTEIN .
BioInfer.d815.s0.p14	N	We have shown that these proteins are indeed PROTEIN : the 14 kd is the PROTEIN  PROTEIN , the 19 kd is the PROTEIN  PROTEIN2 , and the 25 kd is the sperm-specific protein PROTEIN1 .
BioInfer.d816.s0.p0	P	We investigated PROTEIN2 filament turnover rates, length, number, barbed end exposure, and binding of PROTEIN1 in bovine arterial endothelial cells moving at different speeds depending on their position in a confluent monolayer.
BioInfer.d817.s0.p0	P	We previously showed that PROTEIN1 is transported in an unassembled form with its associated proteins PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d817.s0.p1	P	We previously showed that PROTEIN1 is transported in an unassembled form with its associated proteins PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d817.s0.p2	P	We previously showed that PROTEIN1 is transported in an unassembled form with its associated proteins PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d817.s0.p3	N	We previously showed that PROTEIN is transported in an unassembled form with its associated proteins PROTEIN , PROTEIN1 , and PROTEIN2 .
BioInfer.d817.s0.p4	N	We previously showed that PROTEIN is transported in an unassembled form with its associated proteins PROTEIN2 , PROTEIN1 , and PROTEIN .
BioInfer.d817.s0.p5	N	We previously showed that PROTEIN is transported in an unassembled form with its associated proteins PROTEIN2 , PROTEIN , and PROTEIN1 .
BioInfer.d818.s0.p0	N	We propose that PROTEIN1 may act by forming, during the critical period of cerebellar development, a reserve pool of monomeric PROTEIN that can easily be mobilized in cell regions such as growth cones or synaptic junctions where filamentous PROTEIN2 is highly concentrated.
BioInfer.d818.s0.p1	P	We propose that PROTEIN1 may act by forming, during the critical period of cerebellar development, a reserve pool of monomeric PROTEIN2 that can easily be mobilized in cell regions such as growth cones or synaptic junctions where filamentous PROTEIN is highly concentrated.
BioInfer.d818.s0.p2	N	We propose that PROTEIN may act by forming, during the critical period of cerebellar development, a reserve pool of monomeric PROTEIN2 that can easily be mobilized in cell regions such as growth cones or synaptic junctions where filamentous PROTEIN1 is highly concentrated.
BioInfer.d819.s0.p0	N	We report here that PROTEIN , which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN1 and PROTEIN from the cores but does not affect PROTEIN binding by 110-kD PROTEIN2 .
BioInfer.d819.s0.p1	N	We report here that PROTEIN , which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN1 and PROTEIN2 from the cores but does not affect PROTEIN binding by 110-kD PROTEIN .
BioInfer.d819.s0.p2	N	We report here that PROTEIN , which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN1 and PROTEIN from the cores but does not affect PROTEIN2 binding by 110-kD PROTEIN .
BioInfer.d819.s0.p3	P	We report here that PROTEIN2 , which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN1 and PROTEIN from the cores but does not affect PROTEIN binding by 110-kD PROTEIN .
BioInfer.d819.s0.p4	N	We report here that PROTEIN , which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN2 of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN1 and PROTEIN from the cores but does not affect PROTEIN binding by 110-kD PROTEIN .
BioInfer.d819.s0.p5	N	We report here that PROTEIN , which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN and PROTEIN2 from the cores but does not affect PROTEIN binding by 110-kD PROTEIN1 .
BioInfer.d819.s0.p6	P	We report here that PROTEIN , which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN and PROTEIN from the cores but does not affect PROTEIN2 binding by 110-kD PROTEIN1 .
BioInfer.d819.s0.p7	P	We report here that PROTEIN2 , which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN and PROTEIN from the cores but does not affect PROTEIN binding by 110-kD PROTEIN1 .
BioInfer.d819.s0.p8	N	We report here that PROTEIN , which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN2 of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN and PROTEIN from the cores but does not affect PROTEIN binding by 110-kD PROTEIN1 .
BioInfer.d819.s0.p9	N	We report here that PROTEIN , which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN and PROTEIN1 from the cores but does not affect PROTEIN2 binding by 110-kD PROTEIN .
BioInfer.d819.s0.p10	P	We report here that PROTEIN2 , which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN and PROTEIN1 from the cores but does not affect PROTEIN binding by 110-kD PROTEIN .
BioInfer.d819.s0.p11	N	We report here that PROTEIN , which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN2 of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN and PROTEIN1 from the cores but does not affect PROTEIN binding by 110-kD PROTEIN .
BioInfer.d819.s0.p12	P	We report here that PROTEIN2 , which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN and PROTEIN from the cores but does not affect PROTEIN1 binding by 110-kD PROTEIN .
BioInfer.d819.s0.p13	N	We report here that PROTEIN , which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN2 of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN and PROTEIN from the cores but does not affect PROTEIN1 binding by 110-kD PROTEIN .
BioInfer.d819.s0.p14	P	We report here that PROTEIN1 , which is found in the rootlet but not in the microvillus core, can bind to and saturate the PROTEIN2 of isolated cores, and can cause the dissociation of up to 30% of the PROTEIN and PROTEIN from the cores but does not affect PROTEIN binding by 110-kD PROTEIN .
BioInfer.d820.s0.p0	N	We show here that the phenotype of ts PROTEIN1 is highly similar to that of PROTEIN2 and that the functions of the gene products of PROTEIN and PROTEIN are closely interrelated.
BioInfer.d820.s0.p1	N	We show here that the phenotype of ts PROTEIN1 is highly similar to that of PROTEIN and that the functions of the gene products of PROTEIN2 and PROTEIN are closely interrelated.
BioInfer.d820.s0.p2	N	We show here that the phenotype of ts PROTEIN1 is highly similar to that of PROTEIN and that the functions of the gene products of PROTEIN and PROTEIN2 are closely interrelated.
BioInfer.d820.s0.p3	N	We show here that the phenotype of ts PROTEIN is highly similar to that of PROTEIN1 and that the functions of the gene products of PROTEIN2 and PROTEIN are closely interrelated.
BioInfer.d820.s0.p4	N	We show here that the phenotype of ts PROTEIN is highly similar to that of PROTEIN1 and that the functions of the gene products of PROTEIN and PROTEIN2 are closely interrelated.
BioInfer.d820.s0.p5	P	We show here that the phenotype of ts PROTEIN is highly similar to that of PROTEIN and that the functions of the gene products of PROTEIN1 and PROTEIN2 are closely interrelated.
BioInfer.d821.s0.p0	N	We show that the HSV-1 PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , and PROTEIN gene products along with the AAV PROTEIN protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p1	N	We show that the HSV-1 PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN gene products along with the AAV PROTEIN protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p2	N	We show that the HSV-1 PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN gene products along with the AAV PROTEIN protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p3	N	We show that the HSV-1 PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN gene products along with the AAV PROTEIN2 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p4	N	We show that the HSV-1 PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 gene products along with the AAV PROTEIN protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p5	N	We show that the HSV-1 PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , and PROTEIN gene products along with the AAV PROTEIN protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p6	N	We show that the HSV-1 PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN gene products along with the AAV PROTEIN protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p7	N	We show that the HSV-1 PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN gene products along with the AAV PROTEIN protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p8	N	We show that the HSV-1 PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN gene products along with the AAV PROTEIN2 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p9	N	We show that the HSV-1 PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 gene products along with the AAV PROTEIN protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p10	N	We show that the HSV-1 PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN gene products along with the AAV PROTEIN protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p11	N	We show that the HSV-1 PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN gene products along with the AAV PROTEIN protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p12	N	We show that the HSV-1 PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN gene products along with the AAV PROTEIN2 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p13	N	We show that the HSV-1 PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 gene products along with the AAV PROTEIN protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p14	N	We show that the HSV-1 PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN gene products along with the AAV PROTEIN protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p15	N	We show that the HSV-1 PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN gene products along with the AAV PROTEIN2 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p16	N	We show that the HSV-1 PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 gene products along with the AAV PROTEIN protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p17	N	We show that the HSV-1 PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN gene products along with the AAV PROTEIN protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p18	N	We show that the HSV-1 PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 gene products along with the AAV PROTEIN1 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p19	N	We show that the HSV-1 PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN gene products along with the AAV PROTEIN1 protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d821.s0.p20	N	We show that the HSV-1 PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN1 gene products along with the AAV PROTEIN protein are sufficient to initiate replication on duplex DNA containing the AAV origins of replication, resulting in products several hundred nucleotides in length.
BioInfer.d822.s0.p0	P	We speculate that PROTEIN1 may help maintain the parallel growth of PROTEIN2 filaments within the stereocilia.
BioInfer.d823.s0.p0	P	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN - PROTEIN - PROTEIN2 complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN  PROTEIN1 .
BioInfer.d823.s0.p1	P	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN2  PROTEIN1 .
BioInfer.d823.s0.p2	P	Western analysis of gel-purified PROTEIN - PROTEIN2 and PROTEIN - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN  PROTEIN1 .
BioInfer.d823.s0.p3	P	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN - PROTEIN2 - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN  PROTEIN1 .
BioInfer.d823.s0.p4	N	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN2  PROTEIN relative to acetylated PROTEIN  PROTEIN1 .
BioInfer.d823.s0.p5	P	Western analysis of gel-purified PROTEIN2 - PROTEIN and PROTEIN - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN  PROTEIN1 .
BioInfer.d823.s0.p6	P	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN2 - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN  PROTEIN1 .
BioInfer.d823.s0.p7	P	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN2 relative to acetylated PROTEIN  PROTEIN1 .
BioInfer.d823.s0.p8	N	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN - PROTEIN - PROTEIN1 complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN2  PROTEIN .
BioInfer.d823.s0.p9	N	Western analysis of gel-purified PROTEIN - PROTEIN2 and PROTEIN - PROTEIN - PROTEIN1 complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p10	P	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN - PROTEIN2 - PROTEIN1 complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p11	N	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN - PROTEIN - PROTEIN1 complexes demonstrated the predominant presence of acetylated PROTEIN2  PROTEIN relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p12	N	Western analysis of gel-purified PROTEIN2 - PROTEIN and PROTEIN - PROTEIN - PROTEIN1 complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p13	P	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN2 - PROTEIN - PROTEIN1 complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p14	P	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN - PROTEIN - PROTEIN1 complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN2 relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p15	N	Western analysis of gel-purified PROTEIN - PROTEIN2 and PROTEIN - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN1  PROTEIN .
BioInfer.d823.s0.p16	N	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN - PROTEIN2 - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN1  PROTEIN .
BioInfer.d823.s0.p17	N	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN2  PROTEIN relative to acetylated PROTEIN1  PROTEIN .
BioInfer.d823.s0.p18	N	Western analysis of gel-purified PROTEIN2 - PROTEIN and PROTEIN - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN1  PROTEIN .
BioInfer.d823.s0.p19	N	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN2 - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN1  PROTEIN .
BioInfer.d823.s0.p20	N	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN2 relative to acetylated PROTEIN1  PROTEIN .
BioInfer.d823.s0.p21	N	Western analysis of gel-purified PROTEIN - PROTEIN1 and PROTEIN - PROTEIN2 - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p22	N	Western analysis of gel-purified PROTEIN - PROTEIN1 and PROTEIN - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN2  PROTEIN relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p23	P	Western analysis of gel-purified PROTEIN2 - PROTEIN1 and PROTEIN - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p24	N	Western analysis of gel-purified PROTEIN - PROTEIN1 and PROTEIN2 - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p25	P	Western analysis of gel-purified PROTEIN - PROTEIN1 and PROTEIN - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN2 relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p26	N	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN - PROTEIN1 - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN2  PROTEIN relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p27	N	Western analysis of gel-purified PROTEIN2 - PROTEIN and PROTEIN - PROTEIN1 - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p28	P	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN2 - PROTEIN1 - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p29	P	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN - PROTEIN1 - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN2 relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p30	N	Western analysis of gel-purified PROTEIN2 - PROTEIN and PROTEIN - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN1  PROTEIN relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p31	N	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN2 - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN1  PROTEIN relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p32	P	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN1  PROTEIN2 relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p33	N	Western analysis of gel-purified PROTEIN1 - PROTEIN and PROTEIN2 - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p34	P	Western analysis of gel-purified PROTEIN1 - PROTEIN and PROTEIN - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN2 relative to acetylated PROTEIN  PROTEIN .
BioInfer.d823.s0.p35	P	Western analysis of gel-purified PROTEIN - PROTEIN and PROTEIN1 - PROTEIN - PROTEIN complexes demonstrated the predominant presence of acetylated PROTEIN  PROTEIN2 relative to acetylated PROTEIN  PROTEIN .
BioInfer.d824.s0.p0	P	We studied the roles of PROTEIN2 , an PROTEIN1 -binding phosphoprotein, in superoxide production of neutrophil-like HL-60 cells triggered by opsonized zymosan (OZ).
BioInfer.d825.s0.p0	P	We suggest that the PROTEIN1 in the nodes functions, via a cross-linking activity, in the convergence of PROTEIN2 filaments at the membrane during development of the ribs.
BioInfer.d826.s0.p0	N	We tested for the presence of PROTEIN , PROTEIN , PROTEIN , PROTEIN2 (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN1 .
BioInfer.d826.s0.p1	N	We tested for the presence of PROTEIN , PROTEIN , PROTEIN2 , PROTEIN (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN1 .
BioInfer.d826.s0.p2	N	We tested for the presence of PROTEIN2 , PROTEIN , PROTEIN , PROTEIN (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN1 .
BioInfer.d826.s0.p3	N	We tested for the presence of PROTEIN , PROTEIN , PROTEIN , PROTEIN (heavy chain) and cytoskeletal proteins PROTEIN2 and PROTEIN1 .
BioInfer.d826.s0.p4	N	We tested for the presence of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN1 .
BioInfer.d826.s0.p5	N	We tested for the presence of PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN .
BioInfer.d826.s0.p6	N	We tested for the presence of PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN .
BioInfer.d826.s0.p7	N	We tested for the presence of PROTEIN , PROTEIN , PROTEIN , PROTEIN1 (heavy chain) and cytoskeletal proteins PROTEIN2 and PROTEIN .
BioInfer.d826.s0.p8	N	We tested for the presence of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN .
BioInfer.d826.s0.p9	N	We tested for the presence of PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN .
BioInfer.d826.s0.p10	N	We tested for the presence of PROTEIN , PROTEIN , PROTEIN1 , PROTEIN (heavy chain) and cytoskeletal proteins PROTEIN2 and PROTEIN .
BioInfer.d826.s0.p11	N	We tested for the presence of PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN .
BioInfer.d826.s0.p12	N	We tested for the presence of PROTEIN1 , PROTEIN , PROTEIN , PROTEIN (heavy chain) and cytoskeletal proteins PROTEIN2 and PROTEIN .
BioInfer.d826.s0.p13	N	We tested for the presence of PROTEIN1 , PROTEIN2 , PROTEIN , PROTEIN (heavy chain) and cytoskeletal proteins PROTEIN and PROTEIN .
BioInfer.d826.s0.p14	N	We tested for the presence of PROTEIN , PROTEIN2 , PROTEIN , PROTEIN (heavy chain) and cytoskeletal proteins PROTEIN1 and PROTEIN .
BioInfer.d827.s0.p0	N	We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN1 or PROTEIN to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d827.s0.p1	N	We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN1 or PROTEIN2 to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d827.s0.p2	N	We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN1 or PROTEIN to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d827.s0.p3	N	We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN1 or PROTEIN to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d827.s0.p4	N	We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN1 or PROTEIN to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d827.s0.p5	N	We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN or PROTEIN2 to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN .
BioInfer.d827.s0.p6	N	We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN or PROTEIN to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN1 , PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d827.s0.p7	N	We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN or PROTEIN to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d827.s0.p8	N	We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN or PROTEIN to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d827.s0.p9	N	We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN or PROTEIN1 to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN .
BioInfer.d827.s0.p10	N	We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN or PROTEIN1 to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN .
BioInfer.d827.s0.p11	N	We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN or PROTEIN1 to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 .
BioInfer.d827.s0.p12	N	We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN or PROTEIN to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN .
BioInfer.d827.s0.p13	N	We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN or PROTEIN to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 .
BioInfer.d827.s0.p14	N	We then compared colorectal cancers with 'mild' RER (n = 15), and those with 'severe' RER without (n = 11) or with (n = 22) detectable mutations in PROTEIN or PROTEIN to assess the involvement of mononucleotide repeats contained in the coding regions of PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN2 .
BioInfer.d828.s0.p0	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , did not rescue PROTEIN2 delta O6 MeG DNA repair PROTEIN1 -deficient cells from killing by MNNG.
BioInfer.d828.s0.p1	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , did not rescue PROTEIN delta O6 MeG DNA repair PROTEIN1 -deficient cells from killing by MNNG.
BioInfer.d828.s0.p2	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , did not rescue PROTEIN delta O6 MeG DNA repair PROTEIN1 -deficient cells from killing by MNNG.
BioInfer.d828.s0.p3	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , did not rescue PROTEIN delta O6 MeG DNA repair PROTEIN1 -deficient cells from killing by MNNG.
BioInfer.d828.s0.p4	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , did not rescue PROTEIN delta O6 MeG DNA repair PROTEIN1 -deficient cells from killing by MNNG.
BioInfer.d828.s0.p5	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , did not rescue PROTEIN delta O6 MeG DNA repair PROTEIN1 -deficient cells from killing by MNNG.
BioInfer.d828.s0.p6	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , and PROTEIN , did not rescue PROTEIN1 delta O6 MeG DNA repair PROTEIN -deficient cells from killing by MNNG.
BioInfer.d828.s0.p7	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN , PROTEIN , PROTEIN , PROTEIN , and PROTEIN2 , did not rescue PROTEIN1 delta O6 MeG DNA repair PROTEIN -deficient cells from killing by MNNG.
BioInfer.d828.s0.p8	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN , did not rescue PROTEIN1 delta O6 MeG DNA repair PROTEIN -deficient cells from killing by MNNG.
BioInfer.d828.s0.p9	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN , did not rescue PROTEIN1 delta O6 MeG DNA repair PROTEIN -deficient cells from killing by MNNG.
BioInfer.d828.s0.p10	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN , did not rescue PROTEIN1 delta O6 MeG DNA repair PROTEIN -deficient cells from killing by MNNG.
BioInfer.d828.s0.p11	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN2 , did not rescue PROTEIN delta O6 MeG DNA repair PROTEIN -deficient cells from killing by MNNG.
BioInfer.d828.s0.p12	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , and PROTEIN , did not rescue PROTEIN delta O6 MeG DNA repair PROTEIN -deficient cells from killing by MNNG.
BioInfer.d828.s0.p13	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , and PROTEIN , did not rescue PROTEIN delta O6 MeG DNA repair PROTEIN -deficient cells from killing by MNNG.
BioInfer.d828.s0.p14	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , and PROTEIN , did not rescue PROTEIN delta O6 MeG DNA repair PROTEIN -deficient cells from killing by MNNG.
BioInfer.d828.s0.p15	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , and PROTEIN1 , did not rescue PROTEIN delta O6 MeG DNA repair PROTEIN -deficient cells from killing by MNNG.
BioInfer.d828.s0.p16	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN , PROTEIN , PROTEIN2 , PROTEIN , and PROTEIN1 , did not rescue PROTEIN delta O6 MeG DNA repair PROTEIN -deficient cells from killing by MNNG.
BioInfer.d828.s0.p17	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , and PROTEIN1 , did not rescue PROTEIN delta O6 MeG DNA repair PROTEIN -deficient cells from killing by MNNG.
BioInfer.d828.s0.p18	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN , and PROTEIN , did not rescue PROTEIN delta O6 MeG DNA repair PROTEIN -deficient cells from killing by MNNG.
BioInfer.d828.s0.p19	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , and PROTEIN , did not rescue PROTEIN delta O6 MeG DNA repair PROTEIN -deficient cells from killing by MNNG.
BioInfer.d828.s0.p20	N	We used yeast as a model to test this hypothesis and found that chromosome deletion of any known nuclear mitotic mismatch repair genes, including PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , and PROTEIN , did not rescue PROTEIN delta O6 MeG DNA repair PROTEIN -deficient cells from killing by MNNG.
BioInfer.d829.s0.p0	N	When a lyophilized Mf and AO mixture was incubated at 40 degrees C and 65% relative humidity, the conjugation of AO was confirmed at PROTEIN , PROTEIN2 , and PROTEIN1 .
BioInfer.d829.s0.p1	N	When a lyophilized Mf and AO mixture was incubated at 40 degrees C and 65% relative humidity, the conjugation of AO was confirmed at PROTEIN2 , PROTEIN , and PROTEIN1 .
BioInfer.d829.s0.p2	N	When a lyophilized Mf and AO mixture was incubated at 40 degrees C and 65% relative humidity, the conjugation of AO was confirmed at PROTEIN2 , PROTEIN1 , and PROTEIN .
BioInfer.d830.s0.p0	N	When the PROTEIN monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of PROTEIN1 and PROTEIN are down-regulated compared with PROTEIN2 and 19 other proteins selected at random.
BioInfer.d830.s0.p1	N	When the PROTEIN2 monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of PROTEIN1 and PROTEIN are down-regulated compared with PROTEIN and 19 other proteins selected at random.
BioInfer.d830.s0.p2	N	When the PROTEIN monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of PROTEIN1 and PROTEIN2 are down-regulated compared with PROTEIN and 19 other proteins selected at random.
BioInfer.d830.s0.p3	N	When the PROTEIN2 monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of PROTEIN and PROTEIN are down-regulated compared with PROTEIN1 and 19 other proteins selected at random.
BioInfer.d830.s0.p4	N	When the PROTEIN monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of PROTEIN and PROTEIN2 are down-regulated compared with PROTEIN1 and 19 other proteins selected at random.
BioInfer.d830.s0.p5	N	When the PROTEIN1 monomer pool in untransfected myoblasts is increased 70% by treatment with latrunculin A, synthesis of PROTEIN and PROTEIN2 are down-regulated compared with PROTEIN and 19 other proteins selected at random.
BioInfer.d831.s0.p0	N	While levels of most of these proteins decrease, accumulation of PROTEIN and the PROTEIN  PROTEIN2  PROTEIN / PROTEIN1 is observed.
BioInfer.d831.s0.p1	N	While levels of most of these proteins decrease, accumulation of PROTEIN2 and the PROTEIN  PROTEIN  PROTEIN / PROTEIN1 is observed.
BioInfer.d831.s0.p2	P	While levels of most of these proteins decrease, accumulation of PROTEIN and the PROTEIN2  PROTEIN  PROTEIN / PROTEIN1 is observed.
BioInfer.d831.s0.p3	N	While levels of most of these proteins decrease, accumulation of PROTEIN and the PROTEIN  PROTEIN  PROTEIN2 / PROTEIN1 is observed.
BioInfer.d831.s0.p4	N	While levels of most of these proteins decrease, accumulation of PROTEIN2 and the PROTEIN  PROTEIN1  PROTEIN / PROTEIN is observed.
BioInfer.d831.s0.p5	P	While levels of most of these proteins decrease, accumulation of PROTEIN and the PROTEIN2  PROTEIN1  PROTEIN / PROTEIN is observed.
BioInfer.d831.s0.p6	N	While levels of most of these proteins decrease, accumulation of PROTEIN and the PROTEIN  PROTEIN1  PROTEIN2 / PROTEIN is observed.
BioInfer.d831.s0.p7	N	While levels of most of these proteins decrease, accumulation of PROTEIN1 and the PROTEIN2  PROTEIN  PROTEIN / PROTEIN is observed.
BioInfer.d831.s0.p8	N	While levels of most of these proteins decrease, accumulation of PROTEIN1 and the PROTEIN  PROTEIN  PROTEIN2 / PROTEIN is observed.
BioInfer.d831.s0.p9	P	While levels of most of these proteins decrease, accumulation of PROTEIN and the PROTEIN1  PROTEIN  PROTEIN2 / PROTEIN is observed.
BioInfer.d832.s0.p0	P	While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN  PROTEIN , it equally competed with DNA for binding of PROTEIN1  PROTEIN2 and only inefficiently competed with DNA for binding of PROTEIN  PROTEIN .
BioInfer.d832.s0.p1	N	While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN  PROTEIN , it equally competed with DNA for binding of PROTEIN1  PROTEIN and only inefficiently competed with DNA for binding of PROTEIN2  PROTEIN .
BioInfer.d832.s0.p2	N	While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN2  PROTEIN , it equally competed with DNA for binding of PROTEIN1  PROTEIN and only inefficiently competed with DNA for binding of PROTEIN  PROTEIN .
BioInfer.d832.s0.p3	N	While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN  PROTEIN2 , it equally competed with DNA for binding of PROTEIN1  PROTEIN and only inefficiently competed with DNA for binding of PROTEIN  PROTEIN .
BioInfer.d832.s0.p4	N	While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN  PROTEIN , it equally competed with DNA for binding of PROTEIN1  PROTEIN and only inefficiently competed with DNA for binding of PROTEIN  PROTEIN2 .
BioInfer.d832.s0.p5	N	While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN  PROTEIN , it equally competed with DNA for binding of PROTEIN  PROTEIN1 and only inefficiently competed with DNA for binding of PROTEIN2  PROTEIN .
BioInfer.d832.s0.p6	N	While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN2  PROTEIN , it equally competed with DNA for binding of PROTEIN  PROTEIN1 and only inefficiently competed with DNA for binding of PROTEIN  PROTEIN .
BioInfer.d832.s0.p7	N	While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN  PROTEIN2 , it equally competed with DNA for binding of PROTEIN  PROTEIN1 and only inefficiently competed with DNA for binding of PROTEIN  PROTEIN .
BioInfer.d832.s0.p8	N	While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN  PROTEIN , it equally competed with DNA for binding of PROTEIN  PROTEIN1 and only inefficiently competed with DNA for binding of PROTEIN  PROTEIN2 .
BioInfer.d832.s0.p9	N	While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN2  PROTEIN , it equally competed with DNA for binding of PROTEIN  PROTEIN and only inefficiently competed with DNA for binding of PROTEIN1  PROTEIN .
BioInfer.d832.s0.p10	N	While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN  PROTEIN2 , it equally competed with DNA for binding of PROTEIN  PROTEIN and only inefficiently competed with DNA for binding of PROTEIN1  PROTEIN .
BioInfer.d832.s0.p11	P	While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN  PROTEIN , it equally competed with DNA for binding of PROTEIN  PROTEIN and only inefficiently competed with DNA for binding of PROTEIN1  PROTEIN2 .
BioInfer.d832.s0.p12	P	While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN1  PROTEIN2 , it equally competed with DNA for binding of PROTEIN  PROTEIN and only inefficiently competed with DNA for binding of PROTEIN  PROTEIN .
BioInfer.d832.s0.p13	N	While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN1  PROTEIN , it equally competed with DNA for binding of PROTEIN  PROTEIN and only inefficiently competed with DNA for binding of PROTEIN  PROTEIN2 .
BioInfer.d832.s0.p14	N	While poly(ADP-ribose) effectively competed with DNA for binding of PROTEIN  PROTEIN1 , it equally competed with DNA for binding of PROTEIN  PROTEIN and only inefficiently competed with DNA for binding of PROTEIN  PROTEIN2 .
BioInfer.d833.s0.p0	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p1	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN2 and PROTEIN , did not.
BioInfer.d833.s0.p2	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN2 , did not.
BioInfer.d833.s0.p3	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p4	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN2 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p5	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p6	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p7	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p8	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN2 and PROTEIN , did not.
BioInfer.d833.s0.p9	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN2 , did not.
BioInfer.d833.s0.p10	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p11	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p12	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p13	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p14	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN2 , PROTEIN , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p15	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN1 and PROTEIN2 , did not.
BioInfer.d833.s0.p16	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN1 and PROTEIN , did not.
BioInfer.d833.s0.p17	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN1 and PROTEIN , did not.
BioInfer.d833.s0.p18	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN1 and PROTEIN , did not.
BioInfer.d833.s0.p19	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN1 and PROTEIN , did not.
BioInfer.d833.s0.p20	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN1 and PROTEIN , did not.
BioInfer.d833.s0.p21	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN1 , did not.
BioInfer.d833.s0.p22	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN2 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN1 , did not.
BioInfer.d833.s0.p23	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN1 , did not.
BioInfer.d833.s0.p24	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN1 , did not.
BioInfer.d833.s0.p25	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN1 , did not.
BioInfer.d833.s0.p26	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN2 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p27	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN2 and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p28	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p29	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p30	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN2 and PROTEIN1 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p31	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p32	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN1 appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p33	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN , PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p34	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN2 , PROTEIN , PROTEIN , PROTEIN , PROTEIN , PROTEIN1 and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d833.s0.p35	P	Within 1 hour of raising the concentration of calcium ions, PROTEIN2 , PROTEIN1 , PROTEIN , PROTEIN , PROTEIN , PROTEIN and PROTEIN appeared to accumulate at cell-cell borders, whereas the focal contact proteins, PROTEIN and PROTEIN , did not.
BioInfer.d834.s0.p0	N	Within the sieve-tube exudate, PROTEIN1 was present in 15-fold molar excess to PROTEIN2 .
BioInfer.d835.s0.p0	N	YACs containing PROTEIN2 gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the PROTEIN , PROTEIN , PROTEIN , or PROTEIN1 loci.
BioInfer.d835.s0.p1	N	YACs containing PROTEIN gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the PROTEIN , PROTEIN2 , PROTEIN , or PROTEIN1 loci.
BioInfer.d835.s0.p2	N	YACs containing PROTEIN gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the PROTEIN , PROTEIN , PROTEIN2 , or PROTEIN1 loci.
BioInfer.d835.s0.p3	N	YACs containing PROTEIN gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the PROTEIN2 , PROTEIN , PROTEIN , or PROTEIN1 loci.
BioInfer.d835.s0.p4	N	YACs containing PROTEIN1 gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the PROTEIN , PROTEIN2 , PROTEIN , or PROTEIN loci.
BioInfer.d835.s0.p5	N	YACs containing PROTEIN1 gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the PROTEIN , PROTEIN , PROTEIN2 , or PROTEIN loci.
BioInfer.d835.s0.p6	N	YACs containing PROTEIN1 gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the PROTEIN2 , PROTEIN , PROTEIN , or PROTEIN loci.
BioInfer.d835.s0.p7	N	YACs containing PROTEIN gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the PROTEIN , PROTEIN1 , PROTEIN2 , or PROTEIN loci.
BioInfer.d835.s0.p8	N	YACs containing PROTEIN gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the PROTEIN2 , PROTEIN1 , PROTEIN , or PROTEIN loci.
BioInfer.d835.s0.p9	N	YACs containing PROTEIN gene DNA or 1.5 rDNA tandem repeat units were transformed into hosts bearing lesions at the PROTEIN2 , PROTEIN , PROTEIN1 , or PROTEIN loci.
